<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33125495</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>e2022398</StartPage><MedlinePgn>e2022398</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2022398</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2020.22398</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Acetaminophen (paracetamol) and ibuprofen are the most widely prescribed and available over-the-counter medications for management of fever and pain in children. Despite the common use of these medications, treatment recommendations for young children remain divergent.</AbstractText><AbstractText Label="OBJECTIVE">To compare acetaminophen with ibuprofen for the short-term treatment of fever or pain in children younger than 2 years.</AbstractText><AbstractText Label="DATA SOURCES">Systematic search of the databases MEDLINE, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials and the trial registers ClinicalTrials.gov and the Australian New Zealand Clinical Trials Registry from inception to March 2019, with no language limits.</AbstractText><AbstractText Label="STUDY SELECTION">Studies of any design that included children younger than 2 years and directly compared acetaminophen with ibuprofen, reporting antipyretic, analgesic, and/or safety outcomes were considered. There were no limits on length of follow-up.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS">Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline, 2 authors independently extracted data and assessed quality. Data were pooled using a fixed-effects method if I2 was less than 50% and using a random-effects method if I2 was 50% or greater.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcomes were fever or pain within 4 hours of treatment onset. Safety outcomes included serious adverse events, kidney impairment, gastrointestinal bleeding, hepatotoxicity, severe soft tissue infection, empyema, and asthma and/or wheeze.</AbstractText><AbstractText Label="RESULTS">Overall, 19 studies (11 randomized; 8 nonrandomized) of 241&#x202f;138 participants from 7 countries and various health care settings (hospital-based and community-based) were included. Compared with acetaminophen, ibuprofen resulted in reduced temperature at less than 4 hours (4 studies with 435 participants; standardized mean difference [SMD], 0.38; 95% CI, 0.08-0.67; P&#x2009;=&#x2009;.01; I2&#x2009;=&#x2009;49%; moderate quality evidence) and at 4 to 24 hours (5 studies with 879 participants; SMD, 0.24; 95% CI, 0.03-0.45; P&#x2009;=&#x2009;.03; I2&#x2009;=&#x2009;57%; moderate-quality evidence) and less pain at 4 to 24 hours (2 studies with 535 participants; SMD, 0.20; 95% CI, 0.03-0.37; P&#x2009;=&#x2009;.02; I2&#x2009;=&#x2009;25%; moderate-quality evidence). Adverse events were uncommon. Acetaminophen and ibuprofen appeared to have similar serious adverse event profiles (7 studies with 27&#x202f;932 participants; ibuprofen vs aceteminophen: odds ratio, 1.08; 95% CI, 0.87-1.33; P&#x2009;=&#x2009;.50, I2&#x2009;=&#x2009;0%; moderate-quality evidence).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study, use of ibuprofen vs acetaminophen for the treatment of fever or pain in children younger than 2 years was associated with reduced temperature and less pain within the first 24 hours of treatment, with equivalent safety.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eunicia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braithwaite</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinlay</LastName><ForeName>Christopher J D</ForeName><Initials>CJD</Initials><AffiliationInfo><Affiliation>Liggins Institute, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidz First Neonatal Care, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalziel</LastName><ForeName>Stuart R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Emergency Department, Starship Children's Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>WK2XYI10QM</RegistryNumber><NameOfSubstance UI="D007052">Ibuprofen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007052" MajorTopicYN="N">Ibuprofen</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Dalziel reported receiving grants from the Health Research Council of New Zealand, Cure Kids New Zealand, and National Health and Medical Research Council (Australia) and receiving support for attendance at meetings from Fisher and Paykel Healthcare outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>30</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>10</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33125495</ArticleId><ArticleId IdType="pmc">PMC7599455</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.22398</ArticleId><ArticleId IdType="pii">2772373</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morton SMB, Atatoa Carr PE, Grant CC, et al. . Cohort profile: growing up in New Zealand. Int J Epidemiol. 2013;42(1):65-75. doi:10.1093/ije/dyr206</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr206</ArticleId><ArticleId IdType="pubmed">22253317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziesenitz VC, Zutter A, Erb TO, van den Anker JN. Efficacy and safety of ibuprofen in infants aged between 3 and 6 months. Paediatr Drugs. 2017;19(4):277-290. doi:10.1007/s40272-017-0235-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40272-017-0235-3</ArticleId><ArticleId IdType="pubmed">28516288</ArticleId></ArticleIdList></Reference><Reference><Citation>New Zealand Formulary. New Zealand Formulary for Children. Accessed September 1, 2017. https://nzfchildren.org.nz</Citation></Reference><Reference><Citation>Joint Formulary Committee  British National Formulary for children. Accessed August 10, 2020. https://bnfc.nice.org.uk</Citation></Reference><Reference><Citation>Harriet Lane Service (Johns Hopkins Hospital) The Harriet Lane Handbook: A Manual for Pediatric House Officers. 21st ed. Hughes HK, Kahl LK, eds. Elsevier; 2018.</Citation></Reference><Reference><Citation>de Martino M, Chiarugi A, Boner A, Montini G, De&#x2019; Angelis GL. Working towards an appropriate use of ibuprofen in children: an evidence-based appraisal. Drugs. 2017;77(12):1295-1311. doi:10.1007/s40265-017-0751-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-017-0751-z</ArticleId><ArticleId IdType="pmc">PMC5529476</ArticleId><ArticleId IdType="pubmed">28597358</ArticleId></ArticleIdList></Reference><Reference><Citation>Misurac JM, Knoderer CA, Leiser JD, Nailescu C, Wilson AC, Andreoli SP. Nonsteroidal anti-inflammatory drugs are an important cause of acute kidney injury in children. J Pediatr. 2013;162(6):1153-1159, 1159.e1. doi:10.1016/j.jpeds.2012.11.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2012.11.069</ArticleId><ArticleId IdType="pubmed">23360563</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestracci A, Ezquer M, Elmo ME, et al. . Ibuprofen-associated acute kidney injury in dehydrated children with acute gastroenteritis. Pediatr Nephrol. 2015;30(10):1873-1878. doi:10.1007/s00467-015-3105-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-015-3105-7</ArticleId><ArticleId IdType="pubmed">25895445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesko SM, O&#x2019;Brien KL, Schwartz B, Vezina R, Mitchell AA. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics. 2001;107(5):1108-1115. doi:10.1542/peds.107.5.1108</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.107.5.1108</ArticleId><ArticleId IdType="pubmed">11331694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikaeloff Y, Kezouh A, Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol. 2008;65(2):203-209. doi:10.1111/j.1365-2125.2007.02997.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2007.02997.x</ArticleId><ArticleId IdType="pmc">PMC2291221</ArticleId><ArticleId IdType="pubmed">18251759</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubos F, Hue V, Grandbastien B, Catteau B, Martinot A. Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs? Acta Derm Venereol. 2008;88(1):26-30. doi:10.2340/00015555-0333</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/00015555-0333</ArticleId><ArticleId IdType="pubmed">18176746</ArticleId></ArticleIdList></Reference><Reference><Citation>Souyri C, Olivier P, Grolleau S, Lapeyre-Mestre M; French Network of Pharmacovigilance Centres . Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol. 2008;33(3):249-255. doi:10.1111/j.1365-2230.2007.02652.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2230.2007.02652.x</ArticleId><ArticleId IdType="pubmed">18261144</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bourgeois M, Ferroni A, Leruez-Ville M, et al. ; Children, Antibiotics, Nonsteroidal Anti-inflammatory Drugs and Childhood Empyema (ChANCE) Study Group . Nonsteroidal anti-inflammatory drug without antibiotics for acute viral infection increases the empyema risk in children: a matched case-control study. J Pediatr. 2016;175:47-53.e3. doi:10.1016/j.jpeds.2016.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2016.05.025</ArticleId><ArticleId IdType="pmc">PMC7094675</ArticleId><ArticleId IdType="pubmed">27339249</ArticleId></ArticleIdList></Reference><Reference><Citation>Byington CL, Spencer LY, Johnson TA, et al. . An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34(4):434-440. doi:10.1086/338460</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338460</ArticleId><ArticleId IdType="pubmed">11797168</ArticleId></ArticleIdList></Reference><Reference><Citation>Elemraid MA, Thomas MF, Blain AP, et al. ; North East of England Pediatric Respiratory Infection Study Group Newcastle upon Tyne, UK . Risk factors for the development of pleural empyema in children. Pediatr Pulmonol. 2015;50(7):721-726. doi:10.1002/ppul.23041</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.23041</ArticleId><ArticleId IdType="pubmed">24692118</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois P, Desrumaux A, Cans C, Pin I, Pavese P, Labar&#xe8;re J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr. 2010;99(6):861-866. doi:10.1111/j.1651-2227.2010.01734.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2010.01734.x</ArticleId><ArticleId IdType="pubmed">20178517</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman RD. Efficacy and safety of acetaminophen versus ibuprofen for treating children&#x2019;s pain or fever: a meta-analysis. J Pediatr. 2005;146(1):142-143. doi:10.1016/j.jpeds.2004.10.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2004.10.029</ArticleId><ArticleId IdType="pubmed">15644842</ArticleId></ArticleIdList></Reference><Reference><Citation>Etminan M, Sadatsafavi M, Jafari S, Doyle-Waters M, Aminzadeh K, FitzGerald JM. Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest. 2009;136(5):1316-1323. doi:10.1378/chest.09-0865</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.09-0865</ArticleId><ArticleId IdType="pubmed">19696122</ArticleId></ArticleIdList></Reference><Reference><Citation>Beasley R, Clayton T, Crane J, et al. ; ISAAC Phase Three Study Group . Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from phase three of the ISAAC programme. Lancet. 2008;372(9643):1039-1048. doi:10.1016/S0140-6736(08)61445-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)61445-2</ArticleId><ArticleId IdType="pubmed">18805332</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Marcos L, Sanchez-Solis M, Perez-Fernandez V. Early exposure to acetaminophen and allergic disorders. Curr Opin Allergy Clin Immunol. 2011;11(3):162-173. doi:10.1097/ACI.0b013e3283464c28</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACI.0b013e3283464c28</ArticleId><ArticleId IdType="pubmed">21505328</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanabar D, Dale S, Rawat M. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms. Clin Ther. 2007;29(12):2716-2723. doi:10.1016/j.clinthera.2007.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2007.12.021</ArticleId><ArticleId IdType="pubmed">18201589</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman RD, Ko K, Linett LJ, Scolnik D. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann Pharmacother. 2004;38(1):146-150. doi:10.1345/aph.1C391</Citation><ArticleIdList><ArticleId IdType="doi">10.1345/aph.1C391</ArticleId><ArticleId IdType="pubmed">14742809</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children&#x2019;s pain or fever: a meta-analysis. Arch Pediatr Adolesc Med. 2004;158(6):521-526. doi:10.1001/archpedi.158.6.521</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.158.6.521</ArticleId><ArticleId IdType="pubmed">15184213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother. 2010;44(3):489-506. doi:10.1345/aph.1M332</Citation><ArticleIdList><ArticleId IdType="doi">10.1345/aph.1M332</ArticleId><ArticleId IdType="pubmed">20150507</ArticleId></ArticleIdList></Reference><Reference><Citation>Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009;25(9):2207-2222. doi:10.1185/03007990903116255</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007990903116255</ArticleId><ArticleId IdType="pubmed">19606950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, et al. . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Balshem H, Helfand M, Sch&#xfc;nemann HJ, et al. . GRADE guidelines: 3. rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-406. doi:10.1016/j.jclinepi.2010.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.07.015</ArticleId><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoylar S, Ak&#x15f;it S, Ca&#x11f;layan S, Yaprak I, Bakiler R, Cetin F. Evaluation of sponging and antipyretic medication to reduce body temperature in febrile children. Acta Paediatr Jpn. 1997;39(2):215-217. doi:10.1111/j.1442-200X.1997.tb03584.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200X.1997.tb03584.x</ArticleId><ArticleId IdType="pubmed">9141257</ArticleId></ArticleIdList></Reference><Reference><Citation>Autret E, Breart G, Jonville AP, Courcier S, Lassale C, Goehrs JM. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. Eur J Clin Pharmacol. 1994;46(3):197-201. doi:10.1007/BF00192548</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00192548</ArticleId><ArticleId IdType="pubmed">8070499</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan WJ, Mauger DT, Paul IM, et al. ; NIH/NHLBI AsthmaNet . Acetaminophen versus ibuprofen in young children with mild persistent asthma. N Engl J Med. 2016;375(7):619-630. doi:10.1056/NEJMoa1515990</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1515990</ArticleId><ArticleId IdType="pmc">PMC5085065</ArticleId><ArticleId IdType="pubmed">27532828</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Esch A, Van Steensel-Moll HA, Steyerberg EW, Offringa M, Habbema JD, Derksen-Lubsen G. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 1995;149(6):632-637. doi:10.1001/archpedi.1995.02170190042007</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1995.02170190042007</ArticleId><ArticleId IdType="pubmed">7767417</ArticleId></ArticleIdList></Reference><Reference><Citation>Autret E, Reboul-Marty J, Henry-Launois B, et al. . Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. Eur J Clin Pharmacol. 1997;51(5):367-371. doi:10.1007/s002280050215</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002280050215</ArticleId><ArticleId IdType="pubmed">9049576</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlewyn-Lajeunesse MDS, Coppens K, Hunt LP, et al. . Randomised controlled trial of combined paracetamol and ibuprofen for fever. Arch Dis Child. 2006;91(5):414-416. doi:10.1136/adc.2005.087874</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2005.087874</ArticleId><ArticleId IdType="pmc">PMC2082718</ArticleId><ArticleId IdType="pubmed">16464962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Costelloe C, Redmond NM, et al. . Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ. 2008;337:a1302. doi:10.1136/bmj.a1302</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.a1302</ArticleId><ArticleId IdType="pmc">PMC2528896</ArticleId><ArticleId IdType="pubmed">18765450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokki H, Kokki M. Ketoprofen versus paracetamol (acetaminophen) or ibuprofen in the management of fever: results of two randomized, double-blind, double-dummy, parallel-group, repeated-dose, multicentre, phase III studies in children. Clin Drug Investig. 2010;30(6):375-386. doi:10.1007/BF03256907</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03256907</ArticleId><ArticleId IdType="pubmed">20380479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics. 1997;100(6):954-957. doi:10.1542/peds.100.6.954</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.100.6.954</ArticleId><ArticleId IdType="pubmed">9374563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics. 1999;104(4):e39. doi:10.1542/peds.104.4.e39</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.104.4.e39</ArticleId><ArticleId IdType="pubmed">10506264</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre J, Hull D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. Arch Dis Child. 1996;74(2):164-167. doi:10.1136/adc.74.2.164</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.74.2.164</ArticleId><ArticleId IdType="pmc">PMC1511501</ArticleId><ArticleId IdType="pubmed">8660083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrell EM, Wielunsky E, Cohen HA. Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Arch Pediatr Adolesc Med. 2006;160(2):197-202. doi:10.1001/archpedi.160.2.197</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.160.2.197</ArticleId><ArticleId IdType="pubmed">16461878</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf E, Ford L, Geetha R, Cooper S. Safety profile of ibuprofen suspension in young children. Inflammopharmacology. 1999;7(3):219-225. doi:10.1007/s10787-999-0005-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-999-0005-0</ArticleId><ArticleId IdType="pubmed">17638093</ArticleId></ArticleIdList></Reference><Reference><Citation>Asl AH, Samei P, Hosseini AH. Acetaminophen and ibuprofen in controlling fever and preventing convulsion in children with febrile seizure. J Compr Pediatr. 2015;6(1):e25954. doi:10.17795/compreped-25954</Citation><ArticleIdList><ArticleId IdType="doi">10.17795/compreped-25954</ArticleId></ArticleIdList></Reference><Reference><Citation>Celebi S, Hacimustafaoglu M, Aygun D, et al. . Antipyretic effect of ketoprofen. Indian J Pediatr. 2009;76(3):287-291. doi:10.1007/s12098-008-0234-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-008-0234-z</ArticleId><ArticleId IdType="pubmed">19129989</ArticleId></ArticleIdList></Reference><Reference><Citation>Matok I, Elizur A, Perlman A, Ganor S, Levine H, Kozer E. Association of acetaminophen and ibuprofen use with wheezing in children with acute febrile illness. Ann Pharmacother. 2017;51(3):239-244. doi:10.1177/1060028016678006</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028016678006</ArticleId><ArticleId IdType="pubmed">27794128</ArticleId></ArticleIdList></Reference><Reference><Citation>Sordillo JE, Scirica CV, Rifas-Shiman SL, et al. . Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. J Allergy Clin Immunol. 2015;135(2):441-448. doi:10.1016/j.jaci.2014.07.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.07.065</ArticleId><ArticleId IdType="pmc">PMC4323723</ArticleId><ArticleId IdType="pubmed">25441647</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh P, Rothenberg SJ. Wheezing after the use of acetaminophen and or ibuprofen for first episode of bronchiolitis or respiratory tract infection. PLoS One. 2018;13(9):e0203770. doi:10.1371/journal.pone.0203770</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0203770</ArticleId><ArticleId IdType="pmc">PMC6136746</ArticleId><ArticleId IdType="pubmed">30212517</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh P, Rothenberg SJ, Bang H. Safety of ibuprofen in infants younger than six months: A retrospective cohort study. PLoS One. 2018;13(6):e0199493. doi:10.1371/journal.pone.0199493</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0199493</ArticleId><ArticleId IdType="pmc">PMC6023220</ArticleId><ArticleId IdType="pubmed">29953460</ArticleId></ArticleIdList></Reference><Reference><Citation>Oken E, Baccarelli AA, Gold DR, et al. . Cohort profile: Project Viva. Int J Epidemiol. 2015;44(1):37-48. doi:10.1093/ije/dyu008</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu008</ArticleId><ArticleId IdType="pmc">PMC4339753</ArticleId><ArticleId IdType="pubmed">24639442</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan JE, Farrar HC; Section on Clinical Pharmacology and Therapeutics; Committee on Drugs . Fever and antipyretic use in children. Pediatrics. 2011;127(3):580-587. doi:10.1542/peds.2010-3852</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-3852</ArticleId><ArticleId IdType="pubmed">21357332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA. 1995;273(12):929-933. doi:10.1001/jama.1995.03520360043037</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03520360043037</ArticleId><ArticleId IdType="pubmed">7884951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. 2015;18(2):CD003481. doi:10.1002/14651858.CD003481.pub6</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003481.pub6</ArticleId><ArticleId IdType="pubmed">25692606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020;1:CD010061. doi:10.1002/14651858.CD010061.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010061.pub4</ArticleId><ArticleId IdType="pmc">PMC6984659</ArticleId><ArticleId IdType="pubmed">31985831</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy S, Mosca A, Landre-Peigne C, Cosson MA, Pons G. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr. 2007;14(5):477-484. doi:10.1016/j.arcped.2007.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcped.2007.01.012</ArticleId><ArticleId IdType="pubmed">17344039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20816545</PMID><DateCompleted><Year>2010</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>376</Volume><Issue>9743</Issue><PubDate><Year>2010</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study.</ArticleTitle><Pagination><StartPage>773</StartPage><EndPage>783</EndPage><MedlinePgn>773-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(10)61193-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative respiratory adverse events in children are one of the major causes of morbidity and mortality during paediatric anaesthesia. We aimed to identify associations between family history, anaesthesia management, and occurrence of perioperative respiratory adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We prospectively included all children who had general anaesthesia for surgical or medical interventions, elective or urgent procedures at Princess Margaret Hospital for Children, Perth, Australia, from Feb 1, 2007, to Jan 31, 2008. On the day of surgery, anaesthetists in charge of paediatric patients completed an adapted version of the International Study Group for Asthma and Allergies in Childhood questionnaire. We collected data on family medical history of asthma, atopy, allergy, upper respiratory tract infection, and passive smoking. Anaesthesia management and all perioperative respiratory adverse events were recorded.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">9297 questionnaires were available for analysis. A positive respiratory history (nocturnal dry cough, wheezing during exercise, wheezing more than three times in the past 12 months, or a history of present or past eczema) was associated with an increased risk for bronchospasm (relative risk [RR] 8.46, 95% CI 6.18-11.59; p&lt;0.0001), laryngospasm (4.13, 3.37-5.08; p&lt;0.0001), and perioperative cough, desaturation, or airway obstruction (3.05, 2.76-3.37; p&lt;0.0001). Upper respiratory tract infection was associated with an increased risk for perioperative respiratory adverse events only when symptoms were present (RR 2.05, 95% CI 1.82-2.31; p&lt;0.0001) or less than 2 weeks before the procedure (2.34, 2.07-2.66; p&lt;0.0001), whereas symptoms of upper respiratory tract infection 2-4 weeks before the procedure significantly lowered the incidence of perioperative respiratory adverse events (0.66, 0.53-0.81; p&lt;0.0001). A history of at least two family members having asthma, atopy, or smoking increased the risk for perioperative respiratory adverse events (all p&lt;0.0001). Risk was lower with intravenous induction compared with inhalational induction (all p&lt;0.0001), inhalational compared with intravenous maintenance of anaesthesia (all p&lt;0.0001), airway management by a specialist paediatric anaesthetist compared with a registrar (all p&lt;0.0001), and use of face mask compared with tracheal intubation (all p&lt;0.0001).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Children at high risk for perioperative respiratory adverse events could be systematically identified at the preanaesthetic assessment and thus can benefit from a specifically targeted anaesthesia management.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Department of Anaesthesia, Princess Margaret Hospital for Children, Swiss Foundation for Grants in Biology and Medicine, and the Voluntary Academic Society Basel.</AbstractText><CopyrightInformation>Copyright 2010 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Princess Margaret Hospital for Children, Perth, WA, Australia. bvonungern@uhbs.ch</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boda</LastName><ForeName>Krisztina</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Chambers</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials></Author><Author ValidYN="Y"><LastName>Rebmann</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sly</LastName><ForeName>Peter D</ForeName><Initials>PD</Initials></Author><Author ValidYN="Y"><LastName>Habre</LastName><ForeName>Walid</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018681">Anesthetics, General</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014028">Tobacco Smoke Pollution</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2010 Sep 4;376(9743):745-6. doi: 10.1016/S0140-6736(10)61199-3.</RefSource><PMID Version="1">20816527</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="N">Airway Obstruction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018681" MajorTopicYN="N">Anesthetics, General</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006967" MajorTopicYN="N">Hypersensitivity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008487" MajorTopicYN="N">Medical History Taking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014028" MajorTopicYN="N">Tobacco Smoke Pollution</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20816545</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pii">S0140-6736(10)61193-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39266286</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1468-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>Archives of disease in childhood</Title><ISOAbbreviation>Arch Dis Child</ISOAbbreviation></Journal><ArticleTitle>Salbutamol safety in children under 2 years of age with acute wheezing: a meta-analysis of randomised controlled trials.</ArticleTitle><Pagination><StartPage>111</StartPage><EndPage>119</EndPage><MedlinePgn>111-119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/archdischild-2023-326556</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the safety of short-term use of inhaled salbutamol in children under 2 years of age with acute wheezing.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Electronic databases (PubMed, Trip, MEDLINE) and the Cochrane Library were searched for studies published up to October 2022.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">The search was restricted to randomised controlled trials published in English regarding the safety of inhaled salbutamol in wheezing children under the age of 2.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS" NlmCategory="METHODS">The literature search strategy yielded 3532 references. The meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="METHODS">The incidence of adverse reactions associated with inhaled salbutamol administration compared with placebo.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 24 records were included. In 7 studies involving 597 patients, inhaled salbutamol was compared with controls and no statistically significant difference in the incidence of adverse drug reactions was found between the two groups (OR 2.12, 95%&#x2009;CI 0.69 to 6.51; p=0.19). Salbutamol administration via nebulisation was associated with an increased incidence of adverse reactions (OR 6.76, 95%&#x2009;CI 2.01 to 22.71; p=0.002). None of the studies reported severe cardiac side effects that necessitated withdrawal from the study following salbutamol administration. Only one study reported a significant non-cardiac side effect (severe tremulousness) that necessitated withdrawal from therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Inhaled salbutamol can be safely used in children under 2 years of age with acute wheeze with the administration via a metered-dose inhaler being potentially safer than a nebulised formulation. Neither of the formulations was associated with severe adverse effects.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Pierantoni</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Bologna, Emilia-Romagna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Muratore</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Paediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Bologna, Emilia-Romagna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerasi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Paediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Bologna, Emilia-Romagna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zama</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Bologna, Emilia-Romagna, Italy daniele.zama2@unibo.it chiara.delbono@studio.unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Bono</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5772-1472</Identifier><AffiliationInfo><Affiliation>Specialty School of Paediatrics, Alma Mater Studiorum, University of Bologna, Bologna, Italy daniele.zama2@unibo.it chiara.delbono@studio.unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gori</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), Universit&#xe0; di Bologna, Bologna, Emilia-Romagna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masetti</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1264-057X</Identifier><AffiliationInfo><Affiliation>Paediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Bologna, Emilia-Romagna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanari</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Bologna, Emilia-Romagna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Dis Child</MedlineTA><NlmUniqueID>0372434</NlmUniqueID><ISSNLinking>0003-9888</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="Y">Albuterol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="Y">Respiratory Sounds</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="Y">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Child Health</Keyword><Keyword MajorTopicYN="N">Paediatric Emergency Medicine</Keyword><Keyword MajorTopicYN="N">Pharmacology</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>25</Day><Hour>13</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>21</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39266286</ArticleId><ArticleId IdType="doi">10.1136/archdischild-2023-326556</ArticleId><ArticleId IdType="pii">archdischild-2023-326556</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36008492</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1041</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>European journal of clinical pharmacology</Title><ISOAbbreviation>Eur J Clin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies.</ArticleTitle><Pagination><StartPage>1613</StartPage><EndPage>1622</EndPage><MedlinePgn>1613-1622</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00228-022-03374-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Asthma is a heterogeneous disease with a wide range of symptoms. Severe asthma exacerbations (SAEs) are characterized by worsening symptoms and bronchospasm requiring emergency department visits. In addition to conventional strategies for SAEs (inhaled &#x3b2;-agonists, anticholinergics, and systemic corticosteroids), another pharmacological option is represented by ketamine. We performed a systematic review to explore the role of ketamine in refractory SAEs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic search on PubMed and EMBASE up to August 12th, 2021. We selected prospective studies only, and outcomes of interest were oxygenation/respiratory parameters, clinical status, need for invasive ventilation and effects on weaning.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included a total of seven studies, five being randomized controlled trials (RCTs, population range 44-92 patients). The two small prospective studies (n&#x2009;=&#x2009;10 and n&#x2009;=&#x2009;11) did not have a control group. Four studies focused on adults, and three enrolled a pediatric population. We found a large heterogeneity regarding sample size, age and gender distribution, inclusion criteria (different severity scores, if any) and ketamine dosing (bolus and/or continuous infusion). Of the five RCTs, three compared ketamine to placebo, while one used fentanyl and the other aminophylline. The outcomes evaluated by the included studies were highly variable. Despite paucity of data and large heterogeneity, an overview of the included studies suggests absence of clear benefit produced by ketamine in patients with refractory SAE, and some signals towards side effects.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our systematic review does not support the use of ketamine in refractory SAE. A limited number of prospective studies with large heterogeneity was found. Well-designed multicenter RCTs are desirable.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>La Via</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy. luigilavia7@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University of Catania, Catania, Italy. luigilavia7@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuttone</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dezio</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falcone</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Specialization in Anesthesia and Intensive Care, University "Magna Graecia", Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brancati</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crimi</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pneumology, AOU "Policlinico - San Marco", Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astuto</LastName><ForeName>Marinella</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, AOU "Policlinico - San Marco", 95123, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur J Clin Pharmacol</MedlineTA><NlmUniqueID>1256165</NlmUniqueID><ISSNLinking>0031-6970</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018927">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018680">Cholinergic Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>27Y3KJK423</RegistryNumber><NameOfSubstance UI="D000628">Aminophylline</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000628" MajorTopicYN="N">Aminophylline</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018927" MajorTopicYN="Y">Anti-Asthmatic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018680" MajorTopicYN="N">Cholinergic Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="Y">Ketamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aminophylline</Keyword><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Bronchospasm</Keyword><Keyword MajorTopicYN="N">Fentanyl</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Mechanical ventilation</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>23</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36008492</ArticleId><ArticleId IdType="pmc">PMC9482594</ArticleId><ArticleId IdType="doi">10.1007/s00228-022-03374-3</ArticleId><ArticleId IdType="pii">10.1007/s00228-022-03374-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet (London, England) 2018;391(10122):783&#x2013;800. doi: 10.1016/s0140-6736(17)33311-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(17)33311-1</ArticleId><ArticleId IdType="pubmed">29273246</ArticleId></ArticleIdList></Reference><Reference><Citation>To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet LP. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. doi: 10.1186/1471-2458-12-204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-12-204</ArticleId><ArticleId IdType="pmc">PMC3353191</ArticleId><ArticleId IdType="pubmed">22429515</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghoubi M, Adibi A, Safari A, FitzGerald JM, Sadatsafavi M. The projected economic and health burden of uncontrolled asthma in the United States. Am J Respir Crit Care Med. 2019;200(9):1102&#x2013;1112. doi: 10.1164/rccm.201901-0016OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201901-0016OC</ArticleId><ArticleId IdType="pmc">PMC6888652</ArticleId><ArticleId IdType="pubmed">31166782</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Bas&#xe1;&#xf1;ez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernab&#xe9; E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, F&#xe8;vre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Le&#xf2;n FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990&#x2013;2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England) 2012;380(9859):2163&#x2013;2196. doi: 10.1016/s0140-6736(12)61729-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(12)61729-2</ArticleId><ArticleId IdType="pmc">PMC6350784</ArticleId><ArticleId IdType="pubmed">23245607</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R, Cruz AA, Duijts L, Drazen JM, FitzGerald JM, Fleming LJ, Inoue H, Ko FW, Krishnan JA, Levy ML, Lin J, Mortimer K, Pitrez PM, Sheikh A, Yorgancioglu AA, Boulet LP. Global Initiative for Asthma (GINA) Strategy 2021 - executive summary and rationale for key changes. J Allergy Clin Immunol Pract. 2021 doi: 10.1016/j.jaip.2021.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.10.001</ArticleId><ArticleId IdType="pubmed">34718211</ArticleId></ArticleIdList></Reference><Reference><Citation>Donner CF, Amaducci S, Bacci E, Baldacci S, Bartoli ML, Beghi GM, Benfante A, Brighindi S, Casali L, Castiglia D, Cazzola M, Celi A, Cianchetti S, Colombo G, Crimi C, Dente FL, Di Maria G, Di Maria A, Latorre M, Lavorini F, Maio S, Mannini C, Messina R, Paggiaro PL, Pignatti P, Price D, Scichilone N, Simoni M, Spanevello A, Stagno d'Alcontres M, Tan S, Torchio R, Viegi G, Visca D, Wouters EFM, Yu Hui Xin S (2018) Inhalation therapy in the next decade: determinants of adherence to treatment in asthma and COPD. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 88(1): 886. 10.4081/monaldi.2018.886</Citation><ArticleIdList><ArticleId IdType="pubmed">29557582</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelaia C, Crimi C. Indacaterol/Glycopyrronium/Mometasone fixed dose combination for uncontrolled asthma. Expert Rev Respir Med. 2021 doi: 10.1080/17476348.2021.2011222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2021.2011222</ArticleId><ArticleId IdType="pubmed">34845963</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Molecular targets for biological therapies of severe asthma. Front Immunol. 2020;11:603312. doi: 10.3389/fimmu.2020.603312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.603312</ArticleId><ArticleId IdType="pmc">PMC7734054</ArticleId><ArticleId IdType="pubmed">33329598</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffler E, Terranova G, Chessari C, Frazzetto V, Crimi C, Fichera S, Picardi G, Nicolosi G, Porto M, Intravaia R, Crimi N. Point-of-care blood eosinophil count in a severe asthma clinic setting. Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology. 2017;119(1):16&#x2013;20. doi: 10.3389/fimmu.2020.603312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.603312</ArticleId><ArticleId IdType="pubmed">28668237</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimi C, Ferri S, Crimi N. Bronchiectasis and asthma: a dangerous liaison? Curr Opin Allergy Clin Immunol. 2019;19(1):46&#x2013;52. doi: 10.1097/aci.0000000000000492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aci.0000000000000492</ArticleId><ArticleId IdType="pubmed">30516546</ArticleId></ArticleIdList></Reference><Reference><Citation>Caminati M, Vaia R. Uncontrolled asthma: unmet needs in the management of patients. 2021;14:457&#x2013;466. doi: 10.2147/jaa.s260604.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jaa.s260604</ArticleId><ArticleId IdType="pmc">PMC8104981</ArticleId><ArticleId IdType="pubmed">33976555</ArticleId></ArticleIdList></Reference><Reference><Citation>Furci F, Guarnieri G, Senna G, Crimi C, Campisi R, Noto A, Genco S, Cacopardo G, Nolasco S, Crimi N. Comparability of asthma control test scores between self and physician-administered test. Journal of asthma and allergy. 2020;170:106015. doi: 10.2147/jaa.s260604.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jaa.s260604</ArticleId><ArticleId IdType="pubmed">32843163</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Asthma (2021) Global strategy for asthma management and prevention. Available at: http://www.ginasthma.org</Citation></Reference><Reference><Citation>Stefan MS, Nathanson BH, Lagu T, Priya A, Pekow PS, Steingrub JS, Hill NS, Goldberg RJ, Kent DM, Lindenauer PK. Outcomes of Noninvasive and Invasive Ventilation in Patients Hospitalized with Asthma Exacerbation. Ann Am Thorac Soc. 2016;13(7):1096&#x2013;1104. doi: 10.1513/AnnalsATS.201510-701OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201510-701OC</ArticleId><ArticleId IdType="pmc">PMC5015747</ArticleId><ArticleId IdType="pubmed">27070493</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergraft TB, Stanford RH, Beasley R, Stempel DA, Roberts C, McLaughlin T. Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology. 2004;93(1):29&#x2013;35. doi: 10.1016/s1081-1206(10)61444-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1081-1206(10)61444-5</ArticleId><ArticleId IdType="pubmed">15281469</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao M, Rejaei D, Liu H. Ketamine use in current clinical practice. Acta Pharmacol Sin. 2016;37(7):865&#x2013;872. doi: 10.1038/aps.2016.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2016.5</ArticleId><ArticleId IdType="pmc">PMC4933765</ArticleId><ArticleId IdType="pubmed">27018176</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowacka A, Borczyk M. Ketamine applications beyond anesthesia - a literature review. Eur J Pharmacol. 2019;860:172547. doi: 10.1016/j.ejphar.2019.172547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2019.172547</ArticleId><ArticleId IdType="pubmed">31348905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol. 2008;182:313&#x2013;333. doi: 10.1007/978-3-540-74806-9_15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-74806-9_15</ArticleId><ArticleId IdType="pubmed">18175098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA, Jr, Gould TD. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70(3):621&#x2013;660. doi: 10.1124/pr.117.015198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.117.015198</ArticleId><ArticleId IdType="pmc">PMC6020109</ArticleId><ArticleId IdType="pubmed">29945898</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihaljevi&#x107; S, Pavlovi&#x107; M, Reiner K, &#x106;a&#x107;i&#x107; M. Therapeutic mechanisms of ketamine. Psychiatr Danub. 2020;32(3&#x2013;4):325&#x2013;333. doi: 10.24869/psyd.2020.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.24869/psyd.2020.325</ArticleId><ArticleId IdType="pubmed">33370729</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmingsen C, Nielsen PK, Odorico J. Ketamine in the treatment of bronchospasm during mechanical ventilation. Am J Emerg Med. 1994;12(4):417&#x2013;420. doi: 10.1016/0735-6757(94)90051-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-6757(94)90051-5</ArticleId><ArticleId IdType="pubmed">8031424</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med. 2005;46(1):43&#x2013;50. doi: 10.1016/j.annemergmed.2005.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2005.02.024</ArticleId><ArticleId IdType="pubmed">15988425</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmailian M, Koushkian Esfahani M, Heydari F. The effect of low-dose ketamine in treating acute asthma attack; a randomized clinical trial. Emergency (Tehran, Iran) 2018;6(1):e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6036522</ArticleId><ArticleId IdType="pubmed">30009223</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A, Guglani V, Jat KR. Ketamine versus aminophylline for acute asthma in children: a randomized, controlled trial. Annals of thoracic medicine. 2016;11(4):283&#x2013;288. doi: 10.4103/1817-1737.191874.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1817-1737.191874</ArticleId><ArticleId IdType="pmc">PMC5070438</ArticleId><ArticleId IdType="pubmed">27803755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedel W, Costa R, Mendez G, Marin L, Vargas T, Marques L. Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial. Anaesthesiology intensive therapy. 2020;52(3):215&#x2013;218. doi: 10.5114/ait.2020.97765.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ait.2020.97765</ArticleId><ArticleId IdType="pmc">PMC10172964</ArticleId><ArticleId IdType="pubmed">32876408</ArticleId></ArticleIdList></Reference><Reference><Citation>Howton JC, Rose J, Duffy S, Zoltanski T, Levitt MA. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med. 1996;27(2):170&#x2013;175. doi: 10.1016/s0196-0644(96)70319-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0196-0644(96)70319-0</ArticleId><ArticleId IdType="pubmed">8629747</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrillo TM, Fortenberry JD, Linzer JF, Simon HK. Emergency department use of ketamine in pediatric status asthmaticus. The Journal of asthma : official journal of the Association for the Care of Asthma. 2001;38(8):657&#x2013;664. doi: 10.1081/jas-100107543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/jas-100107543</ArticleId><ArticleId IdType="pubmed">11758894</ArticleId></ArticleIdList></Reference><Reference><Citation>Heshmati F, Zeinali MB, Noroozinia H, Abbacivash R, Mahoori A. Use of ketamine in severe status asthmaticus in intensive care unit. Iran J Allergy Asthma Immunol. 2003;2(4):175&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">17301376</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen AP, Naughton M, Dowling J, Walsh A, Ismail F, Shorten G, Scott L, McLoughlin DM, Cryan JF, Dinan TG, Clarke G. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: a comparison of ketamine and ECT. J Affect Disord. 2015;186:306&#x2013;311. doi: 10.1016/j.jad.2015.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2015.06.033</ArticleId><ArticleId IdType="pubmed">26275358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms. Pharmacol Rep. 2021;73(2):323&#x2013;345. doi: 10.1007/s43440-021-00232-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-021-00232-4</ArticleId><ArticleId IdType="pmc">PMC7994242</ArticleId><ArticleId IdType="pubmed">33609274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pabelick CM, Jones KA, Street K, Lorenz RR, Warner DO. Calcium concentration-dependent mechanisms through which ketamine relaxes canine airway smooth muscle. Anesthesiology. 1997;86(5):1104&#x2013;1111. doi: 10.1097/00000542-199705000-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199705000-00014</ArticleId><ArticleId IdType="pubmed">9158360</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal S, Agrawal A. Ketamine in status asthmaticus: a review. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2013;17(3):154&#x2013;161. doi: 10.4103/0972-5229.117048.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-5229.117048</ArticleId><ArticleId IdType="pmc">PMC3777369</ArticleId><ArticleId IdType="pubmed">24082612</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Hirota K, Matsuki A, Zsigmond EK, Rabito SF. The role of the N-methyl-D-aspartic acid receptor in the relaxant effect of ketamine on tracheal smooth muscle. Anesth Analg. 1998;87(6):1383&#x2013;1388. doi: 10.1097/00000539-199812000-00033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-199812000-00033</ArticleId><ArticleId IdType="pubmed">9842833</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol. 2005;204(1):27&#x2013;35. doi: 10.1016/j.taap.2004.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2004.08.011</ArticleId><ArticleId IdType="pubmed">15781291</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera AM, Brand P, Cavada G, Koppmann A, Rivas M, Mackenney J, Sep&#xfa;lveda H, Wevar ME, Cruzat L, Soto S, P&#xe9;rez MA, Le&#xf3;n A, Contreras I, Alvarez C, Walker B, Flores C, Lezana V, Garrido C, Herrera ME, Rojas A, Andrades C, Chala E, Mart&#xed;nez RA, Vega M, Perill&#xe1;n JA, Seguel H, Przybyzsweski I. Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study. Allergol Immunopathol. 2019;47(3):282&#x2013;288. doi: 10.1016/j.aller.2018.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aller.2018.10.003</ArticleId><ArticleId IdType="pmc">PMC7125869</ArticleId><ArticleId IdType="pubmed">30595390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35554785</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-1709</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Sleep &amp; breathing = Schlaf &amp; Atmung</Title><ISOAbbreviation>Sleep Breath</ISOAbbreviation></Journal><ArticleTitle>Perioperative outcomes and the effects of anesthesia in congenital central hypoventilation patients.</ArticleTitle><Pagination><StartPage>505</StartPage><EndPage>510</EndPage><MedlinePgn>505-510</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11325-022-02632-z</ELocationID><Abstract><AbstractText Label="PURPOSE">Patients with congenital central hypoventilation syndrome (CCHS) have autonomic dysfunction and lack ventilatory responses to hypoxemia and hypercarbia and thus are prone to adverse events during general anesthesia.&#xa0;The objective of this study was to describe the perioperative outcomes of patients with&#xa0;CCHS who were undergoing diaphragm pacer (DP) implantation surgeries under general anesthesia.</AbstractText><AbstractText Label="METHODS">A retrospective cohort&#xa0;study was conducted on&#xa0;patients with CCHS who underwent DP implantation surgeries at CHLA between January 2000 and May 2016. Charts were reviewed for demographics, PHOX2B genotype, ventilatory support, comorbidities, anesthesia administered, and perioperative courses.</AbstractText><AbstractText Label="RESULTS">Of 19 patients with CCHS (58% female) mean age at surgeries was 8.6&#x2009;&#xb1;&#x2009;5.8&#xa0;years. Seventeen patients were ventilator-dependent during sleep only; two were ventilator dependent&#xa0;24 h per day. Mean surgery duration was 3.1&#x2009;&#xb1;&#x2009;0.5&#xa0;h. Seventeen patients were extubated to PPV via tracheostomy in the OR. Two patients were extubated to NPPV on postoperative day (POD) 1. Mean transition time to home ventilator or NPPV was 3.0&#x2009;&#xb1;&#x2009;2.2&#xa0;days, and mean hospital stay was 5.0&#x2009;&#xb1;&#x2009;2.1&#xa0;days. One patient premedicated without ventilatory support developed hypoxemia and hypoventilation. Ten patients (52%) had intraoperative events such as bradycardia, hypotension, significant hypoxemia, and bronchospasm. Fifteen patients had postoperative events. Hypoxemia, pneumonia, and atelectasis accounted for most of perioperative complications. One patient experienced seizure on POD 2 due to hypercarbia.</AbstractText><AbstractText Label="CONCLUSION">Patients with CCHS are vulnerable to the cardiorespiratory effects of sedative and anesthetic agents. Therefore, they require vigilant monitoring and optimal ventilatory support in the perioperative period.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Gloria Y</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salazar</LastName><ForeName>Tate</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karnwal</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kun</LastName><ForeName>Sheila S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Division of Pediatric Pulmonology and Sleep Medicine, Children's Hospital Los Angeles, MS 83, 4650 Sunset Blvd, Los Angeles, CA, 900217, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellashek</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pediatric Pulmonology and Sleep Medicine, Children's Hospital Los Angeles, MS 83, 4650 Sunset Blvd, Los Angeles, CA, 900217, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Cathy E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Children's Hospital Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McComb</LastName><ForeName>J Gordon</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery/Division of Neurosurgery, Children's Hospital Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keens</LastName><ForeName>Thomas G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Pulmonology and Sleep Medicine, Children's Hospital Los Angeles, MS 83, 4650 Sunset Blvd, Los Angeles, CA, 900217, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Iris A</ForeName><Initials>IA</Initials><Identifier Source="ORCID">0000-0002-3233-0130</Identifier><AffiliationInfo><Affiliation>Keck School of Medicine of University of Southern California, Los Angeles, CA, USA. iaperez@chla.usc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Pulmonology and Sleep Medicine, Children's Hospital Los Angeles, MS 83, 4650 Sunset Blvd, Los Angeles, CA, 900217, USA. iaperez@chla.usc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Sleep Breath</MedlineTA><NlmUniqueID>9804161</NlmUniqueID><ISSNLinking>1520-9512</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C536209">Congenital central hypoventilation syndrome</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007040" MajorTopicYN="Y">Hypoventilation</DescriptorName><QualifierName UI="Q000151" MajorTopicYN="N">congenital</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020182" MajorTopicYN="Y">Sleep Apnea, Central</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia complications</Keyword><Keyword MajorTopicYN="N">Congenital central hypoventilation syndrome</Keyword><Keyword MajorTopicYN="N">Intraoperative</Keyword><Keyword MajorTopicYN="N">Perioperative</Keyword><Keyword MajorTopicYN="N">Ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>16</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35554785</ArticleId><ArticleId IdType="doi">10.1007/s11325-022-02632-z</ArticleId><ArticleId IdType="pii">10.1007/s11325-022-02632-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weese-Mayer DE, Berry-Kravis EM, Ceccherini I et al (2010) An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am J Respir Crit Care Med 181:626&#x2013;644. https://doi.org/10.1164/rccm.200807-1069ST</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200807-1069ST</ArticleId><ArticleId IdType="pubmed">20208042</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiel J, Laudier B, Atti&#xe9;-Bitach T et al (2003) Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459&#x2013;461. https://doi.org/10.1038/ng1130</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1130</ArticleId><ArticleId IdType="pubmed">12640453</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestri JM, Chen ML, Weese-Mayer DE et al (2002) Idiopathic congenital central hypoventilation syndrome: the next generation. Am J Med Genet 112:46&#x2013;50. https://doi.org/10.1002/ajmg.10819</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.10819</ArticleId><ArticleId IdType="pubmed">12239719</ArticleId></ArticleIdList></Reference><Reference><Citation>Matera I, Bachetti T, Puppo F et al (2004) PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet 41:373&#x2013;380</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2003.015412</ArticleId><ArticleId IdType="pubmed">15121777</ArticleId><ArticleId IdType="pmc">1735781</ArticleId></ArticleIdList></Reference><Reference><Citation>Paton JY, Swaminathan S, Sargent CW, Keens TG (1989) Hypoxic and hypercapnic ventilatory responses in awake children with congenital central hypoventilation syndrome. Am Rev Respir Dis 140:368&#x2013;372. https://doi.org/10.1164/ajrccm/140.2.368</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm/140.2.368</ArticleId><ArticleId IdType="pubmed">2764373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ML, Keens TG (2004) Congenital central hypoventilation syndrome: not just another rare disorder. Paediatr Respir Rev 5:182&#x2013;189. https://doi.org/10.1016/j.prrv.2004.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2004.04.009</ArticleId><ArticleId IdType="pubmed">15276129</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney MA, Kun SS, Keens TG, Perez IA (2018) Congenital central hypoventilation syndrome: diagnosis and management. Expert Rev Respir Med 12:283&#x2013;292. https://doi.org/10.1080/17476348.2018.1445970</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2018.1445970</ArticleId><ArticleId IdType="pubmed">29486608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishara J, Keens TG, Perez IA (2018) The genetics of congenital central hypoventilation syndrome: clinical implications. Appl Clin Genet 11:135&#x2013;144. https://doi.org/10.2147/TACG.S140629</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TACG.S140629</ArticleId><ArticleId IdType="pubmed">30532577</ArticleId><ArticleId IdType="pmc">6241683</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagiakis E, Koutsourelakis I, Perraki E et al (2010) Average volume-assured pressure support in a 16-year-old girl with congenital central hypoventilation syndrome. J Clin Sleep Med 6:609&#x2013;612</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.27997</ArticleId><ArticleId IdType="pubmed">21206552</ArticleId><ArticleId IdType="pmc">3014250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerbl R, Litscher H, Grubbauer HM et al (1996) Congenital central hypoventilation syndrome (Ondine&#x2019;s curse syndrome) in two siblings: delayed diagnosis and successful noninvasive treatment. Eur J Pediatr 155:977&#x2013;980</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02282890</ArticleId><ArticleId IdType="pubmed">8911900</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibballs J, Henning RD (2003) Noninvasive ventilatory strategies in the management of a newborn infant and three children with congenital central hypoventilation syndrome. Pediatr Pulmonol 36:544&#x2013;548. https://doi.org/10.1002/ppul.10392</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.10392</ArticleId><ArticleId IdType="pubmed">14618648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Jawad MH, Noyes J et al (1994) Negative extrathoracic pressure ventilation in central hypoventilation syndrome. Arch Dis Child 70:418&#x2013;423</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.70.5.418</ArticleId><ArticleId IdType="pubmed">8017965</ArticleId><ArticleId IdType="pmc">1029832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ML, Tablizo MA, Kun S, Keens TG (2005) Diaphragm pacers as a treatment for congenital central hypoventilation syndrome. Expert Rev Med Devices 2:577&#x2013;585. https://doi.org/10.1586/17434440.2.5.577</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17434440.2.5.577</ArticleId><ArticleId IdType="pubmed">16293069</ArticleId></ArticleIdList></Reference><Reference><Citation>Diep B, Wang A, Kun S et al (2015) Diaphragm pacing without tracheostomy in congenital central hypoventilation syndrome patients. Respiration 89:534&#x2013;538. https://doi.org/10.1159/000381401</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381401</ArticleId><ArticleId IdType="pubmed">25924848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Kun S, Diep B et al (2018) Obstructive sleep apnea in patients with congenital central hypoventilation syndrome ventilated by diaphragm pacing without tracheostomy. J Clin Sleep Med 14:261&#x2013;264. https://doi.org/10.5664/jcsm.6948</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.6948</ArticleId><ArticleId IdType="pubmed">29351818</ArticleId><ArticleId IdType="pmc">5786846</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahfouz AKM, Rashid M, Khan MS, Reddy P (2011) Late onset congenital central hypoventilation syndrome after exposure to general anesthesia. Can J Anesth. https://doi.org/10.1007/s12630-011-9590-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-011-9590-7</ArticleId><ArticleId IdType="pubmed">21989548</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu SM, Chung FF, AbdelHakim SF, Wong J (2017) Anesthetic considerations for patients with congenital central hypoventilation syndrome: a systematic review of the literature. Anesth Analg 124:169&#x2013;178. https://doi.org/10.1213/ANE.0000000000001470</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001470</ArticleId><ArticleId IdType="pubmed">27918326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasi AS, Kun SS, Keens TG, Perez IA (2018) Adult with PHOX2B mutation and late-onset congenital central hypoventilation syndrome. J Clin Sleep Med 14:2079&#x2013;2081. https://doi.org/10.5664/jcsm.7542</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.7542</ArticleId><ArticleId IdType="pubmed">30518452</ArticleId><ArticleId IdType="pmc">6287728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard HA, Leavitt OS, Chin AC et al (2018) Perioperative anesthetic management of children with congenital central hypoventilation syndrome and rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation undergoing thoracoscopic phrenic nerve-diaphragm pacemaker. Paediatr Anaesth 28:963&#x2013;973. https://doi.org/10.1111/pan.13475</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13475</ArticleId><ArticleId IdType="pubmed">30251310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesel S, Fox GS (1990) Anaesthesia for a patient with central alveolar hypoventilation syndrome (Ondine&#x2019;s curse). Can J Anaesth 37:122&#x2013;126. https://doi.org/10.1007/BF03007492</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03007492</ArticleId><ArticleId IdType="pubmed">2295095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi H, Umezawa K, Hayashi S, Shibutani K (2004) Anesthetic management of a child with congenital central hypoventilation syndrome (CCHS, Ondine&#x2019;s curse) for dental treatment. Anesth Prog 51:102&#x2013;104</Citation><ArticleIdList><ArticleId IdType="pubmed">15497300</ArticleId><ArticleId IdType="pmc">2007484</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaul DB, Danielson PD, McComb JG, Keens TG (2002) Thoracoscopic placement of phrenic nerve electrodes for diaphragmatic pacing in children. J Pediatr Surg 37:974&#x2013;8. discussion 974-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jpsu.2002.33821</ArticleId><ArticleId IdType="pubmed">12077752</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson KJ, Nosanov LB, Bowen KA et al (2015) Thoracoscopic placement of phrenic nerve pacers for diaphragm pacing in congenital central hypoventilation syndrome. J Pediatr Surg 50:78&#x2013;81. https://doi.org/10.1016/j.jpedsurg.2014.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2014.10.002</ArticleId><ArticleId IdType="pubmed">25598098</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, Woo MA, Gozal D et al (1992) Heart rate variability in congenital central hypoventilation syndrome. Pediatr Res 31:291&#x2013;296. https://doi.org/10.1203/00006450-199203000-00020</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-199203000-00020</ArticleId><ArticleId IdType="pubmed">1561018</ArticleId></ArticleIdList></Reference><Reference><Citation>Trang H, Girard A, Laude D, Elghozi J-L (2005) Short-term blood pressure and heart rate variability in congenital central hypoventilation syndrome (Ondine&#x2019;s curse). Clin Sci (Lond) 108:225&#x2013;230. https://doi.org/10.1042/CS20040282</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20040282</ArticleId><ArticleId IdType="pubmed">15544572</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestri JM, Hanna BD, Volgman AS et al (2000) Cardiac rhythm disturbances among children with idiopathic congenital central hypoventilation syndrome. Pediatr Pulmonol 29:351&#x2013;358</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1099-0496(200005)29:5&lt;351::AID-PPUL3&gt;3.0.CO;2-Z</ArticleId><ArticleId IdType="pubmed">10790246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gronli JO, Santucci BA, Leurgans SE et al (2008) Congenital central hypoventilation syndrome: PHOX2B genotype determines risk for sudden death. Pediatr Pulmonol 43:77&#x2013;86. https://doi.org/10.1002/ppul.20744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.20744</ArticleId><ArticleId IdType="pubmed">18041756</ArticleId></ArticleIdList></Reference><Reference><Citation>Laifman E, Keens TG, Bar-Cohen Y, Perez IA (2020) Life-threatening cardiac arrhythmias in congenital central hypoventilation syndrome. Eur J Pediatr 179. https://doi.org/10.1007/s00431-019-03568-5</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27273556</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Pediatric pulmonology</Title><ISOAbbreviation>Pediatr Pulmonol</ISOAbbreviation></Journal><ArticleTitle>The bronchodilator response in preschool children: A systematic review.</ArticleTitle><Pagination><StartPage>1242</StartPage><EndPage>1250</EndPage><MedlinePgn>1242-1250</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.23459</ELocationID><Abstract><AbstractText Label="BACKGROUND">The bronchodilator response (BDR) is frequently used to support diagnostic and therapeutic decision-making for children who wheeze. However, there is little evidence-based guidance describing the role of BDR testing in preschool children and it is unclear whether published cut-off values, which are derived from adult data, can be applied to this population.</AbstractText><AbstractText Label="METHODS">We searched MEDLINE, EMBASE, Web of Science, and Cochrane databases (inception-September 2015) for studies reporting response to a bronchodilator in healthy preschool children, response following placebo inhalation, and the diagnostic efficacy of BDR compared with a clinical diagnosis of asthma/recurrent wheezing.</AbstractText><AbstractText Label="FINDINGS">We included 14 studies. Thirteen studies provided BDR data from healthy preschool children. Two studies reported response to placebo in preschool children with asthma/recurrent wheezing. Twelve studies compared BDR measurements from preschool children with asthma/recurrent wheeze to those from healthy children and seven of these studies reported diagnostic efficacy. Significant differences between the BDR measured in healthy preschool children compared with that in children with asthma/recurrent wheeze were demonstrated in some, but not all studies. Techniques such as interrupter resistance, oscillometry, and plethysmography were more consistently successfully completed than spirometry. Between study heterogeneity precluded determination of an optimum technique.</AbstractText><AbstractText Label="INTERPRETATION">There is little evidence to suggest spirometry-based BDR can be used in the clinical assessment of preschool children who wheeze. Further evaluation of simple alternative techniques is required. Future studies should recruit children in whom airways disease is suspected and should evaluate the ability of BDR testing to predict treatment response. Pediatr Pulmonol. 2016;51:1242-1250. &#xa9; 2016 Wiley Periodicals, Inc.</AbstractText><CopyrightInformation>&#xa9; 2016 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raywood</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lum</LastName><ForeName>Sooky</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aurora</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pike</LastName><ForeName>Katharine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia Section, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom. k.pike@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom. k.pike@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Pulmonol</MedlineTA><NlmUniqueID>8510590</NlmUniqueID><ISSNLinking>1099-0496</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="Y">Bronchodilator Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009991" MajorTopicYN="N">Oscillometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma and early wheeze</Keyword><Keyword MajorTopicYN="N">bronchodilator response</Keyword><Keyword MajorTopicYN="N">preschool child</Keyword><Keyword MajorTopicYN="N">pulmonary function testing (PFT)</Keyword><Keyword MajorTopicYN="N">spirometry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27273556</ArticleId><ArticleId IdType="doi">10.1002/ppul.23459</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37728451</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1731-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Anaesthesiology intensive therapy</Title><ISOAbbreviation>Anaesthesiol Intensive Ther</ISOAbbreviation></Journal><ArticleTitle>Anaesthesia in&#x2006;&#x2006;SARS-CoV-2 infected children - single-centre experience. A&#xa0;case-control study.</ArticleTitle><Pagination><StartPage>223</StartPage><EndPage>228</EndPage><MedlinePgn>223-228</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5114/ait.2023.130791</ELocationID><ELocationID EIdType="pii" ValidYN="Y">51313</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Although manifestation of SARS-CoV-2 infection in children is gene-rally mild or asymptomatic, anaesthetic implications of the infection in children are still a matter of concern. Single reports suggest that patients with SARS-CoV-2 infection are at higher risk of anaesthetic complications.</AbstractText><AbstractText Label="MATERIAL AND METHODS">We performed a retrospective, case control study analysing the risk of general anaesthesia in SARS-CoV-2 infected children admitted to a tertiary paediatric university hospital for the purpose of urgent procedures requiring anaesthesia&#x2006; between April 1st and September 30 th , 2021. The control group consisted of&#x2006; SARS-CoV-2 negative children consecutively anaesthetised for the same reasons during the first month of observation. Our hypothesis was: general anaesthesia can be safely performed in SARS-CoV-2 infected children. Study endpoints: primary - anaesthetic respiratory complications (bronchospasm, laryngospasm, intraoperative desaturation below 94%, desaturation below 94% after awakening, unplanned postoperative mechanical ventilation); secondary - hospital length of stay, thrombotic, cardiac, haemorrhagic events, ICU admission, deaths during hospitalisation.</AbstractText><AbstractText Label="RESULTS">The examined group consisted of 58 SARS-CoV-2 infected children, the matched control group of 198 patients. The rate of complications in both groups was very low, with no significant difference between the groups. The only differences observed were a higher frequency of desaturations in the awakening period and longer time of hospitalisation in SARS-CoV-2 infected patients. Multivariate logistic regression analysis showed that physical status of the patient and duration of the procedure were the main factors influencing the risk of complications.</AbstractText><AbstractText Label="CONCLUSIONS">In our experience anaesthesia of SARS-CoV-2 infected children can be safely performed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jarymowicz</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatric Anesthesiology and Intensive Care, Pediatric Teaching Hospital, University Clinical Center Warsaw Medical University, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baranowski</LastName><ForeName>Artur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Anesthesiology and Intensive Care, Pediatric Teaching Hospital, University Clinical Center Warsaw Medical University, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietrzyk</LastName><ForeName>Justyna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatric Anesthesiology and Intensive Care, Pediatric Teaching Hospital, University Clinical Center Warsaw Medical University, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#x105;gowska-Klimek</LastName><ForeName>Izabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatric Anesthesiology and Intensive Care, Pediatric Teaching Hospital, University Clinical Center Warsaw Medical University, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Anaesthesiol Intensive Ther</MedlineTA><NlmUniqueID>101472620</NlmUniqueID><ISSNLinking>1642-5758</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2 symptoms in children</Keyword><Keyword MajorTopicYN="N">anaesthetic complications</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infected children</Keyword></KeywordList><CoiStatement>none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>12</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37728451</ArticleId><ArticleId IdType="pmc">PMC10496091</ArticleId><ArticleId IdType="doi">10.5114/ait.2023.130791</ArticleId><ArticleId IdType="pii">51313</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soneru CN, Fernandez AM, Bradford V, et al. .; Pediatric Anesthesia COVID-19 Collaborative. A survey of the global impact of COVID-19 on the practice of pediatric anesthesia: a study from the pediatric anes-thesia COVID-19 Collaborative Group. Paediatr Anaesth 2021; 31: 720-729. doi: 10.1111/pan.14174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14174</ArticleId><ArticleId IdType="pmc">PMC8250770</ArticleId><ArticleId IdType="pubmed">33687737</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshari A, Disma N, von Ungern-Sternberg BS, Matava C. COVID-19 implications for pediatric anesthesia: lessons learnt and how to prepare for the next pandemic. Paediatr Anaesth 2022; 32: 385-390. doi: 10.1111/pan.14347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14347</ArticleId><ArticleId IdType="pubmed">34850493</ArticleId></ArticleIdList></Reference><Reference><Citation>Melander S, Almstr&#xf6;m J, Enlund G, Frykholm P. The COVID-19 pandemic first wave in Sweden: a national registry study of the effects on pediatric anesthesia and surgery. Paediatr Anaesth 2021; 31: 846-853. doi: 10.1111/pan.14203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14203</ArticleId><ArticleId IdType="pmc">PMC8242453</ArticleId><ArticleId IdType="pubmed">33971054</ArticleId></ArticleIdList></Reference><Reference><Citation>COVIDSurg Collaborative; GlobalSurg Collaborative . Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia 2021; 76: 1454-1464. doi: 10.1111/anae.15560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15560</ArticleId><ArticleId IdType="pubmed">34371522</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng-Ramos G, Cronin J, Challa C, et al. . Anesthesia and surgery for positive COVID-19 asymptomatic pediatric patients: how long should we wait? Paediatr Anaesth 2021; 31: 730-732. doi: 10.1111/pan.14191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14191</ArticleId><ArticleId IdType="pmc">PMC8250393</ArticleId><ArticleId IdType="pubmed">33834573</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathanielsz J, Toh ZQ, Do LAH, Mulholland K, Licciardi PV. SARS-CoV-2 infection in children and implications for vaccination. Pediatr Res 2022; 15: 1-11. doi: 10.1038/s41390-022-02254-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-022-02254-x</ArticleId><ArticleId IdType="pmc">PMC9376896</ArticleId><ArticleId IdType="pubmed">35970935</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo XI, Hu Y, et al. . Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 16: 16. doi: 10.1542/peds.2020-0702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0702</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaker R, Colas AE, Julien-Marsollier F, et al. . Presenting symptoms of COVID-19 in children: a meta-analysis of published studies. Br J Anaesth 2020; 125: e330-e332. doi: 10.1016/j.bja.2020.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.026</ArticleId><ArticleId IdType="pmc">PMC7261471</ArticleId><ArticleId IdType="pubmed">32534738</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard-Jones AR, Bowen AC, Danchin M, et al. . COVID-19 in children: I. Epidemiology, prevention and indirect impacts. J Paediatr Child Health 2022; 58: 39-45. doi: 10.1111/jpc.15791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.15791</ArticleId><ArticleId IdType="pmc">PMC8662210</ArticleId><ArticleId IdType="pubmed">34643307</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato MA, Zurakowski D, Adams A, et al. . Prevalence of COVID-19 and risk factors for infection among pediatric anesthesia patients: a report from the PEACOC Research Network. Anesth Analg 2023; 137: 383-391. doi: 10.1213/ANE.000000000000622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.000000000000622</ArticleId><ArticleId IdType="pubmed">36269171</ArticleId></ArticleIdList></Reference><Reference><Citation>Gai N, Maynes JT, Aoyama K. Unique challenges in pediatric anesthesia created by COVID-19. J Anesth 2021; 35: 345-350. doi: 10.1007/s00540-020-02837-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-020-02837-0</ArticleId><ArticleId IdType="pmc">PMC7413219</ArticleId><ArticleId IdType="pubmed">32770277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee-Archer P, von Ungern-Sternberg BS. Pediatric anesthetic implications of COVID-19&#x2013;a review of current literature. Paediatr Anaesth 2020; 30: 136-141. doi: 10.1111/pan.13889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13889</ArticleId><ArticleId IdType="pmc">PMC7264528</ArticleId><ArticleId IdType="pubmed">32306440</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng-Ramos G, Nelson J, Lee AC, et al. . Postanesthesia complications in pediatric patients with previous SARS-CoV-2 infection: a cohort study. Paediatr Anaesth 2023; 33: 79-85. doi: 10.1111/pan.14585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14585</ArticleId><ArticleId IdType="pmc">PMC9877943</ArticleId><ArticleId IdType="pubmed">36314047</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter AJ, Ingram ME, Raval MV, et al. . Postoperative respiratory complications in SARS-CoV-2 positive pediatric patients across 20 United States hospitals: a cohort study. J Pediatr Surg 2023; 58: 1543-1549. doi: 10.1016/j.jpedsurg.2022.10.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2022.10.048</ArticleId><ArticleId IdType="pmc">PMC9632239</ArticleId><ArticleId IdType="pubmed">36428183</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin JA, Nelson JH, Farquhar I, et al. . Anesthetic outcomes in pediatric patients with COVID-19: A matched cohort study. Pediatr Anaesth 2021; 31: 733-735. doi: 10.1111/pan.14177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14177</ArticleId><ArticleId IdType="pmc">PMC8250730</ArticleId><ArticleId IdType="pubmed">33713490</ArticleId></ArticleIdList></Reference><Reference><Citation>Saynhalath R, Alex G, Efune PN, Szmuk P, Zhu H, Sanford EL. Anes-thetic complications associated with severe acute respiratory syndrome coronavirus 2 in pediatric patients. Anesth Analg 2021; 133: 483-490. doi: 10.1213/ANE.0000000000005606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005606</ArticleId><ArticleId IdType="pubmed">33886516</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J, Thomas PG, Randolph AG. Immunology of SARS-CoV-2 infection in children. Nat Immunol 2022; 23: 177-185. doi: 10.1038/s41590-021-01123-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01123-9</ArticleId><ArticleId IdType="pmc">PMC8981222</ArticleId><ArticleId IdType="pubmed">35105983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Inhalational versus intravenous induction of anesthesia in children with a high risk of perioperative respiratory adverse events: a randomized controlled trial. Anesthesiology 2018; 128: 1065-1074. doi: 10.1097/ALN.0000000000002152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002152</ArticleId><ArticleId IdType="pubmed">29498948</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker SM, Engelhardt T, Ahmad N, Dobby N; UK Collaborators; NECTARINE Group Steering Committee* . Perioperative critical events and morbidity associated with anesthesia in early life: Subgroup analysis of United Kingdom participation in the NEonate and Children audiT of Anaesthesia pRactice IN Europe [NECTARINE] prospective multicenter observational study. Paediatr Anaesth 2022; 32: 801-814. doi: 10.1111/pan.14457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14457</ArticleId><ArticleId IdType="pmc">PMC9322016</ArticleId><ArticleId IdType="pubmed">35438209</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W, Disma N, Virag K, et al. .; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network . Incidence of severe critical events in paediatric anaesthesia [APRICOT]: a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med 2017; 5: 412-425. doi: 10.1016/S2213-2600(17)30116-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30116-9</ArticleId><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielson C, Suarez D, Taylor IK, Huang Y, Park AH. Surgical outcomes in children with perioperative SARS-CoV-2 diagnosis. Am J Infect Control 2022; 50: 602-607. doi: 10.1016/j.ajic.2022.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2022.02.024</ArticleId><ArticleId IdType="pmc">PMC8920958</ArticleId><ArticleId IdType="pubmed">35301061</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson MB, Gurnaney HG, Disma N, et al. .; PAWS-COVID-19 Group . Complications associated with paediatric airway management during the COVID-19 pandemic: an international, multicentre, observational study. Anaesthesia 2022; 77: 649-658. doi: 10.1016/j.ajic.2022.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2022.02.024</ArticleId><ArticleId IdType="pmc">PMC9111470</ArticleId><ArticleId IdType="pubmed">35319088</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson J, Johansen M, Engelhardt T. SARS-CoV-2 airway reactivity in children: more of the same? Anaesthesia 2022; 77: 956-958. doi: 10.1111/anae.15760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15760</ArticleId><ArticleId IdType="pmc">PMC9347779</ArticleId><ArticleId IdType="pubmed">35587812</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30029599</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2466</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jul</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC pulmonary medicine</Title><ISOAbbreviation>BMC Pulm Med</ISOAbbreviation></Journal><ArticleTitle>Early life vitamin D status and asthma and wheeze: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>120</StartPage><MedlinePgn>120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12890-018-0679-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Vitamin D deficiency has been linked to an increased risk of asthma. This study aimed to quantify the effect of early life vitamin D status on asthma and wheeze later in life.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, CINAHL, and CNKI databases, the Cochrane Central Register of Controlled Trials, and Google Scholar were searched up to July 2017. We included randomized controlled trials (RCTs) and cohort studies with vitamin D level in blood (maternal or cord or infant) or intake (maternal intake during pregnancy or infant intake) and asthma and/or wheeze. Two reviewers independently extracted data. Fixed- and random-effects models were used to summarize the risk estimates of comparisons between highest vs. lowest vitamin D categories.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 1485 studies identified, three RCTs and 33 cohort studies were included. We did not include the RCTs (1619 participants) in the meta-analysis as the comparators and outcome definitions were heterogenous. Three RCTs reported a non-statistically significant effect of vitamin D supplementation during pregnancy on offspring wheeze/asthma at 3&#xa0;years of age. Pooled estimates of cohort studies suggest no association between antenatal blood vitamin D levels or vitamin D intake and offspring asthma assessed either &gt;&#x2009;5&#xa0;years or&#x2009;&#x2264;&#x2009;5&#xa0;years. The estimate for blood vitamin D remained unchanged when two studies assessing asthma in adulthood were excluded, but a significant inverse association emerged between vitamin D intake and childhood asthma. We found no association between antenatal vitamin D level and wheeze. On the other hand, vitamin D intake during pregnancy may have a protective effect against wheeze.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The pooled estimates from cohort studies show no association between antenatal blood vitamin D level and asthma/wheeze in later life. Whereas, the pooled estimates from cohort studies suggest that antenatal vitamin D intake may have an effect on childhood asthma &gt;&#x2009;5&#xa0;years or childhood wheeze. The inconsistent results from studies assessing vitamin D either in blood or intake may be explained by previously reported non-linear association between blood vitamin D<sub>3</sub> and childhood asthma. Further trials with enough power and longer follow-up time should be conducted to confirm the results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Song-Ying</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Junsui Road, Zhujiang Newtown, Tianhe District, Guangzhou, 510623, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Wan-Qing</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Junsui Road, Zhujiang Newtown, Tianhe District, Guangzhou, 510623, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jin-Hua</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Junsui Road, Zhujiang Newtown, Tianhe District, Guangzhou, 510623, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Ming-Yang</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Junsui Road, Zhujiang Newtown, Tianhe District, Guangzhou, 510623, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jian-Rong</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Junsui Road, Zhujiang Newtown, Tianhe District, Guangzhou, 510623, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Hui-Min</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Xiu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Birth Cohort Study, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Junsui Road, Zhujiang Newtown, Tianhe District, Guangzhou, 510623, China. xiu.qiu@bigcs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Kar Keung</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Research, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Kin Bong Hubert</ForeName><Initials>KBH</Initials><AffiliationInfo><Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pulm Med</MedlineTA><NlmUniqueID>100968563</NlmUniqueID><ISSNLinking>1471-2466</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011248" MajorTopicYN="N">Pregnancy Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="N">Vitamin D Deficiency</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Fetal blood</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword><Keyword MajorTopicYN="N">Wheeze</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30029599</ArticleId><ArticleId IdType="pmc">PMC6053833</ArticleId><ArticleId IdType="doi">10.1186/s12890-018-0679-4</ArticleId><ArticleId IdType="pii">10.1186/s12890-018-0679-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355(21):2226&#x2013;2235. doi: 10.1056/NEJMra054308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra054308</ArticleId><ArticleId IdType="pubmed">17124020</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WJ, Kang MG, Chang YS, Cho SH. Epidemiology of adult asthma in Asia: toward a better understanding. Asia Pac Allergy. 2014;4(2):75&#x2013;85. doi: 10.5415/apallergy.2014.4.2.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.5415/apallergy.2014.4.2.75</ArticleId><ArticleId IdType="pmc">PMC4005350</ArticleId><ArticleId IdType="pubmed">24809012</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X. Trends in asthma prevalence, health care use, and mortality in the United States, 2001&#x2013;2010. NCHS data brief, no 94. Hyattsville, MD: National Center for Health Statistics. 2012(94):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22617340</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266&#x2013;281. doi: 10.1056/NEJMra070553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra070553</ArticleId><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>Halicioglu O, Aksit S, Koc F, Akman SA, Albudak E, Yaprak I, Coker I, Colak A, Ozturk C, Gulec ES. Vitamin D deficiency in pregnant women and their neonates in spring time in western Turkey. Paediatr Perinat Epidemiol. 2012;26(1):53&#x2013;60. doi: 10.1111/j.1365-3016.2011.01238.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3016.2011.01238.x</ArticleId><ArticleId IdType="pubmed">22150708</ArticleId></ArticleIdList></Reference><Reference><Citation>Salle BL, Delvin EE, Lapillonne A, Bishop NJ, Glorieux FH. Perinatal metabolism of vitamin D. Am J Clin Nutr. 2000;71(5 Suppl):1317S&#x2013;1324S. doi: 10.1093/ajcn/71.5.1317s.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/71.5.1317s</ArticleId><ArticleId IdType="pubmed">10799409</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandevijvere S, Amsalkhir S, Van Oyen H, Moreno-Reyes R. High prevalence of vitamin D deficiency in pregnant women: a national cross-sectional survey. PLoS One. 2012;7(8):e43868. doi: 10.1371/journal.pone.0043868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043868</ArticleId><ArticleId IdType="pmc">PMC3427250</ArticleId><ArticleId IdType="pubmed">22937114</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuri-Bulos N, Lang RD, Blevins M, Kudyba K, Lawrence L, Davidson M, Faouri S, Halasa NB. Vitamin D deficiency among newborns in Amman, Jordan. Glob J Health Sci. 2014;6(1):162&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825452</ArticleId><ArticleId IdType="pubmed">24373276</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieth Streym S, Kristine Moller U, Rejnmark L, Heickendorff L, Mosekilde L, Vestergaard P. Maternal and infant vitamin D status during the first 9 months of infant life-a cohort study. Eur J Clin Nutr. 2013;67(10):1022&#x2013;1028. doi: 10.1038/ejcn.2013.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2013.152</ArticleId><ArticleId IdType="pubmed">24002039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzetto S, Carraro S, Giordano G, Boner A, Baraldi E. Asthma, allergy and respiratory infections: the vitamin D hypothesis. Allergy. 2012;67(1):10&#x2013;17. doi: 10.1111/j.1398-9995.2011.02711.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2011.02711.x</ArticleId><ArticleId IdType="pubmed">21933195</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurmatov U, Devereux G, Sheikh A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J Allergy Clin Immunol. 2011;127(3):724&#x2013;733 e721&#x2013;730. doi: 10.1016/j.jaci.2010.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2010.11.001</ArticleId><ArticleId IdType="pubmed">21185068</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey NC, Holroyd C, Ntani G, Javaid K, Cooper P, Moon R, Cole Z, Tinati T, Godfrey K, Dennison E, et al. Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess. 2014;18(45):1&#x2013;190. doi: 10.3310/hta18450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta18450</ArticleId><ArticleId IdType="pmc">PMC4124722</ArticleId><ArticleId IdType="pubmed">25025896</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckhaus AA, Garcia-Marcos L, Forno E, Pacheco-Gonzalez RM, Celedon JC, Castro-Rodriguez JA. Maternal nutrition during pregnancy and risk of asthma, wheeze, and atopic diseases during childhood: a systematic review and meta-analysis. Allergy. 2015;70(12):1588&#x2013;1604. doi: 10.1111/all.12729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.12729</ArticleId><ArticleId IdType="pubmed">26296633</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006&#x2013;1012. doi: 10.1016/j.jclinepi.2009.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.005</ArticleId><ArticleId IdType="pubmed">19631508</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen SY, Xiao WQ, Lu JH, Lam KB, Qiu X, Cheng KK. Maternal and infant vitamin D status in relation to asthma and allergic diseases: a systematic review and meta-analysis. 2013.</Citation></Reference><Reference><Citation>Higgins JPT, Altman DG, JAC S. Chapter 8 Assessing risk of bias in included studies. In: JPT H, Green S, editors. Cochrane Handbookfor systematic reviews of interventions. London: Cochrane Collaboration; 2011.</Citation></Reference><Reference><Citation>Cochrane. Tool to Assess Risk of Bias in Cohort Studies. 2013; http://methods.cochrane.org/bias/sites/methods.cochrane.org.bias/files/public/uploads/Tool%20to%20Assess%20Risk%20of%20Bias%20in%20Cohort%20Studies.pdf. Accessed August, 2017.</Citation></Reference><Reference><Citation>Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53&#x2013;58. doi: 10.1210/jc.2010-2704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2010-2704</ArticleId><ArticleId IdType="pmc">PMC3046611</ArticleId><ArticleId IdType="pubmed">21118827</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale CR, Robinson SM, Harvey NC, Javaid MK, Jiang B, Martyn CN, Godfrey KM, Cooper C. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr. 2008;62(1):68&#x2013;77. doi: 10.1038/sj.ejcn.1602680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejcn.1602680</ArticleId><ArticleId IdType="pmc">PMC2629513</ArticleId><ArticleId IdType="pubmed">17311057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AP, Palmer D, Zhang G, Prescott SL. Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy. Pediatrics. 2012;130(5):e1128&#x2013;e1135. doi: 10.1542/peds.2012-1172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-1172</ArticleId><ArticleId IdType="pubmed">23090338</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike KC, Inskip HM, Robinson S, Lucas JS, Cooper C, Harvey NC, Godfrey KM, Roberts G. Maternal late-pregnancy serum 25-hydroxyvitamin D in relation to childhood wheeze and atopic outcomes. Thorax. 2012;67(11):950&#x2013;956. doi: 10.1136/thoraxjnl-2012-201888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2012-201888</ArticleId><ArticleId IdType="pmc">PMC3679514</ArticleId><ArticleId IdType="pubmed">22707522</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothers J, Wright AL, Stern DA, Halonen M, Camargo Jr CA: Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. J Allergy Clin Immunol 2011, 128(5):1093&#x2013;1099.e1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3205280</ArticleId><ArticleId IdType="pubmed">21855975</ArticleId></ArticleIdList></Reference><Reference><Citation>Cates CJ. Simpson&#x2019;s paradox and calculation of number needed to treat from meta-analysis. BMC Med Res Methodol. 2002;2:3. doi: 10.1186/1471-2288-2-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-2-1</ArticleId><ArticleId IdType="pmc">PMC65632</ArticleId><ArticleId IdType="pubmed">11860604</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane. Revman 5. 2014; http://community.cochrane.org/tools/review-production-tools/revman-5. Accessed August, 2017.</Citation></Reference><Reference><Citation>Goldring ST, Griffiths CJ, Martineau AR, Robinson S, Yu C, Poulton S, Kirkby JC, Stocks J, Hooper R, Shaheen SO, et al. Prenatal vitamin d supplementation and child respiratory health: a randomised controlled trial. PLoS One. 2013;8(6):e66627. doi: 10.1371/journal.pone.0066627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0066627</ArticleId><ArticleId IdType="pmc">PMC3691177</ArticleId><ArticleId IdType="pubmed">23826104</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawes BL, Bonnelykke K, Stokholm J, Vissing NH, Bjarnadottir E, Schoos AM, Wolsk HM, Pedersen TM, Vinding RK, Thorsteinsdottir S, et al. Effect of vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: a randomized clinical trial. JAMA. 2016;315(4):353&#x2013;361. doi: 10.1001/jama.2015.18318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.18318</ArticleId><ArticleId IdType="pubmed">26813208</ArticleId></ArticleIdList></Reference><Reference><Citation>Litonjua AA, Carey VJ, Laranjo N, Harshfield BJ, McElrath TF, O'Connor GT, Sandel M, Iverson RE, Jr, Lee-Paritz A, Strunk RC, et al. Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial. JAMA. 2016;315(4):362&#x2013;370. doi: 10.1001/jama.2015.18589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.18589</ArticleId><ArticleId IdType="pmc">PMC7479967</ArticleId><ArticleId IdType="pubmed">26813209</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jongh RT, Crozier SR, D'Angelo S, Pike KC, Roberts G, Lucas JS, Inskip H, Godfrey KM, Cooper C, Harvey NC. Maternal 25-hydroxyvitamin D levels in relation to offspring respiratory symptoms and infections. Eur Respir J. 2014;43(4):1181&#x2013;1183. doi: 10.1183/09031936.00116913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00116913</ArticleId><ArticleId IdType="pmc">PMC3973533</ArticleId><ArticleId IdType="pubmed">24337044</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales E, Romieu I, Guerra S, Ballester F, Rebagliato M, Vioque J, Tardon A, Rodriguez Delhi C, Arranz L, Torrent M, et al. Maternal vitamin D status in pregnancy and risk of lower respiratory tract infections, wheezing, and asthma in offspring. Epidemiology. 2012;23(1):64&#x2013;71. doi: 10.1097/EDE.0b013e31823a44d3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e31823a44d3</ArticleId><ArticleId IdType="pubmed">22082994</ArticleId></ArticleIdList></Reference><Reference><Citation>Zosky GR, Hart PH, Whitehouse AJ, Kusel MM, Ang W, Foong RE, Chen L, Holt PG, Sly PD, Hall GL. Vitamin D deficiency at 16 to 20 weeks&#x2019; gestation is associated with impaired lung function and asthma at 6 years of age. Ann Am Thorac Soc. 2014;11(4):571&#x2013;577. doi: 10.1513/AnnalsATS.201312-423OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201312-423OC</ArticleId><ArticleId IdType="pubmed">24601713</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslova E, Hansen S, Thorne-Lyman AL, Jensen CB, Strom M, Cohen A, Nielsen NO, Olsen SF. Predicted vitamin D status in mid-pregnancy and child allergic disease. Pediatr Allergy Immunol. 2014;25(7):706&#x2013;713. doi: 10.1111/pai.12295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12295</ArticleId><ArticleId IdType="pubmed">25348236</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AK, Shaheen SO, Granell R, Henderson AJ, Fraser WD, Lawlor DA. Maternal 25-hydroxyvitamin D and its association with childhood atopic outcomes and lung function. Clin Exp Allergy. 2013;43(10):1180&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814422</ArticleId><ArticleId IdType="pubmed">24074336</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus MC, Stene LC, Nafstad P, Stigum H, London SJ, Nystad W. Prospective study of maternal mid-pregnancy 25-hydroxyvitamin D level and early childhood respiratory disorders. Paediatr Perinat Epidemiol. 2013;27(6):532&#x2013;541. doi: 10.1111/ppe.12080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ppe.12080</ArticleId><ArticleId IdType="pmc">PMC3811147</ArticleId><ArticleId IdType="pubmed">24134527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CY, Huang SY, Peng YC, Tsai MH, Hua MC, Yao TC, Yeh KW, Huang JL. Maternal vitamin D levels are inversely related to allergic sensitization and atopic diseases in early childhood. Pediatr Allergy Immunol. 2015;26(4):337&#x2013;343. doi: 10.1111/pai.12384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12384</ArticleId><ArticleId IdType="pubmed">25847488</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen S, Maslova E, Strom M, Linneberg A, Halldorsson TI, Granstrom C, Dahl R, Hoffmann HJ, Olsen SF. The long-term programming effect of maternal 25-hydroxyvitamin D in pregnancy on allergic airway disease and lung function in offspring after 20 to 25 years of follow-up. J Allergy Clin Immunol. 2015;136(1):169&#x2013;176. doi: 10.1016/j.jaci.2014.12.1924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.12.1924</ArticleId><ArticleId IdType="pubmed">25649083</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazibara T, den Dekker HT, de Jongste JC, McGrath JJ, Eyles DW, Burne TH, Reiss IK, Franco OH, Tiemeier H, Jaddoe VW, et al. Associations of maternal and fetal 25-hydroxyvitamin D levels with childhood lung function and asthma: the generation R study. Clin Exp Allergy. 2016;46(2):337&#x2013;346. doi: 10.1111/cea.12645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12645</ArticleId><ArticleId IdType="pubmed">26399470</ArticleId></ArticleIdList></Reference><Reference><Citation>Baiz N, Dargent-Molina P, Wark JD, Souberbielle JC, Annesi-Maesano I. Cord serum 25-hydroxyvitamin D and risk of early childhood transient wheezing and atopic dermatitis. J Allergy Clin Immunol. 2014;133(1):147&#x2013;153. doi: 10.1016/j.jaci.2013.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2013.05.017</ArticleId><ArticleId IdType="pubmed">23810764</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo CA, Jr, Thadhani R, Silvers KM, Pattemore PK, Espinola JA, Crane J, Dench C, Duignan M, Epton MJ, Fishwick D, et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011;127(1):e180&#x2013;e187. doi: 10.1542/peds.2010-0442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-0442</ArticleId><ArticleId IdType="pubmed">21187313</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelmach I, Majak P, Jerzynska J, Podlecka D, Stelmach W, Polanska K, Gromadzinska J, Wasowicz W, Hanke W. Cord serum 25-hydroxyvitamin D correlates with early childhood viral-induced wheezing. Respir Med. 2015;109(1):38&#x2013;43. doi: 10.1016/j.rmed.2014.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2014.10.016</ArticleId><ArticleId IdType="pubmed">25468413</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawes BL, Bonnelykke K, Jensen PF, Schoos AM, Heickendorff L, Bisgaard H. Cord blood 25(OH)-vitamin D deficiency and childhood asthma, allergy and eczema: the COPSAC2000 birth cohort study. PLoS One. 2014;9(6):e99856. doi: 10.1371/journal.pone.0099856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099856</ArticleId><ArticleId IdType="pmc">PMC4055727</ArticleId><ArticleId IdType="pubmed">24925304</ArticleId></ArticleIdList></Reference><Reference><Citation>Junge KM, Bauer T, Geissler S, Hirche F, Thurmann L, Bauer M, Trump S, Bieg M, Weichenhan D, Gu L, et al. Increased vitamin D levels at birth and in early infancy increase offspring allergy risk-evidence for involvement of epigenetic mechanisms. J Allergy Clin Immunol. 2016;137(2):610&#x2013;613. doi: 10.1016/j.jaci.2015.06.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.06.040</ArticleId><ArticleId IdType="pubmed">26282283</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer DJ, Sullivan TR, Skeaff CM, Smithers LG, Makrides M. Higher cord blood 25-hydroxyvitamin D concentrations reduce the risk of early childhood eczema: in children with a family history of allergic disease. World Allergy Organ J. 2015;8(1):28. doi: 10.1186/s40413-015-0077-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40413-015-0077-9</ArticleId><ArticleId IdType="pmc">PMC4594897</ArticleId><ArticleId IdType="pubmed">26487907</ArticleId></ArticleIdList></Reference><Reference><Citation>Visness CM, Sandel MT, O'Connor G, Gern JE, Jaffee KF, Wood RA, Kattan M, Bloomberg GR, Dresen A, Gergen PJ, et al. Cord blood vitamin D concentrations are unrelated to atopy and wheeze in 2 diverse birth cohort studies. J Allergy Clin Immunol. 2015;136(4):1108&#x2013;1110. doi: 10.1016/j.jaci.2015.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.03.046</ArticleId><ArticleId IdType="pmc">PMC4600422</ArticleId><ArticleId IdType="pubmed">25979524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolsk HM, Harshfield BJ, Laranjo N, Carey VJ, O'Connor G, Sandel M, Strunk RC, Bacharier LB, Zeiger RS, Schatz M, et al. Vitamin D supplementation in pregnancy, prenatal 25(OH)D levels, race, and subsequent asthma or recurrent wheeze in offspring: secondary analyses from the vitamin D antenatal asthma reduction trial. J Allergy Clin Immunol. 2017;140(5):1423&#x2013;29.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28285844</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollams EM, Teo SM, Kusel M, Holt BJ, Holt KE, Inouye M, De Klerk NH, Zhang G, Sly PD, Hart PH, et al. Vitamin D over the first decade and susceptibility to childhood allergy and asthma. J Allergy Clin Immunol. 2017;139(2):472&#x2013;481. doi: 10.1016/j.jaci.2016.07.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.07.032</ArticleId><ArticleId IdType="pubmed">27726947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegienka G, Havstad S, Zoratti EM, Kim H, Ownby DR, Johnson CC. Association between vitamin D levels and allergy-related outcomes vary by race and other factors. J Allergy Clin Immunol. 2015;136(5):1309&#x2013;1314 e1301-1304. doi: 10.1016/j.jaci.2015.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.04.017</ArticleId><ArticleId IdType="pmc">PMC4640935</ArticleId><ArticleId IdType="pubmed">26078105</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake Y, Sasaki S, Tanaka K, Hirota Y. Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants. Eur Respir J. 2010;35(6):1228&#x2013;1234. doi: 10.1183/09031936.00100609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00100609</ArticleId><ArticleId IdType="pubmed">19840962</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereux G, Litonjua AA, Turner SW, Craig LCA, McNeill G, Martindale S, Helms PJ, Seaton A, Weiss ST. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007;85(3):853&#x2013;859. doi: 10.1093/ajcn/85.3.853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/85.3.853</ArticleId><ArticleId IdType="pubmed">17344509</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan KM, Prabhu N, Craig LC, McNeill G, Kirby B, McLay J, Helms PJ, Ayres JG, Seaton A, Turner SW, et al. Maternal vitamin D and E intakes during pregnancy are associated with asthma in children. Eur Respir J. 2015;45(4):1027&#x2013;1036. doi: 10.1183/09031936.00102214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00102214</ArticleId><ArticleId IdType="pubmed">25359350</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo CA, Jr, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, Kleinman K, Gillman MW. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007;85(3):788&#x2013;795. doi: 10.1093/ajcn/85.3.788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/85.3.788</ArticleId><ArticleId IdType="pmc">PMC4406411</ArticleId><ArticleId IdType="pubmed">17344501</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslova E, Hansen S, Jensen CB, Thorne-Lyman AL, Strom M, Olsen SF. Vitamin D intake in mid-pregnancy and child allergic disease -- a prospective study in 44,825 Danish mother-child pairs. BMC Pregnancy Childbirth. 2013;13(1):199. doi: 10.1186/1471-2393-13-199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2393-13-199</ArticleId><ArticleId IdType="pmc">PMC3871013</ArticleId><ArticleId IdType="pubmed">24176134</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S, Nevalainen J, Veijola R, Pekkanen J, Ilonen J, Simell O, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009;39(6):875&#x2013;882. doi: 10.1111/j.1365-2222.2009.03234.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2009.03234.x</ArticleId><ArticleId IdType="pubmed">19522996</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake Y, Tanaka K, Okubo H, Sasaki S, Arakawa M. Maternal consumption of dairy products, calcium, and vitamin D during pregnancy and infantile allergic disorders. Ann Allergy Asthma Immunol. 2014;113(1):82&#x2013;87. doi: 10.1016/j.anai.2014.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2014.04.023</ArticleId><ArticleId IdType="pubmed">24950846</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson LN, Chen Y, Omand JA, Birken CS, Parkin PC, To T. Maguire JL. Vitamin D exposure during pregnancy, but not early childhood, is associated with risk of childhood wheezing. J Dev Orig Health Dis. 2015;6(4):308&#x2013;316. doi: 10.1017/S2040174415001063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S2040174415001063</ArticleId><ArticleId IdType="pubmed">25885931</ArticleId></ArticleIdList></Reference><Reference><Citation>Back O, Blomquist HK, Hernell O, Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol. 2009;89(1):28&#x2013;32. doi: 10.2340/00015555-0541.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/00015555-0541</ArticleId><ArticleId IdType="pubmed">19197538</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypponen E, Sovio U, Wjst M, Patel S, Pekkanen J, Hartikainen AL, Jarvelinb MR. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci. 2004;1037:84&#x2013;95. doi: 10.1196/annals.1337.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1337.013</ArticleId><ArticleId IdType="pubmed">15699498</ArticleId></ArticleIdList></Reference><Reference><Citation>von Mutius E, Martinez FD. Inconclusive results of randomized trials of prenatal vitamin D for asthma prevention in offspring: curbing the enthusiasm. JAMA. 2016;315(4):347&#x2013;348. doi: 10.1001/jama.2015.18963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.18963</ArticleId><ArticleId IdType="pubmed">26813205</ArticleId></ArticleIdList></Reference><Reference><Citation>Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007;120(5):1031&#x2013;1035. doi: 10.1016/j.jaci.2007.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2007.08.028</ArticleId><ArticleId IdType="pubmed">17919705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wjst M. Is vitamin D supplementation responsible for the allergy pandemic? Curr Opin Allergy Clin Immunol. 2012;12(3):257&#x2013;262. doi: 10.1097/ACI.0b013e3283535833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACI.0b013e3283535833</ArticleId><ArticleId IdType="pubmed">22517291</ArticleId></ArticleIdList></Reference><Reference><Citation>Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76&#x2013;89. doi: 10.1016/S2213-8587(13)70165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(13)70165-7</ArticleId><ArticleId IdType="pubmed">24622671</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke H, Leonardi-Bee J, Hashim A, Pine-Abata H, Chen Y, Cook DG, Britton JR, McKeever TM. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012;129(4):735&#x2013;744. doi: 10.1542/peds.2011-2196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2011-2196</ArticleId><ArticleId IdType="pubmed">22430451</ArticleId></ArticleIdList></Reference><Reference><Citation>King ME, Mannino DM, Holguin F. Risk factors for asthma incidence. A review of recent prospective evidence. Panminerva Med. 2004;46(2):97&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">15507879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasahara AK, Singh RJ, Noymer A. Vitamin D (25OHD) serum seasonality in the United States. PLoS One. 2013;8(6):e65785. doi: 10.1371/journal.pone.0065785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065785</ArticleId><ArticleId IdType="pmc">PMC3689782</ArticleId><ArticleId IdType="pubmed">23805188</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KS, Assar S, Vanderschueren D, Bouillon R, Prentice A, Schoenmakers I. Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in the Gambia and the UK. Osteoporos Int. 2015;26(3):1137&#x2013;1146. doi: 10.1007/s00198-014-2905-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-014-2905-0</ArticleId><ArticleId IdType="pmc">PMC4331602</ArticleId><ArticleId IdType="pubmed">25278297</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J. 1999;14(4):951&#x2013;957. doi: 10.1034/j.1399-3003.1999.14d37.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3003.1999.14d37.x</ArticleId><ArticleId IdType="pubmed">10573248</ArticleId></ArticleIdList></Reference><Reference><Citation>Canova C, Harris JM, Mills P, White C, Moffat S, Shread L, Cullinan P. Epidemiological measures of childhood asthma: cross-sectional and longitudinal consistency. Respir Med. 2012;106(9):1226&#x2013;1235. doi: 10.1016/j.rmed.2012.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2012.05.008</ArticleId><ArticleId IdType="pubmed">22705292</ArticleId></ArticleIdList></Reference><Reference><Citation>Depner M, Fuchs O, Genuneit J, Karvonen AM, Hyvarinen A, Kaulek V, Roduit C, Weber J, Schaub B, Lauener R, et al. Clinical and epidemiologic phenotypes of childhood asthma. Am J Respir Crit Care Med. 2014;189(2):129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">24283801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornish RP, Henderson J, Boyd AW, Granell R, Van Staa T, Macleod J. Validating childhood asthma in an epidemiological study using linked electronic patient records. BMJ Open. 2014;4(4):e005345. doi: 10.1136/bmjopen-2014-005345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-005345</ArticleId><ArticleId IdType="pmc">PMC4010849</ArticleId><ArticleId IdType="pubmed">24760357</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassim R, Russell MA, Lodge CJ, Lowe AJ, Koplin JJ, Dharmage SC. The role of circulating 25 hydroxyvitamin D in asthma: a systematic review. Allergy. 2015;70(4):339&#x2013;354. doi: 10.1111/all.12583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.12583</ArticleId><ArticleId IdType="pubmed">25631639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40167125</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1399-3038</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</Title><ISOAbbreviation>Pediatr Allergy Immunol</ISOAbbreviation></Journal><ArticleTitle>Bedding materials and early infant wheezing: A randomised controlled trial.</ArticleTitle><Pagination><StartPage>e70073</StartPage><MedlinePgn>e70073</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70073</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/pai.70073</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Various observational studies have suggested that infants and young children who regularly sleep in synthetic bedding materials are more likely to experience wheezing and asthma, while children who use feather duvets and/or feather pillows are less likely to wheeze.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In Wellington, New Zealand, we conducted a three-armed, parallel, randomised trial of 460 infants who were assigned to use different bedding materials: synthetic, wool or feather bedding in the form of sleepsacks from 3&#x2009;months of age to 2&#x2009;years of age to test the hypothesis that children exposed to feather materials are less likely to develop wheezing. Pregnant women were recruited before birth. Parents were unaware of the primary research hypothesis and were told this was a study of child warmth and wheezing. We have reported wheezing (parental and GP), a variety of respiratory health parameters and atopic status at 2&#x2009;years.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred and forty-seven infants received a synthetic sleepsack, 150 wool and 144 feather. We have found no significant differences in reported or doctor-diagnosed wheezing or other respiratory health measures by bedding material used. For frequency of wheezing presentation at GP surgery, there was a significant increased rate for children using feather materials compared to synthetic, relative rate 2.00 (95% CI: 1.14, 3.52).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study does not support earlier observational studies that suggest higher rates of wheezing for children using synthetic bedding or lower rates for feather materials, at least for early childhood wheezing. Our study suggests that the explanation for the observational study findings may lie in selection bias, where the parents of at-risk children avoid feather bedding materials.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halley</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Janice</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0007-1049-0866</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Phillipa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keall</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebers</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6359-3144</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>T&#x16b; Kot&#x101;hi M&#x101;ori Asthma and Research Trust, Lower Hutt, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howden-Chapman</LastName><ForeName>Philippa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crane</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Otago Wellington, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>New Zealand Government</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pediatr Allergy Immunol</MedlineTA><NlmUniqueID>9106718</NlmUniqueID><ISSNLinking>0905-6157</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="Y">Respiratory Sounds</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001512" MajorTopicYN="Y">Bedding and Linens</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005241" MajorTopicYN="N">Feathers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N" Type="Geographic">New Zealand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">allergy</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">bedding</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">infants</Keyword><Keyword MajorTopicYN="N">wheezing</Keyword></KeywordList><CoiStatement>None of the authors have any conflicts of interest to declare with regard to this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>1</Day><Hour>11</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>1</Day><Hour>11</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>1</Day><Hour>7</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40167125</ArticleId><ArticleId IdType="pmc">PMC11960039</ArticleId><ArticleId IdType="doi">10.1111/pai.70073</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strachan D, Carey I. The home environment and severe asthma in adolescence: a population based case control study. BMJ. 1995;311:1053&#x2010;1056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2551362</ArticleId><ArticleId IdType="pubmed">7580660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp T, Siebers R, Fishwich D, O'Grady G, Fitzharris P, Crane J. House dust mite allergen in pillows. BMJ. 1996;313:916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2352227</ArticleId><ArticleId IdType="pubmed">8876094</ArticleId></ArticleIdList></Reference><Reference><Citation>Rains N, Siebers R, Rains N, Crane J, Fitzharris P. House dust mite allergen (Der p 1) accumulation on new synthetic and feather pillows. Clin Exp Allergy. 1999;29(2):182&#x2010;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">10051721</ArticleId></ArticleIdList></Reference><Reference><Citation>Strachan D, Carey I. Reduced risk of wheezing in children using feather pillows is confirmed. BMJ. 1997;314:518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2125974</ArticleId><ArticleId IdType="pubmed">9056820</ArticleId></ArticleIdList></Reference><Reference><Citation>Custovic A, Hallam C, Woodcock H, et&#xa0;al. Synthetic pillows contain higher levels of cat and dog allergen than feather pillows. Pediatr Allergy Immunol. 2000;11(2):71&#x2010;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">10893007</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafstad P, Nystad W, Jaakkola JJ. The use of a feather quilt, childhood asthma and allergic rhinitis: a prospective cohort study. Clin Exp Allergy. 2002;32(8):1150&#x2010;1154.</Citation><ArticleIdList><ArticleId IdType="pubmed">12190650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponsonby A, Dwyer T, Kemp A, Cochrane J, Couper D, Carmichael A. Synthetic bedding and wheeze in childhood. Epidemiology. 2003;14:37&#x2010;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">12500044</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell F, Jones K. Feather vs. non&#x2010;feather bedding for asthma. Cochrane Database Syst Rev. 2000;2000(4):CD002154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437889</ArticleId><ArticleId IdType="pubmed">11034743</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebers R, Crane J. Does bedding affect the airway and allergy? Int J Occup Environ Med. 2011;2(2):65&#x2010;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">23022822</ArticleId></ArticleIdList></Reference><Reference><Citation>Trevillian L, Ponsonby A, Dwyer T, et&#xa0;al. Infant sleeping environment and asthma at 7&#x2009;years: a prospective cohort study. Am J Public Health. 2005;95(12):2238&#x2010;2245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1449513</ArticleId><ArticleId IdType="pubmed">16304135</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . WHO Housing and health guidelines. Geneva: World Health Organization. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">30566314</ArticleId></ArticleIdList></Reference><Reference><Citation>ASCIA . Skin prick testing working party. Skin prick testing from the diagnosis of allergic disease. 2016.</Citation></Reference><Reference><Citation>Epton M, Town G, Ingham T, et&#xa0;al. The New Zealand infant cohort study: assembly, demographics and investigations. BMC Public Health. 2007;7:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1819373</ArticleId><ArticleId IdType="pubmed">17397526</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponsonby AL, Kemp A, Dwyer T, Carmichael A, Couper D, Cochrane J. Feather bedding and house dust mite sensitization and airway disease in childhood. J Clin Epidemiol. 2002;55(6):556&#x2010;562.</Citation><ArticleIdList><ArticleId IdType="pubmed">12063097</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasgow NJ, Ponsonby AL, Kemp A, et&#xa0;al. Feather bedding and childhood asthma associated with house dust mite sensitisation: a randomised controlled trial. Arch Dis Child. 2011;96(6):541&#x2010;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3093241</ArticleId><ArticleId IdType="pubmed">21451166</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JM, Platts&#x2010;Mills TAE. Home environmental interventions for house dust mite. J Allergy Clin Immunol Pract. 2018;6(1):1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6474366</ArticleId><ArticleId IdType="pubmed">29310755</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CS, Foden P, Sumner H, Shepley E, Custovic A, Simpson A. Preventing severe asthma exacerbations in children. A randomized trial of mite&#x2010;impermeable bedcovers. Am J Respir Crit Care Med. 2017;196(2):150&#x2010;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">28282501</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaakkola JJ, Oie L, Nafstad P, Botten G, Samuelsen SO, Magnus P. Interior surface materials in the home and the development of bronchial obstruction in young children in Oslo, Norway. Am J Public Health. 1999;89(2):188&#x2010;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508530</ArticleId><ArticleId IdType="pubmed">9949747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpio K, Makinen&#x2010;Kiljunen S, Haahtela T, Hannuksela M. Allergy to feathers. Allergy. 1998;53(2):159&#x2010;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">9534914</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie J, Wickens K, Siebers R, et&#xa0;al. Wheezing and rash associated with endotoxin exposure in a birth cohort of New Zealand children. J Allergy Clin Immunol. 2006;118(6):1265&#x2010;1270.</Citation><ArticleIdList><ArticleId IdType="pubmed">17157655</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams H, McNicol KN. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study. Br Med J. 1969;4(679):321&#x2010;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1629591</ArticleId><ArticleId IdType="pubmed">5386265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25530053</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1735-9694</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>12</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Acta medica Iranica</Title><ISOAbbreviation>Acta Med Iran</ISOAbbreviation></Journal><ArticleTitle>Coincidence of asthma and bronchospasm during anesthesia in tympanomastoidectomy.</ArticleTitle><Pagination><StartPage>905</StartPage><EndPage>908</EndPage><MedlinePgn>905-8</MedlinePgn></Pagination><Abstract><AbstractText>High prevalence of asthma and bronchospasm was observed during induction of anesthesia in patients with chronic suppurative otitis mMedia (CSOM) who underwent tympanomastoidectomy. Although several studies have proposed association of allergic diseases with CSOM but no consensus about it has been established. Current study was designed to determine the coincidence of asthma in CSOM patients. In a cross-sectional study, authors investigated medical records of 106 CSOM patients underwent tympanomastoidectomy, aged 15 to 65 years, and 95 controls, which were matched by age and sex. Participants were admitted to Valiasr Hospital, Tehran, Iran, from April of 2011 to March of 2013. Required information, such as demographic characteristics and history of allergic rhinitis (AR) and asthma were obtained from patients' medical records. The prevalence of AR in the CSOM group was higher than controls' group (19.8% and 15.8%, respectively) (P&gt;0.05). Asthma prevalence was significantly higher in patients with CSOM (P=0.03) (OR=7.67, 95% CI: &#xa0;0.9-62.5). No significant association was found between history of AR and chronic ear infections. However, asthma was significantly more common in CSOM patients. Current study indicates that asthma and risk of bronchospasm need particular attention in patients with CSOM underwent tympanomastoidectomy before and during anesthesia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hosseinzadeh</LastName><ForeName>Nima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. nima_hd87@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samadi</LastName><ForeName>Shahram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. sh_samadi@sina.tums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amali</LastName><ForeName>Amin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. a_amali@sina.tums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafari Javid</LastName><ForeName>Mihan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. mihanjavid@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Acta Med Iran</MedlineTA><NlmUniqueID>14540050R</NlmUniqueID><ISSNLinking>0044-6025</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N">Iran</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010035" MajorTopicYN="N">Otitis Media, Suppurative</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065631" MajorTopicYN="N">Rhinitis, Allergic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25530053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36660020</PMID><DateRevised><Year>2023</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1687-6962</ISSN><JournalIssue CitedMedium="Print"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Anesthesiology research and practice</Title><ISOAbbreviation>Anesthesiol Res Pract</ISOAbbreviation></Journal><ArticleTitle>Perioperative Respiratory Outcome of Patients with Eosinophilia: A Cohort Study in a Tertiary Care Hospital.</ArticleTitle><Pagination><StartPage>8514949</StartPage><MedlinePgn>8514949</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8514949</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2023/8514949</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">A respiratory adverse event is one of the main causes of critical events in the perioperative period. Perioperative distress symptoms like cough and stridor have been reported to occur in patients with hyperreactive airways.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study was conducted to determine the relationship between blood eosinophil count and perioperative adverse respiratory events among different age groups of patients who require general anesthesia for different types of surgeries.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A cohort study was conducted on 197 patients of either gender, aged 3&#x2009;years and above, belonging to ASA classes I-II, who were scheduled to undergo surgery requiring general anesthesia and intubation. Patients were stratified according to absolute eosinophil count into two groups: Group A (AEC 0 to 499/mm<sup>3</sup>) and Group B (AEC 500 to 1000/mm<sup>3</sup>). Patients were monitored for 24&#x2009;hours in the perioperative period for adverse respiratory events such as bronchospasm, laryngospasm, a fall in SPO2&#x2009;&lt;&#x2009;95%, and cough and stridor.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 197 patients were evaluated, with a median age of 37&#x2009;&#xb1;&#x2009;14.4&#x2009;years. The percentage range of adverse respiratory events across different age groups was 35% in adults to 60% in children. Major complications noted were a fall in SPO2&#x2009;&lt;&#x2009;95% (62.5%) and cough (27.7%) as per CTCAE v5.0 (November 27, 2017). The Naranjo score of adverse respiratory events was categorized as possible with mild level 1 severity. Adverse respiratory events were managed with humidified oxygen, antitussives, and bronchodilators.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Eosinophilia is seen in one-third of the patients undergoing surgical interventions. Patients with a blood eosinophil count of &#x2265;400/mm<sup>3</sup> had an increased risk of exacerbations of respiratory adverse events in the perioperative period.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Nari M. Lyngdoh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyngdoh</LastName><ForeName>Nari M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0002-6619-2987</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thabah</LastName><ForeName>Rajani</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2397-4775</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Sunny</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7599-7077</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sailo</LastName><ForeName>Laltanpuii</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6177-4654</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shakya</LastName><ForeName>Raju</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2408-2429</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahlang</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2918-8265</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shylla</LastName><ForeName>Badondor</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6737-8505</Identifier><AffiliationInfo><Affiliation>Nursing College, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naskar</LastName><ForeName>Chhandasi</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0363-0422</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, NEIGRIHMS, Mawdiangdiang, Shillong 793018, Meghalaya, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiol Res Pract</MedlineTA><NlmUniqueID>101532982</NlmUniqueID><ISSNLinking>1687-6962</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>2</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36660020</ArticleId><ArticleId IdType="pmc">PMC9845031</ArticleId><ArticleId IdType="doi">10.1155/2023/8514949</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Warner D. O., Warner M. A., Barnes R. D., et al. Perioperative respiratory complications in patients with asthma. Anesthesiology . 1996;85(3):460&#x2013;467. doi: 10.1097/00000542-199609000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199609000-00003</ArticleId><ArticleId IdType="pubmed">8853074</ArticleId></ArticleIdList></Reference><Reference><Citation>Parameswara G. Anesthetic concerns in patients with hyper-reactive airways. Karnataka Anaesthesia Journal . 2015 Jan 1;1(1):8&#x2013;16. doi: 10.4103/2394-6954.149714.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2394-6954.149714</ArticleId></ArticleIdList></Reference><Reference><Citation>Shomali W., Gotlib J. World Health Organization&#x2010;defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. American Journal of Hematology . 2019;94(10):1149&#x2013;1167. doi: 10.1002/ajh.25617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25617</ArticleId><ArticleId IdType="pubmed">31423623</ArticleId></ArticleIdList></Reference><Reference><Citation>Leru P. M. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Clinical and Translational Allergy . 2019;9(1):36&#x2013;39. doi: 10.1186/s13601-019-0277-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13601-019-0277-4</ArticleId><ArticleId IdType="pmc">PMC6657042</ArticleId><ArticleId IdType="pubmed">31367340</ArticleId></ArticleIdList></Reference><Reference><Citation>Travers J., Rothenberg M. E. Eosinophils in mucosal immune responses. Mucosal Immunology . 2015;8(3):464&#x2013;475. doi: 10.1038/mi.2015.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2015.2</ArticleId><ArticleId IdType="pmc">PMC4476057</ArticleId><ArticleId IdType="pubmed">25807184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravin K. A., Loy M. The eosinophil in infection. Clinical Reviews in Allergy and Immunology . 2016;50(2):214&#x2013;227. doi: 10.1007/s12016-015-8525-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-015-8525-4</ArticleId><ArticleId IdType="pubmed">26690368</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee L. Y., Gu Q., Lin A. H., Khosravi M., Gleich G. Airway hypersensitivity induced by eosinophil granule-derived cationic proteins. Pulmonary Pharmacology and Therapeutics . 2019;57 doi: 10.1016/j.pupt.2019.101804.101804</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2019.101804</ArticleId><ArticleId IdType="pubmed">31096035</ArticleId></ArticleIdList></Reference><Reference><Citation>Schleich F. N., Manise M., Sele J., Henket M., Seidel L., Louis R. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilicvsneutrophilic inflammation. BMC Pulmonary Medicine . 2013 Dec;13(1):11&#x2013;18. doi: 10.1186/1471-2466-13-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2466-13-11</ArticleId><ArticleId IdType="pmc">PMC3657295</ArticleId><ArticleId IdType="pubmed">23442497</ArticleId></ArticleIdList></Reference><Reference><Citation>Miravitlles M., Soler-Catalu&#xf1;a J. J., Soriano J. B., et al. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study. Respiratory Research . 2022;23(1):49&#x2013;50. doi: 10.1186/s12931-022-01965-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-01965-3</ArticleId><ArticleId IdType="pmc">PMC8897916</ArticleId><ArticleId IdType="pubmed">35248041</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelmeier C. F., Kostikas K., Fang J., et al. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations. Respiratory Research . 2019;20(1):178&#x2013;180. doi: 10.1186/s12931-019-1130-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1130-y</ArticleId><ArticleId IdType="pmc">PMC6686508</ArticleId><ArticleId IdType="pubmed">31391053</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S., Brightling C. E. Eosinophilic airway inflammation in COPD. International Journal of COPD . 2006;1(1):39&#x2013;47. doi: 10.2147/copd.2006.1.1.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/copd.2006.1.1.39</ArticleId><ArticleId IdType="pmc">PMC2706606</ArticleId><ArticleId IdType="pubmed">18046901</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotlib J., Cross N. C., Gilliland D. G. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy. Best Practice and Research Clinical Haematology . 2006;19(3):535&#x2013;569. doi: 10.1016/j.beha.2005.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2005.07.013</ArticleId><ArticleId IdType="pubmed">16781488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Kaur A., Suri A. K., Kaur P., Bansal M., Kaur R. Incidence of eosinophilia in rural population in north India: a study at tertiary care hospital. Annals of Pathology and Laboratory Medicine . 2017;4(1):0&#x2013;4. doi: 10.21276/apalm.2017.1044.</Citation><ArticleIdList><ArticleId IdType="doi">10.21276/apalm.2017.1044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki S. Adverse drug reaction and causality assessment scales. Lung India . 2011;28(2):p. 152. doi: 10.4103/0970-2113.80343.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-2113.80343</ArticleId><ArticleId IdType="pmc">PMC3109846</ArticleId><ArticleId IdType="pubmed">21712934</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan R., Ramya G. Adverse drug reaction-causality assessment. International Journal of Research in Pharmacy and Chemistry . 2011;1(3):606&#x2013;612.</Citation></Reference><Reference><Citation>Louis R., Sele J., Henket M., et al. Sputum eosinophil count in a large population of patients with mild to moderate steroid-naive asthma: distribution and relationship with methacholine bronchial hyperresponsiveness. Allergy . 2002;57(10):907&#x2013;912. doi: 10.1034/j.1398-9995.2002.23608.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1398-9995.2002.23608.x</ArticleId><ArticleId IdType="pubmed">12269936</ArticleId></ArticleIdList></Reference><Reference><Citation>Stella S., Massimino M., Manzella L., et al. Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes. International Journal of Molecular Sciences . 2021;22(2):p. 486. doi: 10.3390/ijms22020486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020486</ArticleId><ArticleId IdType="pmc">PMC7825323</ArticleId><ArticleId IdType="pubmed">33418988</ArticleId></ArticleIdList></Reference><Reference><Citation>Insiripong S., Siriyakorn N. Treatment of eosinophilia with albendazole. Southeast Asian Journal of Tropical Medicine and Public Health . 2008;39(3):p. 517.</Citation><ArticleIdList><ArticleId IdType="pubmed">18564693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharanunni S., Varma N., Singh Sachdeva M. U., et al. The spectrum of hypereosinophilia and associated clonal disorders&#x2013;a real world data from a tropical setting. Mediterranean Journal of Hematology and Infectious Diseases . 2018;10(1) doi: 10.4084/mjhid.2018.052.e2018052</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/mjhid.2018.052</ArticleId><ArticleId IdType="pmc">PMC6131107</ArticleId><ArticleId IdType="pubmed">30210745</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhumitha S., Eswaran Y., Jayaganesh P. Study on peripheral eosinophilia among paediatric patients in a tertiary care hospital. Journal of Clinical and Diagnostic Research . 2019;13(9)</Citation></Reference><Reference><Citation>Gurrieri C., Weingarten T. N., Martin D. P., et al. Allergic reactions during anesthesia at a large United States referral center. Anesthesia and Analgesia . 2011;113(5):1202&#x2013;1212. doi: 10.1213/ane.0b013e31822d45ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31822d45ac</ArticleId><ArticleId IdType="pubmed">21865494</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S., McLeod M., Torchia D., Romanelli P. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. The Journal of clinical and aesthetic dermatology . 2013;6(6):31&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718748</ArticleId><ArticleId IdType="pubmed">23882307</ArticleId></ArticleIdList></Reference><Reference><Citation>Roufosse F., Weller P. F. Practical approach to the patient with hypereosinophilia. The Journal of Allergy and Clinical Immunology . 2010;126(1):39&#x2013;44. doi: 10.1016/j.jaci.2010.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2010.04.011</ArticleId><ArticleId IdType="pmc">PMC2902584</ArticleId><ArticleId IdType="pubmed">20538328</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37780080</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6965</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of asthma and allergy</Title><ISOAbbreviation>J Asthma Allergy</ISOAbbreviation></Journal><ArticleTitle>The Effects of a Healthy Diet on Asthma and Wheezing in Children and Adolescents: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1007</StartPage><EndPage>1024</EndPage><MedlinePgn>1007-1024</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JAA.S423884</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Asthma is a public health problem requiring focused attention. This study aimed to systematically evaluate the association between dietary structure and asthma or wheezing in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The study protocol of this meta-analysis has been registered in the International Prospective Register of Systematic Reviews (PROSPERO) with the registration code CRD42023390191. A total of 8397 articles were retrieved, searching PubMed, Medline, Embase, Web of Science, and Scopus databases as of November 21, 2022. Two independent authors were responsible for independently conducting the literature screening process. Effect-size estimates were expressed as odds ratio (OR) in cross-sectional studies and risk ratio (RR) in cohort studies with a 95% confidence interval (CI). Summary effect estimates were evaluated with random-effect models. Meanwhile, subgroup and sensitivity analyses were performed to assess the potential sources of heterogeneity and the robustness of the pooled estimation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 65 studies, including 567,426 subjects had been analyzed. Overall analyses of cross-sectional studies revealed that a healthy diet was protective against asthma (adjusted OR=0.85, 95% CI: 0.80-0.89, P &lt;0.001, I<sup>2</sup>=69.8%, Tau<sup>2</sup>=0.026) and wheezing (adjusted OR=0.85, 95% CI: 0.81-0.89, P &lt;0.001, I<sup>2</sup>=66.8%, Tau<sup>2</sup>=0.015) in children and adolescents. Conversely, unhealthy diets can exacerbate asthma (adjusted OR=1.28, 95% CI: 1.20-1.36, P &lt;0.001, I<sup>2</sup>=64.9%, Tau<sup>2</sup>=0.019) and wheeze (adjusted OR=1.09, 95% CI: 1.02-1.16, P =0.006, I<sup>2</sup>=75.2%, Tau<sup>2</sup>=0.023) in children and adolescents. The same trend was found in cohort studies (adjusted RR=0.72, 95% CI: 0.58-0.90, P =0.003, I<sup>2</sup>=83.5%, Tau<sup>2</sup>=0.105). A clear trend was observed between high-frequency healthy diets (OR=0.80; 95% CI: 0.71-0.89; P &lt;0.001) is more protective against asthma than low-frequency healthy diets (OR=0.81; 95% CI: 0.70-0.94; P =0.007).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our findings highlight the protective effects of a healthy diet on asthma and wheezing in children, including fruit, seafood, cereals, and the Mediterranean diet.</AbstractText><CopyrightInformation>&#xa9; 2023 Zhang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Mengyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Graduate School, Beijing University of Chinese Medicine, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Qiduo</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0009-0003-1495-0111</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongming</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Clinical Research Center for Respiratory Diseases, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chaoyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Asthma Allergy</MedlineTA><NlmUniqueID>101543450</NlmUniqueID><ISSNLinking>1178-6965</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">dietary habits</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">wheezing</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37780080</ArticleId><ArticleId IdType="pmc">PMC10541225</ArticleId><ArticleId IdType="doi">10.2147/JAA.S423884</ArticleId><ArticleId IdType="pii">423884</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Porsbjerg C, Melen E, Lehtimaki L, Shaw D. Asthma. Lancet. 2023;401(10379):858&#x2013;873. doi:10.1016/S0140-6736(22)02125-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02125-0</ArticleId><ArticleId IdType="pubmed">36682372</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern J, Pier J, Litonjua AA. Asthma epidemiology and risk factors. Semin Immunopathol. 2020;42(1):5&#x2013;15. doi:10.1007/s00281-020-00785-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-020-00785-1</ArticleId><ArticleId IdType="pubmed">32020334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortimer K, Lesosky M, Garcia-Marcos L, et al. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. Eur Respir J. 2022;60(3):2102865. doi:10.1183/13993003.02865-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02865-2021</ArticleId><ArticleId IdType="pmc">PMC9474894</ArticleId><ArticleId IdType="pubmed">35210319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawankar R, Canonica GW, Holgate ST, Lockey RF, Blaiss MS. WAO White Book on Allergy. Vol. 3. Milwaukee, WI: World Allergy Organization; 2011:156&#x2013;157.</Citation></Reference><Reference><Citation>Melen E, Koppelman GH, Vicedo-Cabrera AM, Andersen ZJ, Bunyavanich S. Allergies to food and airborne allergens in children and adolescents: role of epigenetics in a changing environment. Lancet Child Adolesc Health. 2022;6(11):810&#x2013;819. doi:10.1016/S2352-4642(22)00215-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00215-2</ArticleId><ArticleId IdType="pubmed">35985346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Pacheco N, Kere M, Melen E. Gene-environment interactions in childhood asthma revisited; expanding the interaction concept. Pediatr Allergy Immunol. 2022;33(5):e13780. doi:10.1111/pai.13780</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13780</ArticleId><ArticleId IdType="pmc">PMC9325482</ArticleId><ArticleId IdType="pubmed">35616899</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisgaard H, Stokholm J, Chawes BL, et al. Fish oil-derived fatty acids in pregnancy and wheeze and asthma in offspring. N Engl J Med. 2016;375(26):2530&#x2013;2539. doi:10.1056/NEJMoa1503734</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1503734</ArticleId><ArticleId IdType="pubmed">28029926</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstegen REM, Kostadinova AI, Merenciana Z, et al. Dietary fibers: effects, underlying mechanisms and possible role in allergic asthma management. Nutrients. 2021;13(11):4153. doi:10.3390/nu13114153</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13114153</ArticleId><ArticleId IdType="pmc">PMC8621630</ArticleId><ArticleId IdType="pubmed">34836408</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthon BS, Macdonald-Wicks LK, Gibson PG, Wood LG. Investigation of the association between dietary intake, disease severity and airway inflammation in asthma. Respirology. 2013;18(3):447&#x2013;454. doi:10.1111/resp.12015</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.12015</ArticleId><ArticleId IdType="pubmed">23145908</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccaro JA, Niego J, Huffman FG. Dietary factors, body weight, and screen time in U.S. children with and without asthma. Children&#x2019;s Health Care. 2016;45(1):22&#x2013;38. doi:10.1080/02739615.2014.948165</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02739615.2014.948165</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad SH, Bateman B, Matthews SM. Primary prevention of asthma and atopy during childhood by allergen avoidance in infancy: a randomised controlled study. Thorax. 2003;58(6):489&#x2013;493. doi:10.1136/thorax.58.6.489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.58.6.489</ArticleId><ArticleId IdType="pmc">PMC1746711</ArticleId><ArticleId IdType="pubmed">12775858</ArticleId></ArticleIdList></Reference><Reference><Citation>Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol. 2017;15(1):55&#x2013;63. doi:10.1038/nrmicro.2016.142</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.142</ArticleId><ArticleId IdType="pubmed">27694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzi L, Apostolaki G, Bibakis I, et al. Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax. 2007;62(8):677&#x2013;683. doi:10.1136/thx.2006.069419</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.069419</ArticleId><ArticleId IdType="pmc">PMC2117278</ArticleId><ArticleId IdType="pubmed">17412780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini B, Berthon BS, Wark P, Wood LG. Effects of fruit and vegetable consumption on risk of asthma, wheezing and immune responses: a systematic review and meta-analysis. Nutrients. 2017;9(4). doi:10.3390/nu9040341</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9040341</ArticleId><ArticleId IdType="pmc">PMC5409680</ArticleId><ArticleId IdType="pubmed">28353635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogenkamp A, Ehlers A, Garssen J, Willemsen LEM. Allergy modulation by N-3 Long chain polyunsaturated fatty acids and fat soluble nutrients of the mediterranean diet. Front Pharmacol. 2020;11:1244. doi:10.3389/fphar.2020.01244</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01244</ArticleId><ArticleId IdType="pmc">PMC7472571</ArticleId><ArticleId IdType="pubmed">32973501</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigham EP, Woo H, McCormack M, et al. Omega-3 and Omega-6 intake modifies asthma severity and response to indoor air pollution in children. Am J Respir Crit Care Med. 2019;199(12):1478&#x2013;1486. doi:10.1164/rccm.201808-1474OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201808-1474OC</ArticleId><ArticleId IdType="pmc">PMC6580674</ArticleId><ArticleId IdType="pubmed">30922077</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams EJ, Berthon BS, Stoodley I, Williams LM, Wood LG. Nutrition in Asthma. Semin Respir Crit Care Med. 2022;43(5):646&#x2013;661. doi:10.1055/s-0042-1742385</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1742385</ArticleId><ArticleId IdType="pubmed">35272384</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, Rinaldi AO, Celebi Sozener Z, et al. The influence of dietary fatty acids on immune responses. Nutrients. 2019;11(12):2990. doi:10.3390/nu11122990</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11122990</ArticleId><ArticleId IdType="pmc">PMC6950146</ArticleId><ArticleId IdType="pubmed">31817726</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter C, Greenhawt M, Meyer RW, et al. EAACI position paper on diet diversity in pregnancy, infancy and childhood: novel concepts and implications for studies in allergy and asthma. Allergy. 2020;75(3):497&#x2013;523. doi:10.1111/all.14051</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14051</ArticleId><ArticleId IdType="pubmed">31520486</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Xun P, Zamora D, et al. Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am J Clin Nutr. 2013;97(1):173&#x2013;178. doi:10.3945/ajcn.112.041145</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.112.041145</ArticleId><ArticleId IdType="pmc">PMC3522136</ArticleId><ArticleId IdType="pubmed">23193002</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaheen SO, Northstone K, Newson RB, Emmett PM, Sherriff A, Henderson AJ. Dietary patterns in pregnancy and respiratory and atopic outcomes in childhood. Thorax. 2009;64(5):411&#x2013;417. doi:10.1136/thx.2008.104703</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2008.104703</ArticleId><ArticleId IdType="pubmed">19213776</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S, Custovic A, Smith JA, Simpson A, Kerry G, Murray CS. Cross-sectional association of dietary patterns with asthma and atopic sensitization in childhood - in a cohort study. Pediatr Allergy Immunol. 2014;25(6):565&#x2013;571. doi:10.1111/pai.12276</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12276</ArticleId><ArticleId IdType="pubmed">25201630</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwarith J, Kahleova H, Crosby L, et al. The role of nutrition in asthma prevention and treatment. Nutr Rev. 2020;78(11):928&#x2013;938. doi:10.1093/nutrit/nuaa005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuaa005</ArticleId><ArticleId IdType="pmc">PMC7550896</ArticleId><ArticleId IdType="pubmed">32167552</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilleminault L, Williams EJ, Scott HA, Berthon BS, Jensen M, Wood LG. Diet and asthma: is it time to adapt our message? Nutrients. 2017;9(11):1227. doi:10.3390/nu9111227</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9111227</ArticleId><ArticleId IdType="pmc">PMC5707699</ArticleId><ArticleId IdType="pubmed">29117118</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Cao L, Wang Z, Wang Z. Dietary meat intake and risk of asthma in children: evidence from a meta-analysis. Medicine. 2020;99(1):e18235. doi:10.1097/MD.0000000000018235</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000018235</ArticleId><ArticleId IdType="pmc">PMC6946446</ArticleId><ArticleId IdType="pubmed">31895767</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219. doi:10.1136/bmj.326.7382.219</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.326.7382.219</ArticleId><ArticleId IdType="pmc">PMC1125071</ArticleId><ArticleId IdType="pubmed">12543843</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey OJ, Cookson JB, Britton J, Tattersfield AE. The effect of lifestyle on wheeze, atopy, and bronchial hyperreactivity in Asian and white children. Am J Respir Crit Care Med. 1996;154(2 Pt 1):537&#x2013;540. doi:10.1164/ajrccm.154.2.8756835</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.154.2.8756835</ArticleId><ArticleId IdType="pubmed">8756835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge L, Salome CM, Peat JK, Haby MM, Xuan W, Woolcock AJ. Consumption of oily fish and childhood asthma risk. Med J Aust. 1996;164(3):137&#x2013;140. doi:10.5694/j.1326-5377.1996.tb122010.x</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.1996.tb122010.x</ArticleId><ArticleId IdType="pubmed">8628130</ArticleId></ArticleIdList></Reference><Reference><Citation>Forastiere F, Pistelli R, Sestini P, et al. Consumption of fresh fruit rich in vitamin C and wheezing symptoms in children. SIDRIA Collaborative Group, Italy (Italian Studies on Respiratory Disorders in Children and the Environment). Thorax. 2000;55(4):283&#x2013;288. doi:10.1136/thorax.55.4.283</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.55.4.283</ArticleId><ArticleId IdType="pmc">PMC1745721</ArticleId><ArticleId IdType="pubmed">10722767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijazi N, Abalkhail B, Seaton A. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia. Thorax. 2000;55(9):775&#x2013;779. doi:10.1136/thorax.55.9.775</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.55.9.775</ArticleId><ArticleId IdType="pmc">PMC1745853</ArticleId><ArticleId IdType="pubmed">10950897</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SL, Lin KC, Pan WH. Dietary factors associated with physician-diagnosed asthma and allergic rhinitis in teenagers: analyses of the first Nutrition and Health Survey in Taiwan. Clin Exp Allergy. 2001;31(2):259&#x2013;264. doi:10.1046/j.1365-2222.2001.00938.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2222.2001.00938.x</ArticleId><ArticleId IdType="pubmed">11251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Takemura Y, Sakurai Y, Honjo S, et al. The relationship between fish intake and the prevalence of asthma: the Tokorozawa childhood asthma and pollinosis study. Prev Med. 2002;34(2):221&#x2013;225. doi:10.1006/pmed.2001.0978</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/pmed.2001.0978</ArticleId><ArticleId IdType="pubmed">11817918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafstad P, Nystad W, Magnus P, Jaakkola JJ. Asthma and allergic rhinitis at 4 years of age in relation to fish consumption in infancy. J Asthma. 2003;40(4):343&#x2013;348. doi:10.1081/JAS-120018633</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/JAS-120018633</ArticleId><ArticleId IdType="pubmed">12870829</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijga AH, Smit HA, Kerkhof M, et al. Association of consumption of products containing milk fat with reduced asthma risk in pre-school children: the PIAMA birth cohort study. Thorax. 2003;58(7):567&#x2013;572. doi:10.1136/thorax.58.7.567</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.58.7.567</ArticleId><ArticleId IdType="pmc">PMC1746729</ArticleId><ArticleId IdType="pubmed">12832666</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir AU, Karakaya G, Bozkurt B, Sekerel BE, Kalyoncu AF. Asthma and allergic diseases in schoolchildren: third cross-sectional survey in the same primary school in Ankara, Turkey. Pediatr Allergy Immunol. 2004;15(6):531&#x2013;538. doi:10.1111/j.1399-3038.2004.00202.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2004.00202.x</ArticleId><ArticleId IdType="pubmed">15610367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong GW, Ko FW, Hui DS, et al. Factors associated with difference in prevalence of asthma in children from three cities in China: multicentre epidemiological survey. BMJ. 2004;329(7464):486. doi:10.1136/bmj.329.7464.486</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.329.7464.486</ArticleId><ArticleId IdType="pmc">PMC515199</ArticleId><ArticleId IdType="pubmed">15331473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JL, Elfman L, Mi Y, Johansson M, Smedje G, Norb&#xe4;ck D. Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment. Indoor Air. 2005;15(3):170&#x2013;182. doi:10.1111/j.1600-0668.2005.00334.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0668.2005.00334.x</ArticleId><ArticleId IdType="pubmed">15865617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis SA, Antoniak M, Venn AJ, et al. Secondhand smoke, dietary fruit intake, road traffic exposures, and the prevalence of asthma: a cross-sectional study in young children. Am J Epidemiol. 2005;161(5):406&#x2013;411. doi:10.1093/aje/kwi059</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwi059</ArticleId><ArticleId IdType="pubmed">15718476</ArticleId></ArticleIdList></Reference><Reference><Citation>Nj&#xe5; F, Nystad W, L&#xf8;drup Carlsen KC, Hetlevik O, Carlsen KH. Effects of early intake of fruit or vegetables in relation to later asthma and allergic sensitization in school-age children. Acta Paediatrica. 2005;94(2):147&#x2013;154. doi:10.1080/08035250410023638</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08035250410023638</ArticleId><ArticleId IdType="pubmed">15981746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickens K, Barry D, Friezema A, et al. Fast foods - are they a risk factor for asthma? Allergy. 2005;60(12):1537&#x2013;1541. doi:10.1111/j.1398-9995.2005.00945.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2005.00945.x</ArticleId><ArticleId IdType="pubmed">16266387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SJ, Lee MS, Lee SY, et al. High body mass index and dietary pattern are associated with childhood asthma. Pediatr Pulmonol. 2006;41(12):1118&#x2013;1124. doi:10.1002/ppul.20372</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.20372</ArticleId><ArticleId IdType="pubmed">17068825</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastorino AC, Rimazza RD, Leone C, Castro AP, Sol&#xe9; D, Jacob CM. Risk factors for asthma in adolescents in a large urban region of Brazil. J Asthma. 2006;43(9):695&#x2013;700. doi:10.1080/02770900600925544</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770900600925544</ArticleId><ArticleId IdType="pubmed">17092851</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabak C, Wijga AH, de Meer G, Janssen NA, Brunekreef B, Smit HA. Diet and asthma in Dutch school children (ISAAC-2). Thorax. 2006;61(12):1048&#x2013;1053. doi:10.1136/thx.2005.043034</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2005.043034</ArticleId><ArticleId IdType="pmc">PMC2117046</ArticleId><ArticleId IdType="pubmed">16244092</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzi L, Torrent M, Romieu I, et al. Diet, wheeze, and atopy in school children in Menorca, Spain. Pediatr Allergy Immunol. 2007;18(6):480&#x2013;485. doi:10.1111/j.1399-3038.2007.00596.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2007.00596.x</ArticleId><ArticleId IdType="pubmed">17680906</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Marcos L, Canflanca IM, Garrido JB, et al. Relationship of asthma and rhinoconjunctivitis with obesity, exercise and Mediterranean diet in Spanish schoolchildren. Thorax. 2007;62(6):503&#x2013;508. doi:10.1136/thx.2006.060020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.060020</ArticleId><ArticleId IdType="pmc">PMC2117202</ArticleId><ArticleId IdType="pubmed">17251311</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoko BJ, Burney PG, Newson RB, Potts JF, Shaheen SO. Childhood asthma and fruit consumption. Eur Respir J. 2007;29(6):1161&#x2013;1168. doi:10.1183/09031936.00097806</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00097806</ArticleId><ArticleId IdType="pubmed">17301090</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai HJ, Tsai AC. The association of diet with respiratory symptoms and asthma in schoolchildren in Taipei, Taiwan. J Asthma. 2007;44(8):599&#x2013;603. doi:10.1080/02770900701539509</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770900701539509</ArticleId><ArticleId IdType="pubmed">17943568</ArticleId></ArticleIdList></Reference><Reference><Citation>Waser M, Michels KB, Bieli C, et al. Inverse association of farm milk consumption with asthma and allergy in rural and suburban populations across Europe. Clin Exp Allergy. 2007;37(5):661&#x2013;670. doi:10.1111/j.1365-2222.2006.02640.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2006.02640.x</ArticleId><ArticleId IdType="pubmed">17456213</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbo GM, Forastiere F, De Sario M, et al. Wheeze and asthma in children: associations with body mass index, sports, television viewing, and diet. Epidemiology. 2008;19(5):747&#x2013;755. doi:10.1097/EDE.0b013e3181776213</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181776213</ArticleId><ArticleId IdType="pubmed">18496466</ArticleId></ArticleIdList></Reference><Reference><Citation>de Batlle J, Garcia-Aymerich J, Barraza-Villarreal A, Ant&#xf3; JM, Romieu I. Mediterranean diet is associated with reduced asthma and rhinitis in Mexican children. Allergy. 2008;63(10):1310&#x2013;1316. doi:10.1111/j.1398-9995.2008.01722.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2008.01722.x</ArticleId><ArticleId IdType="pubmed">18782109</ArticleId></ArticleIdList></Reference><Reference><Citation>Foliaki S, Annesi-Maesano I, Tuuau-Potoi N, et al. Risk factors for symptoms of childhood asthma, allergic rhinoconjunctivitis and eczema in the Pacific: an ISAAC Phase III study. Int J Tuberc Lung Dis. 2008;12(7):799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">18544207</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia E, Aristizabal G, Vasquez C, Rodriguez-Martinez CE, Sarmiento OL, Satizabal CL. Prevalence of and factors associated with current asthma symptoms in school children aged 6&#x2013;7 and 13&#x2013;14 yr old in Bogot&#xe1;, Colombia. Pediatr Allergy Immunol. 2008;19(4):307&#x2013;314. doi:10.1111/j.1399-3038.2007.00650.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2007.00650.x</ArticleId><ArticleId IdType="pubmed">18208464</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Delgado RI, Barraza-Villarreal A, Escamilla-N&#xfa;&#xf1;ez MC, Solano-Gonz&#xe1;lez M, Moreno-Mac&#xed;as H, Romieu I. Consumo de alimentos y asma en ni&#xf1;os escolares de Cuernavaca [Food consumption and asthma in school children in Cuernavaca, Morelos, Mexico]. Salud Publica Mex. 2009;51(3):202&#x2013;211. Spanish. doi:10.1590/S0036-36342009000300010</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0036-36342009000300010</ArticleId><ArticleId IdType="pubmed">19967305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai XM, Becker AB, Liem JJ, Kozyrskyj AL. Fast food consumption counters the protective effect of breastfeeding on asthma in children? Clin Exp Allergy. 2009;39(4):556&#x2013;561. doi:10.1111/j.1365-2222.2008.03169.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2008.03169.x</ArticleId><ArticleId IdType="pubmed">19159404</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez Barcala FJ, Pertega S, Bamonde L, et al. Mediterranean diet and asthma in Spanish schoolchildren. Pediatr Allergy Immunol. 2010;21(7):1021&#x2013;1027. doi:10.1111/j.1399-3038.2010.01080.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2010.01080.x</ArticleId><ArticleId IdType="pubmed">20561232</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Rodr&#xed;guez E, Perea JM, Jim&#xe9;nez AI, Rodr&#xed;guez-Rodr&#xed;guez P, L&#xf3;pez-Sobaler AM, Ortega RM. Fat intake and asthma in Spanish schoolchildren. Eur J Clin Nutr. 2010;64(10):1065&#x2013;1071. doi:10.1038/ejcn.2010.127</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejcn.2010.127</ArticleId><ArticleId IdType="pubmed">20664620</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvaniti F, Priftis KN, Papadimitriou A, et al. Adherence to the Mediterranean type of diet is associated with lower prevalence of asthma symptoms, among 10&#x2013;12 years old children: the PANACEA study. Pediatr Allergy Immunol. 2011;22(3):283&#x2013;289. doi:10.1111/j.1399-3038.2010.01113.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2010.01113.x</ArticleId><ArticleId IdType="pubmed">21457335</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvaniti F, Priftis KN, Papadimitriou A, et al. Salty-snack eating, television or video-game viewing, and asthma symptoms among 10- to 12-year-old children: the PANACEA study. J Am Diet Assoc. 2011;111(2):251&#x2013;257. doi:10.1016/j.jada.2010.10.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jada.2010.10.051</ArticleId><ArticleId IdType="pubmed">21272699</ArticleId></ArticleIdList></Reference><Reference><Citation>Goks&#xf6;r E, Alm B, Thengilsdottir H, Pettersson R, &#xc5;berg N, Wennergren G. Preschool wheeze - impact of early fish introduction and neonatal antibiotics. Acta Paediatrica. 2011;100(12):1561&#x2013;1566. doi:10.1111/j.1651-2227.2011.02411.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2011.02411.x</ArticleId><ArticleId IdType="pubmed">21767307</ArticleId></ArticleIdList></Reference><Reference><Citation>Willers SM, Wijga AH, Brunekreef B, et al. Childhood diet and asthma and atopy at 8 years of age: the PIAMA birth cohort study. Eur Respir J. 2011;37(5):1060&#x2013;1067. doi:10.1183/09031936.00106109</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00106109</ArticleId><ArticleId IdType="pubmed">21109553</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiefte-de Jong JC, de Vries JH, Franco OH, et al. Fish consumption in infancy and asthma-like symptoms at preschool age. Pediatrics. 2012;130(6):1060&#x2013;1068. doi:10.1542/peds.2012-0875</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-0875</ArticleId><ArticleId IdType="pubmed">23147966</ArticleId></ArticleIdList></Reference><Reference><Citation>Goks&#xf6;r E, Alm B, Pettersson R, et al. Early fish introduction and neonatal antibiotics affect the risk of asthma into school age. Pediatr Allergy Immunol. 2013;24(4):339&#x2013;344. doi:10.1111/pai.12078</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12078</ArticleId><ArticleId IdType="pmc">PMC3712479</ArticleId><ArticleId IdType="pubmed">23577718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson JA, Rennie DC, Dosman JA, Cammer AL, Senthilselvan A. Obesity, diet, and activity in relation to asthma and wheeze among rural dwelling children and adolescents. J Obes. 2013;2013:315096. doi:10.1155/2013/315096</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/315096</ArticleId><ArticleId IdType="pmc">PMC3804370</ArticleId><ArticleId IdType="pubmed">24191194</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcay A, Tamay Z, Hocaoglu AB, Ergin A, Guler N. Risk factors affecting asthma prevalence in adolescents living in Istanbul, Turkey. Allergologia Et Immunopathologia. 2014;42(5):449&#x2013;458. doi:10.1016/j.aller.2013.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aller.2013.05.005</ArticleId><ArticleId IdType="pubmed">23969072</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Innocenzo S, Matos SM, Prado MS, et al. Padr&#xe3;o alimentar, asma e sibilo at&#xf3;pico e n&#xe3;o at&#xf3;pico em crian&#xe7;as e adolescentes: estudo SCAALA, Salvador, Bahia, Brasil [Dietary pattern, asthma, and atopic and non-atopic wheezing in children and adolescents: SCAALA study, Salvador, Bahia State, Brazil]. Cad Saude Publica. 2014;30(9):1849&#x2013;1860. Spanish. doi:10.1590/0102-311x00165513</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0102-311x00165513</ArticleId><ArticleId IdType="pubmed">25317514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepeda AM, Del Giacco SR, Villalba S, et al. A traditional diet is associated with a reduced risk of eczema and wheeze in colombian children. Nutrients. 2015;7(7):5098&#x2013;5110. doi:10.3390/nu7075098</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7075098</ArticleId><ArticleId IdType="pmc">PMC4516989</ArticleId><ArticleId IdType="pubmed">26121530</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes de Luna Mde F, Gomes de Luna JR, Fisher GB, de Almeida PC, Chiesa D, Carlos da Silva MG. Factors associated with asthma in adolescents in the city of Fortaleza, Brazil. J Asthma. 2015;52(5):485&#x2013;491. doi:10.3109/02770903.2014.984841</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02770903.2014.984841</ArticleId><ArticleId IdType="pubmed">25405360</ArticleId></ArticleIdList></Reference><Reference><Citation>Han YY, Forno E, Brehm JM, et al. Diet, interleukin-17, and childhood asthma in Puerto Ricans. Ann Allergy Asthma Immunol. 2015;115(4):288&#x2013;293.e281. doi:10.1016/j.anai.2015.07.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2015.07.020</ArticleId><ArticleId IdType="pmc">PMC4721241</ArticleId><ArticleId IdType="pubmed">26319606</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumia M, Takkinen HM, Luukkainen P, et al. Food consumption and risk of childhood asthma. Pediatr Allergy Immunol. 2015;26(8):789&#x2013;796. doi:10.1111/pai.12352</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12352</ArticleId><ArticleId IdType="pubmed">25693000</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulou A, Panagiotakos DB, Hatziagorou E, et al. Antioxidant foods consumption and childhood asthma and other allergic diseases: the Greek cohorts of the ISAAC II survey. Allergologia Et Immunopathologia. 2015;43(4):353&#x2013;360. doi:10.1016/j.aller.2014.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aller.2014.03.002</ArticleId><ArticleId IdType="pubmed">25097022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice JL, Romero KM, Galvez Davila RM, et al. Association between adherence to the mediterranean diet and asthma in peruvian children. Lung. 2015;193(6):893&#x2013;899. doi:10.1007/s00408-015-9792-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-015-9792-9</ArticleId><ArticleId IdType="pmc">PMC4651981</ArticleId><ArticleId IdType="pubmed">26335393</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadeh D, Salameh P, Caillaud D, et al. Prevalence and association of asthma and allergic sensitization with dietary factors in schoolchildren: data from the French six cities study. BMC Public Health. 2015;15(1):993. doi:10.1186/s12889-015-2320-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-015-2320-2</ArticleId><ArticleId IdType="pmc">PMC4589972</ArticleId><ArticleId IdType="pubmed">26423141</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani JM, Asaad AM, Awadalla NJ, Mahfouz AA. Environmental determinants of bronchial asthma among Saudi school children in Southwestern Saudi Arabia. Int J Environ Res Public Health. 2016;14(1):22. doi:10.3390/ijerph14010022</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph14010022</ArticleId><ArticleId IdType="pmc">PMC5295273</ArticleId><ArticleId IdType="pubmed">28036050</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng M, Yang Z, Pan L, et al. Associations of early life exposures and environmental factors with asthma among children in rural and urban areas of Guangdong, China. Chest. 2016;149(4):1030&#x2013;1041. doi:10.1016/j.chest.2015.12.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2015.12.028</ArticleId><ArticleId IdType="pubmed">26836923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascarenhas JM, Silva Rde C, Assis AM, Pinto Ede J, Concei&#xe7;&#xe3;o JS, Barreto ML. Symptoms of asthma and associated factors in adolescents from Salvador, Bahia. Revista brasileira de epidemiologia. 2016;19(1):181&#x2013;193. doi:10.1590/1980-5497201600010016</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1980-5497201600010016</ArticleId><ArticleId IdType="pubmed">27167659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallit S, Raherison C, Abou Abdallah R, Hallit R, Salameh P. Correlation of types of food and asthma diagnosis in childhood: a case-control study. J Asthma. 2018;55(9):966&#x2013;974. doi:10.1080/02770903.2017.1379535</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2017.1379535</ArticleId><ArticleId IdType="pubmed">28925766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SY, Song WJ, Kim MH, et al. Dietary assessment and the development of asthma in Korean adolescents and adults. Allergy. 2018;73(11):2254&#x2013;2256. doi:10.1111/all.13554</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13554</ArticleId><ArticleId IdType="pubmed">29987846</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo B, Rezende L, Machado P, Gouveia N, Levy R. Associations of ultra-processed food and drink products with asthma and wheezing among Brazilian adolescents. Pediatr Allergy Immunol. 2018;29(5):504&#x2013;511. doi:10.1111/pai.12911</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12911</ArticleId><ArticleId IdType="pubmed">29679410</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias BC, Silva JB, Mais LA, Warkentin S, Konstantyner T, Sol&#xe9; D. Factors associated with asthma in Brazilian adolescents: National Adolescent School-Based Health Survey (Pense-2012). Revista Paulista de Pediatria. 2019;37(4):406&#x2013;413. doi:10.1590/1984-0462/;2019;37;4;00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1984-0462/;2019;37;4;00002</ArticleId><ArticleId IdType="pmc">PMC6821479</ArticleId><ArticleId IdType="pubmed">31340242</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaeb D, Hallit S, Sacre H, Malaeb B, Hallit R, Salameh P. Diet and asthma in Lebanese schoolchildren: a cross-sectional study. Pediatr Pulmonol. 2019;54(6):688&#x2013;697. doi:10.1002/ppul.24280</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.24280</ArticleId><ArticleId IdType="pubmed">30920185</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;ien T, Schjelvaag A, Storr&#xf8; O, Johnsen R, Simpson MR. Fish consumption at one year of age reduces the risk of eczema, asthma and wheeze at six years of age. Nutrients. 2019;11(9):1969. doi:10.3390/nu11091969</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11091969</ArticleId><ArticleId IdType="pmc">PMC6770937</ArticleId><ArticleId IdType="pubmed">31438628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence WR, Lin S, Lin Z, et al. Interactions between dietary habits and home environmental exposures on respiratory symptoms in Romanian school children: an analysis of data from the SINPHONIE project. Environ Sci Pollut Res Int. 2020;27(3):2647&#x2013;2657. doi:10.1007/s11356-019-07129-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-019-07129-z</ArticleId><ArticleId IdType="pubmed">31836974</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkosi V, Rathogwa-Takalani F, Voyi K. The frequency of fast food consumption in relation to wheeze and asthma among adolescents in Gauteng and North West Provinces, South Africa. Int J Environ Res Public Health. 2020;17(6):1994. doi:10.3390/ijerph17061994</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17061994</ArticleId><ArticleId IdType="pmc">PMC7143251</ArticleId><ArticleId IdType="pubmed">32197353</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis WP, Chai E, Gaio J, Becerra MB, Banta JE, Dos Santos H. Dietary Factors Associated with Asthma Prevalence Among Children in California. Pediatr Allergy Immunol Pulmonol. 2020;33(2):85&#x2013;91. doi:10.1089/ped.2020.1157</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ped.2020.1157</ArticleId><ArticleId IdType="pmc">PMC8443260</ArticleId><ArticleId IdType="pubmed">35921577</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona-Meza CE, Hanson C, Pollard SL, et al. Dietary patterns and asthma among Peruvian children and adolescents. BMC Pulm Med. 2020;20(1):63. doi:10.1186/s12890-020-1087-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-1087-0</ArticleId><ArticleId IdType="pmc">PMC7071620</ArticleId><ArticleId IdType="pubmed">32171269</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonogeorgos G, Priftis KN, Panagiotakos DB, et al. Exploring the relation between atopic diseases and lifestyle patterns among adolescents living in greece: evidence from the Greek Global Asthma Network (GAN) Cross-Sectional Study. Children. 2021;8(10):932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8534578</ArticleId><ArticleId IdType="pubmed">34682197</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonogeorgos G, Priftis KN, Panagiotakos DB, et al. Parental education and the association between fruit and vegetable consumption and asthma in adolescents: the Greek Global Asthma Network (GAN) Study. Children. 2021;8(4):304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8071508</ArticleId><ArticleId IdType="pubmed">33923381</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes FC, Paci&#xea;ncia I, Cavaleiro Rufo J, et al. Higher diversity of vegetable consumption is associated with less airway inflammation and prevalence of asthma in school-aged children. Pediatr Allergy Immunol. 2021;32(5):925&#x2013;936. doi:10.1111/pai.13446</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13446</ArticleId><ArticleId IdType="pubmed">33394508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JG, Liu B, Kroll F, et al. Increased advanced glycation end product and meat consumption is associated with childhood wheeze: analysis of the National Health and Nutrition Examination Survey. Thorax. 2021;76(3):292&#x2013;294. doi:10.1136/thoraxjnl-2020-216109</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216109</ArticleId><ArticleId IdType="pmc">PMC7892397</ArticleId><ArticleId IdType="pubmed">33443194</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar D, Galffy G, Horvath A, et al. Prevalence of asthma and its associating environmental factors among 6&#x2013;12-year-old schoolchildren in a metropolitan environment-a cross-sectional, questionnaire-based study. Int J Environ Res Public Health. 2021;18(24):13403. doi:10.3390/ijerph182413403</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182413403</ArticleId><ArticleId IdType="pmc">PMC8709131</ArticleId><ArticleId IdType="pubmed">34949011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirshkowitz M, Whiton K, Albert SM, et al. National Sleep Foundation&#x2019;s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1(1):40&#x2013;43. doi:10.1016/j.sleh.2014.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleh.2014.12.010</ArticleId><ArticleId IdType="pubmed">29073412</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv N, Xiao L, Ma J. Dietary pattern and asthma: a systematic review and meta-analysis. J Asthma Allergy. 2014;7:105&#x2013;121. doi:10.2147/JAA.S49960</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JAA.S49960</ArticleId><ArticleId IdType="pmc">PMC4137988</ArticleId><ArticleId IdType="pubmed">25143747</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips JA. Dietary guidelines for Americans, 2020&#x2013;2025. Workplace Health Saf. 2021;69(8):395. doi:10.1177/21650799211026980</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21650799211026980</ArticleId><ArticleId IdType="pubmed">34279148</ArticleId></ArticleIdList></Reference><Reference><Citation>Penard-Morand C, Raherison C, Charpin D, et al. Long-term exposure to close-proximity air pollution and asthma and allergies in urban children. Eur Respir J. 2010;36(1):33&#x2013;40. doi:10.1183/09031936.00116109</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00116109</ArticleId><ArticleId IdType="pubmed">20075054</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 Suppl):1505S&#x2013;1519S. doi:10.1093/ajcn/83.6.1505S</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/83.6.1505S</ArticleId><ArticleId IdType="pubmed">16841861</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavin JL, Jacobs D, Marquart L, Wiemer K. The role of whole grains in disease prevention. J Am Diet Assoc. 2001;101(7):780&#x2013;785. doi:10.1016/S0002-8223(01)00194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8223(01)00194-8</ArticleId><ArticleId IdType="pubmed">11478475</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Rodriguez JA, Garcia-Marcos L, Alfonseda Rojas JD, Valverde-Molina J, Sanchez-Solis M. Mediterranean diet as a protective factor for wheezing in preschool children. J Pediatr. 2008;152(6):823&#x2013;828, 828 e821&#x2013;822. doi:10.1016/j.jpeds.2008.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2008.01.003</ArticleId><ArticleId IdType="pubmed">18492525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan DP; Group IPTS. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Thorax. 2010;65(6):516&#x2013;522. doi:10.1136/thx.2009.128256</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.128256</ArticleId><ArticleId IdType="pubmed">20522849</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellwood P, Asher MI, Garcia-Marcos L, et al. Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) phase three. Thorax. 2013;68(4):351&#x2013;360. doi:10.1136/thoraxjnl-2012-202285</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2012-202285</ArticleId><ArticleId IdType="pubmed">23319429</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick H, Nicklas TA. A review of family and social determinants of children&#x2019;s eating patterns and diet quality. J Am Coll Nutr. 2005;24(2):83&#x2013;92. doi:10.1080/07315724.2005.10719448</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2005.10719448</ArticleId><ArticleId IdType="pubmed">15798074</ArticleId></ArticleIdList></Reference><Reference><Citation>Feunekes GI, de Graaf C, Meyboom S, van Staveren WA. Food choice and fat intake of adolescents and adults: associations of intakes within social networks. Prev Med. 1998;27(5 Pt 1):645&#x2013;656. doi:10.1006/pmed.1998.0341</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/pmed.1998.0341</ArticleId><ArticleId IdType="pubmed">9808794</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellwood P, Asher MI, Bjorksten B, Burr M, Pearce N, Robertson CF. Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group. Eur Respir J. 2001;17(3):436&#x2013;443. doi:10.1183/09031936.01.17304360</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.01.17304360</ArticleId><ArticleId IdType="pubmed">11405522</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Linseisen J. Dietary intake of fatty acids, antioxidants and selected food groups and asthma in adults. Eur J Clin Nutr. 2005;59(1):8&#x2013;15. doi:10.1038/sj.ejcn.1602025</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ejcn.1602025</ArticleId><ArticleId IdType="pubmed">15329676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sausenthaler S, Kompauer I, Borte M, et al. Margarine and butter consumption, eczema and allergic sensitization in children. The LISA birth cohort study. Pediatr Allergy Immunol. 2006;17(2):85&#x2013;93. doi:10.1111/j.1399-3038.2005.00366.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3038.2005.00366.x</ArticleId><ArticleId IdType="pubmed">16618357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte G, Frye C, Hoelscher B, Meyer I, Wjst M, Heinrich J. Margarine consumption and allergy in children. Am J Respir Crit Care Med. 2001;163(1):277&#x2013;279. doi:10.1164/ajrccm.163.1.2006004</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.163.1.2006004</ArticleId><ArticleId IdType="pubmed">11208657</ArticleId></ArticleIdList></Reference><Reference><Citation>Te Morenga L, Montez JM. Health effects of saturated and trans-fatty acid intake in children and adolescents: systematic review and meta-analysis. PLoS One. 2017;12(11):e0186672. doi:10.1371/journal.pone.0186672</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186672</ArticleId><ArticleId IdType="pmc">PMC5693282</ArticleId><ArticleId IdType="pubmed">29149184</ArticleId></ArticleIdList></Reference><Reference><Citation>Sievert K, Lawrence M, Naika A, Baker P. Processed foods and nutrition transition in the pacific: regional trends, patterns and food system drivers. Nutrients. 2019;11(6):1328. doi:10.3390/nu11061328</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11061328</ArticleId><ArticleId IdType="pmc">PMC6628317</ArticleId><ArticleId IdType="pubmed">31200513</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Essential Nutrition Actions: Mainstreaming Nutrition Throughout the Life-Course. Geneva, Switzerland: World Health Organization; 2019.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37941592</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1792-1015</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Experimental and therapeutic medicine</Title><ISOAbbreviation>Exp Ther Med</ISOAbbreviation></Journal><ArticleTitle>Comparison of laryngeal mask airway and endotracheal tube in general anesthesia in children.</ArticleTitle><Pagination><StartPage>554</StartPage><MedlinePgn>554</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">554</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2023.12253</ELocationID><Abstract><AbstractText>At present, there is no relevant expert consensus indicating which ventilation device is more efficient for general anesthesia. The present literature review and meta-analysis compared the effects of the laryngeal mask airway and endotracheal intubation on airway complications during general anesthesia. The keywords 'laryngeal mask airway', 'endotracheal tube', 'tracheal tube', 'children', 'pediatric', 'anesthesia', 'randomized controlled trials' (RCTs) and 'randomized' were used to perform the literature search in PubMed. Quality assessment was performed by two reviewers according to domains defined by the Cochrane Collaboration tool. Data extraction, risk of bias assessment and quality of evidence assessment were performed with the Cochrane tool. A total of 16 RCTs were included. The results indicated that the effects of the laryngeal mask airway group on heart rate variability [mean difference=-13.76; 95% CI, -18.19-(-9.33); P&lt;0.00001], the incidence of hypoxemia [odds ratio (OR)=0.52; 95% CI, 0.28-0.97; P=0.04] and the incidence of postoperative cough (OR=0.22; 95% CI, 0.12-0.40; P&lt;0.0001) were significantly lower than those of the endotracheal intubation group. The success rate of one-time implantation in the laryngeal mask airway group was significantly higher than that noted in the endotracheal intubation group (OR=0.20; 95% CI, 0.07-0.59; P=0.003). However, no significant differences were noted between the two groups in bronchospasm, sore throat, mucosal injury, nausea and vomiting and reflux aspiration. In conclusion, the results indicated that laryngeal mask airway application can reduce complications during general anesthesia compared with endotracheal intubation.</AbstractText><CopyrightInformation>Copyright: &#xa9; Dong et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tianjin Chest Hospital, Tianjin 300222, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Tianjin 300222, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Er</LastName><ForeName>Jianxu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tianjin Chest Hospital, Tianjin 300222, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiapeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tianjin Chest Hospital, Tianjin 300222, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jiange</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tianjin Chest Hospital, Tianjin 300222, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Exp Ther Med</MedlineTA><NlmUniqueID>101531947</NlmUniqueID><ISSNLinking>1792-0981</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">endotracheal intubation</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">laryngeal mask airway</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>9</Day><Hour>4</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37941592</ArticleId><ArticleId IdType="pmc">PMC10628640</ArticleId><ArticleId IdType="doi">10.3892/etm.2023.12253</ArticleId><ArticleId IdType="pii">ETM-26-6-12253</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stein ML, Park RS, Kovatsis PG. Emerging trends, techniques, and equipment for airway management in pediatric patients. Paediatr Anaesth. 2020;30:269&#x2013;279. doi: 10.1111/pan.13814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13814</ArticleId><ArticleId IdType="pubmed">32022437</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindal S, Mittal A, Anand LK, Singh M, Kapoor D. Comparative evaluation of Air-Q blocker and Proseal laryngeal mask airway in patients undergoing elective surgery under general anaesthesia: A randomised controlled trial. Indian J Anaesth. 2021;65 (Suppl 1):S20&#x2013;S26. doi: 10.4103/ija.IJA_1254_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ija.IJA_1254_20</ArticleId><ArticleId IdType="pmc">PMC7993039</ArticleId><ArticleId IdType="pubmed">33814586</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-de Los Santos CA, Cruz-Cruz EF. Laryngeal mask in pediatrics. Rev Esp Anestesiol Reanim (Engl Ed) 2022;69:315&#x2013;316. doi: 10.1016/j.redare.2021.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redare.2021.05.005</ArticleId><ArticleId IdType="pubmed">35637159</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zundert AAJ, Gatt SP, Van Zundert TCRV, Kumar CM, Pandit JJ. Features of new vision-incorporated third-generation video laryngeal mask airways. J Clin Monit Comput. 2022;36:921&#x2013;928. doi: 10.1007/s10877-021-00780-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-021-00780-3</ArticleId><ArticleId IdType="pubmed">34919170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihara F, Ohkawa M, Hiraoka H, Yuki N, Saito S. Benefits of the laryngeal mask for airway management during electroconvulsive therapy. J ECT. 2003;19:211&#x2013;216. doi: 10.1097/00124509-200312000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00124509-200312000-00006</ArticleId><ArticleId IdType="pubmed">14657773</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Nakayama Y, Hashimoto K, Koike K, Watanabe N. Ramped versus sniffing position for tracheal intubation: A systematic review and meta-analysis. Am J Emerg Med. 2021;44:250&#x2013;256. doi: 10.1016/j.ajem.2020.03.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.03.058</ArticleId><ArticleId IdType="pubmed">32276812</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AG, Gentile MA, Coyle JP. Respiratory therapist endotracheal intubation practices. Respir Care. 2020;65:954&#x2013;960. doi: 10.4187/respcare.07338.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.07338</ArticleId><ArticleId IdType="pubmed">32156790</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler K, Winters M. The physiologically difficult intubation. Emerg Med Clin North Am. 2022;40:615&#x2013;627. doi: 10.1016/j.emc.2022.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.emc.2022.05.011</ArticleId><ArticleId IdType="pubmed">35953220</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake-Brockman TF, Ramgolam A, Zhang G, Hall GL, von Ungern-Sternberg BS. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: A randomised controlled trial. Lancet. 2017;389:701&#x2013;708. doi: 10.1016/S0140-6736(16)31719-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31719-6</ArticleId><ArticleId IdType="pubmed">28108038</ArticleId></ArticleIdList></Reference><Reference><Citation>Disma N, Virag K, Riva T, Kaufmann J, Engelhardt T, Habre W. Difficult tracheal intubation in neonates and infants. NEonate and Children audiT of Anaesthesia pRactice IN Europe (NECTARINE): A prospective European multicentre observational study. Br J Anaesth. 2021;126:1173&#x2013;1181. doi: 10.1016/j.bja.2021.02.021. NECTARINE Group of the European Society of Anaesthesiology Clinical Trial Network; AUSTRIA (Maria Vittinghoff); BELGIUM (Francis Veyckemans); CROATIA (Sandra Kralik) et al.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.02.021</ArticleId><ArticleId IdType="pubmed">33812665</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Tan R, Lam WC, Yao L, Wang X, Cheng CW, Liu F, Chan JC, Aixinjueluo Q, Lau CT, et al. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020) Am J Chin Med. 2020;48:1279&#x2013;1313. doi: 10.1142/S0192415X20500639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X20500639</ArticleId><ArticleId IdType="pubmed">32907365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez AV, Marti KM, Roman YM. Meta-Analysis. Chest. 2020;158 (1S):S97&#x2013;S102. doi: 10.1016/j.chest.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.03.003</ArticleId><ArticleId IdType="pubmed">32658658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for literature searches in systematic reviews: A prospective exploratory study. Syst Rev. 2017;6(245) doi: 10.1186/s13643-017-0644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-017-0644-y</ArticleId><ArticleId IdType="pmc">PMC5718002</ArticleId><ArticleId IdType="pubmed">29208034</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA , et al: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343(d5928) doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Martimbianco ALC, S&#xe1; KMM, Santos GM, Santos EM, Pacheco RL, Riera R. Most Cochrane systematic reviews and protocols did not adhere to the Cochrane's risk of bias 2.0 tool. Rev Assoc Med Bras (1992) 2023;69:469&#x2013;472. doi: 10.1590/1806-9282.20221593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20221593</ArticleId><ArticleId IdType="pmc">PMC10004297</ArticleId><ArticleId IdType="pubmed">36820779</ArticleId></ArticleIdList></Reference><Reference><Citation>Nass M, Noble JH Jr. Whither Cochrane. Indian J Med Ethics. 2019;4:1&#x2013;5. doi: 10.20529/IJME.2018.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.20529/IJME.2018.092</ArticleId><ArticleId IdType="pubmed">30683645</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, Espie CA, Garcia-Borreguero D, Gjerstad M, Gon&#xe7;alves M, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26:675&#x2013;700. doi: 10.1111/jsr.12594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.12594</ArticleId><ArticleId IdType="pubmed">28875581</ArticleId></ArticleIdList></Reference><Reference><Citation>Duman A, Og&#xfc;n CO, Okesli S. The effect on intraocular pressure of tracheal intubation or laryngeal mask insertion during sevoflurane anaesthesia in children without the use of muscle relaxants. Paediatr Anaesth. 2001;11:421&#x2013;424. doi: 10.1046/j.1460-9592.2001.00692.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2001.00692.x</ArticleId><ArticleId IdType="pubmed">11442858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha A, Sharma B, Sood J. ProSeal as an alternative to endotracheal intubation in pediatric laparoscopy. Paediatr Anaesth. 2007;17:327&#x2013;332. doi: 10.1111/j.1460-9592.2006.02127.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2006.02127.x</ArticleId><ArticleId IdType="pubmed">17359400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalwani J, Dubey KP, Sahu BS, Shah PJ. ProSeal laryngeal mask airway: An alternative to endotracheal intubation in paediatric patients for short duration surgical procedures. Indian J Anaesth. 2010;54:541&#x2013;545. doi: 10.4103/0019-5049.72644.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.72644</ArticleId><ArticleId IdType="pmc">PMC3016575</ArticleId><ArticleId IdType="pubmed">21224972</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal G, Agarwal M, Taneja S. A randomized comparative study of intraocular pressure and hemodynamic changes on insertion of proseal laryngeal mask airway and conventional tracheal intubation in pediatric patients. J Anaesthesiol Clin Pharmacol. 2012;28:326&#x2013;329. doi: 10.4103/0970-9185.98325.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-9185.98325</ArticleId><ArticleId IdType="pmc">PMC3409941</ArticleId><ArticleId IdType="pubmed">22869938</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan CH, Peng B, Zhang FC. Influence of laryngeal mask airway (LMA) insertion anesthesia on cognitive function after microsurgery in pediatric neurosurgery. Eur Rev Med Pharmacol Sci. 2017;21 (4 Suppl):S37&#x2013;S42.</Citation><ArticleIdList><ArticleId IdType="pubmed">29165767</ArticleId></ArticleIdList></Reference><Reference><Citation>Gul R, Goksu S, Ugur BK, Sahin L, Koruk S, Okumus S, Erbagci I. Comparison of proseal laryngeal mask and endotracheal tube for airway safety in pediatric strabismus surgery. Saudi Med J. 2012;33:388&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">22485233</ArticleId></ArticleIdList></Reference><Reference><Citation>Splinter WM, Smallman B, Rhine EJ, Komocar L. Postoperative sore throat in children and the laryngeal mask airway. Can J Anaesth. 1994;41:1081&#x2013;1083. doi: 10.1007/BF03015658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03015658</ArticleId><ArticleId IdType="pubmed">7828256</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mazrou KA, Abdullah KM, ElGammal MS, Ansari RA, Turkistani A, Abdelmeguid ME. Laryngeal mask airway vs. uncuffed endotracheal tube for nasal and paranasal sinus surgery: Paediatric airway protection. Eur J Anaesthesiol. 2010;27:16&#x2013;19. doi: 10.1097/EJA.0b013e32832c5f09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32832c5f09</ArticleId><ArticleId IdType="pubmed">19444123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdamar D, G&#xfc;ven&#xe7; BH, Toker K, Solak M, Ekingen G. Comparison of the effect of LMA and ETT on ventilation and intragastric pressure in pediatric laparoscopic procedures. Minerva Anestesiol. 2010;76:592&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">20661199</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MG, Swadia V, Bansal G. Prospective randomized comparative study of use of PLMA and ET tube for airway management in children under general anaesthesia. Indian J Anaesth. 2010;54:109&#x2013;115. doi: 10.4103/0019-5049.63643.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.63643</ArticleId><ArticleId IdType="pmc">PMC2900732</ArticleId><ArticleId IdType="pubmed">20661347</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Wu XY, Li L, Ma L, Li YF. A clinical trial evaluating the laryngeal mask airway-Supreme in obese children during general anesthesia. Arch Med Sci. 2017;13:183&#x2013;190. doi: 10.5114/aoms.2017.64719.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2017.64719</ArticleId><ArticleId IdType="pmc">PMC5206376</ArticleId><ArticleId IdType="pubmed">28144270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozden ES, Meco BC, Alanoglu Z, Alk&#x131;s N. Comparison of ProSeal laryngeal mask airway (PLMA) with cuffed and uncuffed endotracheal tubes in infants. Bosn J Basic Med Sci. 2016;16:286&#x2013;291. doi: 10.17305/bjbms.2016.1219.</Citation><ArticleIdList><ArticleId IdType="doi">10.17305/bjbms.2016.1219</ArticleId><ArticleId IdType="pmc">PMC5136765</ArticleId><ArticleId IdType="pubmed">27409643</ArticleId></ArticleIdList></Reference><Reference><Citation>Doksr&#xf8;d S, L&#xf8;fgren B, Nordhammer A, Svendsen MV, Gisselsson L, Raeder J. Reinforced laryngeal mask airway compared with endotracheal tube for adenotonsillectomies. Eur J Anaesthesiol. 2010;27:941&#x2013;946. doi: 10.1097/EJA.0b013e32833d69c6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32833d69c6</ArticleId><ArticleId IdType="pubmed">20739893</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng A, Dodson KM, Thacker LR, Kierce J, Shapiro J, Baldassari CM. Use of laryngeal mask airway in pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg. 2011;137:42&#x2013;46. doi: 10.1001/archoto.2010.230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archoto.2010.230</ArticleId><ArticleId IdType="pubmed">21242545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N, Deng F, Yu C. Anesthesia for pediatric day-case dental surgery: A study comparing the classic laryngeal mask airway with nasal trachea intubation. J Craniofac Surg. 2014;25:e245&#x2013;e248. doi: 10.1097/SCS.0000000000000547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SCS.0000000000000547</ArticleId><ArticleId IdType="pubmed">24820727</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;hlich D, Schwall B, Funk W, Hobbhahn J. Laryngeal mask airway and uncuffed tracheal tubes are equally effective for low flow or closed system anaesthesia in children. Br J Anaesth. 1997;79:289&#x2013;292. doi: 10.1093/bja/79.3.289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/79.3.289</ArticleId><ArticleId IdType="pubmed">9389842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumello D, Brioni M. Severe hypoxemia: Which strategy to choose. Crit Care. 2016;20(132) doi: 10.1186/s13054-016-1304-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1304-7</ArticleId><ArticleId IdType="pmc">PMC4891828</ArticleId><ArticleId IdType="pubmed">27255913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall MC. Laryngeal mask airway as a rescue device for failed endotracheal intubation. Eur J Emerg Med. 2019;26(73) doi: 10.1097/MEJ.0000000000000584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0000000000000584</ArticleId><ArticleId IdType="pubmed">30557235</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroda N, Malesinska M, Kars MS, Smith LP. The use of laryngeal mask airway for adenoidectomy. Int J Pediatr Otorhinolaryngol. 2018;107:42&#x2013;44. doi: 10.1016/j.ijporl.2018.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2018.01.034</ArticleId><ArticleId IdType="pubmed">29501309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaichkin J, McCarney LD, Rhein M. The laryngeal mask: Empowering nurses to rescue newborns. Adv Neonatal Care. 2023;23:140&#x2013;150. doi: 10.1097/ANC.0000000000001044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANC.0000000000001044</ArticleId><ArticleId IdType="pubmed">36354321</ArticleId></ArticleIdList></Reference><Reference><Citation>van Esch BF, Stegeman I, Smit AL. Comparison of laryngeal mask airway vs tracheal intubation: A systematic review on airway complications. J Clin Anesth. 2017;36:142&#x2013;150. doi: 10.1016/j.jclinane.2016.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2016.10.004</ArticleId><ArticleId IdType="pubmed">28183554</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamarul Hoda M, Samad K, Ullah H. ProSeal versus Classic laryngeal mask airway (LMA) for positive pressure ventilation in adults undergoing elective surgery. Cochrane Database Syst Rev. 2017;7(CD009026) doi: 10.1002/14651858.CD009026.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009026.pub2</ArticleId><ArticleId IdType="pmc">PMC6483343</ArticleId><ArticleId IdType="pubmed">28727896</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozhan MO, Eskin MB, Atik B, Suzer MA, Capalar CO. Laryngeal mask airway for general anesthesia in interventional neuroradiology procedures. Saudi Med J. 2019;40:463&#x2013;468. doi: 10.15537/smj.2019.5.24131.</Citation><ArticleIdList><ArticleId IdType="doi">10.15537/smj.2019.5.24131</ArticleId><ArticleId IdType="pmc">PMC6535157</ArticleId><ArticleId IdType="pubmed">31056623</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho ALR, Vital RB, de Lira CCS, Magro IB, Sato PTS, Lima LHN, Braz LG, M&#xf3;dolo NSP. Laryngeal mask airway versus other airway devices for anesthesia in children with an upper respiratory tract infection: A systematic review and meta-analysis of respiratory complications. Anesth Analg. 2018;127:941&#x2013;950. doi: 10.1213/ANE.0000000000003674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003674</ArticleId><ArticleId IdType="pubmed">30059398</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon LV, Torp KD. Laryngeal Mask Airway. StatPearls. Treasure Island, FL, 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">29489214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38788748</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>535</StartPage><EndPage>543</EndPage><MedlinePgn>535-543</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(24)00115-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(24)00115-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tubeless upper airway surgery in children is a complex procedure in which surgeons and anaesthetists share the same operating field. These procedures are often interrupted for rescue oxygen therapy. The efficacy of nasal high-flow oxygen to decrease the frequency of rescue interruptions in children undergoing upper airway surgery is unknown.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this multicentre randomised trial conducted in five tertiary hospitals in Australia, children aged 0-16 years who required tubeless upper airway surgery were randomised (1:1) by a web-based randomisation tool to either nasal high-flow oxygen delivery or standard oxygen therapy (oxygen flows of up to 6 L/min). Randomisation was stratified by site and age (&lt;1 year, 1-4 years, and 5-16 years). Subsequent tubeless upper airway surgery procedures in the same child could be included if there were more than 2 weeks between the procedures, and repeat surgical procedures meeting this condition were considered to be independent events. The oxygen therapy could not be masked, but the investigators remained blinded until outcome data were locked. The primary outcome was successful anaesthesia without interruption of the surgical procedure for rescue oxygenation. A rescue oxygenation event was defined as an interruption of the surgical procedure to deliver positive pressure ventilation using either bag mask technique, insertion of an endotracheal tube, or laryngeal mask to improve oxygenation. There were ten secondary outcomes, including the proportion of procedures with a hypoxaemic event (SpO<sub>2</sub> &lt;90%). Analyses were done on an intention-to-treat (ITT) basis. Safety was assessed in all enrolled participants. This trial is registered in the Australian New Zealand Clinical Trials Registry, ACTRN12618000949280, and is completed.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">From Sept 4, 2018, to April 12, 2021, 581 procedures in 487 children were randomly assigned to high-flow oxygen (297 procedures) or standard care (284 procedures); after exclusions, 528 procedures (267 assigned to high-flow oxygen and 261 assigned to standard care) in 483 children (293 male and 190 female) were included in the ITT analysis. The primary outcome of successful anaesthesia without interruption for tubeless airway surgery was achieved in 236 (88%) of 267 procedures on high-flow oxygen and in 229 (88%) of 261 procedures on standard care (adjusted risk ratio [RR] 1&#xb7;02, 95% CI 0&#xb7;96-1&#xb7;08, p=0&#xb7;82). There were 51 (19%) procedures with a hypoxaemic event in the high-flow oxygen group and 57 (22%) in the standard care group (RR 0&#xb7;86, 95% CI 0&#xb7;58-1&#xb7;24). Of the other prespecified secondary outcomes, none showed a significant difference between groups. Adverse events of epistaxis, laryngospasm, bronchospasm, hypoxaemia, bradycardia, cardiac arrest, hypotension, or death were similar in both study groups.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Nasal high-flow oxygen during tubeless upper airway surgery did not reduce the proportion of interruptions of the procedures for rescue oxygenation compared with standard care. There were no differences in adverse events between the intervention groups. These results suggest that both approaches, nasal high-flow or standard oxygen, are suitable alternatives to maintain oxygenation in children undergoing upper airway surgery.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Thrasher Research Fund, the Australian and New Zealand College of Anaesthetists, the Society for Paediatric Anaesthesia in New Zealand and Australia.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2024 Published by Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia; The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taverner</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Children's Anaesthesia, Women's and Children's Hospital, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Children's Hospital, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skowno</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, The Children's Hospital at Westmead, Sydney, NSW, Australia; School of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallett</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Children's Hospital, Melbourne, VIC, Australia; Murdoch Children's Research Institute, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommerfield</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauser</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia; The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spall</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Trang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkins</LastName><ForeName>Tiffany</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Evidence-Based Healthcare, Bond University, Robina, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Evidence-Based Healthcare, Bond University, Robina, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Children's Anaesthesia, Women's and Children's Hospital, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgoyne</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Children's Anaesthesia, Women's and Children's Hospital, Adelaide, SA, Australia; University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephens</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayasekaran</LastName><ForeName>Shyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Anaesthesia, and Pain Medicine, Perth Children's Hospital, Perth, WA, Australia; University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slee</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose, and Throat Surgery, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Ear, Nose, and Throat Surgery, Queensland Children's Hospital, Brisbane, QLD, Australia; The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franklin</LastName><ForeName>Donna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The University of Queensland, Brisbane, QLD, Australia; Children's Critical Care Research Collaborative Group, Griffith University, Gold Coast University Hospital, Southport, QLD, Australia; Wesley Research Institute, Brisbane, QLD, Australia; Menzies Health Institute Queensland, Southport, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hough</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Australia Catholic University, Department of Physiotherapy, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schibler</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Research Group, St Andrew's War Memorial Hospital, Wesley Research Institute, Brisbane, QLD, Australia; College of Medicine &amp; Dentistry, James Cook University, Townsville, QLD, Australia. Electronic address: andreas.schibler@wesleyresearch.org.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="Y">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="Y">Hypoxia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests AS reports consultancy fees from Fisher &amp; Paykel Healthcare, Auckland, New Zealand. SH reports support for travel and accommodation from Fisher &amp; Paykel Healthcare, Auckland, New Zealand. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>24</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38788748</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(24)00115-2</ArticleId><ArticleId IdType="pii">S2213-2600(24)00115-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28525411</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>266</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Beta-blockers and Traumatic Brain Injury: A Systematic Review, Meta-analysis, and Eastern Association for the Surgery of Trauma Guideline.</ArticleTitle><Pagination><StartPage>952</StartPage><EndPage>961</EndPage><MedlinePgn>952-961</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000002286</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine if beta-(&#x3b2;)-blockers improve outcomes after acute traumatic brain injury (TBI).</AbstractText><AbstractText Label="BACKGROUND">There have been no new inpatient pharmacologic therapies to improve TBI outcomes in a half-century. Treatment of TBI patients with &#x3b2;-blockers offers a potentially beneficial approach.</AbstractText><AbstractText Label="METHODS">Using MEDLINE, EMBASE, and CENTRAL databases, eligible articles for our systematic review and meta-analysis (PROSPERO CRD42016048547) included adult (age &#x2265; 16 years) blunt trauma patients admitted with TBI. The exposure of interest was &#x3b2;-blocker administration initiated during the hospitalization. Outcomes were mortality, functional measures, quality of life, cardiopulmonary morbidity (e.g., hypotension, bradycardia, bronchospasm, and/or congestive heart failure). Data were analyzed using a random-effects model, and represented by pooled odds ratio (OR) with 95% confidence intervals (CI) and statistical heterogeneity (I).</AbstractText><AbstractText Label="RESULTS">Data were extracted from 9 included studies encompassing 2005 unique TBI patients with &#x3b2;-blocker treatment and 6240 unique controls. Exposure to &#x3b2;-blockers after TBI was associated with a reduction of in-hospital mortality (pooled OR 0.39, 95% CI: 0.27-0.56; I = 65%, P &lt; 0.00001). None of the included studies examined functional outcome or quality of life measures, and cardiopulmonary adverse events were rarely reported. No clear evidence of reporting bias was identified.</AbstractText><AbstractText Label="CONCLUSIONS">In adults with acute TBI, observational studies reveal a significant mortality advantage with &#x3b2;-blockers; however, quality of evidence is very low. We conditionally recommend the use of in-hospital &#x3b2;-blockers. However, we recommend further high-quality trials to answer questions about the mechanisms of action, effectiveness on subgroups, dose-response, length of therapy, functional outcome, and quality of life after &#x3b2;-blocker use for TBI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alali</LastName><ForeName>Aziz S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>*Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada &#x2020;Division of Acute Care Surgery, Department of Surgery, Loma Linda University Medical Center, Loma Linda, CA &#x2021;Eastern Association for the Surgery of Trauma, Chicago, IL &#xa7;Department of Critical Care, University Health Network, Toronto, ON, Canada &#xb6;Division of Critical Care and Department of Medicine, Mackenzie Health, Toronto, ON, Canada ||Department of Pediatrics, University of Toronto, Toronto, ON, Canada **Department of Surgery, West Virginia University, Morgantown, WV &#x2020;&#x2020;Department of Surgery, USC+LAC, Los Angeles, CA &#x2021;&#x2021;Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN &#xa7;&#xa7;Departments of Surgery, Anesthesiology/Critical Care Medicine, and Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD &#xb6;&#xb6;Division of Pulmonary and Critical Care Medicine and Center for Health Services Research, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN ||||Research Service, Nashville Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN ***Departments of Surgery and Critical Care Medicine, McGill University Health Centre, Montreal, QC, Canada &#x2020;&#x2020;&#x2020;Division of Trauma, Critical Care, and Burns, Department of Surgery, MetroHealth Medical Center, Cleveland, OH &#x2021;&#x2021;&#x2021;Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, AL, Canada &#xa7;&#xa7;&#xa7;Department of Communication Sciences and Disorders, Oxley College of Health Sciences, The University of Tulsa, Tulsa, OK &#xb6;&#xb6;&#xb6;Department of Hearing and Speech Sciences, Vanderbilt University School of Medicine, Nashville, TN ||||||Department of Surgery, University of Toronto, Toronto, ON, Canada ****Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada &#x2020;&#x2020;&#x2020;&#x2020;Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Departments of Surgery, Neurosurgery, and Hearing and Speech Sciences, Section of Surgical Sciences, Vanderbilt Brain Institute, Vanderbilt Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN &#x2021;&#x2021;&#x2021;&#x2021;Surgical Service, General Surgery Section, Nashville VA Medical Center, Tennessee Valley Healthcare System, US Department of Veterans Affairs, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Kaushik</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>McCredie</LastName><ForeName>Victoria A</ForeName><Initials>VA</Initials></Author><Author ValidYN="Y"><LastName>Golan</LastName><ForeName>Eyal</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Prakesh S</ForeName><Initials>PS</Initials></Author><Author ValidYN="Y"><LastName>Bardes</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Hamblin</LastName><ForeName>Susan E</ForeName><Initials>SE</Initials></Author><Author ValidYN="Y"><LastName>Haut</LastName><ForeName>Elliott R</ForeName><Initials>ER</Initials></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>James C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Khwaja</LastName><ForeName>Kosar</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Nimitt J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>Satish R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Laura D</ForeName><Initials>LD</Initials></Author><Author ValidYN="Y"><LastName>Nathens</LastName><ForeName>Avery B</ForeName><Initials>AB</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Mayur B</ForeName><Initials>MB</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM120484</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL111111</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HS024547</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001930" MajorTopicYN="N">Brain Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>CONFLICT OF INTEREST WITH OTHER SOURCES OF SUPPORT:</b> Dr. Patel has been or is supported by the Vanderbilt Institute for Clinical and Translational Research awards (VR1584, VR5351, VR9276, VR12073) via CTSA grant UL1TR000011 (NCRR/NCATS/NIH), a 2013 EAST Trauma Foundation Research Scholarship, and speaker fees from Pfizer. Drs. Haut and Patel have served on the EAST Guidelines Section and Board of Directors. Dr. Haut is the primary investigator of a AHRQ grant (R01HS024547) of a PCORI contract (CE-12&#x2013;11&#x2013;4489). Dr. Haut receives book royalties from Lippincott, Williams, Wilkins (&#x201c;Avoiding Common ICU Errors&#x201d;), consultant and speaker fees from VHA/Vizient IMPERATIV&#xae; Advantage Performance Improvement Collaborative, and consultant and speaker fees for the Illinois Surgical Quality Improvement Collaborative. Dr. Haut was the paid author of a paper commissioned by the National Academies of Medicine.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28525411</ArticleId><ArticleId IdType="mid">NIHMS946298</ArticleId><ArticleId IdType="pmc">PMC5997270</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000002286</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Menon DK, Zahed C. Prediction of outcome in severe traumatic brain injury. Current Opinion in Critical Care. 2009 Oct;15(5):437&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">19713837</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffernan DS, Inaba K, Arbabi S, Cotton BA. Sympathetic Hyperactivity After Traumatic Brain Injury and the Role of Beta-Blocker Therapy. The Journal of Trauma: Injury, Infection, and Critical Care. 2010 Dec;69(6):1602&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21045744</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TY, Dunne IE, German JW. Beta blockers exposure and traumatic brain injury: a literature review. Neurosurgical Focus. 2008 Oct;25(4):E8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18828706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Berry C, Mirocha J, Salim A. Mortality is Reduced for Heart Rate 80 to 89 After Traumatic Brain Injury. Journal of Surgical Research. 2010 Sep;163(1):142&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20599219</ArticleId></ArticleIdList></Reference><Reference><Citation>Radosevich JJ, Patanwala AE, Erstad BL. Emerging pharmacological agents to improve survival from traumatic brain injury. Brain Inj. 2013 Nov 11;27(13&#x2013;14):1492&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24205899</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry C, Ley EJ, Bukur M, Malinoski D, Margulies DR, Mirocha J, et al. Injury. 11. Vol. 43. Elsevier Ltd; 2012. Nov 1, Redefining hypotension in traumatic brain injury; pp. 1833&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21939970</ArticleId></ArticleIdList></Reference><Reference><Citation>POISE Study Group. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008 May 31;371(9627):1839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann KE, Beckman JA, Buller CE, Calkins H, Fleisher LA, Freeman WK, et al. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade. Journal of the American College of Cardiology. 2009 Nov;54(22):2102&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">19926021</ArticleId></ArticleIdList></Reference><Reference><Citation>Alali AS, McCredie VA, Golan E, Shah PS, Nathens AB. Beta Blockers for Acute Traumatic Brain Injury: A Systematic Review and Meta-analysis. Neurocrit Care. 2013 Sep 6;20(3):514&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24062229</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. BMJ. 7650. Vol. 336. British Medical Journal Publishing Group; 2008. Apr 26, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations; pp. 924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerwin AJ, Haut ER, Burns JB, Como JJ, Haider A, Stassen N, et al. The Eastern Association of the Surgery of Trauma approach to practice management guideline development using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Journal of Trauma and Acute Care Surgery. 73(5 Suppl 4):S283&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23114482</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al. BMJ. 7652. Vol. 336. British Medical Journal Publishing Group; 2008. May 10, Going from evidence to recommendations; pp. 1049&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2376019</ArticleId><ArticleId IdType="pubmed">18467413</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, et al. BMJ. oct 18 2. Vol. 343. British Medical Journal Publishing Group; 2011. The Cochrane Collaboration&#x2019;r assessing risk of bias in randomised trials; pp. d5928&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. Springer Netherlands. 2010 Jul 22;25(9):603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Panczykowski DM, Puccio AM, Scruggs BJ, Bauer JS, Hricik AJ, Beers SR, et al. Prospective Independent Validation of IMPACT Modeling as a Prognostic Tool in Severe Traumatic Brain Injury. J Neurotrauma. 2012 Jan;29(1):47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">21933014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Berry C, Mirocha J, Salim A. Mortality is Reduced for Heart Rate 80 to 89 After Traumatic Brain Injury. Journal of Surgical Research. 2010 Sep;163(1):142&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20599219</ArticleId></ArticleIdList></Reference><Reference><Citation>Neideen T, Lam M, Brasel KJ. Preinjury Beta Blockers are Associated With Increased Mortality in Geriatric Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 2008 Nov;65(5):1016&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">19001968</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider EB, Efron DT, MacKenzie EJ, Rivara FP, Nathens AB, Jurkovich GJ. Premorbid Statin Use Is Associated With Improved Survival and Functional Outcomes in Older Head-Injured Individuals. The Journal of Trauma: Injury, Infection, and Critical Care. 2011 Oct;71(4):815&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21986733</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson CS, Valadka AB, Hannay HJ, Contant CF, Gopinath SP, Cormio M, et al. Prevention of secondary ischemic insults after severe head injury. Critical Care Medicine. 1999 Oct;27(10):2086&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">10548187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukur M, Lustenberger T, Cotton B, Arbabi S, Talving P, Salim A, et al. Beta-blocker exposure in the absence of significant head injuries is associated with reduced mortality in critically ill patients. The American Journal of Surgery. 2012 Nov;204(5):697&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">22578406</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans D, Khoo K, Radulescu A, Cook C, Gerlach A, Papadimos T, et al. Journal of Emergencies, Trauma, and Shock. 4. Vol. 7. Medknow Publications; 2014. Pre-injury beta blocker use does not affect the hyperdynamic response in older trauma patients; pp. 305&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4231268</ArticleId><ArticleId IdType="pubmed">25400393</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman A, Bar-Klein G, Serlin Y, Parmet Y, Heinemann U, Kaufer D. Should losartan be administered following brain injury? Expert Review of Neurotherapeutics. 2014 Nov 26;14(12):1365&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">25346269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hend&#xe9;n PL, S&#xf6;ndergaard S, Rydenhag B, Reinsfelt B, Ricksten S-E, &#xc5;neman A. Can Baroreflex Sensitivity and Heart Rate Variability Predict Late Neurological Outcome in Patients With Traumatic Brain Injury? Journal of Neurosurgical Anesthesiology. 2014 Jan;26(1):50&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24064714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis PR, Dunne CE, Thompson KA, McDonald VS, Calvo RY, Badiee J, et al. Attenuation of cardiovascular stress with sympatholytics does not improve survival in patients with severe isolated traumatic brain injury. Journal of Trauma and Acute Care Surgery. 2016 Apr;80(4):643&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26713971</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohseni S, Talving P, Wallin G, Ljungqvist O, Riddez L. Preinjury &#x3b2;-blockade is protective in isolated severe traumatic brain injury. Journal of Trauma and Acute Care Surgery. 2014 Mar;76(3):804&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24553552</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoup JP, Winkler J, Czap A, Staff I, Fortunato G, McCullough LD, et al. &#x3b2;-Blockers associated with no class-specific survival benefit in acute intracerebral hemorrhage. Journal of the Neurological Sciences. 2014 Jan;336(1&#x2013;2):127&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4956481</ArticleId><ArticleId IdType="pubmed">24183854</ArticleId></ArticleIdList></Reference><Reference><Citation>Velayutham PK, Adhikary SD, Babu SK, Vedantam R, Korula G, Ramachandran A. Oxidative stress&#x2013;associated hypertension in surgically induced brain injury patients: Effects of &#x3b2;-blocker and angiotensin-converting enzyme inhibitor. Journal of Surgical Research. 2013 Jan;179(1):125&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">23020955</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb A, Semple J, Rothwell PM. Greater transmission of aortic pulsatility to the brain on propranolol versus amlodipine: Novel MRI method to measure concurrent beat-to-beat brachial and cerebral arterial pulsatility. Glasgow, UK: pp. 20150338&#x2013;9.</Citation></Reference><Reference><Citation>Naredi S, Olivecrona M, Lindgren C, Ostlund AL, Gr&#xe4;nde PO, Koskinen LOD. Acta Anaesthesiol Scand. 4. Vol. 45. Munksgaard International Publishers; 2001. Apr, An outcome study of severe traumatic head injury using the &#x201c;Lund therapy&#x201d; with low-dose prostacyclin; pp. 402&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11300376</ArticleId></ArticleIdList></Reference><Reference><Citation>Naredi S, Ed&#xe9;n E, Z&#xe4;ll S, Stephensen H, Rydenhag B. Intensive Care Medicine. 5. Vol. 24. Springer-Verlag; 2014. Feb 26, A standardized neurosurgical/neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: clinical results; pp. 446&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">9660259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xe4;nde PO, Nordstrom CH, Asgeirsson B. Current alternative therapy of post-traumatic brain edema. Nord Med. 1994;109(5):157&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7910683</ArticleId></ArticleIdList></Reference><Reference><Citation>Eker C, Asgeirsson B, Grande P-O, Schalen W, Nordstrom C-H. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Critical Care Medicine. 1998 Nov;26(11):1881&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9824083</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgeirsson B, Gr&#xe4;nde PO, Nordstrom CH. Intensive Care Medicine. 4. Vol. 20. Springer-Verlag; 1994. Apr, A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation; pp. 260&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8046119</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson CS, Clifton GL, Taylor AA, Grossman RG. Treatment of hypertension associated with head injury. J Neurosurg. 1983 Sep;59(3):455&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">6886759</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs HJ, Herden HN, Welter J. Effect of metoprolol on the circulation after head trauma. Studies during continuous intravenous administration Deutsche Medizinische Wochenschrift. 105(44):1531&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7428661</ArticleId></ArticleIdList></Reference><Reference><Citation>Do D, Sheen VL, Bromfield E. Journal of Neurology, Neurosurgery &amp; Psychiatry. 6. Vol. 69. BMJ Publishing Group Ltd; 2000. Dec 1, Treatment of paroxysmal sympathetic storm with labetalol; pp. 832&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1737162</ArticleId><ArticleId IdType="pubmed">11185641</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgeirsson B, Gr&#xe4;nde PO, Nordstrom CH, Berntman L, Messeter K, Ryding E. Acta Anaesthesiol Scand. 3. Vol. 39. Blackwell Publishing Ltd; 1995. Apr, Effects of hypotensive treatment with &#x3b1; 2-agonist and &#x3b2; 1-antagonist on cerebral haemodynamics in severely head injured patients; pp. 347&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">7793214</ArticleId></ArticleIdList></Reference><Reference><Citation>Radosevich JJ, Patanwala AE, Erstad BL. Emerging pharmacological agents to improve survival from traumatic brain injury. Brain Inj. 2013 Nov 11;27(13&#x2013;14):1492&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24205899</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Zhang Y, Mahmood A, Chopp M. Investigational agents for treatment of traumatic brain injury. Expert Opinion on Investigational Drugs. 2015 Mar 25;24(6):743&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433440</ArticleId><ArticleId IdType="pubmed">25727893</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bergh WM. Pharmacotherapy of traumatic brain injury. Netherlands Journal of Critical Care. 24(1):6&#x2013;11.</Citation></Reference><Reference><Citation>Koskinen LOD, Olivecrona M, Gr&#xe4;nde PO. Severe traumatic brain injury management and clinical outcome using the Lund concept. Neuroscience. 2014 Dec;283:245&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">24973658</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppola S, Froio S, Chiumello D. Annual Update in Intensive Care and Emergency Medicine 2015. Cham: Springer International Publishing; 2015. &#x3b2;-Blockers in Critically Ill Patients: From Physiology to Clinical Evidence; pp. 139&#x2013;52. (Annual Update in Intensive Care and Emergency Medicine; vol. 2015)</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin GD. Stroke, mTBI, infection, antibiotics and beta blockade: Connecting the dots. Medical Hypotheses. 2015 Aug;85(2):224&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26045369</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti PS, et al. In Vivo Effect of Propranolol Dose and Timing on Cerebral Perfusion After Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2010 Feb;68(2):353&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20154548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti PS, et al. The In Vivo Effect of Propranolol on Cerebral Perfusion and Hypoxia After Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2009 Jan;66(1):154&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">19131818</ArticleId></ArticleIdList></Reference><Reference><Citation>Song D, Xu J, Du T, Yan E, Hertz L, Walz W, et al. Inhibition of Brain Swelling after Ischemia-Reperfusion by &#x3b2;-Adrenergic Antagonists: Correlation with Increased K +and Decreased Ca 2+Concentrations in Extracellular Fluid. BioMed Research International. 2014;2014(3):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247955</ArticleId><ArticleId IdType="pubmed">25478577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruickshank J, Degaute J, Kuurne T, Vincent J, Neil-Dwyer G, Hayes Y, et al. Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade. The Lancet. 1987 Sep;330(8559):585&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">2887885</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, et al. Beta-Blocker Use is Associated With Improved Outcomes in Adult Trauma Patients. The Journal of Trauma: Injury, Infection, and Critical Care. 2007 Jan;62(1):56&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">17215733</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, et al. Beta-Blocker Exposure is Associated With Improved Survival After Severe Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2007 Jan;62(1):26&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">17215730</ArticleId></ArticleIdList></Reference><Reference><Citation>Inaba K, Teixeira PGR, David J-S, Chan LS, Salim A, Brown C, et al. Beta-Blockers in Isolated Blunt Head Injury. Journal of the American College of Surgeons. 2008 Mar;206(3):432&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18308212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko A, Harada MY, Barmparas G, Thomsen GM, Alban RF, Bloom M, et al. Early Propranolol after Traumatic Brain Injury is Associated with Lower Mortality. Journal of Trauma and Acute Care Surgery. 2016 Jan;:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">26808028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohseni S, Talving P, Thelin EP, Wallin G, Ljungqvist O, Riddez L. World Journal of Surgery. Springer US; 2015. Apr 14, The Effect of &#x3b2;-blockade on Survival After Isolated Severe Traumatic Brain Injury; pp. 1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25809062</ArticleId></ArticleIdList></Reference><Reference><Citation>Murry JS, Hoang DM, Barmparas G, Harada MY, Bukur M, Bloom MB, et al. Journal of Surgical Research. 1. Vol. 200. Elsevier Inc; 2016. Jan 1, Prospective evaluation of early propranolol after traumatic brain injury; pp. 221&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26188959</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeppel TJ, Fischer PE, Zarzaur BL, Magnotti LJ, Clement LP, Fabian TC, et al. Beta-Adrenergic Blockade and Traumatic Brain Injury: Protective? The Journal of Trauma: Injury, Infection, and Critical Care. 2010 Oct;69(4):776&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">20938265</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeppel TJ, Sharpe JP, Magnotti LJ, Weinberg JA, Clement LP, Croce MA, et al. Traumatic brain injury and &#x3b2;-blockers. Journal of Trauma and Acute Care Surgery. 2014 Feb;76(2):504&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24458058</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangbar B, Khalil M, Rhee P, Joseph B, Kulvatunyou N, Tang A, et al. Journal of Surgical Research. 2. Vol. 200. Elsevier Inc; 2016. Feb 1, Metoprolol improves survival in severe traumatic brain injury independent of heart rate control; pp. 586&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">26365164</ArticleId></ArticleIdList></Reference><Reference><Citation>Salim A, Hadjizacharia P, Brown C, Inaba K, Teixeira PGR, Chan L, et al. Significance of Troponin Elevation After Severe Traumatic Brain Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 2008 Jan;64(1):46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">18188098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjizacharia P, O&#x2019;Keeffe T, Brown CVR, Inaba K, Salim A, Chan LS, et al. Incidence, risk factors, and outcomes for atrial arrhythmias in trauma patients. The American Surgeon. 2011 May;77(5):634&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21679600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukur M, Mohseni S, Mosheni S, Ley E, Salim A, Margulies D, et al. Efficacy of beta-blockade after isolated blunt head injury: does race matter? J Trauma Acute Care Surg. 2012 Apr;72(4):1013&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22491619</ArticleId></ArticleIdList></Reference><Reference><Citation>Riordan WP, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007 Sep;63(3) 503&#x2013;10&#x2013;discussion510&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">18073593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrick LE, Schroeppel TJ, Sharpe JP, Alsbrook D, Magnotti LJ, Weinberg JA, et al. Impact of Beta-Blockers on Nonhead Injured Trauma Patients. The American Surgeon. 2016 Jul;82(7):575&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27457854</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al. Effect of intravenous corticosteroids on death within 14 days in 10&#x2008;008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. The Lancet. 2004 Oct;364(9442):1321&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15474134</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderson P, Roberts I. BMJ. 7098. Vol. 314. BMJ Group; 1997. Jun 28, Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials; pp. 1855&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2126994</ArticleId><ArticleId IdType="pubmed">9224126</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregson B, Todd NV, Crawford D, Gerber CJ, Fulton B, Tacconi L, et al. CRASH trial is based on problematic meta-analysis. BMJ. 1999 Aug 28;319(7209):578&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1116452</ArticleId><ArticleId IdType="pubmed">10463914</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderson P. Design of CRASH trial. Evidence shows that quality of trial by Faupel et al is good and therefore should not be excluded. BMJ. 1999 Oct 16;319(7216):1068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1116856</ArticleId><ArticleId IdType="pubmed">10521212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, et al. Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension. N Engl J Med. 2016 Sep 22;375(12):1119&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27602507</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D&#x2019;Urso P, et al. Decompressive Craniectomy in Diffuse Traumatic Brain Injury. New England Journal of Medicine. 2011 Apr 21;364(16):1493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">21434843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol A, French C, Little L, Haddad S, Presneill J, Arabi Y, et al. Erythropoeitin in traumatic brain injury (EPO-TBI): A double-blind randomised controlled trial. Lancet. 2015 Dec 19;386(10012):2499&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">26452709</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, et al. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014 Dec 25;371(26):2457&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303469</ArticleId><ArticleId IdType="pubmed">25493974</ArticleId></ArticleIdList></Reference><Reference><Citation>Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014 Dec 25;371(26):2467&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">25493978</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson CS, Hannay HJ, Yamal J-M, Gopinath S, Goodman JC, Tilley BC, et al. Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury. JAMA. 2014 Jul 2;312(1):36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4113910</ArticleId><ArticleId IdType="pubmed">25058216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein D. Opinion: Why Most TBI Studies Fail [Internet] 2016 [cited 2016 Oct 9]. Available from:  http://www.the-scientist.com/?articles.view/articleNo/45434/title/Opinion&#x2013;why-most-tbi-studies-fail/</Citation></Reference><Reference><Citation>Patel MB, McKenna JW, Alvarez JM, Sugiura A, Jenkins JM, Guillamondegui OD, et al. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial. Trials. 2140 ed. BioMed Central. 2012 Sep 26;13(1):232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517360</ArticleId><ArticleId IdType="pubmed">23013802</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. JAMA: The Journal of the American Medical Association. 16. Vol. 310. American Medical Association; 2013. Oct 23, Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial; pp. 1683&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochanek PM, Bramlett HM, Dixon CE, Shear DA, Dietrich WD, Schmid KE, et al. Approach to modeling, therapy evaluation, drug selection, and biomarker assessments for a multicenter pre-clinical drug screening consortium. J Neurotrauma. 2016 Mar 15;33(6):513&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26439468</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30515761</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-0960</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Australasian journal of dermatology</Title><ISOAbbreviation>Australas J Dermatol</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.</ArticleTitle><Pagination><StartPage>181</StartPage><EndPage>185</EndPage><MedlinePgn>181-185</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ajd.12966</ELocationID><Abstract><AbstractText>Recently, several studies have reported their experience in using oral atenolol in patients with infantile haemangioma (IH), especially as an alternative to propranolol, but the efficacy and safety of oral atenolol has not been evaluated. We searched PubMed (Medline), Central, Embase, Web of Science and EBSCOhost (until May 2018) for the eligible studies reporting more than 10 IH patients who were treated with oral atenolol with detailed original data, including outcomes, regimens and adverse events (AEs). The data was standardised and analysed by using R software with meta-package. A total of 9 of 141 identified articles, including 341 infantile haemangioma patients treated with oral atenolol therapy, were included. The pooled response rate of atenolol was 0.90 (95% CI: 0.85-0.93), and the rebound rate was 0.11 (95% CI: 0.08-0.16). Among the 341 patients, 44 patients were switched to atenolol therapy from propranolol due to adverse events. The response rate of subsequent atenolol treatment was 90.9% (40/44). Regarding AEs, 141 patients reported 177 episodes of AEs, and the pooled rate was 0.26 (95% CI: 0.12-0.47). Gastrointestinal symptoms (e.g. constipation, diarrhoea and vomiting) were the most frequent AEs (22.6%). Widely known propranolol-related AEs, including hypoglycaemia, bronchospasm, bradycardia and hypotension, were not recorded. Overall, atenolol appears to be an effective and safe therapy for the treatment of IH and may be a promising alternative to propranolol.</AbstractText><CopyrightInformation>&#xa9; 2018 The Australasian College of Dermatologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9289-9660</Identifier><AffiliationInfo><Affiliation>Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81400862</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81401606</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2015SU04A15</GrantID><Agency>Science Foundation for Excellent Youth Scholars of Sichuan University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Australas J Dermatol</MedlineTA><NlmUniqueID>0135232</NlmUniqueID><ISSNLinking>0004-8380</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058671">Adrenergic beta-1 Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>50VV3VW0TI</RegistryNumber><NameOfSubstance UI="D001262">Atenolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>9Y8NXQ24VQ</RegistryNumber><NameOfSubstance UI="D011433">Propranolol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058671" MajorTopicYN="N">Adrenergic beta-1 Receptor Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001262" MajorTopicYN="N">Atenolol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006391" MajorTopicYN="N">Hemangioma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011433" MajorTopicYN="N">Propranolol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atenolol</Keyword><Keyword MajorTopicYN="N">efficacy</Keyword><Keyword MajorTopicYN="N">infantile hemangioma</Keyword><Keyword MajorTopicYN="N">safety</Keyword><Keyword MajorTopicYN="N">&#x3b2;-blockers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30515761</ArticleId><ArticleId IdType="doi">10.1111/ajd.12966</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40760863</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>10</Issue><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intraoperative Bronchospasm and Future Asthma in Children: A Retrospective Matched Cohort Study.</ArticleTitle><Pagination><StartPage>856</StartPage><EndPage>863</EndPage><MedlinePgn>856-863</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.70029</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Asthma is the most common chronic disease in children. Difficulty in diagnosis can lead to decreased quality of life and increased morbidity and mortality. Children with asthma have increased intraoperative bronchospasm; however, it is unclear whether intraoperative bronchospasm predicts future asthma. We explored intraoperative bronchospasm and subsequent asthma diagnosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analyzed 44,284 children aged 2-18&#x2009;years who underwent non-cardiac surgery under general anesthesia between 2014 and 2020. We collected demographic and peri-operative data, including the occurrence of bronchospasm. We then conducted a subgroup analysis of 35&#x2009;770 patients that received positive pressure ventilation, using logistic regression to assess the relationship between bronchospasm and airway pressures. The association of bronchospasm and subsequent asthma diagnosis was estimated using generalized estimating equations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Intraoperative bronchospasm occurred in 128 patients (0.3%) and was associated with increased risk of asthma (OR 2.29, 95% CI 1.10-4.74, p =&#x2009;0.03). Asthma was diagnosed in 1238 patients (2.8%); 8 had intraoperative bronchospasm (8 of 1238, 0.7%). After adjustment for confounders, male sex (OR 1.57, 95% CI 1.39-1.76, p &lt;&#x2009;0.001) and younger age (OR 0.96, 95% CI 0.94-0.97, p &lt;&#x2009;0.001) were also associated with future asthma diagnosis. In the subgroup analysis, Mean PIP (OR 1.50, 95% CI 1.30-1.74, p &lt;&#x2009;0.001) was associated with asthma.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows intraoperative bronchospasm is associated with an increased risk of future asthma in children. Enhanced collaboration between pediatric anesthesiologists and pediatricians, and further research, is essential to improve asthma detection, risk stratification, and overall care for pediatric patients.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Pediatric Anesthesia published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elliott</LastName><ForeName>Anila B</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0002-1958-2499</Identifier><AffiliationInfo><Affiliation>C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jewell</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tremper</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engoren</LastName><ForeName>Milo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="Y">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">bronchospasm</Keyword><Keyword MajorTopicYN="N">general anesthesia</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>2</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40760863</ArticleId><ArticleId IdType="pmc">PMC12416348</ArticleId><ArticleId IdType="doi">10.1111/pan.70029</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Centers for Disease Control and Prevention
, &#x201c;Asthma CDC National Data,&#x201d;
https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm.</Citation></Reference><Reference><Citation>Seol H. Y., Sohn S., Liu H., et&#xa0;al., &#x201c;Early Identification of Childhood Asthma: The Role of Informatics in an Era of Electronic Health Records,&#x201d; Frontiers in Pediatrics 7 (2019): 113, 10.3389/fped.2019.00113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00113</ArticleId><ArticleId IdType="pmc">PMC6454104</ArticleId><ArticleId IdType="pubmed">31001500</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron S. D., Boulet L. P., Reddel H. K., and Gershon A. S., &#x201c;Underdiagnosis and Overdiagnosis of Asthma,&#x201d; American Journal of Respiratory and Critical Care Medicine 198, no. 8 (2018): 1012&#x2013;1020, 10.1164/rccm.201804-0682ci.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201804-0682ci</ArticleId><ArticleId IdType="pubmed">29756989</ArticleId></ArticleIdList></Reference><Reference><Citation>Molis W. E., Bagniewski S., Weaver A. L., Jacobson R. M., and Juhn Y. J., &#x201c;Timeliness of Diagnosis of Asthma in Children and Its Predictors,&#x201d; Allergy 63, no. 11 (2008): 1529&#x2013;1535, 10.1111/j.1398-9995.2008.01749.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2008.01749.x</ArticleId><ArticleId IdType="pubmed">18925889</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez M. F. and Coutinho M. T., &#x201c;An Overview of Health Disparities in Asthma,&#x201d; Yale Journal of Biology and Medicine 94, no. 3 (2021): 497&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461584</ArticleId><ArticleId IdType="pubmed">34602887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakirtas A., &#x201c;Diagnostic Challenges of Childhood Asthma,&#x201d; Current Opinion in Pulmonary Medicine 23, no. 1 (2017): 27&#x2013;33, 10.1097/mcp.0000000000000338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mcp.0000000000000338</ArticleId><ArticleId IdType="pubmed">27801711</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaatmaca B., Sahiner U. M., Sekerel B. E., and Soyer O., &#x201c;Perioperative Hypersensitivity Reactions During Childhood and Outcomes of Subsequent Anesthesia,&#x201d; Paediatric Anaesthesia 31, no. 4 (2021): 436&#x2013;443, 10.1111/pan.14126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.14126</ArticleId><ArticleId IdType="pubmed">33423333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizov R., Brown R. H., Weiss Y. S., et&#xa0;al., &#x201c;Wheezing During Induction of General Anesthesia in Patients With and Without Asthma. A Randomized, Blinded Trial,&#x201d; Anesthesiology 82, no. 5 (1995): 1111&#x2013;1116, 10.1097/00000542-199505000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199505000-00004</ArticleId><ArticleId IdType="pubmed">7741285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E. S. and Bishop M. J., &#x201c;Endotracheal Intubation, but Not Laryngeal Mask Airway Insertion, Produces Reversible Bronchoconstriction,&#x201d; Anesthesiology 90, no. 2 (1999): 391&#x2013;394, 10.1097/00000542-199902000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199902000-00010</ArticleId><ArticleId IdType="pubmed">9952142</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern&#x2010;Sternberg B. S., Boda K., Chambers N. A., et&#xa0;al., &#x201c;Risk Assessment for Respiratory Complications in Paediatric Anaesthesia: A Prospective Cohort Study,&#x201d; Lancet 376, no. 9743 (2010): 773&#x2013;783, 10.1016/S0140-6736(10)61193-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Dones F., Foresta G., and Russotto V., &#x201c;Update on Perioperative Management of the Child With Asthma,&#x201d; Pediatric Reports 4, no. 2 (2012): e19, 10.4081/pr.2012.e19.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/pr.2012.e19</ArticleId><ArticleId IdType="pmc">PMC3395977</ArticleId><ArticleId IdType="pubmed">22802997</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C. S., Chang C. C., Yeh C. C., Chung C. L., Chen T. L., and Liao C. C., &#x201c;Postoperative Adverse Outcomes in Patients With Asthma: A Nationwide Population&#x2010;Based Cohort Study,&#x201d; Medicine 95, no. 3 (2016): e2548, 10.1097/MD.0000000000002548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000002548</ArticleId><ArticleId IdType="pmc">PMC4998277</ArticleId><ArticleId IdType="pubmed">26817903</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson G. L., &#x201c;Bronchospasm During Anaesthesia. A Computer&#x2010;Aided Incidence Study of 136&#x2009;929 Patients,&#x201d; Acta Anaesthesiologica Scandinavica 31, no. 3 (1987): 244&#x2013;252, 10.1111/j.1399-6576.1987.tb02560.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.1987.tb02560.x</ArticleId><ArticleId IdType="pubmed">3577646</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W., Disma N., Virag K., et&#xa0;al., &#x201c;Incidence of Severe Critical Events in Paediatric Anaesthesia (APRICOT): A Prospective Multicentre Observational Study in 261 Hospitals in Europe,&#x201d; Lancet Respiratory Medicine 5, no. 5 (2017): 412&#x2013;425, 10.1016/S2213-2600(17)30116-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30116-9</ArticleId><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods B. D. and Sladen R. N., &#x201c;Perioperative Considerations for the Patient With Asthma and Bronchospasm,&#x201d; British Journal of Anaesthesia 103, no. Suppl 1 (2009): i57&#x2013;i65, 10.1093/bja/aep271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep271</ArticleId><ArticleId IdType="pubmed">20007991</ArticleId></ArticleIdList></Reference><Reference><Citation>Murat I., Constant I., and Maud'huy H., &#x201c;Perioperative Anaesthetic Morbidity in Children: A Database of 24&#x2009;165 Anaesthetics Over a 30&#x2010;Month Period,&#x201d; Paediatric Anaesthesia 14, no. 2 (2004): 158&#x2013;166, 10.1111/j.1460-9592.2004.01167.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01167.x</ArticleId><ArticleId IdType="pubmed">14962332</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson N. and Waterhouse P., &#x201c;Risk in Pediatric Anesthesia,&#x201d; Paediatric Anaesthesia 21, no. 8 (2011): 848&#x2013;857, 10.1111/j.1460-9592.2010.03366.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2010.03366.x</ArticleId><ArticleId IdType="pubmed">20723093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilgendorff A., Reiss I., Ehrhardt H., Eickelberg O., and Alvira C. M., &#x201c;Chronic Lung Disease in the Preterm Infant: Lessons Learned From Animal Models,&#x201d; American Journal of Respiratory Cell and Molecular Biology 50, no. 2 (2014): 233&#x2013;245, 10.1165/rcmb.2013-0014TR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2013-0014TR</ArticleId><ArticleId IdType="pmc">PMC5455410</ArticleId><ArticleId IdType="pubmed">24024524</ArticleId></ArticleIdList></Reference><Reference><Citation>Emons J. A. and Gerth van Wijk R., &#x201c;Food Allergy and Asthma: Is There a Link? Curr Treat Options,&#x201d; Allergy 5, no. 4 (2018): 436&#x2013;444, 10.1007/s40521-018-0185-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40521-018-0185-1</ArticleId><ArticleId IdType="pmc">PMC6244552</ArticleId><ArticleId IdType="pubmed">30524933</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M., Srinathan S. K., McAuley D. F., et&#xa0;al., &#x201c;The Statistical Significance of Randomized Controlled Trial Results Is Frequently Fragile: A Case for a Fragility Index,&#x201d; Journal of Clinical Epidemiology 67 (2014): 622&#x2013;628, 10.1016/j.jclinepi.2013.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.10.019</ArticleId><ArticleId IdType="pubmed">24508144</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis J. and Goadrich M., &#x201c;The Relationship Between Precision&#x2010;Recall and ROC Curves,&#x201d; in Proceedings of the 23rd International Conference on Machine Learning (Association for Computing Machinery, 2006).</Citation></Reference><Reference><Citation>Chowdhury N. U., Guntur V. P., Newcomb D. C., and Wechsler M. E., &#x201c;Sex and Gender in Asthma,&#x201d; European Respiratory Review 30, no. 162 (2021): 210067, 10.1183/16000617.0067-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0067-2021</ArticleId><ArticleId IdType="pmc">PMC8783601</ArticleId><ArticleId IdType="pubmed">34789462</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakanthi N., Greally J. M., and Rastogi D., &#x201c;Pediatric Obesity&#x2010;Related Asthma: The Role of Metabolic Dysregulation,&#x201d; Pediatrics 137, no. 5 (2016): e20150812, 10.1542/peds.2015-0812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-0812</ArticleId><ArticleId IdType="pmc">PMC4845863</ArticleId><ArticleId IdType="pubmed">27244776</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake K. A., Galanter J. M., and Burchard E. G., &#x201c;Race, Ethnicity and Social Class and the Complex Etiologies of Asthma,&#x201d; Pharmacogenomics 9, no. 4 (2008): 453&#x2013;462, 10.2217/14622416.9.4.453.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/14622416.9.4.453</ArticleId><ArticleId IdType="pmc">PMC2746736</ArticleId><ArticleId IdType="pubmed">18384258</ArticleId></ArticleIdList></Reference><Reference><Citation>Malleske D., Bryant&#x2010;Stephens T. C., and Montoya&#x2010;Williams D., &#x201c;Childhood Asthma Disparities&#x2010;Race, Place, or Not Keeping Pace?,&#x201d; JAMA Pediatrics 176, no. 8 (2022): 739&#x2013;740, 10.1001/jamapediatrics.2022.1457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.1457</ArticleId><ArticleId IdType="pmc">PMC9359892</ArticleId><ArticleId IdType="pubmed">35604670</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39179661</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Comparison of supraglottic airway device and endotracheal tube in former preterm infants receiving general anesthesia: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>19579</StartPage><MedlinePgn>19579</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19579</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-69950-y</ELocationID><Abstract><AbstractText>To date, endotracheal tube (ETT) remains the mainstream for preterm infants receiving general anesthesia. We aim to compare the perioperative respiratory adverse events between using supraglottic airway device (SAD) and ETT in former preterm infants receiving general anesthesia. Former preterm infants below 52&#xa0;weeks of postmenstrual age scheduled for herniorrhaphy were randomized to receive SAD or ETT for general anesthesia. Infants with severe congenital cardiopulmonary disease, prolonged oxygen or mechanical ventilation dependence, and recent respiratory tract infection were excluded. Muscle relaxant agents and opioids were avoided in this study. 40 infants were assigned into SAD or ETT groups. Infants in the SAD group had a much lower rate of intraoperative desaturation than those in the ETT group (21.1% vs. 73.7%, p&#x2009;=&#x2009;0.003). Incidences of other intraoperative and postoperative 24-h respiratory adverse events were similar between groups, including laryngospasm/bronchospasm, cough and stridor during anesthesia, and postoperative apnea, bradycardia, and supplemental oxygen use. All participants were extubated successfully in the operation room. SAD is recommended in former preterm infants receiving general anesthesia for herniorrhaphy in their early infancy as it much decreases the incidence of intraoperative desaturation compared to ETT.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Pin-Yang</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yu-Tang</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Division of Pediatric Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shu-Ting</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Division of Neonatology, Department of Pediatric, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ching-Shu</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Kuang-I</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Miao-Pei</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Kaohsiung Medical University Gangshan Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. cavia0803@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007234" MajorTopicYN="Y">Infant, Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endotracheal intubation</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Herniorrhaphy</Keyword><Keyword MajorTopicYN="N">Newborn</Keyword><Keyword MajorTopicYN="N">Premature</Keyword><Keyword MajorTopicYN="N">Supraglottic airway device</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>23</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39179661</ArticleId><ArticleId IdType="pmc">PMC11343740</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-69950-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-69950-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walther-Larsen, S. &amp; Rasmussen, L. S. The former preterm infant and risk of post-operative apnoea: Recommendations for management. Acta Anaesthesiol. Scand.50, 888&#x2013;893 (2006). 10.1111/j.1399-6576.2006.01068.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2006.01068.x</ArticleId><ArticleId IdType="pubmed">16879474</ArticleId></ArticleIdList></Reference><Reference><Citation>Marlow, N. Anesthesia and long-term outcomes after neonatal intensive care. Paediatr. Anaesth.24, 60&#x2013;67 (2014). 10.1111/pan.12304</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12304</ArticleId><ArticleId IdType="pmc">PMC3995018</ArticleId><ArticleId IdType="pubmed">24330445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad, N. &amp; Greenaway, S. Anaesthesia for inguinal hernia repair in the newborn or ex-premature infant. BJA Educ.18, 211&#x2013;217 (2018). 10.1016/j.bjae.2018.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjae.2018.04.004</ArticleId><ArticleId IdType="pmc">PMC7807980</ArticleId><ArticleId IdType="pubmed">33456835</ArticleId></ArticleIdList></Reference><Reference><Citation>Murat, I., Constant, I. &amp; Maud&#x2019;huy, H. Perioperative anaesthetic morbidity in children: A database of 24 165 anaesthetics over a 30-month period. Paediatr. Anaesth.14, 9 (2004).10.1111/j.1460-9592.2004.01167.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01167.x</ArticleId><ArticleId IdType="pubmed">14962332</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt, T. et al. Incidence of severe critical events in paediatric anaesthesia in the United Kingdom: Secondary analysis of the anaesthesia practice in children observational trial (APRICOT study). Anaesthesia74, 300&#x2013;311 (2019). 10.1111/anae.14520</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.14520</ArticleId><ArticleId IdType="pubmed">30536369</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, M. P. et al. Comparison of laryngeal mask airway and endotracheal tube in preterm neonates receiving general anesthesia for inguinal hernia surgery: A retrospective study. BMC Anesthesiol.21, 195 (2021). 10.1186/s12871-021-01418-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01418-2</ArticleId><ArticleId IdType="pmc">PMC8293587</ArticleId><ArticleId IdType="pubmed">34289809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatch, L. D. et al. Endotracheal intubation in neonates: A prospective study of adverse safety events in 162 infants. J. Pediatr.168(62&#x2013;6), e6 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4698044</ArticleId><ArticleId IdType="pubmed">26541424</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothari, R. et al. Time to desaturation in preterm infants undergoing endotracheal intubation. Arch. Dis. Child Fetal. Neonatal. Ed.106, 603&#x2013;607 (2021). 10.1136/archdischild-2020-319509</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-319509</ArticleId><ArticleId IdType="pmc">PMC8543201</ArticleId><ArticleId IdType="pubmed">33931396</ArticleId></ArticleIdList></Reference><Reference><Citation>Disma, N. et al. Difficult tracheal intubation in neonates and infants. NEonate and Children audiT of Anaesthesia pRactice in Europe (NECTARINE): A prospective European multicentre observational study. Br. J. Anaesth.126, 1173&#x2013;81 (2021). 10.1016/j.bja.2021.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.02.021</ArticleId><ArticleId IdType="pubmed">33812665</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal, S. C., Caoci, S., Dempsey, E., Trevisanuto, D. &amp; Roehr, C. C. The laryngeal mask airway and its use in neonatal resuscitation: A critical review of where we are in 2017/2018. Neonatology113, 152&#x2013;161 (2018). 10.1159/000481979</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481979</ArticleId><ArticleId IdType="pubmed">29232665</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi, M. J. &amp; Kumar, M. Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitation. Cochrane Database Syst. Rev.3, CD003314 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494187</ArticleId><ArticleId IdType="pubmed">29542112</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel, M. G., Swadia, V. &amp; Bansal, G. Prospective randomized comparative study of use of PLMA and ET tube for airway management in children under general anaesthesia. Indian J. Anaesth.54, 109&#x2013;115 (2010). 10.4103/0019-5049.63643</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.63643</ArticleId><ArticleId IdType="pmc">PMC2900732</ArticleId><ArticleId IdType="pubmed">20661347</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake-Brockman, T. F. E., Ramgolam, A., Zhang, G., Hall, G. L. &amp; von Ungern-Sternberg, B. S. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: A randomised controlled trial. The Lancet389, 701&#x2013;708 (2017).10.1016/S0140-6736(16)31719-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31719-6</ArticleId><ArticleId IdType="pubmed">28108038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunenc, F. et al. Use of laryngeal mask airway in anesthesia for treatment of retinopathy of prematurity. Saudi Med. J.32, 1127&#x2013;1132 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22057599</ArticleId></ArticleIdList></Reference><Reference><Citation>Velankar, P., Joshi, M. &amp; Sahu, P. Use of laryngeal mask airway in premature infant. Indian J. Anaesth.57, 634&#x2013;635 (2013). 10.4103/0019-5049.123354</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.123354</ArticleId><ArticleId IdType="pmc">PMC3883414</ArticleId><ArticleId IdType="pubmed">24403639</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Q., Zhao, H. &amp; Feng, Y. Laryngeal mask airway with pressure support ventilation vs. endotracheal tube with pressure controlled ventilation in preterm infants undergoing ROP surgery: A propensity score matching analysis of perioperative complications. J Clin Anesth57, 141&#x2013;2 (2019). 10.1016/j.jclinane.2019.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2019.04.001</ArticleId><ArticleId IdType="pubmed">31004993</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson, S. J., Byrne, P. J., Molesky, M. G., Seal, R. F. &amp; Finucane, B. T. Neonatal resuscitation using the laryngeal mask airway. Anesthesiology80, 1248&#x2013;53 (1994). 10.1097/00000542-199406000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199406000-00012</ArticleId><ArticleId IdType="pubmed">8010471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanous, A. A., Brown, R., Rudser, K. D. &amp; Roberts, K. D. Comparison of laryngeal mask airway and endotracheal tube placement in neonates. J. Perinatol.44, 239&#x2013;243 (2024). 10.1038/s41372-023-01818-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41372-023-01818-x</ArticleId><ArticleId IdType="pubmed">37919512</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo, C. H., Lee, S. Y., Chung, S. H. &amp; Ryu, J. H. Deep vs. awake extubation and LMA removal in terms of airway complications in pediatric patients undergoing anesthesia: A systemic review and meta-analysis. J. Clin. Med.7, 63 (2018). 10.3390/jcm7100353</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7100353</ArticleId><ArticleId IdType="pmc">PMC6210687</ArticleId><ArticleId IdType="pubmed">30322192</ArticleId></ArticleIdList></Reference><Reference><Citation>Obst, S. et al. Perinatal hyperoxia and developmental consequences on the lung-brain axis. Oxid. Med. Cell Longev.2022, 5784146 (2022). 10.1155/2022/5784146</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/5784146</ArticleId><ArticleId IdType="pmc">PMC8894035</ArticleId><ArticleId IdType="pubmed">35251477</ArticleId></ArticleIdList></Reference><Reference><Citation>Askie, L. M. et al. Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration. JAMA319, 2190&#x2013;2201 (2018). 10.1001/jama.2018.5725</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.5725</ArticleId><ArticleId IdType="pmc">PMC6583054</ArticleId><ArticleId IdType="pubmed">29872859</ArticleId></ArticleIdList></Reference><Reference><Citation>Somri, M. et al. Postoperative outcome in high-risk infants undergoing herniorrhaphy: Comparison between spinal and general anaesthesia. Anaesthesia53, 762&#x2013;766 (1998). 10.1046/j.1365-2044.1998.00431.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.1998.00431.x</ArticleId><ArticleId IdType="pubmed">9797520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, G. S., Song, J. G., Gwak, M. S. &amp; Yang, M. Postoperative outcome in formerly premature infants undergoing herniorrhaphy: Comparison of spinal and general anesthesia. J. Korean Med. Sci.18, 691&#x2013;695 (2003). 10.3346/jkms.2003.18.5.691</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2003.18.5.691</ArticleId><ArticleId IdType="pmc">PMC3055113</ArticleId><ArticleId IdType="pubmed">14555822</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson, A. J. et al. Apnea after awake regional and general anesthesia in infants: The general anesthesia compared to spinal anesthesia study-comparing apnea and neurodevelopmental outcomes, a randomized controlled trial. Anesthesiology123, 38&#x2013;54 (2015). 10.1097/ALN.0000000000000709</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000709</ArticleId><ArticleId IdType="pmc">PMC4626294</ArticleId><ArticleId IdType="pubmed">26001033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35748036</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2045-7634</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Cancer medicine</Title><ISOAbbreviation>Cancer Med</ISOAbbreviation></Journal><ArticleTitle>Predictive risk score of respiratory complications in children with mediastinal tumors: A case-control study.</ArticleTitle><Pagination><StartPage>1167</StartPage><EndPage>1176</EndPage><MedlinePgn>1167-1176</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cam4.4972</ELocationID><Abstract><AbstractText Label="BACKGROUND">The aim of this study was to examine risk factors of respiratory complications at the diagnosis and establish an algorithm of clinical management in children and adolescents with mediastinal tumors.</AbstractText><AbstractText Label="METHODS">We retrospectively collected clinical information of all children and adolescents who presented with mediastinal tumors at Saitama Children's Medical Center from 1999 to 2019, including age, sex, pathological diagnosis, eight major clinical symptoms (cough, dyspnea, hypoxia, orthopnea, chest pain, wheeze, superior vena cava syndrome, and stridor), chest computed tomography (CT) findings (tumor location, mediastinal mass ratio, pleural fluid, pericardial effusion, and compression of trachea and bronchi), types of diagnostic procedure and anesthesia, respiratory complications (severe hypoxia, difficult ventilation, respiratory failure, and cardiopulmonary arrest), and clinical outcome. Subsequently, we calculated the risk score for predicting respiratory complications by combining clinical and radiological findings.</AbstractText><AbstractText Label="RESULTS">Of the 57 patients, 7 (12%) developed respiratory complications. Cough, dyspnea, hypoxia, and orthopnea were significantly more common in patients with complications (p&#xa0;=&#xa0;0.02, p&#xa0;=&#xa0;0.02, p&#x2009;&lt;&#x2009;0.01, p&#xa0;=&#xa0;0.03, respectively). The reduction of percentage of tracheal cross-sectional area (%TCA) and compression of the carina in chest CT were also significantly more common in patients with complications (p&#x2009;&lt;&#x2009;0.01 and &lt;0.01, respectively). We calculated the risk score of respiratory complications by combining cough, wheeze, stridor, orthopnea, dyspnea, hypoxia, %TCA&#x2009;&lt;&#x2009;0.5, and compression of the carina. A risk score&#xa0;&#x2265;&#x2009;7 showed high predictive accuracy for complications (sensitivity: 100%, specificity: 97.7%, positive likelihood ratio: 43.0).</AbstractText><AbstractText Label="CONCLUSION">The risk score combining clinical symptoms with radiological findings is a promising predictive tool for respiratory complications in children with mediastinal tumors.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Cancer Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Mamoru</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9135-002X</Identifier><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuki</LastName><ForeName>Arakawa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahiro</LastName><ForeName>Hosokawa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chigusa</LastName><ForeName>Oyama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuichi</LastName><ForeName>Mitani</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makiko</LastName><ForeName>Mori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukuoka</LastName><ForeName>Kohei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koichi</LastName><ForeName>Oshima</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yutaka</LastName><ForeName>Tanami</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Radiology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tetsuya</LastName><ForeName>Ishimaru</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiroshi</LastName><ForeName>Kawashima</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koichi</LastName><ForeName>Mizuta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikuya</LastName><ForeName>Ueta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norifumi</LastName><ForeName>Kuratani</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuyoshi</LastName><ForeName>Koh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Med</MedlineTA><NlmUniqueID>101595310</NlmUniqueID><ISSNLinking>2045-7634</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008479" MajorTopicYN="Y">Mediastinal Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013479" MajorTopicYN="Y">Superior Vena Cava Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">mediastinal tumor</Keyword><Keyword MajorTopicYN="N">respiratory complications</Keyword><Keyword MajorTopicYN="N">risk score</Keyword><Keyword MajorTopicYN="N">tracheal cross-sectional area</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>3</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35748036</ArticleId><ArticleId IdType="pmc">PMC9883441</ArticleId><ArticleId IdType="doi">10.1002/cam4.4972</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shamberger RS, Holzman RS, Griscom NT, Tarbell NJ, Weinstein HJ. CT quantitation of tracheal cross&#x2010;sectional area as a guide to the surgical and anesthetic management of children with anterior mediastinal masses. J Pediatr Surg. 1991;26(2):138&#x2010;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">2023069</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamberger RC, Holzman RS, Griscom NT, Tarbell NJ, Weinstein HJ, Wohl ME. Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses. Surgery. 1995;118(3):468&#x2010;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">7652680</ArticleId></ArticleIdList></Reference><Reference><Citation>Anghelescu DL, Burgoyne LL, Liu T, et al. Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses. Paediatr Anaesth. 2007;17(11):1090&#x2010;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4400730</ArticleId><ArticleId IdType="pubmed">17897276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng A, Bennett J, Bromley P, Davies P, Morland B. Anaesthetic outcome and predictive risk factors in children with mediastinal tumours. Pediatr Blood Cancer. 2007;48(2):160&#x2010;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">16317755</ArticleId></ArticleIdList></Reference><Reference><Citation>Hack HA, Wright NB, Wynn RF. The anaesthetic management of children with anterior mediastinal masses. Anaesthesia. 2008;63(8):837&#x2010;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">18547295</ArticleId></ArticleIdList></Reference><Reference><Citation>Perger L, Lee EY, Shamberger RC. Management of children and adolescents with a critical airway due to compression by an anterior mediastinal mass. J Pediatr Surg. 2008;43(11):1990&#x2010;1997.</Citation><ArticleIdList><ArticleId IdType="pubmed">18970930</ArticleId></ArticleIdList></Reference><Reference><Citation>Stricker PA, Gurnaney HG, Litman RS. Anesthetic management of children with an anterior mediastinal mass. J Clin Anesth. 2010;22(3):159&#x2010;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">20399999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy&#x2010;to&#x2010;use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48(3):452&#x2010;458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>King DR, Patrick LE, Ginn&#x2010;Pease ME, McCoy KS, Klopfenstein K. Pulmonary function is compromised in children with mediastinal lymphoma. J Pediatr Surg. 1997;32(2):294&#x2010;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">9044140</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39618204</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1750-8460</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>British journal of hospital medicine (London, England : 2005)</Title><ISOAbbreviation>Br J Hosp Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Impact of Propofol Administered before Extubation on Respiratory Adverse Events in Pediatric Patients Undergoing Tonsillectomy and Adenoidectomy: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>15</EndPage><MedlinePgn>1-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12968/hmed.2024.0431</ELocationID><Abstract><AbstractText><b>Aims/Background</b> Perioperative respiratory adverse events (PRAEs) are common in pediatric anesthesia, especially in otolaryngology procedures. In this randomized controlled trial, we investigated the impact of administering propofol before extubation on PRAEs in pediatric patients undergoing tonsillectomy and adenoidectomy. <b>Methods</b> We enrolled children aged 3 to 8 years old, of American Society of Anesthesiologists (ASA) classes I to III, scheduled for tonsillectomy, and randomly divided them into propofol and control groups. The subjects in the propofol group received multiple small doses of propofol (0.5 mg/kg per dose, total 1-2 mg/kg) until the patient resumed regular spontaneous breathing and exhibited no bodily movements. The subjects in the control group received 0.15 mL/kg of saline. The primary outcome was the rate of PRAEs, such as laryngospasm, bronchospasm, breath-holding spell, severe coughing, desaturation, and airway obstruction, post-extubation. The secondary outcomes were the extubation time, pre-extubation Richmond Agitation-Sedation Scale (RASS) score, end-tidal sevoflurane concentration at extubation, incidence of postoperative agitation, time to consciousness, and Face, Legs, Activity, Cry, and Consolability (FLACC) pain score in the recovery room. Results were reported with risk ratios (RR) and their 95% confidence intervals (CI), as well as the <i>p</i>-values indicating statistical significance. <b>Results</b> A total of 239 patients were included, including 119 in the propofol group and 120 in the control group. Our findings indicated no significant difference in the rate of PRAEs between the two groups (5.9% vs 10.8%, RR: 0.54, 95% CI: 0.23 to 1.31, <i>p</i> = 0.17). However, the propofol group showed a notable decrease in moderate to severe coughs (13.4% vs 60.0%, RR: 0.22, 95% CI: 0.14 to 0.36, <i>p</i> &lt; 0.001) and postoperative agitation (4.2% vs 60.8%, RR: 0.07, 95% CI: 0.03 to 0.17, <i>p</i> &lt; 0.001). <b>Conclusion</b> This trial demonstrated that while administering repeated small doses of propofol before extubation does not significantly reduce respiratory adverse events in children undergoing tonsillectomy and adenoidectomy, it does significantly reduce the incidence of severe coughing, improving postoperative recovery and clinical outcomes. Moreover, propofol helps reduce postoperative agitation, enhancing the safety and effectiveness of postoperative care, and maintaining its valuable clinical role in postoperative management. <b>Clinical Trial Registration</b> ClinicalTrials.gov (NCT05769842).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Ruting</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhijian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Huiying</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children's Hospital of Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05769842</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Hosp Med (Lond)</MedlineTA><NlmUniqueID>101257109</NlmUniqueID><ISSNLinking>1750-8460</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="Y">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="Y">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="Y">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="Y">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">extubation</Keyword><Keyword MajorTopicYN="N">perioperative respiratory adverse events</Keyword><Keyword MajorTopicYN="N">propofol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>3</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39618204</ArticleId><ArticleId IdType="doi">10.12968/hmed.2024.0431</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39264430</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-5695</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>European journal of emergency medicine : official journal of the European Society for Emergency Medicine</Title><ISOAbbreviation>Eur J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Laryngeal mask vs. laryngeal tube trial in paediatric patients (LaMaTuPe): a single-blinded, open-label, randomised-controlled trial.</ArticleTitle><Pagination><StartPage>123</StartPage><EndPage>130</EndPage><MedlinePgn>123-130</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MEJ.0000000000001178</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In hypoxemic children with difficult airway, or for minor elective procedures, the use of a supraglottic airway device may be preferred to endotracheal intubation, whether with a laryngeal mask or laryngeal tube. Second-generation laryngeal masks may offer a better safety profile. Whether they should be preferred to laryngeal tubes is unknown. This study aimed to compare the efficacy and safety of second-generation laryngeal masks and laryngeal tubes in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This randomised-controlled trial was conducted in a single university hospital in children &lt;18 years undergoing elective anaesthesia in urology, minor paediatric surgery and gynaecology. Patients were 1&#x2005;:&#x2005;1 randomised to the laryngeal mask or laryngeal tube group. Children were allocated a second-generation laryngeal tube or a second-generation laryngeal mask as the primary airway device. The primary endpoint was insertion time. Secondary endpoints included first-attempt success, overall success and complications, which included hypoxia (SpO 2 &#x2005;&lt;&#x2005;90%), laryngospasm, bronchospasm, aspiration and bleeding.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 135 patients were randomised, with 61 allocated to the laryngeal tube and 74 to the laryngeal mask group, with a median age of 5.4 and 4.9 years, respectively. Median insertion time was significantly longer in the laryngeal tube group (37 vs. 31&#x2005;s; difference of medians: 6.0&#x2005;s; 95% confidence interval: 0.0-13.0). The laryngeal tube had a significantly lower first-attempt (41.0%) and overall success rate (45.9%) than the laryngeal mask (90.5% and 97.3%, respectively). Those allocated to the laryngeal tube group had a higher ratio of complications (27.8%) compared to the laryngeal mask group (2.7%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This randomised-controlled trial reported that in children undergoing elective anaesthesia, the use of a laryngeal tube was associated with a longer insertion time.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Katzenschlager</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaltschmidt</LastName><ForeName>Nikolai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peterstorfer</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weilbacher</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Paediatric Surgery, Department of General, Visceral, and Transplantation Surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ries</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Paediatric Neurology and Metabolic Medicine, Centre for Paediatrics and Adolescent Medicine, Heidelberg University, Medical Faculty Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weigand</LastName><ForeName>Markus A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Emerg Med</MedlineTA><NlmUniqueID>9442482</NlmUniqueID><ISSNLinking>0969-9546</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>S.K. is a member of the International Liaison Committee on Resuscitation, Pediatric Life Support Taskforce. For the remaining authors, there are no conflicts of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>26</Day><Hour>18</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39264430</ArticleId><ArticleId IdType="pmc">PMC11855995</ArticleId><ArticleId IdType="doi">10.1097/MEJ.0000000000001178</ArticleId><ArticleId IdType="pii">00063110-990000000-00149</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>G&#xfc;th J, Jung P, Schiele A, Urban B, Parsch A, Matsche B, et al. . Update 2022: Interdisziplin&#xe4;re Stellungnahme zum Atemwegsmanagement mit supraglottischen Atemwegshilfen in der Kindernotfallmedizin &#x2013; die Larynxmaske ist und bleibt State of the Art. Die Anaesthesiologie. 2023; 72:425&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pubmed">37222766</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagannathan N, Ramsey MA, White MC, Sohn L. An update on newer pediatric supraglottic airways with recommendations for clinical use. Paediatr Anaesth. 2015; 25:334&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">25585975</ArticleId></ArticleIdList></Reference><Reference><Citation>Difficult Airway Society. Difficult mask ventilation (MV) - during routine induction of anaesthesia in a child aged 1 to 8 years. Wiley; 2018. https://das.uk.com/files/APA1-DiffMaskVent-FINAL.pdf. [Accessed 14 June 2023].</Citation></Reference><Reference><Citation>Apfelbaum JL, Hagberg CA, Connis RT, Abdelmalak BB, Agarkar M, Dutton RP, et al. . 2022 American Society of Anesthesiologists Practice Guidelines for management of the difficult airway. Anesthesiology. 2022; 136:31&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">34762729</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake-Brockman TFE, Ramgolam A, Zhang G, Hall GL, von Ungern-Sternberg BS. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial. Lancet (London, England). 2017; 389:701&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">28108038</ArticleId></ArticleIdList></Reference><Reference><Citation>Genzwuerker HV, Fritz A, Hinkelbein J, Finteis T, Schlaefer A, Schaeffer M, et al. . Prospective, randomized comparison of laryngeal tube and laryngeal mask airway in pediatric patients. Paediatr Anaesth. 2006; 16:1251&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">17121555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortone L, Ingelmo PM, Ninno GD, et al. . Randomized controlled trial comparing the laryngeal tube and the laryngeal mask in pediatric patients. Pediatric Anesthesia. 2006; 16:251&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">16490088</ArticleId></ArticleIdList></Reference><Reference><Citation>Genzwuerker H, Hohl E, Rapp H-J. Ventilation with the laryngeal tube in pediatric patients undergoing elective ambulatory surgery. Pediatric Anesthesia. 2005; 15:385&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">15828989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya G, Koyuncu O, Turan N, Turan A. Comparison of the Laryngeal Mask (LMATM) and Laryngeal Tube (LT&#xae;) with the perilaryngeal airway (CobraPLA&#xae;) in brief paediatric surgical procedures. Anaesth Intensive Care. 2008; 36:425&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">18564805</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzenschlager S, Kelpanides IK, Ristau P, Huck M, Seewald S, Brenner S, et al. . Out-of-hospital cardiac arrest in children: an epidemiological study based on the German Resuscitation Registry identifying modifiable factors for return of spontaneous circulation. Crit Care. 2023; 27:349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10485980</ArticleId><ArticleId IdType="pubmed">37679812</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P, Bailey CR. A performance comparison of the paediatric i-gel TM with other supraglottic airway devices. Anaesthesia. 2015; 70:84&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25187212</ArticleId></ArticleIdList></Reference><Reference><Citation>Harless J, Ramaiah R, Bhananker S. Pediatric airway management. Int J Crit Illn Inj Sci. 2014; 4:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3982373</ArticleId><ArticleId IdType="pubmed">24741500</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe4;&#xdf;ler M, Ruppert M, Lefering R, Bouillon B, Wafaisade A; TraumaRegister DGU. Schwerverletztenversorgung durch Not&#xe4;rzte aus unterschiedlichen Fachgebieten. Die Unfallchirurgie. 2022; 125:967&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9705456</ArticleId><ArticleId IdType="pubmed">34698885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HE, Schmicker RH, Daya MR, Stephens SW, Idris AH, Carlson JN, et al. . Effect of a strategy of initial laryngeal tube insertion vs endotracheal intubation on 72-hour survival in adults with out-of-hospital cardiac arrest a randomized clinical trial. JAMA. 2018; 320:769&#x2013;778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583103</ArticleId><ArticleId IdType="pubmed">30167699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagberg C. Hagberg and Benumof&#x2019;s Airway Management. Elsevier; 2023.</Citation></Reference><Reference><Citation>von Baeyer CL, Spagrud LJ, McCormick JC, Choo E, Neville K, Connelly MA. Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children&#x2019;s self-reports of pain intensity. Pain. 2009; 143:223&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">19359097</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ttner W, Finke W. Analysis of behavioural and physiological parameters for the assessment of postoperative analgesic demand in newborns, infants and young children: a comprehensive report on seven consecutive studies. Paediatr Anaesth. 2000; 10:303&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">10792748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesnick JA, Moore JX, Zhang Y, Jarvis J, Nichol G, Daya MR, et al. . Airway insertion first pass success and patient outcomes in adult out-of-hospital cardiac arrest: The Pragmatic Airway Resuscitation Trial. Resuscitation. 2021; 158:151&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855546</ArticleId><ArticleId IdType="pubmed">33278521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A-F, Chien Y-C, Lee B-C, Yang W-S, Wang Y-C, Lin H-Y, et al. . Effect of placement of a supraglottic airway device vs endotracheal intubation on return of spontaneous circulation in adults with out-of-hospital cardiac arrest in Taipei, Taiwan. JAMA Network Open. 2022; 5:e2148871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857689</ArticleId><ArticleId IdType="pubmed">35179588</ArticleId></ArticleIdList></Reference><Reference><Citation>Burjek NE, Nishisaki A, Fiadjoe JE, Adams HD, Peeples KN, Raman VT, et al. .; PeDI Collaborative Investigators. Videolaryngoscopy versus fiber-optic intubation through a supraglottic airway in children with a difficult airway. Anesthesiology. 2017; 127:432&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">28650415</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D; for the CONSORT Group. Consort 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332&#x2013;c332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844940</ArticleId><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleine-Brueggeney M, Gottfried A, Nabecker S, Greif R, Book M, Theiler L. Pediatric supraglottic airway devices in clinical practice: a prospective observational study. BMC Anesthesiology. 2017; 17:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5581452</ArticleId><ArticleId IdType="pubmed">28865448</ArticleId></ArticleIdList></Reference><Reference><Citation>Richebe P, Semjen F, Cros A-M, Maurette P. Clinical assessment of the laryngeal tube in pediatric anesthesia. Paediatr Anaesth. 2005; 15:391&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">15828990</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W, Disma N, Virag K, Becke K, Hansen TG, J&#xf6;hr M, et al. .; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. The Lancet Respiratory Medicine. 2017; 5:412&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>APSF. The Laryngeal Mask Airway: Expanding Use Beyond Routine Spontaneous Ventilation for Surgery. 2021. https://www.apsf.org/article/the-laryngeal-mask-airway-expanding-use-beyond-routine-spontaneous-ventilation-for-surgery/ [Accessed 18 July 2024].</Citation></Reference><Reference><Citation>Scheller B, Schalk R, Byhahn C, Peter N, L&#x2019;Allemand N, Kessler P, Meininger D. Laryngeal tube suction II for difficult airway management in neonates and small infants. Resuscitation. 2009; 80:805&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">19410354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedgwick P, Greenwood N. Understanding the Hawthorne effect. BMJ. 2015; 351:h4672.</Citation><ArticleIdList><ArticleId IdType="pubmed">26341898</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21730929</PMID><DateCompleted><Year>2011</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>8</Issue><PubDate><Year>2011</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Continuous intravenous infusion of ketamine for maintenance sedation.</ArticleTitle><Pagination><StartPage>812</StartPage><EndPage>820</EndPage><MedlinePgn>812-20</MedlinePgn></Pagination><Abstract><AbstractText>Ketamine HCl is a rapidly acting general anesthetic with sedative and analgesic properties that has been reported to have favorable effects on the cardiovascular and pulmonary systems. The goal of this review is to determine the hemodynamic and pulmonary effects of continuous intravenous (IV) ketamine infusion in mechanically ventilated patients, and to determine whether sufficient evidence exists to support its use as an agent for maintenance anesthesia. PubMed/Medline, EMBASE, and Index Medicus databases as well as relevant bibliographies were searched. Studies were independently evaluated for inclusion and exclusion criteria, as well as study parameters, by two evaluators. Any discrepancy was resolved by a third evaluator. Twenty studies (281 patients) met the inclusion criteria for this review including 11 prospective studies (250 patients). Data suggests that ketamine decreases airway resistance, improves dynamic compliance, and preserves functional residual capacity, minute ventilation and tidal volume, while retaining protective pharyngeal and laryngeal reflexes. In patients with refractory bronchospasm, continuous infusion of intravenous ketamine decreases audible wheeze, bronchodilator requirements, and hypercarbia. It also improves respiratory rate and oxygenation, and does not promote respiratory depression. Additionally, ketamine does not result in significant perturbations in blood pressure, heart rate, or vascular resistance. Ketamine may be a safe and effective tool for maintenance sedation of mechanically ventilated patients, however a large prospective clinical trial is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, National Institutes of Health, Bethesda, MD, USA. taqwa1@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamin</LastName><ForeName>C T</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Elamin</LastName><ForeName>E M</ForeName><Initials>EM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21730929</ArticleId><ArticleId IdType="pii">R02116307</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37659165</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>Association between preoperative respiratory symptoms and perioperative respiratory adverse events in pediatric patients with positive viral testing.</ArticleTitle><Pagination><StartPage>111241</StartPage><MedlinePgn>111241</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2023.111241</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(23)00191-5</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE">To determine the association between the presence of upper respiratory tract viral infection symptoms and occurrence of perioperative respiratory adverse events (PRAE) in children with positive viral screening, and to analyze the risk of PRAE in children with SARS-CoV-2 compared to non-SARS-CoV-2 infection.</AbstractText><AbstractText Label="DESIGN">A prospective cohort study.</AbstractText><AbstractText Label="SETTING">A tertiary, freestanding pediatric hospital in Dallas, Texas.</AbstractText><AbstractText Label="PATIENTS">Children &lt;18&#xa0;years of age with positive respiratory viral testing who underwent general anesthesia.</AbstractText><AbstractText Label="INTERVENTION">Measurement of incidence of PRAE and severe adverse events during the first 7 postoperative days.</AbstractText><AbstractText Label="MEASUREMENTS">The primary outcome was a composite of PRAE: oxygen saturation&#xa0;&lt;&#xa0;90% for &gt;5&#xa0;min, supplemental oxygen for &gt;2&#xa0;h after anesthesia, laryngospasm, and bronchospasm. The secondary outcome was severe adverse events: high flow nasal cannula &gt;6&#xa0;l of oxygen per minute, admission to the ICU for escalation of respiratory support post-anesthetic, acute respiratory distress syndrome, postoperative pneumonia, cardiovascular arrest, extracorporeal life support, and death.</AbstractText><AbstractText Label="MAIN RESULTS">In this convenience sample of 196 children, 83 were symptomatic and 113 were asymptomatic. The risk of PRAE was similar in children with active viral symptoms and asymptomatic children (risk difference: -1.9%; 95% CI: -10.9, 7.9%), but higher among children with documented fever within 48&#xa0;h of the anesthetic (risk difference: 20.8%; 95% CI: 5.3, 39.7%). The multivariable adjusted odds ratio of PRAE was 0.68 (95% CI: 0.25, 1.85) for symptomatic compared to asymptomatic patients, and 0.46 (95% CI: 0.14, 1.44) for patients with SARS-CoV-2 compared to non-SARS-CoV-2 infection.</AbstractText><AbstractText Label="CONCLUSIONS">There was no significant difference in the incidence of PRAE between symptomatic and asymptomatic children with laboratory confirmed viral respiratory infection, and between children with the Omicron variant of SARS-CoV-2 compared to non-SARS-CoV-2 respiratory viruses. However, the risk was increased in children with recent fever.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saynhalath</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, Division of Pediatric Anesthesia, University of Texas Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States; Children's Health, 1935 Medical District Drive Dallas, TX 75235, United States; Outcomes Research Consortium, 9500 Euclid Avenue Cleveland, OH 44195, United States. Electronic address: Rita.Saynhalath@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efune</LastName><ForeName>Proshad N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, Division of Pediatric Anesthesia, University of Texas Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States; Children's Health, 1935 Medical District Drive Dallas, TX 75235, United States; Outcomes Research Consortium, 9500 Euclid Avenue Cleveland, OH 44195, United States. Electronic address: Proshad.Efune@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakonezny</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States. Electronic address: Paul.Nakonezny@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alex</LastName><ForeName>Gijo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, Division of Pediatric Anesthesia, University of Texas Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States; Children's Health, 1935 Medical District Drive Dallas, TX 75235, United States. Electronic address: Gijo.Alex@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabers</LastName><ForeName>Jessica N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Children's Health, 1935 Medical District Drive Dallas, TX 75235, United States. Electronic address: Jessica.Sabers@childrens.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clintsman</LastName><ForeName>Lee M</ForeName><Initials>LM</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Children's Health, 1935 Medical District Drive Dallas, TX 75235, United States. Electronic address: Lee.Clintsman@childrens.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poppino</LastName><ForeName>Kiley F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, Division of Pediatric Anesthesia, University of Texas Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States. Electronic address: Kiley.Poppino@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szmuk</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, Division of Pediatric Anesthesia, University of Texas Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States; Children's Health, 1935 Medical District Drive Dallas, TX 75235, United States; Outcomes Research Consortium, 9500 Euclid Avenue Cleveland, OH 44195, United States. Electronic address: Peter.Szmuk@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanford</LastName><ForeName>Ethan L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Management, Division of Pediatric Anesthesia, University of Texas Southwestern, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States; Children's Health, 1935 Medical District Drive Dallas, TX 75235, United States; Outcomes Research Consortium, 9500 Euclid Avenue Cleveland, OH 44195, United States. Electronic address: Ethan.Sanford@UTSouthwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthetics</Keyword><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">Prospective studies</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Virus diseases</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>3</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>2</Day><Hour>18</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37659165</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2023.111241</ArticleId><ArticleId IdType="pii">S0952-8180(23)00191-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25605033</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1883</ISSN><JournalIssue CitedMedium="Internet"><Volume>209</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of surgery</Title><ISOAbbreviation>Am J Surg</ISOAbbreviation></Journal><ArticleTitle>Esophageal atresia and transitional care--step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems.</ArticleTitle><Pagination><StartPage>747</StartPage><EndPage>759</EndPage><MedlinePgn>747-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjsurg.2014.09.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9610(14)00576-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Esophageal atresia (EA) is a rare congenital anomaly with high infantile survival rates. The aim of this study was to outline the prevalence of common long-term problems associated with EA repair in patients older than 10 years of age.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Original papers were identified by systematic searching of MEDLINE and EMBASE databases from January 1993 to July 2014. Fifteen articles (907 EA patients) met inclusion criteria.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This is the first systematic review aiming to quantify the prevalence of the long-term problems associated with EA. The main active medical conditions (pooled estimated prevalence) identified were the following: dysphagia (50.3%), gastroesophageal reflux disease with (40.2%) or without (56.5%) histological esophagitis, recurrent respiratory tract infections (24.1%), doctor-diagnosed asthma (22.3%), persistent cough (14.6%), and wheeze (34.7%). The prevalence of Barrett's esophagus (6.4%) was 4 and 26 times higher than the adult (1.6%) and pediatric (.25%) general populations. Adult and pediatric practitioners should focus on how to develop effective long-term follow-up and transitional care for these patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Connor</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Pediatric and Neonatal Surgery, St. George's Healthcare NHS Trust, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Springford</LastName><ForeName>Laurie R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Pediatric and Neonatal Surgery, St. George's Healthcare NHS Trust, University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapetanakis</LastName><ForeName>Venediktos V</ForeName><Initials>VV</Initials><AffiliationInfo><Affiliation>Population Health Research Institute, St. George's University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giuliani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric and Neonatal Surgery, St. George's Healthcare NHS Trust, University of London, London, UK. Electronic address: stefano.giuliani@nhs.net.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Surg</MedlineTA><NlmUniqueID>0370473</NlmUniqueID><ISSNLinking>0002-9610</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004933" MajorTopicYN="N">Esophageal Atresia</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Barrett&#x2019;s esophagus</Keyword><Keyword MajorTopicYN="N">Esophageal atresia</Keyword><Keyword MajorTopicYN="N">Esophageal cancer</Keyword><Keyword MajorTopicYN="N">Gastroesophageal reflux</Keyword><Keyword MajorTopicYN="N">Long-term care</Keyword><Keyword MajorTopicYN="N">Review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25605033</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2014.09.019</ArticleId><ArticleId IdType="pii">S0002-9610(14)00576-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30059398</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Laryngeal Mask Airway Versus Other Airway Devices for Anesthesia in Children With an Upper Respiratory Tract Infection: A Systematic Review and Meta-analysis of Respiratory Complications.</ArticleTitle><Pagination><StartPage>941</StartPage><EndPage>950</EndPage><MedlinePgn>941-950</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000003674</ELocationID><Abstract><AbstractText>There is an association between upper respiratory tract infection (URTI) and an increased incidence of perioperative respiratory adverse events (PRAEs), which is a major risk for morbidity during pediatric anesthesia. The aim of the present study was to compare the risk of PRAEs among different airway devices during anesthesia in children with a URTI. A systematic review according to the Cochrane Handbook and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was conducted. Only randomized clinical trials evaluating anesthesia in children with a URTI and who were submitted to any of the airway devices were included. From 1030 studies identified, 5 randomized clinical trials were included in the final analysis. There were no statistical differences between laryngeal mask airway (LMA&#xae;) and endotracheal tube (ETT) regarding breath holding or apnea (risk ratio [RR], 0.82; 95% confidence interval [CI], 0.41-1.65), laryngospasm (RR, 0.74; 95% CI, 0.18-2.95), and arterial oxygen desaturation (RR, 0.44; 95% CI, 0.16-1.17). The quality of evidence was low for the first outcome and very low for the 2 other outcomes, respectively. The LMA use produced a significant reduction of cough (RR, 0.75; 95% CI, 0.58-0.96, low quality of evidence) compared with ETT. The ideal airway management in children with a URTI remains obscure given that there are few data of perioperative respiratory complications during anesthesia. This systematic review demonstrates that LMA use during anesthesia in children with URTI did not result in decrease of the most feared PRAEs. However, LMA was better than ETT in reducing cough. Further research is needed to define the risks more clearly because cough and laryngospasm have similar triggers, and both bronchospasm and laryngospasm trigger cough.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Carvalho</LastName><ForeName>Ana Lygia R</ForeName><Initials>ALR</Initials><AffiliationInfo><Affiliation>From the Departamento de Anestesiologia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vital</LastName><ForeName>Roberto B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>From the Departamento de Anestesiologia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lira</LastName><ForeName>Carlos C S</ForeName><Initials>CCS</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Psicologia e Psiquiatria, Faculdade de Medicina de Botucatu, UNESP, Universidade Estadual Paulista "J&#xfa;lio de Mesquita Filho," Botucatu, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magro</LastName><ForeName>Igor B</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Departamento de Neurologia, Psicologia e Psiquiatria, Faculdade de Medicina de Botucatu, UNESP, Universidade Estadual Paulista "J&#xfa;lio de Mesquita Filho," Botucatu, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Patr&#xed;cia T S</ForeName><Initials>PTS</Initials><AffiliationInfo><Affiliation>From the Departamento de Anestesiologia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>La&#xed;s H N</ForeName><Initials>LHN</Initials><AffiliationInfo><Affiliation>From the Departamento de Anestesiologia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braz</LastName><ForeName>Leandro G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>From the Departamento de Anestesiologia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf3;dolo</LastName><ForeName>Norma S P</ForeName><Initials>NSP</Initials><AffiliationInfo><Affiliation>From the Departamento de Anestesiologia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Anesth Analg. 2019 Feb;128(2):e37. doi: 10.1213/ANE.0000000000003962.</RefSource><PMID Version="1">30649044</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2019 Jun;128(6):e122-e123. doi: 10.1213/ANE.0000000000004124.</RefSource><PMID Version="1">31094816</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2019 Jun;128(6):e123. doi: 10.1213/ANE.0000000000004125.</RefSource><PMID Version="1">31094817</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30059398</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000003674</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29667726</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Interventions for infantile haemangiomas of the skin.</ArticleTitle><Pagination><StartPage>CD006545</StartPage><MedlinePgn>CD006545</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD006545</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD006545.pub3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Infantile haemangiomas (previously known as strawberry birthmarks) are soft, raised swellings of the skin that occur in 3% to 10% of infants. These benign vascular tumours are usually uncomplicated and tend to regress spontaneously. However, when haemangiomas occur in high-risk areas, such as near the eyes, throat, or nose, impairing their function, or when complications develop, intervention may be necessary. This is an update of a Cochrane Review first published in 2011.</AbstractText><AbstractText Label="OBJECTIVES">To assess the effects of interventions for the management of infantile haemangiomas in children.</AbstractText><AbstractText Label="SEARCH METHODS">We updated our searches of the following databases to February 2017: the Cochrane Skin Group Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO, AMED, LILACS, and CINAHL. We also searched five trials registries and checked the reference lists of included studies for further references to relevant trials.</AbstractText><AbstractText Label="SELECTION CRITERIA">Randomised controlled trials (RCTs) of all types of interventions, versus placebo, active monitoring, or other interventions, in any child with single or multiple infantile haemangiomas (IHs) located on the skin.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS">We used standard methodological procedures expected by Cochrane. The primary outcome measures were clearance, a subjective measure of improvement, and adverse events. Secondary outcomes were other measures of resolution; proportion of parents or children who consider there is still a problem; aesthetic appearance; and requirement for surgical correction. We used GRADE to assess the quality of the evidence for each outcome; this is indicated in italics.</AbstractText><AbstractText Label="MAIN RESULTS">We included 28 RCTs, with a total of 1728 participants, assessing 12 different interventions, including lasers, beta blockers (e.g. propranolol, timolol maleate), radiation therapy, and steroids. Comparators included placebo, an active monitoring approach, sham radiation, and interventions given alone or in combination.Studies were conducted in a number of countries, including China, Egypt, France, and Australia. Participant age ranged from 12 weeks to 13.4 years. Most studies (23/28) included a majority of females and different types of IHs. Duration of follow-up ranged from 7 days to 72 months.We considered most of the trials as at low risk of random sequence generation, attrition bias, and selective reporting bias. Domains such as allocation concealment and blinding were not clearly reported in general. We downgraded evidence for issues related to risk of bias and imprecision.We report results for the three most important comparisons, which we chose on the basis of current use. Outcome measurement of these comparisons was at 24 weeks' follow-up.Oral propranolol versus placeboCompared with placebo, oral propranolol 3 mg/kg/day probably improves clinician-assessed clearance (risk ratio (RR) 16.61, 95% confidence interval (CI) 4.22 to 65.34; 1 study; 156 children; moderate-quality evidence) and probably leads to a clinician-assessed reduction in mean haemangioma volume of 45.9% (95% CI 11.60 to 80.20; 1 study; 40 children; moderate-quality evidence). We found no evidence of a difference in terms of short- or long-term serious adverse events (RR 1.05, 95% CI 0.33 to 3.39; 3 studies; 509 children; low-quality evidence), nor in terms of bronchospasm, hypoglycaemia, or serious cardiovascular adverse events. The results relating to clearance and resolution for this comparison were based on one industry-sponsored study.Topical timolol maleate versus placeboThe chance of reduction of redness, as a measure of clinician-assessed resolution, may be improved with topical timolol maleate 0.5% gel applied twice daily when compared with placebo (RR 8.11, 95% CI 1.09 to 60.09; 1 study; 41 children;low-quality evidence). Regarding short- or long-term serious cardiovascular events, we found no instances of bradycardia (slower than normal heart rate) or hypotension in either group (1 study; 41 children; low-quality evidence). No other safety data were assessed, and clearance was not measured.Oral propranolol versus topical timolol maleateWhen topical timolol maleate (0.5% eye drops applied twice daily) was compared with oral propranolol (via a tablet taken once per day, at a 1.0 mg/kg dose), there was no evidence of a difference in haemangioma size (as a measure of resolution) when measured by the proportion of patients with a clinician-assessed reduction of 50% or greater (RR 1.13, 95% CI 0.64 to 1.97; 1 study; 26 participants; low-quality evidence). Although there were more short- or long-term general adverse effects (such as severe diarrhoea, lethargy, and loss of appetite) in the oral propranolol group, there was no evidence of a difference between groups (RR 7.00, 95% CI 0.40 to 123.35; 1 study; 26 participants; very low-quality evidence). This comparison did not measure clearance.None of our key comparisons evaluated, at any follow-up, a subjective measure of improvement assessed by the parent or child; proportion of parents or children who consider there is still a problem; or physician-, child-, or parent-assessed aesthetic appearance.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS">We found there to be a limited evidence base for the treatment of infantile haemangiomas: a large number of interventions and outcomes have not been assessed in RCTs.Our key results indicate that in the management of IH in children, oral propranolol and topical timolol maleate are more beneficial than placebo in terms of clearance or other measures of resolution, or both, without an increase in harms. We found no evidence of a difference between oral propranolol and topical timolol maleate with regard to reducing haemangioma size, but we are uncertain if there is a difference in safety. Oral propranolol is currently the standard treatment for this condition, and our review has not found evidence to challenge this. However, these results are based on moderate- to very low-quality evidence.The included studies were limited by small sample sizes and risk of bias in some domains. Future trials should blind personnel and participants; describe trials thoroughly in publications; and recruit a sufficient number of children to deduce meaningful results. Future trials should assess patient-reported outcomes, as well as objective outcomes of benefit, and should report adverse events comprehensively. Propranolol and timolol maleate require further assessment in RCTs of all types of IH, including those considered problematic, as do other lesser-used interventions and new interventions. All treatments should be compared against propranolol and timolol maleate, as beta blockers are approved as standard care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Novoa</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Paediatric Dermatology Department, Hospital San Jose-Fundacion Universitaria de Ciencias de la Salud, Carrera 19, No. 8A-32, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baselga</LastName><ForeName>Eulalia</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Beltran</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Giraldo</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Shahbaz</LastName><ForeName>Ali</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Pardo-Hernandez</LastName><ForeName>Hector</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Arevalo-Rodriguez</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>11056-06-7</RegistryNumber><NameOfSubstance UI="D001761">Bleomycin</NameOfSubstance></Chemical><Chemical><RegistryNumber>817W3C6175</RegistryNumber><NameOfSubstance UI="D013999">Timolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical><Chemical><RegistryNumber>9Y8NXQ24VQ</RegistryNumber><NameOfSubstance UI="D011433">Propranolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2011 May 11;(5):CD006545. doi: 10.1002/14651858.CD006545.pub2.</RefSource><PMID Version="1">21563155</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Br J Dermatol. 2019 Mar;180(3):450-451. doi: 10.1111/bjd.17574.</RefSource><PMID Version="1">30821386</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Paediatr Child Health. 2020 Mar;56(3):480-482. doi: 10.1111/jpc.14730.</RefSource><PMID Version="1">32173946</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="N">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001761" MajorTopicYN="N">Bleomycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018324" MajorTopicYN="N">Hemangioma, Capillary</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054025" MajorTopicYN="N">Lasers, Dye</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010778" MajorTopicYN="N">Photochemotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011433" MajorTopicYN="N">Propranolol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013999" MajorTopicYN="N">Timolol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Monica Novoa: nothing to declare.&#x2028;
Eulalia Baselga: I have been the principal investigator for propranolol trials in infantile haemangioma, which included reviewing the final data, and for this I received honorarium/a consulting fee from Pierre Fabre Dermatology. I have received financial support for travel to meetings from Pierre Fabre Dermatology. I have received consultancy fees from the following: Pierre Fabre Dermatology and Sanofi&#x2010;Regeneron. I have received payment for lectures from the following: Ordesa, Meda, Cantabria, and Almirall. I have given paid educational presentations for the following companies: Pierre Fabre Dermatology, Almirall, ISDIN, Novartis, Ferrer, Leo, IFC (Cantabria), and Ordesa. I have received travel/accommodation funding to attend the European Academy of Dermatology &amp; Venereology and Spanish Academy of Dermatology meeting from the following: Novartis, Almirall, Ferrer, ISDIN, Cantabria, and Lao.&#x2028;
Sandra Beltr&#xe1;n: nothing to declare.&#x2028;
Lucia Giraldo: nothing to declare.&#x2028;
Ali Shahbaz: nothing to declare.&#x2028;
Hector Pardo&#x2010;Hernandez: nothing to declare.&#x2028;
Ingrid Arevalo&#x2010;Rodriguez: nothing to declare. Dr Baselga was involved in the development of Leaute&#x2010;Labreze 2015. She did not participate in the 'Risk of bias' assessment and data extraction for this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29667726</ArticleId><ArticleId IdType="pmc">PMC6513200</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD006545.pub3</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Abarzua&#x2010;Araya 2014 {published data only}</Title><Reference><Citation>Abarzua&#x2010;Araya A, Navarrete&#x2010;Dechent CP, Heusser F, Retamal J, Zegpi&#x2010;Trueba MS. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. Journal of the American Academy of Dermatology 2014;70(6):1045&#x2010;9. [CENTRAL: CN&#x2010;00993183; PUBMED: 24656727]</Citation><ArticleIdList><ArticleId IdType="pubmed">24656727</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Aly 2015 {published data only}</Title><Reference><Citation>Aly MMD, Hamza AF, Abdel Kader HM, Saafan HA, Ghazy MS, Ragab IA. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. European Journal of Pediatrics 2015;174(11):1503&#x2010;9. [CENTRAL: CN&#x2010;01106020; PUBMED: 25982338]</Citation><ArticleIdList><ArticleId IdType="pubmed">25982338</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Asilian 2015 {published data only}</Title><Reference><Citation>Asilian A, Mokhtari F, Kamali AS, Abtahi&#x2010;Naeini B, Nilforoushzadeh MA, Mostafaie S. Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: A double&#x2010;blind randomized controlled trial. Advanced Biomedical Research. 2015;4:257. [PUBMED: 26918239]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4746935</ArticleId><ArticleId IdType="pubmed">26918239</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Batta 2002 {published data only}</Title><Reference><Citation>Batta K, Goodyear H, Moss C, Williams H, Hiller L, Waters R. Randomized controlled study of early pulsed dye laser treatment of uncomplicated infantile haemangiomas: results of a 5&#x2010;year analysis. British Journal of Dermatology 2008;159(Suppl 1):113&#x2010;27. [CENTRAL: CN&#x2010;00784022]</Citation><ArticleIdList><ArticleId IdType="pubmed">12241656</ArticleId></ArticleIdList></Reference><Reference><Citation>Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1&#x2010;year analysis. Lancet 2002;360(9332):521&#x2010;7. [CENTRAL: CN&#x2010;00410133]</Citation><ArticleIdList><ArticleId IdType="pubmed">12241656</ArticleId></ArticleIdList></Reference><Reference><Citation>Batta K, Waters R, Titley M, Goodyear H, Moss C. Experience in the very early treatment of childhood haemangiomas with the 585 nm pulsed dye laser (PDL). British Journal of Dermatology 2000;143(Suppl 57):42&#x2010;85. [CENTRAL: CN&#x2010;00783264]</Citation></Reference></ReferenceList><ReferenceList><Title>Bauman 2014 {published data only}</Title><Reference><Citation>Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, et al. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: A randomized clinical trial. JAMA Otolaryngology, Head &amp; Neck Surgery. 2014;140(4):323&#x2010;30. [CENTRAL: CN&#x2010;00988156; PUBMED: 24526257]</Citation><ArticleIdList><ArticleId IdType="pubmed">24526257</ArticleId></ArticleIdList></Reference><Reference><Citation>NCT00967226. Propranolol versus prednisolone for treatment of symptomatic hemangiomas. clinicaltrials.gov/ct2/show/NCT00967226 (accessed 23 April 2010).</Citation></Reference></ReferenceList><ReferenceList><Title>Chan 2013 {published data only}</Title><Reference><Citation>Chan H, McKay C, Adams S, Wargon O. RCT of timolol maleate gel for superficial infantile hemangiomas in 5&#x2010; to 24&#x2010;week&#x2010;olds. Pediatrics 2013;131(6):e1739&#x2010;47. [CENTRAL: CN&#x2010;00876607]</Citation><ArticleIdList><ArticleId IdType="pubmed">23650294</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ehsani 2014 {published data only}</Title><Reference><Citation>Ehsani AH, Noormohammadpoor P, Abdolreza M, Balighi K, Arianian Z, Daklan S. Combination therapy of infantile hemangioma with pulsed dye laser with topical propranolol: a randomized clinical trial. Archives of Iranian Medicine 2014;17(10):657&#x2010;60. [CENTRAL: CN&#x2010;01042472; PUBMED: 25305763]</Citation><ArticleIdList><ArticleId IdType="pubmed">25305763</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Feng 2000 {published data only}</Title><Reference><Citation>Feng LL, Wang XJ, Sun LQ, Zhang ZR, Ma CH. Clinical observation on efficacy of methylthionine chloride in the treatment of hemangiomas in children. Chinese Journal of Dermatology 2000;33(4):284. [CENTRAL: CN&#x2010;00843680]</Citation></Reference></ReferenceList><ReferenceList><Title>Fu 2012 {published data only}</Title><Reference><Citation>Fu S, Wang B, Huang H, Huang L. Primary clinical application of high&#x2010;intensity focused ultrasound on infant hemangiomas. Chung&#x2010;Kuo Hsiu Fu Chung Chien Wai Ko Tsa Chih/Chinese Journal of Reparative &amp; Reconstructive Surgery 2011;25(12):1477&#x2010;80. [CENTRAL: CN&#x2010;00896632]</Citation><ArticleIdList><ArticleId IdType="pubmed">22242350</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu SZ, Wang B, Huang HP, Huang LL. Clinical study on hemangiomas treatment with high&#x2010;intensity focused ultrasound (60 cases). Zhonghua Zheng Xing Wai Ke za Zhi = Zhonghua Zhengxing Waike Zazhi [Chinese Journal of Plastic Surgery] 2012;28(4):252&#x2010;5. [CENTRAL: CN&#x2010;00966758]</Citation><ArticleIdList><ArticleId IdType="pubmed">23173418</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gong 2015 {published data only}</Title><Reference><Citation>Gong H, Xu D&#x2010;P, Li Y&#x2010;X, Cheng C, Li G, Wang X&#x2010;K. Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas. British Journal of Oral &amp; Maxillofacial Surgery 2015;53(9):836&#x2010;40. [CENTRAL: CN&#x2010;01125564; PUBMED: 26427968]</Citation><ArticleIdList><ArticleId IdType="pubmed">26427968</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hogeling 2011 {published data only}</Title><Reference><Citation>Hogeling M, Adams S, Wargon O. A randomized controlled trial of Propranolol for infantile haemangiomas. Australasian Journal of Dermatology 2011;52(Suppl 2):4. [EMBASE: 70558759]</Citation><ArticleIdList><ArticleId IdType="pubmed">21788220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011;128(2):e259&#x2010;66. [PUBMED: 21788220]</Citation><ArticleIdList><ArticleId IdType="pubmed">21788220</ArticleId></ArticleIdList></Reference><Reference><Citation>Wargon O. Randomised placebo controlled trial: Safety and efficacy of topical timolol maleate gel vs placebo for small superficial infantile haemangiomas. Australasian Journal of Dermatology 2013;54(Suppl 2):22&#x2010;3. [EMBASE: 71067708]</Citation></Reference></ReferenceList><ReferenceList><Title>Jung 1977 {published data only}</Title><Reference><Citation>Jung EG. X&#x2010;ray therapy for hemangiomatas [Die strahlentherapie der hamangiome]. Dermatologica 1976;153(2):86&#x2010;7. [CENTRAL: CN&#x2010;00784697]</Citation><ArticleIdList><ArticleId IdType="pubmed">1001594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung EG, Kohler U. Regression of haemangiomata in infants after x&#x2010;ray treatment and mock&#x2010;radiation [R&#xfc;ckbildung fr&#xfc;hkindlicher h&#xe4;mangiome nach r&#xf6;ntgen&#x2010; und pseudobestrahlung]. Archives of Dermatological Research 1977;259(1):21&#x2010;8. [CENTRAL: CN&#x2010;00614355]</Citation><ArticleIdList><ArticleId IdType="pubmed">900990</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kessels 2013 {published data only}</Title><Reference><Citation>Kessels JP, Hamers ET, Ostertag JU. Superficial hemangioma: pulsed dye laser versus wait&#x2010;and&#x2010;see. Dermatologic Surgery 2013;39(3 Pt 1):414&#x2010;21. [CENTRAL: CN&#x2010;00966183; PUBMED: 23279058]</Citation><ArticleIdList><ArticleId IdType="pubmed">23279058</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Leaute&#x2010;Labreze 2013 {published data only}</Title><Reference><Citation>Leaute&#x2010;Labreze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, et al. Double&#x2010;blind randomized pilot trial evaluating the efficacy of oral propranolol on infantile haemangiomas in infants &lt; 4 months of age. British Journal of Dermatology 2013;169(1):181&#x2010;3. [CENTRAL: CN&#x2010;00977604; PUBMED: 23301692]</Citation><ArticleIdList><ArticleId IdType="pubmed">23301692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Leaute&#x2010;Labreze 2015 {published data only}</Title><Reference><Citation>L&#xe9;aut&#xe9;&#x2010;Labr&#xe8;ze C, Hoeger P, Mazereeuw&#x2010;Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. New England Journal of Medicine. 2015;372(8):735&#x2010;46. [CENTRAL: CN&#x2010;01052642; PUBMED: 25693013]</Citation><ArticleIdList><ArticleId IdType="pubmed">25693013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2016 {published data only}</Title><Reference><Citation>Li G, Xu DP, Tong S, Xue L, Sun NN, Wang XK. Oral propranolol with topical timolol maleate therapy for mixed infantile hemangiomas in oral and maxillofacial regions. Journal of Craniofacial Surgery 2016;27(1):56&#x2010;60. [CENTRAL: CN&#x2010;01195472; PUBMED: 26716547]</Citation><ArticleIdList><ArticleId IdType="pubmed">26716547</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lu 2016 {published data only}</Title><Reference><Citation>Lu J, Kuang X, Zhao J, Xiang Y, Huang J, Zeng Q, et al. Concurrent versus sequential combination of propranolol and dual&#x2010;wavelength laser (585 nm and 1064 nm) to treat complicated infantile hemangiomas. International Journal of Clinical and Experimental Medicine 2016;9(8):16132&#x2010;16138. [EMBASE: 20160650632]</Citation></Reference></ReferenceList><ReferenceList><Title>Malik 2013 {published data only}</Title><Reference><Citation>Malik MA, Menon P, Rao KL, Samujh R. Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: A randomized controlled study. Journal of Pediatric Surgery 2013;48(12):2453&#x2010;9. [CENTRAL: CN&#x2010;00921325; PUBMED: 24314186]</Citation><ArticleIdList><ArticleId IdType="pubmed">24314186</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pope 2007 {published data only}</Title><Reference><Citation>Pope E, Krafchik BR, Macarthur C, Stempak D, Stephens D, Weinstein M, et al. Oral versus high&#x2010;dose pulse corticosteroids for problematic infantile hemangiomas: a randomized controlled trial. Pediatrics 2007;119(6):e1239&#x2010;e1247. [CENTRAL: CN&#x2010;00588641; PUBMED: 17485449]</Citation><ArticleIdList><ArticleId IdType="pubmed">17485449</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tan 2012 {published data only}</Title><Reference><Citation>Tan M, Duan B, Zhou CM, Gong H. The therapeutic effect of propranolol with 1064 nm Nd: YAG laser on proliferating hemangioma in body surface. Zhonghua Zheng Xing Wai Ke za Zhi = Zhonghua Zhengxing Waike Zazhi [Chinese Journal of Plastic Surgery] 2012;28(3):164&#x2010;8. [CENTRAL: CN&#x2010;01124671; PUBMED: 22870700]</Citation><ArticleIdList><ArticleId IdType="pubmed">22870700</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tawfik 2015 {published data only}</Title><Reference><Citation>Tawfik AA, Alsharnoubi J. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study. Pediatric dermatology 2015;32(3):369&#x2010;76. [CENTRAL: CN&#x2010;01102313; PUBMED: 25740672]</Citation><ArticleIdList><ArticleId IdType="pubmed">25740672</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tiwari 2016 {published data only}</Title><Reference><Citation>Tiwari P, Pandey V, Gangopadhyay AN, Sharma SP, Gupta DK. Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study. Oral &amp; Maxillofacial Surgery 2016;20(1):73&#x2010;7. [PUBMED: 26481918]</Citation><ArticleIdList><ArticleId IdType="pubmed">26481918</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xu 2006 {published data only}</Title><Reference><Citation>Xu WL. The research of pingyangmycin emulsion on proliferation of tumor cell apoptosis in capillary hemangiomas [translation]. Shijiazhuang, Hebei, China: Hebei Medical University, 2003.</Citation></Reference><Reference><Citation>Xu WL, Niu AG, Li SL, Li ZD. Pingyangmycin emulsion inducing apoptosis in infantile proliferating capillary hemangiomas. Zhonghua Zheng Xing Wai Ke za Zhi = Zhonghua Zhengxing Waike Zazhi [Chinese Journal of Plastic Surgery] 2006;22(5):362&#x2010;4. [CENTRAL: CN&#x2010;00730309]</Citation><ArticleIdList><ArticleId IdType="pubmed">17144454</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu WL, Niu AG, Li ZD, Li SL, Shi BJ, Zhang YB, et al. Effect of pingyangmycin emulsion on the microenvironment of infantile proliferating capillary hemangioma. World Journal of Pediatrics 2006;2(3):217&#x2010;22.</Citation></Reference></ReferenceList><ReferenceList><Title>Zaher 2013 {published data only}</Title><Reference><Citation>Zaher H, Rasheed H, Esmat S, Gawdat HI, Hegazy RA, El&#x2010;Komy M, et al. Propranolol and infantile hemangiomas: Different routes of administration, a randomized clinical trial. European Journal of Dermatology 2013;23(5):646&#x2010;52. [CENTRAL: CN&#x2010;00961393; PUBMED: 24135427]</Citation><ArticleIdList><ArticleId IdType="pubmed">24135427</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zaher 2016 {published data only}</Title><Reference><Citation>Zaher H, Rasheed H, El&#x2010;Komy MM, Hegazy RA, Gawdat HI, Abdel Halim DM, et al. Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial. Journal of the American Academy of Dermatology 2016;74(3):499&#x2010;505. [CENTRAL: CN&#x2010;01138323; PUBMED: 26685718]</Citation><ArticleIdList><ArticleId IdType="pubmed">26685718</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhang 2013 {published data only}</Title><Reference><Citation>Zhang L, Mai HM, Zheng J, Zheng JW, Chen ZG, Wang YA, et al. Preliminary study on plasma RPN concentration of patients with infantile hemangioma treated with propranolol. International journal of clinical and experimental medicine 2013;6(5):342&#x2010;5. [CENTRAL: CN&#x2010;00906420; PUBMED: 23724152]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664000</ArticleId><ArticleId IdType="pubmed">23724152</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhong 2015 {published data only}</Title><Reference><Citation>Zhong S, Tao Y, Zhou J, Yao L, Uu Y, Yan D, et al. Evaluation on efficacy of low dose propranolol combined with 1 064 nm Nd: YAG laser on mixed and deeper infantile hemangioma. Journal of Jilin University Medicine Edition 2015;41(5):1032&#x2010;5. [CENTRAL: CN&#x2010;01177799]</Citation></Reference></ReferenceList><ReferenceList><Title>Zhu 2015 {published data only}</Title><Reference><Citation>Zhu HJ, Liu Q, Deng XL, Guan YX. Efficacy of low&#x2010;dose 90Sr&#x2010;90Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas. Experimental and Therapeutic Medicine 2015;10(3):1013&#x2010;8. [PUBMED: 26622431]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4533184</ArticleId><ArticleId IdType="pubmed">26622431</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Ahn 2004 {published data only}</Title><Reference><Citation>Ahn H, Kim YJ, Hwang ES, Kim IH. Clinical trial of 5% imiquimod cream for eleven cases of infantile hemangioma. Korean Journal of Dermatology 2004;42(6):718&#x2010;23. [EMBASE: 2004354455]</Citation></Reference></ReferenceList><ReferenceList><Title>Ambika 2013 {published data only}</Title><Reference><Citation>Ambika H, Sujatha C, Kumar YH. Topical timolol: A safer alternative for complicated and un&#x2010;complicated infantile hemangiomas. Indian Journal of Dermatology 2013;58(4):330. [PUBMED: 23919041]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3726918</ArticleId><ArticleId IdType="pubmed">23919041</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anonymous 2002 {published data only}</Title><Reference><Citation>Anonymous. Assessing early laser treatment of strawberry naevi. Medicine Today 2002;3(12):10.</Citation></Reference></ReferenceList><ReferenceList><Title>Anonymous 2011 {published data only}</Title><Reference><Citation>Anonymous. Propranolol effective in shrinking infantile hemangioma. Contemporary Pediatrics 2011;28:11&#x2010;2.</Citation></Reference></ReferenceList><ReferenceList><Title>Baselga 2014 {published data only}</Title><Reference><Citation>Baselga E. IS&#x2010;065: Hemangiomas: Oral propanolol and beyond. Archives of Disease in Childhood 2014;99:A20&#x2010;A21.</Citation></Reference></ReferenceList><ReferenceList><Title>Bozena 2012 {published data only}</Title><Reference><Citation>Bozena DB. HEMANGIOL Study: The first worldwide dose&#x2010;effect study concerning propranolol in infantile hemangiomas [Badanie HEMANGIOL &#x2010; pierwsze ogolnoswiatowe badanie zaleznosci dawka&#x2010;efekt dotyczace stosowania propranololu u pacjentow z naczyniakami niemowlecymi]. Przeglad Dermatologiczny 2012;99(4):419. [CENTRAL: CN&#x2010;01028347]</Citation></Reference></ReferenceList><ReferenceList><Title>Branco 2008 {published data only}</Title><Reference><Citation>Branco DFR, Goldenberg DC, Heitor BS, Bastos EO, Alonso N. Early surgical resection of nasal hemangiomas: indications and results [Ressec&#xe7;&#xe3;o cir&#xfa;rgica precoce de hemangiomas nasais: indica&#xe7;&#xf5;es e resultados]. Revista da Sociedade Brasileira de Cirurgia Craniomaxilofacial. 2008;11(3 Suppl):23.</Citation></Reference></ReferenceList><ReferenceList><Title>Chang 2008 {published data only}</Title><Reference><Citation>Chan CJ, Hsiao YC, Mihm MC Jr, Nelson JS. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Lasers in Surgery &amp; Medicine 2008;40(9):605&#x2010;10. [CENTRAL: CN&#x2010;00708211; PUBMED: 18951427]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717850</ArticleId><ArticleId IdType="pubmed">18951427</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chen 2013 {published data only}</Title><Reference><Citation>Chen XD, Ma G, Huang JL, Chen H, Jin YB, Ye XX, et al. Serum&#x2010;level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy. Pediatric Dermatology 2013;30(5):549&#x2010;53. [CENTRAL: CN&#x2010;01122228; PUBMED: 23909679]</Citation><ArticleIdList><ArticleId IdType="pubmed">23909679</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Costinescu 1981 {published data only}</Title><Reference><Citation>Costinescu V, Dinu C, Martu D. Clinical trial of sodium morrhuate in the treatment of ORL angiomas [Experimentarea clinica a moruatului de sodiu in tratamentul angioamelor din sfera O.R.L]. Revista de Chirurgie, Oncologie, Radiologie, O.r.l., Oftalmologie, Stomatologie. Oto&#x2010;rino&#x2010;laringologia 1981;26(1):61&#x2010;2. [PUBMED: 6454221]</Citation><ArticleIdList><ArticleId IdType="pubmed">6454221</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dalby 2013 {published data only}</Title><Reference><Citation>Dalby TK, Lester&#x2010;Smith D. Propranolol for the treatment of infantile haemangioma. Journal of Paediatrics &amp; Child Health 2013;49(2):148&#x2010;51. [PUBMED: 23418706]</Citation><ArticleIdList><ArticleId IdType="pubmed">23418706</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ferahbas 2008 {published data only}</Title><Reference><Citation>Ferahbas A, Kartal D, Taslider N, Utas S. The effectiveness of contact cryotherapy in treatment of infantile hemangiomas. Turkish Journal of Dermatology 2008;2(4):107&#x2010;10.</Citation></Reference></ReferenceList><ReferenceList><Title>Frieden 2009 {published data only}</Title><Reference><Citation>Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatric Dermatology 2009;26(5):642&#x2010;4. [PUBMED: 19840341]</Citation><ArticleIdList><ArticleId IdType="pubmed">19840341</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gajbhiye 2011 {published data only}</Title><Reference><Citation>Gajbhiye V, Nath S, Chatterjee S, De A, Ghosh D, Das SK. Role of propranolol in hemangiomas. Journal of Indian Association of Pediatric Surgeons 2011;16(4):173&#x2010;4. [PUBMED: 22121324]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3221168</ArticleId><ArticleId IdType="pubmed">22121324</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Goelz 2014 {published data only}</Title><Reference><Citation>Goelz R, Moll M, Meisner C, Rocken M, Poets CF, Moehrle MC. Prospective controlled study to evaluate cryocontact therapy for infantile haemangioma in preterm infants. Archives of Disease in Childhood Fetal &amp; Neonatal Edition 2014;99(4):F345&#x2010;6. [CENTRAL: CN&#x2010;01042486]</Citation><ArticleIdList><ArticleId IdType="pubmed">24668831</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Incesoy 2011 {published data only}</Title><Reference><Citation>Incesoy Ozdemir S, Bozkurt C, Orun UA, Sahin G, Yuksek N, Cetinkaya S, et al. Successful treatment of pulmonary arteriovenous malformation and infantile hepatic hemangioendothelioma with alpha&#x2010;interferon. Anadolu Kardiyoloji Dergisi [Anatolian Journal of Cardiology] 2011;11(2):181&#x2010;3. [PUBMED: 21362599]</Citation><ArticleIdList><ArticleId IdType="pubmed">21362599</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jalil 2006 {published data only}</Title><Reference><Citation>Jalil S, Akhtar J, Ahmed S. Corticosteroids therapy in the management of infantile cutaneous hemangiomas. Journal of the College of Physcians &amp; Surgeons &#x2010; Pakistan 2006;16(10):662&#x2010;665. [CENTRAL: CN&#x2010;00608871; PUBMED: 17007757]</Citation><ArticleIdList><ArticleId IdType="pubmed">17007757</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jesitus 2011 {published data only}</Title><Reference><Citation>Jesitus J. Lack of data: More controlled trials needed for infantile hemangioma therapies, experts say. Dermatology Times 2011;32:28&#x2010;34.</Citation></Reference></ReferenceList><ReferenceList><Title>Jha 2012 {published data only}</Title><Reference><Citation>Jha AK, Mallik SK, Raihan M. Topical ophthalmic solution in infantile hemangioma. Journal of Postgraduate Medicine 2012;58(2):163&#x2010;5. [PUBMED: 22718070]</Citation><ArticleIdList><ArticleId IdType="pubmed">22718070</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jiang 2011 {published data only}</Title><Reference><Citation>Jiang C, Hu X, Ma G, Chen D, Jin Y, Chen H, et al. A prospective self&#x2010;controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma. Pediatric Dermatology 2011;28(3):259&#x2010;66. [CENTRAL: CN&#x2010;00799727; PUBMED: 21615472]</Citation><ArticleIdList><ArticleId IdType="pubmed">21615472</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kunzi&#x2010;Rapp 2012 {published data only}</Title><Reference><Citation>Kunzi&#x2010;Rapp K. Topical propranolol therapy for infantile hemangiomas. Pediatric Dermatology 2012;29(2):154&#x2010;9. [CENTRAL: CN&#x2010;00900917]</Citation><ArticleIdList><ArticleId IdType="pubmed">22141326</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liu 2009 {published data only}</Title><Reference><Citation>Liu XJ, Quin ZP, Tai MZ. Angiographic classification and sclerotic therapy of maxillofacial cavernous haemangiomas: a report of 204 cases. Journal of International Medical Research 2009;37(5):1285&#x2010;92. [PUBMED: 19930833]</Citation><ArticleIdList><ArticleId IdType="pubmed">19930833</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McCuaig 2009 {published data only}</Title><Reference><Citation>McCuaig CC, Dubois J, Powell J, Belleville C, David M, Rousseau E, et al. A phase II, open&#x2010;label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatric Dermatology 2009;26(2):203&#x2010;12. [PUBMED: 19419474]</Citation><ArticleIdList><ArticleId IdType="pubmed">19419474</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Menezes 2011 {published data only}</Title><Reference><Citation>Menezes MD, McCarter R, Greene EA, Bauman NM. Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. Annals of Otology, Rhinology, and Laryngology 2011;120(10):686&#x2010;95. [CENTRAL: CN&#x2010;00804792]</Citation><ArticleIdList><ArticleId IdType="pubmed">22097156</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Michel 1998 {published data only}</Title><Reference><Citation>Michel S, Wlotzke U, Hohenleutner U, Landthaler M. Laser and cryotherapy of hemangioma in infants in a direct comparison [Laser&#x2010; und kryotherapie der Sauglingshamangiome im direckten vergleich]. Hautarzt 1998;49(3):192&#x2010;6. [CENTRAL: CN&#x2010;00509698]</Citation><ArticleIdList><ArticleId IdType="pubmed">9565786</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Midena 2008 {published data only}</Title><Reference><Citation>Midena E, Pilotto E, Radin PP, Belvis V. Bolus vs standard photodynamic therapy in the treatment of circumscribed choroidal hemangioma: a randomized, masked study. Investigative Ophthalmology &amp; Visual Science 2004;45:3154. [CENTRAL: CN&#x2010;00598352]</Citation></Reference><Reference><Citation>Urban F, Pilotto E, Parrozzani R, Midena E. Photodynamic therapy of circumscribed choroidal hemangioma: comparison of dosage and timing. Acta Ophthalmologica 2008;86:s243.</Citation></Reference></ReferenceList><ReferenceList><Title>Miranda 2005 {published data only}</Title><Reference><Citation>Miranda Madinya Ricardo, V&#xe1;squez Beckmann Carlos. Importance of absolute alcohol in the treatment of infantile capillary hemangiomas. Dr. Francisco de Ycaza Bustamante&#xf6; Hospital, Guayaquil [Valor del alcohol absoluto en el tratamiento de los hemangiomas capilares infantiles. Hospital Dr. Francisco de Ycaza Bustamante, Guayaquil]. Medicina 2005;10:203&#x2010;6.</Citation></Reference></ReferenceList><ReferenceList><Title>NCT01074437 {published data only}</Title><Reference><Citation>NCT01074437. Corticosteroids with placebo versus corticosteroids with propranolol treatment of infantile hemangiomas. clinicaltrials.gov/ct2/results?term=NCT01074437 (accessed 23 April 2010).</Citation></Reference></ReferenceList><ReferenceList><Title>Pancar 2011 {published data only}</Title><Reference><Citation>Pancar GS, Aydin F, Senturk N, Bek Y, Canturk MT, Turanli AY. Comparison of the 532&#x2010;nm KTP and 1064&#x2010;nm Nd:YAG lasers for the treatment of cherry angiomas. Journal of Cosmetic and Laser Therapy 2011;13(4):138&#x2010;41. [CENTRAL: CN&#x2010;00811208]</Citation><ArticleIdList><ArticleId IdType="pubmed">21689029</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Poetke 2000 {published data only}</Title><Reference><Citation>Poetke M, Philipp C, Berlien HP. Flashlamp&#x2010;pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Archives of Dermatology 2000;136(5):628&#x2010;32. [CENTRAL: CN&#x2010;00277983]</Citation><ArticleIdList><ArticleId IdType="pubmed">10815856</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pope 2013 {published data only}</Title><Reference><Citation>Pope E, Chakkittakandiyil A, Lara&#x2010;Corrales I, Maki E, Weinstein M. Expanding the therapeutic repertoire of infantile haemangiomas: Cohort&#x2010;blinded study of oral nadolol compared with propranolol. British Journal of Dermatology 2013;168(1):222&#x2010;4. [CENTRAL: CN&#x2010;00912475]</Citation><ArticleIdList><ArticleId IdType="pubmed">22762503</ArticleId></ArticleIdList></Reference><Reference><Citation>Pope E, Chakkittakandiyil A, Weinstein M. Expanding the therapeutic repertoire of infantile hemangiomas: Prospective pilot study using oral nadolol. Pediatric Dermatology 2011;28(5):510. [EMBASE: 70661234]</Citation></Reference></ReferenceList><ReferenceList><Title>Rouvas 2009 {published data only}</Title><Reference><Citation>Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A, et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 2009;29(4):536&#x2010;44. [CENTRAL: CN&#x2010;00704491]</Citation><ArticleIdList><ArticleId IdType="pubmed">19190547</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sadan 1996 {published data only}</Title><Reference><Citation>Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. Journal of Pediatrics 1996;128(1):141&#x2010;6. [CENTRAL: CN&#x2010;00122746]</Citation><ArticleIdList><ArticleId IdType="pubmed">8551406</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Schlosser 2009 {published data only}</Title><Reference><Citation>Schlosser KA. Infantile hemangioma: how to treat this benign neoplasm of childhood. JAAPA: Journal of the American Academy of Physician Assistants 2009;22(5):46&#x2010;9. [PUBMED: 19469391]</Citation><ArticleIdList><ArticleId IdType="pubmed">19469391</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Smit 2005 {published data only}</Title><Reference><Citation>Smit JM, Bauland CG, Wijnberg DS, Spauwen PH. Pulsed dye laser treatment, a review of indications and outcome based on published trials. British Journal of Plastic Surgery 2005;58(7):981&#x2010;7. [PUBMED: 16039628]</Citation><ArticleIdList><ArticleId IdType="pubmed">16039628</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Song 2015 {published data only}</Title><Reference><Citation>Song H, Shi H, Zhang X, Wang J, Yu Y, Chen W, et al. Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment. British Journal of Dermatology 2015;172(2):444&#x2010;9. [CENTRAL: CN&#x2010;01052634]</Citation><ArticleIdList><ArticleId IdType="pubmed">25041341</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thaivalappil 2013 {published data only}</Title><Reference><Citation>Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol&#x2010;mediated attenuation of MMP&#x2010;9 excretion in infants with hemangiomas. JAMA Otolaryngology&#x2010;&#x2010; Head &amp; Neck Surgery 2013;139(10):1026&#x2010;31. [CENTRAL: CN&#x2010;00921293]</Citation><ArticleIdList><ArticleId IdType="pubmed">24135743</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tierney 2009 {published data only}</Title><Reference><Citation>Tierney E, Barker A, Ahdout J, Hanke CW, Moy RL, Kouba DJ. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging. Dermatologic Surgery 2009;35(5):725&#x2010;46. [PUBMED: 19309338]</Citation><ArticleIdList><ArticleId IdType="pubmed">19309338</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weienstein 2012 {published data only}</Title><Reference><Citation>Weissenstein A, Villalon G, Luchter E, Bittmann S. Children's haemangiomas: use of new topical therapies. British Journal of Nursing 2012;21(5):274. [PUBMED: 22398997]</Citation><ArticleIdList><ArticleId IdType="pubmed">22398997</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Weissenstein 2015 {published data only}</Title><Reference><Citation>Weissenstein A, Luchter E, Bittmann S. Successful treatment of infantile haemangioma with propranolol. British Journal of Nursing 2015;24(2):96&#x2010;7. [PUBMED: 25615994]</Citation><ArticleIdList><ArticleId IdType="pubmed">25615994</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhao 1997 {published data only}</Title><Reference><Citation>Zhao YL, He CN, Zhi CF, Zhang YX, Wang HJ. Prednisolone acetate mixed up Morrhuate sodium for the treatment of hemangiomas in children. Chinese Journal of Dermatology 1997;30(6):414. [CENTRAL: CN&#x2010;00844079]</Citation></Reference></ReferenceList><ReferenceList><Title>Zhong 2014 {published data only}</Title><Reference><Citation>Zhong SX, Tao YC, Zhou JF, Yao L, Li SS. Evaluation on efficacy of different doses of propranolol in treatment of infantile hemangioma. Journal of Jilin University Medicine Edition 2014;40(4):880&#x2010;3. [CENTRAL: CN&#x2010;01041728]</Citation></Reference></ReferenceList><ReferenceList><Title>Zhou 2000 {published data only}</Title><Reference><Citation>Zhou JY, Fang GJ, Wang XM. Clinical study of microwave operation in treating nasal hemangioma. International and 6th National Head and Neck Cancer Conference. Shanghai, china, 9&#x2010;13 June, 2000. 2000:195. [CENTRAL: CN&#x2010;00343206]</Citation></Reference></ReferenceList><ReferenceList><Title>Zhou 2002 {published data only}</Title><Reference><Citation>Zhou K, Liang C, Yang K, Wang L. A randomised controlled study on the efficacy of modified sclerotherapy in treating angioma of ear, nose and throat. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology] 2002;16(12):681&#x2010;3. [CENTRAL: CN&#x2010;00436296]</Citation><ArticleIdList><ArticleId IdType="pubmed">12669445</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhou 2015 {published data only}</Title><Reference><Citation>Zhou W, He S, Yang Y, Jian D, Chen X, Ding J. Formulation, characterization and clinical evaluation of propranolol hydrochloride gel for transdermal treatment of superficial infantile hemangioma. Drug Development &amp; Industrial Pharmacy 2015;41(7):1109&#x2010;19. [CENTRAL: CN&#x2010;01254273]</Citation><ArticleIdList><ArticleId IdType="pubmed">25151873</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies awaiting assessment</Title><ReferenceList><Title>Kuang 2014 {published data only}</Title><Reference><Citation>Kuang X, Lu J. Concurrent versus sequential combination therapy of propranolol and dual&#x2010;wavelength laser (585nm and 1064nm) to treat refractory infantile hemangiomas. Journal of Dermatology 2014;41:100. [CENTRAL: CN&#x2010;01055093]</Citation></Reference></ReferenceList><ReferenceList><Title>Maier 2012 {published data only}</Title><Reference><Citation>Maier H, Wanka A, Schmalwieser AW, Maier B, Dani T, Neumann R, et al. Prospective, randomized, investigator&#x2010;blind, controlled therapy study on treatment of haemangioma of infancy: Pulsed dye laser versus cryotherapy versus observation. Experimental Dermatology 2012;21(3):e15. [EMBASE: 70792062]</Citation></Reference></ReferenceList><ReferenceList><Title>NCT00004436 {published data only}</Title><Reference><Citation>NCT00004436. Randomized study of hormonal regulation of infantile hemangioma. clinicaltrials.gov/ct2/show/NCT00004436 (accessed 23 April 2010).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT00555464 {published data only}</Title><Reference><Citation>NCT00555464. Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas. clinicaltrials.gov/ct2/show/NCT00555464 (accessed 23 April 2010).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT00744185 {published data only}</Title><Reference><Citation>NCT00744185. Propranolol on capillary hemangiomas. clinicaltrials.gov/ct2/show/NCT00744185 (accessed 23 April 2010).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT01072045 {published data only}</Title><Reference><Citation>NCT01072045. Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma. clinicaltrials.gov/ct2/show/NCT01072045 (accessed 23 April 2010).</Citation></Reference></ReferenceList><ReferenceList><Title>Pandey 2010 {published data only}</Title><Reference><Citation>Pandey A, Gangopadhyay AN, Sharma SP, Kumar V, Gupta DK, Gopal SC. Evaluation of topical steroids in the treatment of superficial hemangioma. SKINmed 2010;8(1):9&#x2010;11. [CENTRAL: CN&#x2010;00760496]</Citation><ArticleIdList><ArticleId IdType="pubmed">20839418</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to ongoing studies</Title><ReferenceList><Title>NCT01147601 {published data only}</Title><Reference><Citation>NCT01147601. Topical Timolol 0.5% solution for proliferating infantile haemangiomas. clinicaltrials.gov/ct2/show/NCT01147601?term=NCT01147601 (accessed 25 March 2011).</Citation></Reference></ReferenceList><ReferenceList><Title>NCT02913612 {published data only}</Title><Reference><Citation>NCT02913612. Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (TIM01). clinicaltrials.gov/ct2/show/NCT02913612 Date first received: 12 August 2016.</Citation></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Abramson 1989</Title><Reference><Citation>Abramson S, Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Clinical and experimental rheumatology 1989;7 Suppl 3:S163&#x2010;70. [PUBMED: 2557993]</Citation><ArticleIdList><ArticleId IdType="pubmed">2557993</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Achauer 1997</Title><Reference><Citation>Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plastic &amp; Reconstructive Surgery 1997;99(5):1301&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9105356</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Al 2003</Title><Reference><Citation>Al Buainian H, Verhaeghe E, Dierckxsens L, Naeyaert JM. Early treatment of hemangiomas with lasers. A review. Dermatology (Basel, Switzerland) 2003;206(4):370&#x2010;3. [PUBMED: 12771489]</Citation><ArticleIdList><ArticleId IdType="pubmed">12771489</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anderson 1981</Title><Reference><Citation>Anderson RR, Parrish JA. The optics of human skin. Journal of Investigative Dermatology 1981;77(1):9&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">7252245</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Antonelli 1991</Title><Reference><Citation>Antonelli G, Currenti M, Turriziani O, Dianzani F. Neutralizing antibodies to interferon&#x2010;alpha: relative frequency in patients treated with different interferon preparations. Journal of Infectious Diseases 1991;163(4):882&#x2010;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109855</ArticleId><ArticleId IdType="pubmed">1901335</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Azzopardi 2012</Title><Reference><Citation>Azzopardi S, Wright TC. Novel strategies for managing infantile hemangiomas: a review. Annals of plastic surgery 2012;68(2):226&#x2010;8. [PUBMED: 21629088]</Citation><ArticleIdList><ArticleId IdType="pubmed">21629088</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Baselga 2016</Title><Reference><Citation>Baselga E, Roe E, Coulie J, Munoz FZ, Boon LM, McCuaig C, et al. Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy. JAMA Dermatology 2016;152(11):1239&#x2010;43. [PUBMED: 27540637]</Citation><ArticleIdList><ArticleId IdType="pubmed">27540637</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bauland 2011</Title><Reference><Citation>Bauland CG, Luning TH, Smit JM, Zeebregts CJ, Spauwen PH. Untreated hemangiomas: growth pattern and residual lesions. Plastic and Reconstructive Surgery 2011;127(4):1643&#x2010;8. [PUBMED: 21460670]</Citation><ArticleIdList><ArticleId IdType="pubmed">21460670</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bayart 2017</Title><Reference><Citation>Bayart CB, Tamburro JE, Vidimos AT, Wang L, Golden AB. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study. Pediatric dermatology 2017;34(4):413&#x2010;21. [PUBMED: 28556385]</Citation><ArticleIdList><ArticleId IdType="pubmed">28556385</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bennett 2001</Title><Reference><Citation>Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence&#x2010;based evaluation. Archives of Dermatology 2001;137(9):1208&#x2010;1213.</Citation><ArticleIdList><ArticleId IdType="pubmed">11559219</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bruckner 2006</Title><Reference><Citation>Bruckner AL, Frieden IJ. Infantile hemangiomas. Journal of the American Academy of Dermatology 2006;55(4):671&#x2010;82. [PUBMED: 17010748]</Citation><ArticleIdList><ArticleId IdType="pubmed">17010748</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Castren 2016</Title><Reference><Citation>Castren E, Salminen P, Gissler M, Stefanovic V, Pitkaranta A, Klockars T. Risk factors and morbidity of infantile haemangioma: preterm birth promotes ulceration. Acta Paediatrica 2016;105(8):940&#x2010;5. [PUBMED: 27146410]</Citation><ArticleIdList><ArticleId IdType="pubmed">27146410</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chang 1997</Title><Reference><Citation>Chang E, Boyd A, Nelson CC, Crowley D, Law T, Keough KM, et al. Successful treatment of infant hemangiomas with interferon alpha&#x2010;2b. Journal of Pediatric Hematology/Oncology 1997;19(3):237&#x2010;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">9201147</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chinnadurai 2016a</Title><Reference><Citation>Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: A systematic review. Lasers in Surgery &amp; Medicine 2016;48(3):221&#x2010;233. [PUBMED: 26711436]</Citation><ArticleIdList><ArticleId IdType="pubmed">26711436</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chinnadurai 2016b</Title><Reference><Citation>Chinnadurai S, Snyder K, Sathe N, Fonnesbeck C, Morad A, Likis FE, et al. In: Agency for Healthcare Research and Quality, editor(s). Diagnosis and Management of Infantile Hemangioma. Vol. AHRQ Publication No.16&#x2010;EHC002&#x2010;EF, Rockville MD: Agency for Healthcare Research and Quality, 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">26889533</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Christou 2012</Title><Reference><Citation>Christou EM, Wargon O. Effect of captopril on infantile haemangiomas: a retrospective case series. The Australasian journal of dermatology 2012;53(3):216&#x2010;8. [PUBMED: 22671578]</Citation><ArticleIdList><ArticleId IdType="pubmed">22671578</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Couto 2012</Title><Reference><Citation>Couto RA, Maclellan RA, Zurakowski D, Greene AK. Infantile hemangioma: clinical assessment of the involuting phase and implications for management. Plastic and reconstructive surgery 2012;130(3):619&#x2010;24. [PUBMED: 22575857]</Citation><ArticleIdList><ArticleId IdType="pubmed">22575857</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Csoma 2017</Title><Reference><Citation>Csoma ZR, Dalmady S, Abraham R, Rozsa T, Racz K, Kemeny L. Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment [Infantilis haemangioma: klinikai es demografiai jellemzok, kezelesi&#x2010;gondozasi tapasztalatok.]. Orvosi Hetilap 2017;158(39):1535&#x2010;44. [PUBMED: 28942665]</Citation><ArticleIdList><ArticleId IdType="pubmed">28942665</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Danarti 2016</Title><Reference><Citation>Danarti R, Ariwibowo L, Radiono S, Budiyanto A. Topical timolol maleate 0.5% for infantile hemangioma: its effectiveness compared to ultrapotent topical corticosteroids &#x2010; a single&#x2010;center experience of 278 cases. Dermatology (Basel, Switzerland) 2016;232(5):566&#x2010;71. [PUBMED: 27592104]</Citation><ArticleIdList><ArticleId IdType="pubmed">27592104</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Daramola 2012</Title><Reference><Citation>Daramola OO, Chun RH, Kerschner JE. Surgical management of auricular infantile hemangiomas. Archives of otolaryngology&#x2010;&#x2010;head &amp; neck surgery 2012;138(1):72&#x2010;5. [PUBMED: 22249633]</Citation><ArticleIdList><ArticleId IdType="pubmed">22249633</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Darrow 2015</Title><Reference><Citation>Darrow DH, Greene AK, Mancini AJ, Nopper AJ. Diagnosis and management of infantile hemangioma. Pediatrics 2015;136(4):e1060&#x2010;104. [PUBMED: 26416931]</Citation><ArticleIdList><ArticleId IdType="pubmed">26416931</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dinehart 2001</Title><Reference><Citation>Dinehart SM, Kincannon J, Geronemus R. Hemangiomas: evaluation and treatment. Dermatologic Surgery 2001;27(5):475&#x2010;85. [PUBMED: 11359498]</Citation><ArticleIdList><ArticleId IdType="pubmed">11359498</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Doshan 1986</Title><Reference><Citation>Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso FS. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients. Journal of cardiovascular pharmacology 1986;8 Suppl 4:S105&#x2010;8. [PUBMED: 2427836]</Citation><ArticleIdList><ArticleId IdType="pubmed">2427836</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>EMC 2018</Title><Reference><Citation>EMC. Summary of product characteristics. www.medicines.org.uk/emc/medicine/1730/SPC/Roferon&#x2010;A+Pre&#x2010;Filled+Syringe/#INTERACTIONS (accessed prior to 21 February 2018).</Citation></Reference></ReferenceList><ReferenceList><Title>Ezekowitz 1992</Title><Reference><Citation>Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa&#x2010;2a therapy for life&#x2010;threatening hemangiomas of infancy. The New England journal of medicine 1992;326(22):1456&#x2010;63. [PUBMED: 1489383]</Citation><ArticleIdList><ArticleId IdType="pubmed">1489383</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fragu 1991</Title><Reference><Citation>Fragu P, Lemarchand&#x2010;Venencie F, Benhamou S, Fran&#xe7;ois P, Jeannel D, Benhamou E, et al. Long&#x2010;term effects in skin and thyroid after radiotherapy for skin angiomas: a French retrospective cohort study. European Journal of Cancer 1991;27(10):1215&#x2010;22. [PUBMED: 1835589]</Citation><ArticleIdList><ArticleId IdType="pubmed">1835589</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>George 2004</Title><Reference><Citation>George ME, Sharma V, Jacobson J, Simon S, Nopper AJ. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Archives of Dermatology 2004;140(8):963&#x2010;9. [PUBMED: 15313812]</Citation><ArticleIdList><ArticleId IdType="pubmed">15313812</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ginimuge 2010</Title><Reference><Citation>Ginimuge PR, Jyothi SD. Methylene blue: revisited. Journal of anaesthesiology, clinical pharmacology 2010;26(4):517&#x2010;20. [PUBMED: 21547182]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3087269</ArticleId><ArticleId IdType="pubmed">21547182</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Glade 2010</Title><Reference><Citation>Glade RS, Vinson K, Becton D, Bhutta S, Buckmiller LM. Management of complicated hemangiomas with vincristine/vinblastine: Quantitative response to therapy using MRI. International journal of pediatric otorhinolaryngology 2010;74(11):1221&#x2010;5. [PUBMED: 20884067]</Citation><ArticleIdList><ArticleId IdType="pubmed">20884067</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Glassberg 1989</Title><Reference><Citation>Glassberg E, Lask G, Rabinowitz LG, Tunnessen WW Jr. Capillary hemangiomas: case study of novel laser treatment and a review of therapeutic options. Journal of Dermatologic Surgery &amp; Oncology 1989;15(11):1214&#x2010;23. [PUBMED: 2808890]</Citation><ArticleIdList><ArticleId IdType="pubmed">2808890</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>GRADEpro GDT [Computer program]</Title><Reference><Citation>McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 27/03/2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.</Citation></Reference></ReferenceList><ReferenceList><Title>Grantzow 2001</Title><Reference><Citation>Grantzow R. [Differential therapy of hemangiomas&#x2010;&#x2010;when cryotherapy, laser therapy or operation?] [Differentialtherapie von Hamangiomen&#x2010;&#x2010;Wann Kryo, Laser oder Operation?]. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress 2001;118:521&#x2010;4. [PUBMED: 11824311]</Citation><ArticleIdList><ArticleId IdType="pubmed">11824311</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Greinwald 1999</Title><Reference><Citation>Greinwald JH Jr, Burke DK, Bonthius DJ, Bauman NM, Smith RJ. An update on the treatment of hemangiomas in children with interferon alfa&#x2010;2a. Archives of Otolaryngology &#x2010; Head and Neck Surgery 1999;125(1):21&#x2010;7. [PUBMED: 9932582]</Citation><ArticleIdList><ArticleId IdType="pubmed">9932582</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2008</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck&#x2010;Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336(7651):995&#x2010;8. [PUBMED: 18456631]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2364804</ArticleId><ArticleId IdType="pubmed">18456631</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011a</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence&#x2010;&#x2010;inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294&#x2010;302. [PUBMED: 21803546]</Citation><ArticleIdList><ArticleId IdType="pubmed">21803546</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011b</Title><Reference><Citation>Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence&#x2010;&#x2010;publication bias. Journal of Clinical Epidemiology 2011;64(12):1277&#x2010;82. [PUBMED: 21802904]</Citation><ArticleIdList><ArticleId IdType="pubmed">21802904</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011c</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence&#x2010;&#x2010;indirectness. Journal of Clinical Epidemiology 2011;64(12):1303&#x2010;10. [PUBMED: 21802903]</Citation><ArticleIdList><ArticleId IdType="pubmed">21802903</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011d</Title><Reference><Citation>Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso&#x2010;Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence&#x2010;&#x2010;study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407&#x2010;15. [PUBMED: 21247734]</Citation><ArticleIdList><ArticleId IdType="pubmed">21247734</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011e</Title><Reference><Citation>Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso&#x2010;Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311&#x2010;6. [PUBMED: 21802902]</Citation><ArticleIdList><ArticleId IdType="pubmed">21802902</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011f</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso&#x2010;Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence&#x2010;&#x2010;imprecision. Journal of Clinical Epidemiology 2011;64(12):1283&#x2010;93. [PUBMED: 21839614]</Citation><ArticleIdList><ArticleId IdType="pubmed">21839614</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011g</Title><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction&#x2010;GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383&#x2010;94. [PUBMED: 21195583]</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Guyatt 2011h</Title><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011;64(4):395&#x2010;400. [PUBMED: 21194891]</Citation><ArticleIdList><ArticleId IdType="pubmed">21194891</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hansson 1975</Title><Reference><Citation>Hansson L, Aberg H, Karlberg BE, Westerlund A. Controlled study of atenolol in treatment of hypertension. British medical journal 1975;2(5967):367&#x2010;70. [PUBMED: 236810]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1673197</ArticleId><ArticleId IdType="pubmed">236810</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration, 2011.</Citation></Reference></ReferenceList><ReferenceList><Title>Holland 2013</Title><Reference><Citation>Holland KE, Drolet BA. Approach to the patient with an infantile hemangioma. Dermatologic Clinics 2013;31(2):289&#x2010;301. [PUBMED: 23557656]</Citation><ArticleIdList><ArticleId IdType="pubmed">23557656</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hopewell 1990</Title><Reference><Citation>Hopewell JW. The skin: its structure and response to ionizing radiation. International journal of radiation biology 1990;57(4):751&#x2010;73. [PUBMED: 1969905]</Citation><ArticleIdList><ArticleId IdType="pubmed">1969905</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hu 2015</Title><Reference><Citation>Hu L, Huang HZ, Li X, Lin XX, Li W. Open&#x2010;label nonrandomized left&#x2010;right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma. Dermatology (Basel, Switzerland) 2015;230(2):150&#x2010;5. [PUBMED: 25633200]</Citation><ArticleIdList><ArticleId IdType="pubmed">25633200</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Itinteang 2011</Title><Reference><Citation>Itinteang T, Brasch HD, Tan ST, Day DJ. Expression of components of the renin&#x2010;angiotensin system in proliferating infantile haemangioma may account for the propranolol&#x2010;induced accelerated involution. Journal of plastic, reconstructive &amp; aesthetic surgery : JPRAS 2011;64(6):759&#x2010;65. [PUBMED: 20870476]</Citation><ArticleIdList><ArticleId IdType="pubmed">20870476</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Izadpanah 2013</Title><Reference><Citation>Izadpanah A, Izadpanah A, Kanevsky J, Belzile E, Schwarz K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta&#x2010;analysis. Plastic Reconstructive Surgery 2013;131(3):601&#x2010;13. [PUBMED: 23142941]</Citation><ArticleIdList><ArticleId IdType="pubmed">23142941</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ji 2015</Title><Reference><Citation>Ji Y, Chen S, Xu C, Li L, Xiang B. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. British Journal of Dermatology 2015;172(1):24&#x2010;32. [PUBMED: 25196392]</Citation><ArticleIdList><ArticleId IdType="pubmed">25196392</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kaplan 1990</Title><Reference><Citation>Kaplan P, Normandin J Jr, Wilson GN, Plauchi H, Lippman A, Vekemans M. Malformations and minor anomalies in children whose mothers had prenatal diagnosis: comparison between CVS and amniocentesis. American Journal of Medical Genetics 1990;37(3):366&#x2010;70. [PUBMED: 2260567]</Citation><ArticleIdList><ArticleId IdType="pubmed">2260567</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kennedy 2005</Title><Reference><Citation>Kennedy JE. High&#x2010;intensity focused ultrasound in the treatment of solid tumours. Nature reviews. Cancer 2005; Vol. 5, issue 4:321&#x2010;7. [PUBMED: 15776004]</Citation><ArticleIdList><ArticleId IdType="pubmed">15776004</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Krupa 2009</Title><Reference><Citation>Krupa Shankar D, Chakravarthi M, Shilpakar R. Carbon dioxide laser guidelines. Journal of cutaneous and aesthetic surgery 2009;2(2):72&#x2010;80. [PUBMED: 20808594]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918344</ArticleId><ArticleId IdType="pubmed">20808594</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Li 2017</Title><Reference><Citation>Li B, Li Z, Wang P, Huang Q, Xu L, He R, et al. Mammalian target of rapamycin complex 1 signalling is essential for germinal centre reaction. Immunology 2017;152(2):276&#x2010;86. [PUBMED: 28557002]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5588811</ArticleId><ArticleId IdType="pubmed">28557002</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Liang 2014</Title><Reference><Citation>Liang MG, Frieden IJ. Infantile and congenital hemangiomas. Seminars in pediatric surgery 2014;23(4):162&#x2010;7. [PUBMED: 25241092]</Citation><ArticleIdList><ArticleId IdType="pubmed">25241092</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Luo 2011</Title><Reference><Citation>Luo QF, Zhao FY. The effects of Bleomycin A5 on infantile maxillofacial haemangioma. Head &amp; face medicine 2011;7:11. [PUBMED: 21736714]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3148961</ArticleId><ArticleId IdType="pubmed">21736714</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>L&#xe9;aut&#xe9;&#x2010;Labr&#xe8;ze 2015</Title><Reference><Citation>L&#xe9;aut&#xe9;&#x2010;Labr&#xe8;ze C, Hoeger P, Mazereeuw&#x2010;Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. New England Journal of Medicine 2015;372(8):735&#x2010;46. [PUBMED: 25693013]</Citation><ArticleIdList><ArticleId IdType="pubmed">25693013</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ma 2017</Title><Reference><Citation>Ma EH, Robertson SJ, Chow CW, Bekhor PS. Infantile hemangioma with minimal or arrested growth: further observations on clinical and histopathologic findings of this unique but underrecognized entity. Pediatric Dermatology 2017;34(1):64&#x2010;71. [PUBMED: 27873347]</Citation><ArticleIdList><ArticleId IdType="pubmed">27873347</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marchuk 2001</Title><Reference><Citation>Marchuk DA. Pathogenesis of hemangioma. Journal of Clinical Investigation 2001;107(6):665&#x2010;6. [PUBMED: 11254664]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC208951</ArticleId><ArticleId IdType="pubmed">11254664</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>McDaniel 1997</Title><Reference><Citation>McDaniel DH, Ash K, Lord J, Newman J, Zukowski M. The erbium: YAG laser: a review and preliminary report on resurfacing of the face, neck, and hands. Aesthetic surgery journal 1997;17(3):157&#x2010;64. [PUBMED: 19327707]</Citation><ArticleIdList><ArticleId IdType="pubmed">19327707</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Medicines.ie 2018</Title><Reference><Citation>Medicines.ie. Summary of product characteristics. www.medicines.ie/medicine/15865/SPC/Capoten+25mg+Tablets/#INTERACTIONS (accessed prior to 21 February 2018).</Citation></Reference></ReferenceList><ReferenceList><Title>Mulliken 2002</Title><Reference><Citation>Mulliken JB, Rogers GF, Marler JJ. Circular excision of hemangioma and purse&#x2010;string closure: the smallest possible scar. Plastic and reconstructive surgery 2002;109(5):1544&#x2010;54; discussion 1555. [PUBMED: 11932595]</Citation><ArticleIdList><ArticleId IdType="pubmed">11932595</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Orsi 2010</Title><Reference><Citation>Orsi F, Arnone P, Chen W, Zhang L. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors. Journal of cancer research and therapeutics 2010;6(4):414&#x2010;20. [PUBMED: 21358073]</Citation><ArticleIdList><ArticleId IdType="pubmed">21358073</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pienaar 2006</Title><Reference><Citation>Pienaar C, Graham R, Geldenhuys S, Hudson DA. Intralesional bleomycin for the treatment of hemangiomas. Plastic and reconstructive surgery 2006;117(1):221&#x2010;6. [PUBMED: 16404271]</Citation><ArticleIdList><ArticleId IdType="pubmed">16404271</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Probert 1975</Title><Reference><Citation>Probert JC, Parker BR. The effects of radiation therapy on bone growth. Radiology 1975;114(1):115&#x2010;62. [PUBMED: 813276]</Citation><ArticleIdList><ArticleId IdType="pubmed">813276</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Qiu 2015</Title><Reference><Citation>Qiu Y, Lin X, Ma G, Chang L, Jin Y, Chen H, et al. Eighteen cases of soft tissue atrophy after intralesional bleomycin a5 injections for the treatment of infantile hemangiomas: a long&#x2010;term follow&#x2010;up. Pediatric Dermatology 2015;32(2):188&#x2010;91. [PUBMED: 25640925]</Citation><ArticleIdList><ArticleId IdType="pubmed">25640925</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Raphael 2011</Title><Reference><Citation>Raphael MF, Graaf M, Breugem CC, Pasmans SG, Breur JM. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas. Journal of the American Academy of Dermatology 2011; Vol. 65, issue 2:420&#x2010;1. [PUBMED: 21763565]</Citation><ArticleIdList><ArticleId IdType="pubmed">21763565</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 5.3 [Computer program]</Title><Reference><Citation>Nordic Cochrane Centre, The Cochrane Collaboration.. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration., 2014.</Citation></Reference></ReferenceList><ReferenceList><Title>Rothfleisch 2002</Title><Reference><Citation>Rothfleisch JE, Kosann MK, Levine VJ, Ashinoff R. Laser treatment of congenital and acquired vascular lesions. A review. Dermatologic Clinics 2002;20(1):1&#x2010;18. [PUBMED: 11859585]</Citation><ArticleIdList><ArticleId IdType="pubmed">11859585</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sethuraman 2014</Title><Reference><Citation>Sethuraman G, Yenamandra VK, Gupta V. Management of infantile hemangiomas: current trends. Journal of cutaneous and aesthetic surgery 2014;7(2):75&#x2010;85. [PUBMED: 25136206]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4134656</ArticleId><ArticleId IdType="pubmed">25136206</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shen 2015</Title><Reference><Citation>Shen L, Zhou G, Zhao J, Li P, Xu Q, Dong Y, et al. Pulsed dye laser therapy for infantile hemangiomas: a systemic review and meta&#x2010;analysis. QJM : Monthly Journal of the Association of Physicians 2015;108(6):473&#x2010;80. [PUBMED: 25376585]</Citation><ArticleIdList><ArticleId IdType="pubmed">25376585</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shorr 1986</Title><Reference><Citation>Shorr N, Seiff SR. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile haemangioma. Ophthalmic Surgery 1986;17(4):229&#x2010;31. [PUBMED: 3714192]</Citation><ArticleIdList><ArticleId IdType="pubmed">3714192</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Smolinski 2005</Title><Reference><Citation>Smolinski KN, Yan AC. Hemangiomas of infancy: clinical and biological characteristics. Clinical Pediatrics 2005;44(9):747&#x2010;66. [PUBMED: 16327961]</Citation><ArticleIdList><ArticleId IdType="pubmed">16327961</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Syed 1999</Title><Reference><Citation>Syed SB. Vascular birthmarks: update on presentation and management. Current Paediatrics 1999;9(1):20&#x2010;6.</Citation></Reference></ReferenceList><ReferenceList><Title>Tollefson 2012</Title><Reference><Citation>Tollefson MM, Frieden IJ. Early growth of infantile hemangiomas: what parents' photographs tell us. Pediatrics 2012;130(2):e314&#x2010;20. [PUBMED: 22826568]</Citation><ArticleIdList><ArticleId IdType="pubmed">22826568</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>van de Kerkhof 1998</Title><Reference><Citation>Kerkhof PCM, Rooij M, Steijlen PM. Spontaneous course of haemangiomas: facts and speculations. International Journal of Dermatology 1998;37(2):101&#x2010;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">9542662</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vega 2017</Title><Reference><Citation>Vega Mata N, Lopez Gutierrez JC, Vivanco Allende B, Fernandez Garcia MS. Different clinical features of acral abortive hemangiomas. Case Reports in Dermatological Medicine 2017;2017:2897617. [PUBMED: 28785492]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5529623</ArticleId><ArticleId IdType="pubmed">28785492</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Waeber 1980</Title><Reference><Citation>Waeber B, Brunner HR, Brunner DB, Curtet AL, Turini GA, Gavras H. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril. Hypertension (Dallas, Tex. : 1979) 1980;2(2):236&#x2010;42. [PUBMED: 6247269]</Citation><ArticleIdList><ArticleId IdType="pubmed">6247269</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wang 2017</Title><Reference><Citation>Wang C, Li Y, Xiang B, Xiong F, Li K, Yang K, et al. Quality of life in children with infantile hemangioma: a case control study. Health and Quality of Life Outcomes 2017;15(1):221. [PUBMED: 29145889]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689165</ArticleId><ArticleId IdType="pubmed">29145889</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wnek 2017</Title><Reference><Citation>Wnek A, Andrzejewska E, Kobos J, Taran K, Przewratil P. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl&#x2010;2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment. Immunology Letters 2017;185:27&#x2010;31. [PUBMED: 28279700]</Citation><ArticleIdList><ArticleId IdType="pubmed">28279700</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Xu 2014</Title><Reference><Citation>Xu S, Jia R, Ge S, Lin M, Fan X. Treatment of periorbital infantile haemangiomas: a systematic literature review on propranolol or steroids. Journal of Paediatrics and Child Health 2014;50(4):271&#x2010;9. [PUBMED: 24754793]</Citation><ArticleIdList><ArticleId IdType="pubmed">24754793</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zhang 2017</Title><Reference><Citation>Zhang L, Wu HW, Yuan W, Zheng JW. Propranolol therapy for infantile hemangioma: our experience. Drug Design, Development and Therapy 2017;11:1401&#x2010;8. [PUBMED: 28507428]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428756</ArticleId><ArticleId IdType="pubmed">28507428</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zheng 2018</Title><Reference><Citation>Zheng L, Li Y. Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta&#x2010;analysis. Archives of Dermatological Research 2018 Jan 23 [Epub ahead of print]. [DOI: 10.1007/s00403-018-1815-y]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00403-018-1815-y</ArticleId><ArticleId IdType="pubmed">29362868</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zimmermann 2010</Title><Reference><Citation>Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. International Journal of Pediatric Otorhinolaryngology 2010;74(4):338&#x2010;42. [PUBMED: 20117846]</Citation><ArticleIdList><ArticleId IdType="pubmed">20117846</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zou 2013</Title><Reference><Citation>Zou HX, Jia J, Zhang WF, Sun ZJ, Zhao YF. Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma. Cardiovascular Pathology 2013;22(3):203&#x2010;10. [PUBMED: 23151525]</Citation><ArticleIdList><ArticleId IdType="pubmed">23151525</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Leonardi&#x2010;Bee 2011</Title><Reference><Citation>Leonardi&#x2010;Bee J, Batta K, O&#x2019;Brien C, Bath&#x2010;Hextall FJ. Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD006545.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006545.pub2</ArticleId><ArticleId IdType="pubmed">21563155</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23076914</PMID><DateCompleted><Year>2012</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2012</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Interventions for primary (intrinsic) tracheomalacia in children.</ArticleTitle><Pagination><StartPage>CD005304</StartPage><MedlinePgn>CD005304</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD005304</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD005304.pub3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tracheomalacia, a disorder of the large airways where the trachea is deformed or malformed during respiration, is commonly seen in tertiary paediatric practice. It is associated with a wide spectrum of respiratory symptoms from life-threatening recurrent apnoea to common respiratory symptoms such as chronic cough and wheeze. Current practice following diagnosis of tracheomalacia includes medical approaches aimed at reducing associated symptoms of tracheomalacia, ventilation modalities of continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP), and surgical approaches aimed at improving the calibre of the airway (airway stenting, aortopexy, tracheopexy).</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the efficacy of medical and surgical therapies for children with intrinsic (primary) tracheomalacia.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">The Cochrane Airways Group searched the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Airways Group's Specialised Register, MEDLINE and EMBASE databases. The Cochrane Airways Group performed the latest searches in March 2012.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">All randomised controlled trials (RCTs) of therapies related to symptoms associated with primary or intrinsic tracheomalacia.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two reviewers extracted data from the included study independently and resolved disagreements by consensus.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We included one RCT that compared nebulised recombinant human deoxyribonuclease (rhDNase) with placebo in 40 children with airway malacia and a respiratory tract infection. We assessed it to be a RCT with overall low risk of bias. Data analysed in this review showed that there was no significant difference between groups for the primary outcome of proportion cough-free at two weeks (odds ratio (OR) 1.38; 95% confidence interval (CI) 0.37 to 5.14). However, the mean change in night time cough diary scores significantly favoured the placebo group (mean difference (MD) 1.00; 95% CI 0.17 to 1.83, P = 0.02). The mean change in daytime cough diary scores from baseline was also better in the placebo group compared to those on nebulised rhDNase, but the difference between groups was not statistically significant (MD 0.70; 95% CI -0.19 to 1.59). Other outcomes (dyspnoea, and difficulty in expectorating sputum scores, and lung function tests at two weeks also favoured placebo over nebulised rhDNase but did not reach levels of significance.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">There is currently an absence of evidence to support any of the therapies currently utilised for management of intrinsic tracheomalacia. It remains inconclusive whether the use of nebulised rhDNase in children with airway malacia and a respiratory tract infection worsens recovery. It is unlikely that any RCT on surgically based management will ever be available for children with severe life-threatening illness associated with tracheomalacia. For those with less severe disease, RCTs on interventions such as antibiotics and chest physiotherapy are clearly needed. Outcomes of these RCTs should include measurements of the trachea and physiological outcomes in addition to clinical outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Vikas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Queensland Children&#x2019;s Medical Research Institute, The University of Queensland, Brisbane, Australia.drvikasgoyal@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masters</LastName><ForeName>I Brent</ForeName><Initials>IB</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Anne B</ForeName><Initials>AB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D003851">Deoxyribonucleases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005304. doi: 10.1002/14651858.CD005304.pub2.</RefSource><PMID Version="1">16235399</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Sao Paulo Med J. 2013;131(1):66. doi: 10.1590/s1516-31802013000100013.</RefSource><PMID Version="1">23538600</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003851" MajorTopicYN="N">Deoxyribonucleases</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055090" MajorTopicYN="N">Tracheomalacia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>None known.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23076914</ArticleId><ArticleId IdType="pmc">PMC11613127</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD005304.pub3</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Boogaard 2009 {published data only}</Title><Reference><Citation>Boogaard R, Jongste JC, Vaessen&#x2010;Verberne A, Hop WCJ, Merkus PJ. Recombinant human DNase in children with airway malacia and lower respiratory tract infection. Pediatric Pulmonology 2009;44(10):962&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">19768804</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Abdel&#x2010;Rahman 2002 {published data only}</Title><Reference><Citation>Abdel&#x2010;Rahman U, Ahrens P, Fieguth HG, Kitz R, Heller K, Moritz A. Surgical treatment of tracheomalacia by bronchoscopic monitored aortopexy in infants and children. Annals of Thoracic Surgery 2002;74(2):315&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12173806</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Corbally 1993 {published data only}</Title><Reference><Citation>Corbally MT, Spitz L, Kiely E, Brereton RJ, Drake DP. Aortopexy for tracheomalacia in oesophageal anomalies. European Journal of Pediatric Surgery 1993;3(5):264&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8292576</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Davis 1998 {published data only}</Title><Reference><Citation>Davis S, Jones M, Kisling J, Angelicchio C, Tepper RS. Effect of continuous positive airway pressure on forced expiratory flows in infants with tracheomalacia. American Journal of Respiratory and Critical Care Medicine 1998;158(1):148&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9655721</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Filler 1993 {published data only}</Title><Reference><Citation>Filler RM, Forte V, Chait P, Weber TR, Othersen HB, Tracy TF, et al. Tracheobronchial stenting for the treatment of airway obstruction. Journal of Pediatric Surgery 1993;33(2):304&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9498407</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gallagher 2011 {published data only}</Title><Reference><Citation>Gallagher T, Maturo S, Fracchia S, Hartnick C. An analysis of children with tracheomalacia treated with ipratropium bromide (Atrovent). Laryngoscope 2011;121(Suppl 4):S211.</Citation></Reference></ReferenceList><ReferenceList><Title>McCarthy 1997 {published data only}</Title><Reference><Citation>McCarthy JF, Hurley JP, Neligan MC, Wood AE. Surgical relief of tracheobronchial obstruction in infants and children. European Journal of Cardio&#x2010;Thoracic Surgery 1997;11(6):1017&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">9237581</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nicolai 2001 {published data only}</Title><Reference><Citation>Nicolai T, Huber RM, Reiter K, Merkenschlager A, Hautmann H, Mantel K. Metal airway stent implantation in children: follow&#x2010;up of seven children. Pediatric Pulmonology 2001;31(4):289&#x2010;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">11288211</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vazquez&#x2010;Jimenez 2001 {published data only}</Title><Reference><Citation>Vazquez&#x2010;Jimenez JF, Sachweh JS, Liakopoulos OJ, Hugel W, Holzki J, Bernuth G, et al. Aortopexy in severe tracheal instability: short&#x2010;term and long&#x2010;term outcome in 29 infants and children. Annals of Thoracic Surgery 2001;72(6):1898&#x2010;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">11789767</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vinograd 1994 {published data only}</Title><Reference><Citation>Vinograd I, Klin B, Efrati Y, Barr J, Behar M, Eshel G. Airway obstruction in neonates and children: surgical treatment. Journal of Cardiovascular Surgery 1994;35(6 Suppl 1):7&#x2010;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">7775560</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Agrawal 1999</Title><Reference><Citation>Agrawal L, Beardsmore CS, MacFadyen UM. Respiratory function in childhood following repair of oesophageal atresia and tracheoesophageal fistula. Archives of Disease in Childhood 1999;81(5):404&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1718113</ArticleId><ArticleId IdType="pubmed">10519713</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Austin 2003</Title><Reference><Citation>Austin J, Ali T. Tracheomalacia and bronchomalacia in children: pathophysiology, assessment, treatment and anaesthesia management. Paediatric Anaesthesia 2003;13(1):3&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">12535032</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Beasley 1998</Title><Reference><Citation>Beasley SW, Qi BQ. Understanding tracheomalacia. Journal of Paediatrics and Child Health 1998;34(3):209&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">9633963</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Benjamin 1976</Title><Reference><Citation>Benjamin B, Cohen D, Glasson M. Tracheomalacia in association with congenital tracheoesophageal fistula. Surgery 1976;79(5):504&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1265658</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bibi 2001</Title><Reference><Citation>Bibi H, Khvolis E, Shoseyov D, Ohaly M, Ben Dor D, London D, et al. The prevalence of gastroesophageal reflux in children with tracheomalacia and laryngomalacia. Chest 2001;119(2):409&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">11171716</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bonnard 2003</Title><Reference><Citation>Bonnard A, Auber F, Fourcade L, Marchac V, Emond S, Revillon Y. Vascular ring abnormalities: a retrospective study of 62 cases. Journal of Pediatric Surgery 2003;38(4):539&#x2010;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">12677561</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Boogaard 2005</Title><Reference><Citation>Boogaard R, Huijsmans SH, Pijnenburg MW, Tiddens HA, Jongste JC, Merkus PJ. Tracheomalacia and bronchomalacia in children: incidence and patient characteristics. Chest 2005;128(5):3391&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16304290</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cates 2003 [Computer program]</Title><Reference><Citation>Cates C. Visual Rx. Online NNT Calculator. Cates C, 2003.</Citation></Reference></ReferenceList><ReferenceList><Title>Chang 1998a</Title><Reference><Citation>Chang AB, Newman RG, Carlin J, Phelan PD, Robertson CF. Subjective scoring of cough in children: parent&#x2010;completed vs child&#x2010;completed diary cards vs an objective method. European Respiratory Journal 1998;11(2):462&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9551755</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chang 1998b</Title><Reference><Citation>Chang AB, Phelan PD, Carlin J, Sawyer SM, Robertson CF. Randomised controlled trial of inhaled salbutamol and beclomethasone for recurrent cough. Archives of Disease in Childhood 1998;79:6&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1717639</ArticleId><ArticleId IdType="pubmed">9771244</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chang 2004</Title><Reference><Citation>Chang AB, Moloney GE, Harms PJ, Masters IB. Endoscopic intratracheal carbon dioxide measurements during pediatric flexible bronchoscopy. Paediatric Anaesthesia 2004;14(8):650&#x2010;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15283823</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chang 2010</Title><Reference><Citation>Chang AB, Robertson CF, Asperen PP, Glasgow NJ, Masters IB, Mellis CM, et al. Can a management pathway for chronic cough in children improve clinical outcomes: protocol for a multicentre evaluation. Trials 2010;11:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989328</ArticleId><ArticleId IdType="pubmed">21054884</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Chang 2012</Title><Reference><Citation>Chang AB, Robertson CF, Asperen PP, Glasgow NJ, Mellis CM, Masters IB, et al. A multi&#x2010;centre study on chronic cough in children: burden and etiologies based on a standardized management pathway. Chest 2012 March 29 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="pubmed">22459773</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Crockett 2001</Title><Reference><Citation>Crockett AJ, Cranston JM, Latimer KM, Alpers JH. Mucolytics for bronchiectasis. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD001289]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001289</ArticleId><ArticleId IdType="pubmed">11279712</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Finder 1997</Title><Reference><Citation>Finder JD. Primary bronchomalacia in infants and children. Journal of Paediatrics 1997;130:59&#x2010;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">9003852</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Gormley 1999</Title><Reference><Citation>Gormley PK, Colreavy MP, Patil N, Woods AE. Congenital vascular anomalies and persistent respiratory symptoms in children. International Journal of Pediatric Otorhinolaryngology 1999;51(1):23&#x2010;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">10622442</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, Available from www.cochrane&#x2010;handbook.org, 2011.</Citation></Reference></ReferenceList><ReferenceList><Title>Horvath 1992</Title><Reference><Citation>Horvath P, Hucin B, Hruda J, Sulc J, Brezovsky P, Tuma S, et al. Intermediate to late results of surgical relief of vascular tracheobronchial compression. European Journal of Cardio&#x2010;Thoracic Surgery 1992;6(7):366&#x2010;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">1497929</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kovesi 2004</Title><Reference><Citation>Kovesi T, Rubin S. Long&#x2010;term complications of congenital esophageal atresia and/or tracheoesophageal fistula. Chest 2004;126(3):915&#x2010;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">15364774</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Marchant 2012</Title><Reference><Citation>Marchant JM, Masters IB, Champion A, Petsky HL, Chang AB. Randomised controlled trial of amoxycillin&#x2010;clavulanate in children with chronic wet cough. Thorax 2012 May 24 [Epub ahead of print]. [DOI: 10.1136/thoraxjnl-2011-201506]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2011-201506</ArticleId><ArticleId IdType="pubmed">22628120</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Masters 2002</Title><Reference><Citation>Masters IB, Chang AB, Patterson L, Wainwright C, Buntain H, Dean BW, et al. Series of laryngomalacia, tracheomalacia, and bronchomalacia disorders and their associations with other conditions in children. Pediatric Pulmonology 2002;34(3):189&#x2010;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">12203847</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Masters 2009</Title><Reference><Citation>Masters IB, Chang AB. Tracheobronchomalacia in children. Expert Review of Respiratory Medicine 2009;3:425&#x2010;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">20477332</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Midulla 2003</Title><Reference><Citation>Midulla F, Blic J, Barbato A, Bush A, Eber E, Kotecha S, et al. Flexible endoscopy of paediatric airways. European Respiratory Journal 2003;22(4):698&#x2010;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">14582925</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>RevMan 2011 [Computer program]</Title><Reference><Citation>The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.</Citation></Reference></ReferenceList><ReferenceList><Title>Rogers 2006</Title><Reference><Citation>Rogers DF, Rubin BK. Mucolytics for COPD. In: Stockley RA, Rennard S, Rabe K, Celli B editor(s). Chronic Obstructive Lung Disease. Blackwell Publishing, Oxford, UK, 2006:756&#x2013;68.</Citation></Reference></ReferenceList><ReferenceList><Title>Rubin 2007</Title><Reference><Citation>Rubin BK. Mucolytics, expectorants, and mucokinetic medications. Respiratory Care 2007;52(7):859&#x2010;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">17594730</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sanchez 2012</Title><Reference><Citation>Sanchez MO, Greer MC, Masters IB, Chang AB. A comparison of fluoroscopic airway screening with flexible bronchoscopy for diagnosing tracheomalacia. Pediatric Pulmonology 2012;47:63&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21830315</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thomson 2002</Title><Reference><Citation>Thomson F, Masters IB, Chang AB. Persistent cough in children and the overuse of medications. Journal of Paediatrics and Child Health 2002;38(6):578&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">12410870</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Valerie 2005</Title><Reference><Citation>Valerie EP, Durrant AC, Forte V, Wales P, Chait P, Kim PC. A decade of using intraluminal tracheal/bronchial stents in the management of tracheomalacia and/or bronchomalacia: is it better than aortopexy?. Journal of Pediatric Surgery 2005;40(6):904&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15991168</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>van Son 1993</Title><Reference><Citation>Son JA, Julsrud PR, Hagler DJ, Sim EK, Pairolero PC, Puga FJ, et al. Surgical treatment of vascular rings: the Mayo Clinic experience. Mayo Clinic Proceedings 1993;68(11):1056&#x2010;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">8231269</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Voynow 2009</Title><Reference><Citation>Voynow JA, Rubin BK. Mucins, Mucus, and Sputum. Chest 2009;135:505&#x2010;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19201713</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wood 1997</Title><Reference><Citation>Wood RE. Localised tracheomalacia or bronchomalacia in children with intractable cough. Journal of Paediatrics 1997;116:404&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2308032</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Wright 2003</Title><Reference><Citation>Wright CD. Tracheomalacia. Chest Surgery Clinics of North America 2003;13(2):349&#x2010;57, viii.</Citation><ArticleIdList><ArticleId IdType="pubmed">12755319</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Zinman 1995</Title><Reference><Citation>Zinman R. Tracheal stenting improves airway mechanics in infants with tracheobronchomalacia. Pediatric Pulmonology 1995;19(5):275&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">7567202</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to other published versions of this review</Title><ReferenceList><Title>Masters 2005</Title><Reference><Citation>Masters IB, Chang AB. Interventions for primary (intrinsic) tracheomalacia in children. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005304.pub2]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD005304.pub2</ArticleId><ArticleId IdType="pubmed">16235399</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22252947</PMID><DateCompleted><Year>2012</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Laryngoscope</Title><ISOAbbreviation>Laryngoscope</ISOAbbreviation></Journal><ArticleTitle>Incidence of laryngospasm and bronchospasm in pediatric adenotonsillectomy.</ArticleTitle><Pagination><StartPage>425</StartPage><EndPage>428</EndPage><MedlinePgn>425-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.22423</ELocationID><Abstract><AbstractText Label="OBJECTIVES/HYPOTHESIS" NlmCategory="OBJECTIVE">To evaluate and describe airway complications in pediatric adenotonsillectomy.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective case-control study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A chart review of patients that underwent adenotonsillectomy between 2006 and 2010 was performed. Perioperative complications, patient characteristics, and surgeon and anesthesia technique were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 682 charts were reviewed. Eleven cases (1.6%) of laryngospasm were identified: one was preoperative, seven occurred in the operating room postextubation, and three occurred in the recovery area. Four patients were given succinylcholine, one was reintubated, and the other cases were managed conservatively. Mean age of patients with laryngospasm was 5.87 years (standard deviation [SD], 4.01; 1.9-15.8 years). There were 12 cases (1.8%) of bronchospasm; all were treated with nebulized albuterol. Mean age of patients with bronchospasm was 5.81 years (SD, 4.17; 1.8-14.1 years). Overall, 22 patients required antiemetics (3.3%), 19 required albuterol (2.9%), and five required racemic epinephrine (0.8%). Compared to the children without airway complications, there was no difference in age, weight, American Society of Anesthesiologists status, length of surgery, need for admission, and anesthesia technique in those that had laryngospasm. Patients with bronchospasm, compared to the patients without complications, had faster surgeries (P &lt; .05), were more likely to have underlying asthma (P &lt; .05), and were more likely to be admitted (P &lt; .05). There were no unexpected admissions or other morbidities.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The rates of laryngospasm (1.6%) and bronchospasm (1.8%) are significantly lower than reported in the literature, reflecting refinements in modern anesthesia/surgical technique. Knowledge of at-risk patients can facilitate planning to potentially reduce the incidence of perioperative airway complications during adenotonsillectomy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 The American Laryngological, Rhinological, and Otological Society, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Orestes</LastName><ForeName>Michael I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>National Capitol Consortium Otolaryngology Residency Training Program, Walter Reed Army Medical Center, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lander</LastName><ForeName>Lina</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Verghese</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Rahul K</ForeName><Initials>RK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Laryngoscope</MedlineTA><NlmUniqueID>8607378</NlmUniqueID><ISSNLinking>0023-852X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="N">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010608" MajorTopicYN="N">Pharyngeal Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22252947</ArticleId><ArticleId IdType="doi">10.1002/lary.22423</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25074619</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>10</Issue><PubDate><Year>2014</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Supraglottic airway devices vs tracheal intubation in children: a quantitative meta-analysis of respiratory complications.</ArticleTitle><Pagination><StartPage>1088</StartPage><EndPage>1098</EndPage><MedlinePgn>1088-98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.12495</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rate of perioperative respiratory complications between tracheal intubation (TI) and laryngeal mask airway remains unclear during pediatric anesthesia.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of the present meta-analysis was to compare the perioperative respiratory complications between laryngeal mask airway and TI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A meta-analysis of available controlled studies comparing laryngeal mask airway to TI was conducted. Studies including patients with airway infection were excluded. Data from each trial were combined to calculate the pooled odds ratios (OR) or mean difference (MD) and 95% confidence intervals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The meta-analysis was performed on 19 studies. In 12 studies, patients were given muscle relaxation, and in 16 studies, ventilation was controlled. During recovery from anesthesia, the incidence of desaturation (OR&#xa0;=&#xa0;0.34 [0.19-0.62]), laryngospasm (OR&#xa0;=&#xa0;0.34 [0.2-0.6]), cough (OR&#xa0;=&#xa0;0.18 [0.11-0.27]), and breath holding (0.19 [0.05-0.68]) was lower when laryngeal mask airway was used to secure the airway. Postoperative incidences of sore throat (OR&#xa0;=&#xa0;0.87 [0.53-1.44]), bronchospasm (OR&#xa0;=&#xa0;0.56 [0.25-1.25]), aspiration (1.33 [0.46-3.91]) and blood staining on the device (OR&#xa0;=&#xa0;0.62 [0.21-1.82]) did not differ between laryngeal mask airway and TI. Results were homogenous across the studies, with the exceptions of blood staining on the device.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis found that the use of laryngeal mask airway in pediatric anesthesia results in a decrease in a number of common postanesthetic complications. It is therefore a valuable device for the management of the pediatric airway.</AbstractText><CopyrightInformation>&#xa9; 2014 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luce</LastName><ForeName>Virginie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care, RobertDebr&#xe9; University Hospital, Paris, France; University Paris Diderot, Paris VII. Paris Sorbonne Cit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harkouk</LastName><ForeName>Hakim</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Brasher</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Michelet</LastName><ForeName>Daphn&#xe9;</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hilly</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Maesani</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Diallo</LastName><ForeName>Thierno</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Mangalsuren</LastName><ForeName>Nyamjargal</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Nivoche</LastName><ForeName>Yves</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Dahmani</LastName><ForeName>Souhayl</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058109" MajorTopicYN="N">Airway Management</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">airway</Keyword><Keyword MajorTopicYN="N">bronchospasm</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">desaturation</Keyword><Keyword MajorTopicYN="N">laryngeal mask</Keyword><Keyword MajorTopicYN="N">laryngospasm</Keyword><Keyword MajorTopicYN="N">respiratory complications</Keyword><Keyword MajorTopicYN="N">tracheal intubation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25074619</ArticleId><ArticleId IdType="doi">10.1111/pan.12495</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35873080</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-6030</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Perioperative care and operating room management</Title><ISOAbbreviation>Perioper Care Oper Room Manag</ISOAbbreviation></Journal><ArticleTitle>Use of clindamycin as an alternative antibiotic prophylaxis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">100278</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pcorm.2022.100278</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Clindamycin serves as an alternative surgical prophylactic antibiotic in patients with penicillin (PCN) or cephalosporin allergy labels. In the previous reports, the use of clindamycin was associated with higher incidences of surgical site infections (SSIs). We aimed to determine the characteristics of PCN or cephalosporin allergic reactions to stratify patient's risk and indicate subsequent management; leading to de-labeling of PCN or cephalosporin allergy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a prospective cohort study of patients receiving clindamycin as surgical antibiotic prophylaxis from September 2021 to March 2022. Data were collected from electronic medical records; included demographic data, antibiotic allergy labels, allergic reaction, and allergy testing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Clindamycin was administered in 445 patients who underwent 451 operations. Among these patients, 53.0% (<i>n</i> = 236) were female with a median age of 15 years (range; 0.5-57.0 years). PCN and cephalosporin allergies were labelled in 83.8% (<i>n</i> = 373) and 25.6% (<i>n</i> = 114) patients, respectively; 11.4% (<i>n</i> = 51) of patients were allergic to both classes of the antibiotics. There were 191 (51.2%) and 73 (64.0%) possible hypersensitivity reactions (HSRs) in PCN and cephalosporin groups, respectively. The most common reactions were rash (PCN: <i>n</i> = 99, 26.5%; cephalosporin: <i>n</i> = 35, 30.7%), and hives (PCN: <i>n</i> = 71, 19.0%; cephalosporin: <i>n</i> = 24, 21.1%). Severe reactions included angioedema (PCN: <i>n</i> = 7, 1.9%; cephalosporin: <i>n</i> = 5, 4.4%), anaphylaxis (PCN: <i>n</i> = 8, 2.1%; cephalosporin: <i>n</i> = 7, 6.1%), bronchospasm (cephalosporin: <i>n</i> = 1, 0.9%), airway involvement (PCN: <i>n</i> = 1, 0.3%; cephalosporin: <i>n</i> = 1, 0.9%), serum sickness (PCN: <i>n</i> = 1, 0.3%), blisters (PCN: <i>n</i> = 1, 0.3%), and drug reaction with eosinophilia and systemic symptoms (DRESS) (PCN: <i>n</i> = 1, 0.3%). Low-risk history of allergy included gastrointestinal side effects (PCN: <i>n</i> = 9, 2.4%; cephalosporin: <i>n</i> = 3, 2.7%), positive family history (PCN: <i>n</i> = 7, 1.9%; cephalosporin: <i>n</i> = 1, 0.9%), and remote history of allergy (PCN: <i>n</i> = 2, 0.5%). There were 201 (53.9%) and 53 (46.5%) unknown reactions in PCN and cephalosporin groups, respectively. In the overall cohort, 3 patients (0.7%) were skin tested for drug allergy (PCN: <i>n</i> = 2, 0.5%; cephalosporin: <i>n</i> = 2, 1.8%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Clindamycin was largely administered in patients with non-severe HSRs, low-risk history or unknown reactions to PCN or cephalosporin, whom cefazolin could have been administered safely. Obtaining a detailed history of antibiotic allergy, allergy testing and/or direct oral challenge can de-label unsubstantiated PCN or cephalosporin allergy and ultimately reduce the incidence of SSIs by optimizing the rate of more effective antibiotic administration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maisat</LastName><ForeName>Wiriya</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia Division, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Harvard Medical School, Boston, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bermudez</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia Division, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuki</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiac Anesthesia Division, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Harvard Medical School, Boston, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Harvard Medical School, Boston, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM127600</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Perioper Care Oper Room Manag</MedlineTA><NlmUniqueID>101672954</NlmUniqueID><ISSNLinking>2405-6030</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Allergy</Keyword><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Beta-lactam</Keyword><Keyword MajorTopicYN="N">Clindamycin</Keyword><Keyword MajorTopicYN="N">Hypersensitivity</Keyword><Keyword MajorTopicYN="N">Surgical prophylaxis</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>25</Day><Hour>3</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35873080</ArticleId><ArticleId IdType="mid">NIHMS1824292</ArticleId><ArticleId IdType="pmc">PMC9306335</ArticleId><ArticleId IdType="doi">10.1016/j.pcorm.2022.100278</ArticleId><ArticleId IdType="pii">100278</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shepard J, Ward W, Milstone A, et al. Financial impact of surgical site infections on hospitals: the hospital management perspective. JAMA Surg. 2013;148(10):907&#x2013;914. 10.1001/jamasurg.2013.2246. Oct.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2013.2246</ArticleId><ArticleId IdType="pubmed">23965750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect. 2013;14(1):73&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">23461695</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Committee HICPA. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20(4):247&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">10219875</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: a literature review. J Emerg Med 2012;42(5):612&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pubmed">21742459</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltran RJ, Kako H, Chovanec T, Ramesh A, Bissonnette B, Tobias JD. Penicillin allergy and surgical prophylaxis: cephalosporin cross-reactivity risk in a pediatric tertiary care center. J Pediatr Surg. 2015;50(5):856&#x2013;859.</Citation><ArticleIdList><ArticleId IdType="pubmed">25783308</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES. The impact of a reported penicillin allergy on surgical site infection risk. Arch Clin Infect Dis. 2018;66(3): 329&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5850334</ArticleId><ArticleId IdType="pubmed">29361015</ArticleId></ArticleIdList></Reference><Reference><Citation>Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin &#x201c;allergy&#x201d; in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133(3):790&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">24188976</ArticleId></ArticleIdList></Reference><Reference><Citation>Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA. 2017;318(1):82&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935455</ArticleId><ArticleId IdType="pubmed">28672303</ArticleId></ArticleIdList></Reference><Reference><Citation>Savic LC, Khan DA, Kopac P, et al. Management of a surgical patient with a label of penicillin allergy: narrative review and consensus recommendations. Br J Anaesth. Jul 2019;123(1):e82&#x2013;e94. 10.1016/j.bja.2019.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2019.01.026</ArticleId><ArticleId IdType="pubmed">30916014</ArticleId></ArticleIdList></Reference><Reference><Citation>Macy E, Ngor EW. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract. 2013;1(3):258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">24565482</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco K, Bates A, Brigham T, Imam J, Burton MC. Clinical outcomes following inpatient penicillin allergy testing: a systematic review and meta-analysis. Allergy. 2017;72(9):1288&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pubmed">28370003</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant JM, Song WH, Shajari S, et al. Safety of administering cefazolin versus other antibiotics in penicillin-allergic patients for surgical prophylaxis at a major Canadian teaching hospital. Surgery. 2021;170(3):783&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">33894984</ArticleId></ArticleIdList></Reference><Reference><Citation>Isserman RS, Cheung J, Varallo D, et al. Increasing cefazolin use for perioperative antibiotic prophylaxis in penicillin-allergic children. Pediatrics. 2022;149(3).</Citation><ArticleIdList><ArticleId IdType="pubmed">35229120</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh KK, Hughes BL, Grotegut CA, et al. Preoperative cefazolin rather than clindamycin or metronidazole is associated with lower postpartum infection among women with chorioamnionitis delivering by cesarean delivery. Am J Obstet Gynecol MFM. 2020;2(1), 100074.</Citation><ArticleIdList><ArticleId IdType="pubmed">33345988</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J, Isaiah A, Dyalram D, Lubek JE. Surgical site infections in patients receiving osteomyocutaneous free flaps to the head and neck. Does choice of antibiotic prophylaxis matter? J Oral Maxillofac Surg. 2017;75(10):2223&#x2013;2229.</Citation><ArticleIdList><ArticleId IdType="pubmed">28282521</ArticleId></ArticleIdList></Reference><Reference><Citation>Linam WM, Margolis PA, Staat MA, et al. Risk factors associated with surgical site infection after pediatric posterior spinal fusion procedure. Infect Control Hosp Epidemiol. 2009;30(2):109&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">19125680</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibamura-Fujiogi M, Ormsby J, Breibart M, et al. Risk factors for pediatric surgical site infection following neurosurgical procedures for hydrocephalus: a retrospective single-center cohort study. BMC Anesthesiol. 2021;21(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8059169</ArticleId><ArticleId IdType="pubmed">33882858</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. Lancet. 2019; 393(10167):183&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6563335</ArticleId><ArticleId IdType="pubmed">30558872</ArticleId></ArticleIdList></Reference><Reference><Citation>Petz LD. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis. 1978;137(Supplement):S74&#x2013;S79.</Citation><ArticleIdList><ArticleId IdType="pubmed">77300</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichichero ME A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005;115(4):1048&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pubmed">15805383</ArticleId></ArticleIdList></Reference><Reference><Citation>SAXON A, BEALL GN, ROHR AS, ADELMAN DC Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med. 1987;107(2):204&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">3300459</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg. 2007;136(3):340&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">17321857</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Allergy A. American college of allergy A, joint council of allergy A, parameters JTFoP. drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">20934625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa-Pinto B, Blumenthal KG, Courtney L, Mancini CM, Jeffres MN. Assessment of the frequency of dual allergy to penicillins and cefazolin: a systematic review and meta-analysis. JAMA Surg. 2021;156(4). e210021&#x2013;e210021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970387</ArticleId><ArticleId IdType="pubmed">33729459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry SB, Veve MP, Wagner JL. Cephalosporins: a focus on side chains and &#x3b2;-lactam cross-reactivity. Pharmacy. 2019;7(3):103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6789778</ArticleId><ArticleId IdType="pubmed">31362351</ArticleId></ArticleIdList></Reference><Reference><Citation>Trubiano JA, Stone CA, Grayson ML, et al. The 3 Cs of antibiotic allergy&#x2014;classification, cross-reactivity, and collaboration. J Allergy Clin Immunol Pract. 2017;5(6):1532&#x2013;1542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5681410</ArticleId><ArticleId IdType="pubmed">28843343</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert DN, Chambers HF, Saag MS, et al. The Sanford guide to Antimicrobial Therapy 2021. Sperryville, VA, USA: Antimicrobial Therapy, Inc.; 2021.</Citation></Reference><Reference><Citation>Smieja M Current indications for the use of clindamycin: a critical review. Can J Infect Dis. 1998;9(1):22&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3250868</ArticleId><ArticleId IdType="pubmed">22346533</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamash DF, Milstone AM, Carroll KC, et al. Changing antibiotic resistance patterns for Staphylococcus aureus surgical site infections. Infect Control Hospital Epidemiol. 2019;40(4):486&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">30782221</ArticleId></ArticleIdList></Reference><Reference><Citation>Macy E Penicillin and beta-lactam allergy: epidemiology and diagnosis. Curr Allergy Asthma Rep. 2014;14(11):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">25216741</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33150974</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Laryngoscope</Title><ISOAbbreviation>Laryngoscope</ISOAbbreviation></Journal><ArticleTitle>Detection of Respiratory Pathogens Does Not Predict Risks After Outpatient Adenotonsillectomy.</ArticleTitle><Pagination><StartPage>E2074</StartPage><EndPage>E2079</EndPage><MedlinePgn>E2074-E2079</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.29236</ELocationID><Abstract><AbstractText Label="OBJECTIVES/HYPOTHESIS">To determine whether the presence of detectable upper respiratory infections (URIs) at the time of adenoidectomy/adenotonsillectomy is associated with increased morbidity, complications, and unexpected admissions.</AbstractText><AbstractText Label="STUDY DESIGN">Prospective double-blinded cohort.</AbstractText><AbstractText Label="METHODS">In this prospective cohort study, nasopharyngeal swabs were obtained intraoperatively from 164 pediatric patients undergoing outpatient adenoidectomy/tonsillectomy with or without pressure equalization tubes (PETs) and were analyzed with PCR for the presence of 22 known URIs, including SARS-CoV-2. Surgeons and families were blinded to the results. At the conclusion of the study, rates of detectable infection were determined and intraoperative and postoperative events (unexpected admissions, length of PACU stay, rates of laryngospasm/bronchospasm, oxygen desaturation, bradycardia, and postoperative presentation to an emergency department) were compared between infected and uninfected patients.</AbstractText><AbstractText Label="RESULTS">Of the 164 patients (50% male, 50% female, ages 8 mo-18 y), 136 patients (82.9%) tested positive for one or more URI at the time of surgery. Forty one patients (25.0%) tested positive for three or more URIs concurrently, and 11 (6.7%) tested positive for five or more URIs concurrently. There were no significant differences in admission rates, length of PACU stay, rates of laryngospasm/bronchospasm, oxygen desaturation, bradycardia, or postoperative presentation to an emergency department between positive and negative patients. No patients tested positive for SARS-CoV-2.</AbstractText><AbstractText Label="CONCLUSIONS">A recent positive URI test does not confer any additional intraoperative or postoperative risk in the setting of outpatient adenoidectomy/tonsillectomy in healthy patients. There is no utility in preoperative URI testing, and delaying surgery due to a recent positive URI test is not warranted in this population.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">3 Laryngoscope, 131:E2074-E2079, 2021.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of American Laryngological, Rhinological and Otological Society Inc, "The Triological Society" and American Laryngological Association (ALA).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vickers</LastName><ForeName>Donald M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Arundathi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akmyradov</LastName><ForeName>Chary</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Pediatric Translational Research Biostatistics, Arkansas Children's Research Institute, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Kesley M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyanton</LastName><ForeName>Bobby L</ForeName><Initials>BL</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Heather D</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Jay A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Childress</LastName><ForeName>Sherry H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartzell</LastName><ForeName>Larry D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Adam B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Key</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolder</LastName><ForeName>Abby R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Gresham T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wineland</LastName><ForeName>Andre' M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-1576-3380</Identifier><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strub</LastName><ForeName>Graham M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0002-2585-4956</Identifier><AffiliationInfo><Affiliation>Otolaryngology-Head and Neck Surgery, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Otolaryngology, Anesthesiology, Pathology and Laboratory Medicine, Arkansas Children's Hospital, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Pediatric Translational Research Biostatistics, Arkansas Children's Research Institute, Little Rock, Arkansas, U.S.A.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UG1 OD024945</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG1OD024945</GrantID><Agency>National Institute of Child Health and Human Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Laryngoscope</MedlineTA><NlmUniqueID>8607378</NlmUniqueID><ISSNLinking>0023-852X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="Y">Adenoidectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000391" MajorTopicYN="Y">Air Microbiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000556" MajorTopicYN="Y">Ambulatory Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Upper respiratory pathogen testing</Keyword><Keyword MajorTopicYN="N">adenoidectomy</Keyword><Keyword MajorTopicYN="N">outpatient surgery</Keyword><Keyword MajorTopicYN="N">tonsillectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>5</Day><Hour>8</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33150974</ArticleId><ArticleId IdType="pmc">PMC8246986</ArticleId><ArticleId IdType="doi">10.1002/lary.29236</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cohen MM, Cameron CB. Should you cancel the operation when a child has an upper respiratory tract infection? Anesth Analg 1991;72:282&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">1994755</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Knight PR. Intraoperative respiratory complications in patients with upper respiratory tract infections. Can J Anaesth 1987;34:300&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">3581401</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill PJ, Richardson SE, Ostrow O, Friedman JN. Testing for respiratory viruses in children: to swab or not to swab. JAMA Pediatr 2017;171:798&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">28672402</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaeder MC, Carson KA, Vricella LA, Alejo DE, Holmes KW. Impact of the viral respiratory season on postoperative outcomes in children undergoing cardiac surgery. Pediatr Cardiol 2011;32:801&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">21479907</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan K, Barlow A, Alphonso N, et al. Impact of viral respiratory pathogens on outcomes after pediatric cardiac surgery. Pediatr Crit Care Med 2017;18:219&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">28114162</ArticleId></ArticleIdList></Reference><Reference><Citation>Niermeyer WL, Ball J, Worobetz N, et al. Respiratory viral panels and pediatric airway evaluation: the role of testing for upper respiratory infections to stratify perioperative risk. Int J Pediatr Otorhinolaryngol 2020;134:110057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172690</ArticleId><ArticleId IdType="pubmed">32388322</ArticleId></ArticleIdList></Reference><Reference><Citation>Advani S, Sengupta A, Forman M, Valsamakis A, Milstone AM. Detecting respiratory viruses in asymptomatic children. Pediatr Infect Dis J 2012;31:1221&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3505556</ArticleId><ArticleId IdType="pubmed">22739572</ArticleId></ArticleIdList></Reference><Reference><Citation>Singleton RJ, Bulkow LR, Miernyk K, et al. Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol 2010;82:1282&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7167028</ArticleId><ArticleId IdType="pubmed">20513097</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall DA, Hoffer ME. Complications of tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg 1998;118:61&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">9450830</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber AL, Everhart K, Daly JA, et al. Multicenter evaluation of BioFire FilmArray respiratory panel 2 for detection of viruses and bacteria in nasopharyngeal swab samples. J Clin Microbiol 2020;23:e00155&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5971546</ArticleId><ArticleId IdType="pubmed">29593057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolters F, van de Bovenkamp J, van den Bosch B, et al. Multi&#x2010;center evaluation of cepheid xpert(R) xpress SARS&#x2010;CoV&#x2010;2 point&#x2010;of&#x2010;care test during the SARS&#x2010;CoV&#x2010;2 pandemic. J Clin Virol 2020;128:104426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211760</ArticleId><ArticleId IdType="pubmed">32417674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Lou X, Yan H, et al. Respiratory virus associated with surgery in children patients. Respir Res 2019;20:126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6580463</ArticleId><ArticleId IdType="pubmed">31208426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16235399</PMID><DateCompleted><Year>2006</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Issue>4</Issue><PubDate><Year>2005</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Interventions for primary (intrinsic) tracheomalacia in children.</ArticleTitle><Pagination><StartPage>CD005304</StartPage><MedlinePgn>CD005304</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tracheomalacia, a disorder of the large airways where the trachea is deformed or malformed during respiration is commonly seen in tertiary paediatric practice. It is associated with a wide spectrum of respiratory symptoms from life threatening recurrent apnea to common respiratory symptoms such as chronic cough and wheeze. Current practice following diagnosis of tracheomalacia include medical approaches aimed at reducing associated symptoms of tracheomalacia, ventilation modalities of continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP) and, surgical approaches aimed at improving the caliber of the airway (airway stenting, aortopexy, tracheopexy).</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the efficacy of medical and surgical therapies for children with intrinsic (primary) tracheomalacia.</AbstractText><AbstractText Label="SEARCH STRATEGY" NlmCategory="METHODS">The Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Airways Group Specialised Register, MEDLINE and EMBASE databases were searched by the Cochrane Airways Group. The latest searches were performed in Feb 2005.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">All randomised controlled trials of therapies related to symptoms associated with primary or intrinsic tracheomalacia.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Results of searches were reviewed against pre-determined criteria for inclusion. No eligible trials were identified and thus no data were available for analysis.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">No randomised controlled trials (RCTs) that examined therapies for intrinsic tracheomalacia were found. Eight of the more recent (last 11 years) non randomised controlled trials reported a benefit from the various surgical interventions. The success was however not universal and in some studies severe adverse events occurred.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">There is currently an absence of evidence to support any of the therapies currently utilised for management of intrinsic tracheomalacia. It is unlikely that any RCT on surgically based management will ever be available for children with severe life threatening illness associated with tracheomalacia. For those with less severe disease, RCTs are clearly needed. Outcomes of these RCTs should include measurements of the trachea and physiological outcomes in addition to clinical outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Masters</LastName><ForeName>I B</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Royal Children's Hospital, Respiratory Medicine, Herston Rd, Herston, Brisbane, Queensland, Australia 4029. brent_masters@health.qld.gov.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>A B</ForeName><Initials>AB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Cochrane Database Syst Rev. 2012 Oct 17;10:CD005304. doi: 10.1002/14651858.CD005304.pub3.</RefSource><PMID Version="1">23076914</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014132" MajorTopicYN="N">Trachea</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014133" MajorTopicYN="N">Tracheal Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>32</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>10</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>2</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>10</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16235399</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD005304.pub2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39798043</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>Prophylactic pharmacological interventions against perioperative respiratory adverse events in children undergoing noncardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>248</StartPage><EndPage>264</EndPage><MedlinePgn>248-264</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-024-03453-y</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Perioperative respiratory adverse event (PRAE) is one of the most common complications in pediatric anesthesia. We aimed to evaluate the efficacy of perioperative pharmacological interventions to prevent the development of PRAE in children undergoing noncardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Embase, Cochrane Library and ClinicalTrials.gov were searched for randomized controlled trials (RCT) of prophylactic pharmacological interventions for PRAE among surgical children from inception to 5 August 2024. Pairwise meta-analyses were conducted to compare the effects of an intervention with placebo or another intervention on overall PRAE and their subtypes, including laryngospasm, bronchospasm, oxygen desaturation, airway obstruction, coughing and stridor. Risk of bias was assessed using the Cochrane Collaboration tool.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven categories of prophylactic interventions were identified. Twenty-nine RCTs with 4452 children were included. Compared with placebo, lidocaine reduced the odds ratio (OR) of overall PRAE ( 0.27 [95% CI] [0.17, 0.42]) and laryngospasm (0.38 [0.22, 0.67]); dexmedetomidine reduced the OR of PRAE (0.31 [0.12, 0.76]), laryngospasm (0.31 [0.10, 0.91]), coughing (0.24 [0.14, 0.41]) and oxygen desaturation (0.54 [0.35, 0.84]); &#x3b2;<sub>2</sub>-adrenoreceptor agonists reduced the OR of PRAE (0.45 [0.24, 0.83]), coughing (0.36 [0.13, 0.95]) and oxygen desaturation (0.66 [0.45, 0.98]). Compared with sevoflurane induction, intravenous propofol induction lowered the OR of PRAE (0.35 [0.16, 0.74]), laryngospasm (0.17 [0.06, 0.48]) and airway obstruction (0.32 [0.17, 0.63]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The meta-analysis demonstrated prophylactic potential of lidocaine, dexmedetomidine, &#x3b2;<sub>2</sub>-adrenoreceptor agonists and propofol induction technique against PRAE, but it should be interpreted cautiously due to inconsistent PRAE definition and correlation of subtypes within the composite outcome.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">PROSPERO (CRD42020220028). Registered 11 December 2020. Updated 3 September 2024.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s) under exclusive licence to Japanese Society of Anesthesiologists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Deng</LastName><ForeName>Qi-Wen</ForeName><Initials>QW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-sen University, No.58, Zhongshan 2Nd Road, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tan</LastName><ForeName>Wen-Cheng</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Department of Endoscopy, Sun Yat-sen University Cancer Center, No. 651, Dongfeng East Road, Guangzhou, 510060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhan</LastName><ForeName>Ya-Qing</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-sen University, No.58, Zhongshan 2Nd Road, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xi-Wen</ForeName><Initials>XW</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-sen University, No.58, Zhongshan 2Nd Road, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Han-Jin</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-sen University, No.58, Zhongshan 2Nd Road, Guangzhou, 510080, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Shi-Hong</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0003-3433-2938</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, the First Affiliated Hospital, Sun Yat-sen University, No.58, Zhongshan 2Nd Road, Guangzhou, 510080, China. wshih@mail.sysu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202201011025</GrantID><Agency>Guangzhou Municipal Science and Technology Project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Anesth. 2025 Aug;39(4):666-667. doi: 10.1007/s00540-025-03480-3.</RefSource><PMID Version="1">40050440</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="Y">Respiration Disorders</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="N">Lidocaine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">Perioperative respiratory adverse events</Keyword><Keyword MajorTopicYN="N">Pharmacological interventions</Keyword><Keyword MajorTopicYN="N">Prophylaxis</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>27</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>11</Day><Hour>14</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>11</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39798043</ArticleId><ArticleId IdType="doi">10.1007/s00540-024-03453-y</ArticleId><ArticleId IdType="pii">10.1007/s00540-024-03453-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, Rebmann C, Johnson C, Sly PD, Habre W. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet. 2010;376(9743):773&#x2013;83.</Citation></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Chanchayanon T, Sriyanaluk B, Saefung B, Nuanjun K. Excess costs and length of hospital stay attributable to perioperative respiratory events in children. Anesth Analg. 2015;120(2):411&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25517194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhananker SM, Ramamoorthy C, Geiduschek JM, Posner KL, Domino KB, Haberkern CM, Campos JS, Morray JP. Anesthesia-related cardiac arrest in children: update from the Pediatric Perioperative Cardiac Arrest Registry. Anesth Analg. 2007;105(2):344&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17646488</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W, Disma N, Virag K, Becke K, Hansen TG, Johr M, Leva B, Morton NS, Vermeulen PM, Zielinska M, Boda K, Veyckmans F. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017;5(5):412&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.</Citation></Reference><Reference><Citation>Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, eds.Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. http://www.handbook.cochrane.org . Published March 2011. Accessed 14 May 2024.</Citation></Reference><Reference><Citation>Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev: DOI; 2019. https://doi.org/10.1002/14651858.ED000142 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.ED000142</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ, Group GW. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924&#x2013;6.</Citation></Reference><Reference><Citation>Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Y, Ma Y, Ni J, Wu L. Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial. BMC Anesthesiol. 2019;19(1):219.</Citation><ArticleIdList><ArticleId IdType="pubmed">31791239</ArticleId><ArticleId IdType="pmc">6886218</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KZ, Ye M, Hu CB, Shen X. Dexmedetomidine vs remifentanil intravenous anaesthesia and spontaneous ventilation for airway foreign body removal in children. Br J Anaesth. 2014;112(5):892&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24554548</ArticleId></ArticleIdList></Reference><Reference><Citation>Di M, Huang C, Chen F, Zeng R, Yu C, Shangguan W, Lian Q, Li J. Effect of single-dose dexmedetomidine on recovery profiles after sevoflurane anesthesia with spontaneous respiration in pediatric patients undergoing cleft lip and palate repair. Zhonghua Yi Xue Za Zhi. 2014;94(19):1466&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25143165</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler G, Akin A, Tosun Z, Ors S, Esmaoglu A, Boyaci A. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Paediatr Anaesth. 2005;15(9):762&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16101707</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Wang X, Zheng S, Shi Y. Effects of dexmedetomidine infusion on laryngeal mask airway removal and postoperative recovery in children anaesthetised with sevoflurane. Anaesth Intensive Care. 2013;41(3):328&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">23659394</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen F, Zhang Q, Xu Y, Wang X, Xia J, Chen C, Liu H, Zhang Y. Effect of Intranasal Dexmedetomidine or Midazolam for Premedication on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomy and Adenoidectomy: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(8): e2225473.</Citation><ArticleIdList><ArticleId IdType="pubmed">35943745</ArticleId><ArticleId IdType="pmc">9364121</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M, Miao S, Gu T, Wang D, Zhang H, Liu J. Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial. Drug Des Devel Ther. 2019;13:897&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">30936683</ArticleId><ArticleId IdType="pmc">6421876</ArticleId></ArticleIdList></Reference><Reference><Citation>Lili X, Jianjun S, Haiyan Z. The application of dexmedetomidine in children undergoing vitreoretinal surgery. J Anesth. 2012;26(4):556&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">22415678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Sommerfield D, Slevin L, Drake-Brockman TFE, Zhang G, von Ungern-Sternberg BS. Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children. Br J Anaesth. 2017;119(1):150&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28974069</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Sommerfield D, Slevin L, Drake-Brockman TFE, Zhang G, Hall GL. Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial. JAMA Pediatr. 2019;173(6):527&#x2013;33.</Citation></Reference><Reference><Citation>Kim EH, Lee SH, Kim JK, Park YH, Kang P, Park JB, Ji SH, Jang YE, Lee JH, Kim JT, Kim HS. Effect of Tulobuterol Patch Versus Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: A Randomized Controlled Trial. Anesth Analg. 2023;136(6):1067&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">36727868</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraka A. Intravenous lidocaine controls extubation laryngospasm in children. Anesth Analg. 1978;57(4):506&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">360878</ArticleId></ArticleIdList></Reference><Reference><Citation>Khattak R, Haq IU, Abbasi T, Ahmad A, Khan SA, Raja MH, Khan SA. Efficacy Of Intravenous Lignocain Vs Sevoflurane In Prevention Of Coughing And Desaturation At Extubation In Children. J Ayub Med Coll Abbottabad. 2018;30(2):167&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">29938412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheirabadi D, Shafa A, Hirmanpour A, Zareh F. Prophylactic Effects of Intravenous Dexamethasone and Lidocaine on Attenuating Hemodynamic-Respiratory and Pain Complications in Children Undergoing Cleft Palate Repair Surgery With General Anesthesia. J Pain Palliat Care Pharmacother. 2020;34(2):63&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31922432</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc C, Kocaman F, Aygenc E, Ozdem C, Cekic A. The use of preoperative lidocaine to prevent stridor and laryngospasm after tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg. 1998;118(6):880&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">9627258</ArticleId></ArticleIdList></Reference><Reference><Citation>Leicht P, Wisborg T, Chraemmer-Jorgensen B. Does intravenous lidocaine prevent laryngospasm after extubation in children? Anesth Analg. 1985;64(12):1193&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">4061902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanikop C, Bhat S. Efficacy of intravenous lidocaine in prevention of post extubation laryngospasm in children undergoing cleft palate surgeries. Indian J Anaesth. 2010;54(2):132&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20661351</ArticleId><ArticleId IdType="pmc">2900736</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LW, He L, Ai Y, Chu Q, Zhang W. Site-directed topical lidocaine spray attenuates perioperative respiratory adverse events in children undergoing elective surgery. J Surg Res. 2016;203(1):206&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">27338551</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill B, Templeton JJ, Caramico L, Schreiner MS. The laryngeal mask airway in pediatric patients: factors affecting ease of use during insertion and emergence. Anesth Analg. 1994;78(4):659&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8135383</ArticleId></ArticleIdList></Reference><Reference><Citation>Schebesta K, Guloglu E, Chiari A, Mayer N, Kimberger O. Topical lidocaine reduces the risk of perioperative airway complications in children with upper respiratory tract infections. Can J Anaesth. 2010;57(8):745&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">20524104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulhas N, Durmus M, Demirbilek S, Togal T, Ozturk E, Ersoy MO. The use of magnesium to prevent laryngospasm after tonsillectomy and adenoidectomy: a preliminary study. Paediatr Anaesth. 2003;13(1):43&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12535038</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzban S, Haddadi S, Naghipour MR, Sayah Varg Z, Naderi NB. The effect of intravenous magnesium sulfate on laryngospasm after elective adenotonsillectomy surgery in children. Anesth Pain Med. 2014;4(1): e15960.</Citation><ArticleIdList><ArticleId IdType="pubmed">24660159</ArticleId><ArticleId IdType="pmc">3961025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw CA, Kelleher AA, Gill CP, Murdoch LJ, Stables RH, Black AE. Comparison of the incidence of complications at induction and emergence in infants receiving oral atropine vs no premedication. Br J Anaesth. 2000;84(2):174&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10743449</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Burke C, Voepel-Lewis T, Chiravuri D, Wagner D, Malviya S. Glycopyrrolate does not reduce the incidence of perioperative adverse events in children with upper respiratory tract infections. Anesth Analg. 2007;104(2):265&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">17242078</ArticleId></ArticleIdList></Reference><Reference><Citation>Batra YK, Ivanova M, Ali SS, Shamsah M, Al Qattan AR, Belani KG. The efficacy of a subhypnotic dose of propofol in preventing laryngospasm following tonsillectomy and adenoidectomy in children. Paediatr Anaesth. 2005;15(12):1094&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16324030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar D, Afshan G, Zubair M, Hamid M. Isoflurane alone versus small dose propofol with isoflurane for removal of laryngeal mask airway in children-a randomized controlled trial. J Pak Med Assoc. 2019;69(11):1596&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">31740862</ArticleId></ArticleIdList></Reference><Reference><Citation>Guard BC, Sikich N, Lerman J, Levine M. Maintenance and recovery characteristics after sevoflurane or propofol during ambulatory surgery in children with epidural blockade. Can J Anaesth. 1998;45(11):1072&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10021955</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam C, Zeeni C, Yazbeck-Karam V, Shebbo FM, Khalili A, Abi Raad SG, Beresian J, Aouad MT, Kaddoum R. Respiratory Adverse Events After LMA(R) Mask Removal in Children: A Randomized Trial Comparing Propofol to Sevoflurane. Anesth Analg. 2023;136(1):25&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">35213484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Inhalational versus Intravenous Induction of Anesthesia in Children with a High Risk of Perioperative Respiratory Adverse Events: A Randomized Controlled Trial. Anesthesiology. 2018;128(6):1065&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">29498948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SS, Wang NN, Postonogova T, Yang GJ, McGillion M, Beique F, Schricker T. Intravenous lidocaine to prevent postoperative airway complications in adults: a systematic review and meta-analysis. Br J Anaesth. 2020;124(3):314&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">32000978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebbar KC, Reddy A, Luthra A, Chauhan R, Meena SC, Tripathi M. Comparison of the efficacy of intranasal atomised dexmedetomidine versus intranasal atomised ketamine as a premedication for sedation and anxiolysis in children undergoing spinal dysraphism surgery: A randomized controlled trial. Eur J Anaesthesiol. 2024;41(4):288&#x2013;95.</Citation></Reference><Reference><Citation>He H, Cui Q, Chen H, Huang X, Wang S, Yu T, Feng J, Shao Y. The Effect of Intranasal Dexmedetomidine on Emergence Delirium Prevention in Pediatric Ambulatory Dental Rehabilitation Under General Anesthesia: A Randomized Clinical Trial. Drug Des Devel Ther. 2023;17:3563&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">38054181</ArticleId><ArticleId IdType="pmc">10695126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yin J, Li Y, Zhang Y, Bai Y, Yang H. Effect of dexmedetomidine on preventing perioperative respiratory adverse events in children: A systematic review and meta-analysis of randomized controlled trials. Exp Ther Med. 2023;25(6):286.</Citation><ArticleIdList><ArticleId IdType="pubmed">37206556</ArticleId><ArticleId IdType="pmc">10189613</ArticleId></ArticleIdList></Reference><Reference><Citation>Virag K, Sabourdin N, Thomas M, Veyckemans F, Habre W, Network AGotESoACT. Epidemiology and incidence of severe respiratory critical events in ear, nose and throat surgery in children in Europe: A prospective multicentre observational study. Eur J Anaesthesiol. 2019;36(3):185&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">30640246</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter LL, Blaauwendraad SM, Pieters BM. Respiratory and hemodynamic perioperative adverse events in intravenous versus inhalational induction in pediatric anesthesia: A systematic review and meta-analysis. Paediatr Anaesth. 2020;30(8):859&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">32358815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27310994</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>24</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Oral atenolol therapy for proliferating infantile hemangioma: A prospective study.</ArticleTitle><Pagination><StartPage>e3908</StartPage><MedlinePgn>e3908</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3908</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000003908</ELocationID><Abstract><AbstractText>Propranolol, a lipophilic nonselective &#x3b2;-blocker, has recently been reported to be the treatment of choice for select types of infantile hemangiomas (IHs). Atenolol is a hydrophilic, selective &#x3b2;1-blocker and therefore may be not associated with side effects attributable to &#x3b2;2-adrenergic receptor blockade and lipophilicity. However, the efficacy and safety of atenolol in the treatment of IH are poorly understood. The aim of this study was to evaluate the efficacy and safety of atenolol in the treatment of proliferating IHs.A study of 76 infants between the ages of 5 to 20 weeks with superficial or mixed IH was conducted between August 2013 and March 2015. Oral atenolol was administered in a progressive schedule to 1&#x200a;mg/kg per day in a single dose. Efficacy was assessed using the Hemangioma Activity Score (HAS) at weeks 0, 1, 4, 12, and 24. Safety was evaluated at weeks 0, 1, 4, 8, 12, 16, 20, and 24.In total, 70 patients completed 24 weeks of treatment. IH growth abruptly stopped for 93.4% of patients within the fourth week of treatment with atenolol. In ulcerated IHs, complete healing of the ulcerations occurred in an average treatment time of 5.5 weeks. Atenolol treatment promoted dramatic decreases in HAS scores after week 1. An "excellent" treatment response (compete or nearly complete resolution of the IH) was observed in 56.5% of patients at week 24. No significant hypoglycemia, bronchospasm, bradycardia, or hypotension occurred. The most common adverse event was diarrhea, followed by agitation and sleep disturbance.This study demonstrated that atenolol was effective and safe at a dose of 1&#x200a;mg/kg per day for 24 weeks in the treatment of proliferating IHs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu, China Pediatric Intensive Care Unit, West China Hospital of Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhicheng</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Lin</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xiaoping</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058671">Adrenergic beta-1 Receptor Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>50VV3VW0TI</RegistryNumber><NameOfSubstance UI="D001262">Atenolol</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C535860">Hemangioma, capillary infantile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Medicine (Baltimore). 2016 Aug 07;95(31):e5074. doi: 10.1097/01.md.0000490009.39850.74.</RefSource><PMID Version="1">31265618</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058671" MajorTopicYN="N">Adrenergic beta-1 Receptor Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001262" MajorTopicYN="N">Atenolol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018324" MajorTopicYN="N">Hemangioma, Capillary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009386" MajorTopicYN="N">Neoplastic Syndromes, Hereditary</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27310994</ArticleId><ArticleId IdType="pmc">PMC4998480</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000003908</ArticleId><ArticleId IdType="pii">00005792-201606140-00054</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen TS, Eichenfield LF, Friedlander SF. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics 2013;131:99&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">23266916</ArticleId></ArticleIdList></Reference><Reference><Citation>Darrow DH, Greene AK, Mancini AJ, et al. Diagnosis and management of infantile hemangioma. Pediatrics 2015;136:e1060&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">26416931</ArticleId></ArticleIdList></Reference><Reference><Citation>George ME, Sharma V, Jacobson J, et al. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004;140:963&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15313812</ArticleId></ArticleIdList></Reference><Reference><Citation>Leaute-Labreze C, Dumas DLRE, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">18550886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19706583</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulie J, Coyette M, Moniotte S, et al. Has propranolol eradicated the need for surgery in the management of infantile hemangioma? Plast Reconstr Surg 2015;136:154.</Citation><ArticleIdList><ArticleId IdType="pubmed">38739875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Mostyn RH, Oram S. Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet 1975;1:1213&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">48835</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange BA, Dolan RJ. Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci U S A 2004;101:11454&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC509222</ArticleId><ArticleId IdType="pubmed">15269349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonergan MH, Olivera-Figueroa LA, Pitman RK, et al. Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis. J Psychiatry Neurosci 2013;38:222&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3692719</ArticleId><ArticleId IdType="pubmed">23182304</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley A, Pope E. Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas. Br J Dermatol 2015;172:13&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25175684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y, Chen S, Xu C, et al. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action. Br J Dermatol 2015;172:24&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">25196392</ArticleId></ArticleIdList></Reference><Reference><Citation>Janmohamed SR, de Waard-van DSF, Madern GC, et al. Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS). Clin Exp Dermatol 2011;36:715&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">21933230</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf M, Raphael MF, Breugem CC, et al. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group. J Plast Reconstr Aesthet Surg 2013;66:1732&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">24011909</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael MF, de Graaf M, Breugem CC, et al. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas. J Am Acad Dermatol 2011;65:420&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">21763565</ArticleId></ArticleIdList></Reference><Reference><Citation>Abarzua-Araya A, Navarrete-Dechent CP, Heusser F, et al. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. J Am Acad Dermatol 2014;70:1045&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24656727</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18676554</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollefson MM, Frieden IJ. Early growth of infantile hemangiomas: what parents&#x2019; photographs tell us. Pediatrics 2012;130:e314&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">22826568</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauland CG, Luning TH, Smit JM, et al. Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg 2011;127:1643&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21460670</ArticleId></ArticleIdList></Reference><Reference><Citation>Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015;372:735&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">25693013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou HH, Koshakji RP, Silberstein DJ, et al. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med 1989;320:565&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">2536896</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter CP, Joubert PH. Ethnic differences in response to beta 1-adrenoceptor blockade by propranolol. J Cardiovasc Pharmacol 1984;6:361&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">6200729</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37206556</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1792-1015</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Experimental and therapeutic medicine</Title><ISOAbbreviation>Exp Ther Med</ISOAbbreviation></Journal><ArticleTitle>Effect of dexmedetomidine on preventing perioperative respiratory adverse events in children: A systematic review and meta&#x2011;analysis of randomized controlled trials.</ArticleTitle><Pagination><StartPage>286</StartPage><MedlinePgn>286</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">286</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2023.11985</ELocationID><Abstract><AbstractText>The most common critical incidents in pediatric anesthesia are perioperative respiratory adverse events (PRAEs). The present meta-analysis aimed to assess the preventive effect of dexmedetomidine on PRAEs in children. Dexmedetomidine is a highly selective &#x3b1;<sub>2</sub>-adrenoceptor agonist that provides sedation, anxiolysis and analgesic effects without causing respiratory depression. Dexmedetomidine can diminish airway and circulatory responses during extubation in children. Original randomized controlled trial data were analyzed to study the putative effect of dexmedetomidine on PRAEs. By searched the Cochrane Library, EMBASE and PubMed, a total of ten randomized controlled trials (1,056 patients) was identified. PRAEs included cough, breath holding, laryngospasm, bronchospasm, desaturation (percutaneous oxygen saturation &lt;95%), body movement and pulmonary rales. Compared with placebo, dexmedetomidine resulted in a significant reduction of incidence of cough, breath holding, laryngospasm and emergence agitation. The incidence of PRAEs was significantly reduced in dexmedetomidine compared with active comparators group. Moreover, dexmedetomidine decreased heart rate and increased post-anesthesia care unit stay duration by 11.18 min. The present analysis suggested that dexmedetomidine improved the airway function and decreased risks associated with general anesthesia in children. The present data demonstrated that dexmedetomidine may be a good choice to prevent PRAEs in children.</AbstractText><CopyrightInformation>Copyright: &#xa9; Zhang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Junli</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tangshan Maternal and Child Health Care Hospital, Tangshan, Hebei 063000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tangshan Maternal and Child Health Care Hospital, Tangshan, Hebei 063000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tangshan Maternal and Child Health Care Hospital, Tangshan, Hebei 063000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tangshan Maternal and Child Health Care Hospital, Tangshan, Hebei 063000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Yaowu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tangshan Maternal and Child Health Care Hospital, Tangshan, Hebei 063000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Hongyuan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Tangshan Maternal and Child Health Care Hospital, Tangshan, Hebei 063000, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Exp Ther Med</MedlineTA><NlmUniqueID>101531947</NlmUniqueID><ISSNLinking>1792-0981</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">perioperative respiratory adverse event</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37206556</ArticleId><ArticleId IdType="pmc">PMC10189613</ArticleId><ArticleId IdType="doi">10.3892/etm.2023.11985</ArticleId><ArticleId IdType="pii">ETM-25-6-11985</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li L, Zhang Z, Yao Z, Wang HJ, Wang HB, An H, Yao J. The impact of laryngeal mask versus other airways on perioperative respiratory adverse events in children: A systematic review and meta-analysis of randomized controlled trials. Int J Surg. 2019;64:40&#x2013;48. doi: 10.1016/j.ijsu.2019.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2019.02.020</ArticleId><ArticleId IdType="pubmed">30878762</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake-Brockman TFE, Ramgolam A, Zhang G, Hall GL, von Ungern-Sternberg BS. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: A randomised controlled trial. Lancet. 2017;389:701&#x2013;708. doi: 10.1016/S0140-6736(16)31719-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31719-6</ArticleId><ArticleId IdType="pubmed">28108038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Rath GP, Prabhakar H, Dash HH. Effect of intraoperative dexmedetomidine on postoperative recovery profile of children undergoing surgery for spinal dysraphism. J Neurosurg Anesthesioly. 2013;25:271&#x2013;278. doi: 10.1097/ANA.0b013e31828cb6c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0b013e31828cb6c0</ArticleId><ArticleId IdType="pubmed">23519371</ArticleId></ArticleIdList></Reference><Reference><Citation>Bong CL, Tan J, Lim S, Low Y, Sim SW, Rajadurai VS, Khoo PC, Allen J, Meaney M, Koh WP. Randomised controlled trial of dexmedetomidine sedation vs general anaesthesia for inguinal hernia surgery on perioperative outcomes in infants. Br J Anaesth. 2019;122:662&#x2013;670. doi: 10.1016/j.bja.2018.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.12.027</ArticleId><ArticleId IdType="pubmed">30916007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat R, Mudukanagoudar M, Shetty S, Kamath S. Study of dose related effects of dexmedetomidine on laryngeal mask airway removal in children-A double blind randomized study. Anaesthesia Pain Intensive Care. 2018;22:368&#x2013;373.</Citation></Reference><Reference><Citation>Chrysostomou C, Schmitt CG. Dexmedetomidine: Sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol. 2008;4:619&#x2013;627. doi: 10.1517/17425255.4.5.619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425255.4.5.619</ArticleId><ArticleId IdType="pubmed">18484919</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M, Miao S, Gu T, Wang D, Zhang H, Liu J. Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: A double-blind, randomized trial. Drug Des Devel Ther. 2019;13:897&#x2013;905. doi: 10.2147/DDDT.S196075.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S196075</ArticleId><ArticleId IdType="pmc">PMC6421876</ArticleId><ArticleId IdType="pubmed">30936683</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MJ, Schneider JB, Asaro LA, Dodson BL, Hall BA, Simone SL, Cowl AS, Munkwitz MM, Wypij D, Curley MA. Dexmedetomidine use in critically Ill children with acute respiratory failure. Pediatr Crit Care Med. 2016;17:1131&#x2013;1141. doi: 10.1097/PCC.0000000000000941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000941</ArticleId><ArticleId IdType="pmc">PMC5138139</ArticleId><ArticleId IdType="pubmed">27654816</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1) doi: 10.1186/2046-4053-4-1. PRISMA-P Group.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K, Wu SR, Ji FH, Li J. Premedication with dexmedetomidine in pediatric patients: A systematic review and meta-analysis. Clinics (Sao Paulo) 2014;69:777&#x2013;786. doi: 10.6061/clinics/2014(11)12.</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2014(11)12</ArticleId><ArticleId IdType="pmc">PMC4255070</ArticleId><ArticleId IdType="pubmed">25518037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi Y, Ma Y, Ni J, Wu L. Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: A randomized, double-blind, placebo-controlled clinical trial. BMC Anesthesiol. 2019;19(219) doi: 10.1186/s12871-019-0892-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0892-6</ArticleId><ArticleId IdType="pmc">PMC6886218</ArticleId><ArticleId IdType="pubmed">31791239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Li W, Chen K. Efficacy and safety of spontaneous ventilation technique using dexmedetomidine for rigid bronchoscopic airway foreign body removal in children. Paediatr Anaesth. 2013;23:1048&#x2013;1053. doi: 10.1111/pan.12197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12197</ArticleId><ArticleId IdType="pubmed">23701115</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KZ, Ye M, Hu CB, Shen X. Dexmedetomidine vs remifentanil intravenous anaesthesia and spontaneous ventilation for airway foreign body removal in children. Br J Anaesth. 2014;112:892&#x2013;897. doi: 10.1093/bja/aet490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet490</ArticleId><ArticleId IdType="pubmed">24554548</ArticleId></ArticleIdList></Reference><Reference><Citation>Di M, Han Y, Yang Z, Liu H, Ye X, Lai H, Li J, ShangGuan W, Lian Q. Tracheal extubation in deeply anesthetized pediatric patients after tonsillectomy: A comparison of high-concentration sevoflurane alone and low-concentration sevoflurane in combination with dexmedetomidine pre-medication. BMC Anesthesiol. 2017;17(28) doi: 10.1186/s12871-017-0317-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-017-0317-3</ArticleId><ArticleId IdType="pmc">PMC5320744</ArticleId><ArticleId IdType="pubmed">28222678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauber JA, Davis PJ, Bendel LP, Martyn SV, McCarthy D, Ecans MC, Cladis FP, Cunningham S, Lang RS, Campbell NF, et al. Dexmedetomidine as a rapid bolus for treatment and prophylactic prevention of emergence agitation in anesthetized Children. Anesth Analg. 2015;121:1308&#x2013;1315. doi: 10.1213/ANE.0000000000000931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000931</ArticleId><ArticleId IdType="pubmed">26332857</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Wang X, Zheng S, Shi Y. Effects of dexmedetomidine infusion on laryngeal mask airway removal and postoperative recovery in children anaesthetised with sevoflurane. Anaesth Intensive Care. 2013;41:328&#x2013;333. doi: 10.1177/0310057X1304100309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0310057X1304100309</ArticleId><ArticleId IdType="pubmed">23659394</ArticleId></ArticleIdList></Reference><Reference><Citation>Koceroglu I, Devrim S, Bingol Tanriverdi T, Gura Celik M. The effects of dexmedetomidine and tramadol on post-operative pain and agitation, and extubation quality in paediatric patients undergoing adenotonsillectomy surgery: A randomized trial. J Clin Pharm Ther. 2020;45:340&#x2013;346. doi: 10.1111/jcpt.13080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpt.13080</ArticleId><ArticleId IdType="pubmed">31802525</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao H, Xie Z, Jia J. Pediatric premedication: A double-blind randomized trial of dexmedetomidine or ketamine alone versus a combination of dexmedetomidine and ketamine. BMC Anesthesiol. 2017;17(158) doi: 10.1186/s12871-017-0454-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-017-0454-8</ArticleId><ArticleId IdType="pmc">PMC5708105</ArticleId><ArticleId IdType="pubmed">29187151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lili X, Jianjun S, Haiyan Z. The application of dexmedetomidine in children undergoing vitreoretinal surgery. J Anest. 2012;26:556&#x2013;561. doi: 10.1007/s00540-012-1354-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00540-012-1354-1</ArticleId><ArticleId IdType="pubmed">22415678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang PJ, Wang X, Zhang XF, Zhou ZJ, Wang Q. Postoperative respiratory and analgesic effects of dexmedetomidine or morphine for adenotonsillectomy in children with obstructive sleep apnoea. Anaesthesia. 2011;66:989&#x2013;993. doi: 10.1111/j.1365-2044.2011.06817.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2011.06817.x</ArticleId><ArticleId IdType="pubmed">21883123</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamie C, Habre W, Delhumeau C, Argiroffo CB, Morabia A. Incidence and risk factors of perioperative respiratory adverse events in children undergoing elective surgery. Paediatr Anaesth. 2004;14:218&#x2013;224. doi: 10.1111/j.1460-9592.2004.01169.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01169.x</ArticleId><ArticleId IdType="pubmed">14996260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wei L, Deng X. Other factors affect the occurrence of perioperative respiratory adverse events. Anesthesiology. 2019;130:507&#x2013;508. doi: 10.1097/ALN.0000000000002574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002574</ArticleId><ArticleId IdType="pubmed">30762637</ArticleId></ArticleIdList></Reference><Reference><Citation>Steward DJ. Assessment of pediatric patients for general anesthesia: The child with an upper respiratory infection and the ex-premature infant. Semin Pediatr Surg. 1999;8:13&#x2013;17. doi: 10.1016/s1055-8586(99)70003-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1055-8586(99)70003-x</ArticleId><ArticleId IdType="pubmed">10065564</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mazrou KA, Abdullah KM, ElGammal MS, Ansari RA, Turkistani A, Abdelmeguid ME. Laryngeal mask airway vs. uncuffed endotracheal tube for nasal and paranasal sinus surgery: paediatric airway protection. Eur J Anaesthesiol. 2010;27:16&#x2013;19. doi: 10.1097/EJA.0b013e32832c5f09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32832c5f09</ArticleId><ArticleId IdType="pubmed">19444123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, Crosby GJ, Bhattacharyya N. Airway protection and the laryngeal mask airway in sinus and nasal surgery. Laryngoscope. 2004;114:652&#x2013;655. doi: 10.1097/00005537-200404000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005537-200404000-00010</ArticleId><ArticleId IdType="pubmed">15064618</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason KP, Lerman J. Review article: Dexmedetomidine in children: Current knowledge and future applications. Anesth Analg. 2011;113:1129&#x2013;1142. doi: 10.1213/ANE.0b013e31822b8629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e31822b8629</ArticleId><ArticleId IdType="pubmed">21821507</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukry M, Clyde MC, Kalarickal PL, Ramadhyani U. Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia? Paediatr Anaesth. 2005;15:1098&#x2013;1104. doi: 10.1111/j.1460-9592.2005.01660.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2005.01660.x</ArticleId><ArticleId IdType="pubmed">16324031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheta SA, Al-Sarheed MA, Abdelhalim AA. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: A double-blinded randomized controlled trial. Paediatr Anaesth. 2014;24:181&#x2013;189. doi: 10.1111/pan.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12287</ArticleId><ArticleId IdType="pubmed">24237879</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestieau SR, Quezado ZMN, Johnson YJ, Anderson JL, Cheng YI, McCarter RJ, Choi S, Finkel J. High-dose Dexmedetomidine increases the opioid-free interval and decreases opioid requirement after tonsillectomy in children. Can J Anaesth. 2011;58:540&#x2013;550. doi: 10.1007/s12630-011-9493-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-011-9493-7</ArticleId><ArticleId IdType="pubmed">21461792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni J, Wei J, Yao Y, Jiang X, Luo L, Luo D. Effect of dexmedetomidine on preventing postoperative agitation in children: A meta-analysis. PLoS One. 2015;10(e0128450) doi: 10.1371/journal.pone.0128450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128450</ArticleId><ArticleId IdType="pmc">PMC4440759</ArticleId><ArticleId IdType="pubmed">25997021</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler G, Akin A, Tosun Z, Ors S, Esmaoglu A, Boyaci A. Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Paediatr Anaesth. 2005;15:762&#x2013;766. doi: 10.1111/j.1460-9592.2004.01541.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01541.x</ArticleId><ArticleId IdType="pubmed">16101707</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa MF, Abdel Aal FA, Ali IH, Ibrahim AK, Herdan R. Dexmedetomidine during suprazygomatic maxillary nerve block for pediatric cleft palate repair, randomized double-blind controlled study. Korean J Pain. 2020;33:81&#x2013;89. doi: 10.3344/kjp.2020.33.1.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.3344/kjp.2020.33.1.81</ArticleId><ArticleId IdType="pmc">PMC6944365</ArticleId><ArticleId IdType="pubmed">31888322</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38171956</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-5037</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of pediatric surgery</Title><ISOAbbreviation>J Pediatr Surg</ISOAbbreviation></Journal><ArticleTitle>Laryngeal Mask Airway as an Appropriate Option in Pediatric Laparoscopic Inguinal Hernia Repair: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>660</StartPage><EndPage>666</EndPage><MedlinePgn>660-666</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpedsurg.2023.11.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3468(23)00738-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To elucidate the safety and effectiveness of laryngeal mask airway (LMA) use in pediatric patients undergoing laparoscopic inguinal hernia repair.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Studies were searched on the PubMed, EMBASE, and Cochrane Library databases. Only randomized controlled trials (RCTs) were included. Primary outcomes were major perioperative respiratory adverse events (PRAEs), namely laryngospasm, bronchospasm, desaturation, and aspiration. Secondary outcomes were minor PRAEs, anesthesia time, and recovery time. A meta-analysis was performed to calculate risk ratios (RR), weighted mean difference (WMD), and 95&#xa0;% confidence intervals (CI) by using random effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 5 RCTs comprising 402 patients were included. Regarding major PRAEs, laryngospasm (RR: 0.43, 95&#xa0;% CI: 0.12 to 1.47; p&#xa0;=&#xa0;0.18), bronchospasm, and aspiration all demonstrated no difference between the laryngeal and endotracheal groups. Desaturation exhibited a trend, but this trend was not sufficiently supported with statistical evidence (p&#xa0;=&#xa0;0.09). For minor PRAEs, fewer patients experienced incidence of cough after laryngeal mask use (RR: 0.27, 95&#xa0;% CI: 0.11 to 0.67; p&#xa0;=&#xa0;0.005). Other PRAE, namely hoarseness (p&#xa0;=&#xa0;0.06), sore throat (RR: 1.88, 95&#xa0;% CI: 0.76 to 4.66; p&#xa0;=&#xa0;0.18), and stridor, did not differ between the 2 groups. Additionally, both anesthesia time (WMD:&#xa0;-6.88&#xa0;min, 95&#xa0;% CI:&#xa0;-11.88 to&#xa0;-1.89; p&#xa0;&lt;&#xa0;0.00001) and recovery time (WMD:&#xa0;-4.85&#xa0;min, 95&#xa0;% CI:&#xa0;-6.51 to&#xa0;-3.19; p&#xa0;&lt;&#xa0;0.00001) were shortened in the LMA group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LMA used in pediatric laparoscopic inguinal hernia repair demonstrated no greater safety risks than endotracheal tube intubation did. Thus, anesthesiologists may shift from conventional endotracheal tube use to LMA use. Moreover, anesthesia and recovery times were shortened in the LMA group, which resulted in more efficient use of the operating room. Because of these benefits, LMA could be an appropriate option for pediatric patients undergoing laparoscopic inguinal hernia repair.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Treatment Study, LEVEL III.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Cheng-Jui</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Po-Lung</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Medical Education, Taipei Medical University Hospital, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yan-Jiun</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University Hospital, Taipei City, Taiwan; Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Fu-Huan</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Division of Pediatric Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei City, Taiwan. Electronic address: 191009@h.tmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Surg</MedlineTA><NlmUniqueID>0052631</NlmUniqueID><ISSNLinking>0022-3468</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006552" MajorTopicYN="Y">Hernia, Inguinal</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="Y">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059685" MajorTopicYN="Y">Herniorrhaphy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endotracheal tube</Keyword><Keyword MajorTopicYN="N">Laparoscopic inguinal hernia repair</Keyword><Keyword MajorTopicYN="N">Laryngeal mask airway</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pediatric</Keyword><Keyword MajorTopicYN="N">Perioperative respiratory adverse event</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>3</Day><Hour>21</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38171956</ArticleId><ArticleId IdType="doi">10.1016/j.jpedsurg.2023.11.024</ArticleId><ArticleId IdType="pii">S0022-3468(23)00738-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36727868</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>136</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Effect of Tulobuterol Patch Versus Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>1067</StartPage><EndPage>1074</EndPage><MedlinePgn>1067-1074</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000006355</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of the transdermal &#x3b2;-2 agonist, tulobuterol, compared with that of placebo on the incidence of perioperative respiratory adverse events in pediatric patients undergoing tonsillectomy.</AbstractText><AbstractText Label="METHODS">In this triple-blinded (patient, anesthesia provider, and outcome assessor) randomized controlled trial, 188 patients were randomly allocated to receive tulobuterol or a placebo. The tulobuterol groups received a tulobuterol patch (1 mg) masked with a bandage, whereas the placebo only received the bandage. The assigned bandage was applied to the patients 8 to 10 hours before the surgery. The primary outcome was the occurrence of any perioperative respiratory adverse events: oxygen desaturation &lt;95%, airway obstruction, laryngospasm, bronchospasm, severe coughing, or stridor. The outcomes were evaluated using the average relative effect test, which estimates the effect of individual components of a composite outcome and then averages effects across components.</AbstractText><AbstractText Label="RESULTS">A total of 88 and 94 patients who received tulobuterol and placebo, respectively, were analyzed. The incidence of any perioperative respiratory adverse event was lower with tulobuterol (n = 13/88; 14.7%) than that with the placebo (n = 40/94; 42.5%), with an estimated average relative risk (95% confidence interval) across components of 0.35 (0.20-0.60; P &lt; .001). The symptoms of airway obstruction were lower with tulobuterol (n = 8/88; 9.0%) than that with the placebo (n = 32/94; 34.0%), with relative risk (95% CI) of 0.31 (0.17-0.56; P &lt; .001). The occurrence of severe coughing was lower with tulobuterol (n = 1/88; 1.1%) than that with the placebo (n = 8/94; 8.5%), with relative risk (95% CI) of 0.15 (0.03-0.68; P = .014).</AbstractText><AbstractText Label="CONCLUSIONS">In preschool children undergoing tonsillectomy, the preoperative application of a tulobuterol patch could decrease the occurrence of perioperative respiratory adverse events. Further studies are needed to elucidate the effect of the tulobuterol patch in a broad spectrum of pediatric anesthesia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 International Anesthesia Research Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eun-Hee</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin Kyoung</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yong-Hee</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Chung-Ang University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Pyoyoon</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jung-Bin</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Sang-Hwan</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Young-Eun</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ji-Hyun</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jin-Tae</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hee-Soo</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04057469</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>591I9SU0F7</RegistryNumber><NameOfSubstance UI="C010809">tulobuterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>N8ONU3L3PG</RegistryNumber><NameOfSubstance UI="D013726">Terbutaline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2023 Jun 1;136(6):1064-1066. doi: 10.1213/ANE.0000000000006368.</RefSource><PMID Version="1">37205802</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013726" MajorTopicYN="N">Terbutaline</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="Y">Airway Obstruction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>7</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36727868</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000006355</ArticleId><ArticleId IdType="pii">00000539-202306000-00010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Graaff JC, Sarfo MC, van Wolfswinkel L, van der Werff DB, Schouten AN. Anesthesia-related critical incidents in the perioperative period in children; a proposal for an anesthesia-related reporting system for critical incidents in children. Paediatr Anaesth. 2015;25:621&#x2013;629.</Citation></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Prediction of peri-operative adverse respiratory events in children: the role of exhaled nitric oxide. Anaesthesia. 2015;70:1160&#x2013;1164.</Citation></Reference><Reference><Citation>von Ungern-Sternberg BS, Ramgolam A, Hall GL, Sly PD, Habre W. Peri-operative adverse respiratory events in children. Anaesthesia. 2015;70:440&#x2013;444.</Citation></Reference><Reference><Citation>Schleelein LE, Vincent AM, Jawad AF, et al. Pediatric perioperative adverse events requiring rapid response: a retrospective case-control study. Paediatr Anaesth. 2016;26:734&#x2013;741.</Citation></Reference><Reference><Citation>Subramanyam R, Yeramaneni S, Hossain MM, Anneken AM, Varughese AM. Perioperative respiratory adverse events in pediatric ambulatory anesthesia: development and validation of a risk prediction tool. Anesth Analg. 2016;122:1578&#x2013;1585.</Citation></Reference><Reference><Citation>von Ungern-Sternberg BS, Sommerfield D, Slevin L, Drake-Brockman TFE, Zhang G, Hall GL. Effect of albuterol premedication vs placebo on the occurrence of respiratory adverse events in children undergoing tonsillectomies: the REACT randomized clinical trial. JAMA Pediatr. 2019;173:527&#x2013;533.</Citation></Reference><Reference><Citation>McGuire SR, Doyle NM. Update on the safety of anesthesia in young children presenting for adenotonsillectomy. World J Otorhinolaryngol Head Neck Surg. 2021;7:179&#x2013;185.</Citation></Reference><Reference><Citation>Sanders K, Osterbauer B, Forman N, et al. Perioperative respiratory adverse events in children undergoing triple endoscopy. Paediatr Anaesth. 2021;31:1290&#x2013;1297.</Citation></Reference><Reference><Citation>Quinn AC, Samaan A, McAteer EM, Moss E, Vucevic M. The reinforced laryngeal mask airway for dento-alveolar surgery. Br J Anaesth. 1996;77:185&#x2013;188.</Citation></Reference><Reference><Citation>Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg. 1996;82:129&#x2013;133.</Citation></Reference><Reference><Citation>Sanders JC, King MA, Mitchell RB, Kelly JP. Perioperative complications of adenotonsillectomy in children with obstructive sleep apnea syndrome. Anesth Analg. 2006;103:1115&#x2013;1121.</Citation></Reference><Reference><Citation>von Ungern-Sternberg BS, Davies K, Hegarty M, Erb TO, Habre W. The effect of deep vs. awake extubation on respiratory complications in high-risk children undergoing adenotonsillectomy: a randomised controlled trial. Eur J Anaesthesiol. 2013;30:529&#x2013;536.</Citation></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Inhalational versus intravenous induction of anesthesia in children with a high risk of perioperative respiratory adverse events: a randomized controlled trial. Anesthesiology. 2018;128:1065&#x2013;1074.</Citation></Reference><Reference><Citation>Drake-Brockman TF, Ramgolam A, Zhang G, Hall GL, von Ungern-Sternberg BS. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial. Lancet. 2017;389:701&#x2013;708.</Citation></Reference><Reference><Citation>Tait AR, Malviya S, Voepel-Lewis T, Munro HM, Seiwert M, Pandit UA. Risk factors for perioperative adverse respiratory events in children with upper respiratory tract infections. Anesthesiology. 2001;95:299&#x2013;306.</Citation></Reference><Reference><Citation>Dadure C, Sabourdin N, Veyckemans F, et al. Management of the child&#x2019;s airway under anaesthesia: the French guidelines. Anaesth Crit Care Pain Med. 2019;38:681&#x2013;693.</Citation></Reference><Reference><Citation>von Ungern-Sternberg BS, Habre W, Erb TO, Heaney M. Salbutamol premedication in children with a recent respiratory tract infection. Paediatr Anaesth. 2009;19:1064&#x2013;1069.</Citation></Reference><Reference><Citation>Huang HF, Chiu YC, Hunag CJ. Paediatric patients receiving salbutamol inhalation before general anaesthesia are associated with a reduced risk of perioperative adverse respiratory events. Anaesth Crit Care Pain Med. 2021;40:100730.</Citation></Reference><Reference><Citation>Tamura G, Ichinose M, Fukuchi Y, Miyamoto T. Transdermal tulobuterol patch, a long-acting&#x3b2;(2)-agonist. Allergol Int. 2012;61:219&#x2013;229.</Citation></Reference><Reference><Citation>Kim CK, Callaway Z, Choi J, et al.; KAPARD Work Group on Asthma Medication Compliance. Multicenter adherence study of asthma medication for children in Korea. Allergy Asthma Immunol Res. 2019;11:222&#x2013;230.</Citation></Reference><Reference><Citation>Lee DW, Kim ES, Do WS, Lee HB, Kim EJ, Kim CH. The effect of tulobuterol patches on the respiratory system after endotracheal intubation. J Dent Anesth Pain Med. 2017;17:265&#x2013;270.</Citation></Reference><Reference><Citation>Mascha EJ, Imrey PB. Factors affecting power of tests for multiple binary outcomes. Stat Med. 2010;29:2890&#x2013;2904.</Citation></Reference><Reference><Citation>Mascha EJ, Sessler DI. Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research. Anesth Analg. 2011;112:1461&#x2013;1471.</Citation></Reference><Reference><Citation>Ng SK, Lee DL, Li AM, Wing YK, Tong MC. Reproducibility of clinical grading of tonsillar size. Arch Otolaryngol Head Neck Surg. 2010;136:159&#x2013;162.</Citation></Reference><Reference><Citation>Ramgolam A, Hall GL, Sommerfield D, et al. Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children. Br J Anaesth. 2017;119:150&#x2013;157.</Citation></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083&#x2013;3107.</Citation></Reference><Reference><Citation>Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702&#x2013;706.</Citation></Reference><Reference><Citation>Fukuchi Y, Nagai A, Seyama K, et al.; Research Group TB. Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol. Treat Respir Med. 2005;4:447&#x2013;455.</Citation></Reference><Reference><Citation>Yamagata T, Hirano T, Sugiura H, et al. Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists. Pulm Pharmacol Ther. 2008;21:160&#x2013;165.</Citation></Reference><Reference><Citation>Ebihara S, Ebihara T, Arai H. Cough and transdermal long-acting beta2 agonist in Japan. Respir Med. 2008;102:1497.</Citation></Reference><Reference><Citation>Fu L, Guan J, Zhang Y, et al. Tulobuterol patch alleviates allergic asthmic inflammation by blockade of Syk and NF-&#x3ba;B activation in mice. Oncotarget. 2018;9:12154&#x2013;12163.</Citation></Reference><Reference><Citation>Elwood T, Morris W, Martin LD, et al. Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia. Can J Anaesth. 2003;50:277&#x2013;284.</Citation></Reference><Reference><Citation>Kobayashi Y, Yasuba H, Kudou M, Kita H. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler. J Asthma. 2007;44:77&#x2013;81.</Citation></Reference><Reference><Citation>Inoue H, Niimi A, Matsumoto H, et al. A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma. Clin Exp Pharmacol Physiol. 2017;44:21&#x2013;29.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37645006</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2228-7531</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Anesthesiology and pain medicine</Title><ISOAbbreviation>Anesth Pain Med</ISOAbbreviation></Journal><ArticleTitle>Effect of Laryngeal Mask Airway on Image Quality in Pediatric Patients Undergoing Brain Magnetic Resonance Imaging: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>e129532</StartPage><MedlinePgn>e129532</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e129532</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5812/aapm-129532</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Magnetic resonance imaging (MRI) is highly sensitive to motion, resulting in artifacts and lowering image quality. Laryngeal mask airway (LMA) provides numerous advantages over endotracheal tubes as it reduces laryngospasm, coughing, and the risk of postoperative desaturation.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">We aimed to compare LMA with oral airway for airway management during brain MRI in terms of reducing motion artifacts, which can improve image quality.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This randomized, controlled, double-blind trial was carried out on 40 pediatrics aged 1 - 18 years, American Society of Anesthesiologists (ASA) physical status &#x406; and &#x41f; undergoing brain MRI. Patients were randomized into two equal groups according to the airway method, the control (Guedel oral airway) group and the LMA group. A compatible anesthesia machine was used to provide O<sub>2</sub> and sevoflurane 2% - 4%.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The mean MRI image quality score was significantly higher in the LMA group than in the control group (26.10 &#xb1; 3.97 versus 18.60 &#xb1; 5.30, P &lt; 0.001). Mean arterial blood pressure and heart rate were significantly lower in the LMA group than in the control group at all study times except at baseline and immediate post-extubation (P &lt; 0.05). Cough was significantly lower in LMA than in the control group (15% vs. 50%, P = 0.040). Airway complications (sore throat, laryngeal spasm, and bronchospasm), nausea, and vomiting did not have a significantly different between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Compared to Guedel oral airway, using LMA for airway management in pediatrics undergoing MRI scans improved the image quality with less cough and better hemodynamics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wadod</LastName><ForeName>Mohamed A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-1952-5849</Identifier><AffiliationInfo><Affiliation>ICU and Pain Relief, National Cancer Institute, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboelazm</LastName><ForeName>Omnia Mohammed</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>National Cancer Institute, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Rawas</LastName><ForeName>Mai Mohammed</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>ICU and Pain Relief, National Cancer Institute, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Anesth Pain Med</MedlineTA><NlmUniqueID>101585412</NlmUniqueID><ISSNLinking>2228-7523</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway Management</Keyword><Keyword MajorTopicYN="N">Guedel Oral Airway</Keyword><Keyword MajorTopicYN="N">Image Quality</Keyword><Keyword MajorTopicYN="N">Laryngeal Mask Airway</Keyword><Keyword MajorTopicYN="N">Magnetic Resonance Imaging</Keyword></KeywordList><CoiStatement>Conflict of Interests: There is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>3</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37645006</ArticleId><ArticleId IdType="pmc">PMC10461386</ArticleId><ArticleId IdType="doi">10.5812/aapm-129532</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Artunduaga M, Liu CA, Morin CE, Serai SD, Udayasankar U, Greer MC, et al. Safety challenges related to the use of sedation and general anesthesia in pediatric patients undergoing magnetic resonance imaging examinations. Pediatr Radiol. 2021;51(5):724&#x2013;35. doi: 10.1007/s00247-021-05044-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-021-05044-5</ArticleId><ArticleId IdType="pmc">PMC8049862</ArticleId><ArticleId IdType="pubmed">33860861</ArticleId></ArticleIdList></Reference><Reference><Citation>McJury MJ. Acoustic Noise and Magnetic Resonance Imaging: A Narrative/Descriptive Review. J Magn Reson Imaging. 2022;55(2):337&#x2013;46. doi: 10.1002/jmri.27525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27525</ArticleId><ArticleId IdType="pubmed">33629790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ucisik-Keser FE, Chi TL, Hamid Y, Dinh A, Chang E, Ferson DZ. Impact of airway management strategies on magnetic resonance image quality. Br J Anaesth. 2016;117 Suppl 1:i97&#x2013;i102. doi: 10.1093/bja/aew210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aew210</ArticleId><ArticleId IdType="pubmed">27566792</ArticleId></ArticleIdList></Reference><Reference><Citation>Havsteen I, Ohlhues A, Madsen KH, Nybing JD, Christensen H, Christensen A. Are Movement Artifacts in Magnetic Resonance Imaging a Real Problem?-A Narrative Review. Front Neurol. 2017;8:232. doi: 10.3389/fneur.2017.00232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00232</ArticleId><ArticleId IdType="pmc">PMC5447676</ArticleId><ArticleId IdType="pubmed">28611728</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad R, Hu HH, Krishnamurthy R, Krishnamurthy R. Reducing sedation for pediatric body MRI using accelerated and abbreviated imaging protocols. Pediatr Radiol. 2018;48(1):37&#x2013;49. doi: 10.1007/s00247-017-3987-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-017-3987-6</ArticleId><ArticleId IdType="pubmed">29292482</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlachov Y, Ganatra RH. Sedation/anaesthesia in paediatric radiology. Br J Radiol. 2012;85(1019):e1018&#x2013;31. doi: 10.1259/bjr/28871143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr/28871143</ArticleId><ArticleId IdType="pmc">PMC3500799</ArticleId><ArticleId IdType="pubmed">22898157</ArticleId></ArticleIdList></Reference><Reference><Citation>Strametz R, Pachler C, Kramer JF, Byhahn C, Siebenhofer A, Weberschock T. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adult patients. Cochrane Database Syst Rev. 2014;2014(6):CD009901. doi: 10.1002/14651858.CD009901.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009901.pub2</ArticleId><ArticleId IdType="pmc">PMC6464046</ArticleId><ArticleId IdType="pubmed">24979320</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho ALR, Vital RB, de Lira CCS, Magro IB, Sato PTS, Lima LHN, et al. Laryngeal Mask Airway Versus Other Airway Devices for Anesthesia in Children With an Upper Respiratory Tract Infection: A Systematic Review and Meta-analysis of Respiratory Complications. Anesth Analg. 2018;127(4):941&#x2013;50. doi: 10.1213/ANE.0000000000003674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003674</ArticleId><ArticleId IdType="pubmed">30059398</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevescanin A, Vickov J, Elezovic Baloevic S, Pogorelic Z. Laryngeal Mask Airway Versus Tracheal Intubation for Laparoscopic Hernia Repair in Children: Analysis of Respiratory Complications. J Laparoendosc Adv Surg Tech A. 2020;30(1):76&#x2013;80. doi: 10.1089/lap.2019.0382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2019.0382</ArticleId><ArticleId IdType="pubmed">31613680</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Cao H, Tan X, Qiao L, Zhang Q, Shi L. Comparison of the Effect of Laryngeal Mask Airway Versus Endotracheal Tube on Airway Management in Pediatric Patients with Tonsillar Hypertrophy. J Perianesth Nurs. 2021;36(2):142&#x2013;6. doi: 10.1016/j.jopan.2020.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jopan.2020.06.020</ArticleId><ArticleId IdType="pubmed">33168406</ArticleId></ArticleIdList></Reference><Reference><Citation>Klucka J, Senkyrik J, Skotakova J, Stoudek R, Toukalkova M, Krikava I, et al. Laryngeal mask airway Unique position in paediatric patients undergoing magnetic resonance imaging (MRI): prospective observational study. BMC Anesthesiol. 2018;18(1):153. doi: 10.1186/s12871-018-0617-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-018-0617-2</ArticleId><ArticleId IdType="pmc">PMC6201529</ArticleId><ArticleId IdType="pubmed">30355285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JJ, Chuang YH, Wu CY. Feasibility and Safety of Using Supraglottic Airway Devices for Pediatric Patients Undergoing Magnetic Resonance Imaging: A Case Series of High-Risk Patients. Asian J Anesthesiol. 2021;59(3):96&#x2013;101. doi: 10.6859/aja.202109_59(3).0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.6859/aja.202109_59(3).0003</ArticleId><ArticleId IdType="pubmed">34266229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tith S, Lalwani K, Fu R. Complications of three deep sedation methods for magnetic resonance imaging. J Anaesthesiol Clin Pharmacol. 2012;28(2):178&#x2013;84. doi: 10.4103/0970-9185.94837.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0970-9185.94837</ArticleId><ArticleId IdType="pmc">PMC3339721</ArticleId><ArticleId IdType="pubmed">22557739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaballos M, Bastida E, Del Castillo T, De Villoria JG, Jimenez C. In vitro study of magnetic resonance imaging artefacts of six supraglottic airway devices. Anaesthesia. 2010;65(6):569&#x2013;72. doi: 10.1111/j.1365-2044.2010.06299.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2010.06299.x</ArticleId><ArticleId IdType="pubmed">20337623</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Nazir N, Khan RM, Ahmed SM. A prospective randomized control study comparing classic laryngeal mask airway with Guedel's airway for tracheal tube exchange and smooth extubation. Anesth Essays Res. 2016;10(3):552&#x2013;6. doi: 10.4103/0259-1162.186611.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.186611</ArticleId><ArticleId IdType="pmc">PMC5062217</ArticleId><ArticleId IdType="pubmed">27746550</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri A, Hajimohamadi F, Soltanghoraee H, Moin A. Complications of using laryngeal mask airway during anaesthesia in patients undergoing major ear surgery. Acta Otorhinolaryngol Ital. 2009;29(3):151&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815362</ArticleId><ArticleId IdType="pubmed">20140161</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31124887</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-4801</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of pediatric gastroenterology and nutrition</Title><ISOAbbreviation>J Pediatr Gastroenterol Nutr</ISOAbbreviation></Journal><ArticleTitle>Dexamethasone Reduces Postoperative Nausea in Pediatric Upper Endoscopy With Deep Sedation: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>281</StartPage><EndPage>286</EndPage><MedlinePgn>281-286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MPG.0000000000002398</ELocationID><Abstract><AbstractText Label="OBJECTIVES">We aimed to evaluate the effect of a single dose of preoperative dexamethasone on postoperative nausea and vomiting (PONV), a frequent complication and a major cause of delayed recovery in pediatric upper gastrointestinal endoscopy (UGIE) under sedation.</AbstractText><AbstractText Label="METHODS">In this double-blind randomized controlled study, 98 children aged 2 to 14, with American Society of Anesthesiologists status I to II, and undergoing elective UGIE with deep sedation were included and randomly assigned to 2 groups. Preoperatively, after anesthesia induction with sodium thiopental and maintenance with sevoflurane, patients in the intervention (n&#x200a;=&#x200a;49) and control (n&#x200a;=&#x200a;49) groups, respectively received 0.1&#x200a;mg/kg i.v. dexamethasone and 2&#x200a;cm i.v. 0.9% saline. Postoperatively, PONV incidence was measured as the primary outcome.</AbstractText><AbstractText Label="RESULTS">PONV incidence was significantly less in dexamethasone group (8.2%) compared to the control group (26.5%) (difference&#x200a;=&#x200a;18.3%, 95% confidence interval: 3.4%-33%, P&#x200a;=&#x200a;0.016). For secondary outcomes, between-group differences were not statistically significant: incidence of bronchospasm or laryngospasm (both 4.1%, P&#x200a;=&#x200a;1); emergence delirium assessed with Pediatric Anesthesia Emergence Delirium scale (5.9&#x200a;&#xb1;&#x200a;3.4 vs 5.7&#x200a;&#xb1;&#x200a;3.2, P&#x200a;=&#x200a;0.751); Modified Aldrete score at 0 minutes (9.4&#x200a;&#xb1;&#x200a;0.8 vs 9.3&#x200a;&#xb1;&#x200a;0.9, P&#x200a;=&#x200a;0.909) and at 5 minutes (9.5&#x200a;&#xb1;&#x200a;0.7 vs 9.4&#x200a;&#xb1;&#x200a;0.9, P&#x200a;=&#x200a;0.527); and recovery time (21.1&#x200a;&#xb1;&#x200a;6.6 vs 23.4&#x200a;&#xb1;&#x200a;8.6&#x200a;minutes, P&#x200a;=&#x200a;0.130).</AbstractText><AbstractText Label="CONCLUSIONS">A single preoperative dose of i.v. dexamethasone reduces PONV in children undergoing elective UGIE with deep sedation, but has no significant effect on the patient recovery time or the incidence of postoperative bronchospasm or laryngospasm and emergence delirium.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moheimani</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Students' Scientific Research Center, School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yaseri</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>IRCT</DataBankName><AccessionNumberList><AccessionNumber>IRCT20180929041173N1</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Gastroenterol Nutr</MedlineTA><NlmUniqueID>8211545</NlmUniqueID><ISSNLinking>0277-2116</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000932">Antiemetics</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2019 Sep;69(3):271-272. doi: 10.1097/MPG.0000000000002419.</RefSource><PMID Version="1">31211766</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):e52. doi: 10.1097/MPG.0000000000002561.</RefSource><PMID Version="1">31978037</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr Gastroenterol Nutr. 2020 Feb;70(2):e52-e53. doi: 10.1097/MPG.0000000000002560.</RefSource><PMID Version="1">31978038</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000932" MajorTopicYN="N">Antiemetics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054810" MajorTopicYN="Y">Deep Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005773" MajorTopicYN="Y">Gastroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020250" MajorTopicYN="N">Postoperative Nausea and Vomiting</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31124887</ArticleId><ArticleId IdType="doi">10.1097/MPG.0000000000002398</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40023371</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2201</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>The journal of allergy and clinical immunology. In practice</Title><ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation></Journal><ArticleTitle>Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).</ArticleTitle><Pagination><StartPage>1190</StartPage><EndPage>1200.e3</EndPage><MedlinePgn>1190-1200.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2025.02.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2198(25)00196-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Owing to limited treatment options for peanut allergy, patients remain at risk for allergic reactions due to accidental exposure. Epicutaneous immunotherapy (EPIT) is a novel treatment being investigated for peanut allergy.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study assessed long-term safety of EPIT with VIASKIN peanut patch 250 &#x3bc;g (VP250) via an open-label extension of the REAL Life Use and Safety of EPIT (REALISE) trial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">REALISE was a phase 3 trial in peanut-allergic children aged 4 through 11 years that included a 6-month, randomized, double-blind, placebo-controlled treatment phase, followed by an open-label, single-arm, active treatment period for up to 36 months.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 392 participants (male 54.8%; median age 7.2 y) who received at least 1 dose of treatment, 77.8% completed the 36-month active treatment. Mean adherence to treatment was high at 96.4%. Most participants (98.7%) experienced at least 1 treatment-emergent adverse event (TEAE); the majority were mild or moderate and decreased in frequency and severity over time. Most participants (94.6%) experienced at least 1 treatment-related TEAE. Local skin reactions were the most common treatment-related TEAE with the incidence decreasing from year 1 (87.8%) to year 3 (19.2%). Serious treatment-related TEAEs were reported in 2 participants. No specific safety signals were identified in the 14 participants enrolled with a history of severe anaphylaxis (Anaphylaxis Staging System grade 3).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Consistent with previous phase 3 studies, long-term EPIT with VIASKIN peanut patch 250 &#x3bc;g was well tolerated with high adherence in peanut-allergic children aged 4 through 11 years (clinicaltrials.gov; NCT: NCT02916446).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pongracic</LastName><ForeName>Jacqueline A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Allergy and Immunology, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: jpongracic@luriechildrens.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagnon</LastName><ForeName>R&#xe9;mi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Clinique Sp&#xe9;cialis&#xe9;e en Allergie de la Capitale, Quebec, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sussman</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gordon Sussman Clinical Research, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siri</LastName><ForeName>Dareen</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Midwest Allergy Sinus Asthma, Sneeze, Wheeze &amp; Itch Associates (SWIA), Clinical Research Center, Normal, Ill; Department of Otolaryngology, Head &amp; Neck Surgery, Southern Illinois University School of Medicine, Springfield, Ill.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oriel</LastName><ForeName>Roxanne C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital, Department of Pediatrics, Division of Allergy and Immunology, Elliot and Roslyn Jaffe Food Allergy Institute, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown-Whitehorn</LastName><ForeName>Terri F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anvari</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Immunology, Allergy and Retrovirology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>William E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Allergy and Asthma Solutions, Trabuco Canyon, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bird</LastName><ForeName>J Andrew</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Edmond S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, British Columbia Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinthrajah</LastName><ForeName>R Sharon</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Hey J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fineman</LastName><ForeName>Stanley M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emory University School of Medicine, Atlanta Allergy and Asthma, Atlanta, Ga.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischer</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital Colorado, University of Colorado Denver School of Medicine, Aurora, Colo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Reyes</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>South Texas Allergy and Asthma Medical Professionals, San Antonio, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Edwin H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Division of Pediatric Allergy and Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanser</LastName><ForeName>Bruce J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine, Denver and Aurora, Colo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacGinnitie</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Immunology, Medical College of Wisconsin, Milwaukee, Wis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Hemalini</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Allergy and Asthma Specialists, PA, Minneapolis, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petroni</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Seattle Allergy and Asthma Research Institute, Seattle, Wash; Clinical Development, BioCryst Pharmaceuticals, Inc., Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rupp</LastName><ForeName>Ned</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Allergy and Asthma Research, North Charleston, SC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Lynda C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Division of Immunology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scurlock</LastName><ForeName>Amy M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Arkansas for Medical Sciences, and Arkansas Children's Hospital, Little Rock, Ark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sher</LastName><ForeName>Lawrence D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Peninsula Research Associates, Rolling Hills Estates, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shreffler</LastName><ForeName>Wayne G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Food Allergy Center and Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sindher</LastName><ForeName>Sayantani B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Palo Alto, Calif.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology and Allergy, Westmead Children's Hospital, Westmead, NSW, Australia; Ottawa Allergy Research Corporation, Ottawa, Ont, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>Hugh A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, Kravis Children's Hospital, Department of Pediatrics, Division of Allergy and Immunology, Elliot and Roslyn Jaffe Food Allergy Institute, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bois</LastName><ForeName>Timoth&#xe9;e</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>DBV Technologies SA, Montrouge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Todd D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Division of Allergy and Immunology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pa; DBV Technologies SA, Montrouge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Dianne E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>DBV Technologies SA, Montrouge, France; Department of Clinical Immunology and Allergy, Westmead Children's Hospital, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bee</LastName><ForeName>Katharine J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>DBV Technologies SA, Montrouge, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe9;gin</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Section of Allergy, Immunology and Rheumatology, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02916446</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D017428">Clinical Trial, Phase III</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol Pract</MedlineTA><NlmUniqueID>101597220</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000485">Allergens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021183" MajorTopicYN="Y">Peanut Hypersensitivity</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003888" MajorTopicYN="Y">Desensitization, Immunologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000485" MajorTopicYN="Y">Allergens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010367" MajorTopicYN="N">Arachis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000279" MajorTopicYN="N">Administration, Cutaneous</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Desensitization</Keyword><Keyword MajorTopicYN="N">Epicutaneous immunotherapy</Keyword><Keyword MajorTopicYN="N">Food allergy</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Long-term safety</Keyword><Keyword MajorTopicYN="N">Peanut allergy</Keyword><Keyword MajorTopicYN="N">Real-world setting, Children</Keyword><Keyword MajorTopicYN="N">VIASKIN</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>9</Day><Hour>12</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>3</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>1</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40023371</ArticleId><ArticleId IdType="doi">10.1016/j.jaip.2025.02.024</ArticleId><ArticleId IdType="pii">S2213-2198(25)00196-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40158183</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>The selection of ventilation devices in children with mild or moderate upper respiratory tract infections: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>112</StartPage><MedlinePgn>112</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">112</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-025-08815-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Administering anaesthesia to children with upper respiratory tract infections (URTIs) increases the risk of perioperative respiratory adverse events (PRAEs). Several observational studies have suggested that the supraglottic airway (SGA) technique could be a potential alternative for airway management in children. This randomised controlled trial assesses whether using a SGA instead of an endotracheal tube (ETT) in children with mild or moderate URTIs affects the incidence of PRAEs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 78 paediatric patients with mild or moderate URTIs who received either a SGA or ETT were included. Patients were monitored for adverse events such as cough, laryngospasm, bronchospasm, breath-holding, postoperative stridor or desaturation (&lt;&#x2009;90%) during the following stages: induction of anaesthesia, tube placement, surgery, tube removal and postanaesthesia care.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Throughout the perioperative period, 56.4% (44/78) of children experienced PRAEs. The incidence was 77.5% (31/40) in those receiving ETT and 34.1% (13/38) in those receiving SGA. The relative risk (RR) of PRAEs in children receiving SGA was 0.417 (95% CI: 0.248-0.701) compared with those receiving ETT (p&#x2009;&lt;&#x2009;0.001). Specifically, the incidence of minor PRAEs was significantly lower in the SGA group (28.9%, 11/38) compared with the ETT group (67.5%, 27/40) (RR: 0.429, 95% CI: 0.249-0.738, p&#x2009;&lt;&#x2009;0.001). There were significant differences between the groups in the incidence of perioperative cough (p&#x2009;=&#x2009;0.043) and desaturation (p&#x2009;=&#x2009;0.031).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Using a SGA reduced the incidence of coughing, bronchospasm and oxygen desaturation, providing an acceptable alternative to ETT in children with mild or moderate URTIs.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hebei Children's Hospital, NO.166 jianhuanan street, Shijiazhuang, Hebei, 050000, China. shij10208jing@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hebei Children's Hospital, NO.166 jianhuanan street, Shijiazhuang, Hebei, 050000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenjing</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hebei Children's Hospital, NO.166 jianhuanan street, Shijiazhuang, Hebei, 050000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Wenjuan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Hebei Children's Hospital, NO.166 jianhuanan street, Shijiazhuang, Hebei, 050000, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20211805 and 20211524</GrantID><Agency>Medical science research project of Hebei Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="Y">Respiration, Artificial</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway management</Keyword><Keyword MajorTopicYN="N">Paediatric anaesthesia</Keyword><Keyword MajorTopicYN="N">Postanaesthesia care unit</Keyword><Keyword MajorTopicYN="N">Respiratory adverse events</Keyword><Keyword MajorTopicYN="N">Upper respiratory tract infection</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study was conducted in accordance with the declaration of Helsinki.This study was conducted with approval from the Ethics Committee of Hebei Children&#x2019;s Hospital (No.165).Written informed consent was obtained from all parents/guardians. Consent for publication: The manuscript is not submitted for publication or consideration elsewhere. Competing interests: The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>30</Day><Hour>23</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>30</Day><Hour>23</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>29</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40158183</ArticleId><ArticleId IdType="pmc">PMC11954290</ArticleId><ArticleId IdType="doi">10.1186/s13063-025-08815-9</ArticleId><ArticleId IdType="pii">10.1186/s13063-025-08815-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim HS, Kim YS, Lim BG, Lee JH, Song J, Kim H. Risk assessment of perioperative respiratory adverse events and validation of the COLDS score in children with upper respiratory tract infection. Medicina (Kaunas). 2022;58(10): 1340. 10.3390/medicina58101340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9611335</ArticleId><ArticleId IdType="pubmed">36295501</ArticleId></ArticleIdList></Reference><Reference><Citation>Parnis SJ, Barker DS, Van Der Walt JH. Clinical predictors of anaesthetic complications in children with respiratory tract infections. Paediatr Anaesth. 2001;11(1):29&#x2013;40. 10.1046/j.1460-9592.2001.00607.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">11123728</ArticleId></ArticleIdList></Reference><Reference><Citation>Regli A, Becke K, von Ungern-Sternberg BS. An update on the perioperative management of children with upper respiratory tract infections. Curr Opin Anaesthesiol. 2017;30(3):362&#x2013;7. 10.1097/ACO.0000000000000460.</Citation><ArticleIdList><ArticleId IdType="pubmed">28291127</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejada-Perdomo JH, Melo-Moreno CE, Tovar-Cardozo JH, Ramos-Castaneda JA. Supraglottic airway devices for blind endotracheal intubation: a systematic review. PLoS ONE. 2024;19(12): e0315301. 10.1371/journal.pone.0315301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11634001</ArticleId><ArticleId IdType="pubmed">39661586</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagannathan N, Pandit JJ. A deeper dive into the world of airway management: a new era for anaesthesia &amp; analgesia. Anesth Analg. 2025;140(2):239&#x2013;41. 10.1213/ANE.0000000000007329.</Citation><ArticleIdList><ArticleId IdType="pubmed">39804588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Medical Association. Clinical diagnosis and treatment guidelines &#xb7; pediatric internal medicine volume [M]. Beijing: People 's Health Sheng Publishing House. 2005:12.</Citation></Reference><Reference><Citation>Liu X, Tan X, Zhang Q, Qiao L, Shi L. A randomised crossover comparison of airway sealing with the laryngeal mask airway Ambu AuraFlex at three intracuff pressures in pediatric laparoscopic surgery. Am J Perinatol. 2021;38(3):231&#x2013;6. 10.1055/s-0039-1696643.</Citation><ArticleIdList><ArticleId IdType="pubmed">31529447</ArticleId></ArticleIdList></Reference><Reference><Citation>Becke K. anaesthesia in children with a cold. Curr Opin Anaesthesiol. 2012;25(3):333&#x2013;9. 10.1097/ACO.0b013e3283534e80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22499163</ArticleId></ArticleIdList></Reference><Reference><Citation>Luce V, Harkouk H, Brasher C, Michelet D, Hilly J, Maesani M, Diallo T, Mangalsuren N, Nivoche Y, Dahmani S. Supraglottic airway devices vs tracheal intubation in children: a quantitative meta-analysis of respiratory complications. Paediatr Anaesth. 2014;24(10):1088&#x2013;98. 10.1111/pan.12495.</Citation><ArticleIdList><ArticleId IdType="pubmed">25074619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Ding S, Cai M, Bai J, Zhang M, Huang Y, Zheng J. Impact of upper respiratory tract infections on perioperative outcomes of children undergoing therapeutic cardiac catheterisation. Acta Anaesthesiol Scand. 2018;62(7):915&#x2013;23. 10.1111/aas.13113.</Citation><ArticleIdList><ArticleId IdType="pubmed">29569250</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel F, Vacher T, Julien-Marsollier F, Dadure C, Aubineau JV, Lejus C, Sabourdin N, Woodey E, Orliaguet G, Brasher C, Dahmani S. Peri-operative respiratory adverse events in children with upper respiratory tract infections allowed to proceed with anaesthesia: a French national cohort study. Eur J Anaesthesiol. 2018;35(12):919&#x2013;28. 10.1097/EJA.0000000000000875.</Citation><ArticleIdList><ArticleId IdType="pubmed">30124501</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Pandit UA, Voepel-Lewis T, Munro HM, Malviya S. Use of the laryngeal mask airway in children with upper respiratory tract infections: a comparison with endotracheal intubation. Anesth Analg. 1998;86:706&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9539588</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake-Brockman TF, Ramgolam A, Zhang G, Hall GL, von Ungern-Sternberg BS. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial. Lancet. 2017;389:701&#x2013;8. 10.1016/S0140-6736(16)31719-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28108038</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, Rebmann C, Johnson C, Sly PD, Habre W. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet. 2010;376:773&#x2013;83. 10.1016/S0140-6736(10)61193-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Cao HY, Tan XN, et al. Comparison of the effect of laryngeal mask airway versus endotracheal tube on airway management in pediatric patients with tonsillar hypertrophy. J Peri Anesth Nurs. 2021;36(2):142&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33168406</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu PY, Chang YT, Yang ST, Wu CS, Cheng KI, Su MP. Comparison of supraglottic airway device and endotracheal tube in former preterm infants receiving general anesthesia: a randomised controlled trial. Sci Rep. 2024;14(1):19579. 10.1038/s41598-024-69950-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11343740</ArticleId><ArticleId IdType="pubmed">39179661</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JR, Lee JH, Lee HM, Kim N, Kim MH. Independent risk factors for adverse events associated with propofol-based pediatric sedation performed by anesthesiologists in the radiology suite: a prospective observational study. Eur J Pediatr. 2021;180(5):1413&#x2013;22. 10.1007/s00431-020-03916-w.</Citation><ArticleIdList><ArticleId IdType="pubmed">33386997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Inhalational versus intravenous induction of anaesthesia in children with a high risk of perioperative respiratory adverse events: a randomised controlled trial. Anesthesiology. 2018;128(6):1065&#x2013;74. 10.1097/ALN.0000000000002152.</Citation><ArticleIdList><ArticleId IdType="pubmed">29498948</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Schwab C, Sims C, Johnson C, Habre W. Laryngeal mask airway is associated with an increased incidence of adverse respiratory events in children with recent upper respiratory tract infections. Anesthesiology. 2007;107(5):714&#x2013;9. 10.1097/01.anes.0000286925.25272.b5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18073545</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaaban AR, Kamal SM. Comparison between betamethasone gel applied over endotracheal tube and ketamine gargle for attenuating postoperative sore throat, cough and hoarseness of voice. Middle East J Anaesthesiol. 2012;21(4):513&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23327023</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37469048</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0030-9982</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>JPMA. The Journal of the Pakistan Medical Association</Title><ISOAbbreviation>J Pak Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Impact Of Incentive-Based Game Therapy And Transporting Children On Toy Vehicle To Operation Theatre On Reducing Anxiety Prior To Induction Of Anesthesia.</ArticleTitle><Pagination><StartPage>1388</StartPage><EndPage>1392</EndPage><MedlinePgn>1388-1392</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.47391/JPMA.6630</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To see if transporting paediatric patents to operation theatres using a battery operated vehicle decreases preoperative anxiety and reduce incidents of postoperative adverse events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study was conducted from May to August 2019 at the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, and comprised paediatric patients aged 3-5 years assessed as American Society of Anaesthesiologists grade I and II who were scheduled to undergo elective intrathecal chemotherapy under general anaesthesia. The subjects were randomised into intervention group A and control group B. Patients in group A were part of an incentive-based game in the holding bay area and were transported to the operation theatre using a battery-operated toy vehicle. Those in group B watched a pre-decided cartoon on television screen in the holding bay and were transported further using wheel chair. Induction of anaesthesia was done in the presence of guardians in both the groups. Patient anxiety was assessed using the modified Yale Preoperative Anxiety Scale in holding bay area T0, prior to induction of anaesthesia T1, and postoperative anaesthesia-related recovery T2. Data was analysed using SPSS 22.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 36 patients, 18(50%) were in group A; 12(66.6%) boys and 6(33.3%) girls with mean age 4.01&#xb1;0.48 years. The remaining 18(50%) subjects were in group B; 13(72.2%) boys and 5(27.8%) girls with mean age 3.96 years. The difference in anxiety between the groups at T0 was non-significant (p=0.73). At T1 and T2, the scores were significantly lower group A compared to group B (p&lt;0.05). Group A patients had better bag mask ventilation compliance at induction and remarkably less incidence of hypoxia, bronchospasm, postoperative agitation and early discharge from PACU.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Incentive-based game therapy decreased anxiety among paediatric patients preoperatively, made them more compliant and improved postoperative recovery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akhtar</LastName><ForeName>Ahmed Bilal</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najeeb</LastName><ForeName>Hammad Nabeel</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehman Ghafoor</LastName><ForeName>Ateeq Ur</ForeName><Initials>AU</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Pak Med Assoc</MedlineTA><NlmUniqueID>7501162</NlmUniqueID><ISSNLinking>0030-9982</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="Y">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="Y">Anxiety</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthesia, Anxiety, Children, Game therapy, Induction.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>0</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37469048</ArticleId><ArticleId IdType="doi">10.47391/JPMA.6630</ArticleId><ArticleId IdType="pii">6630</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17362249</PMID><DateCompleted><Year>2007</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0105-4538</ISSN><JournalIssue CitedMedium="Print"><Volume>62</Volume><Issue>4</Issue><PubDate><Year>2007</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Allergy</Title><ISOAbbreviation>Allergy</ISOAbbreviation></Journal><ArticleTitle>Rhinoconjunctivitis in 5-year-old children: a population-based birth cohort study.</ArticleTitle><Pagination><StartPage>385</StartPage><EndPage>393</EndPage><MedlinePgn>385-93</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is a paucity of data on the prevalence, risk factors and natural history of rhinitis in early childhood.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Within the context of a whole-population birth cohort we investigated the prevalence of and risk factors for current rhinoconjunctivitis (CRC) at age 5 years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Children were followed prospectively to age 5 years [questionnaires (n = 815), skin testing (n = 717), specific immunoglobulin E (n = 478), lung function (n = 711), dry air challenge (n = 556)]. Endotoxin and allergen exposures were measured in dust samples.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of rhinitis ever, current rhinitis and rhinoconjunctivitis was 28.2%, 26.1%, and 12.1%, respectively. Asthma, wheeze and eczema coexisted with CRC (P &lt; or = 0.01). In a multivariate model, maternal asthma (OR 2.38, 95% CI: 1.30-4.38, P = 0.005), paternal hay fever (1.96, 1.11-3.46, P = 0.02) and sensitization to grass (3.46, 1.86-6.42, P &lt; 0.001) and cat (2.42, 1.14-5.18, P = 0.02) remained significant and independent associates of CRC. Whilst almost half of children with CRC were nonatopic, there was little difference in risk factors between atopic and nonatopic CRC. Amongst children with current wheeze, the presence of concurrent CRC had no effect on either severity or frequency of wheezy episodes. There was no difference in specific airway resistance, forced expiratory volume in 1 second (FEV(1)) or airway reactivity between children with and without CRC after adjustment for the presence of wheeze.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Family history of allergic disease and sensitization to inhalant allergens are risk factors for rhinoconjunctivitis in preschool children. In this age group, there is no association between the presence of rhinoconjunctivitis and severity of wheeze, increased airway reactivity and reduced lung function.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Manchester, Academic Division of Medicine and Surgery, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kissen</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Custovic</LastName><ForeName>A</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Allergy</MedlineTA><NlmUniqueID>7804028</NlmUniqueID><ISSNLinking>0105-4538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000485">Allergens</NameOfSubstance></Chemical><Chemical><RegistryNumber>37341-29-0</RegistryNumber><NameOfSubstance UI="D007073">Immunoglobulin E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Allergy. 2007 Apr;62(4):344-7. doi: 10.1111/j.1398-9995.2007.01349.x.</RefSource><PMID Version="1">17362243</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000485" MajorTopicYN="N">Allergens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001985" MajorTopicYN="N">Bronchial Provocation Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003231" MajorTopicYN="N">Conjunctivitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004485" MajorTopicYN="N">Eczema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007073" MajorTopicYN="N">Immunoglobulin E</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012129" MajorTopicYN="N">Respiratory Function Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012220" MajorTopicYN="N">Rhinitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012882" MajorTopicYN="N">Skin Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>3</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>5</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>3</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17362249</ArticleId><ArticleId IdType="doi">10.1111/j.1398-9995.2006.01294.x</ArticleId><ArticleId IdType="pii">ALL1294</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26198283</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2016</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-4995</ISSN><JournalIssue CitedMedium="Internet"><Volume>126</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Laryngoscope</Title><ISOAbbreviation>Laryngoscope</ISOAbbreviation></Journal><ArticleTitle>Effects of different bronchoalveolar lavage methods on tracheobronchial foreign body patients.</ArticleTitle><Pagination><StartPage>1000</StartPage><EndPage>1005</EndPage><MedlinePgn>1000-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lary.25484</ELocationID><Abstract><AbstractText Label="OBJECTIVES/HYPOTHESIS" NlmCategory="OBJECTIVE">To compare the different effects of bronchoalveolar lavage (BAL) with diverse combinations of lidocaine, epinephrine, and dexamethasone on pediatric patients with an inhaled tracheobronchial foreign body (TFB).</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Randomized controlled study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two hundred forty cases of pediatric patients with inhaled TFB were included in this study, and were randomly divided into four groups using three kinds of drugs for BAL, namely 0.9% saline (S) group, 2% lidocaine with diluted epinephrine (LE) group, 2% lidocaine with diluted epinephrine and 0.5% dexamethasone (LED), control group (C) without BAL. The incidences of intraoperative or postoperative complications and recovery periods were compared. Meanwhile, the concentrations of interleukin (IL)-1&#x3b2;, IL-6, and tumor necrosis factor (TNF)-&#x3b1; in BAL fluids and plasma were evaluated by enzyme-linked immunosorbent assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidences of bronchospasm, hypoxemia, and postoperative fever were significantly lower in the LED group than other groups (P&#x2009;&lt;&#x2009;.001). Fever after the TFB removal procedure appeared later in the LED group than the other groups. The improvement and healing periods in the LE and LED groups were significantly shorter than those in the C and S groups (P&#x2009;&lt;&#x2009;.001). The concentrations of IL-1&#x3b2;, IL-6, and TNF-&#x3b1; in BAL fluids were significantly higher in the LE and LED groups than those in the S group (P&#x2009;&lt;&#x2009;.001), but those in the plasma of the C and S groups were lower compared with the LE and LED groups (P&#x2009;&lt;&#x2009;.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">BAL with lidocaine, epinephrine, and dexamethasone could promote recovery for TFB patients and reduce incidences of complications, possibly by regulating release of proinflammatory cytokines.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">1b.</AbstractText><CopyrightInformation>&#xa9; 2015 The American Laryngological, Rhinological and Otological Society, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Hua-Nan</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, The Second Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Si-Jing</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, The Second Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Hai-Li</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, The Second Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zheng-Hui</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, The Second Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Xiao-Yong</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, The Second Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Laryngoscope</MedlineTA><NlmUniqueID>8607378</NlmUniqueID><ISSNLinking>0023-852X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YKH834O4BH</RegistryNumber><NameOfSubstance UI="D004837">Epinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018893" MajorTopicYN="N">Bronchoalveolar Lavage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004837" MajorTopicYN="N">Epinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005547" MajorTopicYN="N">Foreign Bodies</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="N">Lidocaine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Tracheobronchial foreign body</Keyword><Keyword MajorTopicYN="N">bronchoalveolar lavage</Keyword><Keyword MajorTopicYN="N">dexamethasone</Keyword><Keyword MajorTopicYN="N">epinephrine</Keyword><Keyword MajorTopicYN="N">lidocaine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26198283</ArticleId><ArticleId IdType="doi">10.1002/lary.25484</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35301198</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2052-4439</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>BMJ open respiratory research</Title><ISOAbbreviation>BMJ Open Respir Res</ISOAbbreviation></Journal><ArticleTitle>Treatment patterns and frequency of key outcomes in acute severe asthma in children: a Paediatric Research in Emergency Departments International Collaborative (PREDICT) multicentre cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001137</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjresp-2021-001137</ELocationID><Abstract><AbstractText Label="RATIONALE">Severe acute paediatric asthma may require treatment escalation beyond systemic corticosteroids, inhaled bronchodilators and low-flow oxygen. Current large asthma datasets report parenteral therapy only.</AbstractText><AbstractText Label="OBJECTIVES">To identify the use and type of escalation of treatment in children presenting to hospital with acute severe asthma.</AbstractText><AbstractText Label="METHODS">Retrospective cohort study of children with an emergency department diagnosis of asthma or wheeze at 18 Australian and New Zealand hospitals. The main outcomes were use and type of escalation treatment (defined as any of intensive care unit admission, nebulised magnesium, respiratory support or parenteral bronchodilator treatment) and hospital length of stay (LOS).</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Of 14 029 children (median age 3 (IQR 1-3) years; 62.9% male), 1020 (7.3%, 95% CI 6.9% to 7.7%) had treatment escalation. Children with treatment escalation had a longer LOS (44.2 hours, IQR 27.3-63.2 hours) than children without escalation 6.7 hours, IQR 3.5-16.3 hours; p&lt;0.001). The most common treatment escalations were respiratory support alone (400; 2.9%, 95% CI 2.6% to 3.1%), parenteral bronchodilator treatment alone (380; 2.7%, 95% CI 2.5% to 3.0%) and both respiratory support and parenteral bronchodilator treatment (209; 1.5%, 95% CI 1.3% to 1.7%). Respiratory support was predominantly nasal high-flow therapy (99.0%). The most common intravenous medication regimens were: magnesium alone (50.4%), magnesium and aminophylline (24.6%) and magnesium and salbutamol (10.0%).</AbstractText><AbstractText Label="CONCLUSIONS">Overall, 7.3% children with acute severe asthma received some form of escalated treatment, with 4.2% receiving parenteral bronchodilators and 4.3% respiratory support. There is wide variation treatment escalation.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Craig</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2594-1643</Identifier><AffiliationInfo><Affiliation>Paediatric Emergency Department, Monash Medical Centre, Monash Emergency Research Collaborative, Monash Health, Clayton, Victoria, Australia simon.craig@monash.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Colin V E</ForeName><Initials>CVE</Initials><AffiliationInfo><Affiliation>Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Sidra Medicine, Ad-Dawhah, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nixon</LastName><ForeName>Gillian M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Melbourne Children's Sleep Centre, Monash Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oakley</LastName><ForeName>Ed</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Emergency Department, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Research, Clinical Sciences, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Paediatrics and Critical Care, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hort</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Department, Children's Hospital at Westmead, Westmead, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Sydney Sydney Medical School, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>David S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-5933-705X</Identifier><AffiliationInfo><Affiliation>Respiratory and Sleep Medicine, Monash Children's Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranganathan</LastName><ForeName>Sarath</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Respiratory Medicine, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Murdoch Childrens Research Institute, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kochar</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency Department, Women's and Children's Hospital Adelaide, North Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Research, Clinical Sciences, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>Shane</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8880-1245</Identifier><AffiliationInfo><Affiliation>School of Medicine and Dentistry, Griffith University, Southport, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Medicine and Children's Critical Care Service, Gold Coast University Hospital, Southport, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Child Health Research Centre, Faculty of Medicine, University of Queensland, South Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-7616-5712</Identifier><AffiliationInfo><Affiliation>Child Health Research Centre, Faculty of Medicine, University of Queensland, South Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, Queensland Children's Hospital, South Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furyk</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Department, Townsville Hospital and Health Service, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, University Hospital Geelong, Geelong, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawton</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Emergency Department, Queensland Children's Hospital, South Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, Logan Hospital, Loganholme, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borland</LastName><ForeName>Meredith L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Emergency Department, Perth Children's Hospital, Nedlands, Western Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Divisions of Emergency Medicine and Paediatrics, School of Medicine, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, Perth Children's Hospital, Nedlands, Western Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, Curtin University Faculty of Health Sciences, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neutze</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kidz First Emergency Department, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lithgow</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Royal Darwin Hospital, Tiwi, Northern Territory of Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Department, Royal Darwin Hospital, Tiwi, Northern Territory of Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watkins</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Emergency Department, Royal Hobart Hospital, Hobart, Tasmania, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brannigan</LastName><ForeName>Domhnall</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emergency Department, Royal Hobart Hospital, Hobart, Tasmania, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Department, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Charmaine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Department, Flinders Medical Centre, Bedford Park, South Australia, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hearps</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Murdoch Childrens Research Institute, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramage</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Paediatric Emergency Department, Monash Medical Centre, Monash Emergency Research Collaborative, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Intensive Care, Monash Children's Hospital, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency Research, Clinical Sciences, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lew</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Department, Canberra Hospital, Canberra, Australian Capital Territory, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Leonie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Emergency Department, Townsville Hospital and Health Service, Townsville, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graudins</LastName><ForeName>Andis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency Department, Dandenong Hospital, Monash Emergency Research Collaborative, Monash Health, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalziel</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Emergency Department, Starship Children's Health, Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Surgery and Paediatrics, The University of Auckland Faculty of Medical and Health Sciences, Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babl</LastName><ForeName>Franz E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Emergency Department, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Research, Clinical Sciences, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Paediatrics and Critical Care, University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open Respir Res</MedlineTA><NlmUniqueID>101638061</NlmUniqueID><ISSNLinking>2052-4439</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">paediatric asthma</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>18</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35301198</ArticleId><ArticleId IdType="pmc">PMC8932260</ArticleId><ArticleId IdType="doi">10.1136/bmjresp-2021-001137</ArticleId><ArticleId IdType="pii">9/1/e001137</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acworth J, Babl F, Borland M, et al. . Patterns of presentation to the Australian and New Zealand paediatric emergency research network. Emerg Med Australas 2009;21:59&#x2013;66. 10.1111/j.1742-6723.2009.01154.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-6723.2009.01154.x</ArticleId><ArticleId IdType="pubmed">19254314</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss AJ, Wier LM, Stocks C. Overview of Emergency Department Visits in the United States, 2011: Statistical Brief #174. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality (US), 2006.</Citation><ArticleIdList><ArticleId IdType="pubmed">25144109</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath JB, Hsia RY. Children's emergency department use for asthma, 2001-2010. Acad Pediatr 2015;15:225&#x2013;30. 10.1016/j.acap.2014.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acap.2014.10.011</ArticleId><ArticleId IdType="pmc">PMC4355310</ArticleId><ArticleId IdType="pubmed">25596899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantor DB, Phipatanakul W. Intravenous &#x3b2; agonists and severe pediatric asthma exacerbation: time for a closer look at terbutaline? Ann Allergy Asthma Immunol 2014;112:187. 10.1016/j.anai.2014.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2014.01.005</ArticleId><ArticleId IdType="pubmed">24565592</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor MG, Saville BR, Hartert TV, et al. . Treatment variability of asthma exacerbations in a pediatric emergency department using a severity-based management protocol. Clin Pediatr 2014;53:1288&#x2013;90. 10.1177/0009922813520071</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0009922813520071</ArticleId><ArticleId IdType="pmc">PMC4251715</ArticleId><ArticleId IdType="pubmed">24463950</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris I, Lyttle MD, O'Sullivan R, et al. . Which intravenous bronchodilators are being administered to children presenting with acute severe wheeze in the UK and Ireland? Thorax 2015;70:88&#x2013;91. 10.1136/thoraxjnl-2014-206041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2014-206041</ArticleId><ArticleId IdType="pubmed">25303945</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyttle MD, O'Sullivan R, Doull I, et al. . Variation in treatment of acute childhood wheeze in emergency departments of the United Kingdom and Ireland: an international survey of clinician practice. Arch Dis Child 2015;100:121&#x2013;5. 10.1136/archdischild-2014-306591</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2014-306591</ArticleId><ArticleId IdType="pubmed">25157178</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartshorn S, O'Sullivan R, Maconochie IK, et al. . Establishing the research priorities of paediatric emergency medicine clinicians in the UK and Ireland. Emerg Med J 2015;32:864&#x2013;8. 10.1136/emermed-2014-204484</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2014-204484</ArticleId><ArticleId IdType="pubmed">25678575</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane HC, Wilson CL, Babl FE, et al. . PREDICT prioritisation study: establishing the research priorities of paediatric emergency medicine physicians in Australia and New Zealand. Emerg Med J 2018;35:39&#x2013;45. 10.1136/emermed-2017-206727</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2017-206727</ArticleId><ArticleId IdType="pubmed">28855237</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller SZ, Rinc&#xf3;n H, Kuppermann N, et al. . Revisiting the emergency medicine services for children research agenda: priorities for multicenter research in pediatric emergency care. Acad Emerg Med 2008;15:377&#x2013;83. 10.1111/j.1553-2712.2008.00072.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1553-2712.2008.00072.x</ArticleId><ArticleId IdType="pubmed">18370994</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MD, Zorc JJ, Nelson DS, et al. . Intravenous magnesium in asthma pharmacotherapy: variability in use in the PECARN registry. J Pediatr 2020;220:165&#x2013;74. 10.1016/j.jpeds.2020.01.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2020.01.062</ArticleId><ArticleId IdType="pubmed">32147221</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths B, Kew KM. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. Cochrane Database Syst Rev 2016;4:CD011050. 10.1002/14651858.CD011050.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011050.pub2</ArticleId><ArticleId IdType="pmc">PMC6599814</ArticleId><ArticleId IdType="pubmed">27126744</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteverde-Fernandez N, Diaz-Rubio F, V&#xe1;squez-Hoyos P, et al. . Variability in care for children with severe acute asthma in Latin America. Pediatr Pulmonol 2021;56:384&#x2013;91. 10.1002/ppul.25212</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25212</ArticleId><ArticleId IdType="pubmed">33333632</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig S, Babl FE, Dalziel SR, et al. . Acute severe paediatric asthma: study protocol for the development of a core outcome set, a pediatric emergency Reserarch networks (PERN) study. Trials 2020;21:72. 10.1186/s13063-019-3785-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-019-3785-6</ArticleId><ArticleId IdType="pmc">PMC6956506</ArticleId><ArticleId IdType="pubmed">31931862</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig SS, Dalziel SR, Powell CV, et al. . Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane reviews. Cochrane Database Syst Rev 2020;8:Cd012977. 10.1002/14651858.CD012977.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD012977.pub2</ArticleId><ArticleId IdType="pmc">PMC8078579</ArticleId><ArticleId IdType="pubmed">32767571</ArticleId></ArticleIdList></Reference><Reference><Citation>Babl F, Borland M, Ngo P, et al. . Paediatric research in emergency departments international collaborative (predict): first steps towards the development of an Australian and New Zealand research network. Emerg Med Australas 2006;18:143&#x2013;7. 10.1111/j.1742-6723.2006.00823.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-6723.2006.00823.x</ArticleId><ArticleId IdType="pubmed">16669940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hew M, Lee J, Susanto NH, et al. . The 2016 Melbourne thunderstorm asthma epidemic: risk factors for severe attacks requiring hospital admission. Allergy 2019;74:122&#x2013;30. 10.1111/all.13609</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13609</ArticleId><ArticleId IdType="pubmed">30243030</ArticleId></ArticleIdList></Reference><Reference><Citation>Anon . The Australasian triage scale. Emerg Med Australas 2002;14:335&#x2013;6. 10.1046/j.1442-2026.2002.00371.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1442-2026.2002.00371.x</ArticleId><ArticleId IdType="pubmed">12549430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji AH, Schriger D, Green S. Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies. Ann Emerg Med 2014;64:292&#x2013;8. 10.1016/j.annemergmed.2014.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2014.03.025</ArticleId><ArticleId IdType="pubmed">24746846</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al. . The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573&#x2013;7. 10.7326/0003-4819-147-8-200710160-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-147-8-200710160-00010</ArticleId><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin D, Babl FE, Schlapbach LJ, et al. . A randomized trial of high-flow oxygen therapy in infants with bronchiolitis. N Engl J Med 2018;378:1121&#x2013;31. 10.1056/NEJMoa1714855</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1714855</ArticleId><ArticleId IdType="pubmed">29562151</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudin F, Buisson A, Vanel B, et al. . Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care 2017;7:55. 10.1186/s13613-017-0278-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-017-0278-1</ArticleId><ArticleId IdType="pmc">PMC5440424</ArticleId><ArticleId IdType="pubmed">28534235</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauto Ben&#xed;tez R, Morilla Sanabria LP, Pavlicich V, et al. . High flow nasal cannula oxygen therapy in patients with asthmatic crisis in the pediatric emergency department. Rev Chil Pediatr 2019;90:642&#x2013;8. 10.32641/rchped.v90i6.1145</Citation><ArticleIdList><ArticleId IdType="doi">10.32641/rchped.v90i6.1145</ArticleId><ArticleId IdType="pubmed">32186587</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin D, Shellshear D, Babl FE, et al. . High flow in children with respiratory failure: A randomised controlled pilot trial - A paediatric acute respiratory intervention study. J Paediatr Child Health 2021;57:273&#x2013;81. 10.1111/jpc.15259</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.15259</ArticleId><ArticleId IdType="pubmed">33377568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruangsomboon O, Limsuwat C, Praphruetkit N, et al. . Nasal high-flow oxygen versus conventional oxygen therapy for acute severe asthma patients: a pilot randomized controlled trial. Acad Emerg Med 2021;28:530&#x2013;41. 10.1111/acem.14187</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.14187</ArticleId><ArticleId IdType="pmc">PMC8247327</ArticleId><ArticleId IdType="pubmed">33258213</ArticleId></ArticleIdList></Reference><Reference><Citation>National Asthma Council Australia . Australian asthma Handbook, version 2.1. Melbourne: National Asthma Council Australia, 2020. http://www.asthmahandbook.org.au</Citation></Reference><Reference><Citation>The Royal Children&#x2019;s Hospital, Melbourne, Australia . Clinical practice guideline on asthma, acute, 2020. Available: https://wwww.rch.org.au/clinicalguide/ [Accessed Feb 2021].</Citation></Reference><Reference><Citation>Asher I, McNamara D, Davies C, et al. . Asthma and respiratory Foundation NZ child and adolescent asthma guidelines: a quick reference guide. N Z Med J 2017;130:10&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29197898</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistrates Court of Tasmania: Coronial Division . Record of investigation into death of Hb (without inquest), 2021. Available: https://www.magistratescourt.tas.gov.au/about_us/coroners/coronial-findings-2019- [Accessed 16 Feb 2022].</Citation></Reference><Reference><Citation>Griffiths B, Kew KM. Intravenous magnesium sulfate for treating children with acute asthma in the emergency department. Cochrane Database Syst Rev 2016;4:Cd011050. 10.1002/14651858.CD011050.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011050.pub2</ArticleId><ArticleId IdType="pmc">PMC6599814</ArticleId><ArticleId IdType="pubmed">27126744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database Syst Rev 2012;11:Cd009293. 10.1002/14651858.CD009293.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009293.pub2</ArticleId><ArticleId IdType="pmc">PMC6483733</ArticleId><ArticleId IdType="pubmed">23152273</ArticleId></ArticleIdList></Reference><Reference><Citation>Knightly R, Milan SJ, Hughes R, et al. . Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2017;11:Cd003898. 10.1002/14651858.CD003898.pub6</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003898.pub6</ArticleId><ArticleId IdType="pmc">PMC6485984</ArticleId><ArticleId IdType="pubmed">29182799</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuh S, Sweeney J, Rumantir M, et al. . Effect of nebulized magnesium vs placebo added to albuterol on hospitalization among children with refractory acute asthma treated in the emergency department: a randomized clinical trial. JAMA 2020;324:2038&#x2013;47. 10.1001/jama.2020.19839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19839</ArticleId><ArticleId IdType="pmc">PMC7686869</ArticleId><ArticleId IdType="pubmed">33231663</ArticleId></ArticleIdList></Reference><Reference><Citation>Travers AH, Jones AP, Camargo CA, et al. . Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Cochrane Database Syst Rev 2012;12:Cd010256. 10.1002/14651858.CD010256</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010256</ArticleId><ArticleId IdType="pmc">PMC11663504</ArticleId><ArticleId IdType="pubmed">23235686</ArticleId></ArticleIdList></Reference><Reference><Citation>Travers AH, Milan SJ, Jones AP, et al. . Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst Rev 2012;12:Cd010179. 10.1002/14651858.CD010179</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD010179</ArticleId><ArticleId IdType="pmc">PMC11289706</ArticleId><ArticleId IdType="pubmed">23235685</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair P, Milan SJ, Rowe BH. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev 2012;12:Cd002742. 10.1002/14651858.CD002742.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002742.pub2</ArticleId><ArticleId IdType="pmc">PMC7093892</ArticleId><ArticleId IdType="pubmed">23235591</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray CS, Powell CVE, Babl FE, et al. . Variability of outcome measures in trials of intravenous therapy in acute severe paediatric asthma: a systematic review. Emerg Med J 2019;36:225&#x2013;30. 10.1136/emermed-2018-207929</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2018-207929</ArticleId><ArticleId IdType="pubmed">30482777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23122975</PMID><DateCompleted><Year>2013</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2013</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-4529</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2012</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of clinical anesthesia</Title><ISOAbbreviation>J Clin Anesth</ISOAbbreviation></Journal><ArticleTitle>The ProSeal Laryngeal Mask Airway is more effective than the LMA-Classic in pediatric anesthesia: a meta-analysis.</ArticleTitle><Pagination><StartPage>639</StartPage><EndPage>646</EndPage><MedlinePgn>639-46</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jclinane.2012.04.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0952-8180(12)00281-4</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">To determine, in pediatric patients, whether the ProSeal Laryngeal Mask Airway (PLMA) has advantages over the LMA-Classic (cLMA) in leak pressure, placement difficulty, incidence of adverse events, postoperative blood staining, laryngospasm, bronchospasm, and hoarseness.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Meta-analysis.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Metropolitan university medical center.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">MEDLINE (1966-2011), EMBASE (1980-2011), and the CENTRAL (1977-2011) databases was searched for randomized controlled trials (RCTs). The relative risk (RR), mean difference (MD), and corresponding 95% confidence intervals (CIs) were calculated using RevMan 5 statistical software for dichotomous and continuous outcomes, respectively.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Of the 13 RCTs that met study inclusion criteria, 8 trials comprising 557 patients were analyzed. Leak pressure was higher in the PLMA (RR = 5.02, 95% CI = 3.64, 6.4). The difference in rate of successful placement on the first attempt did not differ between the two devices (RR = 1.00, 95% CI = 0.94, 1.06). The incidence of gastric insufflation was lower with the PLMA (RR = 0.20, 95% CI = 0.07, 0.61). The incidence of postoperative blood staining on the mask did not differ (RR = 1.08, 95% CI = 0.52, 2.21), nor was there any difference between the two devices in incidence of laryngospasm or bronchospasm (RR = 0.75, 95% CI = 0.18, 3.21), or hoarseness (RR = 3.00, 95% CI = 0.13, 70.83). There was no difference in laryngeal view between the PLMA and cLMA (RR = 1.06, 95% CI = 0.90, 1.26). The maximum tidal volume per kg was greater with the PLMA (MD = 4.16, 95% CI = 3.56, 4.76).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The PLMA (in sizes 1,1.5, 2, and 2.5) offers some advantages over the cLMA in pediatric anesthesia.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaolong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>First School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Minghui</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Quan</ForeName><Initials>Q</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Anesth</MedlineTA><NlmUniqueID>8812166</NlmUniqueID><ISSNLinking>0952-8180</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001801" MajorTopicYN="N">Blood Stains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006685" MajorTopicYN="N">Hoarseness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23122975</ArticleId><ArticleId IdType="doi">10.1016/j.jclinane.2012.04.012</ArticleId><ArticleId IdType="pii">S0952-8180(12)00281-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">14996260</PMID><DateCompleted><Year>2004</Year><Month>04</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1155-5645</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2004</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Incidence and risk factors of perioperative respiratory adverse events in children undergoing elective surgery.</ArticleTitle><Pagination><StartPage>218</StartPage><EndPage>224</EndPage><MedlinePgn>218-24</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Adverse respiratory events remain one of the major causes of morbidity during anaesthesia, especially in children. The purpose of this prospective study was to determine the incidence of perioperative respiratory adverse events (PRAE) during elective paediatric surgery and to identify the risk factors for these events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Potential risk factors (atopy, eczema, rhinitis, food allergy, previous allergic tests, pollens or animal allergy, passive smoking, obstructive sleep disorders) were assessed using the International Society on Allergy and Asthma (ISAAC) questionnaire, which was submitted to the parents during preoperative anaesthetic assessment. Anaesthetic and surgical conditions were systematically recorded. A multivariate logistic regression explaining PRAE was developed in 800 children.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The intraoperative incidence of respiratory adverse events was 21% and the incidence in the postanesthetic care unit was 13%. According to the multivariate analysis, children not anaesthetized by a specialist paediatric anaesthesiologist have 1.7 increased risk to present PRAE (95% CI = 1.13-2.57). Children anaesthetized for ear, nose, throat (ENT) surgery had a 1.57-fold higher risk of PRAE compared with other procedures (95% CI = 1.01-2.44). Furthermore, there was a synergistic interaction when two risk factors: residents and ENT surgery, were concomitant: the odds ratio (OR) of PRAE during non-ENT surgical procedures was 1.43 (95% CI = 0.91-2.24), but increased to 2.74-fold (95% CI = 1.15-4.32) for ENT surgery. The risk of PRAE was significantly lower when the anaesthetic technique included tracheal intubation with relaxants (OR = 0.6, 95% CI = 0.45-0.95) and decreased by 8% with each increasing year of age.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study demonstrates a high incidence of PRAE in paediatric surgical patients without respiratory tract infections, which appears to be primarily determined by the age of the child and the anaesthetic care rather than by the child's medical history.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mamie</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Paediatric Anaesthesia Unit, Division of Anesthesia, University Hospital of Geneva, Geneva, Switzerland. chantal.mamie@hcuge.ch</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habre</LastName><ForeName>Walid</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Delhumeau</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Argiroffo</LastName><ForeName>Constance Barazzone</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Morabia</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="N">Airway Obstruction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>3</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>4</Month><Day>30</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>3</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14996260</ArticleId><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01169.x</ArticleId><ArticleId IdType="pii">1169</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37201356</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-818X</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>American journal of otolaryngology</Title><ISOAbbreviation>Am J Otolaryngol</ISOAbbreviation></Journal><ArticleTitle>Diagnostic clues for the identification of pediatric foreign body aspirations and consideration of novel imaging techniques.</ArticleTitle><Pagination><StartPage>103919</StartPage><MedlinePgn>103919</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjoto.2023.103919</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0196-0709(23)00133-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To better understand the diagnosis of foreign body aspiration by elucidating key components of its clinical presentation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective cohort study of pediatric patients with suspected foreign body aspiration. We collected information regarding demographics, history, symptoms, physical exam, imaging, and operative findings for rigid bronchoscopies. An evaluation of these findings for an association with foreign body aspiration and the overall diagnostic algorithm was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">518 pediatric patients presented with 75.2&#xa0;% presenting within one day of the inciting event. Identified history findings included wheeze (OR: 5.83, p&#xa0;&lt;&#xa0;0.0001) and multiple encounters (OR: 5.46, p&#xa0;&lt;&#xa0;0.0001). Oxygen saturation was lower in patients with foreign body aspiration (97.3&#xa0;%, p&#xa0;&lt;&#xa0;0.001). Identified physical exam findings included wheeze (OR: 7.38, p&#xa0;&lt;&#xa0;0.001) and asymmetric breath sounds (OR: 5.48, p&#xa0;&lt;&#xa0;0.0001). The sensitivity and specificity of history findings was 86.7&#xa0;% and 23.1&#xa0;%, physical exam was 60.8&#xa0;% and 88.4&#xa0;%, and chest radiographs was 45.3&#xa0;% and 88.0&#xa0;%. 25 CT scans were performed with a sensitivity and specificity of 100&#xa0;% and 85.7&#xa0;%. Combining two components of the diagnostic algorithm yielded a high sensitivity and moderate specificity; the best combination was the history and physical exam. 186 rigid bronchoscopies were performed with 65.6&#xa0;% positive for foreign body aspiration.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Accurate diagnosis of foreign body aspiration requires careful history taking and examination. Low-dose CT should be included in the diagnostic algorithm. The combination of any two components of the diagnostic algorithm is the most accurate for foreign body aspiration.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94122, USA. Electronic address: brandon.truong@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luu</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, Division of Pediatric Otolaryngology, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94122, USA. Electronic address: kimberly.luu@ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Otolaryngol</MedlineTA><NlmUniqueID>8000029</NlmUniqueID><ISSNLinking>0196-0709</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053120" MajorTopicYN="Y">Respiratory Aspiration</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005547" MajorTopicYN="Y">Foreign Bodies</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001980" MajorTopicYN="N">Bronchi</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chest radiographs</Keyword><Keyword MajorTopicYN="N">Diagnostic algorithm</Keyword><Keyword MajorTopicYN="N">Foreign body aspiration</Keyword><Keyword MajorTopicYN="N">Low dose computed tomography</Keyword><Keyword MajorTopicYN="N">Rigid bronchoscopy</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>18</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37201356</ArticleId><ArticleId IdType="doi">10.1016/j.amjoto.2023.103919</ArticleId><ArticleId IdType="pii">S0196-0709(23)00133-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36823069</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1478-5242</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>728</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The British journal of general practice : the journal of the Royal College of General Practitioners</Title><ISOAbbreviation>Br J Gen Pract</ISOAbbreviation></Journal><ArticleTitle>Comparing GPs' antibiotic prescribing decisions to a clinical prediction rule: an online vignette study.</ArticleTitle><Pagination><StartPage>e176</StartPage><EndPage>e185</EndPage><MedlinePgn>e176-e185</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3399/BJGP.2020.0802</ELocationID><Abstract><AbstractText Label="BACKGROUND">The 'STARWAVe' clinical prediction rule (CPR) uses seven factors to guide risk assessment and antibiotic prescribing in children with cough (Short illness duration, Temperature, Age, Recession, Wheeze, Asthma, Vomiting).</AbstractText><AbstractText Label="AIM">To assess the influence of STARWAVe factors on GPs' unaided risk assessments and prescribing decisions.</AbstractText><AbstractText Label="DESIGN AND SETTING">Clinical vignettes administered to 188 UK GPs online.</AbstractText><AbstractText Label="METHOD">GPs were randomly assigned to view 32 (out of a possible 64) vignettes online depicting children with cough. The vignettes comprised the seven STARWAVe factors, which were varied systematically. For each vignette, GPs assessed risk of deterioration in one of two ways (sliding-scale versus risk-category selection) and indicated whether they would prescribe antibiotics. Finally, GPs saw an additional vignette, suggesting that the parent was concerned. Mixed-effects regressions were used to measure the influence of STARWAVe factors, risk-elicitation method, and parental concern on GPs' assessments and decisions.</AbstractText><AbstractText Label="RESULTS">Six STARWAVe risk factors correctly increased GPs' risk assessments (<i>b</i>s<sub>sliding-scale</sub>&#x2265;0.66, odds ratios [ORs]<sub>category-selection</sub>&#x2265;1.75, <i>P</i>s&#x2264;0.001), whereas one incorrectly reduced them (short illness duration: <i>b</i> <sub>sliding-scale</sub> -0.30, OR<sub>category-selection</sub> 0.80, <i>P</i>&#x2264;0.039). Conversely, one STARWAVe factor increased prescribing odds (temperature: OR 5.22, <i>P</i>&lt;0.001), whereas the rest either reduced them (short illness duration, age, and recession: ORs&#x2264;0.70, <i>P</i>s&lt;0.001) or had no significant impact (wheeze, asthma, and vomiting: <i>P</i>s&#x2265;0.065). Parental concern increased risk assessments (<i>b</i> <sub>sliding-scale</sub> 1.29, OR<sub>category-selection</sub> 2.82, <i>P</i>&#x2264;0.003) but not prescribing odds (<i>P</i> = 0.378).</AbstractText><AbstractText Label="CONCLUSION">GPs use some, but not all, STARWAVe factors when making unaided risk assessments and prescribing decisions. Such discrepancies must be considered when introducing CPRs to clinical practice.</AbstractText><CopyrightInformation>&#xa9; The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nurek</LastName><ForeName>Martine</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4252-4692</Identifier><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Alastair D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0003-3012-375X</Identifier><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Bristol Medical School: Population Health Sciences, University of Bristol, Bristol.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostopoulou</LastName><ForeName>Olga</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-9643-0838</Identifier><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Gen Pract</MedlineTA><NlmUniqueID>9005323</NlmUniqueID><ISSNLinking>0960-1643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Br J Gen Pract. 2024 Jan 25;74(739):58-59. doi: 10.3399/bjgp24X736185.</RefSource><PMID Version="1">38272700</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="Y">Cough</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081415" MajorTopicYN="N">Clinical Decision Rules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="N">Attitude of Health Personnel</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">STARWAVe</Keyword><Keyword MajorTopicYN="N">antimicrobial stewardship</Keyword><Keyword MajorTopicYN="N">decision support</Keyword><Keyword MajorTopicYN="N">general practice</Keyword><Keyword MajorTopicYN="N">primary care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36823069</ArticleId><ArticleId IdType="pmc">PMC9975984</ArticleId><ArticleId IdType="doi">10.3399/BJGP.2020.0802</ArticleId><ArticleId IdType="pii">BJGP.2020.0802</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Government HM. Tackling antimicrobial resistance 2019&#x2013;2024 the UK&#x2019;s five-year national action plan. 2019.   https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/784894/UK_AMR_5_year_national_action_plan.pdf (accessed 13 Jan 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">30826342</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health England, NHS England  The NHS atlas of variation in healthcare Reducing unwarranted variation to increase value and improve quality. 2015  https://www.networks.nhs.uk/nhs-networks/staffordshire-shropshire-and-black-country-newborn/documents/documents/atlas-of-unwarranted-variation-in-maternity-care-1 (accessed 13 Jan 2023).</Citation></Reference><Reference><Citation>McCormick A, Fleming D, Charlton J. Morbidity statistics from general practice: fourth national study 1991&#x2013;1992. London: Her Majesty&#x2019;s Stationery Office; 1995.</Citation></Reference><Reference><Citation>Hay AD, Redmond NM, Turnbull S, et al. Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study. Lancet Respir Med. 2016;4(11):902&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5080970</ArticleId><ArticleId IdType="pubmed">27594440</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinks A, Glasziou PP, Del Mar CB. Antibiotics for sore throat. Cochrane Database Syst Rev. 2013;2013(11):CD000023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457983</ArticleId><ArticleId IdType="pubmed">24190439</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2014;(3):CD000245.</Citation><ArticleIdList><ArticleId IdType="pubmed">24585130</ArticleId></ArticleIdList></Reference><Reference><Citation>Venekamp RP, Sanders SL, Glasziou PP, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2015;2015(6):CD000219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7043305</ArticleId><ArticleId IdType="pubmed">26099233</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwood J, Cabral C, Hay AD, Ingram J. Primary care clinician antibiotic prescribing decisions in consultations for children with RTIs: a qualitative interview study. Br J Gen Pract. 2016. DOI: .</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp16X683821</ArticleId><ArticleId IdType="pmc">PMC4758501</ArticleId><ArticleId IdType="pubmed">26852795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas P, Cabral C, Hay AD, et al. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand J Prim Health Care. 2015;33(1):11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377734</ArticleId><ArticleId IdType="pubmed">25716427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral C, Lucas PJ, Ingram J, et al. &#x201c;It&#x2019;s safer to&#x2026;&#x201d; parent consulting and clinician antibiotic prescribing decisions for children with respiratory tract infections: an analysis across four qualitative studies. Soc Sci Med. 2015;136&#x2013;137:156&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">26004209</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  Respiratory tract infections (self-limiting): prescribing antibiotics. CG69. 2019.   http://www.nice.org.uk/guidance/cg69 (accessed 13 Jan 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">31815394</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull SL, Redmond NM, Lucas P, et al. The CHICO (Children&#x2019;s Cough) Trial protocol: a feasibility randomised controlled trial investigating the clinical and cost-effectiveness of a complex intervention to improve the management of children presenting to primary care with acute respiratory tract infection. BMJ Open. 2015;5(9):e008615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4577930</ArticleId><ArticleId IdType="pubmed">26373406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang PP-C, Glance D, Walker J, et al. Implementing a QCancer risk tool into general practice consultations: an exploratory study using simulated consultations with Australian general practitioners. Br J Cancer. 2015;112(Suppl 1 (Suppl 1)):S77&#x2013;S83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385980</ArticleId><ArticleId IdType="pubmed">25734392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek M, Delaney BC, Kostopoulou O. Risk assessment and antibiotic prescribing decisions in children presenting to UK primary care with cough: a vignette study. BMJ Open. 2020;10(7):e035761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375509</ArticleId><ArticleId IdType="pubmed">32690738</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirota M, Round T, Samaranayaka S, Kostopoulou O. Expectations for antibiotics increase their prescribing: causal evidence about localized impact. Health Psychol. 2017;36(4):402&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">28206788</ArticleId></ArticleIdList></Reference><Reference><Citation>StataCorp LP. Stata multilevel mixed-effects reference manual: release 13. College Station, TX: StataCorp; 2013.</Citation></Reference><Reference><Citation>Williams R. Understanding and interpreting generalized ordered logit models. J Math Sociol. 2016;40(1):7&#x2013;20.</Citation></Reference><Reference><Citation>Williams R. Generalized ordered logit/partial proportional odds models for ordinal dependent variables. Stata J. 2006;6(1):58&#x2013;82.</Citation></Reference><Reference><Citation>Dempsey PP, Businger AC, Whaley LE, et al. Primary care clinicians&#x2019; perceptions about antibiotic prescribing for acute bronchitis: a qualitative study. BMC Fam Pract. 2014;15:194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4275949</ArticleId><ArticleId IdType="pubmed">25495918</ArticleId></ArticleIdList></Reference><Reference><Citation>Petursson P. GPs&#x2019; reasons for &#x2018;non-pharmacological&#x2019; prescribing of antibiotics: a phenomenological study. Scand J Prim Health Care. 2005;23(2):120&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">16036552</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler CC, Rollnick S, Pill R, et al. Understanding the culture of prescribing: qualitative study of general practitioners&#x2019; and patients&#x2019; perceptions of antibiotics for sore throats. BMJ. 1998;317(7159):637&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28658</ArticleId><ArticleId IdType="pubmed">9727992</ArticleId></ArticleIdList></Reference><Reference><Citation>Borek AJ, Campbell A, Dent E, et al. Implementing interventions to reduce antibiotic use: a qualitative study in high-prescribing practices. BMC Fam Pract. 2021;22(25):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7825381</ArticleId><ArticleId IdType="pubmed">33485324</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Mecklenbeck M, K&#xfc;hberger A, Ranyard R. A handbook of process tracing methods for decision research: a critical review and user&#x2019;s guide. New York, NY: Psychology Press; 2010.</Citation></Reference><Reference><Citation>Nurek M, Kostopoulou O. What you find depends on how you measure it: reactivity of response scales measuring predecisional information distortion in medical diagnosis. PLOS One. 2016;11(9):e0162562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023159</ArticleId><ArticleId IdType="pubmed">27627673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangione-Smith R, McGlynn EA, Elliott MN, et al. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics. 1999;103(4):711&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pubmed">10103291</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen KA, Melbye H, Kelly MJ, et al. Influence of CRP testing and clinical findings on antibiotic prescribing in adults presenting with acute cough in primary care. Scand J Prim Health Care. 2010;28(4):229&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3444795</ArticleId><ArticleId IdType="pubmed">20704523</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31771436</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1819-6357</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Libyan journal of medicine</Title><ISOAbbreviation>Libyan J Med</ISOAbbreviation></Journal><ArticleTitle>Ketofol performance to reduce postoperative emergence agitation in children undergoing adenotonsillectomy.</ArticleTitle><Pagination><StartPage>1688450</StartPage><MedlinePgn>1688450</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1688450</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/19932820.2019.1688450</ELocationID><Abstract><AbstractText><b>Background</b>: Emergence agitation is a reformed state of mindfulness, which starts with a sudden form of anesthesia and progresses through the early repossession age. Thus, the purpose of this study is to evaluate 1:3 ketofol performance on children 3-15 years old undergoing adenotonsillectomy.<b>Methods</b>: A total of 60 children aged 3-15 years undergoing adenotonsillectomy were randomly allocated to receive low-dose ketamine 0.15 mg/kg followed by propofol 0.45 mg/kg i.v. ketofol (1:3) about 10 min before the end of surgery in comparison to 60 children aged 3-15 years who received only normal saline and dextrose. Anesthesia was induced and maintained with sevoflurane. Postoperative pain and EA were assessed with objective pain score (OPS) and the Pediatric Anesthesia Emergence Delirium (PAED) scale, respectively. EA was defined as a PAED 10 points. Recovery profile and postoperative complications were also recorded.<b>Results</b>: The incidence and severity of EA were found significantly lower in the ketofol group in comparison to the control group with a percentage of (13.33% vs 48.33%) (8% vs 15%) respectively (P &lt; 0.05). Also, the time for interaction from anesthetic tainted to extubating in the ketofol set was significantly less than in the control group (P &lt; 0.05). Interestingly, there are no opposing events such as nausea, laryngospasm, bronchospasm, hypotension, bradycardia, bleeding, or postoperative respiratory depression (respiratory rate: &lt;16) were noticed in the ketofol supervision (P &gt; 0.05). Moreover, the heart rate was meaningfully higher in the control group starting at the time of tracheal extubating in comparison to the children undergone ketofol (P &lt; 0.05). Alert score and time from painkilling tainted till liberation from PACU showed substantial significant changes at ketofol set (P &lt; 0.05).<b>Conclusion</b>: Ketofol (1:3) shows significant performance to reduce postoperative agitation in the children undergone adenotonsillectomy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Idress</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Alwehda Teaching Hospital, Dhamar University, Dhamar city, Yemen.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alahdal</LastName><ForeName>Murad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shenzhen Key Laboratory of Tissue Engineering, Shenzhen Laboratory of Digital Orthopedic Engineering, Shenzhen Second People's Hospital (The First Hospital Affiliated to Shenzhen University, Health Science Center), Shenzhen, P. R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Laboratories, school of medicine, Hodeidah University, Al-Hudaydah city, Yemen.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Haifa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S El Moughrabi</LastName><ForeName>Arafa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oral &amp; Maxillofacial Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiqian</LastName><ForeName>Huang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Shanglong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Libyan J Med</MedlineTA><NlmUniqueID>101299403</NlmUniqueID><ISSNLinking>1819-6357</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="N">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anesthesia</Keyword><Keyword MajorTopicYN="N">adenotonsillectomy</Keyword><Keyword MajorTopicYN="N">emergency agitation</Keyword><Keyword MajorTopicYN="N">ketamine</Keyword><Keyword MajorTopicYN="N">propofol</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31771436</ArticleId><ArticleId IdType="pmc">PMC6882471</ArticleId><ArticleId IdType="doi">10.1080/19932820.2019.1688450</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marzullo LR, Laurie R. Pharmacologic management of the agitated child. Pediatr Emerg Care. 2014;30(4):269&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Huddy N. Emergence agitation in children. Br J Anaesth. 2010;105(1):95&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">20551033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak KH. Emergence agitation/delirium: we still don&#x2019;t know. Korean J Anesthesiol. 2010;59(2):73&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2926432</ArticleId><ArticleId IdType="pubmed">20740209</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S. Combining ketamine and propofol (&#x201c;Ketofol&#x201d;) for emergency department procedural sedation and analgesia: a review. West J Emerg Med. 2008;9(1):20&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2672224</ArticleId><ArticleId IdType="pubmed">19561698</ArticleId></ArticleIdList></Reference><Reference><Citation>Willman EV, Andolfatto G. A prospective evaluation of &#x201c;ketofol&#x201d; (Ketamine/Propofol Combination) for procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2007;49(1):23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">17059854</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia N, Tramer MR. Ketamine and postoperative pain&#x2013;a quantitative systematic review of randomised trials. Pain. 2005;113(1):61&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">15621365</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115(6):1363&#x2013;1381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3698859</ArticleId><ArticleId IdType="pubmed">22020140</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonenberg M, Reichwald U, Domes G, et al. Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims. J Psychopharmacol. 2008;22(5):493&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">18208917</ArticleId></ArticleIdList></Reference><Reference><Citation>Paslakis G, Gilles M, Meyer-Lindenberg A, et al. Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series. Pharmacopsychiatry. 2010;43(01):33&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">20013614</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinis-Oliveira RJ. Metabolism and metabolomics of ketamine: a toxicological approach. Forensic Sci Res. 2017;2(1):2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6197107</ArticleId><ArticleId IdType="pubmed">30483613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalanne L, Nicot C, Lang J-P, et al. Experience of the use of Ketamine to manage opioid withdrawal in an addicted woman: a case report. BMC Psychiatry. 2016;16(1):395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5105239</ArticleId><ArticleId IdType="pubmed">27832755</ArticleId></ArticleIdList></Reference><Reference><Citation>Miner JR, Burton JH. Clinical practice advisory: emergency department procedural sedation with propofol. Ann Emerg Med. 2007;50(2):182&#x2013;187.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">17321006</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuaid KR, Laine L. A systematic review and meta-analysis of randomized, controlled trials of moderate sedation for routine endoscopic procedures. Gastrointest Endosc. 2008;67(6):910&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">18440381</ArticleId></ArticleIdList></Reference><Reference><Citation>Machata AM, Willschke H, Kabon B, et al. Propofol-based sedation regimen for infants and children undergoing ambulatory magnetic resonance imaging. Br J Anaesth. 2008;101(2):239&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">18534971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan JW, McLeod SL, Iansavitchene A. Ketamine-propofol versus propofol alone for procedural sedation in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2015;22(9):1003&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">26292077</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapani G, Altomare C, Sanna E, et al. Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem. 2000;7(2):249&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">10637364</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y, Shimazawa M, Yoshimura S, et al. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008;14(2):95&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494023</ArticleId><ArticleId IdType="pubmed">18482023</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips W, Anderson A, Rosengreen M, et al. Propofol versus propofol/ketamine for brief painful procedures in the emergency department: clinical and bispectral index scale comparison. J Pain Palliat Care Pharmacother. 2010;24(4):349&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">21133742</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moraes AG, Africano CJ, Hoskote SS, et al. Ketamine and propofol combination (&#x201c;Ketofol&#x201d;) for endotracheal intubations in critically Ill patients: a case series. Am J Case Rep. 2015;16:81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4332295</ArticleId><ArticleId IdType="pubmed">25676819</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn T, Mossop D, Newton A, et al. Propofol for procedural sedation in the emergency department. Emer Med J. 2007;24(7):459&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2658387</ArticleId><ArticleId IdType="pubmed">17582032</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay SP, Tripathy A, Mallick PN. A practical guide to sedation and analgesia in Paediatric Intensive Care Unit (ICU). J Anim Sci. 2017;4(1).</Citation></Reference><Reference><Citation>Alletag MJ, Auerbach M, Baum CR. Ketamine, propofol, and ketofol use for pediatric sedation. Pediatr Emerg Care. 2012;28(12):1391&#x2013;1395.</Citation><ArticleIdList><ArticleId IdType="pubmed">23222112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokcinar D, Ergin V, Cumaoglu A, et al. Effects of ketamine, propofol, and ketofol on proinflammatory cytokines and markers of oxidative stress in a rat model of endotoxemia-induced acute lung injury. Acta Biochim Pol. 2013;60(3):451&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">24020061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tar&#x131;k&#x131; K&#x131;l&#x131; Ebru KR. Comparison of ketamine-propofol mixture (ketofol) and midazolam-meperidine in endoscopic retrograde cholangiopancreatography (ERCP) for oldest old patients. Ther Clin Risk Manag. 2019;15:755&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592063</ArticleId><ArticleId IdType="pubmed">31417263</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh C, Kim Y, Eom H, et al. Procedural sedation using a propofol&#x2013;ketamine combination (Ketofol) vs. propofol alone in the Loop Electrosurgical Excision Procedure (LEEP): a randomized controlled trial. J Clin Med. 2019;8(7):943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6678246</ArticleId><ArticleId IdType="pubmed">31261820</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuya A, Matsukawa T, Ozaki M, et al. Intravenous ketamine attenuates arterial pressure changes during the induction of anaesthesia with propofol. Eur J Anaesthesiol. 2001;18(2):88&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11270030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Park H-P, Jeong M-H, et al. Efficacy of ketamine for postoperative pain following robotic thyroidectomy: A prospective randomised study. J Int Med Res. 2018;46(3):1109&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5972244</ArticleId><ArticleId IdType="pubmed">29124992</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin A, Esmaoglu A, Guler G, et al. Propofol and propofol&#x2013;ketamine in pediatric patients undergoing cardiac catheterization. Pediatr Cardiol. 2005;26(5):553&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">16132313</ArticleId></ArticleIdList></Reference><Reference><Citation>Daabiss M, Elsherbiny M, Alotibi R. Assessment of different concentration of ketofol in procedural operation. Br J Med Pract. 2009;2(1):27&#x2013;31.</Citation></Reference><Reference><Citation>Ghojazadeh M, Sanaie S, Paknezhad SP, et al. Using ketamine and propofol for procedural sedation of adults in the emergency department: a systematic review and meta-analysis. Adv Pharm Bull. 2019;9(1):5&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6468222</ArticleId><ArticleId IdType="pubmed">31011553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortero RF, Clark LD, Tolan MM, et al. The effects of small-dose ketamine on propofol sedation: respiration, postoperative mood, perception, cognition, and pain. Anesthesia Analg. 2001;92(6):1465&#x2013;1469.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375826</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin A, Guler G, Esmaoglu A, et al. A comparison of fentanyl-propofol with a ketamine-propofol combination for sedation during endometrial biopsy. J Clin Anesth. 2005;17(3):187&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">15896585</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed AA. Prevention of sevoflurane agitation in children undergoing congenital hernia repair, impact of adding dexmedetomidine to caudal analgesia. Egypt J Anaesth. 2015;31(3):227&#x2013;231.</Citation></Reference><Reference><Citation>Vlajkovic G, Sindjelic R. Emergence delirium in children: many questions, few answers. Anesthesia Analg. 2007;104(1):84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">17179249</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34781421</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2468-824X</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Asian journal of anesthesiology</Title><ISOAbbreviation>Asian J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Effect of Intramuscular Dexmedetomidine Administration Before Extubation on Post-Extubation Haemodynamics, Postoperative Sedation, and Analgesic Requirements: A Double Blind Placebo Controlled Study.</ArticleTitle><Pagination><StartPage>102</StartPage><EndPage>110</EndPage><MedlinePgn>102-110</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.6859/aja.202109_59(3).0004</ELocationID><Abstract><AbstractText Label="BACKGROUND">Dexmedetomidine, an &#x3b1;2-adrenoreceptor agonist has been successfully used for attenuating stress response to laryngoscopy. The present study was designed to evaluate the effects of intramuscular dexmedetomidine 30 minutes before extubation on hemodynamic response in patients undergoing laminectomy for prolapsed intervertebral disc (PIVD) under endotracheal intubation and general anesthesia.</AbstractText><AbstractText Label="METHODS">Present double-blinded randomized placebo-controlled study, included 100 patients from either sex with American Society of Anesthesiologists grades I and II and age from 18 to 60 years undergoing laminectomy for PIVD under general anesthesia. Patients were randomly divided into two groups of 50 each based on computer generated random numbers. The study group received dexmedetomidine (2.0 &#x3bc;g/ kg, i.m.) in 2.5 mL saline, and the control group received normal saline (placebo, i.m.) 2.5 mL. Drugs had been administered 30 minutes before anticipated time of extubation intramuscularly at the deltoid region. Comparison of continuous variables between two groups was done by using student's unpaired t-test. Categorical data were analyzed by using chi-square test and Fischer Exact test as applicable.</AbstractText><AbstractText Label="RESULTS">Heart rate was found to be significantly lower in the study group, 15 minutes before extubation (P = 0.003), during and after extubation (P &#xff1c; 0.0001). The systolic and diastolic blood pressure was significantly lower in the study group during and after extubation (P &#xff1c; 0.05). Cough was significantly lower in the study group during extubation. No significant difference was observed in other complications (respiratory stridor, incidence of laryngospasm or bronchospasm and reintubation) between the two groups. Pain score at 5 minutes, 2 hours, and 4 hours post-extubation was significantly lower in the study group (P &#xff1c; 0.01). P-value &#xff1c; 0.05 was considered statistically significant.</AbstractText><AbstractText Label="CONCLUSIONS">Dexmedetomidine provides haemodynamic stability during extubation and post-extubation. It also provides post-operative calmness and reduces analgesic requirement and post-extubation complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ambesh</LastName><ForeName>S P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubey</LastName><ForeName>Madhulika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care Unit, Department of Anesthesiology, Era's Lucknow Medical College and Hospital, Lucknow, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China (Republic : 1949- )</Country><MedlineTA>Asian J Anesthesiol</MedlineTA><NlmUniqueID>101710889</NlmUniqueID><ISSNLinking>2468-824X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>15</Day><Hour>21</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34781421</ArticleId><ArticleId IdType="doi">10.6859/aja.202109_59(3).0004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36340703</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>A novel nomogram for predicting respiratory adverse events during transport after interventional cardiac catheterization in children.</ArticleTitle><Pagination><StartPage>1044791</StartPage><MedlinePgn>1044791</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1044791</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2022.1044791</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The rate and predictors of respiratory adverse events (RAEs) during transport discharged from operating room after interventional cardiac catheterization in children remain unclear. This study aimed to investigate the incidence and predictors, and to construct a nomogram for predicting RAEs during transport in this pediatric surgical treatment.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This prospective cohort study enrolled 290 consecutive pediatric patients who underwent ventricular septal defects (VSD), atrial septal defects (ASD), and patent ductus arteriosus (PDA) between February 2019 and December 2020. Independent predictors were used to develop a nomogram, and a bootstrap resampling approach was used to conduct internal validation. Composite RAEs were defined as the occurrence of at least 1 complication regarding laryngospasm, bronchospasm, apnea, severe cough, airway secretions, airway obstruction, and oxygen desaturation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The rate of RAEs during transport was 23.1% (67 out of 290). Multivariate analysis identified age (vs. &#x2264;3 years, adjusted odds ratio (aOR)&#x2009;=&#x2009;0.507, 95% con&#xfb01;dence interval (CI), 0.268-0.958, <i>P</i>&#x2009;=&#x2009;0.036), preoperative upper respiratory tract infections (URI, aOR&#x2009;=&#x2009;2.335, 95% CI, 1.223-4.460, <i>P</i>&#x2009;=&#x2009;0.01), type of surgery (vs. VSD, for ASD, aOR&#x2009;=&#x2009;&#x2009;2.856, 95% CI, 1.272-6.411, <i>P</i>&#x2009;=&#x2009;0.011; for PDA, aOR&#x2009;=&#x2009;5.518, 95% CI, 2.425-12.553, <i>P</i>&#x2009;&lt;&#x2009;0.001), morphine equivalent (vs. &#x2264;0.153&#x2005;mg/kg, aOR&#x2009;=&#x2009;2.904, 95% CI, 1.371-6.150, <i>P</i>&#x2009;=&#x2009;0.005), atropine usage (aOR&#x2009;=&#x2009;0.463, 95% CI, 0.244-0.879, <i>P</i>&#x2009;=&#x2009;0.019), and RAEs during extubation to transport (aOR&#x2009;=&#x2009;5.004, 95% CI, 2.633-9.511, <i>P</i>&#x2009;&lt;&#x2009;0.001) as independent predictors of RAEs during transport. These six candidate predictors were used to develop a nomogram, which showed a C-statistic value of 0.809 and good calibration (<i>P</i>&#x2009;=&#x2009;0.844). Internal validation revealed similarly good discrimination (C-statistic, 0.782; 95% CI, 0.726-0.837) and calibration. Decision curve analysis (DCA) also demonstrated the clinical usefulness of the nomogram.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The high rate of RAEs during transport reminds us of the need for more medical care and attention. The proposed nomogram can reliably identify pediatric patients at high risk of RAEs during transport and guide clinicians to make proper transport plans. Our findings have important and meaningful implications for RAEs risk prediction, clinical intervention and healthcare quality control.</AbstractText><CopyrightInformation>&#xa9; 2022 Tong, Liu, Zhang, Liu and Zheng.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Chaoyang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shanghai Children's Medical Center, School of Medicine and National Children's Medical Center, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Peiwen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shanghai Children's Medical Center, School of Medicine and National Children's Medical Center, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shanghai Children's Medical Center, School of Medicine and National Children's Medical Center, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shanghai Children's Medical Center, School of Medicine and National Children's Medical Center, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jijian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shanghai Children's Medical Center, School of Medicine and National Children's Medical Center, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac catheterization</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">nomogram</Keyword><Keyword MajorTopicYN="N">predictors</Keyword><Keyword MajorTopicYN="N">respiratory adverse events</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>7</Day><Hour>5</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36340703</ArticleId><ArticleId IdType="pmc">PMC9631021</ArticleId><ArticleId IdType="doi">10.3389/fped.2022.1044791</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murat I, Constant I, Maud'huy H. Perioperative anesthetic morbidity in children: a database of 24,165 anesthetics over a 30-month period. Paediatr Anaesth. (2004) 14(2):158&#x2013;66. 10.1111/j.1460-9592.2004.01167.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01167.x</ArticleId><ArticleId IdType="pubmed">14962332</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Sommerfield D, Slevin L, Drake-Brockman TFE, Zhang G, Hall GL. Effect of albuterol premedication vs placebo on the occurrence of respiratory adverse events in children undergoing tonsillectomies: the REACT randomized clinical trial. JAMA Pediatr. (2019) 173(6):527&#x2013;33. 10.1001/jamapediatrics.2019.0788</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2019.0788</ArticleId><ArticleId IdType="pmc">PMC6547220</ArticleId><ArticleId IdType="pubmed">31009034</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen F, Zhang Q, Xu Y, Wang X, Xia J, Chen C, et al. Effect of intranasal dexmedetomidine or midazolam for premedication on the occurrence of respiratory adverse events in children undergoing tonsillectomy and adenoidectomy: a randomized clinical trial. JAMA Netw Open. (2022) 5(8):e2225473. 10.1001/jamanetworkopen.2022.25473</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.25473</ArticleId><ArticleId IdType="pmc">PMC9364121</ArticleId><ArticleId IdType="pubmed">35943745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay CL, Tan GM, Ng SB. Critical incidents in pediatric anesthesia: an audit of 10 000 anesthetics in Singapore. Pediatr Anaesth. (2001) 11(6):711&#x2013;8. 10.1046/j.1460-9592.2001.00767.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2001.00767.x</ArticleId><ArticleId IdType="pubmed">11696149</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Chanchayanon T, Sriyanaluk B, Saefung B, et al. Excess costs and length of hospital stay attributable to perioperative respiratory events in children. Anesth Analg. (2015) 120(2):411&#x2013;9. 10.1213/ANE.0000000000000557</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000557</ArticleId><ArticleId IdType="pubmed">25517194</ArticleId></ArticleIdList></Reference><Reference><Citation>Malviya S, Voepel-Lewis T, Siewert M, Pandit UA, Riegger LQ, Tait AR. Risk factors for adverse postoperative outcomes in children presenting for cardiac surgery with upper respiratory tract infections. Anesthesiology. (2003) 98(3):628&#x2013;32. 10.1097/00000542-200303000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200303000-00009</ArticleId><ArticleId IdType="pubmed">12606905</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, Rebmann C, Johnson C, Sly PD, et al. Risk assessment for respiratory complications in pediatric anesthesia: a prospective cohort study. Lancet. (2010) 376(9743):773&#x2013;83. 10.1016/S0140-6736(10)61193-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanyam R, Yeramaneni S, Hossain MM, Anneken AM, Varughese AM. Perioperative respiratory adverse events in pediatric ambulatory anesthesia: development and validation of a risk prediction tool. Anesth Analg. (2016) 122(5):1578&#x2013;85. 10.1213/ANE.0000000000001216</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001216</ArticleId><ArticleId IdType="pubmed">27101501</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq S, Syed M, Martin T, Zhang X, Schmitz M. Rates of perioperative respiratory adverse events among Caucasian and African American children undergoing general anesthesia. Anesth Analg. (2018) 127(1):181&#x2013;7. 10.1213/ANE.0000000000003430</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003430</ArticleId><ArticleId IdType="pubmed">29750690</ArticleId></ArticleIdList></Reference><Reference><Citation>Wudineh DM, Berhe YW, Chekol WB, Adane H, Workie MM. Perioperative respiratory adverse events among pediatric surgical patients in university hospitals in northwest Ethiopia; A prospective observational study. Front Pediatr. (2022) 10:827663. 10.3389/fped.2022.827663</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.827663</ArticleId><ArticleId IdType="pmc">PMC8873930</ArticleId><ArticleId IdType="pubmed">35223702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman J. Perioperative respiratory complications in children. Lancet. (2010) 376(9743):745&#x2013;6. 10.1016/S0140-6736(10)61199-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61199-3</ArticleId><ArticleId IdType="pubmed">20816527</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Voepel-Lewis T, Christensen R, O'Brien LM. The STBUR questionnaire for predicting perioperative respiratory adverse events in children at risk for sleep-disordered breathing. Paediatr Anaesth. (2013) 23(6):510&#x2013;6. 10.1111/pan.12155</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12155</ArticleId><ArticleId IdType="pmc">PMC3648590</ArticleId><ArticleId IdType="pubmed">23551934</ArticleId></ArticleIdList></Reference><Reference><Citation>Welliver RC, Sr, Checchia PA, Bauman JH, Fernandes AW, Mahadevia PJ, Hall CB. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Curr Med Res Opin. (2010) 26(9):2175&#x2013;81. 10.1185/03007995.2010.505126</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2010.505126</ArticleId><ArticleId IdType="pubmed">20666690</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Corcoran C, Witte MK, Ampofo K, Castillo R, Bodily S, Bratton SL. The impact of human rhinovirus infection in pediatric patients undergoing heart surgery. Pediatr Cardiol. (2014) 35(8):1387&#x2013;94. 10.1007/s00246-014-0941-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-014-0941-3</ArticleId><ArticleId IdType="pubmed">24939564</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan K, Barlow A, Alphonso N, Anderson B, Johnson J, Nourse C, et al. Impact of viral respiratory pathogens on outcomes after pediatric cardiac surgery. Pediatr Crit Care Med. (2017) 18(3):219&#x2013;27. 10.1097/PCC.0000000000001083</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000001083</ArticleId><ArticleId IdType="pubmed">28114162</ArticleId></ArticleIdList></Reference><Reference><Citation>Promphan W, Qureshi SA. What interventional cardiologists are still leaving to the surgeons? Front Pediatr. (2016) 4:59. 10.3389/fped.2016.00059</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2016.00059</ArticleId><ArticleId IdType="pmc">PMC4904017</ArticleId><ArticleId IdType="pubmed">27379218</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CH, Hegde S, Marshall AC, Porras D, Gauvreau K, Balzer DT, et al. Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol. (2014) 35(1):140&#x2013;8. 10.1007/s00246-013-0752-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-013-0752-y</ArticleId><ArticleId IdType="pmc">PMC3882522</ArticleId><ArticleId IdType="pubmed">23900744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Ding S, Cai M, Bai J, Zhang M, Huang Y, et al. Impact of upper respiratory tract infections on perioperative outcomes of children undergoing therapeutic cardiac catheterisation. Acta Anaesthesiol Scand. (2018) 62(7):915&#x2013;23. 10.1111/aas.13113</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13113</ArticleId><ArticleId IdType="pubmed">29569250</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Wang S, Li M, Wu C, Sun L, Zhang S, et al. Anesthesia timing for children undergoing therapeutic cardiac catheterization after upper respiratory infection: a prospective observational study. Minerva Anestesiol. (2020) 86(8):835&#x2013;43. 10.23736/S0375-9393.20.14293-7</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0375-9393.20.14293-7</ArticleId><ArticleId IdType="pubmed">32251574</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon DB, Stevenson KK, Griffie J, Muchka S, Rapp C, Ford-Roberts K. Opioid equianalgesic calculations. J Palliat Med. (1999) 2(2):209&#x2013;18. 10.1089/jpm.1999.2.209</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.1999.2.209</ArticleId><ArticleId IdType="pubmed">15859817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. (2010) 105(Suppl 1):i16&#x2013;23. 10.1093/bja/aeq312</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq312</ArticleId><ArticleId IdType="pubmed">21148651</ArticleId></ArticleIdList></Reference><Reference><Citation>Long DR, Lihn AL, Friedrich S, Scheffenbichler FT, Safavi KC, Burns SM, et al. Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in new England. Br J Anaesth. (2018) 120(5):1090&#x2013;102. 10.1016/j.bja.2017.12.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.12.044</ArticleId><ArticleId IdType="pubmed">29661386</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Malviya S, Voepel-Lewis T, Munro HM, Seiwert M, Pandit UA. Risk factors for perioperative adverse respiratory events in children with upper respiratory tract infections. Anesthesiology. (2001) 95(2):299&#x2013;306. 10.1097/00000542-200108000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200108000-00008</ArticleId><ArticleId IdType="pubmed">11506098</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. (2018) 74(6):796&#x2013;804. 10.1016/j.eururo.2018.08.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2018.08.038</ArticleId><ArticleId IdType="pmc">PMC6261531</ArticleId><ArticleId IdType="pubmed">30241973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cron DC, Englesbe MJ, Bolton CJ, Joseph MT, Carrier KL, Moser SE, et al. Preoperative opioid use is independently associated with increased costs and worse outcomes after major abdominal surgery. Ann Surg. (2017) 265(4):695&#x2013;701. 10.1097/SLA.0000000000001901</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001901</ArticleId><ArticleId IdType="pubmed">27429021</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LW, He L, Ai Y, Chu Q, Zhang W. Site-directed topical lidocaine spray attenuates perioperative respiratory adverse events in children undergoing elective surgery. J Surg Res. (2016) 203(1):206&#x2013;10. 10.1016/j.jss.2016.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2016.03.011</ArticleId><ArticleId IdType="pubmed">27338551</ArticleId></ArticleIdList></Reference><Reference><Citation>Poonai N, Spohn J, Vandermeer B, Ali S, Bhatt M, Hendrikx S, et al. Intranasal dexmedetomidine for procedural distress in children: a systematic review. Pediatrics. (2020) 145(1):e20191623. 10.1542/peds.2019-1623</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2019-1623</ArticleId><ArticleId IdType="pubmed">31862730</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Zhang R, Cai M, Zhang K, Zhang M, Zheng J. Intranasal dexmedetomidine premedication in children with recent upper respiratory tract infection undergoing interventional cardiac catheterisation: a randomised controlled trial. Eur J Anaesthesiol. (2020) 37(2):85&#x2013;90. 10.1097/EJA.0000000000001097</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000001097</ArticleId><ArticleId IdType="pubmed">31644515</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel F, Vacher T, Julien-Marsollier F, Dadure C, Aubineau JV, Lejus C, et al. Peri-operative respiratory adverse events in children with upper respiratory tract infections allowed to proceed with anaesthesia: a French national cohort study. Eur J Anaesthesiol. (2018) 35(12):919&#x2013;28. 10.1097/EJA.0000000000000875</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000875</ArticleId><ArticleId IdType="pubmed">30124501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LK, Bernardo MKL, Grogan TR, Elashoff DA, Ren WHP. Perioperative respiratory adverse event risk assessment in children with upper respiratory tract infection: validation of the COLDS score. Paediatr Anaesth. (2018) 28(11):1007&#x2013;14. 10.1111/pan.13491</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.13491</ArticleId><ArticleId IdType="pubmed">30281195</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao S, Zhang T, Wang K, Xie F, Ni L, Mei Z, et al. Identification of the risk factors in perioperative respiratory adverse events in children under general anesthesia and the development of a predictive model. Transl Pediatr. (2021) 10(7):1877&#x2013;82. 10.21037/tp-21-257</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tp-21-257</ArticleId><ArticleId IdType="pmc">PMC8349961</ArticleId><ArticleId IdType="pubmed">34430435</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Shen F, Wei Q, Liu H, Li B, Zhang Q, et al. Development and validation of a risk nomogram model for perioperative respiratory adverse events in children undergoing airway surgery: an observational prospective cohort study. Risk Manag Healthc Policy. (2022) 15:1&#x2013;12. 10.2147/RMHP.S347401</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/RMHP.S347401</ArticleId><ArticleId IdType="pmc">PMC8747787</ArticleId><ArticleId IdType="pubmed">35023976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26032864</PMID><DateCompleted><Year>2015</Year><Month>12</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>Prediction of peri-operative adverse respiratory events in children: the role of exhaled nitric oxide.</ArticleTitle><Pagination><StartPage>1160</StartPage><EndPage>1164</EndPage><MedlinePgn>1160-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.13123</ELocationID><Abstract><AbstractText>Increased levels of exhaled nitric oxide (eNO) may be a more objective predictor in identifying children at higher risk of peri-operative adverse respiratory events than the presence of risk factors such as recent cold or wheeze. Children with either none or &#x2265;&#xa0;2 risk factors had eNO measured before surgery and any peri-operative adverse respiratory events were recorded. We found that an elevated eNO level was only predictive of adverse respiratory events in children with &#x2265;&#xa0;2 risk factors (OR 2.96 (95% CI 1.48-5.93), p&#xa0;=&#xa0;0.002). The presence of risk factors had a better predictive capability than a raised eNO level (OR 3.83 (95% CI 1.85-7.95), p&#xa0;&lt;&#xa0;0.001). The combination of both predictors did not improve the predictive capability for adverse respiratory events (OR 1.93 (95% CI 1.44-2.59), p&#xa0;&lt;&#xa0;0.001). We conclude that measuring eNO levels does not lead to improved prediction of adverse respiratory events and that, in routine clinical practice, an accurate history of risk factors remains the most appropriate tool for successfully identifying children at risk of peri-operative adverse respiratory events.</AbstractText><CopyrightInformation>&#xa9; 2015 The Association of Anaesthetists of Great Britain and Ireland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramgolam</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Respiratory Physiology, Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>G L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Pediatric Respiratory Physiology, Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Public Health, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegarty</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>B S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Pharmacology, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001944" MajorTopicYN="N">Breath Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013511" MajorTopicYN="N">Minor Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26032864</ArticleId><ArticleId IdType="doi">10.1111/anae.13123</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30384855</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Risk prediction tool for use and predictors of duration of postoperative oxygen therapy in children undergoing non-cardiac surgery: a case-control study.</ArticleTitle><Pagination><StartPage>137</StartPage><MedlinePgn>137</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">137</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-018-0595-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">We aimed to construct a prediction tool for postoperative oxygen therapy and determine predictors of duration of use among children undergoing non-cardiac surgery.</AbstractText><AbstractText Label="METHODS">Data from this case-control study was obtained from a database of 9820 children aged &lt;&#x2009;15&#xa0;years who underwent general anesthesia between January 2010 and December 2013 at a tertiary care hospital in southern Thailand. The primary outcomes were the use and duration (hours) of postoperative oxygen therapy (cases). Cases were matched with controls on age group and year of surgery in a ratio of 1:4. A negative binomial hurdle model was used to obtain significant predictors of any use and number of hours of oxygen therapy. A risk score was derived from the coefficients of the significant predictors. The risk score, adjusted odds ratio (OR) for any use and count ratio (CR) for duration of postoperative oxygen therapy and 95% confidence interval (CI) were determined.</AbstractText><AbstractText Label="RESULTS">A total of 288 cases and 1152 controls were included. The median (inter-quartile range) duration of oxygen therapy delivered was 17 (9-22) hours. An optimal risk score for predictors of oxygen use was 12 (0-32) giving an area under the receiver operating characteristic curve of 0.93. Predictors of high risk need for oxygen therapy (score&#x2009;&#x2265;&#x2009;12) were thoracic surgery (OR&#x2009;=&#x2009;278, 95% CI&#x2009;=&#x2009;44.6-1733) and having desaturation perioperatively (OR&#x2009;=&#x2009;459.8, 95% CI&#x2009;=&#x2009;169.7-1246). Intermediate risk factors (score 8-11) were having bronchospasm (OR&#x2009;=&#x2009;92.4, 95% CI&#x2009;=&#x2009;29.7-287.5) and upper airway obstruction/laryngospasm (OR&#x2009;=&#x2009;61.5, 95% CI&#x2009;=&#x2009;14.4-262.4) perioperatively. Significant predictors of duration of oxygen therapy were probably difficult airway (CR&#x2009;=&#x2009;2.2, 95% CI&#x2009;=&#x2009;1.4-3.5), history of delayed development (CR&#x2009;=&#x2009;2.3, 95% CI&#x2009;=&#x2009;1.5-3.6), airway (CR&#x2009;=&#x2009;3.0, 95% CI&#x2009;=&#x2009;1.6-5.8), orthopedic (CR&#x2009;=&#x2009;2.1, 95% CI&#x2009;=&#x2009;1.1-4.3), thoracic (CR&#x2009;=&#x2009;4.9, 95% CI&#x2009;=&#x2009;2.3-10.1) and abdominal surgery (CR&#x2009;=&#x2009;4.2, 95% CI&#x2009;=&#x2009;2.1-8.1), compared to eye surgery.</AbstractText><AbstractText Label="CONCLUSIONS">Our risk prediction tool for the use of postoperative oxygen therapy provided a high predictive ability. Children who have thoracic surgery, desaturation, bronchospasm, upper airway obstruction or laryngospasm will most likely need postoperative oxygen therapy, regardless of other factors, while those with a probably difficult airway, history of delayed development, or thoracic/abdominal surgery will most likely need longer duration of oxygen therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oofuvong</LastName><ForeName>Maliwan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5840-5965</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Songkhla, 90112, Thailand. oomaliwa@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratprasert</LastName><ForeName>Siriwimol</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Songkhla, 90112, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chanchayanon</LastName><ForeName>Thavat</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, 15 Kanjanavanich Road, Songkhla, 90112, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Duration of use</Keyword><Keyword MajorTopicYN="N">Pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">Postoperative oxygen therapy</Keyword><Keyword MajorTopicYN="N">Predictors</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by the Institutional Ethics Committee of the Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand, Chairperson Assoc. Prof. Boonsin Tangtrakulwanich, EC number 57294081 on October 8, 2014 and amendment approval EC number 57294081 on February 6, 2017. The consent to participate was not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30384855</ArticleId><ArticleId IdType="pmc">PMC6214164</ArticleId><ArticleId IdType="doi">10.1186/s12871-018-0595-4</ArticleId><ArticleId IdType="pii">10.1186/s12871-018-0595-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singh V, Gupta P, Khatana S, Bhagol A. Supplemental oxygen therapy: important considerations in oral and maxillofacial surgery. Natl J of Maxillofac Surg. 2011;2:10&#x2013;14. doi: 10.4103/0975-5950.85846.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0975-5950.85846</ArticleId><ArticleId IdType="pmc">PMC3304228</ArticleId><ArticleId IdType="pubmed">22442602</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman J. Perioperative respiratory complications in children. Lancet. 2010;376:745&#x2013;746. doi: 10.1016/S0140-6736(10)61199-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61199-3</ArticleId><ArticleId IdType="pubmed">20816527</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS. Respiratory complications in the pediatric postanesthesia care unit. Anesthesiol Clin. 2014;32:45&#x2013;61. doi: 10.1016/j.anclin.2013.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anclin.2013.10.004</ArticleId><ArticleId IdType="pubmed">24491649</ArticleId></ArticleIdList></Reference><Reference><Citation>Baijal RG, Bidani SA, Minard CG, Watcha MF. Perioperative respiratory complications following awake and deep extubation in children undergoing adenotonsillectomy. Paediatr Anaesth. 2015;25:392&#x2013;399. doi: 10.1111/pan.12561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12561</ArticleId><ArticleId IdType="pubmed">25370474</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue FS, Tong SY, Liao X, Liu JH, Zhang RJ, An G, Luo LK. Observation of the correlation of postanesthesia recovery scores with early postoperative hypoxaemia in children. Paediatr Anaesth. 1999;9:145&#x2013;151. doi: 10.1046/j.1460-9592.1999.9220256.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.1999.9220256.x</ArticleId><ArticleId IdType="pubmed">10189656</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui N, Arzola C, Teresi J, Fox G, Guerina L, Friedman Z. Predictors of desaturation in the postoperative anesthesia care unit: an observational study. J Clin Anesth. 2013;25:612&#x2013;617. doi: 10.1016/j.jclinane.2013.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2013.04.018</ArticleId><ArticleId IdType="pubmed">24095886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hintong T, Klanarong S, Suksompong S, Chua-in W, Chatmongkolchat S, Werawatganon T. The Thai Anesthesia Incident Monitoring Study (Thai AIMS) of oxygen desaturation in the post-anesthetic care unit. J Med Assoc Thail. 2008;91:1531&#x2013;1538.</Citation><ArticleIdList><ArticleId IdType="pubmed">18972896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallstrom TJ. American Association for Respiratory Care (AARC).AARC clinical practice guideline: oxygen therapy for adults in the acute care facility--2002 revision &amp; update. Respir Care. 2002;47:717&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">12078655</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Pattaravit N, Nuanjun K. Risk over time and risk factors of intraoperative respiratory events: a historical cohort study of 14,153 children. BMC Anesthesiol. 2014;14:13. doi: 10.1186/1471-2253-14-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-14-13</ArticleId><ArticleId IdType="pmc">PMC4016417</ArticleId><ArticleId IdType="pubmed">24597484</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue FS, Luo LK, Tong SY, Liao X, Deng XM, An G. Study of the safe threshold of apneic period in children during anesthesia induction. J Clin Anesth. 1996;8:568&#x2013;574. doi: 10.1016/S0952-8180(96)00138-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-8180(96)00138-9</ArticleId><ArticleId IdType="pubmed">8910179</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu MC, Pavlicova M, Nunes EV. Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial. Am J Drug Alcohol Abuse. 2011;37:367&#x2013;375. doi: 10.3109/00952990.2011.597280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00952990.2011.597280</ArticleId><ArticleId IdType="pmc">PMC3238139</ArticleId><ArticleId IdType="pubmed">21854279</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelon B, Chang HH, Ling Q, Hastings NS. Spatiotemporal hurdle models for zeroinflated count data: exploring trends in emergency department visits. Stat Methods Med Res. 2016;25:2558&#x2013;2576. doi: 10.1177/0962280214527079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280214527079</ArticleId><ArticleId IdType="pubmed">24682266</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanyam R, Yeramaneni S, Hossain MM, Anneken AM, Varughese AM. Perioperative respiratory adverse events in pediatric ambulatory anesthesia: development and validation of a risk prediction tool. Anesth Analg. 2016;122:1578&#x2013;1585. doi: 10.1213/ANE.0000000000001216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001216</ArticleId><ArticleId IdType="pubmed">27101501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomori H, Kobayashi R. Postoperative pulmonary complications in patients undergoing thoracic surgery with special reference to preoperative respiratory muscle strength and nutrition. Nihon KyobuGeka Gakkai Zasshi. 1994;42:1272&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">7989783</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz LE. Postoperative complications of thoracic surgery: their recognition and treatment. AANA J. 1980;48:222&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">7415773</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito H, Minamiya Y, Kawai H, Motoyama S, Katayose Y, Kimura K, Saito R, Ogawa JI. Estimation of pulmonary oxygen consumption in the early postoperative period after thoracic surgery. Anesthesia. 2007;62:648&#x2013;653. doi: 10.1111/j.1365-2044.2007.05058.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2007.05058.x</ArticleId><ArticleId IdType="pubmed">17567338</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Voepel-Lewis T, Christensen R, O&#x2019;Brien LM. The STBUR questionnaire for predicting perioperative respiratory adverse events in children at risk for sleep-disordered breathing. Paediatr Anaesth. 2013;23:510&#x2013;516. doi: 10.1111/pan.12155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12155</ArticleId><ArticleId IdType="pmc">PMC3648590</ArticleId><ArticleId IdType="pubmed">23551934</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, Rebmann C, Johnson C, Sly PD, Habre W. Risk assessment for respiratory complications in pediatric anesthesia: a prospective cohort study. Lancet. 2010;376:773&#x2013;783. doi: 10.1016/S0140-6736(10)61193-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Pattaravit N, Nuanjun K. Association between intraoperative and post-anesthetic care unit respiratory events among 12,641 children in southern Thailand. BJMMR. 2015;6:1101&#x2013;1112. doi: 10.9734/BJMMR/2015/15789.</Citation><ArticleIdList><ArticleId IdType="doi">10.9734/BJMMR/2015/15789</ArticleId></ArticleIdList></Reference><Reference><Citation>Uakritdathikarn T, Chongsuvivatwong V, Geater AF, Vasinanukorn M, Thinchana S, Klayna S. Perioperative desaturation and risk factors in general anesthesia. J Med Assoc Thail. 2008;91:1020&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">18839840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Voepel-Lewis T, Burke C, Kostrzewa A, Lewis I. Incidence and risk factors for perioperative adverse respiratory events in children who are obese. Anesthesiology. 2008;108:375&#x2013;380. doi: 10.1097/ALN.0b013e318164ca9b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318164ca9b</ArticleId><ArticleId IdType="pubmed">18292674</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Valois T, Withington DE. Laryngeal mask airway and difficult airway management in adolescent: a case report. Paediatr Anaesth. 2008;18:1228&#x2013;1229. doi: 10.1111/j.1460-9592.2008.02724.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2008.02724.x</ArticleId><ArticleId IdType="pubmed">18717805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanchayanon T, Suraseranivongse S, Chau-in W. The Thai Anesthesia Incidents Study (THAI Study) of difficult intubation: a qualitative analysis. J Med Assoc Thail. 2005;88(Suppl 7):S62&#x2013;S68.</Citation><ArticleIdList><ArticleId IdType="pubmed">16858984</ArticleId></ArticleIdList></Reference><Reference><Citation>Oofuvong M, Geater AF, Chongsuvivatwong V, Chanchayanon T, Sriyanaluk B, Saefung B, Nuanjun K. Excess costs and length of hospital stay attributable to perioperative respiratory events in children. Anesth Analg. 2015;120:411&#x2013;419. doi: 10.1213/ANE.0000000000000557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000557</ArticleId><ArticleId IdType="pubmed">25517194</ArticleId></ArticleIdList></Reference><Reference><Citation>Proesmans M, Vreys M, Huenaerts E, Haest E, Coremans S, Vermeulen F, Feys H. Respiratory morbidity in children with profound intellectual and multiple disability. Pediatr Pulmonol. 2015;50:1033&#x2013;1038. doi: 10.1002/ppul.23114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.23114</ArticleId><ArticleId IdType="pubmed">25327770</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil&#xe9;si C, Boubal M, Jacquot A, Baleine J, Durand S, Odena MP, Cambonie G. Highflow nasal cannula: recommendations for daily practice in pediatrics. Ann Intensive Care. 2014;4:29. doi: 10.1186/s13613-014-0029-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-014-0029-5</ArticleId><ArticleId IdType="pmc">PMC4273693</ArticleId><ArticleId IdType="pubmed">25593745</ArticleId></ArticleIdList></Reference><Reference><Citation>AARC AARC clinical practice guideline. Oxygen therapy in the home or alternate site health care facility--2007 revision &amp; update. Respir Care. 2007;52:1063&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">17715561</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh J, McGrath-Morrow SA, Collaco JM. Oxygen weaning after hospital discharge in children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2016;51:1206&#x2013;1211. doi: 10.1002/ppul.23442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.23442</ArticleId><ArticleId IdType="pmc">PMC5556369</ArticleId><ArticleId IdType="pubmed">27093064</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindal SK. Oxygen therapy: important considerations. Indian J Chest Dis Allied Sci. 2008;50:97&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">18610694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler L, James J, Byrne S, Forton J. Audit of oxygen prescribing in a children&#x2019;s hospital. Arch Dis Child. 2016;101:e2. doi: 10.1136/archdischild-2016-311535.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2016-311535.36</ArticleId><ArticleId IdType="pubmed">27540216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36119548</PMID><DateRevised><Year>2022</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1687-9740</ISSN><JournalIssue CitedMedium="Print"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>International journal of pediatrics</Title><ISOAbbreviation>Int J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study.</ArticleTitle><Pagination><StartPage>4423558</StartPage><MedlinePgn>4423558</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4423558</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/4423558</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To examine admission trends, complications, and costs for inpatient infantile hemangioma (IH) associated with propranolol therapy utilizing the Pediatric Health Information System (PHIS) database. <i>Study Design</i>. A retrospective cohort study was completed using the PHIS database. The PHIS database was queried from 2008 to 2020 for children without cardiac disease and between the ages of three weeks and one year who were admitted with a diagnosis of IH and administered propranolol. Admissions were trended annually and by geographic region. Primary outcomes were length of stay (LOS), readmission, mortality, propranolol-related complications, and costs. Bivariate and multivariable analyses were employed to identify predictors of the primary outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 2290 unique patient encounters were identified. Admissions steadily decreased after 2011, with variations by geographic region. There was no mortality and only 60 (2.6%) propranolol-related complications. African-American race (odds ratio (OR) 1.20 [95% CI: 1.02-1.41]), respiratory comorbidities (OR 2.04 [95% CI: 1.42-2.93]), neurologic conditions (OR 1.34 [95% CI: 1.09-1.59]), admission to an intensive care unit (OR 1.31 [95% CI: 1.09-1.59]), bronchospasm (OR 1.37 [95% CI: 1.22-1.55]), and hyperkalemia (OR 1.86 [95% CI: 1.08-3.20]) were associated with increased LOS. Neurologic conditions (OR 2.87 [95% CI: 1.76-4.67]) and respiratory comorbidities (OR 2.48 [CI: 1.43-4.30]) were associated with readmission. Average cost per admission was $5,158 ($3,259 to $8,560 range).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There is an overall national decline in rate of admissions for IH propranolol therapy. Inpatient admission may be beneficial for patients with neurologic or respiratory conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Muhammad Abu-Rmaileh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abu-Rmaileh</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hairston</LastName><ForeName>Hayden C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaniletti</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Children's Hospital Association, Biostatistician, Lenexa, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kompelli</LastName><ForeName>Anvesh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Kyle P</ForeName><Initials>KP</Initials><Identifier Source="ORCID">0000-0002-7333-9000</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardner</LastName><ForeName>James Reed</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolin</LastName><ForeName>Elijah H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Section of Pediatric Cardiology, University of Arkansas for Medical Sciences, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Gresham T</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Pediatr</MedlineTA><NlmUniqueID>101517077</NlmUniqueID><ISSNLinking>1687-9740</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>19</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36119548</ArticleId><ArticleId IdType="pmc">PMC9481381</ArticleId><ArticleId IdType="doi">10.1155/2022/4423558</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Darrow D. H., Greene A. K., Mancini A. J., Nopper A. J., SECTION ON DERMATOLOGY Diagnosis and management of infantile hemangioma: executive summary. Pediatrics . 2015;136(4):786&#x2013;791. doi: 10.1542/peds.2015-2482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2015-2482</ArticleId><ArticleId IdType="pubmed">26416928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y., Chen S., Xiang B., et al. Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective study. Scientific Reports . 2016;6(1) doi: 10.1038/srep31744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31744</ArticleId><ArticleId IdType="pmc">PMC4987646</ArticleId><ArticleId IdType="pubmed">27530723</ArticleId></ArticleIdList></Reference><Reference><Citation>Janmohamed S. R., de Waard-van der Spek F. B., Madern G. C., de Laat P. C. J., Hop W. C. J., Oranje A. P. Scoring the proliferative activity of haemangioma of infancy: the haemangioma activity score (HAS) Clinical and Experimental Dermatology . 2011;36(7):715&#x2013;723. doi: 10.1111/j.1365-2230.2011.04080.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2230.2011.04080.x</ArticleId><ArticleId IdType="pubmed">21933230</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins Finn M., Glowacki J., Mulliken J. B. Congenital vascular lesions: clinical application of a new classification. Journal of Pediatric Surgery . 1983;18(6):894&#x2013;900. doi: 10.1016/S0022-3468(83)80043-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3468(83)80043-8</ArticleId><ArticleId IdType="pubmed">6663421</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;aut&#xe9;-Labr&#xe8;ze C., de la Roque E. D., Hubiche T., Boralevi F., Thambo J. B., Ta&#xef;eb A. Propranolol for severe hemangiomas of infancy. The New England Journal of Medicine . 2008;358(24):2649&#x2013;2651. doi: 10.1056/NEJMc0708819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc0708819</ArticleId><ArticleId IdType="pubmed">18550886</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Gu Y., Yu Z., et al. When to stop propranolol for infantile hemangioma. Scientific Reports . 2017;7(1) doi: 10.1038/srep43292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43292</ArticleId><ArticleId IdType="pmc">PMC5320547</ArticleId><ArticleId IdType="pubmed">28225076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y., Chen S., Wang Q., et al. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management. Scientific Reports . 2018;8(1):p. 4264. doi: 10.1038/s41598-018-22787-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22787-8</ArticleId><ArticleId IdType="pmc">PMC5844887</ArticleId><ArticleId IdType="pubmed">29523832</ArticleId></ArticleIdList></Reference><Reference><Citation> PHIS.  https://www.childrenshospitals.org/phis.</Citation></Reference><Reference><Citation>Krowchuk D. P., Frieden I. J., Mancini A. J., et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics . 2019;143(1, article e20183475) doi: 10.1542/peds.2018-3475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2018-3475</ArticleId><ArticleId IdType="pubmed">30584062</ArticleId></ArticleIdList></Reference><Reference><Citation>Drolet B. A., Frommelt P. C., Chamlin S. L., et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics . 2013;131(1):128&#x2013;140. doi: 10.1542/peds.2012-1691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-1691</ArticleId><ArticleId IdType="pmc">PMC3529954</ArticleId><ArticleId IdType="pubmed">23266923</ArticleId></ArticleIdList></Reference><Reference><Citation>Espahbodi M., Yan K., Chun R. H., McCormick M. E. Management trends of infantile hemangioma: a national perspective. International Journal of Pediatric Otorhinolaryngology . 2018;104:84&#x2013;87. doi: 10.1016/j.ijporl.2017.10.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2017.10.044</ArticleId><ArticleId IdType="pubmed">29287888</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K. H., Choi T. H., Choi Y., et al. Comparison of efficacy and safety between propranolol and steroid for infantile hemangioma: a randomized clinical trial. JAMA Dermatology . 2017;153(6):529&#x2013;536. doi: 10.1001/jamadermatol.2017.0250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2017.0250</ArticleId><ArticleId IdType="pmc">PMC5817616</ArticleId><ArticleId IdType="pubmed">28423174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Ye X., Qiu Y., et al. Is propranolol safe and effective for outpatient use for infantile hemangioma? A prospective study of 679 cases from one center in China. Annals of Plastic Surgery . 2016;76(5):559&#x2013;563. doi: 10.1097/SAP.0000000000000506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SAP.0000000000000506</ArticleId><ArticleId IdType="pubmed">26101993</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh S. R., Darrow D. H., Grimmer J. F., Manning S. C., Richter G. T., Perkins J. A. Propranolol use for infantile hemangiomas. JAMA Otolaryngology &#x2013; Head &amp; Neck Surgery . 2013;139(2):153&#x2013;156. doi: 10.1001/jamaoto.2013.1218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2013.1218</ArticleId><ArticleId IdType="pubmed">23429945</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N. J., Bauman N. M. How should propranolol be initiated for infantile hemangiomas: inpatient versus outpatient? The Laryngoscope . 2014;124(6):1279&#x2013;1281. doi: 10.1002/lary.24363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.24363</ArticleId><ArticleId IdType="pubmed">24347141</ArticleId></ArticleIdList></Reference><Reference><Citation>Putterman E., Wan J., Streicher J. L., Yan A. C. Evaluation of a modified outpatient model for using propranolol to treat infantile hemangiomas. Pediatric Dermatology . 2019;36(4):471&#x2013;476. doi: 10.1111/pde.13843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pde.13843</ArticleId><ArticleId IdType="pubmed">31120143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y., Chen S., Xiang B., Li Y., Li L., Wang Q. Jagged1/Notch3 signaling modulates hemangioma-derived pericyte proliferation and maturation. Cellular Physiology and Biochemistry . 2016;40(5):895&#x2013;907. doi: 10.1159/000453148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453148</ArticleId><ArticleId IdType="pubmed">27941324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi K., Steinberg J. S., Snyder C. S. Cost-effectiveness of treating infantile haemangioma with propranolol in an outpatient setting. Cardiology in the Young . 2018;28:1105&#x2013;1108. doi: 10.1017/S1047951118000987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951118000987</ArticleId><ArticleId IdType="pubmed">30047346</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29627188</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6833</ISSN><JournalIssue CitedMedium="Internet"><Volume>198</Volume><PubDate><Year>2018</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of pediatrics</Title><ISOAbbreviation>J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Maternal Black Race and Persistent Wheezing Illness in Former Extremely Low Gestational Age Newborns: Secondary Analysis of a Randomized Trial.</ArticleTitle><Pagination><StartPage>201</StartPage><EndPage>208.e3</EndPage><MedlinePgn>201-208.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpeds.2018.02.032</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3476(18)30220-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To evaluate the relationship between maternal self-reported race/ethnicity and persistent wheezing illness in former high-risk, extremely low gestational age newborns, and to quantify the contribution of socioeconomic, environmental, and biological factors on this relationship.</AbstractText><AbstractText Label="STUDY DESIGN">We assessed persistent wheezing illness determined at 18-24 months corrected (for prematurity) age in survivors of a randomized trial. Parents/caregivers were surveyed for wheeze and inhaled asthma medication use quarterly to 12 months, and at 18 and 24 months. We used multivariable analysis to evaluate the relationship of maternal race to persistent wheezing illness, and identified mediators for this relationship via formal mediation analysis.</AbstractText><AbstractText Label="RESULTS">Of 420 infants (25.2&#x2009;&#xb1;&#x2009;1.2 weeks of gestation and 714&#x2009;&#xb1;&#x2009;166 g at birth, 57% male, 34% maternal black race), 189 (45%) had persistent wheezing illness. After adjustment for gestational age, birth weight, and sex, infants of black mothers had increased odds of persistent wheeze compared with infants of nonblack mothers (OR&#x2009;=&#x2009;2.9, 95% CI 1.9, 4.5). Only bronchopulmonary dysplasia, breast milk diet, and public insurance status were identified as mediators. In this model, the direct effect of race accounted for 69% of the relationship between maternal race and persistent wheeze, whereas breast milk diet, public insurance status, and bronchopulmonary dysplasia accounted for 8%, 12%, and 10%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS">Among former high-risk extremely low gestational age newborns, infants of black mothers have increased odds of developing persistent wheeze. A substantial proportion of this effect is directly accounted for by race, which may reflect unmeasured environmental influences, and acquired and innate biological differences.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov: NCT01022580.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wai</LastName><ForeName>Katherine C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hibbs</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steurer</LastName><ForeName>Martina A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Dennis M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselin</LastName><ForeName>Jeanette M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, UCSF Benioff Children's Hospital, Oakland, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichenwald</LastName><ForeName>Eric C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The University of Pennsylvania, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballard</LastName><ForeName>Philip L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballard</LastName><ForeName>Roberta A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Roberta L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, CA. Electronic address: kellerr@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Trial of Late Surfactant (TOLSURF) Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01022580</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>U01 HL094338</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL094355</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000004</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr</MedlineTA><NlmUniqueID>0375410</NlmUniqueID><ISSNLinking>0022-3476</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Pediatr. 2018 Jul;198:1-2. doi: 10.1016/j.jpeds.2018.04.063.</RefSource><PMID Version="1">29936956</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="Y">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062071" MajorTopicYN="N">Infant, Extremely Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007235" MajorTopicYN="N">Infant, Premature, Diseases</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009035" MajorTopicYN="Y">Mothers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">prematurity</Keyword><Keyword MajorTopicYN="N">socioeconomic factors</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Strong</LastName><ForeName>Suzanne Hamilton</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>UCSF Benioff Children's Hospital, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Immamura-Ching</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UCSF Benioff Children's Hospital, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Orfanos-Villalobos</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UCSF Benioff Children's Hospital, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UCSF Benioff Children's Hospital, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Durand</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Alta Bates Summit Medical Center, Berkeley, CA; UCSF Benioff Children's Hospital Oakland, Oakland, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Merrill</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Alta Bates Summit Medical Center, Berkeley, CA; UCSF Benioff Children's Hospital Oakland, Oakland, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Horton</LastName><ForeName>Dolia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Alta Bates Summit Medical Center, Berkeley, CA; UCSF Benioff Children's Hospital Oakland, Oakland, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pacello</LastName><ForeName>Loretta</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Alta Bates Summit Medical Center, Berkeley, CA; UCSF Benioff Children's Hospital Oakland, Oakland, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Willard</LastName><ForeName>April</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alta Bates Summit Medical Center, Berkeley, CA; UCSF Benioff Children's Hospital Oakland, Oakland, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Truog</LastName><ForeName>William E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Children's Mercy Hospital, Kansas City, MO.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gauldin</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Children's Mercy Hospital, Kansas City, MO.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Holmes</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Mercy Hospital, Kansas City, MO.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Patrice</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Children's Mercy Hospital, Kansas City, MO.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meinert</LastName><ForeName>Kerrie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Children's Mercy Hospital, Kansas City, MO.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Anne Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Women and Children's Hospital of Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lucie</LastName><ForeName>Janine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Women and Children's Hospital of Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Conway</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Women and Children's Hospital of Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sacilowski</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Women and Children's Hospital of Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Leadersdorff</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Women and Children's Hospital of Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Orbank</LastName><ForeName>Pam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Women and Children's Hospital of Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wynn</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Women and Children's Hospital of Buffalo, Buffalo, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Steinhorn</LastName><ForeName>Robin H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Anne and Robert H. Lurie Children's Hospital/Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>deUngria</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anne and Robert H. Lurie Children's Hospital/Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Janine Yasmin</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Anne and Robert H. Lurie Children's Hospital/Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hamann</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Anne and Robert H. Lurie Children's Hospital/Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Schau</LastName><ForeName>Molly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anne and Robert H. Lurie Children's Hospital/Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Brad</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Anne and Robert H. Lurie Children's Hospital/Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Jenson</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Anne and Robert H. Lurie Children's Hospital/Northwestern University, Chicago, IL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Garcia</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Texas Children's Hospital, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Parekh</LastName><ForeName>Aruna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Shariff</LastName><ForeName>Jila</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>McGovern</LastName><ForeName>Rose</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Adelman</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Combs</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Tjersland</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mayock</LastName><ForeName>Dennis E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Howland</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Longoria</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meo</LastName><ForeName>Holly</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>McDavid</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Burson</LastName><ForeName>Katrina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hinojosa</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>Shawna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wright</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Texas Health Science Center, Houston, TX.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hudak</LastName><ForeName>Mark L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barnette</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kellum</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Burcke</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hayes</LastName><ForeName>Christie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chadwick</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Howard</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Prince</LastName><ForeName>Renee</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Florida College of Medicine, Jacksonville, UF Health Shands Hospital, Wolfson Children's Hospital, Jacksonville, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Helderman</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine and Forsyth Medical Center, Winston Salem, NC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>O'Shea</LastName><ForeName>T Michael</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine and Forsyth Medical Center, Winston Salem, NC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Stefanescu</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine and Forsyth Medical Center, Winston Salem, NC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Warden</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine and Forsyth Medical Center, Winston Salem, NC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Patty</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine and Forsyth Medical Center, Winston Salem, NC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Griffin</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine and Forsyth Medical Center, Winston Salem, NC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Conley</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine and Forsyth Medical Center, Winston Salem, NC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bendel</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>University of Minnesota Amplatz Children's Hospital, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Georgieff</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Minnesota Amplatz Children's Hospital, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Davern</LastName><ForeName>Bridget</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Minnesota Amplatz Children's Hospital, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mills</LastName><ForeName>Marla</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Minnesota Amplatz Children's Hospital, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ritter</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Minnesota Amplatz Children's Hospital, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wagner</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ryan</LastName><ForeName>Rita M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fanning</LastName><ForeName>Deanna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Roberson</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mammel</LastName><ForeName>Mark C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, St. Paul, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lampland</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, St. Paul, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Meyers</LastName><ForeName>Pat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, St. Paul, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brey</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, St. Paul, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bendel-Stenzel</LastName><ForeName>Ellen M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mulrooney</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Worwa</LastName><ForeName>Cathy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dixon</LastName><ForeName>Pam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ebert</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hejl</LastName><ForeName>Cathy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maxwell</LastName><ForeName>Molly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>McCullough</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Children's Hospitals and Clinics of Minnesota, Minneapolis, MN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dhanireddy</LastName><ForeName>Ramasubbareddy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>El Abiad</LastName><ForeName>Mohammed T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Talati</LastName><ForeName>Ajay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Dempsey</LastName><ForeName>Sheila</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gammage</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gower</LastName><ForeName>Gayle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>James</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>LeNoue</LastName><ForeName>Pam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Tennessee Health Science Center, Memphis, TN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>McKay</LastName><ForeName>Victor J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>All Children's Hospital, St. Petersburg, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Suzi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>All Children's Hospital, St. Petersburg, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bruton</LastName><ForeName>Dawn</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>All Children's Hospital, St. Petersburg, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Beaulieu</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>All Children's Hospital, St. Petersburg, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>All Children's Hospital, St. Petersburg, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wadhawan</LastName><ForeName>Rajan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Florida Hospital for Children, Orlando, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Barron-Nelson</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Florida Hospital for Children, Orlando, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>Shane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Florida Hospital for Children, Orlando, FL.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Courtney</LastName><ForeName>Sherry E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Arkansas Children's Hospital, University of Arkansas Medical Sciences, Little Rock, AK.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sikes</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Arkansas Children's Hospital, University of Arkansas Medical Sciences, Little Rock, AK.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Lowe</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Arkansas Children's Hospital, University of Arkansas Medical Sciences, Little Rock, AK.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Proffitt</LastName><ForeName>Betty</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Arkansas Children's Hospital, University of Arkansas Medical Sciences, Little Rock, AK.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>Elizabeth E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Clinical Coordinating Center; Department of Pediatrics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Chapin</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinical Coordinating Center; Department of Pediatrics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Horneman</LastName><ForeName>Hart</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Coordinating Center; Department of Pediatrics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hamann</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinical Coordinating Center; Department of Pediatrics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kelley</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Coordinating Center; Department of Pediatrics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Knowles</LastName><ForeName>Karin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newton</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Coordinating Center; Department of Pediatrics, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vittinghoff</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Data Coordinating Center; Department of Epidemiology and Biostatistics , University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hietpas</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Data Coordinating Center; Department of Epidemiology and Biostatistics , University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Denton</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Data Coordinating Center; Department of Epidemiology and Biostatistics , University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Palermo</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Data Coordinating Center; Department of Epidemiology and Biostatistics , University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Data Coordinating Center; Department of Epidemiology and Biostatistics , University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29627188</ArticleId><ArticleId IdType="mid">NIHMS945678</ArticleId><ArticleId IdType="pmc">PMC6019148</ArticleId><ArticleId IdType="doi">10.1016/j.jpeds.2018.02.032</ArticleId><ArticleId IdType="pii">S0022-3476(18)30220-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harju M, Keski-Nisula L, Georgiadis L, Raisanen S, Gissler M, Heinonen S. The burden of childhood asthma and late preterm and early term births. J Pediatr. 2014;164:295&#x2013;9.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">24210922</ArticleId></ArticleIdList></Reference><Reference><Citation>Astle V, Broom M, Todd DA, Charles B, Ringland C, Ciszek K, et al. Respiratory outcomes study (RESPOS) for preterm infants at primary school age. J Asthma. 2015;52:40&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25162302</ArticleId></ArticleIdList></Reference><Reference><Citation>Been JV, Lugtenberg MJ, Smets E, van Schayck CP, Kramer BW, Mommers M, et al. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3904844</ArticleId><ArticleId IdType="pubmed">24492409</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards MO, Kotecha SJ, Lowe J, Richards L, Watkins WJ, Kotecha S. Management of Prematurity-Associated Wheeze and Its Association with Atopy. PLoS One. 2016;11:e0155695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4874578</ArticleId><ArticleId IdType="pubmed">27203564</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar GJ, Masaquel AS, Li SX, Walsh EM, Kipnis P. Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy. BMC Pediatr. 2013;13:97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3703269</ArticleId><ArticleId IdType="pubmed">23782528</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinbami LJ, Simon AE, Rossen LM. Changing Trends in Asthma Prevalence Among Children. Pediatrics. 2016;137</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755484</ArticleId><ArticleId IdType="pubmed">26712860</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold DR, Rotnitzky A, Damokosh AI, Ware JH, Speizer FE, Ferris BG, Jr, et al. Race and gender differences in respiratory illness prevalence and their relationship to environmental exposures in children 7 to 14 years of age. Am Rev Respir Dis. 1993;148:10&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8317784</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam JY, Keller RL, Aschner JL, Hartert TV, Moore PE. Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia. Am J Respir Crit Care Med. 2015;192:134&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532824</ArticleId><ArticleId IdType="pubmed">26038806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R, Yu Y, Story RE, Pongracic JA, Gupta R, Pearson C, et al. Prematurity, chorioamnionitis, and the development of recurrent wheezing: a prospective birth cohort study. J Allergy Clin Immunol. 2008;121:878&#x2013;84.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2993062</ArticleId><ArticleId IdType="pubmed">18313129</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar GJ, Ragins A, Li SX, Prager L, Masaquel AS, Kipnis P. Recurrent wheezing in the third year of life among children born at 32 weeks&#x2019; gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life. Arch Pediatr Adolesc Med. 2010;164:915&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">20921348</ArticleId></ArticleIdList></Reference><Reference><Citation>Robison RG, Kumar R, Arguelles LM, Hong X, Wang G, Apollon S, et al. Maternal smoking during pregnancy, prematurity and recurrent wheezing in early childhood. Pediatr Pulmonol. 2012;47:666&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756665</ArticleId><ArticleId IdType="pubmed">22290763</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickland MJ, Klein M, Flanders WD, Chang HH, Mulholland JA, Tolbert PE, et al. Modification of the effect of ambient air pollution on pediatric asthma emergency visits: susceptible subpopulations. Epidemiology. 2014;25:843&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4727963</ArticleId><ArticleId IdType="pubmed">25192402</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbs AM, Babineau DC, Wang X, Redline S. Race differences in the association between multivitamin exposure and wheezing in preterm infants. J Perinatol. 2015;35:192&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4342282</ArticleId><ArticleId IdType="pubmed">25275695</ArticleId></ArticleIdList></Reference><Reference><Citation>Taveras EM, Camargo CA, Jr, Rifas-Shiman SL, Oken E, Gold DR, Weiss ST, et al. Association of birth weight with asthma-related outcomes at age 2 years. Pediatr Pulmonol. 2006;41:643&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1488724</ArticleId><ArticleId IdType="pubmed">16703577</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AF, Huang B, Simmons JM, Moncrief T, Sauers HS, Chen C, et al. Role of financial and social hardships in asthma racial disparities. Pediatrics. 2014;133:431&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934338</ArticleId><ArticleId IdType="pubmed">24488745</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck AF, Huang B, Auger KA, Ryan PH, Chen C, Kahn RS. Explaining Racial Disparities in Child Asthma Readmission Using a Causal Inference Approach. JAMA Pediatr. 2016;170:695&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5503118</ArticleId><ArticleId IdType="pubmed">27182793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, et al. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr. 2016;168:23&#x2013;9.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4698022</ArticleId><ArticleId IdType="pubmed">26500107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wai KC, Kohn MA, Ballard RA, Truog WE, Black DM, Asselin JM, et al. Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. J Pediatr. 2016;177:97&#x2013;102.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5037007</ArticleId><ArticleId IdType="pubmed">27470692</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller RL, Eichenwald EC, Hibbs AM, Rogers EE, Wai KC, Black DM, et al. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017;183:19&#x2013;25.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367937</ArticleId><ArticleId IdType="pubmed">28100402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakefield M, Banham D, Martin J, Ruffin R, McCaul K, Badcock N. Restrictions on smoking at home and urinary cotinine levels among children with asthma. Am J Prev Med. 2000;19:188&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">11020596</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaco JM, Aherrera AD, Breysse PN, Winickoff JP, Klein JD, McGrath-Morrow SA. Hair nicotine levels in children with bronchopulmonary dysplasia. Pediatrics. 2015;135:e678&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4533246</ArticleId><ArticleId IdType="pubmed">25647675</ArticleId></ArticleIdList></Reference><Reference><Citation>Litonjua AA, Carey VJ, Laranjo N, Harshfield BJ, McElrath TF, O&#x2019;Connor GT, et al. Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The VDAART Randomized Clinical Trial. JAMA. 2016;315:362&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7479967</ArticleId><ArticleId IdType="pubmed">26813209</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">3806354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenkranz RA, Das A, Wrage LA, Poindexter BB, Higgins RD, Stoll BJ, et al. Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res. 2011;69:522&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3090495</ArticleId><ArticleId IdType="pubmed">21378596</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou JY, Park DS, Burchard EG, Torgerson DG, Pino-Yanes M, Song YS, et al. Genetic and socioeconomic study of mate choice in Latinos reveals novel assortment patterns. Proc Natl Acad Sci U S A. 2015;112:13621&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4640764</ArticleId><ArticleId IdType="pubmed">26483472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, et al. Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation. N Engl J Med. 2006;355:343&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16870913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard RA. Inhaled nitric oxide in preterm infants&#x2013;correction. N Engl J Med. 2007;357:1444&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17914048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibbs AM, Walsh MC, Martin RJ, Truog WE, Lorch SA, Alessandrini E, et al. One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial. J Pediatr. 2008;153:525&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2745607</ArticleId><ArticleId IdType="pubmed">18534620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynne J, Hull D. Why are children admitted to hospital? Br Med J. 1977;2:1140&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1632263</ArticleId><ArticleId IdType="pubmed">589026</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson JP, Cowen P, Lewis RA. The relationship between asthma admission rates, routes of admission, and socioeconomic deprivation. Eur Respir J. 1996;9:2087&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">8902471</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpern ER, Stanley RM, Gorelick MH, Donaldson A, Knight S, Teach SJ, et al. Epidemiology of a pediatric emergency medicine research network: the PECARN Core Data Project. Pediatr Emerg Care. 2006;22:689&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">17047467</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin JA, Anderson EJ, Wu X, Ambrose CS, Simoes EA. Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32&#x2013;35 Weeks Gestational Age. Open Forum Infect Dis. 2016;3:ofw163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5047408</ArticleId><ArticleId IdType="pubmed">27704018</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell S, To T. Breastfeeding and asthma in young children: findings from a population-based study. Arch Pediatr Adolesc Med. 2001;155:1261&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11695937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial asthma in childhood: a systematic review with meta-analysis of prospective studies. J Pediatr. 2001;139:261&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487754</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinbami LJ, Kit BK, Simon AE. Impact of environmental tobacco smoke on children with asthma, United States, 2003&#x2013;2010. Acad Pediatr. 2013;13:508&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756763</ArticleId><ArticleId IdType="pubmed">24021528</ArticleId></ArticleIdList></Reference><Reference><Citation>Howrylak JA, Spanier AJ, Huang B, Peake RW, Kellogg MD, Sauers H, et al. Cotinine in children admitted for asthma and readmission. Pediatrics. 2014;133:e355&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3904280</ArticleId><ArticleId IdType="pubmed">24446438</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFranco E, Moravec W, Xu F, Hall E, Hossain M, Haynes EN, et al. Exposure to airborne particulate matter during pregnancy is associated with preterm birth: a population-based cohort study. Environ Health. 2016;15:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4714531</ArticleId><ArticleId IdType="pubmed">26768419</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins JW, Jr, Rankin KM, David RJ. African American women&#x2019;s lifetime upward economic mobility and preterm birth: the effect of fetal programming. Am J Public Health. 2011;101:714&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3052339</ArticleId><ArticleId IdType="pubmed">21330589</ArticleId></ArticleIdList></Reference><Reference><Citation>Burchard EG, Silverman EK, Rosenwasser LJ, Borish L, Yandava C, Pillari A, et al. Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med. 1999;160:919&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">10471619</ArticleId></ArticleIdList></Reference><Reference><Citation>Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348:1170&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">12646676</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng TL, Goodman E. Race, ethnicity, and socioeconomic status in research on child health. Pediatrics. 2015;135:e225&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923597</ArticleId><ArticleId IdType="pubmed">25548336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Pacheco N, Flores C, Oh SS, Burchard EG, Pino-Yanes M. What Ancestry Can Tell Us About the Genetic Origins of Inter-Ethnic Differences in Asthma Expression. Curr Allergy Asthma Rep. 2016;16:53.</Citation><ArticleIdList><ArticleId IdType="pubmed">27393700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright AL, Holberg CJ, Taussig LM, Martinez FD. Relationship of infant feeding to recurrent wheezing at age 6 years. Arch Pediatr Adolesc Med. 1995;149:758&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7795765</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocks J, Dezateux C. The effect of parental smoking on lung function and development during infancy. Respirology. 2003;8:266&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">14528876</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldrich MC, Kumar R, Colangelo LA, Williams LK, Sen S, Kritchevsky SB, et al. Genetic ancestry-smoking interactions and lung function in African Americans: a cohort study. PLoS One. 2012;7:e39541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3380861</ArticleId><ArticleId IdType="pubmed">22737244</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvoy CT, Schilling D, Clay N, Jackson K, Go MD, Spitale P, et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. JAMA. 2014;311:2074&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4296045</ArticleId><ArticleId IdType="pubmed">24838476</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller RL, Feng R, DeMauro SB, Ferkol T, Hardie W, Rogers EE, et al. Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. J Pediatr. 2017;187:89&#x2013;97.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5533632</ArticleId><ArticleId IdType="pubmed">28528221</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold DR, Burge HA, Carey V, Milton DK, Platts-Mills T, Weiss ST. Predictors of repeated wheeze in the first year of life: the relative roles of cockroach, birth weight, acute lower respiratory illness, and maternal smoking. Am J Respir Crit Care Med. 1999;160:227&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">10390405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly NP, Gold DR, Weiss ST, Celedon JC. Recurrent wheeze in early childhood and asthma among children at risk for atopy. Pediatrics. 2006;117:e1132&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16740815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallol J, Garcia-Marcos L, Sole D, Brand P. International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources. Thorax. 2010;65:1004&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20855440</ArticleId></ArticleIdList></Reference><Reference><Citation>Pless CE, Pless IB. How well they remember. The accuracy of parent reports. Arch Pediatr Adolesc Med. 1995;149:553&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7735412</ArticleId></ArticleIdList></Reference><Reference><Citation>Boggs E, Minich N, Hibbs AM. Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm. Open J Pediatr. 2013;3:260&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3997171</ArticleId><ArticleId IdType="pubmed">24772379</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza-Vazirani D, Minkovitz CS, Strobino DM. Validity of maternal report of acute health care use for children younger than 3 years. Arch Pediatr Adolesc Med. 2005;159:167&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699311</ArticleId></ArticleIdList></Reference><Reference><Citation>Torgerson DG, Giri T, Druley TE, Zheng J, Huntsman S, Seibold MA, et al. Pooled Sequencing of Candidate Genes Implicates Rare Variants in the Development of Asthma Following Severe RSV Bronchiolitis in Infancy. PLoS One. 2015;10:e014264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4654486</ArticleId><ArticleId IdType="pubmed">26587832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha SJ, Edwards MO, Watkins WJ, Henderson AJ, Paranjothy S, Dunstan FD, et al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax. 2013;68:760&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23604458</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27639938</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6825</ISSN><JournalIssue CitedMedium="Internet"><Volume>139</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of allergy and clinical immunology</Title><ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>In utero exposure to 25-hydroxyvitamin D and risk of childhood asthma, wheeze, and respiratory tract infections: A&#xa0;meta-analysis of birth cohort studies.</ArticleTitle><Pagination><StartPage>1508</StartPage><EndPage>1517</EndPage><MedlinePgn>1508-1517</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2016.06.065</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0091-6749(16)30962-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies of the associations between in utero 25-hydroxyvitamin D (25[OH]D) exposure and risk of childhood asthma, wheeze, and respiratory tract infections are inconsistent and inconclusive.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We sought to assess associations between 25(OH)D levels in cord blood or maternal venous blood and risk of offspring's asthma, wheeze, and respiratory tract infections.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data were derived from PubMed, Embase, Google Scholar, references from relevant articles, and de novo results from published studies until December 2015. A&#xa0;random-effects meta-analysis was conducted among 16 birth cohort studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Comparing the highest with the lowest category of 25(OH)D levels, the pooled odds ratios were 0.84 (95% CI, 0.70-1.01; P&#xa0;=&#xa0;.064) for asthma, 0.77 (95% CI, 0.58-1.03; P&#xa0;=&#xa0;.083) for wheeze, and 0.85 (95% CI, 0.66-1.09; P&#xa0;=&#xa0;.187) for respiratory tract infections. The observed inverse association for wheeze was more pronounced and became statistically significant in the studies that measured 25(OH)D levels in cord blood (0.43; 95% CI, 0.29-0.62; P&#xa0;&lt;&#xa0;.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Accumulated evidence generated from this meta-analysis suggests that increased in utero exposure to 25(OH)D is inversely associated with the risk of asthma and wheeze during childhood. These findings are in keeping with the results of 2 recently published randomized clinical trials of vitamin D supplementation during pregnancy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Haixia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xun</LastName><ForeName>Pengcheng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health-Bloomington, Indiana University, Bloomington, Ind.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pike</LastName><ForeName>Katharine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Respiratory, Critical Care and Anaesthesia, UCL Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wills</LastName><ForeName>Andrew K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chawes</LastName><ForeName>Bo L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bisgaard</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, and the Shanghai Institute of Pediatric Research, Shanghai, China; Department of Pediatric Surgery, Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Yanping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address: wanyp204@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ka</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health-Bloomington, Indiana University, Bloomington, Ind. Electronic address: kahe@indiana.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G9815508</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol</MedlineTA><NlmUniqueID>1275002</NlmUniqueID><ISSNLinking>0091-6749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>A288AR3C9H</RegistryNumber><NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005312" MajorTopicYN="N">Fetal Blood</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008431" MajorTopicYN="Y">Maternal-Fetal Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="Y">Respiratory Sounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">25(OH)D</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">birth cohort studies</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">respiratory tract infections</Keyword><Keyword MajorTopicYN="N">wheeze</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27639938</ArticleId><ArticleId IdType="doi">10.1016/j.jaci.2016.06.065</ArticleId><ArticleId IdType="pii">S0091-6749(16)30962-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19854614</PMID><DateCompleted><Year>2010</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-0020</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>1</Issue><PubDate><Year>2010</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of oral and maxillofacial surgery</Title><ISOAbbreviation>Int J Oral Maxillofac Surg</ISOAbbreviation></Journal><ArticleTitle>Complications of sevoflurane-fentanyl versus midazolam-fentanyl anesthesia in pediatric cleft lip and palate surgery: a randomized comparison study.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>9</EndPage><MedlinePgn>5-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijom.2009.09.007</ELocationID><Abstract><AbstractText>Careful choice of anesthetic agents in pediatric patients reduces the frequency of anesthesia-related complications. The frequency and type of intraoperative and postoperative complications of sevoflurane-fentanyl versus midazolam-fentanyl anesthesia were compared in 140 consecutive children (aged 3 months to 10 years) undergoing cleft lip and palate repair. Midazolam-fentanyl anesthesia was induced with midazolam (0.05 mg/kg), fentanyl (0.005 mg/kg) and vecuronium (0.1mg/kg), and maintained with the same agents according to the defined parametars. Sevoflurane-fentanyl anesthesia was induced and maintained with sevoflurane (5-8 vol% and 0.8-1 vol%, respectively) in an oxygen/air mixture and supplemented with fentanyl (0.005 mg/kg). Both groups were comparable in basic demographic data, hemodynamic and respiratory parameters. Difficult intubation occurred in 6 of 76 children (midazolam-fentanyl group) and 4 of 64 children (sevoflurane-fentanyl group) (P=0.754). Ventricular extrasystole and bronchospasm occurred in one patient each in the sevoflurane-fentanyl group. Postoperatively, emergence agitation was observed in the sevoflurane-fentanyl group (17 cases; P&lt;0.001); postoperative nausea and vomiting occurred in 2 children (midazolam-fentanyl group) and 3 children (sevoflurane-fentanyl group) (P=0.660). Midazolam-based anesthesia in children is safer than sevoflurane-based anesthesia regarding occurrence of emergence agitation.</AbstractText><CopyrightInformation>Copyright 2009 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mili&#x107;</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Dubrava University Hospital, Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goranovi&#x107;</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Knezevi&#x107;</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Int J Oral Maxillofac Surg</MedlineTA><NlmUniqueID>8605826</NlmUniqueID><ISSNLinking>0901-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019162">Anesthetics, Combined</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003473">Neuromuscular Nondepolarizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>7E4PHP5N1D</RegistryNumber><NameOfSubstance UI="D014673">Vecuronium Bromide</NameOfSubstance></Chemical><Chemical><RegistryNumber>R60L0SM5BC</RegistryNumber><NameOfSubstance UI="D008874">Midazolam</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019162" MajorTopicYN="N">Anesthetics, Combined</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002971" MajorTopicYN="N">Cleft Lip</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002972" MajorTopicYN="N">Cleft Palate</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="N">Methyl Ethers</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008874" MajorTopicYN="N">Midazolam</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003473" MajorTopicYN="N">Neuromuscular Nondepolarizing Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010149" MajorTopicYN="N">Pain, Postoperative</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020250" MajorTopicYN="N">Postoperative Nausea and Vomiting</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011229" MajorTopicYN="N">Preanesthetic Medication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011595" MajorTopicYN="N">Psychomotor Agitation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014673" MajorTopicYN="N">Vecuronium Bromide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018879" MajorTopicYN="N">Ventricular Premature Complexes</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2009</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19854614</ArticleId><ArticleId IdType="doi">10.1016/j.ijom.2009.09.007</ArticleId><ArticleId IdType="pii">S0901-5027(09)01103-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34188527</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>International journal of general medicine</Title><ISOAbbreviation>Int J Gen Med</ISOAbbreviation></Journal><ArticleTitle>Pressure-Controlled Volume-Guaranteed Ventilation Improves Respiratory Dynamics in Pediatric Patients During Laparoscopic Surgery: A Prospective Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>2721</StartPage><EndPage>2728</EndPage><MedlinePgn>2721-2728</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S318008</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Pressure-controlled volume-guaranteed (PCV-VG) combines the characteristics of pressure-controlled ventilation (PCV) and volume-controlled ventilation (VCV). It has been reported that PCV-VG decreases airway pressure and improves oxygenation among the adult group. In this study, the respiratory dynamics of PCV-VG and VCV are compared in pediatric patients ventilated with laryngeal mask airway and underwent laparoscopic hernia of the sac ligation.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Sixty-four pediatric patients were included in this prospective, randomized clinical trial. Pediatric patients were randomly allocated to receive VCV and PCV-VG ventilation during the general anesthesia. The hemodynamic and respiratory variables were recorded at the time when laryngeal mask airway was placed, pneumoperitoneum began, 5 mins after pneumoperitoneum began, pneumoperitoneum ended, and the operation ended respectively. The respiratory adverse events were recorded after the operation and on the first day after the operation. In this study, respiratory adverse events are defined as cough, hoarseness, hypoxemia, laryngospasm, bronchospasm, and sore throat.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no statistical difference in hemodynamic variables at all time points between the two groups. Compared to the VCV group, peak airway pressure (Ppeak) and plateau airway pressure in the PCV-VG group decreased significantly. Pulmonary dynamic compliance (Cydn) in the PCV-VG group was significantly higher than that in the VCV group. The respiratory adverse events appeared to have no statistical difference between VCV and PCV groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PCV-VG provides a lower Ppeak and better Cydn in pediatric patients compared with the VCV group during laparoscopic surgery. The results suggested that PCV-VG may be a superior way of mechanical ventilation for pediatric patients who ventilated with laryngeal mask airway and experienced laparoscopic surgery.</AbstractText><CopyrightInformation>&#xa9; 2021 Liu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yuanyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xuesheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Erwei</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3855-7627</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Int J Gen Med</MedlineTA><NlmUniqueID>101515487</NlmUniqueID><ISSNLinking>1178-7074</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse events</Keyword><Keyword MajorTopicYN="N">mechanical ventilation</Keyword><Keyword MajorTopicYN="N">pediatric anesthesia</Keyword><Keyword MajorTopicYN="N">pediatric intensive care</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34188527</ArticleId><ArticleId IdType="pmc">PMC8235931</ArticleId><ArticleId IdType="doi">10.2147/IJGM.S318008</ArticleId><ArticleId IdType="pii">318008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Keidan I, Berkenstadt H, Segal E, et al. Pressure versus volume-controlled ventilation with a laryngeal mask airway in paediatric patients. Paediatr Anaesth. 2001;11:691&#x2013;694. doi:10.1046/j.1460-9592.2001.00746.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2001.00746.x</ArticleId><ArticleId IdType="pubmed">11696145</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, Zhu H, Shi H, et al. Volume-targeted ventilation is more suitable than pressure-limited ventilation for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2014;99:F158&#x2013;165. doi:10.1136/archdischild-2013-304613</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2013-304613</ArticleId><ArticleId IdType="pubmed">24277660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Lee SK, Kim KM, et al. Comparison of volume-controlled ventilation mode and pressure-controlled ventilation with volume-guaranteed mode in the prone position during lumbar spine surgery. BMC Anesthesiol. 2019;19:133. doi:10.1186/s12871-019-0806-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-019-0806-7</ArticleId><ArticleId IdType="pmc">PMC6661081</ArticleId><ArticleId IdType="pubmed">31351445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghabach MB, El Hajj EM, El Dib RD, et al. Ventilation of nonparalyzed patients under anesthesia with laryngeal mask airway, comparison of three modes of ventilation: volume controlled ventilation, pressure controlled ventilation, and pressure controlled ventilation-volume guarantee. Anesth Essays Res. 2017;11:197&#x2013;200. doi:10.4103/0259-1162.200238</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0259-1162.200238</ArticleId><ArticleId IdType="pmc">PMC5341651</ArticleId><ArticleId IdType="pubmed">28298784</ArticleId></ArticleIdList></Reference><Reference><Citation>Natalini G, Facchetti P, Dicembrini MA, et al. Pressure controlled versus volume controlled ventilation with laryngeal mask airway. J Clin Anesth. 2001;13:436&#x2013;439. doi:10.1016/S0952-8180(01)00297-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-8180(01)00297-5</ArticleId><ArticleId IdType="pubmed">11578888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadi P, Guenoun T, Journois D, et al. Pressure-controlled ventilation improves oxygenation during laparoscopic obesity surgery compared with volume-controlled ventilation. Br J Anaesth. 2008;100:709&#x2013;716. doi:10.1093/bja/aen067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen067</ArticleId><ArticleId IdType="pubmed">18407943</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Casas JB, Montoya R. Difference in inspiratory flow between volume and pressure control ventilation in patients with flow dyssynchrony. J Crit Care. 2017;42:264&#x2013;267. doi:10.1016/j.jcrc.2017.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.08.007</ArticleId><ArticleId IdType="pubmed">28802791</ArticleId></ArticleIdList></Reference><Reference><Citation>Toker MK, Altiparmak B, Uysal AI, et al. [Comparison of pressure-controlled volume-guaranteed ventilation and volume-controlled ventilation in obese patients during gynecologic laparoscopic surgery in the Trendelenburg position]. Rev Bras Anestesiol. 2019;69:553&#x2013;560. (Portuguese). doi:10.1016/j.bjan.2019.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjan.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC9391862</ArticleId><ArticleId IdType="pubmed">31836201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothari A, Baskaran D. Pressure-controlled volume guaranteed mode improves respiratory dynamics during laparoscopic cholecystectomy: a comparison with conventional modes. Anesth Essays Res. 2018;12:206&#x2013;212. doi:10.4103/aer.AER_96_17</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aer.AER_96_17</ArticleId><ArticleId IdType="pmc">PMC5872865</ArticleId><ArticleId IdType="pubmed">29628583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YS, Won YJ, Lee DK, et al. Lung ultrasound score-based perioperative assessment of pressure-controlled ventilation-volume guaranteed or volume-controlled ventilation in geriatrics: a prospective randomized controlled trial. Clin Interv Aging. 2019;14:1319&#x2013;1329. doi:10.2147/CIA.S212334</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S212334</ArticleId><ArticleId IdType="pmc">PMC6646045</ArticleId><ArticleId IdType="pubmed">31409981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Lee SK, Rhim CC, et al. Comparison of volume-controlled, pressure-controlled, and pressure-controlled volume-guaranteed ventilation during robot-assisted laparoscopic gynecologic surgery in the Trendelenburg position. Int J Med Sci. 2020;17:2728&#x2013;2734. doi:10.7150/ijms.49253</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.49253</ArticleId><ArticleId IdType="pmc">PMC7645327</ArticleId><ArticleId IdType="pubmed">33162800</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao W, Yang M, Cheng Q, et al. Effect of pressure-controlled ventilation-volume guaranteed on one-lung ventilation in elderly patients undergoing thoracotomy. Med Sci Monit. 2020;26:e921417. doi:10.12659/MSM.921417</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.921417</ArticleId><ArticleId IdType="pmc">PMC7058148</ArticleId><ArticleId IdType="pubmed">32092047</ArticleId></ArticleIdList></Reference><Reference><Citation>Song SY, Jung JY, Cho MS, et al. Volume-controlled versus pressure-controlled ventilation-volume guaranteed mode during one-lung ventilation. Korean J Anesthesiol. 2014;67:258&#x2013;263. doi:10.4097/kjae.2014.67.4.258</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kjae.2014.67.4.258</ArticleId><ArticleId IdType="pmc">PMC4216788</ArticleId><ArticleId IdType="pubmed">25368784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31791239</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial.</ArticleTitle><Pagination><StartPage>219</StartPage><MedlinePgn>219</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">219</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-019-0892-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Tracheobronchial foreign body aspiration in children is a life-threatening, emergent situation. Currently, the use of fiberoptic bronchoscopy for removing foreign bodies is attracting increasing attention. Oxygen desaturation, body movement, laryngospasm, bronchospasm, and breath-holding are common adverse events during foreign body removal. Dexmedetomidine, as a highly selective &#x3b1;<sub>2</sub>-adrenergic agonist, produces sedative and analgesic effects, and does not induce respiratory depression. We hypothesized that intranasal dexmedetomidine at 1&#xa0;&#x3bc;g&#xa0;kg&#x2009;-&#x2009;1 administered 25&#x2009;min before anesthesia induction can reduce the incidence of adverse events during fiberoptic bronchoscopy under inhalation general anesthesia with sevoflurane.</AbstractText><AbstractText Label="METHODS">In all, 40 preschool-aged children (6-48&#x2009;months) with an American Society of Anesthesiologists physical status of I or II were randomly allocated to receive either intranasal dexmedetomidine at 1&#xa0;&#x3bc;g&#xb7;kg&#x2009;-&#x2009;1 or normal saline at 0.01&#xa0;ml&#xa0;kg<sup>-&#x2009;1</sup> 25&#x2009;min before anesthesia induction. The primary outcome was the incidence of perioperative adverse events. Heart rate, respiratory rate, parent-child separation score, tolerance of the anesthetic mask, agitation score, consumption of sevoflurane, and recovery time were also recorded.</AbstractText><AbstractText Label="RESULTS">Following pre-anesthesia treatment with either intranasal dexmedetomidine or saline, the incidences of laryngospasm (15% vs. 50%), breath-holding (10% vs. 40%), and coughing (5% vs. 30%) were significantly lower in patients given dexmedetomidine than those given saline. Patients who received intranasal dexmedetomidine had a lower parent-child separation score (P&#xa0;=&#x2009;0.017), more satisfactory tolerance of the anesthetic mask (P&#xa0;=&#x2009;0.027), and less consumption of sevoflurane (38.18&#x2009;&#xb1;&#x2009;14.95 vs. 48.03&#x2009;&#xb1;&#x2009;14.45&#x2009;ml, P&#xa0;=&#x2009;0.041). The frequency of postoperative agitation was significantly lower in patients given intranasal dexmedetomidine (P&#xa0;=&#x2009;0.004), and the recovery time was similar in the two groups.</AbstractText><AbstractText Label="CONCLUSIONS">Intranasal dexmedetomidine 1&#xa0;&#x3bc;g&#xb7;kg<sup>-&#x2009;1</sup>, with its sedative and analgesic effects, reduced the incidences of laryngospasm, breath-holding, and coughing during fiberoptic bronchoscopy for FB removal. Moreover, it reduced postoperative agitation without a prolonged recovery time.</AbstractText><AbstractText Label="TRAIL REGISTRATION">The study was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR1800017273) on July 20, 2018.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Yanmei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yushan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4246-7648</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China. lwu2019@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan Province, China. lwu2019@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ChiCTR</DataBankName><AccessionNumberList><AccessionNumber>ChiCTR1800017273</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="N">Dexmedetomidine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005336" MajorTopicYN="N">Fiber Optic Technology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005547" MajorTopicYN="N">Foreign Bodies</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011292" MajorTopicYN="N">Premedication</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053120" MajorTopicYN="N">Respiratory Aspiration</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dexmedetomidine</Keyword><Keyword MajorTopicYN="N">Fiberoptic bronchoscopy</Keyword><Keyword MajorTopicYN="N">Foreign body</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31791239</ArticleId><ArticleId IdType="pmc">PMC6886218</ArticleId><ArticleId IdType="doi">10.1186/s12871-019-0892-6</ArticleId><ArticleId IdType="pii">10.1186/s12871-019-0892-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahajan JK, Rathod KK, Bawa M, Rao KL. Tracheobronchial foreign body aspirations: lessons learned from a 10-year audit. J Bronchol Interv Pulmonol. 2011;18:223&#x2013;228. doi: 10.1097/LBR.0b013e31822386a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/LBR.0b013e31822386a4</ArticleId><ArticleId IdType="pubmed">23208564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai J, Wu XY, Han N, Wang LY, Chen WM. A retrospective study of anesthesia during rigid bronchoscopy for airway foreign body removal in children: propofol and sevoflurane with spontaneous ventilation. Paediatr Anaesth. 2014;24:1031&#x2013;1036. doi: 10.1111/pan.12509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12509</ArticleId><ArticleId IdType="pubmed">25145573</ArticleId></ArticleIdList></Reference><Reference><Citation>Inglis AF, Wagner DV. Lower complication rates associated with bronchial foreign bodies over the last 20 years. Ann Otol Rhinol Larygnol. 1992;101:61&#x2013;66. doi: 10.1177/000348949210100115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348949210100115</ArticleId><ArticleId IdType="pubmed">1728887</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell PT. Rigid bronchoscopy for foreign body removal: anaesthesia and ventilation. Paediatr Anaesth. 2004;14:84&#x2013;89. doi: 10.1046/j.1460-9592.2003.01194.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2003.01194.x</ArticleId><ArticleId IdType="pubmed">14717878</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson KL. Airway foreign bodies: what&#x2019;s new? Semin Respir Crit Care Med. 2004;25:405&#x2013;411. doi: 10.1055/s-2004-832713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2004-832713</ArticleId><ArticleId IdType="pubmed">16088484</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissberg D, Schwartz I. Foreign bodies in the tracheobronchial tree. Chest. 1987;91:730&#x2013;733. doi: 10.1378/chest.91.5.730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.91.5.730</ArticleId><ArticleId IdType="pubmed">3568776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev A, Chhawchharia R. Flexible Fiberoptic bronchoscopy in pediatric practice. Indian Pediatr. 2019;56:578&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pubmed">31333214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehgal IS, Dhooria S, Ram B, Singh N, Aggarwal AN, Gupta D, Agarwal R, et al. Foreign body inhalation in the adult population: experience of 25,998 bronchoscopies and systematic review of literature. Respir Care. 2015;60:1438&#x2013;1448. doi: 10.4187/respcare.03976.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.03976</ArticleId><ArticleId IdType="pubmed">25969517</ArticleId></ArticleIdList></Reference><Reference><Citation>Gang W, Zhengxia P, Hongbo L, Yonggang L, Jiangtao D, Shengde W, et al. Diagnosis and treatment of tracheobronchial foreign bodies in 1024 children. J Pediatr Surg. 2012;47:2004&#x2013;2010. doi: 10.1016/j.jpedsurg.2012.07.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2012.07.036</ArticleId><ArticleId IdType="pubmed">23163990</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheta SA, AI-Sarheed MA, Abdelhalim AA. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial. Paediatr Anaesth. 2014;24:181&#x2013;189. doi: 10.1111/pan.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pan.12287</ArticleId><ArticleId IdType="pubmed">24237879</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg. 2008;106:1715&#x2013;1721. doi: 10.1213/ane.0b013e31816c8929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e31816c8929</ArticleId><ArticleId IdType="pubmed">18499600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao YS, Qian B, Chen YQ, Zhou LJ, Liu J. Intranasal dexmedetomidine premedication reduces the minimum alveolar concentration of sevoflurane for tracheal intubation in children: a randomized trial. J Clin Anesth. 2014;26:309&#x2013;314. doi: 10.1016/j.jclinane.2013.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2013.12.012</ArticleId><ArticleId IdType="pubmed">24875890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngwenyama NE, Anderson J, Hoernschemeyer DG, Tobias JD. Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents. Paediatr Anaesth. 2008;18:1190&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pubmed">19076573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu JH, Lee SW, Lee JH, Lee EH, Do SH, Kim CS. Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth. 2012;108:503&#x2013;511. doi: 10.1093/bja/aer400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aer400</ArticleId><ArticleId IdType="pubmed">22174346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KZ, Ye M, Hu CB, Shen X. Dexmedetomidine vs remifentanil intravenous anaesthesia and spontaneous ventilation for airway foreign body removal in children. Br J Anaesth. 2014;112:892&#x2013;897. doi: 10.1093/bja/aet490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aet490</ArticleId><ArticleId IdType="pubmed">24554548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao W, Ma G, Su QG, Fang Y, Gu BC, Zou XM. Dexmedetomidine versus midazolam for conscious sedation in postoperative patients undergoing flexible bronchoscopy: a randomized study. J Int Med Res. 2012;40:1371&#x2013;1380. doi: 10.1177/147323001204000415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/147323001204000415</ArticleId><ArticleId IdType="pubmed">22971488</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JW, Balyan R, Dong M, Mahmoud M, Lam JE, Pratap JN, et al. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study. Br J Anaesth. 2018;120:1056&#x2013;1065. doi: 10.1016/j.bja.2018.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2018.01.035</ArticleId><ArticleId IdType="pubmed">29661383</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen VM, Hui TW, Irwin MG, Yao T-J, Wong GL, Yuen MK. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia. 2010;65:922&#x2013;929. doi: 10.1111/j.1365-2044.2010.06453.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2010.06453.x</ArticleId><ArticleId IdType="pubmed">20645951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk T, Erbuyun K, Keles GT, Ozer M, Yuksel H. Tok Demet. The effect of remifentanil on the emergence characteristics of children undergoing FBO for bronchoalveolar lavage with sevoflurane anaesthesia. Eur J Anaesthesiol. 2009;26:338&#x2013;342. doi: 10.1097/EJA.0b013e32831de50d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32831de50d</ArticleId><ArticleId IdType="pubmed">19401665</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao R, Li JY, Liu GY. Comparison of sevoflurane volatile induction/maintenance anaesthesia and propofol-remifentanil total intravenous anaesthesia for rigid bronchoscopy under spontaneous breathing for tracheal/bronchial foreign body removal in children. Eur J Anaesthesiol. 2010;27:930&#x2013;934. doi: 10.1097/EJA.0b013e32833d69ad.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32833d69ad</ArticleId><ArticleId IdType="pubmed">20683333</ArticleId></ArticleIdList></Reference><Reference><Citation>Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin. 2009;25:451&#x2013;469. doi: 10.1016/j.ccc.2009.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2009.04.004</ArticleId><ArticleId IdType="pubmed">19576524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101:787&#x2013;790. doi: 10.1097/00000542-200409000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200409000-00028</ArticleId><ArticleId IdType="pubmed">15329604</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A, Boyaci A. Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand. 2005;49:1088&#x2013;1091. doi: 10.1111/j.1399-6576.2005.00780.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2005.00780.x</ArticleId><ArticleId IdType="pubmed">16095449</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan G, Ozgultekin A, Turan C, Dincer E, Yuksel G. Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery. Eur J Anaesthesiol. 2008;25:816&#x2013;820. doi: 10.1017/S0265021508004201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0265021508004201</ArticleId><ArticleId IdType="pubmed">18400140</ArticleId></ArticleIdList></Reference><Reference><Citation>Piastra M, Pizza A, Gaddi S, Luca E, Genovese O, Picconi E, et al. Dexmedetomidine is effective and safe during NIV in infants and young children with acute respiratory failure. BMC Pediatr. 2018;18:282. doi: 10.1186/s12887-018-1256-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-018-1256-y</ArticleId><ArticleId IdType="pmc">PMC6109351</ArticleId><ArticleId IdType="pubmed">30144795</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Kang K, Liu H, Jia L, Tang R, Yu K, et al. Effect of dexmedetomidine and midazolam for flexible fiberoptic bronchoscopy in intensive care unit patients: a retrospective study. Medicine (Baltimore) 2017;96:e7090. doi: 10.1097/MD.0000000000007090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000007090</ArticleId><ArticleId IdType="pmc">PMC5484192</ArticleId><ArticleId IdType="pubmed">28640084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoh T, Kanamaru A, Tsubone H, Nishimura R, Sasaki N. Respiratory reflexes in response to upper-airway administration of sevoflurane and isoflurane in anesthetized, spontaneously breathing dogs. Vet Surg. 2001;30:87&#x2013;96. doi: 10.1053/jvet.2001.20329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jvet.2001.20329</ArticleId><ArticleId IdType="pubmed">11172464</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurg J, Lechamy JB, Laudenbach V, Henzel D, Peytavin G, Desmonts JM. Anesthetics affect the uptake but not the depolarization-evoked release of GABA in rats striatal synaptosomes. Anesthesiology. 1995;82:502&#x2013;511. doi: 10.1097/00000542-199502000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199502000-00020</ArticleId><ArticleId IdType="pubmed">7856908</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara M, Kai Y, Ikemoto Y. Enhancement by propofol of the gamma-aminobutyric acidA response in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology. 1994;81:988&#x2013;994. doi: 10.1097/00000542-199410000-00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-199410000-00026</ArticleId><ArticleId IdType="pubmed">7943850</ArticleId></ArticleIdList></Reference><Reference><Citation>Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth. 2005;94:821&#x2013;824. doi: 10.1093/bja/aei119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aei119</ArticleId><ArticleId IdType="pubmed">15764627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud M, Radhakrishman R, Gunter J, Sadhasivam S, Schapiro A, McAuliffe J. Effect of increasing depth of dexmedetomidine anesthesia on upper airway morphology in children. Pediatr Anaesth. 2010;20:506&#x2013;515. doi: 10.1111/j.1460-9592.2010.03311.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2010.03311.x</ArticleId><ArticleId IdType="pubmed">20412456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud M, Gunter J, Donnelly LF, Wang Y, Nick TD, Sadhasivam S. A comparison of dexmedetomidine with propofol for magnetic resonance imaging sleep studies in children. Anesth Analg. 2009;109:745&#x2013;753. doi: 10.1213/ane.0b013e3181adc506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181adc506</ArticleId><ArticleId IdType="pubmed">19690241</ArticleId></ArticleIdList></Reference><Reference><Citation>Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002;95:461&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">12145072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim NY, Kim SY, Yoon HJ, Kil HK. Effect of dexmedetomidine on sevoflurane requirements and emergence agitation in children undergoing ambulatory surgery. Yonsei Med J. 2014;55:209&#x2013;215. doi: 10.3349/ymj.2014.55.1.209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2014.55.1.209</ArticleId><ArticleId IdType="pmc">PMC3874907</ArticleId><ArticleId IdType="pubmed">24339309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Act Anaesthesiol Scand. 2010;54:710&#x2013;716. doi: 10.1111/j.1399-6576.2009.02177.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2009.02177.x</ArticleId><ArticleId IdType="pubmed">20003127</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Zoghbi JF, Zhu W, Grafe MR, Brambrink AM. Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats. Br J Anaesth. 2017;119:506&#x2013;516. doi: 10.1093/bja/aex222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex222</ArticleId><ArticleId IdType="pubmed">28969317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 2009;110:1077&#x2013;1085. doi: 10.1097/ALN.0b013e31819daedd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31819daedd</ArticleId><ArticleId IdType="pubmed">19352168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Xiong M, Nadavaluru PR, Zuo W, Ye JH, Eloy JD, et al. Dexmedetomidine attenuates neurotoxicity induced by prenatal propofol exposure. J Neurosurg Anesthesiol. 2016;28:51&#x2013;64. doi: 10.1097/ANA.0000000000000181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0000000000000181</ArticleId><ArticleId IdType="pubmed">25844953</ArticleId></ArticleIdList></Reference><Reference><Citation>Andropoulos DB. Effect of anesthesia on the developing brain: infant and fetus. Fetal Diagn Ther. 2018;43:1&#x2013;11. doi: 10.1159/000475928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000475928</ArticleId><ArticleId IdType="pubmed">28586779</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18931209</PMID><DateCompleted><Year>2008</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2008</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><Issue>5</Issue><PubDate><Year>2008</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>A prospective, randomized comparison of cobra perilaryngeal airway and laryngeal mask airway unique in pediatric patients.</ArticleTitle><Pagination><StartPage>1523</StartPage><EndPage>1530</EndPage><MedlinePgn>1523-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ane.0b013e3181852617</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Cobra Perilaryngeal Airway (PLA) provides better sealing pressure than the Laryngeal Mask Airway Unique (LMAU) during positive-pressure ventilation in adults. We compared the performance of the CobraPLA and LMAU in infants and children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Two-hundred pediatric patients were randomly assigned to a CobraPLA or an Laryngeal Mask Airway (LMA). We measured airway sealing at cuff inflation pressures of 40 and 60 cm H2O; ease and time of insertion; device stability; efficacy of ventilation; number of insertion attempts; incidence of postoperative sore throat, dysphonia, laryngospasm, bronchospasm, and gastric gas insufflation. Steady-state end-tidal(CO2) was measured at the head of the CobraPLA and at the "Y-piece" piece of the anesthetic circuit. For the major outcomes, the airway groups were subdivided post hoc into small and large CobraPLA and small and large LMA subgroups. Results are presented as means +/- sds; P &lt; 0.05 was considered statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Airway sealing pressure with the cuff inflated to 60 cm H2O in the large CobraPLA subgroup (22 +/- 7 cm H2O) was significantly more than that of the small CobraPLA subgroup (18 +/- 5 cm H2O) and large LMA subgroup (16 +/- 5 cm H2O; P &lt; 0.001). The CobraPLA was more stable than the LMA (same anatomic fit score before and after surgery) and produced less gastric insufflation. Head CobraPLA end-tidal(CO2) values were 6.4 +/- 6 mm Hg more than those of the Y piece of the circle circuit.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The CobraPLA airway performed as well as the LMAU during anesthesia in pediatric patients for a large range of outcomes and was superior for some.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szmuk</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Texas Southwestern Medical School and Children's Medical Center at Dallas, 1935, B3304, Motor St., Dallas, TX 75235, USA. peter.szmuk@utsouthwestern.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghelber</LastName><ForeName>Oscar</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Matuszczak</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rabb</LastName><ForeName>Marry F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Ezri</LastName><ForeName>Tiberiu</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000769" MajorTopicYN="N">Anesthesia, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004867" MajorTopicYN="N">Equipment Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>10</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>11</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>10</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18931209</ArticleId><ArticleId IdType="doi">10.1213/ane.0b013e3181852617</ArticleId><ArticleId IdType="pii">107/5/1523</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28108038</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>389</Volume><Issue>10070</Issue><PubDate><Year>2017</Year><Month>Feb</Month><Day>18</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>701</StartPage><EndPage>708</EndPage><MedlinePgn>701-708</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(16)31719-6</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(16)31719-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative respiratory adverse events (PRAE) are the most common critical incidents in paediatric anaesthesia and occur more often in infants. Use of laryngeal mask airways (LMAs) is associated with reduced PRAE compared with endotracheal tubes in older children (&gt;1 year). We aimed to evaluate the effect of these devices on the incidence of PRAE in infants.</AbstractText><AbstractText Label="METHODS">We did a randomised controlled trial at the Princess Margaret Hospital for Children in Perth (WA, Australia) by recruiting infants (aged 0-12 months) undergoing general (with or without regional or local) anaesthesia with anticipated fentanyl dose 1 &#x3bc;g/kg or lower for minor elective surgery. We excluded patients contraindicated for LMA or endotracheal tube; who had known cardiac disease or airway or thoracic malformations; who were receiving midazolam premedication; who were undergoing airway, thoracic, or abdomen surgery at the time of participation; and if the parents did not speak English. Written parental or guardian consent was obtained before enrolment. Participants were randomly assigned (1:1), by computer-generated variable block randomisation, to receive an LMA (PRO-Breathe, Well Lead Medical Co Ltd, Panyu, China) or an endotracheal tube (Microcuff, Halyard Health Inc, Atlanta, GA, USA). Sealed randomisation envelopes were used to conceal device assignment. An interim analysis was planned once half the number of infants needed (145) had been recruited. The primary outcome was incidence of PRAE, assessed in the intention-to-treat population. The institutional ethics committee at the Princess Margaret Hospital for Children granted ethical approval (1786/EP). The trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12610000250033).</AbstractText><AbstractText Label="FINDINGS">The trial began on July 8, 2010, and was ended early on May 7, 2015, after the interim analysis results met the study stopping rules. During this time, 239 infants were assessed and 181 eligible infants were randomly assigned to receive an LMA (n=85) or an endotracheal tube (n=95). Four infants were not included in the analysis (two due to cancelled procedures, one did not meet inclusion criteria, and one with missing dataset). In the intention-to-treat analysis, PRAE occurred in 50 (53%) infants in the endotracheal tube group and in 15 (18%) infants in the LMA group (risk ratio [RR] 2&#xb7;94, 95% CI 1&#xb7;79-4&#xb7;83, p&lt;0&#xb7;0001). Laryngospasm and bronchospasm (major PRAE) were recorded in 18 (19%) infants in the endotracheal tube group and in three (4%) infants in the LMA group (RR 5&#xb7;30, 95% CI 1&#xb7;62-17&#xb7;35, p=0&#xb7;002). No deaths were reported.</AbstractText><AbstractText Label="INTERPRETATION">In infants undergoing minor elective procedures, LMAs were associated with clinically significantly fewer PRAE and lower occurrence of major PRAE (laryngospasm and bronchospasm) than endotracheal tubes. This difference should be a consideration in airway device selection.</AbstractText><AbstractText Label="FUNDING">Princess Margaret Hospital Foundation, National Health and Australian Medical Research Council, Stan Perron Charitable Trust, and Callahan Estate.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Drake-Brockman</LastName><ForeName>Thomas F E</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, WA, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramgolam</LastName><ForeName>Anoop</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, WA, Australia; Children's Lung Health, Telethon Kids Institute, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guicheng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, WA, Australia; School of Public Health, Curtin University, Perth, WA, Australia; Centre for Genetic Origins of Health and Disease, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Graham L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Centre of Child Health Research, University of Western Australia, Perth, WA, Australia; Children's Lung Health, Telethon Kids Institute, Perth, WA, Australia; School of Physiotherapy and Exercise Science, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, WA, Australia; School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Children's Lung Health, Telethon Kids Institute, Perth, WA, Australia. Electronic address: britta.regli-vonungern@health.wa.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2017 Feb 18;389(10070):673-674. doi: 10.1016/S0140-6736(17)30120-4.</RefSource><PMID Version="1">28108039</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="Y">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28108038</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(16)31719-6</ArticleId><ArticleId IdType="pii">S0140-6736(16)31719-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29108938</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>39</EndPage><MedlinePgn>29-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(17)30424-1</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(17)30424-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">Chronic non-specific respiratory symptoms are difficult to manage. This trial aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) and the response to inhaled corticosteroids in patients with non-specific respiratory symptoms.</AbstractText><AbstractText Label="METHODS">In this double-blind randomised placebo-controlled trial, we enrolled undiagnosed patients, aged 18-80 years, with cough, wheeze, or dyspnoea and less than 20% bronchodilator reversibility across 26 primary care centres and hospitals in the UK and Singapore. Patients were assessed for 2 weeks before being randomly assigned (1:1) to 4 weeks of treatment with extrafine inhaled corticosteroids (QVAR 80 &#x3bc;g, two puffs twice per day, equivalent to 800 &#x3bc;g per day beclomethasone dipropionate) or placebo. Randomisation was stratified by baseline FeNO measurement: normal (&#x2264;25 parts per billion [ppb]), intermediate (&gt;25 tp &lt;40 ppb), and high (&#x2265;40 ppb). The primary endpoint was change in Asthma Control Questionnaire (ACQ7) mean score. We used generalised linear modelling to assess FeNO as a predictor of response, estimating an interaction effect between FeNO and treatment on change in ACQ7. We did our primary and secondary analyses in the per-protocol set, which excluded patients with non-completion of the primary endpoint, non-compliance to treatment (ascertained by patient report), and study visits made outside the predefined visit windows. This study is registered on ClinicalTrials.gov, number NCT02294279.</AbstractText><AbstractText Label="FINDINGS">Between Feb 4, 2015, and July 12, 2016, we randomly assigned 294 patients to extrafine inhaled corticosteroid treatment (n=148) or placebo (n=146). Following exclusions due to protocol violations, we analysed 214 patients (114 extrafine inhaled corticosteroids and 100 placebo). We observed a significant interaction between baseline FeNO and treatment group for every 10 ppb increase in baseline FeNO, with the change in ACQ7 greater in the extrafine inhaled corticosteroids group than in the placebo group (difference between groups 0&#xb7;071, 95% CI 0&#xb7;002 to 0&#xb7;139; p=0&#xb7;044). The most common adverse events were nasopharyngitis (18 [12%] patients in the treatment group vs 13 [9%] in the placebo group), infections and infestations (25 [17%] vs 21 [14%]), and respiratory, thoracic, and mediastinal disorders (13 [9%] vs 17 [12%]).</AbstractText><AbstractText Label="INTERPRETATION">FeNO measurement is an easy and non-invasive tool to use in clinical practice in patients with non-specific respiratory symptoms to predict response to inhaled corticosteroids. Further research is needed to examine its role in patients with evidence of other airway diseases, such as chronic obstructive pulmonary disease.</AbstractText><AbstractText Label="FUNDING">Sponsored by OPRI with partial funding by Circassia and study drugs provided by TEVA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Price</LastName><ForeName>David B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>University of Aberdeen, Aberdeen, UK; Observational &amp; Pragmatic Research Institute, Singapore. Electronic address: dprice@opri.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buhl</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Mainz University Hospital, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Singapore General Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Daryl</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mundesley Medical Centre, Norfolk, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardener</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godley</LastName><ForeName>Clifford</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Avondale Medical Practice, Strathaven, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruffydd-Jones</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Box Surgery, Box, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGarvey</LastName><ForeName>Lorcan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohta</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Hospital Organization Tokyo National Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Dermot</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syk</LastName><ForeName>J&#xf6;rgen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Stockholm, Sweden; Uppsala University, Uppsala, Sweden; Academic Primary Health Care Centre, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ngiap Chuan</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>SingHealth Polyclinics, Singapore; Duke-NUS Medical School, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>TzeLee</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Mike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konduru</LastName><ForeName>Priyanka Raju</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Optimum Patient Care, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngantcha</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Alcontres</LastName><ForeName>Martina Stagno</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Observational &amp; Pragmatic Research Institute, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapperre</LastName><ForeName>Therese S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>National University of Singapore, Singapore; Pulmonary Department, Bispebjerg Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02294279</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018927">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>KGZ1SLC28Z</RegistryNumber><NameOfSubstance UI="D001507">Beclomethasone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2018 Jan;6(1):3-5. doi: 10.1016/S2213-2600(17)30429-0.</RefSource><PMID Version="1">29108939</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018927" MajorTopicYN="N">Anti-Asthmatic Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001507" MajorTopicYN="N">Beclomethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045853" MajorTopicYN="N">Exhalation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29108938</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(17)30424-1</ArticleId><ArticleId IdType="pii">S2213-2600(17)30424-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27594440</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>11</Issue><PubDate><Year>2016</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study.</ArticleTitle><Pagination><StartPage>902</StartPage><EndPage>910</EndPage><MedlinePgn>902-910</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(16)30223-5</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(16)30223-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Antimicrobial resistance is a serious threat to public health, with most antibiotics prescribed in primary care. General practitioners (GPs) report defensive antibiotic prescribing to mitigate perceived risk of future hospital admission in children with respiratory tract infections. We developed a clinical rule aimed to reduce clinical uncertainty by stratifying risk of future hospital admission.</AbstractText><AbstractText Label="METHODS">8394 children aged between 3 months and 16 years presenting with acute cough (for &#x2264;28 days) and respiratory tract infection were recruited to a prognostic cohort study from 247 general practitioner practices in England. Exposure variables included demographic characteristics, parent-reported symptoms, and physical examination signs. The outcome was hospital admission for respiratory tract infection within 30 days, collected using a structured, blinded review of medical records.</AbstractText><AbstractText Label="FINDINGS">8394 (100%) children were included in the analysis, with 78 (0&#xb7;9%, 95% CI 0&#xb7;7%-1&#xb7;2%) admitted to hospital: 15 (19%) were admitted on the day of recruitment (day 1), 33 (42%) on days 2-7; and 30 (39%) on days 8-30. Seven characteristics were independently associated (p&lt;0&#xb7;01) with hospital admission: age &lt;2 years, current asthma, illness duration of 3 days or less, parent-reported moderate or severe vomiting in the previous 24 h, parent-reported severe fever in the previous 24 h or a body temperature of 37&#xb7;8&#xb0;C or more at presentation, clinician-reported intercostal or subcostal recession, and clinician-reported wheeze on auscultation. The area under the receiver operating characteristic (AUROC) curve for the coefficient-based clinical rule was 0&#xb7;82 (95% CI 0&#xb7;77-0&#xb7;87, bootstrap validated 0&#xb7;81). Assigning one point per characteristic, a points-based clinical rule consisting of short illness, temperature, age, recession, wheeze, asthma, and vomiting (mnemonic STARWAVe; AUROC 0&#xb7;81, 0&#xb7;76-0&#xb7;85) distinguished three hospital admission risk strata: very low (0&#xb7;3%, 0&#xb7;2-0&#xb7;4%) with 1 point or less, normal (1&#xb7;5%, 1&#xb7;0-1&#xb7;9%) with 2 or 3 points, and high (11&#xb7;8%, 7&#xb7;3-16&#xb7;2%) with 4 points or more.</AbstractText><AbstractText Label="INTERPRETATION">Clinical characteristics can distinguish children at very low, normal, and high risk of future hospital admission for respiratory tract infection and could be used to reduce antibiotic prescriptions in primary care for children at very low risk.</AbstractText><AbstractText Label="FUNDING">National Institute for Health Research (NIHR).</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Alastair D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK. Electronic address: alastair.hay@bristol.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redmond</LastName><ForeName>Niamh M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornton</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Little</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Primary Care and Population Sciences Unit, University of Southampton, Aldermoor Health Centre, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, Saint Mary's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovering</LastName><ForeName>Andrew M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muir</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Specialist Virology Centre, Public Health Laboratory Bristol, Public Health England, Myrtle Road, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leeming</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vipond</LastName><ForeName>Barry</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Specialist Virology Centre, Public Health Laboratory Bristol, Public Health England, Myrtle Road, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stuart</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Primary Care and Population Sciences Unit, University of Southampton, Aldermoor Health Centre, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Tim J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>School of Clinical Sciences, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>School of Social and Community Medicine, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CDF-2009-02-10</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR-RP-02-12-012</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RP-PG-0608-10018</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2016 Nov;4(11):850-852. doi: 10.1016/S2213-2600(16)30272-7.</RefSource><PMID Version="1">27594439</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27594440</ArticleId><ArticleId IdType="pmc">PMC5080970</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(16)30223-5</ArticleId><ArticleId IdType="pii">S2213-2600(16)30223-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Department of Health  UK Five Year Antimicrobial Resistance Strategy 2013 to 2018. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>The White House Washington  National Strategy for Combating Antibiotic Resistant Bacteria. http://www.cdc.gov/drugresistance/pdf/carb_national_strategy.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>WHO  Antimicrobial resistance: Global Report on Surveillance. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1 (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>NHS England  The NHS Atlas of Variation in Healthcare: reducing unwarranted variation to increase value and improve quality. http://www.rightcare.nhs.uk/atlas/RC_nhsAtlas3_HIGH_150915.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Public Health England  English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Report 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/362374/ESPAUR_Report_2014__3_.pdf (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.</Citation><ArticleIdList><ArticleId IdType="pubmed">20483949</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research  About antimicrobial resistance. http://www.themedcalls.nihr.ac.uk/amr/about-antimicrobial-resistance (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Okkes M, Oskam SK, HL The probability of specific diagnoses for patients presenting with common symptoms to Dutch family physicians. J Fam Pract. 2002;51:31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">11927060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Heron J, Ness A, the ALSPAC study team The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): a prospective cohort study. Fam Pract. 2005;22:367&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">15897210</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ. 1998;317:637&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28658</ArticleId><ArticleId IdType="pubmed">9727992</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral C, Lucas PJ, Ingram J, Hay AD, Horwood J. &#x201c;It's safer to &#x2026;&#x201d; parent consulting and clinician antibiotic prescribing decisions for children with respiratory tract infections: an analysis across four qualitative studies. Soc Sci Med. 2015;136&#x2013;137:156&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">26004209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas PJ, Cabral C, Hay AD, Horwood J. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand J Prim Health Care. 2015;33:11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377734</ArticleId><ArticleId IdType="pubmed">25716427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003;326:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140007</ArticleId><ArticleId IdType="pubmed">12531847</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwood J, Cabral C, Hay AD, Ingram J. Primary care clinician antibiotic prescribing decisions in consultations for children with RTIs: a qualitative interview study. Br J Gen Pract. 2016;66:e207&#x2013;e213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758501</ArticleId><ArticleId IdType="pubmed">26852795</ArticleId></ArticleIdList></Reference><Reference><Citation>Redmond NM, Davies R, Christensen H. The TARGET cohort study protocol: a prospective primary care cohort study to derive and validate a clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses. BMC Health Services Rese. 2013;13:322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765099</ArticleId><ArticleId IdType="pubmed">23958109</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Birnie K, Busby J. The diagnosis of urinary tract infections in young children (DUTY): a diagnostic and prospective observational study to derive and validate a clinical algorithm for the diagnosis of UTI in children presenting to primary care with an acute illness. Health Technol Assess. 2016;20:1&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4958930</ArticleId><ArticleId IdType="pubmed">27401902</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Fahey T, Peters TJ, Wilson A. Predicting complications from a acute cough in pre-school children in primary care: a prospective cohort study. Br J Gen Pract. 2004;54:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1314771</ArticleId><ArticleId IdType="pubmed">14965400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract. 2003;20:696&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">14701895</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, Kengne AP, Woodward M. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pubmed">22397945</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig JV, Lancaster GA, Williamson PR, Smyth RL. Temperature measured at the axilla compared with rectum in children and young people: systematic review. BMJ. 2000;320:1174&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27359</ArticleId><ArticleId IdType="pubmed">10784539</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackway-Jones K, Molyneux E, Phillips B, Wieteska S. Advanced paediatric life support&#x2014;the practical approach. 4 edn. Blackwell Publishing Ltd; Oxford: 2005.</Citation></Reference><Reference><Citation>NICE  Feverish illness in children. Assessment and initial management in children younger than 5 years. https://www.nice.org.uk/guidance/cg47?unlid=335701897201612317341 (accessed Aug 19, 2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lad M. English Indices of Deprivation 2010. Department for Communities and Local Government; London: 2010.</Citation></Reference><Reference><Citation>Steyerberg EW, Harrell FE, Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pubmed">11470385</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Census statistical bulletin: population and household estimates for Wales. March 2011. http://www.ons.gov.uk/ons/rel/census/2011-census/population-and-household-estimates-for-wales/stb-2011-census-wales.html (accessed Oct 6, 2013).</Citation></Reference><Reference><Citation>Office for National Statistics . Integrated Household Survey April 2011 to March 2012: Experimental Statistics. Her Majesty's Stationary Office (HMSO); London: 2012.</Citation></Reference><Reference><Citation>Oostenbrink R, Thompson M, Lakhanpaul M. Children with fever and cough at emergency care: diagnostic accuracy of a clinical model to identify children at low risk of pneumonia. Eur J Emerg Med. 2013;20:273&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">22868746</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward G, Thompson M, Hay AD. What factors influence prognosis in children with acute cough and respiratory tract infection in primary care? BMJ. 2012;345:e6212.</Citation><ArticleIdList><ArticleId IdType="pubmed">22996938</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pubmed">17182981</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocks N, Fahey T. Labelling of acute respiratory illness: evidence of between-practitioner variation in the UK. Fam Pract. 2002;19:375&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">12110558</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharek PJ, Horbar JD, Mason W. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics. 2006;118:1332&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">17015521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Fahey T, Peters TJ, Wilson AD. Predicting complications from acute cough in pre-school children in primary care: a prospective cohort study. Br J Gen Pract. 2004;54:9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1314771</ArticleId><ArticleId IdType="pubmed">14965400</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Gorst C, Montgomery A, Peters TJ, Fahey T. Validation of a clinical rule to predict complications of acute cough in preschool children: a prospective study in primary care. Br J Gen Pract. 2007;57:530&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2099635</ArticleId><ArticleId IdType="pubmed">17727745</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D, European Research Network on Recognising Serious Infection investigators Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010;375:834&#x2013;845.</Citation><ArticleIdList><ArticleId IdType="pubmed">20132979</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Aertgeerts B, Bruyninckx R, Aerts M, Buntinx F. Signs and symptoms for diagnosis of serious infections in children: a prospective study in primary care. Br J Gen Pract. 2007;57:538&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2099636</ArticleId><ArticleId IdType="pubmed">17727746</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen I, Johnson AM, Islam A, Duckworth G, Livermore DM, Hayward AC. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ. 2007;335:982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2072032</ArticleId><ArticleId IdType="pubmed">17947744</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Care and Health Excellence  Respiratory tract infections: prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. https://www.nice.org.uk/guidance/CG69 (accessed Aug 19, 2016).</Citation></Reference><Reference><Citation>Finkelstein JA, Davis RL, Dowell SF. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11433046</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Care and Health Excellence  Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. https://www.nice.org.uk/Guidance/NG15 (accessed Aug 19, 2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8210248</ArticleId><ArticleId IdType="pubmed">34222900</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulliford MC, Van Staa T, Dregan A. Electronic health records for intervention research: a cluster randomized trial to reduce antibiotic prescribing in primary care (eCRT Study) Ann Fam Med. 2014;12:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096472</ArticleId><ArticleId IdType="pubmed">25024243</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Vodicka T, Cohen H. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013;347:f7027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898587</ArticleId><ArticleId IdType="pubmed">24335668</ArticleId></ArticleIdList></Reference><Reference><Citation>Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001;322:336&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26576</ArticleId><ArticleId IdType="pubmed">11159657</ArticleId></ArticleIdList></Reference><Reference><Citation>Little P, Moore MV, Turner S. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ. 2010;340:c199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2817051</ArticleId><ArticleId IdType="pubmed">20139214</ArticleId></ArticleIdList></Reference><Reference><Citation>Little P, Stuart B, Hobbs FD. Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study. BMJ. 2013;347:f6867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898431</ArticleId><ArticleId IdType="pubmed">24277339</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24406806</PMID><DateCompleted><Year>2014</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>May</Month></PubDate></JournalIssue><Title>Archives of disease in childhood</Title><ISOAbbreviation>Arch Dis Child</ISOAbbreviation></Journal><ArticleTitle>Conservative management of antenatally diagnosed cystic lung malformations.</ArticleTitle><Pagination><StartPage>432</StartPage><EndPage>437</EndPage><MedlinePgn>432-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/archdischild-2013-304048</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To review the outcome of all antenatally diagnosed conservatively managed congenital lung malformations (CLMs) managed at our centre.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients diagnosed antenatally with cystic lung malformations from 2001 to 2011, at a tertiary referral paediatric surgical centre practising a policy of conservative management of asymptomatic cases, were retrospectively reviewed. Data were collected from medical case notes and radiology reports. Ethical approval was obtained from our institutional research and development department.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The complete records of 74 fetuses antenatally diagnosed with CLM were reviewed. There were 72 live births, at a median gestation of 39.6 weeks. Emergency lobectomy was performed in one symptomatic neonate. Elective lobectomies were performed at parental request in three asymptomatic infants, one of whom had a family history of synovial sarcoma. Two patients developed pneumonia in the affected lobe during early childhood and proceeded to lobectomy at the age of 3 years. One patient with a bronchopulmonary sequestration required embolisation for cyanotic episodes. The remaining 65 patients have been conservatively managed to date, and none have required hospital admission. Less than a quarter report mild respiratory symptoms such as cough or wheeze. Median follow-up is 5 years.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This retrospective cohort study of 74 consecutive CLMs diagnosed antenatally over a 10-year period demonstrates that most of these lesions will remain asymptomatic throughout childhood. Although the natural history of CLMs in later years remains to be elucidated, we hope that this report on medium-term outcomes will be useful to clinicians who undertake antenatal counselling and may inform the discussion on how best to manage these children.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Christabella</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, University Hospital Southampton NHS Foundation Trust, , Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanwell</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Burge</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Stanton</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Dis Child</MedlineTA><NlmUniqueID>0372434</NlmUniqueID><ISSNLinking>0003-9888</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C535735">Congenital lobar emphysema</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001994" MajorTopicYN="N">Bronchogenic Cyst</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001998" MajorTopicYN="N">Bronchopulmonary Sequestration</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015615" MajorTopicYN="N">Cystic Adenomatoid Malformation of Lung, Congenital</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011013" MajorTopicYN="N">Pneumonectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011296" MajorTopicYN="Y">Prenatal Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011656" MajorTopicYN="N">Pulmonary Emphysema</DescriptorName><QualifierName UI="Q000151" MajorTopicYN="Y">congenital</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fetal Medicine</Keyword><Keyword MajorTopicYN="N">General Paediatrics</Keyword><Keyword MajorTopicYN="N">Respiratory</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24406806</ArticleId><ArticleId IdType="doi">10.1136/archdischild-2013-304048</ArticleId><ArticleId IdType="pii">archdischild-2013-304048</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24597484</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1471-2253</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Risk over time and risk factors of intraoperative respiratory events: a historical cohort study of 14,153 children.</ArticleTitle><Pagination><StartPage>13</StartPage><MedlinePgn>13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2253-14-13</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The variation in the rate of intraoperative respiratory events (IRE) over time under anesthesia and the influence of anesthesia-related factors have not yet been described. The objectives of this study were to describe the risk over time and the risk factors for IRE in children at a tertiary care hospital in southern Thailand.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The surveillance anesthetic database and chart review of IRE of 14,153 children who received surgery at Songklanagarind Hospital during January 2005 to December 2011 were used to obtain demographic, surgical and anesthesia-related data. Incidence density of IRE per person-time was determined by a Poisson modelling. Risk of IRE over time was displayed using Kaplan Meier survival and Nelson-Aalen curves. Multivariate Cox regression was employed to identify independent predictors for IRE. Adjusted hazard ratios (HR) and their 95% confidence intervals (CI) were obtained from the final Cox model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, IRE occurred in 315 out of 14,153 children. The number (%) of desaturation, wheezing or bronchospasm, laryngospasm, reintubation and upper airway obstruction were 235 (54%), 101 (23%), 75 (17%), 21 (5%) and 4 (1%) out of 315 IRE, respectively. The incidence density per 100,000 person-minutes of IRE at the induction period (61.3) was higher than that in the maintenance (13.7) and emergence periods (16.5) (p&#x2009;&lt;&#x2009;0.001). The risk of desaturation, wheezing and laryngospasm was highest during the first 15, 20 and 30&#xa0;minutes of anesthesia, respectively. After adjusting for age, history of respiratory disease and American Society of Anesthesiologist (ASA) classification, anesthesia-related risk factors for laryngospasm were assisted ventilation via facemask (HR: 18.1, 95% CI: 6.4-51.4) or laryngeal mask airway (HR: 12.5, 95% CI: 4.6-33.9) compared to controlled ventilation via endotracheal tube (p&#x2009;&lt;&#x2009;0.001), and desflurane (HR: 11.0, 95% CI: 5.1-23.9) compared to sevoflurane anesthesia (p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">IRE risk was highest in the induction and early maintenance period. Assisted ventilation via facemask or LMA and desflurane anesthesia were anesthesia-related risk factors for laryngospasm. Therefore, anesthesiologists should pay more attention during the induction and early maintenance period especially when certain airway devices incorporated with assisted ventilation or desflurane are used.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oofuvong</LastName><ForeName>Maliwan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. oomaliwa@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geater</LastName><ForeName>Alan Frederick</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Chongsuvivatwong</LastName><ForeName>Virasakdi</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Pattaravit</LastName><ForeName>Ngamjit</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Nuanjun</LastName><ForeName>Kanjana</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24597484</ArticleId><ArticleId IdType="pmc">PMC4016417</ArticleId><ArticleId IdType="doi">10.1186/1471-2253-14-13</ArticleId><ArticleId IdType="pii">1471-2253-14-13</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morray JP. Cardiac arrest in anesthetized children: recent advances and challenges for the future. Paediatr Anaesth. 2011;21:722&#x2013;729. doi: 10.1111/j.1460-9592.2010.03440.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2010.03440.x</ArticleId><ArticleId IdType="pubmed">21091590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhananker SM, Ramamoorthy C, Geiduschek JM, Posner KL, Domino KB, Haberkern CM, Campos JS, Morray JP. Anesthesia-related cardiac arrest in children: update from the pediatric perioperative cardiac arrest registry. Anesth Analg. 2007;105:344&#x2013;350. doi: 10.1213/01.ane.0000268712.00756.dd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000268712.00756.dd</ArticleId><ArticleId IdType="pubmed">17646488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Knight PR. Intraoperative respiratory complications in patients with upper respiratory tract infections. Can J Anaesth. 1987;34:300&#x2013;303. doi: 10.1007/BF03015170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03015170</ArticleId><ArticleId IdType="pubmed">3581401</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunchungmongkol N, Somboonviboon W, Suraseranivongse S, Vasinanukorn M, Chau-in W, Hintong T. Pediatric anesthesia adverse events: the Thai Anesthesia Incidents Study (THAI Study) database of 25,098 cases. J Med Assoc Thai. 2007;90:2072&#x2013;2079.</Citation><ArticleIdList><ArticleId IdType="pubmed">18041426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Malviya S, Voepel-Lewis T, Munro HM, Seiwert M, Pandit UA. Risk factors for perioperative adverse respiratory events in children with upper respiratory tract infections. Anesthesiology. 2001;95:299&#x2013;306. doi: 10.1097/00000542-200108000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200108000-00008</ArticleId><ArticleId IdType="pubmed">11506098</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamie C, Habre W, Delhumeau C, Argiroffo CB, Morabia A. Incidence and risk factors of perioperative respiratory adverse events in children undergoing elective surgery. Paediatr Anaesth. 2004;14:218&#x2013;224. doi: 10.1111/j.1460-9592.2004.01169.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2004.01169.x</ArticleId><ArticleId IdType="pubmed">14996260</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Voepel-Lewis T, Burke C, Kostrzewa A, Lewis I. Incidence and risk factors for perioperative adverse respiratory events in children who are obese. Anesthesiology. 2008;108:375&#x2013;380. doi: 10.1097/ALN.0b013e318164ca9b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318164ca9b</ArticleId><ArticleId IdType="pubmed">18292674</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, Rebmann C, Johnson C, Sly PD, Habre W. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet. 2010;376:773&#x2013;783. doi: 10.1016/S0140-6736(10)61193-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue FS, Luo LK, Tong SY, Liao X, Deng XM, An G. Study of the safe threshold of apneic period in children during anesthesia induction. J Clin Anesth. 1996;8:568&#x2013;574. doi: 10.1016/S0952-8180(96)00138-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-8180(96)00138-9</ArticleId><ArticleId IdType="pubmed">8910179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chongsuvivatwong V. In: Analysis of Epidemiological Data using R and Epicalc. 2. McNeil EB, editor. Songkhla: Chanmuang Press; 2008. Survival analysis; pp. 225&#x2013;236.</Citation></Reference><Reference><Citation>Uakritdathikarn T, Chongsuvivatwong V, Geater AF, Vasinanukorn M, Thinchana S, Klayna S. Perioperative desaturation and risk factors in general anesthesia. J Med Assoc Thai. 2008;91:1020&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">18839840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunchungmongkol N, Punjasawadwong Y, Chumpathong S, Somboonviboon W, Suraseranivongse S, Vasinanukorn M, Srisawasdi S, Thienthong S, Pranootnarabhal T. Anesthesia-related cardiac arrest in children: the Thai Anesthesia Incidents Study (THAI Study) J Med Assoc Thai. 2009;92:523&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">19374304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallan S, Molaug PO, Arnulf V, Gisvold SE. Causes and risk factors of intraoperative anesthesia complications. A prospective study of 14,735 anesthesias. Tidsskr Nor Laegeforen. 1990;110:38&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">2300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Flick RP, Wilder RT, Pieper SF, van Koeverden K, Ellison KM, Marienau ME, Hanson AC, Schroeder DR, Sprung J. Risk factors for laryngospasm in children during general anesthesia. Paediatr Anaesth. 2008;18:289&#x2013;296. doi: 10.1111/j.1460-9592.2008.02447.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2008.02447.x</ArticleId><ArticleId IdType="pubmed">18315633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordet F, Allaouchiche B, Lansiaux S, Combet S, Pouyau A, Taylor P, Bonnard C, Chassard D. Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth. 2002;12:762&#x2013;769. doi: 10.1046/j.1460-9592.2002.00987.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1460-9592.2002.00987.x</ArticleId><ArticleId IdType="pubmed">12519134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait AR, Pandit UA, Voepel-Lewis T, Munro HM, Malviya S. Use of the laryngeal mask airway in children with upper respiratory tract infections: a comparison with endotracheal intubation. Anesth Analg. 1998;86:706&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">9539588</ArticleId></ArticleIdList></Reference><Reference><Citation>Harnett M, Kinirons B, Heffernan A, Motherway C, Casey W. Airway complications in infants: comparison of laryngeal mask airway and the facemask-oral airway. Can J Anesth. 2000;47:315&#x2013;318. doi: 10.1007/BF03020944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03020944</ArticleId><ArticleId IdType="pubmed">10764174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman J, Hammer GB, Verghese S, Ehlers M, Khalil SN, Betts E, Trillo R, Deutsch J. Airway response to desflurane during maintenance of anesthesia and recovery in children with laryngeal mask airways. Paediatr Anaesth. 2010;20:495&#x2013;505. doi: 10.1111/j.1460-9592.2010.03305.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2010.03305.x</ArticleId><ArticleId IdType="pubmed">20456065</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoh T, Taki Y, Tsubone H. Desflurane but not sevoflurane augments laryngeal C-fiber inputs to nucleus tractus solitarii neurons by activating transient receptor potential-A1. Life Sci. 2013;92:821&#x2013;828. doi: 10.1016/j.lfs.2013.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2013.02.015</ArticleId><ArticleId IdType="pubmed">23499557</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-alami AA, Zestos MM, Baraka AS. Pediatric laryngospasm: prevention and treatment. Curr Opin Anaesthesiol. 2009;22:388&#x2013;395. doi: 10.1097/ACO.0b013e32832972f3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e32832972f3</ArticleId><ArticleId IdType="pubmed">19434787</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparr HJ. Choice of the muscle relaxant for rapid-sequence induction. Eur J Anaesthesiol Suppl. 2001;23:71&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">11766251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ing C, Chui I, Ohkawa S, Kakavouli A, Sun L. Incidence and causes of perioperative endotracheal reintubation in children: a review of 28208 anesthetics. Paediatr Anaesth. 2013;23:621&#x2013;626. doi: 10.1111/j.1460-9592.2012.03920.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2012.03920.x</ArticleId><ArticleId IdType="pubmed">22817271</ArticleId></ArticleIdList></Reference><Reference><Citation>Rujirojindakul P, Geater AF, McNeil EB, Vasinanukorn P, Prathep S, Asim W, Naklongdee J. Risk factors for reintubation in the post-anaesthetic care unit: a case-control study. Br J Anaesth. 2012;109:636&#x2013;642. doi: 10.1093/bja/aes226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes226</ArticleId><ArticleId IdType="pubmed">22777658</ArticleId></ArticleIdList></Reference><Reference><Citation>Orestes MI, Lander L, Verghese S, Shah RK. Incidence of laryngospasm and bronchospasm in pediatric adenotonsillectomy. Laryngoscope. 2012;122:425&#x2013;428. doi: 10.1002/lary.22423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.22423</ArticleId><ArticleId IdType="pubmed">22252947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman J. Perioperative respiratory complications in children. Lancet. 2010;376:745&#x2013;746. doi: 10.1016/S0140-6736(10)61199-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61199-3</ArticleId><ArticleId IdType="pubmed">20816527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25557228</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Prophylactic methylprednisolone to reduce inflammation and improve outcomes from one lung ventilation in children: a randomized clinical trial.</ArticleTitle><Pagination><StartPage>587</StartPage><EndPage>594</EndPage><MedlinePgn>587-94</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.12601</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">One lung ventilation (OLV) results in inflammatory and mechanical injury, leading to intraoperative and postoperative complications in children. No interventions have been studied in children to minimize such injury.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We hypothesized that a single 2-mg&#xb7;kg(-1) dose of methylprednisolone given 45-60&#xa0;min prior to lung collapse would minimize injury from OLV and improve physiological stability.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-eight children scheduled to undergo OLV were randomly assigned to receive 2&#xa0;mg&#xb7;kg(-1) methylprednisolone (MP) or normal saline (placebo group) prior to OLV. Anesthetic management was standardized, and data were collected for physiological stability (bronchospasm, respiratory resistance, and compliance). Plasma was assayed for inflammatory markers related to lung injury at timed intervals related to administration of methylprednisolone.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three children in the placebo group experienced clinically significant intraoperative and postoperative respiratory complications. Respiratory resistance was lower (P&#xa0;=&#xa0;0.04) in the methylprednisolone group. Pro-inflammatory cytokine IL-6 was lower (P&#xa0;=&#xa0;0.01), and anti-inflammatory cytokine IL-10 was higher (P&#xa0;=&#xa0;0.001) in the methylprednisolone group. Tryptase, measured before and after OLV, was lower (P&#xa0;=&#xa0;0.03) in the methylprednisolone group while increased levels of tryptase were seen in placebo group after OLV (did not achieve significance). There were no side effects observed that could be attributed to methylprednisolone in this study.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Methylprednisolone at 2&#xa0;mg&#xb7;kg(-1) given as a single dose prior to OLV provides physiological stability to children undergoing OLV. In addition, methylprednisolone results in lower pro-inflammatory markers and higher anti-inflammatory markers in the children's plasma.</AbstractText><CopyrightInformation>&#xa9; 2015 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Theroux</LastName><ForeName>Mary C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA; Department of Anesthesiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA; Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Alicia Olivant</ForeName><Initials>AO</Initials></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Maria E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Brislin</LastName><ForeName>Robert P</ForeName><Initials>RP</Initials></Author><Author ValidYN="Y"><LastName>Reichard</LastName><ForeName>Kirk W</ForeName><Initials>KW</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Suken A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>McCoy</LastName><ForeName>Matt</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Melinda</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dabney</LastName><ForeName>Kirk W</ForeName><Initials>KW</Initials></Author><Author ValidYN="Y"><LastName>Mackenzie</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Douglas A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Shaffer</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P20 RR020173</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008562</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5T32GM008562-17</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber><NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Paediatr Anaesth. 2015 Jun;25(6):649-50. doi: 10.1111/pan.12662.</RefSource><PMID Version="1">25917357</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Paediatr Anaesth. 2015 Oct;25(10):1066-7. doi: 10.1111/pan.12725.</RefSource><PMID Version="1">26333481</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061810" MajorTopicYN="Y">One-Lung Ventilation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">methylprednisolone</Keyword><Keyword MajorTopicYN="N">one lung ventilation</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword><Keyword MajorTopicYN="N">tryptases</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25557228</ArticleId><ArticleId IdType="mid">NIHMS643965</ArticleId><ArticleId IdType="pmc">PMC4414674</ArticleId><ArticleId IdType="doi">10.1111/pan.12601</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hammer GB. Single-lung ventilation in infants and children. Paediatr Anaesth. 2004;14:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">14717881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozian A, Schilling T, Fred&#xe9;n F, Maripuu E, R&#xf6;cken C, Strang C, et al. One-lung ventilation induces hyperperfusion and alveolar damage in the ventilated lung: an experimental study. Br J Anaesth. 2008;100:549&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">18308740</ArticleId></ArticleIdList></Reference><Reference><Citation>Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190:255&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">10685060</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Gribbin E, Emanuel S, Orndorff R, Walker J, Weese J, et al. Histochemical alterations in one lung ventilation. J Surg Res. 2007;137:16&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17112543</ArticleId></ArticleIdList></Reference><Reference><Citation>Theroux MC, Olivant A, Lim D, Bernardi JP, Costarino AT, Shaffer TH, et al. Low dose methylprednisolone prophylaxis to reduce inflammation during one-lung ventilation. Paediatr Anaesth. 2008;18:857&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">18768046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery. 2000;127:117&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">10686974</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xfc;ber F, Wrigge H, Schroeder S, Wetegrove S, Zinserling J, Hoeft A, et al. Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory response in patients with acute lung injury. Intensive Care Med. 2002;28:834&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pubmed">12122519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanwar S, Kubes P. Ischemia/reperfusion-induced granulocyte influx is a multistep process mediated by mast cells. Microcirculation. 1994;1:175&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">8790588</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelet P, D'Journo XB, Roch A, Doddoli C, Marin V, Papazian L, et al. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology. 2006;105:911&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">17065884</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Hopewell S, Schulz KF, Montori V, G&#xf8;tzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010. 63:e1&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">20346624</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller TL, Costarino TA, Olivant A, Lim D, Shaffer TH, Theroux MC. An animal model for the study of lung protective therapies during one lung ventilation (OLV) in children. Open Anesthesiol J. 2008;2:58&#x2013;62.</Citation></Reference><Reference><Citation>Theroux MC, Fisher AO, Horner LM, Rodriguez ME, Costarino AT, Miller TL, et al. Protective ventilation to reduce inflammatory injury from one lung ventilation in a piglet model. Paediatr Anaesth. 2010;20:356&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">19919624</ArticleId></ArticleIdList></Reference><Reference><Citation>Slinger P. Pro: low tidal volume is indicated during one-lung ventilation. Anesth Analg. 2006;103:268&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">16861400</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimopoulou I, Orfanos S, Kotanidou A, Livaditi O, Giamarellos-Bourboulis E, Athanasiou C, et al. Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine. 2008;41:263&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">18191577</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan JS, Kilpatrick L, Costarino AT, Jr, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr. 1992;120:510&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">1552388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanwar S, Kubes P. Mast cells contribute to ischemia-reperfusion-induced granulocyte infiltration and intestinal dysfunction. Am J Physiol. 1994;267:G316&#x2013;G321.</Citation><ArticleIdList><ArticleId IdType="pubmed">8074230</ArticleId></ArticleIdList></Reference><Reference><Citation>Grisham MB, Granger DN. Metabolic sources of reactive oxygen metabolites during oxidant stress and ischemia with reperfusion. Clin Chest Med. 1989;10:71&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">2650965</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubes P, Granger DN. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res. 1996;32(4):699&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pubmed">8915188</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivant Fisher A, Husain K, Wolfson MR, Hubert TL, Rodriguez E, Shaffer TH, et al. Hyperoxia during one lung ventilation: inflammatory and oxidative responses. Pediatr Pulmonol. 2012;47:979&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3888791</ArticleId><ArticleId IdType="pubmed">22431368</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JA, Laverne RG, Fairley HB, Thomas AN. Pulmonary oxygen exchange during endobronchial anesthesia: effect of tidal volume and PEEP. Anesthesiology. 1982;56:164&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">7036798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta N, Shimaoka M, Imanaka H, Nishimura M, Taenaka N, Kiyono H, et al. Glucocorticoid suppresses neutrophil activation in ventilator-induced lung injury. Crit Care Med. 2001;29:1012&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">11378614</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot S, Atkins PC, Zweiman B. In vivo effects of corticosteroids on human allergic responses. I. Effects of systemic administrations of steroids. Ann Allergy. 1987;58:363&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">2437837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rk J, Goldschmidt T, Smedeg&#xe5;rd G, Arfors KE. Methylprednisolone acts at the endothelial cell level reducing inflammatory responses. Acta Physiol Scand. 1985;123:221&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">2580420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura E, Kitagawa Y, Ozawa S, Suda K, Ando N, Ueda M, et al. Role of steroid administration to reduce inflammation after thoracotomy in a rat surgical stress model. J Surg Res. 2006;135:364&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">16815450</ArticleId></ArticleIdList></Reference><Reference><Citation>Slinger P, Scott WA. Arterial oxygenation during one-lung ventilation. A comparison of enflurane and isoflurane. Anesthesiology. 1995;82:940&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pubmed">7717566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25806562</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.</ArticleTitle><Pagination><StartPage>CD009515</StartPage><MedlinePgn>CD009515</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">CD009515</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD009515.pub2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Children with congenital heart disease often undergo heart surgery at a young age. They are at risk for postoperative low cardiac output syndrome (LCOS) or death. Milrinone may be used to provide inotropic and vasodilatory support during the immediate postoperative period.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This review examines the effectiveness of prophylactic postoperative use of milrinone to prevent LCOS or death in children having undergone surgery for congenital heart disease.</AbstractText><AbstractText Label="SEARCH METHODS" NlmCategory="METHODS">Electronic and manual literature searches were performed to identify randomised controlled trials. We searched CENTRAL, MEDLINE, EMBASE and Web of Science in February 2014 and conducted a top-up search in September 2014 as well as clinical trial registries and reference lists of published studies. We did not apply any language restrictions.</AbstractText><AbstractText Label="SELECTION CRITERIA" NlmCategory="METHODS">Only randomised controlled trials were selected for analysis. We considered studies with newborn infants, infants, toddlers, and children up to 12 years of age.</AbstractText><AbstractText Label="DATA COLLECTION AND ANALYSIS" NlmCategory="METHODS">Two review authors independently extracted data according to a pre-defined protocol. We obtained additional information from all study authors.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Three of the five included studies compared milrinone versus levosimendan, one study compared milrinone with placebo, and one compared milrinone verus dobutamine, with 101, 242, and 50 participants, respectively. Three trials were at low risk of bias while two were at higher risk of bias. The number and definitions of outcomes were non-uniform as well. In one study comparing two doses of milrinone and placebo, there was some evidence in an overall comparison of milrinone versus placebo that milrinone lowered risk for LCOS (risk ratio (RR) 0.52, 95% confidence interval (CI) 0.28 to 0.96; 227 participants). The results from two small studies do not provide enough information to determine whether milrinone increases the risk of LCOS when compared to levosimendan (RR 1.22, 95% CI 0.32 to 4.65; 59 participants). Mortality rates in the studies were low, and there was insufficient evidence to draw conclusions on the effect of milrinone compared to placebo or levosimendan or dobutamine regarding mortality, the duration of intensive care stay, hospital stay, mechanical ventilation, or maximum inotrope score (where available). Numbers of patients requiring mechanical cardiac support were also low and did not allow a comparison between studies, and none of the participants of any study received a heart transplantation up to the end of the respective follow-up period. Time to death within three months was not reported in any of the included studies. A number of adverse events was examined, but differences between the treatment groups could not be proven for hypotension, intraventricular haemorrhage, hypokalaemia, bronchospasm, elevated serum levels of liver enzymes, or a reduced left ventricular ejection fraction &lt; 50% or reduced left ventricular fraction of shortening &lt; 28%. Our analysis did not prove an increased risk of arrhythmias in patients treated prophylactically with milrinone compared with placebo (RR 3.59, 95% CI 0.83 to 15.42; 238 participants), a decreased risk of pleural effusions (RR 1.78, 95% CI 0.92 to 3.42; 231 participants), or a difference in risk of thrombocytopenia on milrinone compared with placebo (RR 0.86, 95% CI 0.39 to 1.88; 238 participants). Comparisons of milrinone with levosimendan or with dobutamine, respectively, did not clarify the risk of arrhythmia and were not possible for pleural effusions or thrombocytopenia.</AbstractText><AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">There is insufficient evidence of the effectiveness of prophylactic milrinone in preventing death or low cardiac output syndrome in children undergoing surgery for congenital heart disease, compared to placebo. So far, no differences have been shown between milrinone and other inodilators, such as levosimendan or dobutamine, in the immediate postoperative period, in reducing the risk of LCOS or death. The existing data on the prophylactic use of milrinone has to be viewed cautiously due to the small number of small trials and their risk of bias.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Burkhardt</LastName><ForeName>Barbara E U</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Kinderspital Zurich, Steinwiesstrasse 75, Zurich, Switzerland, 8032.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xfc;cker</LastName><ForeName>Gerta</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Stiller</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002316">Cardiotonic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical><Chemical><RegistryNumber>3S12J47372</RegistryNumber><NameOfSubstance UI="D004280">Dobutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>JU9YAX04C7</RegistryNumber><NameOfSubstance UI="D020105">Milrinone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>doi: 10.1002/14651858.CD009515</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002303" MajorTopicYN="N">Cardiac Output, Low</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002316" MajorTopicYN="N">Cardiotonic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004280" MajorTopicYN="N">Dobutamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="N">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020105" MajorTopicYN="N">Milrinone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Barbara E.U. Burkhardt: Joined the institution where one of the trials had been conducted (Cavigelli 2013) seven months after identifying the study for this review in a clinical trial database. The study had already been finished by then, and this author was not involved in its conduct. Eight months later, it was published as an abstract, again without this author's involvement. Brigitte Stiller: none known. Gerta R&#xfc;cker: none known.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>3</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25806562</ArticleId><ArticleId IdType="pmc">PMC11032183</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD009515.pub2</ArticleId></ArticleIdList><ReferenceList><Title>References to studies included in this review</Title><ReferenceList><Title>Cavigelli 2013 {published and unpublished data}</Title><Reference><Citation>Cavigelli&#x2010;Brunner A, Hug MI, Dave H, Cannizzaro V, Baenziger O, Buerki C, et al. Therapy of low cardiac output syndrome after cardiac surgery in infants and children: a double blind randomized study comparing dobutamine and milrinone. Cardiology in the Young. May 2013; Vol. 23, Supplement S1:S34; O11&#x2010;3.</Citation></Reference></ReferenceList><ReferenceList><Title>Hoffman (HD vs. placebo) {published and unpublished data}</Title><Reference><Citation>Hoffman TM, Wernovsky G, Atz AM, Bailey JM, Akbary A, Kocsis JF, et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. American Heart Journal 2002;143(1):15&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">11773907</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107(7):996&#x2010;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">12600913</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hoffman (LD vs. placebo) {published and unpublished data}</Title><Reference><Citation>Hoffman TM, Wernovsky G, Atz AM, Bailey JM, Akbary A, Kocsis JF, et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. American Heart Journal 2002;143(1):15&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">11773907</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107(7):996&#x2010;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">12600913</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Hoffman 2003 {published and unpublished data}</Title><Reference><Citation>Hoffman TM, Wernovsky G, Atz AM, Bailey JM, Akbary A, Kocsis JF, et al. Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study.. American Heart Journal 2002;143(1):15&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">11773907</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107(7):996&#x2010;1002.</Citation><ArticleIdList><ArticleId IdType="pubmed">12600913</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lechner 2012 {published and unpublished data}</Title><Reference><Citation>Lechner E, Hofer A, Leitner&#x2010;Peneder G, Freynschlag R, Mair R, Weinzettel R, et al. Levosimendan versus milrinone in neonates and infants after corrective open&#x2010;heart surgery: a pilot study. Pediatric Critical Care Medicine 2012;13(5):542&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22622649</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Momeni 2011 {published data only}</Title><Reference><Citation>Momeni M, Rubay J, Matta A, Rennotte MT, Veyckemans F, Poncelet AJ, et al. Levosimendan in congenital cardiac surgery: a randomized, double&#x2010;blind clinical trial. Journal of Cardiothoracic and Vascular Anesthesia 2011;25(3):419&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">20829069</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pellicer 2013 {published data only}</Title><Reference><Citation>Pellicer A, Riera J, Lopez&#x2010;Ortego P, Bravo MC, Madero R, Perez&#x2010;Rodriguez J, et al. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pediatric Research 2013;73(1):95&#x2010;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">23138399</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies excluded from this review</Title><ReferenceList><Title>Bailey 2004 {published data only}</Title><Reference><Citation>Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. Journal of Pharmacokinetics and Pharmacodynamics 2004;31(1):43&#x2010;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">15346851</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cai 2008a {published data only}</Title><Reference><Citation>Cai J, Su Z, Shi Z, Zhou Y, Xu Z, Xu Z, et al. Nitric oxide and milrinone: combined effect on pulmonary circulation after Fontan&#x2010;type procedure: a prospective, randomized study. Annals of Thoracic Surgery 2008;86(3):882&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18721577</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Cai 2008b {published data only}</Title><Reference><Citation>Cai J, Su Z, Shi Z, Zhou Y, Xu Z, Liu J, et al. Nitric oxide in conjunction with milrinone better stabilized pulmonary hemodynamics after Fontan procedure. Artificial Organs 2008;32(11):864&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18959679</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Carmona 2010 {published data only}</Title><Reference><Citation>Carmona MJ, Martins LM, Vane MF, Longo BA, Paredes LS, Malbouisson LM. Comparison of the effects of dobutamine and milrinone on hemodynamic parameters and oxygen supply in patients undergoing cardiac surgery with low cardiac output after anesthetic induction. Revista Brasileira de Anestesiologia 2010;60(3):237&#x2010;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">20682156</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Doolan 1997 {published data only}</Title><Reference><Citation>Doolan LA, Jones EF, Kalman J, Buxton BF, Tonkin AM. A placebo&#x2010;controlled trial verifying the efficacy of milrinone in weaning high&#x2010;risk patients from cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 1997;11(1):37&#x2010;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">9058218</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Farah 2013 {published data only}</Title><Reference><Citation>Farah P, Ahmad&#x2010;Ali A, Hanane G, Abbas E. Additive effect of phosphodiesterase inhibitors in control of pulmonary hypertension after congenital cardiac surgery in children. Iranian Journal of Pediatrics 2013;23(1):19&#x2010;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3574987</ArticleId><ArticleId IdType="pubmed">23550065</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Khazin 2004 {published data only}</Title><Reference><Citation>Khazin V, Kaufman Y, Zabeeda D, Medalion B, Sasson L, Schachner A, et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. Journal of Cardiothoracic and Vascular Anesthesia 2004;18(2):156&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15073704</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Maslow 2004 {published data only}</Title><Reference><Citation>Maslow AD, Regan MM, Schwartz C, Bert A, Singh A. Inotropes improve right heart function in patients undergoing aortic valve replacement for aortic stenosis. Anesthesia and Analgesia 2004;98(4):891&#x2010;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">15041568</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Oztekin 2007 {published data only}</Title><Reference><Citation>Oztekin I, Yazici S, Oztekin DS, Goksel O, Issever H, Canik S. Effects of low&#x2010;dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension. Yakugaku Zasshi 2007;127(2):375&#x2010;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">17268158</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ricci 2012 {published data only}</Title><Reference><Citation>Ricci Z, Garisto C, Favia I, Vitale V, Chiara L, Cogo PE. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Intensive Care Medicine 2012;38(7):1198&#x2010;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">22527079</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Thul 1999 {published data only}</Title><Reference><Citation>Thul J, Hundt F, Will J, Schindler F, Akint&#xfc;rk H, Valeske K, et al. Enoximon vs. milrinon by myocardial dysfunction after cardio&#x2010;surgical operations in infants. Zeitschrift fur Kardiologie 1999;88(9):758. [CN&#x2010;00340079]</Citation></Reference></ReferenceList><ReferenceList><Title>Zuppa 2006 {published data only}</Title><Reference><Citation>Zuppa AF, Nicolson SC, Adamson PC, Wernovsky G, Mondick JT, Burnham N, et al. Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesthesia and Analgesia 2006;102(4):1062&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16551899</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>References to studies awaiting assessment</Title><ReferenceList><Title>Costello 2014 {published data only}</Title><Reference><Citation>Costello JM, Dunbar&#x2010;Masterson C, Allan CK, Gauvreau K, Newburger JW, McGowan FX Jr, et al. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double&#x2010;blind, placebo&#x2010;controlled trial. Circulation Heart Failure 2014;7(4):596&#x2010;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">24906491</ArticleId></ArticleIdList></Reference><Reference><Citation>Costello JM, Masterson CD, Allan CK, Gauvreau K, Newburger JW, McGowan FX, et al. Impact of empiric nesiritide or milrinone infusion on early postoperative recovery following fontan surgery: A randomized, double&#x2010;blind, placebo&#x2010;controlled clinical trial. Circulation. 2013; Vol. 128(22 suppl):A12099.</Citation><ArticleIdList><ArticleId IdType="pubmed">24906491</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Abraham 2005</Title><Reference><Citation>Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. In&#x2010;hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). Journal of the American College of Cardiology 2005;46(1):57&#x2010;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">15992636</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Allen 2014</Title><Reference><Citation>Allen LA, Fonarow GC, Grau&#x2010;Sepulveda MV, Hernandez AF, Peterson PN, Partovian C, et al. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With The Guidelines. Circulation Heart Failure 2014;7(2):251&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5459367</ArticleId><ArticleId IdType="pubmed">24488983</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Alousi 1986</Title><Reference><Citation>Alousi AA, Johnson DC. Pharmacology of the bipyridines: amrinone and milrinone. Circulation 1986;73(3 Pt 2):III10&#x2010;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">2417744</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Anonymous 2011</Title><Reference><Citation>Anonymous. Heads of Medicines Agencies EU worksharing procedure for assessment of paediatric data for milrinone. http://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/Paediatric_Regulation/Assessment_Reports/Article_45_work&#x2010;sharing/Milrinone&#x2010;_2011_06_Art.45PaedPdAR.pdf 06/07/2011.</Citation></Reference></ReferenceList><ReferenceList><Title>Bailey 1999</Title><Reference><Citation>Bailey JM, Miller BE, Lu W, Tosone SR, Kanter KR, Tam VK. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999;90(4):1012&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201672</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bassler 2006</Title><Reference><Citation>Bassler D, Choong K, McNamara P, Kirpalani H. Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biology of the Neonate 2006;89(1):1&#x2010;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">16155380</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Baysal 2010</Title><Reference><Citation>Baysal A, Sa&#x15f;mazel A, Y&#x131;ld&#x131;r&#x131;m A&#x130;, Ko&#xe7;ak T, Sunar H, Zeybek R. The effects of thyroid hormones and interleukin&#x2010;8 levels on prognosis after congenital heart surgery [Do&#x11f;u&#x15f;tan kalp cerrahisinde tiroit fonksiyonlar&#x131; ve interl&#xf6;kin&#x2010;8 de&#x11f;erlerinin prognoz &#xfc;zerine etkisi.]. Turk Kardiyoloji Dernegi Arsivi 2010;38(8):537&#x2010;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">21248453</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bohn 2011</Title><Reference><Citation>Bohn D. Objective assessment of cardiac output in infants after cardiac surgery. Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual 2011;14(1):19&#x2010;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">21444044</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Charpie 2000</Title><Reference><Citation>Charpie JR, Dekeon MK, Goldberg CS, Mosca RS, Bove EL, Kulik TJ. Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. Journal of Thoracic and Cardiovascular Surgery 2000;120(1):73&#x2010;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">10884658</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Delmo Walter 2010</Title><Reference><Citation>Delmo Walter EM, Alexi&#x2010;Meskishvili V, Huebler M, Loforte A, Stiller B, Weng Y, et al. Extracorporeal membrane oxygenation for intraoperative cardiac support in children with congenital heart disease. Interactive Cardiovascular and Thoracic Surgery 2010;10(5):753&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20139198</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Dilber 2010</Title><Reference><Citation>Dilber D, Malci&#x107; I. Spectrum of congenital heart defects in Croatia. European Journal of Pediatrics 2010 May;169(5):543&#x2010;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">19756728</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>EACTS 2011</Title><Reference><Citation>EACTS Congenital Database [European Association for Cardio&#x2010;Thoracic Surgery Congenital Database]. http://www.eactscongenitaldb.org 31.08.2011.</Citation></Reference></ReferenceList><ReferenceList><Title>el Allaf 1984</Title><Reference><Citation>Allaf D, D'Orio V, Carlier J. The new inotropic phosphodiesterase inhibitors. Archives of Physiology and Biochemistry 1984;92(4):S69&#x2010;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">6085243</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Ermis 2011</Title><Reference><Citation>Ermis PR, Morales DL. The adult Fontan patient: update for 2011. Methodist Debakey Cardiovascular Journal 2011;7(2):3&#x2010;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21685840</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Feneck 1992</Title><Reference><Citation>Feneck RO. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. Journal of Cardiothoracic and Vascular Anesthesia 1992;6(5):554&#x2010;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">1421066</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Fleming 2008</Title><Reference><Citation>Fleming GA, Murray KT, Yu C, Byrne JG, Greelish JP, Petracek MR, et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation 2008;118(16):1619&#x2010;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2770257</ArticleId><ArticleId IdType="pubmed">18824641</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Follath 2011</Title><Reference><Citation>Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, et al. Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM&#x2010;HF). Intensive Care Medicine 2011;37(4):619&#x2010;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">21210078</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Harbord 2006</Title><Reference><Citation>Harbord RM, Egger M, Sterne JA. A modified test for small&#x2010;study effects in meta&#x2010;analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443&#x2010;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2002</Title><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta&#x2010;analysis. Statistics in Medicine 2002;21(11):1539&#x2010;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Higgins 2011</Title><Reference><Citation>Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane&#x2010;handbook.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Hochman 1999</Title><Reference><Citation>Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. New England Journal of Medicine 1999;341(9):625&#x2010;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">10460813</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Huntsman 1983</Title><Reference><Citation>Huntsman LL, Stewart DK, Barnes SR, Franklin SB, Colocousis JS, Hessel EA. Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation 1983;67(3):593&#x2010;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">6821902</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Jeon 2006</Title><Reference><Citation>Jeon Y, Ryu JH, Lim YJ, Kim CS, Bahk JH, Yoon SZ, et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone&#x2010;induced hypotension in off&#x2010;pump coronary artery bypass surgical patients. European Journal of Cardiothoracic Surgery 2006;29(6):952&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16675238</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Kim 2006</Title><Reference><Citation>Kim J, Dreyer J, Chang A. Arterial pulse wave analysis: an accurate means of determining cardiac output in children. Pediatric Critical Care Medicine 2006;7:532&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17006382</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lefebvre, 2011</Title><Reference><Citation>Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors).Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane&#x2010;handbook.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Lemson 2008</Title><Reference><Citation>Lemson J, Boode WP, Hopman JC, Singh SK, Hoeven JG. Validation of transpulmonary thermodilution cardiac output measurement in a pediatric animal model. Pediatric Critical Care Medicine 2008;9(3):313&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18446111</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Lindinger 2010</Title><Reference><Citation>Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007) [Pr&#xe4;valenz angeborener Herzfehler bei Neugeborenen in Deutschland: Ergebnisse des ersten Geburtsjahrganges (Juli 2006 bis Juni 2007)]. Klinische P&#xe4;diatrie 2010;222(5):321&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20665366</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>MHRA 2005</Title><Reference><Citation>Medicines and Healthcare Products Regulatory Agency (UK), Paediatric Working Party &#x2010; Committee on Safety of Medicines. Review of paediatric data &#x2010; Primacor Injection. http://www.mhra.gov.uk/home/groups/pl&#x2010;p/documents/websiteresources/con2030490.pdf 2005, Apr 27; Vol. Accessed 2014, Sep 11.</Citation></Reference></ReferenceList><ReferenceList><Title>Moffett 2015</Title><Reference><Citation>Moffett BS, Price JF. National prescribing trends for heart failure medications in children. Congenital Heart Disease 2015;10(1):78&#x2010;85. [DOI: 10.1111/chd.12183]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/chd.12183</ArticleId><ArticleId IdType="pubmed">24725766</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moher 2009</Title><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta&#x2010;analyses: the PRISMA statement. BMJ 2009;339:b2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Nieminen 2006</Title><Reference><Citation>Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. European Heart Journal 2006;27(22):2725&#x2010;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">17000631</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Paradisis 2009</Title><Reference><Citation>Paradisis M, Evans N, Kluckow M, Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. Journal of Pediatrics 2009;154(2):189&#x2010;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">18822428</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Pasquali 2008</Title><Reference><Citation>Pasquali SK, Hall M, Slonim AD, Jenkins KJ, Marino BS, Cohen MS, et al. Off&#x2010;label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circulation: Cardiovascular Quality and Outcomes 2008;1(2):74&#x2010;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">20031793</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>R 2013 [Computer program]</Title><Reference><Citation>R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna 2013. Vienna: R Foundation, 2013.</Citation></Reference></ReferenceList><ReferenceList><Title>Ramamoorthy 1998</Title><Reference><Citation>Ramamoorthy C, Anderson GD, Williams GD, Lynn AM. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesthesia and Analgesia 1998;86(2):283&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9459233</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Rao 1996</Title><Reference><Citation>Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. Journal of Thoracic and Cardiovascular Surgery 1996;112(1):38&#x2010;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">8691884</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>R&#xfc;cker 2011</Title><Reference><Citation>R&#xfc;cker G, Schwarzer G, Carpenter JR, Binder H, Schumacher M. Treatment&#x2010;effect estimates adjusted for small&#x2010;study effects via a limit meta&#x2010;analysis. Biostatistics 2011;12(1):122&#x2010;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">20656692</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sanofi Aventis 2010</Title><Reference><Citation>Sanofi Aventis. Drug reference Corotrop&#xae; (Milrinone) [Fachinformation Corotrop&#xae;]. Rote Liste&#xae;&#xa0;Service&#xa0;GmbH&#xa0;&#x2022;&#xa0; Mainzer&#xa0;Landstr.&#xa0;55&#xa0;&#x2022;&#xa0;60329&#xa0;Frankfurt/Main August 2010.</Citation></Reference></ReferenceList><ReferenceList><Title>Schwarzer 2007</Title><Reference><Citation>Schwarzer G. meta: An R package for Meta&#x2010;Analysis. R News 2007;7(3):40&#x2010;5.</Citation></Reference></ReferenceList><ReferenceList><Title>Schwarzer 2010</Title><Reference><Citation>Schwarzer G, R&#xfc;cker G. Statistical methods for detecting and adjusting for publication bias. Zeitschrift f&#xfc;r Evidenz, Fortbildung und Qualit&#xe4;t im Gesundheitswesen (ZEFQ) 2010;104(4):306&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">20701110</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shi 2008</Title><Reference><Citation>Shi S, Zhao Z, Liu X, Shu Q, Tan L, Lin R, et al. Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest 2008;134(4):768&#x2010;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">18625673</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Shore 2001</Title><Reference><Citation>Shore S, Nelson DP, Pearl JM, Manning PB, Wong H, Shanley TP, et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. American Journal of Cardiology 2001;88(5):591&#x2010;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11524081</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stocker 2006</Title><Reference><Citation>Stocker CF. Recent developments in the perioperative management of the paediatric cardiac patient. Current Opinion in Anaesthesiology 2006;19(4):375&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">16829717</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Stocker 2007</Title><Reference><Citation>Stocker CF, Shekerdemian LS, N&#xf8;rgaard MA, Brizard CP, Mynard JP, Horton SB, et al. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Critical Care Medicine 2007;35(1):252&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17133188</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Sweeting 2004</Title><Reference><Citation>Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta&#x2010;analysis of sparse data. Statistics in Medicine 2004;23(9):1351&#x2010;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">15116347</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Teng 2011</Title><Reference><Citation>Teng S, Kaufman J, Pan Z, Czaja A, Shockley H, Cruz E. Continuous arterial pressure waveform monitoring in pediatric cardiac transplant, cardiomyopathy and pulmonary hypertension patients. Intensive Care Medicine 2011;37(8):1297&#x2010;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">21626432</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tibby 2002</Title><Reference><Citation>Tibby SM, Murdoch IA. Measurement of cardiac output and tissue perfusion. Current Opinion in Pediatrics 2002;14:303&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12011669</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Tierney 2007</Title><Reference><Citation>Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time&#x2010;to&#x2010;event data into meta&#x2010;analysis. Trials 2007;8:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1920534</ArticleId><ArticleId IdType="pubmed">17555582</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vogt 2011a</Title><Reference><Citation>Vogt W, L&#xe4;er S. Treatment for paediatric low cardiac output syndrome: results from the European EuLoCOS&#x2010;Paed survey. Archives of Disease in Childhood 2011;96(12):1180&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22034494</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Vogt 2011b</Title><Reference><Citation>Vogt W, L&#xe4;er S. Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS&#x2010;Paed. Paediatric Anaesthesia 2011;21(12):1176&#x2010;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">21851475</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Warnes 2001</Title><Reference><Citation>Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, et al. Task force 1: the changing profile of congenital heart disease in adult life. Journal of the American College of Cardiology 2001;37(5):1170&#x2010;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11300418</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26994025</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-2715</ISSN><JournalIssue CitedMedium="Print"><Volume>53</Volume><Issue>198</Issue><PubDate><Year>2015</Year><Season>Apr-Jun</Season></PubDate></JournalIssue><Title>JNMA; journal of the Nepal Medical Association</Title><ISOAbbreviation>JNMA J Nepal Med Assoc</ISOAbbreviation></Journal><ArticleTitle>Adverse Events in Children Receiving General Anaesthesia with Laryngeal Mask Airway Insertion.</ArticleTitle><Pagination><StartPage>77</StartPage><EndPage>82</EndPage><MedlinePgn>77-82</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Perioperative adverse events are more common in children compared to adult population. Reporting an adverse event proves effective in identifying problems and helps in prevention and early management. Our objective was to identify the types, incidence, and the time of occurrence of perioperative adverse event. We also aimed to find out whether the occurrence of the types of adverse events differ in children below and above five years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective study in 242, ASA Physical Status I and II children aged day one to 14 years, receiving general anesthesia with laryngeal mask airway for various elective surgeries. Adverse events observed in the perioperative period were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Adverse events related to respiratory system (n=26, 55%) were the most common followed by cardiovascular system (n= 14, 30%). Adverse events were observed in 24(10%) children in the operating room and in 20 (8%) children in the post anaesthesia care unit. In the operating room, majority (14 of 27, 52%) of the events occurred immediately after removal of laryngeal mask airway. Respiratory events were more common in children below five years (p=0.007), whereas cardiac events were more common in children above five years (p=0.02).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The commonest adverse event in children is related to respiratory system. Adverse events occur more frequently in the operating room, mostly immediately after removal of laryngeal mask airway. Respiratory events are more frequent in children below five years whereas cardiac events are more frequent in children above five years.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khatiwada</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattarai</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pokharel</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subedi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, BPKIHS, Dharan, Nepal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Nepal</Country><MedlineTA>JNMA J Nepal Med Assoc</MedlineTA><NlmUniqueID>0045233</NlmUniqueID><ISSNLinking>0028-2715</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="N">Airway Obstruction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009390" MajorTopicYN="N">Nepal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse events; children; laryngeal mask airway; laryngospasm; perioperative.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26994025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27516725</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1916-7245</ISSN><JournalIssue CitedMedium="Internet"><Volume>2016</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>Canadian respiratory journal</Title><ISOAbbreviation>Can Respir J</ISOAbbreviation></Journal><ArticleTitle>Clinical Utility of Bronchoalveolar Lavage Pepsin in Diagnosis of Gastroesophageal Reflux among Wheezy Infants.</ArticleTitle><Pagination><StartPage>9480843</StartPage><MedlinePgn>9480843</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9480843</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2016/9480843</ELocationID><Abstract><AbstractText>Background. There is no gold standard test for diagnosis of gastroesophageal reflux disease (GERD) associated infantile wheezing. Objectives. To evaluate the value of bronchoalveolar lavage (BAL) pepsin assay in diagnosis of GERD in wheezy infants. Methods. Fifty-two wheezy infants were evaluated for GERD using esophageal combined impedance-pH (MII-pH) monitoring, esophagogastroduodenoscopy with esophageal biopsies, and BAL pepsin. Tracheobronchial aspirates from 10 healthy infants planned for surgery without history of respiratory problems were examined for pepsin. Results. Wheezy infants with silent reflux and wheezy infants with typical GERD symptoms but normal MII-pH had significantly higher BAL pepsin compared to healthy control (45.3 &#xb1; 8.6 and 42.8 &#xb1; 8 versus 29 &#xb1; 2.6, P &lt; 0.0001 and P = 0.011, resp.). BAL pepsin had sensitivity (61.7%, 72 %, and 70%) and specificity (55.5%, 52.9%, and 53%) to diagnose GERD associated infantile wheeze compared to abnormal MII-pH, reflux esophagitis, and lipid laden macrophage index, respectively. Conclusion. A stepwise approach for assessment of GERD in wheezy infants is advised. In those with silent reflux, a trial of antireflux therapy is warranted with no need for further pepsin assay. But when combined MII-pH is negative despite the presence of typical GERD symptoms, pepsin assay will be needed to rule out GERD related aspiration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdallah</LastName><ForeName>Ahmed Fathi</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Gastroenterology and Hepatology Unit, Pediatric Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Desoky</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Allergy, Respiratory, and Clinical Immunology Unit, Pediatric Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fathi</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pediatric Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkashef</LastName><ForeName>Wagdy Fawzi</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Pathology Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaki</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6359-5572</Identifier><AffiliationInfo><Affiliation>Allergy, Respiratory, and Clinical Immunology Unit, Pediatric Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can Respir J</MedlineTA><NlmUniqueID>9433332</NlmUniqueID><ISSNLinking>1198-2241</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.23.1</RegistryNumber><NameOfSubstance UI="D010434">Pepsin A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016145" MajorTopicYN="N">Endoscopy, Digestive System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050782" MajorTopicYN="N">Esophageal pH Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004947" MajorTopicYN="N">Esophagus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005764" MajorTopicYN="N">Gastroesophageal Reflux</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010434" MajorTopicYN="N">Pepsin A</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27516725</ArticleId><ArticleId IdType="pmc">PMC4969502</ArticleId><ArticleId IdType="doi">10.1155/2016/9480843</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martinez F. D., Wright A. L., Taussig L. M., et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. The New England Journal of Medicine. 1995;332(3):133&#x2013;138. doi: 10.1056/nejm199501193320301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm199501193320301</ArticleId><ArticleId IdType="pubmed">7800004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisgaard H., Szefler S. Prevalence of asthma-like symptoms in young children. Pediatric Pulmonology. 2007;42(8):723&#x2013;728. doi: 10.1002/ppul.20644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.20644</ArticleId><ArticleId IdType="pubmed">17598172</ArticleId></ArticleIdList></Reference><Reference><Citation>Orenstein S. R., Shalaby T. M., Cohn J. F. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clinical Pediatrics. 1996;35(12):607&#x2013;614. doi: 10.1177/000992289603501201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000992289603501201</ArticleId><ArticleId IdType="pubmed">8970752</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenplas Y., Rudolph C. D., Di Lorenzo C., et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Journal of Pediatric Gastroenterology and Nutrition. 2009;49(4):498&#x2013;547. doi: 10.1097/mpg.0b013e3181b7f563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mpg.0b013e3181b7f563</ArticleId><ArticleId IdType="pubmed">19745761</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenplas Y., Hassall E. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. Journal of Pediatric Gastroenterology and Nutrition. 2002;35(2):119&#x2013;136. doi: 10.1097/00005176-200208000-00005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-200208000-00005</ArticleId><ArticleId IdType="pubmed">12187285</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainie I., Tutuian R., Agrawal A., Adams D., Castell D. O. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. British Journal of Surgery. 2006;93(12):1483&#x2013;1487. doi: 10.1002/bjs.5493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.5493</ArticleId><ArticleId IdType="pubmed">17051602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazachkov M. Y., Muhlebach M. S., Livasy C. A., Noah T. L. Lipid-laden macrophage index and inflammation in bronchoalveolar lavage fluids in children. European Respiratory Journal. 2001;18(5):790&#x2013;795. doi: 10.1183/09031936.01.00047301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.01.00047301</ArticleId><ArticleId IdType="pubmed">11757629</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan U., Mitchell J. D., Tobias V., Day A. S., Bohane T. D. Fat laden macrophages in tracheal aspirates as a marker of reflux aspiration: a negative report. Journal of Pediatric Gastroenterology and Nutrition. 2002;35(3):309&#x2013;313. doi: 10.1097/00005176-200209000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-200209000-00013</ArticleId><ArticleId IdType="pubmed">12352518</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell S., McMaster C., Gibson D., Shields M. D., McCallion W. A. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration. Journal of Pediatric Surgery. 2006;41(2):289&#x2013;293. doi: 10.1016/j.jpedsurg.2005.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2005.11.002</ArticleId><ArticleId IdType="pubmed">16481237</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenplas Y., Belli D., Boige N., et al. A standardized protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux. Journal of Pediatric Gastroenterology &amp; Nutrition. 1992;14(4):467&#x2013;471. doi: 10.1097/00005176-199205000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-199205000-00017</ArticleId><ArticleId IdType="pubmed">1517953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener G. J., Richter J. E., Copper J. B., Wu W. C., Castell D. O. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. The American Journal of Gastroenterology. 1988;83(4):358&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">3348191</ArticleId></ArticleIdList></Reference><Reference><Citation>Breumelhof R., Smout A. J. P. M. The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. American Journal of Gastroenterology. 1991;86(2):160&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">1992627</ArticleId></ArticleIdList></Reference><Reference><Citation>Weusten B. L. A. M., Roelofs J. M. M., Akkermans L. M. A., Van Berge-Henegouwen G. P., Smout A. P. M. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology. 1994;107(6):1741&#x2013;1745. doi: 10.1016/0016-5085(94)90815-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0016-5085(94)90815-x</ArticleId><ArticleId IdType="pubmed">7958686</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenplas Y., Badriul H., Verghote M., Hauser B., Kaufman L. Oesophageal pH monitoring and reflux oesophagitis in irritable infants. European Journal of Pediatrics. 2004;163(6):300&#x2013;304. doi: 10.1007/s00431-004-1403-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-004-1403-3</ArticleId><ArticleId IdType="pubmed">15346910</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilic D., Fr&#xf6;hlich T., N&#xf6;h F., et al. Detection of gastroesophageal reflux in children using combined multichannel intraluminal impedance and pH measurement: data from the German Pediatric Impedance Group. Journal of Pediatrics. 2011;158(4):650&#x2013;654. doi: 10.1016/j.jpeds.2010.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2010.09.033</ArticleId><ArticleId IdType="pubmed">21035128</ArticleId></ArticleIdList></Reference><Reference><Citation>Corwin R. W., Irwin R. S. The lipid-laden alveolar macrophage as a marker of aspiration in parenchymal lung disease. American Review of Respiratory Disease. 1985;132(3):576&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">4037530</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaoude P. A., Knight P. R., Ohtake P., El-Solh A. A. Biomarkers in the diagnosis of aspiration syndromes. Expert Review of Molecular Diagnostics. 2010;10(3):309&#x2013;319. doi: 10.1586/erm.10.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erm.10.7</ArticleId><ArticleId IdType="pmc">PMC2882092</ArticleId><ArticleId IdType="pubmed">20370588</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleeson K., Eggli D. F., Maxwell S. L. Quantitative aspiration during sleep in normal subjects. Chest. 1997;111(5):1266&#x2013;1272. doi: 10.1378/chest.111.5.1266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.111.5.1266</ArticleId><ArticleId IdType="pubmed">9149581</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts N. B. Review article: human pepsins&#x2014;their multiplicity, function and role in reflux disease. Alimentary Pharmacology &amp; Therapeutics. 2006;24(supplement 2):2&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16939427</ArticleId></ArticleIdList></Reference><Reference><Citation>Elabiad M. T., Zhang J. Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. Journal of Pediatric Gastroenterology and Nutrition. 2011;53(4):401&#x2013;403. doi: 10.1097/mpg.0b013e31821a4b78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mpg.0b013e31821a4b78</ArticleId><ArticleId IdType="pubmed">21970995</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerson K. D., Foster C. D., Zhang P., Zhang Z., Rosenblatt M. M., Guttentag S. H. Pepsinogen C proteolytic processing of surfactant protein B. The Journal of Biological Chemistry. 2008;283(16):10330&#x2013;10338. doi: 10.1074/jbc.m707516200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m707516200</ArticleId><ArticleId IdType="pmc">PMC2447652</ArticleId><ArticleId IdType="pubmed">18256027</ArticleId></ArticleIdList></Reference><Reference><Citation>Niimi A., Chung K. F. Airway inflammation and remodelling changes in patients with chronic cough: do they tell us about the cause of cough? Pulmonary Pharmacology and Therapeutics. 2004;17(6):441&#x2013;446. doi: 10.1016/j.pupt.2004.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pupt.2004.09.004</ArticleId><ArticleId IdType="pubmed">15564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Starosta V., Kitz R., Hartl D., Marcos V., Reinhardt D., Griese M. Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease. Chest. 2007;132(5):1557&#x2013;1564. doi: 10.1378/chest.07-0316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.07-0316</ArticleId><ArticleId IdType="pubmed">17925430</ArticleId></ArticleIdList></Reference><Reference><Citation>Postma G. N., Belafsky P. C., Tomek M. S., Koufman J. A. Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease. Annals of Otology, Rhinology &amp; Laryngology. 2001;110(12):1114&#x2013;1116. doi: 10.1177/000348940111001205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348940111001205</ArticleId><ArticleId IdType="pubmed">11768699</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener G. J., Tsukashima R., Kelly C., et al. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. Journal of Voice. 2009;23(4):498&#x2013;504. doi: 10.1016/j.jvoice.2007.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvoice.2007.12.005</ArticleId><ArticleId IdType="pubmed">18468849</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen R., Johnston N., Hart K., Khatwa U., Nurko S. The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux. Neurogastroenterology and Motility. 2012;24(2):129&#x2013;e85. doi: 10.1111/j.1365-2982.2011.01826.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2011.01826.x</ArticleId><ArticleId IdType="pmc">PMC3307906</ArticleId><ArticleId IdType="pubmed">22141343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacco O., Mattioli G., Girosi D., Battistini E., Jasonni V., Rossi G. A. Gastroesophageal reflux and its clinical manifestation at gastroenteric and respiratory levels in childhood: physiology, signs and symptoms, diagnosis and treatment. Expert Review of Respiratory Medicine. 2007;1(3):391&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">20477178</ArticleId></ArticleIdList></Reference><Reference><Citation>Thilmany C., Beck-Ripp J., Griese M. Acid and non-acid gastro-esophageal refluxes in children with chronic pulmonary diseases. Respiratory Medicine. 2007;101(5):969&#x2013;976. doi: 10.1016/j.rmed.2006.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2006.09.006</ArticleId><ArticleId IdType="pubmed">17049220</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23176987</PMID><DateCompleted><Year>2014</Year><Month>03</Month><Day>12</Day></DateCompleted><DateRevised><Year>2014</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1806-907X</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>6</Issue><PubDate><Year>2012</Year><Season>Nov-Dec</Season></PubDate></JournalIssue><Title>Revista brasileira de anestesiologia</Title><ISOAbbreviation>Rev Bras Anestesiol</ISOAbbreviation></Journal><ArticleTitle>The use of disposable laryngeal mask airway for adenotonsillectomies.</ArticleTitle><Pagination><StartPage>788</StartPage><EndPage>797</EndPage><MedlinePgn>788-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0034-7094(12)70179-4</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0034-7094(12)70179-4</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Tracheal intubation associated with airway operations can cause complications such as laryngospasm, bronchospasm and periods of reduced oxygen saturation. Such complications are frequently reported during adenotonsillectomies, a procedure that by nature increases the incidence of airway complications. The objective of this study was to compare the occurrence of respiratory problems during adenotonsillectomies while using either a disposable laryngeal mask airway (LMA) or an endotracheal tube (TT).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We evaluated 204 pediatric patients undergoing general anesthesia for adenotonsillectomies. The patients were randomly allocated into either the tracheal intubation group (TT, n=100) or the laryngeal mask airway group (LMA, n=104). It was measured the level of oxygen saturation by pulse oximetry (SpO(2)) after the induction of anesthesia (SpO(2)-1), after establishing the operative field (SpO(2)-2), at the end of the surgical procedure (SpO(2)-3), three minutes after the removal of the contained breathing apparatus (SpO(2)-4) and upon admission to the post-anesthesia care unit (SpO(2)-5). All respiratory complications were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean SpO(2) values and standard deviations for the TT and LMA groups were as follows: SpO(2)-1: 98.9&#xb1;1.0 and 98.7&#xb1;0.8 (p&gt;0.25), SpO(2)-2: 97.4&#xb1;1.0 and 94.9&#xb1;4.3 (p&lt;0.001), SpO(2)-3: 96.9&#xb1;1.1 and 97.2&#xb1;1.1 (p=0.037), SpO(2)-4: 91.7&#xb1;9.0 and 95.2&#xb1;2.2 (p&lt;0.001) and SpO(2)-5: 94.0&#xb1;2.1 and 95.8&#xb1;2.6 (p&lt;0.001), respectively. In the LMA group, 12 patients required some maneuvering to fix positioning and leaks during surgery. In four patients, the LMA had to be replaced with a TT. Respiratory complications were similar between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Performing adenotonsillectomies in pediatric patients using a LMA resulted in a lower intraoperative SpO(2), compared to using a TT. In some cases, the LMA had to be replaced with an endotracheal tube. Although the surgery may be performed with LMA, the use of a TT is preferred for safety.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Editora Ltda. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Dante</ForeName><Initials>D</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculdade de Medicina de Botucatu, Universidade Estadual de S&#xe3;o Paulo (FMB, UNESP), SC, Brazil. deranieri@terra.com.br</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neubauer</LastName><ForeName>Adecir Geraldo</ForeName><Initials>AG</Initials></Author><Author ValidYN="Y"><LastName>Ranieri</LastName><ForeName>Denise Marchi</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>do Nascimento</LastName><ForeName>Paulo</ForeName><Initials>P</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Bras Anestesiol</MedlineTA><NlmUniqueID>0401316</NlmUniqueID><ISSNLinking>0034-7094</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Braz J Anesthesiol. 2014 Jan-Feb;64(1):71. doi: 10.1016/j.bjane.2013.11.001.</RefSource><PMID Version="1">24565392</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Braz J Anesthesiol. 2014 Jan-Feb;64(1):72. doi: 10.1016/j.bjane.2013.11.002.</RefSource><PMID Version="1">24565393</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="Y">Adenoidectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004209" MajorTopicYN="N">Disposable Equipment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23176987</ArticleId><ArticleId IdType="doi">10.1016/S0034-7094(12)70179-4</ArticleId><ArticleId IdType="pii">S0034-7094(12)70179-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29258438</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Supreme&#x2122; laryngeal mask airway use in general Anesthesia for category 2 and 3 Cesarean delivery: a prospective cohort study.</ArticleTitle><Pagination><StartPage>169</StartPage><MedlinePgn>169</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">169</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-017-0460-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Supreme&#x2122; laryngeal mask airway (SLMA) is a single-use LMA with double lumen design that allows separation of the respiratory and the alimentary tract, hence potentially reducing the gastric volume and risk of aspiration. The purpose of this prospective cohort study is to evaluate the the role of the SLMA as an airway technique for women undergoing category 2 and 3 Cesarean delivery under general anesthesia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We recruited 584 parturients who underwent category 2 or 3 Cesarean delivery under general anesthesia, in which 193 parturients underwent category 2 and 391 parturients underwent category 3 Cesarean delivery. The primary outcome was insertion success rate at 1st attempt in SLMA insertion. The secondary outcomes included anaesthetic, obstetric outcomes and maternal side effects associated with airway device.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 1st attempt insertion success rate was 98.3%, while the overall insertion success rate was 100%. The mean (Standard deviation) time to effective ventilation was 15.6 (4.4) seconds. Orogastric tube insertion was successful at the 1st attempt in all parturients. There was no clinical evidence of aspiration or regurgitation. No episodes of hypoxemia, laryngospasm or bronchospasm were observed intra-operatively. The incidence of complications was low and with good maternal satisfaction reported.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The SLMA could be an alternative effective airway in category 2 and 3 parturients emergency Cesarean Delivery under general anesthesia in a carefully-selected obstetric population.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinical Trials Registration: Clinicaltrials.gov Registration NCT02026882 . Registered on December 31, 2013.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shi Yang</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Quanzhou Macare Women's Hospital, Department of Anesthesiology and Perioperative Medicine, Quanzhou, 362000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Wei Yu</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Quanzhou Macare Women's Hospital, Department of Anesthesiology and Perioperative Medicine, Quanzhou, 362000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yong Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Qinghai University Affiliated Hospital, Xining, Qinghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tay</LastName><ForeName>Wen Shu</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Department of Women's Anaesthesia, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Nian-Lin Reena</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Division of Clinical Support Services, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sultana</LastName><ForeName>Rehena</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assam</LastName><ForeName>Pryseley N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>Singapore Clinical Research Institute, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sia</LastName><ForeName>Alex Tiong-Heng</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Women's Anaesthesia, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sng</LastName><ForeName>Ban Leong</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0001-5374-4271</Identifier><AffiliationInfo><Affiliation>Department of Women's Anaesthesia, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore, 229899, Singapore. sng.ban.leong@singhealth.com.sg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. sng.ban.leong@singhealth.com.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02026882</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058109" MajorTopicYN="N">Airway Management</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway management</Keyword><Keyword MajorTopicYN="N">Emergency Cesarean section</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Supreme&#x2122; laryngeal mask</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by Institutional Review Board at the Quanzhou Women&#x2019;s and Children&#x2019;s Hospital in China. The study was registered with the hospital ethics committee (dated 11th Nov 2013). All patients signed a written informed consent before enrolment. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29258438</ArticleId><ArticleId IdType="pmc">PMC5735892</ArticleId><ArticleId IdType="doi">10.1186/s12871-017-0460-x</ArticleId><ArticleId IdType="pii">10.1186/s12871-017-0460-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper GM, JH MC. Maternal deaths from anaesthesia. An extract from why mothers die 2000-2002, the confidential enquiries into maternal deaths in the United Kingdom: chapter 9: anaesthesia. Br J Anaesth. 2005;94(4):417&#x2013;423. doi: 10.1093/bja/aei066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aei066</ArticleId><ArticleId IdType="pubmed">15758081</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhyre JM, Riesner MN, Polley LS, Naughton NN. A series of anesthesia-related maternal deaths in Michigan, 1985-2003. Anesthesiology. 2007;106(6):1096&#x2013;1104. doi: 10.1097/01.anes.0000267592.34626.6b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.anes.0000267592.34626.6b</ArticleId><ArticleId IdType="pubmed">17525583</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnardo PD, Jenkins JG. Failed tracheal intubation in obstetrics: a 6-year review in a UK region. Anaesthesia. 2000;55(7):690&#x2013;694. doi: 10.1046/j.1365-2044.2000.01536.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2044.2000.01536.x</ArticleId><ArticleId IdType="pubmed">10919428</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawthorne L, Wilson R, Lyons G, Dresner M. Failed intubation revisited: 17-yr experience in a teaching maternity unit. Br J Anaesth. 1996;76(5):680&#x2013;684. doi: 10.1093/bja/76.5.680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/76.5.680</ArticleId><ArticleId IdType="pubmed">8688269</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn AC, Milne D, Columb M, Gorton H, Knight M. Failed tracheal intubation in obstetric anaesthesia: 2 yr national case-control study in the UK. Br J Anaesth. 2013;110(1):74&#x2013;80. doi: 10.1093/bja/aes320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes320</ArticleId><ArticleId IdType="pubmed">22986421</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman K, Jenkins JG. Failed tracheal intubation in obstetrics: no more frequent but still managed badly. Anaesthesia. 2005;60(2):168&#x2013;171. doi: 10.1111/j.1365-2044.2004.04069.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2004.04069.x</ArticleId><ArticleId IdType="pubmed">15644015</ArticleId></ArticleIdList></Reference><Reference><Citation>Brimacombe J. Analysis of 1500 laryngeal mask uses by one anaesthetist in adults undergoing routine anaesthesia. Anaesthesia. 1996;51(1):76&#x2013;80. doi: 10.1111/j.1365-2044.1996.tb07660.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.1996.tb07660.x</ArticleId><ArticleId IdType="pubmed">8669573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook TM, Lee G, Nolan JP. The ProSeal laryngeal mask airway: a review of the literature. Can J Anaesth. 2005;52(7):739&#x2013;760. doi: 10.1007/BF03016565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03016565</ArticleId><ArticleId IdType="pubmed">16103390</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg. 1996;82(1):129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">8712387</ArticleId></ArticleIdList></Reference><Reference><Citation>Awan R, Nolan JP, Cook TM. Use of a ProSeal laryngeal mask airway for airway maintenance during emergency caesarean section after failed tracheal intubation. Br J Anaesth. 2004;92(1):144&#x2013;146. doi: 10.1093/bja/aeh019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeh019</ArticleId><ArticleId IdType="pubmed">14665568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook TM, Brooks TS, Van der Westhuizen J, Clarke M. The Proseal LMA is a useful rescue device during failed rapid sequence intubation: two additional cases. Can J Anaesth. 2005;52(6):630&#x2013;633. doi: 10.1007/BF03015775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03015775</ArticleId><ArticleId IdType="pubmed">15983151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasham FM, Andrews PJ, Juneja MM, Ackerman WE., 3rd The laryngeal mask airway facilitates intubation at cesarean section. A case report of difficult intubation. Int J Obstet Anesth. 1993;2(3):181&#x2013;182. doi: 10.1016/0959-289X(93)90014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0959-289X(93)90014-9</ArticleId><ArticleId IdType="pubmed">15636882</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma B, Sahai C, Sood J, Kumra VP. The ProSeal laryngeal mask airway in two failed obstetric tracheal intubation scenarios. Int J Obstet Anesth. 2006;15(4):338&#x2013;339. doi: 10.1016/j.ijoa.2006.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijoa.2006.04.010</ArticleId><ArticleId IdType="pubmed">16945516</ArticleId></ArticleIdList></Reference><Reference><Citation>Halaseh BK, Sukkar ZF, Hassan LH, Sia AT, Bushnaq WA, Adarbeh H. The use of ProSeal laryngeal mask airway in caesarean section--experience in 3000 cases. Anaesth Intensive Care. 2010;38(6):1023&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">21226432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong DT, Yang JJ, Jagannathan N. Brief review: the LMA supreme supraglottic airway. Can J Anaesth. 2012;59(5):483&#x2013;493. doi: 10.1007/s12630-012-9673-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-012-9673-0</ArticleId><ArticleId IdType="pubmed">22318376</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao WY, Li SY, Sng BL, Lim Y, Sia AT. The LMA supreme in 700 parturients undergoing Cesarean delivery: an observational study. Can J Anaesth. 2012;59(7):648&#x2013;654. doi: 10.1007/s12630-012-9718-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12630-012-9718-4</ArticleId><ArticleId IdType="pubmed">22556005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas DN, Yentis SM, Kinsella SM, Holdcroft A, May AE, Wee M, et al. Urgency of caesarean section: a new classification. J R Soc Med. 2000;93(7):346&#x2013;350. doi: 10.1177/014107680009300703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014107680009300703</ArticleId><ArticleId IdType="pmc">PMC1298057</ArticleId><ArticleId IdType="pubmed">10928020</ArticleId></ArticleIdList></Reference><Reference><Citation>Han TH, Brimacombe J, Lee EJ, Yang HS. The laryngeal mask airway is effective (and probably safe) in selected healthy parturients for elective Cesarean section: a prospective study of 1067 cases. Can J Anaesth. 2001;48(11):1117&#x2013;1121. doi: 10.1007/BF03020379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03020379</ArticleId><ArticleId IdType="pubmed">11744589</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge ET, Nicholas SD, Newton JR, Temple JG. Gastro-oesophageal reflux in pregnancy. Altered function of the barrier to reflux in asymptomatic women during early pregnancy. Scand J Gastroenterol. 1984;19(1):85&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">6538697</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, et al. Association of body mass index with heartburn, regurgitation and esophagitis: results of the progression of Gastroesophageal reflux disease study. J Gastroenterol Hepatol. 2007;22(11):1728&#x2013;1731. doi: 10.1111/j.1440-1746.2006.04549.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1746.2006.04549.x</ArticleId><ArticleId IdType="pubmed">17914941</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts RB, Shirley MA. Reducing the risk of acid aspiration during cesarean section. Anesth Analg. 1974;53(6):859&#x2013;868. doi: 10.1213/00000539-197453060-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/00000539-197453060-00010</ArticleId><ArticleId IdType="pubmed">4473928</ArticleId></ArticleIdList></Reference><Reference><Citation>Bercker S, Schmidbauer W, Volk T, Bogusch G, Bubser HP, Hensel M, et al. A comparison of seal in seven supraglottic airway devices using a cadaver model of elevated esophageal pressure. Anesth Analg. 2008;106(2):445&#x2013;448. doi: 10.1213/ane.0b013e3181602ae1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181602ae1</ArticleId><ArticleId IdType="pubmed">18227299</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans NR, Gardner SV, James MF. ProSeal laryngeal mask protects against aspiration of fluid in the pharynx. Br J Anaesth. 2002;88(4):584&#x2013;587. doi: 10.1093/bja/88.4.584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/88.4.584</ArticleId><ArticleId IdType="pubmed">12066738</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller C, Brimacombe J, Kleinsasser A, Loeckinger A. Does the ProSeal laryngeal mask airway prevent aspiration of regurgitated fluid? Anesth Analg. 2000;91(4):1017&#x2013;1020. doi: 10.1097/00000539-200010000-00046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200010000-00046</ArticleId><ArticleId IdType="pubmed">11004067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y, Goel S, Brimacombe JR. The ProSeal laryngeal mask airway is an effective alternative to laryngoscope-guided tracheal intubation for gynaecological laparoscopy. Anaesth Intensive Care. 2007;35(1):52&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">17323666</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidbauer W, Bercker S, Volk T, Bogusch G, Mager G, Kerner T. Oesophageal seal of the novel supralaryngeal airway device I-gel in comparison with the laryngeal mask airways classic and ProSeal using a cadaver model. Br J Anaesth. 2009;102(1):135&#x2013;139. doi: 10.1093/bja/aen319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aen319</ArticleId><ArticleId IdType="pubmed">19011262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol. 1946;52:191&#x2013;205. doi: 10.1016/S0002-9378(16)39829-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9378(16)39829-5</ArticleId><ArticleId IdType="pubmed">20993766</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushambi MC, Kinsella SM, Popat M, Swales H, Ramaswamy KK, Winton AL, Quinn AC. Obstetric Anaesthetists' Association and difficult airway society guidelines for the management of difficult and failed tracheal intubation in obstetrics. Anaesthesia. 2015;70(11):1286&#x2013;1306. doi: 10.1111/anae.13260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.13260</ArticleId><ArticleId IdType="pmc">PMC4606761</ArticleId><ArticleId IdType="pubmed">26449292</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini S, Ahuja S, Guleria K. To evaluate the use of ProSeal laryngeal mask airway in patients undergoing elective lower segment Cesarean section under general anesthesia: a prospective randomized controlled study. J Obstet Anaesth Crit Care. 2016;6:11&#x2013;15. doi: 10.4103/2249-4472.181059.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2249-4472.181059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17052415</PMID><DateCompleted><Year>2007</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2006</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1022-386X</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2006</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of the College of Physicians and Surgeons--Pakistan : JCPSP</Title><ISOAbbreviation>J Coll Physicians Surg Pak</ISOAbbreviation></Journal><ArticleTitle>Comparison of armoured laryngeal mask airway with endotracheal tube for adenotonsillectomy.</ArticleTitle><Pagination><StartPage>685</StartPage><EndPage>688</EndPage><MedlinePgn>685-8</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the reliability of armoured laryngeal mask airway for adenotonsillectomy and to compare the haemodynamic changes during anaesthesia with those of endotracheal tube.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A prospective comparative study.</AbstractText><AbstractText Label="PLACE AND DURATION OF STUDY" NlmCategory="METHODS">Services Hospital Lahore/ Services Institute of Medical Sciences from April to September 2003.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A total of 100 patients undergoing adenotonsillectomy between ages 10-35 years and ASA I status were enrolled for the study. Two groups with 50 patients in each group were formed. Group I patients underwent surgery with armoured laryngeal mask airway while group II underwent surgery with endotracheal intubation. Baseline heart rate, systolic blood pressure and diastolic blood pressure were noted pre-operatively, one minute after insertion and every five minutes after induction in both the groups. A change in all these haemodynamic parameters from the baseline was noted. The effect of Boyle Davis Gag and adequacy of surgical access were also noted. Occurrence of cough, laryngospasm and stridor were noted at the time of recovery in both the groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Baseline variables in both groups were identical. Surgical access was adequate in 48/50 patients in group I while it was adequate in 49/50 patients in group II. The frequencies of cough, laryngeal spasm and stridor were lower in group I. In group I, there was insignificant change from baseline in heart rate, systolic and diastolic blood pressure at one, five and ten minutes after induction. In group II, significant change from baseline was observed in heart rate (p &lt; 0.01), systolic blood pressure (p &lt; 0.05) and diastolic blood pressure (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Armoured laryngeal mask is reliable for performing adenotonsillectomies. It provides adequate surgical access for adenotonsillectomy. It is also associated with lower occurrence of cough, bronchospasm and stridor at recovery. Use of armoured laryngeal mask is associated with fewer haemodynamic changes compared with those of endotracheal tube.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Leena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Services Institute of Medical Sciences/ Services Hospital, Lahore. drayub@wol.net.pk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Khalid</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Pakistan</Country><MedlineTA>J Coll Physicians Surg Pak</MedlineTA><NlmUniqueID>9606447</NlmUniqueID><ISSNLinking>1022-386X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="Y">Adenoidectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="Y">Intubation, Intratracheal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007828" MajorTopicYN="N">Laryngoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="Y">Tonsillectomy</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>10</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>9</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>10</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17052415</ArticleId><ArticleId IdType="pii">040579197</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22415678</PMID><DateCompleted><Year>2012</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1438-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2012</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of anesthesia</Title><ISOAbbreviation>J Anesth</ISOAbbreviation></Journal><ArticleTitle>The application of dexmedetomidine in children undergoing vitreoretinal surgery.</ArticleTitle><Pagination><StartPage>556</StartPage><EndPage>561</EndPage><MedlinePgn>556-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00540-012-1354-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Dexmedetomidine is a highly selective alpha-2 adrenergic agonist that has a sedative effect and has been shown to reduce anesthetic requirements. It also has a sympatholytic effect, which may prove useful when used to blunt the sympathetic surge during intubation and extubation. However, its effects on intraocular pressure, hemodynamic stability, attenuation of extubation response, and emergence agitation remain unclear for pediatric patients undergoing vitreoretinal surgery. We focused on these effects in this study.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty ASA I-II patients undergoing vitreoretinal surgery, were anesthetized with sevoflurane 1-2% end-tidal concentration in oxygen supplemented by remifentanil 0.2&#xa0;&#x3bc;g/kg/min. Intraocular pressure was measured after inhalation of sevoflurane (IOP(Baseline)) and 10&#xa0;min after intravenous administration of dexmedetomidine 0.5&#xa0;&#x3bc;g/kg or normal saline (IOP(10min)), after induction of anesthesia. Blood pressure and heart rate were recorded every 5&#xa0;min during surgery. The incidence and severity of coughing and emergence agitation and untoward airway events after extubation, for example breath holding, laryngospasm, bronchospasm, and oxygen desaturation, were assessed. Extubation time and emergence time were also documented.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no significant difference in intraocular pressure at the two time points between the groups (p&#xa0;&gt;&#xa0;0.05). In both groups mean arterial pressure and heart rate decreased from baseline after anesthetic induction (p&#xa0;&lt;&#xa0;0.05). The increase from intraoperative values in mean arterial pressure and heart rate associated with extubation was diminished in the dexmedetomidine group compared with the control group (p&#xa0;&lt;&#xa0;0.05). Coughing after extubation was less common (10 vs. 21) and less severe (3 moderate and 7 minimal; vs. 2 severe, 7 moderate and 12 minimal) in the dexmedetomidine group than in the control group (p&#xa0;&lt;&#xa0;0.05). There were no significant differences between the groups in time to emergence or extubation (p&#xa0;&gt;&#xa0;0.05). The dexmedetomidine group had a lower incidence of emergence agitation than the control group (10 vs. 43.3%, p&#xa0;&lt;&#xa0;0.05). The incidence of breath holding, laryngospasm, bronchospasm and oxygen desaturation was not significantly different between the groups (p&#xa0;&gt;&#xa0;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dexmedetomidine 0.5&#xa0;&#xb5;g/kg had no effect on intraoperative hemodynamics or intraocular pressure, but attenuated the hemodynamic response to extubation and diminished emergence agitation in pediatric patients undergoing vitreoretinal surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lili</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Second Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jianjun</LastName><ForeName>Shen</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Haiyan</LastName><ForeName>Zhou</ForeName><Initials>Z</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Anesth</MedlineTA><NlmUniqueID>8905667</NlmUniqueID><ISSNLinking>0913-8668</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000762" MajorTopicYN="N">Anesthesia Recovery Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="N">Arterial Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="Y">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="N">Methyl Ethers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013508" MajorTopicYN="N">Ophthalmologic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011229" MajorTopicYN="N">Preanesthetic Medication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014822" MajorTopicYN="N">Vitreous Body</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22415678</ArticleId><ArticleId IdType="doi">10.1007/s00540-012-1354-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anaesthesia. 1994 Oct;49(10):853-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7802178</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1993 May;78(5):813-20</Citation><ArticleIdList><ArticleId IdType="pubmed">8098190</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 1992 Jun;68(6):570-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1351736</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Anaesth. 2006 Jan;16(1):59-62</Citation><ArticleIdList><ArticleId IdType="pubmed">16409531</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaesthesia. 1997 Aug;52(8):736-44</Citation><ArticleIdList><ArticleId IdType="pubmed">9291757</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2005 Sep;49(8):1088-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16095449</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Anaesth. 2005 Sep;15(9):762-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16101707</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2002 Aug;95(2):461-6, table of contents</Citation><ArticleIdList><ArticleId IdType="pubmed">12145072</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2000 Apr;90(4):834-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10735784</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1998 Nov;87(5):1170-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9806703</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Anaesth. 2002 Feb;12(2):171-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11882231</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1997 Dec;87(6):1298-300</Citation><ArticleIdList><ArticleId IdType="pubmed">9416712</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2005 Aug;103(2):269-73</Citation><ArticleIdList><ArticleId IdType="pubmed">16052108</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Anaesth. 2000;10(3):303-18</Citation><ArticleIdList><ArticleId IdType="pubmed">10792748</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Anaesth. 2006 Jul;16(7):748-53</Citation><ArticleIdList><ArticleId IdType="pubmed">16879517</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2004 Jan;98(1):60-63</Citation><ArticleIdList><ArticleId IdType="pubmed">14693585</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2001 Oct;87(4):608-24</Citation><ArticleIdList><ArticleId IdType="pubmed">11878732</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Anaesth Soc J. 1986 Mar;33(2):195-208</Citation><ArticleIdList><ArticleId IdType="pubmed">3516335</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29402235</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2296</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC family practice</Title><ISOAbbreviation>BMC Fam Pract</ISOAbbreviation></Journal><ArticleTitle>What gives rise to clinician gut feeling, its influence on management decisions and its prognostic value for children with RTI in primary care: a prospective cohort study.</ArticleTitle><Pagination><StartPage>25</StartPage><MedlinePgn>25</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12875-018-0716-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">The objectives were to identify 1) the clinician and child characteristics associated with; 2) clinical management decisions following from, and; 3) the prognostic value of; a clinician's 'gut feeling something is wrong' for children presenting to primary care with acute cough and respiratory tract infection (RTI).</AbstractText><AbstractText Label="METHODS">Multicentre prospective cohort study where 518 primary care clinicians across 244 general practices in England assessed 8394 children aged &#x2265;3&#xa0;months and &lt;&#x2009;16&#xa0;years for acute cough and RTI. The main outcome measures were: Self-reported clinician 'gut feeling'; clinician management decisions (antibiotic prescribing, referral for acute admission); and child's prognosis (reconsultation with evidence of illness deterioration, hospital admission in the 30&#xa0;days following recruitment).</AbstractText><AbstractText Label="RESULTS">Clinician years since qualification, parent reported symptoms (illness severity score&#x2009;&#x2265;&#x2009;7/10, severe fever &lt;&#x2009;24&#xa0;h, low energy, shortness of breath) and clinical examination findings (crackles/ crepitations on chest auscultation, recession, pallor, bronchial breathing, wheeze, temperature&#x2009;&#x2265;&#x2009;37.8&#xa0;&#xb0;C, tachypnoea and inflamed pharynx) independently contributed towards a clinician 'gut feeling that something was wrong'. 'Gut feeling' was independently associated with increased antibiotic prescribing and referral for secondary care assessment. After adjustment for other associated factors, gut feeling was not associated with reconsultations or hospital admissions.</AbstractText><AbstractText Label="CONCLUSIONS">Clinicians were more likely to report a gut feeling something is wrong, when they were more experienced or when children were more unwell. Gut feeling is independently and strongly associated with antibiotic prescribing and referral to secondary care, but not with two indicators of poor child health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. Sophie.turnbull@bristol.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PS, UK. Sophie.turnbull@bristol.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Patricia J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>School for Policy Studies, University of Bristol, 8 Priory Road, Bristol, BS8 1TZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redmond</LastName><ForeName>Niamh M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care West (NIHR CLAHRC West), University Hospitals Bristol NHS Foundation Trust, 9th Floor, Whitefriars, Lewins Mead, Bristol, BS1 2NT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornton</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabral</LastName><ForeName>Christie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Level D, St Michael's Hospital, Southwell St, Bristol, BS2 8EG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Brendan C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, St Mary's Hospital, W2 1NY, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Washington, Seattle, WA, 98195-4696, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Little</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Primary Care and Population Sciences Unit, University of Southampton, Aldermoor Health Centre, Aldermoor Close, Southampton, SO16 5ST, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Tim J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>School of Clinical Sciences, University of Bristol, 69 St Michael's Hill, Bristol, BS2 8DZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Alastair D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Centre for Academic Primary Care, Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CDF-2009-02-10</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RP-PG-0608-10018</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Fam Pract</MedlineTA><NlmUniqueID>100967792</NlmUniqueID><ISSNLinking>1471-2296</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="N">General Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009722" MajorTopicYN="N">Nurse Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="Y">Referral and Consultation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">Cough</Keyword><Keyword MajorTopicYN="N">Decision making</Keyword><Keyword MajorTopicYN="N">Emotions</Keyword><Keyword MajorTopicYN="N">Paediatric</Keyword><Keyword MajorTopicYN="N">Primary health care</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Respiratory tract infections</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was approved by the South West Central Bristol Research Ethics Committee, UK (reference number: 10/H0102/54) and research governance approvals were obtained for all areas prior to the start of recruitment. The study was sponsored by the University of Bristol, which ensured the study met all regulatory approvals. All participants&#x2019; parent or legal carers gave written, informed consent on behalf of the child. All children aged 11 and over gave informed assent. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29402235</ArticleId><ArticleId IdType="pmc">PMC5800050</ArticleId><ArticleId IdType="doi">10.1186/s12875-018-0716-7</ArticleId><ArticleId IdType="pii">10.1186/s12875-018-0716-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hay AD, Heron J, Ness A. The prevalence of symptoms and consultations in pre-school children in the Avon longitudinal study of parents and children (ALSPAC): a prospective cohort study. Fam Pract. 2005;22(4):367&#x2013;374. doi: 10.1093/fampra/cmi035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmi035</ArticleId><ArticleId IdType="pubmed">15897210</ArticleId></ArticleIdList></Reference><Reference><Citation>Okkes IM, Oskam SK, Lamberts H. The probability of specific diagnoses for patients presenting with common symptoms to Dutch family physicians. J Fam Pract. 2002;51(1):31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">11927060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay AD, Redmond NM, Turnbull S, Christensen H, Thornton H, Little P, Thompson M, Delaney B, Lovering AM, Muir P, et al. Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study. Lancet Respir Med. 2016;11:902&#x2013;10. doi: 10.1016/S2213-2600(16)30223-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)30223-5</ArticleId><ArticleId IdType="pmc">PMC5080970</ArticleId><ArticleId IdType="pubmed">27594440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas PJ, Cabral C, Hay AD, Horwood J. A systematic review of parent and clinician views and perceptions that influence prescribing decisions in relation to acute childhood infections in primary care. Scand J Prim Health Care. 2015:33(1):11-20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377734</ArticleId><ArticleId IdType="pubmed">25716427</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwood J, Cabral C, Hay AD, Ingram J. Primary care clinician antibiotic prescribing decisions in consultations for children with RTIs: a qualitative interview study. B J Gen Pract. 2016;66(644):e207&#x2013;13. doi: 10.3399/bjgp16X683821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp16X683821</ArticleId><ArticleId IdType="pmc">PMC4758501</ArticleId><ArticleId IdType="pubmed">26852795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral C, Lucas PJ, Ingram J, Hay AD, Horwood J. "It's safer to ..." parent consulting and clinician antibiotic prescribing decisions for children with respiratory tract infections: an analysis across four qualitative studies. Soc Sci Med. 2015;136-137C:156&#x2013;164. doi: 10.1016/j.socscimed.2015.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2015.05.027</ArticleId><ArticleId IdType="pubmed">26004209</ArticleId></ArticleIdList></Reference><Reference><Citation>Washington TWH. National strategy for combating antibioticresistant bacteria. Washington: Centers for Disease Control and Prevention publisher location; 2014.</Citation></Reference><Reference><Citation>Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.</Citation><ArticleIdList><ArticleId IdType="pubmed">20483949</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley A, Kostopoulou O. Clinical intuition in family medicine: more than first impressions. Ann Fam Med. 2013;11(1):60&#x2013;66. doi: 10.1370/afm.1433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.1433</ArticleId><ArticleId IdType="pmc">PMC3596024</ArticleId><ArticleId IdType="pubmed">23319507</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson VA, Prowse Turner JA, Pennycook G. Intuition, reason, and metacognition. Cogn Psychol. 2011;63(3):107&#x2013;140. doi: 10.1016/j.cogpsych.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cogpsych.2011.06.001</ArticleId><ArticleId IdType="pubmed">21798215</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolper E, van Bokhoven M, Houben P, Van Royen P, van de Wiel M, van der Weijden T, Jan Dinant G. The diagnostic role of gut feelings in general practice. A focus group study of the concept and its determinants. BMC Fam Pract. 2009;10:17. doi: 10.1186/1471-2296-10-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2296-10-17</ArticleId><ArticleId IdType="pmc">PMC2649045</ArticleId><ArticleId IdType="pubmed">19226455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahneman D. A perspective on judgment and choice: mapping bounded rationality. Am Psychol. 2003;58(9):697&#x2013;720. doi: 10.1037/0003-066X.58.9.697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0003-066X.58.9.697</ArticleId><ArticleId IdType="pubmed">14584987</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JS, Stanovich KE. Dual-Process Theories of Higher Cognition: Advancing the Debate. 2013;8(3):223&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">26172965</ArticleId></ArticleIdList></Reference><Reference><Citation>Toplak ME, West RF, Stanovich KE. The cognitive reflection test as a predictor of performance on heuristics-and-biases tasks. Mem Cogn. 2011;39(7):1275&#x2013;1289. doi: 10.3758/s13421-011-0104-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13421-011-0104-1</ArticleId><ArticleId IdType="pubmed">21541821</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Thompson M, Buntinx F, Mant D. Clinicians' gut feeling about serious infections in children: observational study. BMJ. 2012;345:e6144. doi: 10.1136/bmj.e6144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e6144</ArticleId><ArticleId IdType="pmc">PMC3458229</ArticleId><ArticleId IdType="pubmed">23015034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hams SP. A gut feeling? Intuition and critical care nursing. Intensive Crit Care Nurs. 2000;16(5):310&#x2013;318. doi: 10.1054/iccn.2000.1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/iccn.2000.1500</ArticleId><ArticleId IdType="pubmed">11000605</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010;375(9717):834&#x2013;845. doi: 10.1016/S0140-6736(09)62000-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)62000-6</ArticleId><ArticleId IdType="pubmed">20132979</ArticleId></ArticleIdList></Reference><Reference><Citation>Redmond NM, Davies R, Christensen H, Blair PS, Lovering AM, Leeming JP, Muir P, Vipond B, Thornton H, Fletcher M, et al. The TARGET cohort study protocol: a prospective primary care cohort study to derive and validate a clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses. BMC Health Serv Res. 2013;13:322. doi: 10.1186/1472-6963-13-322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-13-322</ArticleId><ArticleId IdType="pmc">PMC3765099</ArticleId><ArticleId IdType="pubmed">23958109</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening The Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Lad M.&#xa0;English Indices of Deprivation 2010.&#xa0;London: Department for Communities and Local Government; 2010.</Citation></Reference><Reference><Citation>Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract. 2003;20(6):696&#x2013;705. doi: 10.1093/fampra/cmg613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmg613</ArticleId><ArticleId IdType="pubmed">14701895</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Vodicka T, Cohen H, Blair P, Biuckley T, Heneghan C, Hay A. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013;347:f7027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898587</ArticleId><ArticleId IdType="pubmed">24335668</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig JV, Lancaster GA, Williamson PR, Smyth RL. Temperature measured at the axilla compared with rectum in children and young people: systematic review. BMJ. 2000;320(7243):1174&#x2013;1178. doi: 10.1136/bmj.320.7243.1174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.320.7243.1174</ArticleId><ArticleId IdType="pmc">PMC27359</ArticleId><ArticleId IdType="pubmed">10784539</ArticleId></ArticleIdList></Reference><Reference><Citation>Strozik KS, Pieper CH, Roller J. Capillary refilling time in newborn babies: normal values. Arch Dis Child Fetal Neonatal Ed. 1997;76(3):F193&#x2013;F196. doi: 10.1136/fn.76.3.F193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fn.76.3.F193</ArticleId><ArticleId IdType="pmc">PMC1720653</ArticleId><ArticleId IdType="pubmed">9175951</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibby SM, Hatherill M, Murdoch IA. Capillary refill and core-peripheral temperature gap as indicators of haemodynamic status in paediatric intensive care patients. Arch Dis Child. 1999;80(2):163&#x2013;166. doi: 10.1136/adc.80.2.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.80.2.163</ArticleId><ArticleId IdType="pmc">PMC1717816</ArticleId><ArticleId IdType="pubmed">10325733</ArticleId></ArticleIdList></Reference><Reference><Citation>National Collaborating Centre for Women&#x2019;s and Children&#x2019;s Health.&#xa0;Feverish Illness in Children: Assessment and Initial Management in Children Younger than 5 Years.&#xa0;London: National Collaborating Centre for Women&#x2019;s and Children&#x2019;s Health; 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson J. Advanced paediatric life support. 3. London: BMJ Books; 2001.</Citation></Reference><Reference><Citation>Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. doi: 10.1136/bmj.b2393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2393</ArticleId><ArticleId IdType="pmc">PMC2714692</ArticleId><ArticleId IdType="pubmed">19564179</ArticleId></ArticleIdList></Reference><Reference><Citation>Census statistical bulletin: Population and Household Estimates for Wales, March 2011 [http://www.ons.gov.uk/ons/rel/census/2011-census/population-and-household-estimates-for-wales/stb-2011-census-wales.html].</Citation></Reference><Reference><Citation>Little P, Stuart B, Smith S, Thompson MJ, Knox K, van den Bruel A, Lown M, Moore M, Mant D. Antibiotic prescription strategies and adverse outcome for uncomplicated lower respiratory tract infections: prospective cough complication cohort (3C) study. BMJ. 2017;357:j2148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439222</ArticleId><ArticleId IdType="pubmed">28533265</ArticleId></ArticleIdList></Reference><Reference><Citation>Redmond NM, Turnbull S, Stuart B, Thornton HV, Christensen H, Blair PS, Delaney BC, Thompson M, Peters TJ, Hay AD et al: Do antibiotics prescribed for children presenting to primary care with cough and respiratory tract infections (RTIs) modify adverse outcomes? In submission 2017.</Citation></Reference><Reference><Citation>Stolper E, Van de Wiel M, Van Royen P, Van Bokhoven M, Van der Weijden T, Dinant GJ. Gut feelings as a third track in general practitioners' diagnostic reasoning. J Gen Intern Med. 2011;26(2):197&#x2013;203. doi: 10.1007/s11606-010-1524-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-010-1524-5</ArticleId><ArticleId IdType="pmc">PMC3019314</ArticleId><ArticleId IdType="pubmed">20967509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogarth RM. Educating intuition. Chicago, IL: University of Chicago Press; 2001.</Citation></Reference><Reference><Citation>Betsch T. The nature of intuition and its neglect in research on judgment and decision making. New York, NY: Psychology Press; 2008.</Citation></Reference><Reference><Citation>Hjertholm P, Moth G, Ingeman ML, Vedsted P. Predictive values of GPs&#x2019; suspicion of serious disease: a population-based follow-up study. Br J Gen Pract. 2014;64(623):e346&#x2013;e353. doi: 10.3399/bjgp14X680125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp14X680125</ArticleId><ArticleId IdType="pmc">PMC4032017</ArticleId><ArticleId IdType="pubmed">24868072</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwood J, Cabral C, Hay AD, Ingram J. Society for Academic Primary Care Annual Research Meeting. Glasgow: Society for Academic Primary Care; 2012. &#x201c;Recognising the sick child in amongst the just unwell&#x201d;: health practitioner prescribing decisions in consultations for acute RTI in children.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33152965</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8464</ISSN><JournalIssue CitedMedium="Internet"><Volume>138</Volume><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>International journal of pediatric otorhinolaryngology</Title><ISOAbbreviation>Int J Pediatr Otorhinolaryngol</ISOAbbreviation></Journal><ArticleTitle>Higher doses of fentanyl during bronchoscopy in infants significantly reduces perioperative complication rates.</ArticleTitle><Pagination><StartPage>110374</StartPage><MedlinePgn>110374</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijporl.2020.110374</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-5876(20)30517-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The specific aim of this study was to assess the effect of higher fentanyl doses on reducing perioperative complication rates among infants undergoing rigid bronchoscopy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty children who underwent rigid bronchoscopy for foreign body removal were enlisted in our 2-year prospective cohort study at the Department of ENT and Head &amp; Neck Surgery, Medical University - Sofia. Infants were randomly distributed into two groups according to fentanyl dose (group 1 - 1-2&#xa0;&#x3bc;g/kg vs group 2 - 6-7&#xa0;&#x3bc;g/kg). Hemodynamic parameters and perioperative complications were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of the whole study group was 1.94 years. Five minutes prior to anesthesia both groups presented with similar parameter levels and no statistically significant difference was found. In contrast, at 5th and 10th minutes after intubation the heart rate, systolic and diastolic blood pressure levels were recorded at significantly higher levels in group 1 compared to group 2 (p&#xa0;=&#xa0;.000). Same results were obtained five minutes after extubation. Additionally, after performing the Pearson chi-Square test we found that bronchospasm and laryngospasm were significantly more frequent among patients from group 1 infused with lower dosage of fentanyl in comparison to the infants that were administered with a higher dose of this medication (p&#xa0;=&#xa0;.020). Phi and Cramer's V tests both display moderate strength of this association (V&#xa0;=&#xa0;0.302).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In the current study we propose refinement of current anesthetic protocols by using higher doses of fentanyl during rigid bronchoscopy in infants. This significantly reduces perioperative complication rates and improves intraoperative hemodynamics without presenting any newly formed risks.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ts</LastName><ForeName>Marinov</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Medical University-Sofia, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belitova</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Medical University-Sofia, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popov</LastName><ForeName>T M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of ENT and Head and Neck Surgery, Medical University-Sofia, Sofia, Bulgaria. Electronic address: popov@todorpopov.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Pediatr Otorhinolaryngol</MedlineTA><NlmUniqueID>8003603</NlmUniqueID><ISSNLinking>0165-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="Y">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005547" MajorTopicYN="N">Foreign Bodies</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bronchoscopy</Keyword><Keyword MajorTopicYN="N">Bronchospasm</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Fentanyl</Keyword><Keyword MajorTopicYN="N">Foreign bodies</Keyword><Keyword MajorTopicYN="N">Laryngospasm</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33152965</ArticleId><ArticleId IdType="doi">10.1016/j.ijporl.2020.110374</ArticleId><ArticleId IdType="pii">S0165-5876(20)30517-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19950740</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2014</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0544-0440</ISSN><JournalIssue CitedMedium="Print"><Volume>20</Volume><Issue>3</Issue><PubDate><Year>2009</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Middle East journal of anaesthesiology</Title><ISOAbbreviation>Middle East J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>ProSeal laryngeal mask airway in infants and toddlers with upper respiratory tract infections: a randomized control trial of spontaneous vs pressure control ventilation.</ArticleTitle><Pagination><StartPage>437</StartPage><EndPage>442</EndPage><MedlinePgn>437-42</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">ProSeal LMA (PLMA), one of the advanced supraglottic devices has been successfully used to provide both spontaneous and controlled ventilation in children with upper respiratory tract infection (URTI). URTI does not imply restriction of disease to upper respiratory tract; it has been shown to produce pulmonary dysfunction. PEEP has been shown to improve oxygenation in such cases. This randomized prospective study was designed to compare postoperative adverse events associated with spontaneous respiration (SR) and pressure control ventilation (PCV) with PEEP in infants and toddlers with URTI when using PLMA as an airway device.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the present study, 90 children, 6 months-2 years, scheduled for infra umbilical surgery were randomized to receive either SR or PCV with PEEP of 5cm H2O. Patients with risk of aspiration, bronchial asthma, anticipated difficult airway, snoring, passive smoking, morbid obesity, coexisting pulmonary and cardiac disease, lower respiratory tract infection, fever &gt; 38 degrees C and sneezing, were excluded. At emergence, airway secretions, coughing, breath holding, bronchospasm, upper airway obstruction or laryngospasm (LS) were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The adverse events were significantly higher in spontaneously breathing patients. Score of adverse events was 6.33 +/- 1.6 in PCV and 7.7 +/- 2.2 in SR group (P = 0.001). The mean SpO2 (%) in PACU was 96.5 +/- 2 in PCV and 94.4 +/- 1.37 in SR (P = 000).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pressure control ventilation with PEEP using PLMA is associated with lower incidence of adverse events in comparison to spontaneous respiration in infants and toddlers with upper respiratory tract infection undergoing infra umbilical surgeries under general anesthesia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Aparna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept. of Anesthesia, Pain and Perioperative Medicine, Sir Ganga Ram Hospital, New Delhi, India. apsin@hotmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Bimla</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sood</LastName><ForeName>Jayashree</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Lebanon</Country><MedlineTA>Middle East J Anaesthesiol</MedlineTA><NlmUniqueID>8604187</NlmUniqueID><ISSNLinking>0544-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19950740</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21147783</PMID><DateCompleted><Year>2011</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>2</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Intubating conditions and adverse events during sevoflurane induction in infants.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>229</EndPage><MedlinePgn>225-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aeq346</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to compare intubating conditions and adverse events after sevoflurane induction in infants, with or without the use of rocuronium or alfentanil.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Seventy-five infants, aged 1-24 months, undergoing elective surgery under general anaesthesia were randomly assigned to receive 8% sevoflurane with either placebo (i.v. saline 0.5 ml kg&#x207b;&#xb9;), rocuronium (0.3 mg kg&#x207b;&#xb9;), or alfentanil (20 &#xb5;g kg&#x207b;&#xb9;). The primary outcome measure was intubating conditions evaluated 90 s after test drug injection by an anaesthetist unaware of the patient's group. The secondary outcome criteria were respiratory (Sp(O&#x2082;) &lt;90%, laryngospasm, closed vocal cords preventing intubation, bronchospasm) and haemodynamic adverse events (heart rate and mean arterial pressure variations &#x2265;30% control value).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Intubating conditions were significantly better in the rocuronium group, with clinically acceptable intubating conditions in 92%, vs 70% in the alfentanil group and 63% in the placebo group (P=0.044). Adverse respiratory events were significantly less frequent in the rocuronium group: 0% vs 33% in the placebo group and 30% in the alfentanil group (P=0.006). Haemodynamic adverse events were more frequent in the alfentanil group: 48% vs 7% in the placebo group and 16% in the rocuronium group (P=0.0019).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In 1- to 24-month-old infants, the addition of 0.3 mg kg&#x207b;&#xb9; rocuronium to 8% sevoflurane improved intubating conditions and decreased the frequency of respiratory adverse events. Alfentanil provided no additional benefit in this study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Devys</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Fondation Ophtalmologique Adolphe de Rothschild, 25&#x2013;29 rue Manin, 75019 Paris, France. jmdevys@fo-rothschild.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mourissoux</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Donnette</LastName><ForeName>F X</ForeName><Initials>FX</Initials></Author><Author ValidYN="Y"><LastName>Plat</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Schauvli&#xe8;ge</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Le Bigot</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Dureau</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Plaud</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000732">Androstanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018685">Anesthetics, Inhalation</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008738">Methyl Ethers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003473">Neuromuscular Nondepolarizing Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>1N74HM2BS7</RegistryNumber><NameOfSubstance UI="D015760">Alfentanil</NameOfSubstance></Chemical><Chemical><RegistryNumber>38LVP0K73A</RegistryNumber><NameOfSubstance UI="D000077149">Sevoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>WRE554RFEZ</RegistryNumber><NameOfSubstance UI="D000077123">Rocuronium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015760" MajorTopicYN="N">Alfentanil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000732" MajorTopicYN="N">Androstanols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018685" MajorTopicYN="N">Anesthetics, Inhalation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008738" MajorTopicYN="N">Methyl Ethers</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003473" MajorTopicYN="N">Neuromuscular Nondepolarizing Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077123" MajorTopicYN="N">Rocuronium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077149" MajorTopicYN="N">Sevoflurane</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21147783</ArticleId><ArticleId IdType="doi">10.1093/bja/aeq346</ArticleId><ArticleId IdType="pii">S0007-0912(17)33328-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16398965</PMID><DateCompleted><Year>2006</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2006</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1022-386X</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2005</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of the College of Physicians and Surgeons--Pakistan : JCPSP</Title><ISOAbbreviation>J Coll Physicians Surg Pak</ISOAbbreviation></Journal><ArticleTitle>Predicting postoperative cardio-pulmonary complications by a test of stair climbing.</ArticleTitle><Pagination><StartPage>761</StartPage><EndPage>764</EndPage><MedlinePgn>761-4</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess whether a test of stair climbing ability could be used to predict the risk of developing postoperative cardiopulmonary complications in patients undergoing general anesthesia.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cohort study.</AbstractText><AbstractText Label="PLACE AND DURATION OF STUDY" NlmCategory="METHODS">The Aga Khan University Hospital, Karachi. The duration of the study was from December 2003 to December 2004.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">This study was carried out on consecutive, adult patients presenting for elective thoracic or abdominal surgery under general anesthesia. Pre-operatively, patients were asked to climb a standard staircase. Number of steps climbed was recorded. Those unable to climb stairs due to debilitating cardiac, pulmonary or rheumatologic disease were categorized as 0 stairs climbed. Outcome variables were postoperative cardiopulmonary complications or mortality. Period of follow-up was until hospital discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-eight patients were enrolled, 59 (75.6%) climbed 1 flight of stairs, 19 (24.3%) climbed &lt; 1 flight. All-cause cardiopulmonary complications rate was 26 %. The most frequent complication was lobar atelectasis, followed by bronchospasm and acute MI. The complication rate was 22.8% in those able to climb 1 flight and 40% in those patients who climbed &lt; 1 flight. The group that climbed &lt; 1 flight tended to have complications associated with poor reserves of the cardiopulmonary systems, i.e. pulmonary edema, exacerbation of underlying lung disease. The relative risk of developing complications, if unable to climb at least 1 flight of stairs, was calculated to be 1.8 (95% CI 0.7 - 4.6).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Stair climbing can be a useful pre-operative tool to predict the risk of postoperative cardiopulmonary complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>Nawal</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Section of Pulmonary and Critical Care Medicine, Department of Medicine, The Aga Khan University, Stadium Road. Karachi-74800, Pakistan. nawal.salahuddin@aku.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fatimi</LastName><ForeName>Saulat</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>Nawal</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Huda</LastName><ForeName>Shehzad</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Islam</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Shafquat</LastName><ForeName>Azam</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Pakistan</Country><MedlineTA>J Coll Physicians Surg Pak</MedlineTA><NlmUniqueID>9606447</NlmUniqueID><ISSNLinking>1022-386X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="N">Exercise Test</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>1</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>5</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>1</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16398965</ArticleId><ArticleId IdType="pii">040579197</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33067310</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Archives of disease in childhood</Title><ISOAbbreviation>Arch Dis Child</ISOAbbreviation></Journal><ArticleTitle>Impact of oral corticosteroids on respiratory outcomes in acute preschool wheeze: a randomised clinical trial.</ArticleTitle><Pagination><StartPage>339</StartPage><EndPage>344</EndPage><MedlinePgn>339-344</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/archdischild-2020-318971</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To determine if administration of oral prednisolone to preschool children with acute wheeze alters respiratory outcomes.</AbstractText><AbstractText Label="DESIGN">Double-blind, randomised, placebo-controlled equivalence trial.</AbstractText><AbstractText Label="SETTING">Three hospitals in New Zealand.</AbstractText><AbstractText Label="PATIENTS">477 children aged 24-59 months with acute wheeze associated with respiratory illness.</AbstractText><AbstractText Label="INTERVENTIONS">2 mg/kg (maximum 40 mg) oral prednisolone or similar placebo, once daily for 3 days.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Primary outcome was change in Preschool Respiratory Assessment Measure (PRAM) score 24 hours after intervention. Secondary outcomes included PRAM score at 4 hours, length of emergency department and inpatient stays, admission and representation rates, time to return to normal activities and use of additional oral prednisolone or intravenous medications. Analysis was by intention-to-treat.</AbstractText><AbstractText Label="RESULTS">There was no difference between groups for change in PRAM score at 24 hours (difference between means -0.39, 95% CI -0.84 to 0.06, p=0.09). Absolute PRAM score was lower in the prednisolone group at 4 hours (median (IQR) 1 (0-2) vs 2 (0-3), p=0.01) and 24 hours (0 (0-1) vs 0 (0-1), p=0.01), when symptoms had resolved for most children regardless of initial treatment. Admission rate, requirement for additional oral prednisolone and use of intravenous medication were lower in the prednisolone group, although there were no differences between groups for time taken to return to normal activities or rates of representation within 7 days.</AbstractText><AbstractText Label="CONCLUSION">Oral prednisolone does not alter respiratory outcomes at 24 hours or beyond in preschool children presenting with acute wheeze.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2192-3245</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, Waikato Hospital, Hamilton, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>Owen</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Department, Waitakere Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shepherd</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Emergency Department, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neutze</LastName><ForeName>Jocelyn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidz First, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trenholme</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kidz First, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eunicia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Emergency Department, Middlemore Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brabyn</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Department, Waikato Hospital, Hamilton, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonisch</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Emergency Department, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grey</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Departments of Paediatrics, Emergency Medicine, and Pharmacology and Physiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>John M D</ForeName><Initials>JMD</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asher</LastName><ForeName>Innes</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Medicine, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalziel</LastName><ForeName>Stuart R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand s.dalziel@auckland.ac.nz.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Emergency Department, Starship Children's Health, Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, The University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arch Dis Child</MedlineTA><NlmUniqueID>0372434</NlmUniqueID><ISSNLinking>0003-9888</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010919">Placebos</NameOfSubstance></Chemical><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Arch Dis Child. 2021 Apr 21;106(5):e27. doi: 10.1136/archdischild-2020-318971corr1.</RefSource><PMID Version="1">33785530</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N" Type="Geographic">New Zealand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012135" MajorTopicYN="N">Respiratory Sounds</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">general paediatrics</Keyword><Keyword MajorTopicYN="N">respiratory</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33067310</ArticleId><ArticleId IdType="doi">10.1136/archdischild-2020-318971</ArticleId><ArticleId IdType="pii">archdischild-2020-318971</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23701115</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-9592</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>11</Issue><PubDate><Year>2013</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Paediatric anaesthesia</Title><ISOAbbreviation>Paediatr Anaesth</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of spontaneous ventilation technique using dexmedetomidine for rigid bronchoscopic airway foreign body removal in children.</ArticleTitle><Pagination><StartPage>1048</StartPage><EndPage>1053</EndPage><MedlinePgn>1048-53</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pan.12197</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In children, removal of an airway foreign body is usually performed by rigid bronchoscopy under general anesthesia. Debate continues regarding the respiratory mode (spontaneous or controlled ventilation) and appropriate anesthetic drugs. Dexmedetomidine has several desirable pharmacologic properties and appears to be a useful agent for airway surgeries.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study evaluates the efficacy of spontaneous ventilation (SV) technique using dexmedetomidine for bronchoscopic removal of foreign bodies in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Eighty pediatric patients undergoing rigid bronchoscopy for airway foreign body removal were randomly divided into two groups. In the SV group, dexmedetomidine (4 &#x3bc;g&#x2219;kg(-1)) and topical lidocaine (3-5 mg&#x2219;kg(-1)) were administered and the patients were breathing spontaneously throughout the procedure. In the manual jet ventilation (MJV) group, anesthesia was induced with fentanyl (2 &#x3bc;g&#x2219;kg(-1)), propofol (3-5 mg&#x2219;kg(-1)), and succinylcholine (1 mg&#x2219;kg(-1)), and MJV was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The success rates of foreign body removal, the incidence of body movement and other perioperative adverse events, and hemodynamic changes were similar between the two groups. The SV patients required longer stays in the postanesthesia care unit (P &lt; 0.01) but experienced less coughing (P = 0.029) in the recovery room.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dexmedetomidine may provide appropriately deep anesthesia and ideal conditions for rigid bronchoscopic airway foreign body removal without respiratory depression or hemodynamic instability.</AbstractText><CopyrightInformation>&#xa9; 2013 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Yirong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenxian</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Kaizheng</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Paediatr Anaesth</MedlineTA><NlmUniqueID>9206575</NlmUniqueID><ISSNLinking>1155-5645</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>67VB76HONO</RegistryNumber><NameOfSubstance UI="D020927">Dexmedetomidine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058109" MajorTopicYN="N">Airway Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000769" MajorTopicYN="N">Anesthesia, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062485" MajorTopicYN="N">Breath Holding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001999" MajorTopicYN="N">Bronchoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020927" MajorTopicYN="Y">Dexmedetomidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005547" MajorTopicYN="N">Foreign Bodies</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006611" MajorTopicYN="N">High-Frequency Jet Ventilation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="Y">Hypnotics and Sedatives</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011229" MajorTopicYN="Y">Preanesthetic Medication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012137" MajorTopicYN="Y">Respiratory System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bronchoscopy</Keyword><Keyword MajorTopicYN="N">dexmedetomidine</Keyword><Keyword MajorTopicYN="N">foreign bodies</Keyword><Keyword MajorTopicYN="N">ventilation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23701115</ArticleId><ArticleId IdType="doi">10.1111/pan.12197</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31149004</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1729-0503</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>African health sciences</Title><ISOAbbreviation>Afr Health Sci</ISOAbbreviation></Journal><ArticleTitle>Comparison of effects of propofol and ketofol (Ketamine-Propofol mixture) on emergence agitation in children undergoing tonsillectomy.</ArticleTitle><Pagination><StartPage>1736</StartPage><EndPage>1744</EndPage><MedlinePgn>1736-1744</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4314/ahs.v19i1.50</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this study was to compare the effect of propofol and ketofol (ketamine-propofol mixture) on EA in children undergoing tonsillectomy.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">In this randomized clinical trial, 87 ASA class I and II patients, aged 3-12 years, who underwent tonsillectomy, were divided into two groups to receive either propofol 100 &#xb5;g/kg/min (group p, n=44) or ketofol : ketamine 25 &#xb5;g/kg/min + propofol 75 &#xb5;g/kg/min (group k, n= 43). Incidence and severity of EA was evaluated using the Pediatric Anesthesia Emergence Delirium (PAED) scales on arrival at the recovery room, and 10 and 30 min after that time.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There was no statistically significant difference in demographic data between the two groups. In the ketofol group, the need for agitation treatment and also mean recovery duration were lower than in the propofol group (30 and 41%, and 29.9 and 32.7 min), without statistically significant difference (P value=0.143 and P value=0.187). Laryngospasm or bronchospasm occurred in 2 patients in each group and bleeding was observed in only one individual in the ketofol group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Infusion of ketofol in children undergoing tonsillectomy provides shorter recovery time and lower incidence of EA despite the non significant difference with propofol.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jalili</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anesthesiologist, Assistant Professor of Anesthesiology, Department of Anesthesiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esmaeeili</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesiologist, Department of Anesthesiology, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamali</LastName><ForeName>Koorosh</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>PhD, Associate Professor of Epidemiology, Department of Public Health, School of Public Health, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashtchi</LastName><ForeName>Vahideh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesiologist, Assistant Professor of Anesthesiology, Department of Anesthesiology, School of Nursing and Midwifery, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Afr Health Sci</MedlineTA><NlmUniqueID>101149451</NlmUniqueID><ISSNLinking>1680-6905</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018686">Anesthetics, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>YI7VU623SF</RegistryNumber><NameOfSubstance UI="D015742">Propofol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018686" MajorTopicYN="N">Anesthetics, Intravenous</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071257" MajorTopicYN="N">Emergence Delirium</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emergence agitation</Keyword><Keyword MajorTopicYN="N">ketofol</Keyword><Keyword MajorTopicYN="N">propofol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31149004</ArticleId><ArticleId IdType="pmc">PMC6531964</ArticleId><ArticleId IdType="doi">10.4314/ahs.v19i1.50</ArticleId><ArticleId IdType="pii">jAFHS.v19.i1.pg1736</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Voepel-Lewis T, Burke C, Hadden S.M, Tait AR, Malviya S. Nurses' diagnoses and treatment decisions regarding care of the agitated child. J Perianesth Nurs. 2005;20(4):239&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">16102704</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya Akihiro. Emergence agitation in children: risk factors, prevention, and treatment. J Anesth. 2016;30:261&#x2013;267. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">26601849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasar VG, Hannallah RS. Emergence agitation in children: a review. MEJ Anesth. 2011;21(2):175&#x2013;184. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">22435269</ArticleId></ArticleIdList></Reference><Reference><Citation>Beskow A, Westrin P. Sevoflurane causes more postoperative agitation in children than does halothane. Acta-Anaesthesiol Scand. 1999;43(5):536&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">10342001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollister GR, Burn JM. Side effects of ketamine in pediatric anesthesia. Anesth Analg. 1974;53(2):264&#x2013;267. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">4856136</ArticleId></ArticleIdList></Reference><Reference><Citation>De grood PM, Coenen LG, Van Egmond J, Booij LH, Crul JF. Propofol emulsion for induction and maintenance of anesthesia. A combined technique of general and regional aneshtsia. Acta Anaesthesiol Scand. 1987;31:219&#x2013;223. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">3495089</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Shahwan I, Chowdary K. Ketamine is effective in decreasing the incidence of emergence agitation in children undergoing dental repair under sevoflurane general anesthesia. Paediatric Anaesthesia. 2007;17(9):846&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">17683402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepous&#xe9; C, Lautner CA, Liu L, Gomis P, Leon A. Emergence delirium in adults in the post-anaesthesia care unit. Brit J Anaesth. 2006;96(6):747&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pubmed">16670111</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohkamkar M, Farhoudi F, Alam-Sahebpour A, et al. Postanesthetic Emergence Agitation in Pediatric Patients under General Anesthesia. Iran J Pediatr. 2014;24(2):184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4268839</ArticleId><ArticleId IdType="pubmed">25535538</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlajkovic GP, Sindjelic RP. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007;104(1):84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">17179249</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmani S, Delivet H, Hilly J. Emergence delirium in children: an update. Current Opinion in Anaesthesiology. 2014;27(3):309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">24784918</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, Moon BE, Kim H, Lee JR. Comparison of propofol and fentanyl administered at the end of anaesthesia for prevention of emergence agitation after sevofluraneanaesthesia in children. British Journal of Anaesthesia. 2013;110(2):274&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">23103775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen IT, Finkel JC, Hannallah RS, et al. Rapid emergence does not explain agitation following sevofluraneanaesthesia in infants and children: a comparison with propofol. Paediatr Anaesth. 2003;13:63&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12535042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lop&#xe9;z Gil ML, Brimacombe J, Clar B. Sevoflurane versus propofol for induction and maintenance of anaesthesia with the laryngeal mask airway in children. Paediatr Anaesth. 1999;9:485&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">10597550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama S, Furukawa H, Yanai H. Propofol reduces the incidence of emergence agitation in preschool-aged children as well as in school-aged children: a comparison with sevoflurane. J Anesth. 2007;21:19&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">17285408</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard V, Dumont L, Pellegrini M. Quality of recovery in children: sevoflurane versus propofol. Acta Anaesthesiol Scand. 2000;44:307&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">10714845</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahn EL, Holt KR. Procedural sedation and analgesia: a review and new concepts. Emergency Med Clin North Am. 2005;23:503&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">15829394</ArticleId></ArticleIdList></Reference><Reference><Citation>De grood PM, Coenen LG, Van Egmond J, Booij LH, Crul JF. Propofol emulsion for induction and maintenance of anesthesia. A combined technique of general and regional aneshtsia. Acta Anaesthesiol Scand. 1987;31:219&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">3495089</ArticleId></ArticleIdList></Reference><Reference><Citation>Green SM, Krauss B. The semantics of ketamine. Ann Emergency Med. 2000;39:480&#x2013;482. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">11054203</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu F, Vanlersberghe C. Pharmacology of systemic analgesics. Best Pract Res ClinAnaesthesiol. 2002;16:475&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">12516886</ArticleId></ArticleIdList></Reference><Reference><Citation>Warncke T, Stubhaug A, et al. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 1997;72:99&#x2013;106. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">9272793</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieters BJ, Penn E, Nicklaus P, Bruegger D, Mehta B, Weatherly R. Emergence delirium and postoperative pain in children undergoing adenotonsillectomy: a comparison of propofolvssevoflurane anesthesia. Paediatric Anaesthesia. 2010;20(10):944&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">20735801</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyama K, Inomata S, Okubo N, Watanabe I. Pretreatment with small-dose ketamine reduces predicted effect-site concentration of propofol required for loss of consciousness and laryngeal mask airway insertion in women. J ClinAnesth. 2011;23:113&#x2013;118. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">21377074</ArticleId></ArticleIdList></Reference><Reference><Citation>Godambe SA, Elliot V, Matheny D, Pershad J. Comparison of propofol/fentanyl versus ketamine/midazolam for brief orthopedic procedural sedation in a pediatric emergency department. Pediatrics. 2003;112:116&#x2013;123. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">12837876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharieff GQ, Trocinski DR, Kanegaye JT, Fisher B, Harley JR. Ketamine-propofol combination sedation for fracture reduction in the pediatric emergency department. Pediatr Emergency Care. 2007;23(12):881&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">18091596</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A, Mosdossy G, McLeod S, Lehnhardt K, Peddle M, Rieder M. A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children. Ann Emergency Med. 2011;57(5):425&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">20947210</ArticleId></ArticleIdList></Reference><Reference><Citation>Andolfatto G, Willman E. A prospective case series of pediatric procedural sedation and analgesia in the emergency department using single-syringe ketamine-propofol combination (ketofol) Acad Emergency Med. 2010;17(2):194&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">20370749</ArticleId></ArticleIdList></Reference><Reference><Citation>David H, Shipp J. Randomized controlled trial of ketamine/propofol versus propofol alone for emergency department procedural sedation. Ann Emergency Med. 2011;57(5):435.</Citation><ArticleIdList><ArticleId IdType="pubmed">21256626</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora S. Combining ketamine and propofol (&#x201c;ketofol&#x201d;) for emergency department procedural sedation and analgesia: a review. West J Emergency Med. 2008;9(1):20&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2672224</ArticleId><ArticleId IdType="pubmed">19561698</ArticleId></ArticleIdList></Reference><Reference><Citation>Daabiss M, Elsherbiny M, AlOtibi R. Assessment of different concentrations of ketofol in procedural operation. BJMP. 2009;2(1):27&#x2013;31.</Citation></Reference><Reference><Citation>Wang Y, Jiang X, Pang L, et al. A randomized double-blind controlled study of the efficacy of ketofol with propofol-fentanyl and propofol alone in termination of pregnancy. Afr J pharm pharmacol. 2012;6(34):2510&#x2013;2514.</Citation></Reference><Reference><Citation>Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology. 2004;100(5):1138&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">15114210</ArticleId></ArticleIdList></Reference><Reference><Citation>Somaini M, Engelhardt T, Fumagalli R, Ingelmo PM. Emergence delirium or pain after anaesthesia--how to distinguish between the two in young children: a retrospective analysis of observational studies. Br J Anaesth. 2016;116:377.</Citation><ArticleIdList><ArticleId IdType="pubmed">26865130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwa SA, Costi D, Cyna AM. A comparison of emergence delirium scales following general anesthesia in children. Paediatr Anaesth. 2010;20:704&#x2013;711. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">20497353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaya A, Kuratani N, Satoh D, Kurosawa S. Lower incidence of emergence agitation in children after propofol anesthesia compared with sevoflurane: a meta-analysis of randomized controlled trials. J Anesth. 2014;28:4&#x2013;11. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">23800983</ArticleId></ArticleIdList></Reference><Reference><Citation>Costi D, Cyna AM, Ahmed S, et al. Effects of sevoflurane versus other general anaesthesia on emergence agitation in children. Cochrane Database Syst Rev. 2014:CD007084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10898224</ArticleId><ArticleId IdType="pubmed">25212274</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalens BJ, Pinard AM, L&#xe9;tourneau DR, et al. Prevention of emergence agitation after sevoflurane anesthesia for pediatric cerebral magnetic resonance imaging by small doses of ketamine or nalbuphine administered just before discontinuing anesthesia. Anesth Analg. 2006;102:1056.</Citation><ArticleIdList><ArticleId IdType="pubmed">16551898</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahmani S, Stany I, Brasher C, et al. Pharmacological Prevention of Sevoflurane- and Desflurane-Related Emergence Agitation in Children: A Meta-Analysis of Published Studies. British Journal of Anaesthesia. 2010;104:216&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047899</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva LM, Braz LG, M&#xf3;dolo NS. Emergence agitation in pediatric anesthesia: current features. J Pediatr (Rio J) 2008;84(2):107&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">18372935</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis PG, Greeberg JA, Genldeman M, Fertal K. Recovery characteristics of sevoflurane and halothane in preschool-aged children undergoing bilateral myringotomy and pressure equalization tube insertion. Anesth Analg. 1999;88:34&#x2013;38. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">9895062</ArticleId></ArticleIdList></Reference><Reference><Citation>Isik B, M Arslan, Tunga AD, Kurtipec O. Dexmedetomidine decreases emergence agitation in pediatric pacientes after sevoflurane anesthesia without surgery. Paediatr Anaesth. 2006;16:748&#x2013;753. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">16879517</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldon BC, Bell M, Craddock T. The effect of caudal analgesia on emergence agitation in children after sevoflurane versus halothane anesthesia. Anesth Analg. 2004;98:321&#x2013;326. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">14742362</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui TW, Short TG, Hong W, et al. Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology. 1995;82:641&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">7879932</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallimore D, Anderson BJ, Short TG, et al. Ketamine anesthesia in children-exploring infusion regimens. Pediatr Anesth. 2008;18:708&#x2013;714. PubMed.</Citation><ArticleIdList><ArticleId IdType="pubmed">18613930</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulter Finn LS, Hannam Jacqueline A, Anderson Brian J. Ketofol dosingsimulations for procedural sedation. Pediatric Emergency Care. 2014;30(9)</Citation><ArticleIdList><ArticleId IdType="pubmed">25162687</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin A, Esmaoglu A, Guler G, Demircioglu R, Narin N, Boyaci A. Propofol and propofol-ketamine in pediatric patients undergoing cardiac catheterization. Pediatr-Cardiol. 2005;26(5):553&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pubmed">16132313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosun Z, Esmaoglu A, Coruh A. Propofol -ketamine vspropofol-fentanyl combinations for deep sedation and analgesia in pediatric patients undergoing burn dressing changes. Pediatr Anesth. 2008;18:43&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18095965</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulter FLS, Hannam JA, Anderson BJ. Ketofol dosing simulations for procedural sedation. Pediatric Emergency Care. 2014;30(9):621&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">25162687</ArticleId></ArticleIdList></Reference><Reference><Citation>Amornyotin S. Ketofol: A Combination of Ketamine and Propofol. Journal of Anesthesia &amp; Critical Care. 2014;1(15)</Citation></Reference><Reference><Citation>Sherry N, Riz k, Enas M, Samir Use of ketofol to control emergence agitation in children undergoing adenotonsillectomy. Egyptian Journal of Anaesthesia. 2014;30:13&#x2013;19.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29514655</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2431</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC pediatrics</Title><ISOAbbreviation>BMC Pediatr</ISOAbbreviation></Journal><ArticleTitle>Respiratory morbidity through the first decade of life in a national cohort of children born extremely preterm.</ArticleTitle><Pagination><StartPage>102</StartPage><MedlinePgn>102</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12887-018-1045-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Advances in perinatal care have markedly increased the prospects of survival for infants born extremely preterm (EP). The aim of this study was to investigate hospitalisation rates and respiratory morbidity from five to 11&#xa0;years of age in a prospective national cohort of EP children born in the surfactant era.</AbstractText><AbstractText Label="METHODS">This was a national prospective cohort study of all children born in Norway during 1999 and 2000 with gestational age (GA) &lt;&#x2009;28&#xa0;weeks or birth weight&#x2009;&lt;&#x2009;1000&#xa0;grams, and of individually matched term-born controls recruited for a regional subsample. Data on hospital admissions, respiratory symptoms, and use of asthma medication was obtained by parental questionnaires at 11&#xa0;years of age.</AbstractText><AbstractText Label="RESULTS">Questionnaires were returned for 232/372 (62%) EP-born and 57/61 (93%) regional term-born controls. Throughout the study period, 67 (29%) EP-born and seven (13%) term-born&#xa0;controls were admitted to hospital (odds ratio (OR) 2.90, 95% confidence interval (CI): 1.25, 6.72). Admissions were mainly due to surgical procedures, with only 12% due to respiratory causes, and were not influenced by neonatal bronchopulmonary dysplasia (BPD) or low GA(&#x2264; 25&#xa0;weeks). Respiratory symptoms, asthma and use of asthma medication tended to be more common for EP-born, significantly so for medication use and wheeze on exercise. Neonatal BPD was a risk factor for medication use, but not for current wheeze. In multivariate regression models, home oxygen after discharge (OR 4.84, 95%&#xa0;CI: 1.38, 17.06) and parental asthma (OR 4.38, 95%&#xa0;CI: 1.69, 11.38) predicted current asthma, but neither BPD nor low GA were associated with respiratory symptoms at 11&#xa0;years of age.</AbstractText><AbstractText Label="CONCLUSIONS">Hospitalisation rates five to 11&#xa0;years after EP birth were low, but twice those of term-born&#xa0;controls, and unrelated to neonatal BPD and low GA. Respiratory causes were rare. Respiratory complaints were more common in children born EP, but the burden of symptoms had declined since early childhood.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skromme</LastName><ForeName>Kaia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9029-5807</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Haukeland University Hospital, N-5021, Bergen, Norway. kaia.skromme@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volls&#xe6;ter</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Haukeland University Hospital, N-5021, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd8;ymar</LastName><ForeName>Knut</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markestad</LastName><ForeName>Trond</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halvorsen</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Haukeland University Hospital, N-5021, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pediatr</MedlineTA><NlmUniqueID>100967804</NlmUniqueID><ISSNLinking>1471-2431</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062071" MajorTopicYN="Y">Infant, Extremely Premature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007235" MajorTopicYN="N">Infant, Premature, Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">Extremely low birth weight</Keyword><Keyword MajorTopicYN="N">Extremely preterm</Keyword><Keyword MajorTopicYN="N">Hospitalisation</Keyword><Keyword MajorTopicYN="N">Respiratory health</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The study was based on written parental consent, which was received for all participants in the study, and was approved by the Regional committee on Medical Research Ethics and the Norwegian Data Inspectorate (Reference number: 2009/2271; Date 10.12.09). CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29514655</ArticleId><ArticleId IdType="pmc">PMC5840932</ArticleId><ArticleId IdType="doi">10.1186/s12887-018-1045-7</ArticleId><ArticleId IdType="pii">10.1186/s12887-018-1045-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network. Pediatrics. 2010;126(3):443&#x2013;456. doi: 10.1542/peds.2009-2959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2009-2959</ArticleId><ArticleId IdType="pmc">PMC2982806</ArticleId><ArticleId IdType="pubmed">20732945</ArticleId></ArticleIdList></Reference><Reference><Citation>Markestad T, Kaaresen PI, Ronnestad A, Reigstad H, Lossius K, Medbo S, et al. Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics. 2005;115(5):1289&#x2013;1298. doi: 10.1542/peds.2004-1482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2004-1482</ArticleId><ArticleId IdType="pubmed">15867037</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723&#x2013;1729. doi: 10.1164/ajrccm.163.7.2011060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.163.7.2011060</ArticleId><ArticleId IdType="pubmed">11401896</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19):1946&#x2013;1955. doi: 10.1056/NEJMra067279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra067279</ArticleId><ArticleId IdType="pubmed">17989387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, et al. Premature birth and later insulin resistance. N Engl J Med. 2004;351(21):2179&#x2013;2186. doi: 10.1056/NEJMoa042275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa042275</ArticleId><ArticleId IdType="pubmed">15548778</ArticleId></ArticleIdList></Reference><Reference><Citation>Crump C, Sundquist K, Sundquist J, Winkleby MA. Gestational age at birth and mortality in young adulthood. JAMA : the journal of the American Medical Association. 2011;306(11):1233&#x2013;1240. doi: 10.1001/jama.2011.1331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.1331</ArticleId><ArticleId IdType="pubmed">21934056</ArticleId></ArticleIdList></Reference><Reference><Citation>Risnes KR, Vatten LJ, Baker JL, Jameson K, Sovio U, Kajantie E, et al. Birthweight and mortality in adulthood: a systematic review and meta-analysis. Int J Epidemiol. 2011;40(3):647&#x2013;661. doi: 10.1093/ije/dyq267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq267</ArticleId><ArticleId IdType="pubmed">21324938</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle LW, Ford G, Davis N. Health and hospitalistions after discharge in extremely low birth weight infants. Seminars in neonatology : SN. 2003;8(2):137&#x2013;145. doi: 10.1016/S1084-2756(02)00221-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1084-2756(02)00221-X</ArticleId><ArticleId IdType="pubmed">15001150</ArticleId></ArticleIdList></Reference><Reference><Citation>Leversen KT, Sommerfelt K, Ronnestad A, Kaaresen PI, Farstad T, Skranes J, et al. Prediction of neurodevelopmental and sensory outcome at 5 years in Norwegian children born extremely preterm. Pediatrics. 2011;127(3):e630&#x2013;e638. doi: 10.1542/peds.2010-1001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-1001</ArticleId><ArticleId IdType="pubmed">21321031</ArticleId></ArticleIdList></Reference><Reference><Citation>Skromme K, Leversen KT, Eide GE, Markestad T, Halvorsen T. Respiratory illness contributed significantly to morbidity in children born extremely premature or with extremely low birthweights in 1999-2000. Acta Paediatr. 2015;104(11):1189&#x2013;1198. doi: 10.1111/apa.13165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.13165</ArticleId><ArticleId IdType="pubmed">26303868</ArticleId></ArticleIdList></Reference><Reference><Citation>Leversen KT, Sommerfelt K, Ronnestad A, Kaaresen PI, Farstad T, Skranes J, et al. Predicting neurosensory disabilities at two years of age in a national cohort of extremely premature infants. Early Hum Dev. 2010;86(9):581&#x2013;586. doi: 10.1016/j.earlhumdev.2010.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2010.07.009</ArticleId><ArticleId IdType="pubmed">20800392</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollsaeter M, Skromme K, Satrell E, Clemm H, Roksund O, Oymar K, et al. Children born preterm at the turn of the millennium had better lung function than children born similarly preterm in the early 1990s. PLoS One. 2015;10(12):e0144243. doi: 10.1371/journal.pone.0144243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144243</ArticleId><ArticleId IdType="pmc">PMC4671691</ArticleId><ArticleId IdType="pubmed">26641080</ArticleId></ArticleIdList></Reference><Reference><Citation>Skjaerven R, Gjessing HK, Bakketeig LS. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand. 2000;79(6):440&#x2013;449. doi: 10.1080/j.1600-0412.2000.079006440.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/j.1600-0412.2000.079006440.x</ArticleId><ArticleId IdType="pubmed">10857867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CK, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, et al. Global variation in the prevalence and severity of asthma symptoms: phase three of the international study of asthma and allergies in childhood (ISAAC) Thorax. 2009;64(6):476&#x2013;483. doi: 10.1136/thx.2008.106609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2008.106609</ArticleId><ArticleId IdType="pubmed">19237391</ArticleId></ArticleIdList></Reference><Reference><Citation>Thunqvist P, Tufvesson E, Bjermer L, Winberg A, Fellman V, Domellof M, et al. Lung function after extremely preterm birth-a population-based cohort study (EXPRESS). Pediatr Pulmonol. 2017; 10.1002/ppul.23919.</Citation><ArticleIdList><ArticleId IdType="pubmed">29152899</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawke J, Lum S, Kirkby J, Hennessy E, Marlow N, Rowell V, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med. 2010;182(2):237&#x2013;245. doi: 10.1164/rccm.200912-1806OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200912-1806OC</ArticleId><ArticleId IdType="pmc">PMC2913237</ArticleId><ArticleId IdType="pubmed">20378729</ArticleId></ArticleIdList></Reference><Reference><Citation>Krokstad S, Langhammer A, Hveem K, Holmen TL, Midthjell K, Stene TR, et al. Cohort profile: the HUNT study. Norway Int J Epidemiol. 2013;42(4):968&#x2013;977. doi: 10.1093/ije/dys095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys095</ArticleId><ArticleId IdType="pubmed">22879362</ArticleId></ArticleIdList></Reference><Reference><Citation>Brostrom EB, Thunqvist P, Adenfelt G, Borling E, Katz-Salamon M. Obstructive lung disease in children with mild to severe BPD. Respir Med. 2010;104(3):362&#x2013;370. doi: 10.1016/j.rmed.2009.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2009.10.008</ArticleId><ArticleId IdType="pubmed">19906521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hack M, Schluchter M, Andreias L, Margevicius S, Taylor HG, Drotar D, et al. Change in prevalence of chronic conditions between childhood and adolescence among extremely low-birth-weight children. JAMA : the journal of the American Medical Association. 2011;306(4):394&#x2013;401. doi: 10.1001/jama.2011.1025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.1025</ArticleId><ArticleId IdType="pmc">PMC3575170</ArticleId><ArticleId IdType="pubmed">21791688</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick MC, Workman-Daniels K, Brooks-Gunn J, Peckham GJ. Hospitalization of very low birth weight children at school age. J Pediatr. 1993;122(3):360&#x2013;365. doi: 10.1016/S0022-3476(05)83417-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(05)83417-1</ArticleId><ArticleId IdType="pubmed">8441088</ArticleId></ArticleIdList></Reference><Reference><Citation>Saigal S, Stoskopf BL, Streiner DL, Burrows E. Physical growth and current health status of infants who were of extremely low birth weight and controls at adolescence. Pediatrics. 2001;108(2):407&#x2013;415. doi: 10.1542/peds.108.2.407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.108.2.407</ArticleId><ArticleId IdType="pubmed">11483807</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle LW, Cheung MM, Ford GW, Olinsky A, Davis NM, Callanan C. Birth weight &lt;1501 g and respiratory health at age 14. Arch Dis Child. 2001;84(1):40&#x2013;44. doi: 10.1136/adc.84.1.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.84.1.40</ArticleId><ArticleId IdType="pmc">PMC1718620</ArticleId><ArticleId IdType="pubmed">11124782</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenough A, Alexander J, Boorman J, Chetcuti PA, Cliff I, Lenney W, et al. Respiratory morbidity, healthcare utilisation and cost of care at school age related to home oxygen status. Eur J Pediatr. 2011;170(8):969&#x2013;975. doi: 10.1007/s00431-010-1381-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-010-1381-6</ArticleId><ArticleId IdType="pubmed">21225284</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LJ, van Asperen PP, McKay KO, Selvadurai H, Fitzgerald DA. Reduced exercise capacity in children born very preterm. Pediatrics. 2008;122(2):e287&#x2013;e293. doi: 10.1542/peds.2007-3657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3657</ArticleId><ArticleId IdType="pubmed">18676514</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle LW. Victorian infant collaborative study G. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992. Pediatr Pulmonol. 2006;41(6):570&#x2013;576. doi: 10.1002/ppul.20412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.20412</ArticleId><ArticleId IdType="pubmed">16617453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacking DF, Gibson AM, Robertson C, Doyle LW. Victorian infant collaborative study G. Respiratory function at age 8-9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatr Pulmonol. 2013;48(5):449&#x2013;455. doi: 10.1002/ppul.22619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.22619</ArticleId><ArticleId IdType="pubmed">22826206</ArticleId></ArticleIdList></Reference><Reference><Citation>Siltanen M, Savilahti E, Pohjavuori M, Kajosaari M. Respiratory symptoms and lung function in relation to atopy in children born preterm. Pediatr Pulmonol. 2004;37(1):43&#x2013;49. doi: 10.1002/ppul.10402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.10402</ArticleId><ArticleId IdType="pubmed">14679488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai XM, Gaddlin PO, Nilsson L, Finnstrom O, Bjorksten B, Jenmalm MC, et al. Asthma, lung function and allergy in 12-year-old children with very low birth weight: a prospective study. Pediatr Allergy Immunol. 2003;14(3):184&#x2013;192. doi: 10.1034/j.1399-3038.2003.00045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3038.2003.00045.x</ArticleId><ArticleId IdType="pubmed">12787297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodrup Carlsen KC, Haland G, Devulapalli CS, Munthe-Kaas M, Pettersen M, Granum B, et al. Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth cohort study. Allergy. 2006;61(4):454&#x2013;460. doi: 10.1111/j.1398-9995.2005.00938.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2005.00938.x</ArticleId><ArticleId IdType="pubmed">16512808</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy JD, Edward LJ, Bates DJ, Martin AJ, Dip SN, Haslam RR, et al. Effects of birthweight and oxygen supplementation on lung function in late childhood in children of very low birth weight. Pediatr Pulmonol. 2000;30(1):32&#x2013;40. doi: 10.1002/1099-0496(200007)30:1&lt;32::AID-PPUL6&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1099-0496(200007)30:1&lt;32::AID-PPUL6&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">10862160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulasekaran K, Gray PH, Masters B. Chronic lung disease of prematurity and respiratory outcome at eight years of age. J Paediatr Child Health. 2007;43(1&#x2013;2):44&#x2013;48. doi: 10.1111/j.1440-1754.2007.01001.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1754.2007.01001.x</ArticleId><ArticleId IdType="pubmed">17207055</ArticleId></ArticleIdList></Reference><Reference><Citation>Darlow BA, Horwood LJ, Mogridge N. Very low birthweight and asthma by age seven years in a national cohort. Pediatr Pulmonol. 2000;30(4):291&#x2013;296. doi: 10.1002/1099-0496(200010)30:4&lt;291::AID-PPUL3&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1099-0496(200010)30:4&lt;291::AID-PPUL3&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">11015128</ArticleId></ArticleIdList></Reference><Reference><Citation>Vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr. 2013; 10.1016/j.jpeds.2013.07.045.</Citation><ArticleIdList><ArticleId IdType="pubmed">24055328</ArticleId></ArticleIdList></Reference><Reference><Citation>Klitkou ST, Iversen T, Stensvold HJ, Ronnestad A. Use of hospital-based health care services among children aged 1 through 9 years who were born very preterm - a population-based study. BMC Health Serv Res. 2017;17(1):571. doi: 10.1186/s12913-017-2498-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-017-2498-3</ArticleId><ArticleId IdType="pmc">PMC5561635</ArticleId><ArticleId IdType="pubmed">28818072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19142544</PMID><DateCompleted><Year>2009</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1980-5322</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>1</Issue><PubDate><Year>2009</Year></PubDate></JournalIssue><Title>Clinics (Sao Paulo, Brazil)</Title><ISOAbbreviation>Clinics (Sao Paulo)</ISOAbbreviation></Journal><ArticleTitle>Non-asthmatic patients show increased exhaled nitric oxide concentrations.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>10</EndPage><MedlinePgn>5-10</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Evaluate whether exhaled nitric oxide may serve as a marker of intraoperative bronchospasm.</AbstractText><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Intraoperative bronchospasm remains a challenging event during anesthesia. Previous studies in asthmatic patients suggest that exhaled nitric oxide may represent a noninvasive measure of airway inflammation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 146,358 anesthesia information forms, which were received during the period from 1999 to 2004, were reviewed. Bronchospasm was registered on 863 forms. From those, three groups were identified: 9 non-asthmatic patients (Bronchospasm group), 12 asthmatics (Asthma group) and 10 subjects with no previous airway disease or symptoms (Control group). All subjects were submitted to exhaled nitric oxide measurements (parts/billion), spirometry and the induced sputum test. The data was compared by ANOVA followed by the Tukey test and Kruskal-Wallis followed by Dunn's test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The normal lung function test results for the Bronchospasm group were different from those of the asthma group (p &lt;0.05). The median percentage of eosinophils in induced sputum was higher for the Asthma [2.46 (0.45-6.83)] compared with either the Bronchospasm [0.55 (0-1.26)] or the Control group [0.0 (0)] (p &lt;0.05); exhaled nitric oxide followed a similar pattern for the Asthma [81.55 (57.6-86.85)], Bronchospasm [46.2 (42.0 -62.6] and Control group [18.7 (16.0-24.7)] (p&lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Non-asthmatic patients with intraoperative bronchospasm detected during anesthesia and endotracheal intubation showed increased expired nitric oxide.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saraiva-Romanholo</LastName><ForeName>Beatriz M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>Fabio S</ForeName><Initials>FS</Initials></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Francine M</ForeName><Initials>FM</Initials></Author><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Maria do Patroc&#xed;nio T</ForeName><Initials>Mdo P</Initials></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Milton A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Joaquim E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clinics (Sao Paulo)</MedlineTA><NlmUniqueID>101244734</NlmUniqueID><ISSNLinking>1807-5932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000769" MajorTopicYN="N">Anesthesia, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004804" MajorTopicYN="N">Eosinophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045853" MajorTopicYN="N">Exhalation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013147" MajorTopicYN="N">Spirometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013183" MajorTopicYN="N">Sputum</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>1</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>1</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>26</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19142544</ArticleId><ArticleId IdType="pmc">PMC2671975</ArticleId><ArticleId IdType="doi">10.1590/s1807-59322009000100002</ArticleId><ArticleId IdType="pii">S1807-5932(22)02698-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Olsson GL. Bronchospasm during anesthesia. A computer-aided incidence study of 136,929 patients. Acta Anaesthesiol Scand. 1987;31:244&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">3577646</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizov R, Brown RH, Weiss YS, Baranov D, Hennes H, Baker S, et al. Wheezing during induction of general anesthesia in patients with and without asthma. A randomized, blinded trial. Anesthesiology. 1995;82:1111&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">7741285</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner DO, Warner MA, Barnes RD, Offord KP, Schroeder DR, Gray DT, et al. Perioperative respiratory complications in patients with asthma. Anesthesiology. 1996;85:460&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8853074</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. National Heart, Lung and Blood Institute Global Strategy for Asthma Management and
          PreventionIssued January, 1995. Updated 2005. [http://www.ginasthma.org]</Citation></Reference><Reference><Citation>Silkoff PE, McClean PA, Caramori M, Slutsky AS, Zamel N. A significant proportion of exhaled nitric oxide arises in large airways in normal subjects. Respir Physiol. 1998;113:33&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9776548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med. 1994;149:538&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">7508323</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado CM, Leick-Maldonado EA, Kasahara DI, Capelozzi VL, Martins MA, Tiberio IFLC. Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. Am J Physiol Lung Cell Mol Physiol. 2005;289:L677&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">15937069</ArticleId></ArticleIdList></Reference><Reference><Citation>Leme AS, Kasahara DI, Nunes MP, Martins MA, Vieira JE. Exhaled nitric oxide collected with two different mouthpieces: a study in asthmatic patients. Braz J Med Biol Res. 2002;35:1133&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12424484</ArticleId></ArticleIdList></Reference><Reference><Citation>Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996;153:1510&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">8630594</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl Med. 2005;352:2163&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15914548</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. National Heart, Lung and Blood Institute Global Strategy for Asthma Management and PreventionIssued January, 1995. Updated 2002. NIH Publication. No 02-3659.2002</Citation></Reference><Reference><Citation>American Thoracic Society Standardization of spirometry. Am J Respir Crit Care Med. 1995;152:1107&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">7663792</ArticleId></ArticleIdList></Reference><Reference><Citation>American Thoracic Society Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med. 1999;160:2104&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">10588636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J. 1997;10:1683&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">9230267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzichini E, Pizzichini MMM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9:1174&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">8804934</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rensen EL, Straathof KC, Veseselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils and exhaled nitric oxide levels in patients with asthma. Thorax. 1999;54:403&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1763792</ArticleId><ArticleId IdType="pubmed">10212103</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraiva-Romanholo BM, Barnabe V, Carvalho AL, Martins MA, Saldiva PH, Nunes Mdo P. Comparison of three methods for differential cell count in induced sputum. Chest. 2003;124:1060&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12970038</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter WE, Hardt NS, Fuhrman S. Immunoglobulin E: importance in parasitic infections and hypersensitivity responses. Arch Pathol Lab Med. 2000;124:1382&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10975945</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreborg S. Skin testing. The safety of skin tests and the information obtained from using different methods and concentrations of allergen. Allergy. 1993;48:473&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8238806</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima RG, Pastorino AC, Casagrande RR, Sole D, Leone C, Jacob CM. Prevalence of asthma, rhinitis and eczema in 6 - 7 years old students from the western districts of S&#xe3;o Paulo City, using the standardized questionnaire of the &#x201c;International Study of Asthma and Allergies in Childhood&#x201d; (ISAAC)-phase IIIB. Clinics. 2007;62:225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">17589661</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Toorn LM, Prins JB, Overbeek SE, Hoogsteden HC, De Jongste JC. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsivenes. Am J Respir Crit Care Med. 2000;162:953&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10988112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharitonov SA, O&#x2019;Connor BJ, Evans DJ, Barnes PJ. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med. 1995;151:1894&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">7767537</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitt M. Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report. Clin Ther. 2005;27:1238&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">16199248</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz MJ, Leung DYM, McCormick DR, Harbeck R, Szefler SJ, White CW. Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbations of pediatric asthma. Pediatr Pulmonol. 1997;24:305&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">9407562</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes PJ, Kharitonov SA. Exhaled nitric oxide: a new lung function test. Thorax. 1996;51:233&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1090631</ArticleId><ArticleId IdType="pubmed">8779123</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraldi E, Azzolin NM, Zanconato S, Dario C, Zacchello F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr. 1997;131:381&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9329413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Jataknaon A, John M, Gilbey T, O&#x2019;Connor BJ, Chung K, et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med. 1999;159:22&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">9872813</ArticleId></ArticleIdList></Reference><Reference><Citation>Jilma B, Kastner J, Mensik C, Vondrovec B, Hildebrandt J, Krejcy K, et al. Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci. 1996;58:469&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">8569419</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson PG, Henry RL, Thomas P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J. 2000;16:1008&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">11153569</ArticleId></ArticleIdList></Reference><Reference><Citation>Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758706</ArticleId><ArticleId IdType="pubmed">9624291</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol. 2000;106:638&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">11031333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinose M, Takahashi T, Sugiura H, Endoh E, Miura M, Mashito Y, et al. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre. Eur Respir J. 2000;15:248&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">10706487</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogami H, Shoji S, Nishima S. Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients. J Asthma. 2003;40:653&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14579996</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Giudice MM, Brunese FP, Piacentini GL, Pedulla M, Capristo C, Decimo F, et al. Fractional exhaled nitric oxide (FENO), lung function and airway hyperresponsiveness in na&#xef;ve atopic asthmatic children. J Asthma. 2004;41:759&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">15584636</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley SJ, Goldthorpe S, Custovic A, Woodcock A. Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. Ann Allergy Asthma Immunol. 2003;91:398&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">14582820</ArticleId></ArticleIdList></Reference><Reference><Citation>Spallarossa D, Battistini E, Silvestri M, Sabatini F, Fregonese L, Brazzola G, et al. Steroid-na&#xef;ve adolescents with mild intermittent allergic asthma have airway hyperresponsiveness and exhaled nitric oxide levels. J Asthma. 2003;40:301&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12807174</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-na&#xef;ve patients with mild asthma. Am J Resp Crit Care Med. 1998;157:894&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9517608</ArticleId></ArticleIdList></Reference><Reference><Citation>Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med. 1998;157:4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9445270</ArticleId></ArticleIdList></Reference><Reference><Citation>Birrell MA, Battram CH, Woodman P, McCluskie K, Belvisi MG.Dissociation by steroids of eosinophilic inflammation from
            airway hyperresponsiveness in murine airways Respir
            Res 200343[http://www.respiratory-research/content/4/1/3]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC152648</ArticleId><ArticleId IdType="pubmed">12657158</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31009034</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6211</ISSN><JournalIssue CitedMedium="Internet"><Volume>173</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA pediatrics</Title><ISOAbbreviation>JAMA Pediatr</ISOAbbreviation></Journal><ArticleTitle>Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>527</StartPage><EndPage>533</EndPage><MedlinePgn>527-533</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapediatrics.2019.0788</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Tonsillectomy is a common pediatric procedure for the treatment of sleep-disordered breathing and chronic tonsillitis. Up to half of children having this procedure experience a perioperative respiratory adverse event.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether inhaled albuterol sulfate (salbutamol sulfate) premedication decreases the risk of perioperative respiratory adverse events in children undergoing anesthesia for tonsillectomy.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">A randomized, triple-blind, placebo-controlled trial (the Reducing Anesthetic Complications in Children Undergoing Tonsillectomies [REACT] trial) was conducted at Perth Children's Hospital (formerly Princess Margaret Hospital for Children), the only tertiary pediatric hospital in Western Australia. Participants included 484 children aged 0 to 8 years who were undergoing anesthesia for tonsillectomy. The study was conducted between July 15, 2014, and May 18, 2017.</AbstractText><AbstractText Label="INTERVENTIONS">Participants were randomized to receive either albuterol (2 actuations, 200 &#x3bc;g) or placebo before their surgery.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Occurrence of perioperative respiratory adverse events (bronchospasm, laryngospasm, airway obstruction, desaturation, coughing, and stridor) until discharge from the postanesthesia care unit.</AbstractText><AbstractText Label="RESULTS">Of 484 randomized children (median [range] age, 5.6 [1.6-8.9] years; 285 [58.9%] boys), 479 data sets were available for intention-to-treat analysis. Perioperative respiratory adverse events occurred in 67 of 241 children (27.8%) receiving albuterol and 114 of 238 children (47.9%) receiving placebo. After adjusting for age, type of airway device, and severity of obstructive sleep apnea in a binary logistic regression model, the likelihood of perioperative respiratory adverse events remained significantly higher in the placebo group compared with the albuterol group (odds ratio, 2.8; 95% CI, 1.9-4.2; P&#x2009;&lt;&#x2009;.001). Significant differences were seen in children receiving placebo vs albuterol in laryngospasm (28 [11.8%] vs 12 [5.0%]; P&#x2009;=&#x2009;.009), coughing (79 [33.2%] vs 27 [11.2%]; P&#x2009;&lt;&#x2009;.001), and oxygen desaturation (54 [22.7%] vs 36 [14.9%]; P&#x2009;=&#x2009;.03).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Albuterol premedication administered before tonsillectomy under general anesthesia in young children resulted in a clinically significant reduction in rates of perioperative respiratory adverse events compared with the rates in children who received placebo. Premedication with albuterol should be considered for children undergoing tonsillectomy.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Australian New Zealand Clinical Trials Registry identifier: ACTRN12614000739617.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesiology, Medical School, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommerfield</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesiology, Medical School, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slevin</LastName><ForeName>Lliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake-Brockman</LastName><ForeName>Thomas F E</ForeName><Initials>TFE</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Perth Children's Hospital, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesiology, Medical School, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guicheng</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Public Health, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Genetic Origins of Health and Disease, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Graham L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Telethon Kids Institute, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physiotherapy and Exercise Science, Curtin University, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Child Health Research, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Pediatr</MedlineTA><NlmUniqueID>101589544</NlmUniqueID><ISSNLinking>2168-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001993">Bronchodilator Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Arch Dis Child Educ Pract Ed. 2020 Dec;105(6):383-384. doi: 10.1136/archdischild-2019-318590.</RefSource><PMID Version="1">31969376</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="N">Albuterol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001993" MajorTopicYN="N">Bronchodilator Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr von Ungern-Sternberg reported receiving grants from the Perth Children&#x2019;s Hospital (PCH) Foundation and Australia and New Zealand College of Anaesthetists (ANZCA), and other support from the PCH Foundation during the conduct of the study. Dr Sommerfield reported receiving grants from the PCH Foundation and from Australian and New Zealand College of Anaesthetists during the conduct of the study. Ms Slevin reported receiving grants from the PCH Foundation and ANZCA during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31009034</ArticleId><ArticleId IdType="pmc">PMC6547220</ArticleId><ArticleId IdType="doi">10.1001/jamapediatrics.2019.0788</ArticleId><ArticleId IdType="pii">2731129</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>ENTUK Indications for Tonsillectomy: Position Paper. London, UK: Royal College of Surgeons of England; 2009.</Citation></Reference><Reference><Citation>Burton MJ, Glasziou PP, Chong LY, Venekamp RP. Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis. Cochrane Database Syst Rev. 2014;(11):CD001802. doi:10.1002/14651858.CD001802.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD001802.pub3</ArticleId><ArticleId IdType="pmc">PMC7075105</ArticleId><ArticleId IdType="pubmed">25407135</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Intercollegiate Guidelines Network Management of sore throat and indications for tonsillectomy. Edinburgh, UK: Scottish Intercollegiate Guidelines Network; 2010.</Citation></Reference><Reference><Citation>von Ungern-Sternberg BS, Davies K, Hegarty M, Erb TO, Habre W. The effect of deep vs. awake extubation on respiratory complications in high-risk children undergoing adenotonsillectomy: a randomised controlled trial. Eur J Anaesthesiol. 2013;30(9):529-536. doi:10.1097/EJA.0b013e32835df608</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e32835df608</ArticleId><ArticleId IdType="pubmed">23344124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders JC, King MA, Mitchell RB, Kelly JP. Perioperative complications of adenotonsillectomy in children with obstructive sleep apnea syndrome. Anesth Analg. 2006;103(5):1115-1121. doi:10.1213/01.ane.0000244318.77377.67</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000244318.77377.67</ArticleId><ArticleId IdType="pubmed">17056942</ArticleId></ArticleIdList></Reference><Reference><Citation>Regli A, von Ungern-Sternberg BS. Diagnosis and management of respiratory adverse events in the operating room. Curr Anesthesiol Rep. 2015;5(2):156-167. doi:10.1007/s40140-015-0103-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40140-015-0103-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Inhalational versus intravenous induction of anesthesia in children with a high risk of perioperative respiratory adverse events: a randomized controlled trial. Anesthesiology. 2018;128(6):1065-1074. doi:10.1097/ALN.0000000000002152</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002152</ArticleId><ArticleId IdType="pubmed">29498948</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake-Brockman TFE, Ramgolam A, Zhang G, Hall GL, von Ungern-Sternberg BS. The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomised controlled trial. Lancet. 2017;389(10070):701-708. doi:10.1016/S0140-6736(16)31719-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31719-6</ArticleId><ArticleId IdType="pubmed">28108038</ArticleId></ArticleIdList></Reference><Reference><Citation>Scalfaro P, Sly PD, Sims C, Habre W. Salbutamol prevents the increase of respiratory resistance caused by tracheal intubation during sevoflurane anesthesia in asthmatic children. Anesth Analg. 2001;93(4):898-902. doi:10.1097/00000539-200110000-00019</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200110000-00019</ArticleId><ArticleId IdType="pubmed">11574353</ArticleId></ArticleIdList></Reference><Reference><Citation>Elwood T, Morris W, Martin LD, et al. . Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia. Can J Anaesth. 2003;50(3):277-284. doi:10.1007/BF03017798</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03017798</ArticleId><ArticleId IdType="pubmed">12620952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramgolam A, Hall GL, Sommerfield D, et al. . Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children. Br J Anaesth. 2017;119(1):150-157. doi:10.1093/bja/aex139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex139</ArticleId><ArticleId IdType="pubmed">28974069</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Habre W, Erb TO, Heaney M. Salbutamol premedication in children with a recent respiratory tract infection. Paediatr Anaesth. 2009;19(11):1064-1069. doi:10.1111/j.1460-9592.2009.03130.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2009.03130.x</ArticleId><ArticleId IdType="pubmed">19694973</ArticleId></ArticleIdList></Reference><Reference><Citation>Regli A, Becke K, von Ungern-Sternberg BS. An update on the perioperative management of children with upper respiratory tract infections. Curr Opin Anaesthesiol. 2017;30(3):362-367. doi:10.1097/ACO.0000000000000460</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000460</ArticleId><ArticleId IdType="pubmed">28291127</ArticleId></ArticleIdList></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, et al. . Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet. 2010;376(9743):773-783. doi:10.1016/S0140-6736(10)61193-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61193-2</ArticleId><ArticleId IdType="pubmed">20816545</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W, Disma N, Virag K, et al. ; APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network . Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017;5(5):412-425. doi:10.1016/S2213-2600(17)30116-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30116-9</ArticleId><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavreska V, Verheggen M, Oostryck J, Stick SM, Hall GL. Determining the time to maximal bronchodilator response in asthmatic children. J Asthma. 2009;46(1):25-29. doi:10.1080/02770900802460555</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770900802460555</ArticleId><ArticleId IdType="pubmed">19191133</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Commission on Safety and Quality in Health Care The First Australian Atlas of Healthcare Variation. Canberra, Australia: ACSQHC; 2015.</Citation></Reference><Reference><Citation>Ramgolam A, Hall GL, Zhang G, Hegarty M, von Ungern-Sternberg BS. Deep or awake removal of laryngeal mask airway in children at risk of respiratory adverse events undergoing tonsillectomy&#x2014;a randomised controlled trial. Br J Anaesth. 2018;120(3):571-580. doi:10.1016/j.bja.2017.11.094</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.11.094</ArticleId><ArticleId IdType="pubmed">29452814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaw R, Chung F, Pasupuleti V, Mehta J, Gay PC, Hernandez AV. Meta-analysis of the association between obstructive sleep apnoea and postoperative outcome. Br J Anaesth. 2012;109(6):897-906. doi:10.1093/bja/aes308</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aes308</ArticleId><ArticleId IdType="pubmed">22956642</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KA, Morin I, Hickey C, Manoukian JJ, Nixon GM, Brouillette RT. Urgent adenotonsillectomy: an analysis of risk factors associated with postoperative respiratory morbidity. Anesthesiology. 2003;99(3):586-595. doi:10.1097/00000542-200309000-00013</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200309000-00013</ArticleId><ArticleId IdType="pubmed">12960542</ArticleId></ArticleIdList></Reference><Reference><Citation>McColley SA, April MM, Carroll JL, Naclerio RM, Loughlin GM. Respiratory compromise after adenotonsillectomy in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992;118(9):940-943. doi:10.1001/archotol.1992.01880090056017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.1992.01880090056017</ArticleId><ArticleId IdType="pubmed">1503720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawar D. Common post-operative complications in children. Indian J Anaesth. 2012;56(5):496-501. doi:10.4103/0019-5049.103970</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.103970</ArticleId><ArticleId IdType="pmc">PMC3531006</ArticleId><ArticleId IdType="pubmed">23293390</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi Y, Kuwahara M, Nanji A, et al. . The difference in citric acid-induced cough in congenitally bronchial-hypersensitive (BHS) and bronchial-hyposensitive (BHR) guinea pigs. Exp Anim. 2001;50(5):371-378. doi:10.1538/expanim.50.371</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.50.371</ArticleId><ArticleId IdType="pubmed">11769539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26889104</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1512-7680</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Materia socio-medica</Title><ISOAbbreviation>Mater Sociomed</ISOAbbreviation></Journal><ArticleTitle>INFLUENCE OF OVERWEIGHT AND OBESITY IN CHILDREN ON ANESTHESIOLOGICAL COMPLICATIONS APPEARANCE DURING ADENOIDECTOMY AND ADENOTONSILLECTOMY.</ArticleTitle><Pagination><StartPage>425</StartPage><EndPage>428</EndPage><MedlinePgn>425-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5455/msm.2015.27.425-428</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Obesity in children is becoming from year to year enormous medical and socio-epidemilogical problem according to increasing number of overweight and obese children. Overweight and obesity in children mostly affects on cardiovascular, respiratory and endocrine system disturbances. Adenoidectomy and adenotonsillectomy belong to group of most often done operation in children population. Anesthesiology complications during adenodecotomy and adenotonsillectomy in children are known as very disturbing and dramatic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective-prospective study includes 162 children, both genders, 3 to 12 years old, who are hospitalized and operated (adenoidectomies and adenotonsillectomies) on Otorihinolaryngolic clinic of University clinical centre Tuzla in the four year period. Purpose of the study is to show the influence of overweight in children on appearance of anesthesiology complications such as difficult intubation, bronchospasm and laryngospasm. Body mass index (BMI), which is used as universal measure, is adapted with gender specific scales of National statistic centre of United States of America. All children with BMI over 25 are referred as overweight and those over 30 as obese. These children categories were compared to those with normal BMI according to anesthesiology complications incidence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overweight in operated children is noticed in 21%, and 11% of children was obese and there wasn't distinction between boys and girls. Anesthesiology complications are evaluated in 12 of them (7.4%). Total analyzed sample show significant connection and influence of overweight with appearance of anesthesiology complications. Separate comparison for two types of operations is indicating that during adenoidectomies there hasn't been noticed connection between overweight and anestehesiological complications, while in case of adenotonsillectomies direct and significant correlation is proven.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">According to increased risk of anesthesiology complications in overweight and obese children during adenodectomies and adenotonsillectomies it is important for anesthesiologists to do much serious preoperative evaluation of obese children, and to be more prepared for every of possible unwished supersize during perioperative period.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmetasevic</LastName><ForeName>Dzenita</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinic for Anesthesiology and Reanimation, University Clinical Centre Tuzla, Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmetasevic</LastName><ForeName>Emir</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Surgery Clinic, University Clinical Centre Tuzla, Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brkic</LastName><ForeName>Selmira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Faculty of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazlagic</LastName><ForeName>Seid</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Faculty of Medicine, University of Tuzla, Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasanovic</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Surgery Clinic, University Clinical Centre Tuzla, Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Bosnia and Herzegovina</Country><MedlineTA>Mater Sociomed</MedlineTA><NlmUniqueID>101281595</NlmUniqueID><ISSNLinking>1512-7680</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adenoidectomy</Keyword><Keyword MajorTopicYN="N">anesthesiology complications</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">overweight</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST: NONE DECLARED.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26889104</ArticleId><ArticleId IdType="pmc">PMC4733551</ArticleId><ArticleId IdType="doi">10.5455/msm.2015.27.425-428</ArticleId><ArticleId IdType="pii">MSM-27-425</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stipan&#x10d;i&#x107; G. Body mass index. Va&#x161;e zdravlje. 2004;34(2)</Citation></Reference><Reference><Citation>Haslam DW, James WP. Obesity. Lancet. 2005;336:1197&#x2013;1209.</Citation><ArticleIdList><ArticleId IdType="pubmed">16198769</ArticleId></ArticleIdList></Reference><Reference><Citation>Simi&#x107; B. Medicinska dijetetika. Medicinski fakultet Univerziteta u Beogradu. 1998:48&#x2013;67.</Citation></Reference><Reference><Citation>Alford M, Guruswamy V. A national survey of the anesthetic management of tonsillectomy surgery in children. Pediatric anesthesia. 2009;19(2):145&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">19143956</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafiu OO, Green GE, Walton S, Morris M, Reddy S, Tremper KK. Obesity and riskof perioperative complications in children presenting for adenotonsillectomy. Pediatric otorhinolaryngology. 2009;73(1):89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">18996603</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin G Cox. Anesthetic management of pediatric adenotonsillectomy. Canadian Journal of Anesthesia. 2007;54:1021&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">18056214</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder T, Nolte M, Kox WJ, Spies C. Anesthesia in extreme obesity. Anestehesiology. 2001;26(3):222&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">11413802</ArticleId></ArticleIdList></Reference><Reference><Citation>Tait A, Voepel-Lewis T, Burke C, Kostrzewa A, Lewis I. Incidence and risk factors for perioperative adverse respiratory events in children who are obese. Anesthesiology. 2008;108:375&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">18292674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Zhang G, Huang P, Li Y. Postoperative respiraatory complications of adenotonsillectomy for obstructive sleep apnea syndrome in older children: prevalence, risk faactors, and impact on clinical outcome. Otorhinolaryngology head neck surgery. 2009;38(1):4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19344613</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector A, Scheid S, Hassink S, Deutsch ES, Reilly JS, Cook SP. Adenotonsillectomy in the morbidly obese child. Int J Pediatr Otorhinolaryngol. 2003;67(4):359&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">12663107</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafiu OO, Reynolds PI, Bambgade OA, Morris M, Kasa-Vubu JZ. Prevalence of overweight and obesity in a US pediatric surgical population. Journal of national medical association. 2007;99(1):46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2569597</ArticleId><ArticleId IdType="pubmed">17304968</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa D, Mitchel R. Adenotonsillectomy for obstructive sleep apnea in obese children: A meta analysis. Otorhinolaryngology-Head and neck surgery. 2009;140:455&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">19328330</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon B, Donelly M, Mc Shane O. Tonsillitis, tonsillectomy and weight disturbances. Inteernational journal of pediatric otorhinolaryngology. 1997;42(1):17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">9477349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafiu OO, Ndao-Brumbly K, Bamgbade OA, Morris M, Kasa Vubu JZ. Chilhood BMI and perioperative complications. Pediatr Anesth. 2007;17(5):426&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">17474948</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake Lee A, Stokes M. A prospective study of the lenght of stayof a 150 children following tonsillectomy and/or adenoidectomy. Clin Otolaryngology Allied Sci. 1998;23(6):491&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">9884801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendrick D, Gibbin K. An audit of the complications of pediatric tonsillectomy, adenoidectomy and adenotonsillectomy. Clin Otolaryngol Allied Sci. 1993;18(2):115&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">8508540</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33168406</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8473</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses</Title><ISOAbbreviation>J Perianesth Nurs</ISOAbbreviation></Journal><ArticleTitle>Comparison of the Effect of Laryngeal Mask Airway Versus Endotracheal Tube on Airway Management in Pediatric Patients with Tonsillar Hypertrophy.</ArticleTitle><Pagination><StartPage>142</StartPage><EndPage>146</EndPage><MedlinePgn>142-146</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jopan.2020.06.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1089-9472(20)30189-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The laryngeal mask airway (LMA) has become an important choice in both routine and difficult airway management. We aimed to evaluate the safety and effectiveness of LMA use in pediatric patients with tonsillar hypertrophy.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This study was a randomized controlled trial.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included 100 pediatric patients who had first or second degree tonsillar hypertrophy. Pediatric patients undergoing elective laparoscopic inguinal hernia repair were randomly divided into two groups (n&#xa0;= 50): LMA group and the endotracheal tube (ETT) group. The primary outcomes were ventilation leak volume, peak airway pressure, and partial pressure of end-tidal carbon dioxide (P<sub>ET</sub>co<sub>2</sub>). Data for primary outcomes were collected before and 5-, 15-, and 25-minute after opening pneumoperitoneum, and on closing the pneumoperitoneum. Complications such as laryngospasm, bronchospasm, desaturation, severe coughing, blood on the device after removal, and sore throat were recorded.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">A total of 100 pediatric patients were assessed and 97 eligible patients were randomly assigned to receive an LMA (n&#xa0;= 49) or an ETT (n&#xa0;= 48). There was no statistically significant difference in ventilation leak volume and P<sub>ET</sub>co<sub>2</sub> between the LMA and ETT groups (P&#xa0;&gt;&#xa0;.05). Compared with T<sub>1-4</sub>, peak airway pressure was significantly lower in T<sub>0</sub> (LMA group 12.6&#xa0;&#xb1;&#xa0;0.9, 95% confidence interval 12.2 to 13.0; ETT group 12.8&#xa0;&#xb1;&#xa0;1.2, 95% confidence interval 12.2 to 13.3; P&#xa0;&lt;&#xa0;.05). The incidences of laryngospasm 11 (22.9%), desaturation 18 (37.5%), and severe coughing 13 (27%) were higher in the ETT group (11 [22.9%] vs 3 [6.1%], 18 [37.5%] vs 6 [12.2%], 13 [27%] vs 3 [6.1%]; P&#xa0;&lt;&#xa0;.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The application of LMA has a lower incidence of complications. LMA as an airway device is effective and perhaps superior in appropriate patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Operating Room and Anesthesiology, Hebei Medical University Affiliated Children's Hospital of Hebei Province, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Operating Room and Anesthesiology, Hebei Medical University Affiliated Children's Hospital of Hebei Province, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Xiaona</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurological Rehabilitation, Hebei Medical University Affiliated Children's Hospital of Hebei Province, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Operating Room and Anesthesiology, Hebei Medical University Affiliated Children's Hospital of Hebei Province, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Operating Room and Anesthesiology, Hebei Medical University Affiliated Children's Hospital of Hebei Province, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Operating Room and Anesthesiology, Hebei Medical University Affiliated Children's Hospital of Hebei Province, Shijiazhuang, China. Electronic address: shileilx@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Perianesth Nurs</MedlineTA><NlmUniqueID>9610507</NlmUniqueID><ISSNLinking>1089-9472</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006984" MajorTopicYN="N">Hypertrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="Y">Laryngismus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010612" MajorTopicYN="Y">Pharyngitis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anesthesia, general</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">supraglottic airway</Keyword><Keyword MajorTopicYN="N">surgical procedures, laparoscopic</Keyword><Keyword MajorTopicYN="N">tonsillar hypertrophy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>10</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33168406</ArticleId><ArticleId IdType="doi">10.1016/j.jopan.2020.06.020</ArticleId><ArticleId IdType="pii">S1089-9472(20)30189-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23344124</PMID><DateCompleted><Year>2014</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1365-2346</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>9</Issue><PubDate><Year>2013</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of anaesthesiology</Title><ISOAbbreviation>Eur J Anaesthesiol</ISOAbbreviation></Journal><ArticleTitle>The effect of deep vs. awake extubation on respiratory complications in high-risk children undergoing adenotonsillectomy: a randomised controlled trial.</ArticleTitle><Pagination><StartPage>529</StartPage><EndPage>536</EndPage><MedlinePgn>529-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/EJA.0b013e32835df608</ELocationID><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">There is ongoing debate regarding the optimal timing for tracheal extubation in children at increased risk of perioperative respiratory adverse events, particularly following adenotonsillectomy.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the occurrence of perioperative respiratory adverse events in children undergoing elective adenotonsillectomy extubated under deep anaesthesia or when fully awake.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, randomised controlled trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary paediatric hospital.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">One hundred children (&lt;16 years), with at least one risk factor for perioperative respiratory adverse events (current or recent upper respiratory tract infection in the past 2 weeks, eczema, wheezing in the past 12 months, dry nocturnal cough, wheezing on exercise, family history of asthma, eczema or hay fever as well as passive smoking).</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Deep or awake extubation.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">The occurrence of perioperative respiratory adverse events (laryngospasm, bronchospasm, persistent coughing, airway obstruction, desaturation&#x200a;&lt;95%).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no differences between the two groups with regard to age, medical and surgical parameters. The overall incidence of complications did not differ between the two groups; tracheal extubation in fully awake children was associated with a greater incidence of persistent coughing (60 vs. 35%, P&#x200a;=&#x200a;0.028), whereas the incidence of airway obstruction relieved by simple airway manoeuvres in children extubated while deeply anaesthetised was greater (26 vs. 8%, P&#x200a;=&#x200a;0.03). There was no difference in the incidence of oxygen desaturation lasting more than 10&#x200a;s.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">There was no difference in the overall incidence of perioperative respiratory adverse events. Both extubation techniques may be used in high-risk children undergoing adenotonsillectomy provided that the child is monitored closely in the postoperative period.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Australian New Zealand Clinical Trials Registry: ACTRN12609000387224.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>Britta S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Subiaco, WA 6008, Australia. britta.regli-vonungern@health.wa.gov.au</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Kylie</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Hegarty</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Erb</LastName><ForeName>Thomas O</ForeName><Initials>TO</Initials></Author><Author ValidYN="Y"><LastName>Habre</LastName><ForeName>Walid</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Anaesthesiol</MedlineTA><NlmUniqueID>8411711</NlmUniqueID><ISSNLinking>0265-0215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="N">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000402" MajorTopicYN="N">Airway Obstruction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001986" MajorTopicYN="N">Bronchial Spasm</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007826" MajorTopicYN="N">Laryngismus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014851" MajorTopicYN="Y">Wakefulness</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23344124</ArticleId><ArticleId IdType="doi">10.1097/EJA.0b013e32835df608</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28974069</PMID><DateCompleted><Year>2018</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children.</ArticleTitle><Pagination><StartPage>150</StartPage><EndPage>157</EndPage><MedlinePgn>150-157</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aex139</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative respiratory adverse events (PRAE) remain the leading cause of morbidity and mortality in the paediatric population. This double-blinded randomized control trial investigated whether inhaled salbutamol premedication decreased the occurrence of PRAE in children identified as being at high risk of PRAE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Children with at least two parentally reported risk factors for PRAE undergoing elective surgery were eligible for recruitment. They were randomized to receive either salbutamol (200 &#xb5;g) or placebo prior to their surgery and PRAE (bronchospasm, laryngospasm, airway obstruction, desaturation, coughing and stridor) were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 470 children (6-16&#x2009;yr, 277 males, 59%) recruited, 462 were available for an intention-to-treat analysis. Thirty-two (14%) and 27 (12%) children from the placebo and salbutamol groups experienced PRAE. This difference was not significant [odds ratio (OR): 0.83, 95% confidence interval (CI): 0.48-1.44, P : 0.51]. Oxygen desaturation [14/232 (6%) vs 14/230 (6%), OR: 1.01, 95% CI: 0.47-2.17, P : 0.98] and severe coughing [12/232 (5%) vs 10/230 (4%), OR: 0.83, 95% CI: 0.35-1.97, P : 0.68] were the most common PRAE, but did not significantly differ between the groups. The occurrence of PRAE was slightly lower in children with respiratory symptoms who received salbutamol compared with placebo [16/134 (12%) vs 21/142 (15%), OR: 0.93, 95% CI: 0.38-2.26, P : 0.87], but was not significantly different.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Premedication with salbutamol to children aged between 6 and 16&#x2009;years and at high risk of PRAE prior to their surgery did not reduce their risk of PRAE.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">ACTRN12612000626864 ( www.anzctr.org.au ).</AbstractText><CopyrightInformation>&#xa9; The Author 2017. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramgolam</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>G L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physiotherapy and Exercise Science, Curtin University.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Child Health Research, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommerfield</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slevin</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drake-Brockman</LastName><ForeName>T F E</ForeName><Initials>TFE</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Public Health, Curtin University; Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ungern-Sternberg</LastName><ForeName>B S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Roberts Road, Perth, WA 6008, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Lung Health, Telethon Kids Institute.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058666">Adrenergic beta-2 Receptor Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>QF8SVZ843E</RegistryNumber><NameOfSubstance UI="D000420">Albuterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058666" MajorTopicYN="N">Adrenergic beta-2 Receptor Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000420" MajorTopicYN="N">Albuterol</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="N">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011292" MajorTopicYN="Y">Premedication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">paediatric population</Keyword><Keyword MajorTopicYN="N">perioperative respiratory adverse events</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">salbutamol</Keyword><Keyword MajorTopicYN="N">&#x3b2;-2 agonist</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28974069</ArticleId><ArticleId IdType="doi">10.1093/bja/aex139</ArticleId><ArticleId IdType="pii">S0007-0912(17)33749-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22221685</PMID><DateCompleted><Year>2012</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2012</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-452X</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>4</Issue><PubDate><Year>2011</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists</Title><ISOAbbreviation>Acta Anaesthesiol Taiwan</ISOAbbreviation></Journal><ArticleTitle>Use of laryngeal mask airway in children with upper respiratory tract infection, compared with face mask: randomized, single blind, clinical trial.</ArticleTitle><Pagination><StartPage>136</StartPage><EndPage>140</EndPage><MedlinePgn>136-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aat.2011.11.008</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The incidence of postoperative cough (primary outcome) and adverse respiratory events (secondary outcome) in children who received anesthesia by laryngeal mask airway (LMA) with children who received anesthesia by face mask (FM) was compared in a blind randomized trial with uncomplicated upper respiratory track infection (URI) undergoing general anesthesia. Previous studies of pediatric patients with URI receiving anesthesia by endotracheal tube have reported a greater number of anesthetic complications; however reports concerning adverse effects in pediatric patients with URI receiving anesthesia by LMA or FM are scanty.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">For the present trial, 150 children with uncomplicated URI and requiring general anesthesia for ophthalmic procedures were enrolled. Once the severity of preoperative URI symptoms was stratified, the children were randomized to receive general anesthesia by FM or LMA. Anesthesia was induced with sevoflurane and nitrous oxide in oxygen (N(2)O in O(2)). Respiratory adverse events were evaluated peri- and post-operatively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The two groups did not differ in age, weight, American Society of Anesthesiologists (ASA) physical status, sex, duration of surgery or severity of URI symptoms. The incidences of cough (19% in LMA vs. 42% in FM), vomiting (4% in LMA vs. 12% in FM) and intervention to maintain the patency of the airway were statistically higher in the FM group (p&lt;0.05). There were no differences between the two groups with respect to the incidences of apnea, laryngospasm, desaturation, bronchospasm, readmission and sore throat.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In children with uncomplicated URI, the administration of inhalation anesthetics in general anesthesia by LMA is likely to cause fewer adverse events than the use of FM.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gharaei</LastName><ForeName>Babak</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Anesthesia Research Center, Shahid Beheshti University of Medical Sciences, Labbafinejad Hospital, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aghamohammadi</LastName><ForeName>Homayoun</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Jafari</LastName><ForeName>Alireza</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Razavi</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Kamranmanesh</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kermany</LastName><ForeName>Alireza Shafiei Poor</ForeName><Initials>AS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>China (Republic : 1949- )</Country><MedlineTA>Acta Anaesthesiol Taiwan</MedlineTA><NlmUniqueID>101214918</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017214" MajorTopicYN="Y">Laryngeal Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008397" MajorTopicYN="Y">Masks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22221685</ArticleId><ArticleId IdType="doi">10.1016/j.aat.2011.11.008</ArticleId><ArticleId IdType="pii">S1875-4597(11)00096-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15846522</PMID><DateCompleted><Year>2006</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0941-4355</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>12</Issue><PubDate><Year>2005</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</Title><ISOAbbreviation>Support Care Cancer</ISOAbbreviation></Journal><ArticleTitle>Use of midazolam and ketamine as sedation for children undergoing minor operative procedures.</ArticleTitle><Pagination><StartPage>1001</StartPage><EndPage>1009</EndPage><MedlinePgn>1001-9</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We used intravenous midazolam and ketamine for children undergoing minor operative procedures with satisfactory results. We aimed to further evaluate its efficacy and adverse effects in pediatric ward setting.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective study of all children undergoing minor operations with sedation in our pediatric general and oncology wards from July 1998 to June 1999. The procedures included lumber puncture+/-intrathecal chemotherapy, bone marrow aspiration+/-trephine biopsy, central venous catheter removal, skin biopsy, or their combination. All sedation procedures were started with midazolam 0.1 mg/kg and ketamine 1 mg/kg; they were increased gradually to 0.4 and 4 mg/kg, respectively, if necessary. Heart rate and SaO2 were continuously monitored.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Altogether, 369 minor operations were performed in 112 patients (male:female=2:1, median age 6 years, range 5 months-17 years). All achieved adequate sedation, with 96% within 30 s and 75% required just the starting dose. Younger children required a higher dosage (p=0.003 for midazolam, p&lt;0.001 for ketamine). The median recovery time was 87 min, with no association with age, sex, or dosage of sedation, but was longer in patients having hallucination (p=0.001). Adverse effects included tachycardia (27.9%), increased secretion (17.6%), agitation (13.6%), nausea and vomiting (9.2%), hallucination (8.7%), desaturation (8.4%), and cataleptic reaction (0.8%). All desaturation episodes were transient and responded to oxygen supplement alone. None developed bronchospasm or convulsion. Some adverse effects were dose-related. Half of the children who received 0.3 mg/kg midazolam developed desaturation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intravenous midazolam-ketamine can provide rapid, effective, and safe sedation for children undergoing minor operations in ward setting. Adverse effects are mild. Midazolam above 0.3 mg/kg should be used with caution.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheuk</LastName><ForeName>D K L</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, 121 Pokfulam Road, Hong Kong, Hong Kong. gcfchan@hkucc.hku.hk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>W H S</ForeName><Initials>WH</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>T L</ForeName><Initials>TL</Initials></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>S Y</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Y L</ForeName><Initials>YL</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>G C F</ForeName><Initials>GC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2005</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Support Care Cancer</MedlineTA><NlmUniqueID>9302957</NlmUniqueID><ISSNLinking>0941-4355</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000778">Anesthetics, Dissociative</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006993">Hypnotics and Sedatives</NameOfSubstance></Chemical><Chemical><RegistryNumber>690G0D6V8H</RegistryNumber><NameOfSubstance UI="D007649">Ketamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>R60L0SM5BC</RegistryNumber><NameOfSubstance UI="D008874">Midazolam</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000778" MajorTopicYN="N">Anesthetics, Dissociative</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016292" MajorTopicYN="Y">Conscious Sedation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006993" MajorTopicYN="N">Hypnotics and Sedatives</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007649" MajorTopicYN="N">Ketamine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008874" MajorTopicYN="N">Midazolam</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013511" MajorTopicYN="Y">Minor Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2005</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>4</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>2</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>4</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15846522</ArticleId><ArticleId IdType="doi">10.1007/s00520-005-0821-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drug Saf. 1996 Mar;14(3):146-57</Citation><ArticleIdList><ArticleId IdType="pubmed">8934577</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Mar 30;342(13):938-45</Citation><ArticleIdList><ArticleId IdType="pubmed">10738053</ArticleId></ArticleIdList></Reference><Reference><Citation>Minerva Anestesiol. 2003 May;69(5):468-71</Citation><ArticleIdList><ArticleId IdType="pubmed">12768186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Emerg Care. 2004 Mar;20(3):162-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15094573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2004 Nov;44(5):460-71</Citation><ArticleIdList><ArticleId IdType="pubmed">15520705</ArticleId></ArticleIdList></Reference><Reference><Citation>Paediatr Anaesth. 1999;9(1):61-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10712717</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1998 Jan;88(1):82-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9447860</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Crit Care Med. 2001 Jan;2(1):20-23</Citation><ArticleIdList><ArticleId IdType="pubmed">12797883</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Med J. 2001 Jan;18(1):39-45</Citation><ArticleIdList><ArticleId IdType="pubmed">11310461</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2001 Mar;107(3):E43</Citation><ArticleIdList><ArticleId IdType="pubmed">11230624</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2000 Jan;35(1):35-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10613938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2000 Mar;35(3):297-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10692201</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Hematol Oncol. 2004 Mar;21(2):161-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15160515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2003 Jul;112(1 Pt 1):116-23</Citation><ArticleIdList><ArticleId IdType="pubmed">12837876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1998 Oct;102(4 Pt 1):956-63</Citation><ArticleIdList><ArticleId IdType="pubmed">9755272</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Anaesth. 1989 Mar;36(2):186-97</Citation><ArticleIdList><ArticleId IdType="pubmed">2650898</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 1997 Jan;15(1):94-102</Citation><ArticleIdList><ArticleId IdType="pubmed">8996129</ArticleId></ArticleIdList></Reference><Reference><Citation>Pain. 1995 Jul;62(1):1-2</Citation><ArticleIdList><ArticleId IdType="pubmed">7478697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2003 Nov;42(5):627-35</Citation><ArticleIdList><ArticleId IdType="pubmed">14581914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1992 Oct;90(4):537-41</Citation><ArticleIdList><ArticleId IdType="pubmed">1408506</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 1980 May;59(5):355-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7189381</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 1983 Nov;55(11):1107-11</Citation><ArticleIdList><ArticleId IdType="pubmed">6639827</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1996 Feb;84(2):459-71</Citation><ArticleIdList><ArticleId IdType="pubmed">8602682</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Emerg Med. 2002 Sep;20(5):463-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12216045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2000 Dec;36(6):579-88</Citation><ArticleIdList><ArticleId IdType="pubmed">11097698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2000 Oct;106(4):633-44</Citation><ArticleIdList><ArticleId IdType="pubmed">11015502</ArticleId></ArticleIdList></Reference><Reference><Citation>J Perianesth Nurs. 2000 Dec;15(6):415-22</Citation><ArticleIdList><ArticleId IdType="pubmed">11811266</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1997 Mar;99(3):427-31</Citation><ArticleIdList><ArticleId IdType="pubmed">9041300</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 1965 May-Jun;6:279-91</Citation><ArticleIdList><ArticleId IdType="pubmed">14296024</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrointest Endosc. 2004 May;59(6):659-63</Citation><ArticleIdList><ArticleId IdType="pubmed">15114309</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Hematol Oncol. 2003 Jun;20(4):291-301</Citation><ArticleIdList><ArticleId IdType="pubmed">12746161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 1999 Oct;34(4 Pt 1):483-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10499949</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pract. 1998 Jan-Feb;52(1):46-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9536569</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Clin Invest. 2003 Nov;33 Suppl 2:17-22</Citation><ArticleIdList><ArticleId IdType="pubmed">14641552</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Med Clin North Am. 1995 May;13(2):357-79</Citation><ArticleIdList><ArticleId IdType="pubmed">7737025</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1998 Nov;26(11):1900-4</Citation><ArticleIdList><ArticleId IdType="pubmed">9824086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 1990 Sep;19(9):1033-46</Citation><ArticleIdList><ArticleId IdType="pubmed">2203290</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trop Pediatr. 2004 Aug;50(4):224-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15357562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1990 Sep;86(3):463-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2388795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 2000 Mar;35(3):229-38</Citation><ArticleIdList><ArticleId IdType="pubmed">10692189</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Nephrol. 1998 Feb;12(2):147-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9543377</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 1992 Jun;89(6 Pt 1):1110-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1594358</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Fam Physician. 1997 Feb 15;55(3):909-16</Citation><ArticleIdList><ArticleId IdType="pubmed">9048510</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Pediatr Adolesc Med. 2003 Nov;157(11):1090-6</Citation><ArticleIdList><ArticleId IdType="pubmed">14609900</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pediatr Gastroenterol Nutr. 2001 Jan;32(1):26-33</Citation><ArticleIdList><ArticleId IdType="pubmed">11176320</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Emerg Care. 1999 Jun;15(3):173-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10389951</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1990 Nov;73(5):826-30</Citation><ArticleIdList><ArticleId IdType="pubmed">2122773</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Emerg Med. 1998 May;31(5):663-677</Citation><ArticleIdList><ArticleId IdType="pubmed">28140125</ArticleId></ArticleIdList></Reference><Reference><Citation>J Child Psychol Psychiatry. 2004 Mar;45(3):609-21</Citation><ArticleIdList><ArticleId IdType="pubmed">15055379</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 1986 Nov;65(5):492-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3777478</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Med (Fremantle). 2001 Mar;13(1):82-90</Citation><ArticleIdList><ArticleId IdType="pubmed">11476419</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17867472</PMID><DateCompleted><Year>2007</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1025-9589</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2007</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>Journal of Ayub Medical College, Abbottabad : JAMC</Title><ISOAbbreviation>J Ayub Med Coll Abbottabad</ISOAbbreviation></Journal><ArticleTitle>Analysis of tracheobronchial foreign bodies with respect to sex, age, type and presentation.</ArticleTitle><Pagination><StartPage>13</StartPage><EndPage>15</EndPage><MedlinePgn>13-5</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Foreign body inhalation is one of the life threatening emergencies. It may happen at any age, however, most of these accidents occur in children especially below the age of five.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective study was done at Department of Otolaryngology, Head and Neck Surgery, Ayub Teaching Hospital, Abbottabad, from 1 January 2003 to 30 June 2005. A total of Eighty one patients, referred from the casualty and Paediatric unit with suspicion of tracheobronchial foreign body were included in the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty one were studied. Fifty (61.7%) were male and thirty one (38.3%) were female. Sixty three (77.8%) were below five years, thirteen (16%) were between five and fifteen years and five (6.2%) were above fifteen years. Sixty seven patients (82.7%), presented mainly with chocking, while fifty nine patients (72.8%) had stridor and forty five patients (55.6%) had cough at initial presentation. Seventy two (88.9%) patients had decreased air entry and forty two (51.9%) had wheeze on auscultation, whereas cyanosis was noticed in five (6.2%) patients. Peanut was the commonest foreign body, retrieved in forty five patients (55.6%). Other foreign bodies were whistle (18.5%), maize seed (13.6%), bean seed (6.2 %), nuts (2.5%), sewing needle with thread, dice and denture (1.2%) each.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Foreign body inhalation is more common in male patients, mostly below five years of age. Chocking is the commonest symptom and decreased air entry on auscultation is the typical examination finding. Peanut has been found to be the commonest type of foreign body.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asif</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of ENT, Gomal Medical College, DI Khan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Shahid Ali</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Farida</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ghani</LastName><ForeName>Rehman</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Ayub Med Coll Abbottabad</MedlineTA><NlmUniqueID>8910750</NlmUniqueID><ISSNLinking>1025-9589</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010367" MajorTopicYN="Y">Arachis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001980" MajorTopicYN="N">Bronchi</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005547" MajorTopicYN="N">Foreign Bodies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005548" MajorTopicYN="N">Foreign-Body Migration</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014132" MajorTopicYN="N">Trachea</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="Y">injuries</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>9</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>11</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>9</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17867472</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31587265</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Respiratory complications after adenotonsillectomy in high-risk children with obstructive sleep apnea: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>292</StartPage><EndPage>300</EndPage><MedlinePgn>292-300</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13488</ELocationID><Abstract><AbstractText Label="BACKGROUND">Obstructive sleep apnea (OSA) occurs in 1%-4% of children; adenotonsillectomy is an effective treatment. Mortality/severe brain injury occurs among 0.6/10&#xa0;000 adenotonsillectomies; in children, 60% are secondary to airway/respiratory events. Earlier studies identified that children aged &lt;2&#xa0;years, extremes of weight, with co-morbidities of craniofacial, neuromuscular, cardiac/respiratory disease, or severe OSA are at high risk for adverse post-operative respiratory events (AE). We aimed to: Firstly, investigate which risk factors were associated with AEs either in the post-anesthesia care unit (PACU), pediatric intensive care unit (PICU), or both in this population. Secondly, we investigated factors associated with post-operative PICU AE despite no event in the PACU in order to predict need of post-operative PICU after their PACU stay.</AbstractText><AbstractText Label="METHODS">Retrospective study of children admitted to the PICU after adenotonsillectomy between 08/2006-09/2015. Demographics, risk factors, and occurrence of AE (oxygen saturation &lt;92, stridor, bronchospasm, pneumonia, pulmonary edema, re-intubation) were recorded.</AbstractText><AbstractText Label="RESULTS">During the studied time period 4029 tonsil/adenoid procedures were performed in 3997 children. 179, admitted to the PICU post-operatively, met criteria for analysis. PICU AEs occurred in 59%: 44%-83% in any particular risk category. PACU AEs occurred in 42%. Of those with PACU events: 92% suffered AEs in the PICU; however, 35% of those without a PACU AE still suffered a PICU AE.</AbstractText><AbstractText Label="CONCLUSIONS">Among high-risk children undergoing TA, absence of adverse events in PACU during a 2-hour observation period does not predict absence of subsequent AEs in the PICU.</AbstractText><CopyrightInformation>&#xa9; 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ekstein</LastName><ForeName>Margaret</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5008-8774</Identifier><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zac</LastName><ForeName>Lilach</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schvartz</LastName><ForeName>Reut</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goren</LastName><ForeName>Or</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiniger</LastName><ForeName>Carolyn F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Intensive Care, and Pain Medicine, Sackler Faculty of Medicine, Tel-Aviv Medical Center, Tel-Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeRowe</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology Head and Neck and Maxillofacial Surgery, Pediatric Otolaryngology Unit, Tel Aviv Medical Center, Dana-Dwek Children's Hospital, Tel Aviv Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fishman</LastName><ForeName>Gad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology Head and Neck and Maxillofacial Surgery, Pediatric Otolaryngology Unit, Tel Aviv Medical Center, Dana-Dwek Children's Hospital, Tel Aviv Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="N">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007557" MajorTopicYN="N" Type="Geographic">Israel</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="N">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">obstructive sleep apnea</Keyword><Keyword MajorTopicYN="N">pediatric tonsillectomy and adenoidectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31587265</ArticleId><ArticleId IdType="doi">10.1111/aas.13488</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Brown KA. Outcome, risk, and error and the child with obstructive sleep apnea. Paediatr Anaesth. 2011;21:771-780.</Citation></Reference><Reference><Citation>Bhattacharyya N, Lin HW. Changes and consistencies in the epidemiology of pediatric adenotonsillar surgery, 1996-2006. Otolaryngol - Head Neck Surg. 2010;143:680-684.</Citation></Reference><Reference><Citation>Parker NP, Walner DL. Trends in the indications for pediatric tonsillectomy or adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2011;75:282-285.</Citation></Reference><Reference><Citation>Trosman I. Childhood obstructive sleep apnea syndrome: A review of the 2012 American Academy of Pediatrics Guidelines. Pediatr Ann. 2013;42:e205-e209.</Citation></Reference><Reference><Citation>Marcus CL, Moore RH, Rosen CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368:2366-2376.</Citation></Reference><Reference><Citation>Urquhart D. Investigation and management of childhood sleep apnoea. Hippokratia. 2013;17:196-202.</Citation></Reference><Reference><Citation>Hill CA, Litvak A, Canapari C, et al. A pilot study to identify pre- and peri-operative risk factors for airway complications following adenotonsillectomy for treatment of severe pediatric OSA. Int J Pediatr Otorhinolaryngol. 2011;75:1385-1390.</Citation></Reference><Reference><Citation>McCormick ME, Sheyn A, Haupert M, Thomas R, Folbe AJ. Predicting complications after adenotonsillectomy in children 3 years old and younger. Int J Pediatr Otorhinolaryngol. 2011;75:1391-1394.</Citation></Reference><Reference><Citation>Kieran S, Gorman C, Kirby A, et al. Risk factors for desaturation after tonsillectomy: analysis of 4092 consecutive pediatric cases. Laryngoscope. 2013;123:2554-2559.</Citation></Reference><Reference><Citation>Roland PS, Rosenfeld RM, Brooks LJ, et al. Clinical practice guideline: Polysomnography for sleep-disordered breathing prior to tonsillectomy in children. Otolaryngol-Head Neck Surg. 2011;145:S1-S15.</Citation></Reference><Reference><Citation>Thongyam A, Marcus CL, Lockman JL, et al. Predictors of perioperative complications in higher risk children after adenotonsillectomy for obstructive sleep apnea: a prospective study. Otolaryngol Head Neck Surg. 2014;151:1046-1054.</Citation></Reference><Reference><Citation>Rosen GM, Muckle RP, Mahowald MW, Goding GS, Ullevig C. Postoperative respiratory compromise in children with obstructive sleep apnea syndrome: can it be anticipated? Pediatrics. 1994;93:784-788.</Citation></Reference><Reference><Citation>Cohen D, Dor M. Morbidity and mortality of post-tonsillectomy bleeding: analysis of cases. J Laryngol Otol. 2008;122:88-92.</Citation></Reference><Reference><Citation>Tweedie DJ, Bajaj Y, Ifeacho SN, et al. Peri-operative complications after adenotonsillectomy in a UK pediatric tertiary referral centre. Int J Pediatr Otorhinolaryngol. 2012;76:809-815.</Citation></Reference><Reference><Citation>Theilhaber M, Arachchi S, Armstrong DS, Davey MJ, Nixon GM. Routine post-operative intensive care is not necessary for children with obstructive sleep apnea at high risk after adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2014;78:744-747.</Citation></Reference><Reference><Citation>Leong AC, Davis JP. Morbidity after adenotonsillectomy for paediatric obstructive sleep apnoea syndrome: waking up to a pragmatic approach. J Laryngol Otol. 2007;121:809-817.</Citation></Reference><Reference><Citation>Rhodes CB, Eid A, Muller G, et al. Postoperative monitoring following adenotonsillectomy for severe obstructive sleep apnea. Ann Otol Rhinol Laryngol. 2018;127:783-790.</Citation></Reference><Reference><Citation>Ye J, Liu H, Zhang G, Huang Z, Huang P, Li Y. Postoperative respiratory complications of adenotonsillectomy for obstructive sleep apnea syndrome in older children: prevalence, risk factors, and impact on clinical outcome. J Otolaryngol Head Neck Surg. 2009;38:49-58.</Citation></Reference><Reference><Citation>Walker P, Whitehead B, Rowley M. Criteria for elective admission to the paediatric intensive care unit following adenotonsillectomy for severe obstructive sleep apnoea. Anaesth Intensive Care. 2004;32:43-46.</Citation></Reference><Reference><Citation>Saur JS, Brietzke SE. Polysomnography results versus clinical factors to predict post-operative respiratory complications following pediatric adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2017;98:136-142.</Citation></Reference><Reference><Citation>Arambula AM, Xie DX, Whigham AS. Respiratory events after adenotonsillectomy requiring escalated admission status in children with obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2018;107:31-36.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40396523</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2515-7949</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of perioperative practice</Title><ISOAbbreviation>J Perioper Pract</ISOAbbreviation></Journal><ArticleTitle>Preoperative nebulised lidocaine for children with mild symptoms of upper respiratory tract infections: A randomised controlled trial.</ArticleTitle><Pagination><StartPage>278</StartPage><EndPage>284</EndPage><MedlinePgn>278-284</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/17504589241276651</ELocationID><Abstract><AbstractText>Nebulised lidocaine was previously used in infants and children undergoing flexible bronchoscopy and was safe and beneficial. The aim of this randomised controlled trial was to assess the impact of preoperative nebulised lidocaine on the incidence of perioperative respiratory adverse events in children aged one to five&#x2009;years proposed for ilioinguinal ambulatory surgery while having mild symptoms of upper respiratory tract infection. Patients were randomly allocated to one of the two groups of the study: Group L (lidocaine) received 4&#x2009;mg/kg of nebulised lidocaine 2% (0.2&#x2009;ml/kg), and Group P (placebo) received 0.2&#x2009;ml/kg of normal saline nebulisation, 30&#x2009;minutes before anaesthesia. Nebulised lidocaine reduced the risk of bronchospasm, with p&#x2009;=&#x2009;0.003 and a risk ratio (RR)&#x2009;=&#x2009;0.326 [0.140-0.760], and prolonged oxygen support postoperatively, with p&#x2009;=&#x2009;0.004 and RR&#x2009;=&#x2009;0.222 [0.067-0.732]. It also reduced the risk of hospitalisation, with p&#x2009;=&#x2009;0.001 and RR&#x2009;=&#x2009;0.138 [0.033-0.577]. No side effects for nebulised lidocaine 2% were noted. Preoperative nebulised lidocaine seems to be a safe and efficient premedication for children with upper respiratory tract infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jarraya</LastName><ForeName>Anouar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4488-5491</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammoun</LastName><ForeName>Manel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherif</LastName><ForeName>Olfa</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khcherem</LastName><ForeName>Jaouhar</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhedi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatric Anaesthesia, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mhiri</LastName><ForeName>Riadh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Paediatric Surgery, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Perioper Pract</MedlineTA><NlmUniqueID>101271023</NlmUniqueID><ISSNLinking>1750-4589</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="Y">Anesthetics, Local</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="Y">Lidocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009330" MajorTopicYN="N">Nebulizers and Vaporizers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="Y">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anaesthetics&#x2013;management and care</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Paediatric surgery</Keyword><Keyword MajorTopicYN="N">Patient safety</Keyword><Keyword MajorTopicYN="N">Risk management</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>7</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40396523</ArticleId><ArticleId IdType="doi">10.1177/17504589241276651</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39844310</PMID><DateRevised><Year>2025</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-0525</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>Perioperative medicine (London, England)</Title><ISOAbbreviation>Perioper Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>The effect of continuous positive airway pressure (CPAP) application on airway problems in pediatric patients with subglottic stenosis who undergo balloon dilatation.</ArticleTitle><Pagination><StartPage>10</StartPage><MedlinePgn>10</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13741-024-00478-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Subglottic stenosis is a significant clinical challenge in pediatric anesthesia, often necessitating interventions that can lead to various postoperative complications. The aim of this study was to determine the effect of prophylactic continuous positive airway pressure (CPAP) application on recovery time and airway complications in pediatric patients with subglottic stenosis undergoing balloon dilatation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective, double-blinded, parallel-group, randomized controlled study was conducted at Health Sciences University &#xdc;mraniye Training and Research Hospital on pediatric patients with subglottic stenosis, aged from 0 to 12&#xa0;years and who underwent elective balloon dilatation under general anesthesia. Patients were randomized in a 1:1 ratio into the CPAP or non-CPAP group. The primary outcome was the duration of recovery time. Secondary outcomes included bronchospasm, the number of desaturation episodes, intubation, tracheostomy, and the need for intensive care.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 84 patients were enrolled in this randomized controlled trial, 81 of which received the allocated treatment and were analyzed (non-CPAP n&#x2009;=&#x2009;41, CPAP n&#x2009;=&#x2009;40). Compared to controls, the proportions of bronchospasm, tracheal secretion, need for intensive care, and tracheostomy were consistently lower in the CPAP group, whereas the requirement of intubation was higher. Further, the mean recovery time was significantly shorter in the CPAP group compared to the non-CPAP group (mean difference&#x2009;-&#x2009;3.3&#xa0;min, 95%CI&#x2009;-&#x2009;5.16 to&#x2009;-&#x2009;1.44, p&#x2009;=&#x2009;0.0007). Despite lacking statistical significance, the CPAP group had reduced odds of developing bronchospasm, tracheal secretion, need for intensive care, and tracheostomy, but higher odds of requiring intubation when compared to the controls.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Prophylactic CPAP application following therapeutic balloon dilatation in pediatric patients who have developed subglottic stenosis due to acquired or congenital causes appears to effectively shorten recovery time and may have a role in decreasing postoperative pulmonary complications; however, more research is recommended to further confirm these findings.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">The protocol for this clinical trial was retrospectively registered on clinicaltrials.gov with registration ID NCT06183515 on 30 November 2023.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tuncel</LastName><ForeName>Zeliha</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Reanimation, &#xdc;mraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;ksu</LastName><ForeName>&#x15e;enay</ForeName><Initials>&#x15e;</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Reanimation, &#xdc;mraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delig&#xf6;z</LastName><ForeName>&#xd6;zlem</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Reanimation, Haydarpa&#x15f;a Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Kemal Tolga</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU, and Perioperative Medicine, Hazm Mebaireek General Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albasha</LastName><ForeName>Abdulatif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU, and Perioperative Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdallah</LastName><ForeName>Bushra M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saracoglu</LastName><ForeName>Ayten</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine, QU Health, Qatar University, Doha, Qatar. saracogluayten@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, ICU, and Perioperative Medicine, Aisha Bint Hamad Al-Attiyah Hospital, Hamad Medical Corporation, Doha, Qatar. saracogluayten@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06183515</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perioper Med (Lond)</MedlineTA><NlmUniqueID>101609072</NlmUniqueID><ISSNLinking>2047-0525</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Apneic ventilation</Keyword><Keyword MajorTopicYN="N">CPAP</Keyword><Keyword MajorTopicYN="N">Pediatric airway</Keyword><Keyword MajorTopicYN="N">Subglottic stenosis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval consent to participate: The study protocol received ethical approval from the Umraniye Training and Research Hospital Ethics Committee with decision number 35 dated 16th of December 2021 (approval number: B.10.1.TKH.4.34.H.GP.0.01/352). Before the conduct of the study or any study-related procedures, written informed consent was obtained from all legal guardians of the participants. The study was designed following the Declaration of Helsinki defined in 2013. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>23</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39844310</ArticleId><ArticleId IdType="pmc">PMC11756109</ArticleId><ArticleId IdType="doi">10.1186/s13741-024-00478-5</ArticleId><ArticleId IdType="pii">10.1186/s13741-024-00478-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdel-Ghaffar HS, Youseff HA, Abdelal FA, Osman MA, Sayed JA, Riad MAF, Abdel-Rady MM. Post-extubation continuous positive airway pressure improves oxygenation after pediatric laparoscopic surgery: A randomized controlled trial. Acta Anaesthesiol Scand. 2019;63(5):620&#x2013;9. 10.1111/aas.13324.</Citation><ArticleIdList><ArticleId IdType="pubmed">30761530</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta CM, Lopez Vargas MP, Oropel F, Valente L, Ricci L, Natal M, Suarez Sipmann F, Tusman G. Prevention of atelectasis by continuous positive airway pressure in anaesthetised children: A randomised controlled study. Eur J Anaesthesiol. 2021;38(1):41&#x2013;8. 10.1097/EJA.0000000000001351.</Citation><ArticleIdList><ArticleId IdType="pubmed">33009190</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonasso PC, Dassinger MS, Ryan ML, Gowen MS, Burford JM, Smith SD. 24-h and 30-days perioperative mortality in pediatric surgery. J Pedriatr Surg. 2019;54:628&#x2013;30. 10.1016/j.jpedsurg.2018.06.026.</Citation><ArticleIdList><ArticleId IdType="pubmed">30017066</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantarella G, Gaffuri M, Torretta S, Neri S, Ambrosini MT, D&#x2019;Onghia A, Pignataro L, Sandu K. Outcomes of balloon dilation for paediatric laryngeal stenosis. Acta Otorhinolaryngol Ital. 2020;40(5):360&#x2013;7. 10.14639/0392-100X-N0830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726638</ArticleId><ArticleId IdType="pubmed">33299226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M, Bimonte S, Di Napoli R. Delayed Emergence from Anesthesia: What We Know and How We Act. Local Reg Anesth. 2020;13:195&#x2013;206. 10.2147/LRA.S230728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652217</ArticleId><ArticleId IdType="pubmed">33177867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccozzi A, Pizzi B, Vittori A, Piroli A, Marrocco G, Della Vecchia F, Cascella M, Petrucci E, Marinangeli F. The perioperative anesthetic management of the pediatric patient with special needs: an overview of literature. Children (Basel). 2022;9(10):1438. 10.3390/children9101438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9600107</ArticleId><ArticleId IdType="pubmed">36291372</ArticleId></ArticleIdList></Reference><Reference><Citation>Frykholm P, Disma N, Andersson H, Beck C, Bouvet L, Cercueil E, Elliott E, Hofmann J, Isserman R, Klaucane A, Kuhn F, de Queiroz SM, Rosen D, Rudolph D, Schmidt AR, Schmitz A, Stocki D, S&#xfc;mpelmann R, Stricker PA, Thomas M, Veyckemans F, Afshari A. Pre-operative fasting in children: A guideline from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol. 2022;39(1):4&#x2013;25. 10.1097/EJA.0000000000001599.</Citation><ArticleIdList><ArticleId IdType="pubmed">34857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gungor A. Balloon dilation of the pediatric airway: potential for disaster. Am J Otolaryngol. 2012;33(1):147&#x2013;9. 10.1016/j.amjoto.2011.05.004.</Citation><ArticleIdList><ArticleId IdType="pubmed">21784553</ArticleId></ArticleIdList></Reference><Reference><Citation>Habre W, Disma N, Virag K, Becke K, Hansen TG, J&#xf6;hr M, Leva B, Morton NS, Vermeulen PM, Zielinska M, Boda K, Veyckemans F. APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med. 2017;5:412 &#x2013; 425. 10.1016/S2213-2600(17)30116-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28363725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hautefort C, Teissier N, Viala P, Van Den Abbeele T. Balloon dilation laryngoplasty for subglottic stenosis in children: eight years&#x2019; experience. Arch Otolaryngol Head Neck Surg. 2012;138(3):235&#x2013;40. 10.1001/archoto.2011.1439.</Citation><ArticleIdList><ArticleId IdType="pubmed">22351854</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys S, von Ungern-Sternberg BS, Skowno J, Williams T, Taylor J, Taverner F, Gibbons K, Burgoyne L, Sommerfield D, Stephens P, Hallett B, Vijayasekaran S, Slee N, Burns H, Sowa M, Davidson A, Schibler A. High-flow oxygen for children&#x2019;s airway surgery: randomised controlled trial protocol (HAMSTER). BMJ Open. 2019;9: e031873. 10.1136/bmjopen-2019-031873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6797255</ArticleId><ArticleId IdType="pubmed">31615801</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer NP, Rotta AT, Essouri S, Fioretto JR, Craven HJ, Whipple EC, Ramnarayan P, Abu-Sultaneh S, Khemani RG. Association of extubation failure rates with high-flow nasal cannula, continuous positive airway pressure, and bilevel positive airway pressure vs conventional oxygen therapy in infants and young children: a systematic review and network meta-analysis. JAMA Pediatr. 2023;177(8):774&#x2013;81. 10.1001/jamapediatrics.2023.1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10242512</ArticleId><ArticleId IdType="pubmed">37273226</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Duke T, Chisti MJ, Kepreotes E, Kalinowski V, Li J. Efficacy of high-flow nasal cannula vs standard oxygen therapy or nasal continuous positive airway pressure in children with respiratory distress: a meta-analysis. J Pediatr. 2019;215:199&#x2013;208.e8. 10.1016/j.jpeds.2019.07.059.</Citation><ArticleIdList><ArticleId IdType="pubmed">31570155</ArticleId></ArticleIdList></Reference><Reference><Citation>Misal US, Joshi SA, Shaikh MM. Delayed recovery from anesthesia: a postgraduate educational review. Anesth Essays Res. 2016;10(2):164&#x2013;72. 10.4103/0259-1162.165506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4864680</ArticleId><ArticleId IdType="pubmed">27212741</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Hopewell S, Schulz KF, Montori V, G&#xf8;tzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;23(340): c869. 10.1136/bmj.c869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844943</ArticleId><ArticleId IdType="pubmed">20332511</ArticleId></ArticleIdList></Reference><Reference><Citation>Percul C, Lerendegui L, Lobos P, Liberto D, Moldes J, Urquizo MM. Association between subglottic stenosis and endotracheal intubation in tracheostomized pediatric patients. Cir Pediatr. 2023;36(3):110&#x2013;5. 10.54847/cp.2023.03.10.</Citation><ArticleIdList><ArticleId IdType="pubmed">37417214</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell S, Keltie K, Burn J, Cole H, Donne A, Morrison G, Stephenson K, Daniel M, Gupta S, Wyatt M, Patrick H, Sims A. Balloon dilatation for paediatric airway stenosis: Evidence from the UK Airway Intervention Registry. Clin Otolaryngol. 2020;45(3):334&#x2013;41. 10.1111/coa.13492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7317836</ArticleId><ArticleId IdType="pubmed">31845458</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials BMJ 2010 340 c33210.1136/bmj.c332</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844940</ArticleId><ArticleId IdType="pubmed">20332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva CR, Andrade LB, Maux DA, Bezerra AL, Duarte MC. Effectiveness of prophylactic non-invasive ventilation on respiratory function in the postoperative phase of pediatric cardiac surgery: a randomized controlled trial. Braz J Phys Ther. 2016;20(6):494&#x2013;501. 10.1590/bjpt-rbf.2014.0191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5176203</ArticleId><ArticleId IdType="pubmed">27706462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuzuner A, Bas C, Jafarov S, Bahcecitapar M, Aydin E. Respiratory problems and associated factors following endoscopic balloon dilatation procedure in children with acquired subglottic stenos&#x131;s. Eur Arch Otorhinolaryngol. 2022;279(5):2493&#x2013;500. 10.1007/s00405-021-07208-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">35037169</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191&#x2013;4. 10.1001/jama.2013.281053.</Citation><ArticleIdList><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Zeng X, Wang T, Dong B, Wu M, Jia A, Ye L. Early versus delayed postoperative oral hydration in children following general anesthesia: a prospective randomized trial. BMC Anesthesiol. 2020;20(1):174. 10.1186/s12871-020-01086-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7368717</ArticleId><ArticleId IdType="pubmed">32682394</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25909156</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1806-3756</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Season>May-Jun</Season></PubDate></JournalIssue><Title>Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia</Title><ISOAbbreviation>J Bras Pneumol</ISOAbbreviation></Journal><ArticleTitle>Risk factors for respiratory complications after adenotonsillectomy in children with obstructive sleep apnea.</ArticleTitle><Pagination><StartPage>238</StartPage><EndPage>245</EndPage><MedlinePgn>238-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1590/S1806-37132015000004415</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1806-37132015005004415</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify risk factors for respiratory complications after adenotonsillectomy in children &#x2264; 12 years of age with obstructive sleep apnea who were referred to the pediatric ICU (PICU).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional historical cohort study analyzing 53 children after adenotonsillectomy who met predetermined criteria for PICU referral in a tertiary level teaching hospital. The Student's t-test, Mann-Whitney test, and chi-square test were used to identify risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 805 children undergoing adenotonsillectomy between January of 2006 and December of 2012 in the teaching hospital, 53 were referred to the PICU. Twenty-one children (2.6% of all those undergoing adenotonsillectomy and 39.6% of those who were referred to the PICU) had respiratory complications. Of those 21, 12 were male. The mean age was 5.3 &#xb1; 2.6 years. A high apnea-hypopnea index (AHI; p = 0.0269), a high oxygen desaturation index (ODI; p = 0.0082), a low SpO2 nadir (p = 0.0055), prolonged orotracheal intubation (p = 0.0011), and rhinitis (p = 0.0426) were found to be independent predictors of respiratory complications. Some of the complications observed were minor (SpO2 90-80%), whereas others were major (SpO2 &#x2264; 80%, laryngospasm, bronchospasm, acute pulmonary edema, pneumonia, and apnea).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among children up to 12 years of age with OSA, those who have a high AHI, a high ODI, a low SpO2 nadir, or rhinitis are more likely to develop respiratory complications after adenotonsillectomy than are those without such characteristics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Renato Oliveira</ForeName><Initials>RO</Initials><AffiliationInfo><Affiliation>School of Medicine, S&#xe3;o Paulo State University Botucatu, Botucatu, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castello-Branco</LastName><ForeName>Nuria</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Medicine, University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Jefferson Luis de</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Botucatu School of Medicine, S&#xe3;o Paulo State University, Botucatu, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Silke Anna Theresa</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Botucatu School of Medicine, S&#xe3;o Paulo State University, Botucatu, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>J Bras Pneumol</MedlineTA><NlmUniqueID>101222274</NlmUniqueID><ISSNLinking>1806-3713</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000233" MajorTopicYN="N">Adenoidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017286" MajorTopicYN="N">Polysomnography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012120" MajorTopicYN="N">Respiration Disorders</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020181" MajorTopicYN="N">Sleep Apnea, Obstructive</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014068" MajorTopicYN="N">Tonsillectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="OBJETIVO:">Identificar fatores de risco para complica&#xe7;&#xf5;es respirat&#xf3;rias ap&#xf3;s adenotonsilectomia em crian&#xe7;as &#x2264; 12 anos com apneia obstrutiva do sono encaminhadas &#xe0; UTI pedi&#xe1;trica (UTIP).</AbstractText><AbstractText Label="M&#xc9;TODOS:">Estudo de coorte hist&#xf3;rica com corte transversal que analisou 53 crian&#xe7;as ap&#xf3;s adenotonsilectomia que preencheram os crit&#xe9;rios pr&#xe9;-estabelecidos para encaminhamento &#xe0; UTIP em um hospital escola de n&#xed;vel terci&#xe1;rio. Foram utilizados o teste t de Student, o teste de Mann-Whitney e o teste do qui-quadrado para identificar os fatores de risco.</AbstractText><AbstractText Label="RESULTADOS:">Das 805 crian&#xe7;as submetidas &#xe0; adenotonsilectomia entre janeiro de 2006 e dezembro de 2012 no hospital escola, 53 foram encaminhadas &#xe0; UTIP. Vinte e uma crian&#xe7;as (2,6% do total de submetidas &#xe0; adenotonsilectomia e 39,6% das que foram encaminhadas &#xe0; UTIP) apresentaram complica&#xe7;&#xf5;es respirat&#xf3;rias, sendo 12 do g&#xea;nero masculino e a idade m&#xe9;dia de 5,3 &#xb1; 2,6 anos. Maior &#xed;ndice de apneia-hipopneia (IAH; p = 0,0269), maior &#xed;ndice de dessatura&#xe7;&#xe3;o de oxig&#xea;nio (IDO; p = 0,0082), baixo nadir da SpO<sub>2</sub> (p = 0,0055), maior tempo de intuba&#xe7;&#xe3;o orotraqueal (p = 0,0011) e rinopatia (p = 0,0426) foram preditores independentes de complica&#xe7;&#xf5;es respirat&#xf3;rias. Foram observadas complica&#xe7;&#xf5;es respirat&#xf3;rias menores (SpO<sub>2</sub> entre 90-80%) e maiores (SpO<sub>2</sub> &#x2264; 80%, laringoespasmos, broncoespasmos, edema agudo de pulm&#xe3;o, pneumonia e apneia).</AbstractText><AbstractText Label="CONCLUS&#xd5;ES:">Em crian&#xe7;as de at&#xe9; 12 anos e com apneia obstrutiva do sono, aquelas que t&#xea;m maior IAH, maior IDO, menor nadir da SpO<sub>2</sub> e/ou rinopatia s&#xe3;o mais predispostas a desenvolver complica&#xe7;&#xf5;es respirat&#xf3;rias ap&#xf3;s adenotonsilectomia do que aquelas sem essas caracter&#xed;sticas.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25909156</ArticleId><ArticleId IdType="pmc">PMC4541759</ArticleId><ArticleId IdType="doi">10.1590/S1806-37132015000004415</ArticleId><ArticleId IdType="pii">S1806-37132015005004415</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baugh RF, Archer SM, Mitchell RB, Rosenfeld RM, Amin R, Burns JJ. Clinical practice guideline: tonsillectomy in children. Otolaryngol Head Neck Surg. 2011;144:S1&#x2013;30. doi: 10.1177/0194599810389949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599810389949</ArticleId><ArticleId IdType="pubmed">21493257</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldbart AD, Levitas A, Greenberg-Dotan S, Ben Shimol S, Broides A, Puterman M. B-type natriuretic peptide and cardiovascular function in young children with obstructive sleep apnea. Chest. 2010;138(3):528&#x2013;535. doi: 10.1378/chest.10-0150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-0150</ArticleId><ArticleId IdType="pubmed">20558551</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Springer C, Perles Z, Koplewitz BZ, Avital A, Revel-Vilk S. Cardiac, lung, and brain thrombosis in a child with obstructive sleep apnea. Pediatr Pulmonol. 2010;45(8):836&#x2013;839. doi: 10.1002/ppul.21256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.21256</ArticleId><ArticleId IdType="pubmed">20597078</ArticleId></ArticleIdList></Reference><Reference><Citation>Freezer NJ, Bucens IK, Robertson CF. Obstructive sleep apnoea presenting as failure to thrive in infancy. J Paediatr Child Health. 1995;31(3):172&#x2013;175. doi: 10.1111/j.1440-1754.1995.tb00779.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1754.1995.tb00779.x</ArticleId><ArticleId IdType="pubmed">7669373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld RM, Green RP. Tonsillectomy and adenoidectomy: changing trends. Pt 1Ann Otol Rhinol Laryngol. 1990;99(3):187&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">2178542</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson BK, Larson DR, St Sauver JL, Meverden RA, Orvidas LJ. Changes in incidence and indications of tonsillectomy and adenotonsillectomy, 1970-2005. Otolaryngol Head Neck Surg. 2009;140(6):894&#x2013;901. doi: 10.1016/j.otohns.2009.01.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otohns.2009.01.044</ArticleId><ArticleId IdType="pubmed">19467411</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran KD, Nguyen CD, Weedon J, Goldstein NA. Child behavior and quality of life in pediatric obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 2005;131(1):52&#x2013;57. doi: 10.1001/archotol.131.1.52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.131.1.52</ArticleId><ArticleId IdType="pubmed">15655186</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigger MT, Brietzke SE. Outpatient tonsillectomy in children: a systematic review. Otolaryngol Head Neck Surg. 2006;135(1):1&#x2013;7. doi: 10.1016/j.otohns.2006.02.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otohns.2006.02.036</ArticleId><ArticleId IdType="pubmed">16815173</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen GM, Muckle RP, Mahowald MW, Goding GS, Ullevig C. Postoperative respiratory compromise in children with obstructive sleep apnea syndrome: can it be anticipated? Pediatrics. 1994;93(5):784&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">8165079</ArticleId></ArticleIdList></Reference><Reference><Citation>McColley SA, April MM, Carroll JL, Naclerio RM, Loughlin GM. Respiratory compromise after adenotonsillectomy in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992;118(9):940&#x2013;943. doi: 10.1001/archotol.1992.01880090056017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.1992.01880090056017</ArticleId><ArticleId IdType="pubmed">1503720</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson K, Lakheeram I, Morielli A, Brouillette R, Brown K. Can assessment for obstructive sleep apnea help predict postadenotonsillectomy respiratory complications. Anesthesiology. 2002;96(2):313&#x2013;322. doi: 10.1097/00000542-200202000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200202000-00015</ArticleId><ArticleId IdType="pubmed">11818762</ArticleId></ArticleIdList></Reference><Reference><Citation>Tweedie DJ, Bajaj Y, Ifeacho SN, Jonas NE, Jephson CG, Cochrane LA. Peri-operative complications after adenotonsillectomy in a UK pediatric tertiary referral centre. Int J Pediatr Otorhinolaryngol. 2012;76(6):809&#x2013;815. doi: 10.1016/j.ijporl.2012.02.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2012.02.048</ArticleId><ArticleId IdType="pubmed">22469495</ArticleId></ArticleIdList></Reference><Reference><Citation>Biavati MJ, Manning SC, Phillips DL. Predictive factors for respiratory complications after tonsillectomy and adenoidectomy in children. Arch Otolaryngol Head Neck Surg. 1997;123(5):517&#x2013;521. doi: 10.1001/archotol.1997.01900050067009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.1997.01900050067009</ArticleId><ArticleId IdType="pubmed">9158400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra M, Buncher R, Amin RS. Asthma as a risk factor for respiratory complications after adenotonsillectomy in children with obstructive breathing during sleep. Ann Allergy Asthma Immunol. 2005;94(5):549&#x2013;552. doi: 10.1016/S1081-1206(10)61132-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1081-1206(10)61132-5</ArticleId><ArticleId IdType="pubmed">15945558</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaryszak EM, Shah RK, Vanison CC, Lander L, Choi SS. Polysomnographic variables predictive of adverse respiratory events after pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg. 2011;137(1):15&#x2013;18. doi: 10.1001/archoto.2010.226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archoto.2010.226</ArticleId><ArticleId IdType="pubmed">21242540</ArticleId></ArticleIdList></Reference><Reference><Citation>Suen JS, Arnold JE, Brooks LJ. Adenotonsillectomy for treatment of obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg. 1995;121(5):525&#x2013;530. doi: 10.1001/archotol.1995.01890050023005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.1995.01890050023005</ArticleId><ArticleId IdType="pubmed">7727086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill CA, Litvak A, Canapari C, Cummings B, Collins C, Keamy DG. A pilot study to identify pre- and peri-operative risk factors for airway complications following adenotonsillectomy for treatment of severe pediatric OSA. Int J Pediatr Otorhinolaryngol. 2011;75(11):1385&#x2013;1390. doi: 10.1016/j.ijporl.2011.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2011.07.034</ArticleId><ArticleId IdType="pubmed">21871668</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick ME, Sheyn A, Haupert M, Thomas R, Folbe AJ. Predicting complications after adenotonsillectomy in children 3 years old and younger. Int J Pediatr Otorhinolaryngol. 2011;75(11):1391&#x2013;1394. doi: 10.1016/j.ijporl.2011.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2011.07.035</ArticleId><ArticleId IdType="pubmed">21889216</ArticleId></ArticleIdList></Reference><Reference><Citation>Shine NP, Coates HL, Lannigan FJ, Duncan AW. Adenotonsillar surgery in morbidly obese children: routine elective admission of all patients to the intensive care unit is unnecessary. Anaesth Intensive Care. 2006;34(6):724&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">17183889</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KA, Morin I, Hickey C, Manoukian JJ, Nixon GM, Brouillette RT. Urgent adenotonsillectomy: an analysis of risk factors associated with postoperative respiratory morbidity. Anesthesiology. 2003;99(3):586&#x2013;595. doi: 10.1097/00000542-200309000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200309000-00013</ArticleId><ArticleId IdType="pubmed">12960542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruboyianes JM, Cruz RM. Pediatric adenotonsillectomy for obstructive sleep apnea. Ear Nose Throat J. 1996;75(7):430&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">8764705</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafiu OO, Green GE, Walton S, Morris M, Reddy S, Tremper KK. Obesity and risk of peri-operative complications in children presenting for adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2009;73(1):89&#x2013;95. doi: 10.1016/j.ijporl.2008.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2008.09.027</ArticleId><ArticleId IdType="pubmed">18996603</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung E, Cave D, Witmans M, Gan K, El-Hakim H. Postoperative respiratory complications and recovery in obese children following adenotonsillectomy for sleep-disordered breathing: a case-control study. Otolaryngol Head Neck Surg. 2010;142(6):898&#x2013;905. doi: 10.1016/j.otohns.2010.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.otohns.2010.02.012</ArticleId><ArticleId IdType="pubmed">20493365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleich SJ, Olson MD, Sprung J, Weingarten TN, Schroeder DR, Warner DO. Perioperative outcomes of severely obese children undergoing tonsillectomy. Paediatr Anaesth. 2012;22(12):1171&#x2013;1178. doi: 10.1111/j.1460-9592.2012.03905.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2012.03905.x</ArticleId><ArticleId IdType="pmc">PMC3470734</ArticleId><ArticleId IdType="pubmed">22776351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra M, Kimball TR, Daniels SR, LeMasters G, Willging PJ, Rutter M. Structural cardiac changes as a predictor of respiratory complications after adenotonsillectomy for obstructive breathing during sleep in children. Sleep Med. 2005;6(3):241&#x2013;245. doi: 10.1016/j.sleep.2004.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2004.10.004</ArticleId><ArticleId IdType="pubmed">15854854</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder JW, Jr, Anstead AS, Wong H. Complications in children who electively remain intubated after adenotonsillectomy for severe obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2009;73(8):1095&#x2013;1099. doi: 10.1016/j.ijporl.2009.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijporl.2009.04.007</ArticleId><ArticleId IdType="pubmed">19467719</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozal D, Burnside MM. Increased upper airway collapsibility in children with obstructive sleep apnea during wakefulness. Am J Respir Crit Care Med. 2004;169(2):163&#x2013;167. doi: 10.1164/rccm.200304-590OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200304-590OC</ArticleId><ArticleId IdType="pubmed">14525806</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus CL, McColley SA, Carroll JL, Loughlin GM, Smith PL, Schwartz AR. Upper airway collapsibility in children with obstructive sleep apnea syndrome. J Appl Physiol (1985) 1994;77(2):918&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">8002548</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown KA, Laferri&#xe8;re A, Moss IR. Recurrent hypoxemia in young children with obstructive sleep apnea is associated with reduced opioid requirement for analgesia. Anesthesiology. 2004;100(4):806&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">15087614</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters KA, McBrien F, Stewart P, Hinder M, Wharton S. Effects of OSA, inhalational anesthesia, and fentanyl on the airway and ventilation of children. J Appl Physiol (1985) 2002;92(5):1987&#x2013;1994.</Citation><ArticleIdList><ArticleId IdType="pubmed">11960949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>